UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K


(Mark One)

/X/ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 1997

/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 1-1011

CVS CORPORATION
(Exact name of registrant as specified in its charter)


              Delaware                            05-0494040
    (State or other jurisdiction               (I.R.S. Employer
  of incorporation or organization)           Identification No.)

          One CVS Drive
      Woonsocket, Rhode Island                       02895
(Address of principal executive offices)           (Zip Code)

Registrant's telephone number, including area code: (401) 765-1500

Securities registered pursuant to Section 12(b) of the Exchange Act:

  Title of each class                Name of each exchange on which registered
-----------------------              -----------------------------------------
Common Stock, par value
  $.01 per share                                New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Exchange Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]

The aggregate market value of the registrant's voting stock* held by non-affiliates** of the registrant (without admitting that any person whose shares are not included in such calculation is an affiliate) on March 2, 1998 was approximately $12,669,785,088, based on the last sale price as reported by the New York Stock Exchange.

As of March 2, 1998, the registrant had 172,557,470 shares of Common Stock outstanding.


* Does not include 5,324,504 outstanding shares of Series One ESOP Convertible Preference Stock ("ESOP Preference Stock"). As of March 2, 1998, each share of ESOP Preference Stock is entitled to 1.2 votes per share on all matters submitted to a vote of the holders of Common Stock.

** Only voting stock held by directors and executive officers is excluded.


DOCUMENTS INCORPORATED BY REFERENCE

The following documents (or parts thereof) are incorporated by reference into this Annual Report on Form 10-K: certain information required in Part II, Items 6, 7 and 8; and Part IV, Item 14 of this Annual Report on Form 10-K is incorporated from the Registrant's Annual Report to Shareholders for the year ended December 31, 1997; certain information required in Part III, Items 10, 11, 12 and 13 of this Annual Report on Form 10-K is incorporated by reference to the Registrant's Proxy Statement for the 1998 Annual Meeting of Stockholders, to be held on May 13, 1998.


PART I

ITEM 1. BUSINESS

GENERAL

CVS Corporation, a Delaware corporation ("CVS" or the "Company"), is a leader in the chain drugstore industry in the United States, with over $12.7 billion in revenue in 1997. Additionally, as of December 31, 1997, the Company operated 3,888 stores in 24 states in the Northeast, Mid-Atlantic, Midwest and Southeast regions and in the District of Columbia, making CVS one of the largest drugstore chains in the nation in terms of store count. The Company's stores are well positioned, operating in 48 of the top 100 drugstore markets in the country. CVS commands the number one or two share position in approximately 80% of these markets. CVS also is among the industry leaders in terms of store productivity and operating profit margin.

A primary focus of the Company's operations is its pharmacy business, which represented approximately 54% of total sales for the year. In 1997, the Company dispensed over 225 million prescriptions, making it the largest drugstore chain in the United States in terms of prescriptions filled and pharmacy sales. The Company believes that its pharmacy operations will continue to represent a critical part of its business and strategy due to favorable trends, including an aging American population, greater responsibility being borne by Americans for their healthcare, an increasing demand for retail formats that provide easy access and convenience, discovery of new and better drug therapies, and the need for cost effective healthcare solutions.

In addition to prescription drugs and services, the Company offers a broad selection of general merchandise, presented in a well-organized fashion, in stores that are designed to be warm, inviting and easy to shop. Merchandise categories include, among other things, over-the-counter drugs, greeting cards, film and photo-finishing services, beauty and cosmetics, seasonal merchandise and convenience foods. The Company also offers over 1,300 products under the CVS private label brand, which accounted for approximately 11% of the Company's front store sales in 1997. Total front store sales, which are generally higher margin than pharmacy sales, represented approximately 46% of total sales for the year.

The Company's principal executive offices are located at One CVS Drive, Woonsocket, Rhode Island 02895, telephone (401) 765-1500. As of December 31, 1997, the Company and its subsidiaries had approximately 90,000 employees.

CVS STRATEGIC RESTRUCTURING PROGRAM

In October 1995, the Board of Directors approved a comprehensive restructuring plan that was the product of a strategic review initiated in 1994. The purpose of the restructuring plan was, among other things, to enhance stockholder value by transforming Melville Corporation ("Melville") from a diversified retailer with a wide range of specialty retail businesses into an industry-focused retail healthcare company, CVS. The restructuring plan included, among other things:

(i) the continued operation of CVS (which would include CVS and, initially, Linens 'n Things and Bob's Stores);

(ii) the disposal of Marshalls, Kay-Bee Toys, Wilsons and This End Up;

(iii) the spinoff of Footstar, Inc. (the holding company for Meldisco, Footaction and Thom McAn); and

(iv) the elimination of certain corporate overhead costs.

In May 1996, the Board of Directors approved further refinements to the restructuring plan. The refinements included: (i) a formal plan to separate Linens 'n Things and Bob's Stores from CVS; and (ii) a formal plan to convert 80 to 100 Thom McAn stores to the Footaction format and to sell or close the remaining Thom McAn stores, and thereby exit the Thom McAn business by mid-1997.

On November 20, 1996, following shareholder approval, CVS, a newly-formed Delaware corporation, became the new holding company for Melville (which is a New York corporation) and its subsidiaries. This was accomplished by merging a

1

special purpose subsidiary of CVS with and into Melville, with Melville surviving such merger and becoming a wholly-owned subsidiary of CVS.

For more information regarding the Company's strategic restructuring program, see Note 3 of Notes to Consolidated Financial Statements.

ACQUISITION OF REVCO D.S., INC.

On May 29, 1997, CVS completed its acquisition of Revco D.S., Inc. ("Revco") pursuant to a stock-for-stock merger that was tax free to Revco's stockholders. The merger was accounted for as a pooling of interests.

The merger resulted in CVS becoming one of the largest chain drugstore companies in the United States based on store count, with approximately 4,000 stores in 24 states and the District of Columbia. Pursuant to a consent decree with the Federal Trade Commission entered into in connection with the merger, the Company divested 120 Revco stores during 1997, primarily in the Tidewater area of Virginia.

In the merger, each outstanding share of Revco common stock was exchanged for 0.8842 of a share of CVS common stock, resulting in CVS issuing an aggregate of approximately 60.3 million shares of its common stock. In addition, outstanding Revco stock options were converted at the same exchange ratio into options to purchase approximately 3.3 million shares of CVS common stock.

AGREEMENT TO ACQUIRE ARBOR DRUGS, INC.

On February 8, 1998, CVS entered into an Agreement and Plan of Merger with Arbor Drugs, Inc. ("Arbor"). Under the terms of the merger agreement, subject to satisfaction of certain customary closing conditions, CVS will acquire Arbor in an exchange of stock that is expected to be accounted for as a pooling of interests, and to be tax free to Arbor stockholders. If the merger is completed, Arbor stockholders will receive, for each Arbor share, 0.3182 of a share of CVS common stock, resulting in CVS issuing an aggregate of approximately 18.9 million shares of its common stock. In addition, outstanding Arbor stock options will be converted at the same exchange ratio into options to purchase approximately 2.6 million shares of CVS common stock.

Arbor is the leading drugstore chain in southeastern Michigan in terms of store count and sales volume. The merger would strengthen CVS' position as one of the nation's leading chain drugstore companies by bringing CVS into a high-growth, contiguous geographic market where CVS has no existing presence.

The merger is subject to approval by Arbor's shareholders, expiration of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and certain other customary closing conditions. Subject to satisfying these conditions, management expects to complete the merger on or about March 31, 1998.

PHARMACY OPERATIONS AND MANAGED CARE

In 1997, pharmacy sales increased 23.6% to $6.9 billion, representing approximately 54% of total sales for the year, compared to pharmacy sales of $5.6 billion in 1996, representing approximately 51% of total sales for such year. CVS pharmacies fill an average of about 1,200 prescriptions per store per week, which is significantly higher than the average community pharmacy. The Company believes that its pharmacy operations will continue to represent a critical part of its business and strategy due to favorable trends, including an aging American population, greater responsibility being borne by Americans for their healthcare, an increasing demand for retail formats that provide easy access and convenience, discovery of new and better drug therapies, and the need for cost effective healthcare solutions.

During fiscal 1997, approximately 80% of pharmacy sales were attributable to payments by third party providers under prescription drug plans, as compared to approximately 76% in 1996. The growth in managed care has substantially increased the use of prescription drugs as managed care providers have (i) made the cost of prescription drugs more affordable to a greater number of people and (ii) supported prescription drug therapy as an alternative to more expensive forms of treatment, such as surgery. In a typical third party payment plan, the Company has a contract with a third party payor, such as an insurance company, a prescription benefit management

2

company, a governmental agency, a private employer, a health maintenance organization or other managed care provider, which agrees to pay for all or a portion of a customer's eligible prescription purchases in exchange for reduced prescription rates. Although third party payment plans provide a high volume of prescription drug sales, such sales typically generate lower gross margins than other prescription drug sales due to the cost containment efforts of these large third party payors and the increasing competition among pharmacies for this business. During 1997, the top 5 third party providers accounted for approximately 36% of pharmacy sales. Any significant loss of third party provider business could have a material adverse affect on the Company's business and results of operations.

CVS' experience in providing solutions to managed care providers, and its existing store base which affords easy access and convenience to consumers, are factors that should contribute to the Company's continued ability to attract and maintain third party business. In addition, the Company's RX2000 pharmacy computer system facilitates the management of third party healthcare plans and enables CVS to provide managed care providers with a level of information which the Company believes is unmatched by competitors. By analyzing this data, CVS and its managed care partners are able to evaluate treatment outcomes with an eye toward improving care and containing costs. The Company's emphasis on customer service extends from the expert advice and service that individual customers receive from CVS pharmacists to the managed care portion of the Company's business, where Managed Care Service Teams are responsible for ensuring the high level of service that CVS' managed care partners receive.

The Company's pharmacy business also continues to benefit from an "independent file buy" program, in which CVS purchases prescription files from one or more independent pharmacies. During 1997, CVS purchased 190 prescription files, containing an average weekly prescription count of nearly 500, from independent pharmacies. The Company believes that independent file buys are productive investments. In many cases, the independent pharmacist will move to CVS, thereby providing continuity in the pharmacist-patient relationship.

PHARMACARE AND STRATEGIC HEALTHCARE ALLIANCES

CVS is committed to being part of an integrated healthcare approach that brings together industry participants such as physicians, pharmaceutical companies, managed care providers and pharmacies in order to provide patients with the best possible care at the lowest cost. The Company's efforts to date have primarily concentrated on two main areas: (i) the operation and expansion of PharmaCare, the Company's prescription benefit management subsidiary and (ii) the creation of strategic alliances with healthcare partners.

PharmaCare provides managed care providers a full range of prescription benefit management services, including plan design and administration, formulary management, claims processing and generic substitution, with a focus on providing integrated solutions to the delivery of healthcare. In the three and a half years since it was established, PharmaCare has grown considerably and, at the end of 1997, managed healthcare services for more than 5 million people through a preferred national pharmacy network of approximately 40,000 pharmacies. In December 1997, PharmaCare merged with Revco's prescription benefit management subsidiary, called Rx Connections, and also assumed Revco's mail order pharmacy operations, thereby strengthening and broadening PharmaCare's services network.

One of the features that sets PharmaCare apart from other prescription benefit management providers is its proprietary Clinical Information Management System ("CIMS"). CIMS enables CVS pharmacists to work more efficiently with physicians by facilitating communication and information-sharing, with the objective of improving patient care and reducing costs. Approximately 20,000 physicians are currently using CIMS, which began with only 500 physicians in 1994. In addition, PharmaCare plays an increasing role in healthcare management through integrated partnerships with several large managed care providers.

CVS also pursues strategic alliances with healthcare partners to develop products and services that create new opportunities for revenue and profit growth. For example, CVS has entered into a joint venture, called CVS Health Connection, with Pfizer Health Solutions, Inc., a subsidiary of Pfizer, Inc. Through this partnership, community health screening centers are established in CVS store settings. The first CVS Health Connection center opened in September 1997 in a New Bedford, Massachusetts CVS store. Harvard Pilgrim Healthcare, one of the nation's largest and most progressive HMOs, has contracted to offer health screening services through this center to its members.

3

FRONT STORE OPERATIONS

In 1997, front store sales increased 8.8% to $5.8 billion, representing approximately 46% of total sales for the year, compared to front store sales of $5.3 billion in 1996, representing approximately 49% of total sales for such year. The Company's front store merchandising strategies are designed to improve customer satisfaction, selection and convenience, and establish CVS stores as a destination for a growing number of front store merchandise categories, such as greeting cards, photo-finishing, beauty, seasonal merchandise and over-the-counter drugs. The Company's 10,125 square-foot freestanding prototype stores have helped to enable the Company to improve store layout, convenience and selection through the addition of product categories and the enhancement of assortments within product categories. In addition, over the past several years, the Company has made significant investments in systems and technology to more effectively respond to customer needs, manage inventory and control costs.

Through its point-of-sale scanning technology, the Company has developed an advanced retail data warehouse of information that has enabled CVS to adopt a category management approach to front end merchandising. Through category management, CVS works in partnership with major suppliers to refine and tailor assortments within product categories to the specific purchasing preferences of customers within each market. Category management enables the Company to analyze the impact of pricing, promotion and mix on a category's sales and profitability and develop tactical merchandising plans for each category by market. Among CVS' key destination categories are over-the-counter drugs, greeting cards, film and photo-finishing services, beauty and cosmetics and convenience foods.

The Company believes that effective category management increases customer satisfaction and that its category management approach has been a primary factor in its front store comparable sales gains and improved gross margins. In addition, the Company believes that its ability to satisfy customers through category management will be enhanced through its implementation of supply chain management. Supply chain management is designed to more effectively link CVS' stores and distribution centers with suppliers to speed the delivery of merchandise to CVS stores in a manner that both reduces out-of-stock positions and lowers the Company's investment in inventory. The Company expects to see tangible benefits of its supply chain management project beginning in 1998.

CVS STORES

At December 31, 1997, the Company operated 3,888 stores in 24 states in the Northeast, Mid-Atlantic, Midwest and Southeast regions and the District of Columbia, making CVS one of the nation's largest chain drugstore companies based on store count. CVS stores, which are located primarily in "strip" shopping centers or in freestanding units, generally range in size from approximately 8,000 to 10,000 square feet, with an average store size of approximately 9,000 square feet. The Company has extended store hours in many locations and, at the end of 1997, approximately 160 of its stores were operated on a 24-hour basis. The following is a breakdown by state of the locations of the Company's stores at the end of 1997:

Alabama..............................  164     New Hampshire........................   30

Connecticut..........................  118     New Jersey...........................  175

Delaware.............................    3     New York.............................  340

District of Columbia.................   46     North Carolina.......................  309

Florida..............................   23     Ohio.................................  395

Georgia..............................  316     Pennsylvania.........................  317

Illinois.............................   69     Rhode Island.........................   50

Indiana..............................  298     South Carolina.......................  188

Kentucky.............................   68     Tennessee............................  148

Maine................................   20     Vermont..............................    2

Maryland.............................  170     Virginia.............................  258

Massachusetts........................  314     West Virginia........................   63

Mississippi..........................    4

To support growth in its existing stores, the Company has in place an active remodeling and remerchandising program, which seeks to remodel 20% of the Company's existing stores each year and to remerchandise another 20% each year. In addition, as described more fully below, the Company is actively seeking to relocate many of its strip center locations to freestanding sites. During 1997,

4

the Company opened 287 new stores, including 116 relocations, and in 1998 expects to open approximately 300 new stores, including approximately 150 relocations. During 1997, the Company also began the process of converting all retained Revco stores into the CVS store format. The conversion process consists of three elements: converting the Revco point-of-sale and pharmacy computer systems to CVS' systems, revising the Revco planograms to reflect the CVS merchandise mix, and remodeling the Revco stores to the "look and feel" of a CVS store. The conversion of Revco's systems has been completed and the revision of planograms is expected to be completed during the first half of 1998. Approximately 500 Revco stores had been remodeled into the CVS "look and feel" as of December 31, 1997, and the Company expects to complete the Revco store remodeling project by the end of 1998.

The addition of new stores has played, and will continue to play, a major role in the Company's continued growth. As new stores have been opened, the Company has maintained its objective of securing strong positions in each market that its stores serve. This provides the Company several important advantages, including an ability to save on advertising and distribution costs. It is also an important consideration for managed care providers, who want to provide their members with convenient access to pharmacy services. Management anticipates that most of the planned store openings will be based on CVS' 10,125 square foot freestanding prototype, which includes a drive-thru pharmacy. New sites will be selected based on convenience, with an emphasis on freestanding locations at traffic controlled intersections.

Management expects that relocations of existing in-line strip center stores to freestanding locations will account for approximately 50% of store openings over the next several years. Historically, as a result of their more convenient locations and larger size, relocated stores have typically realized significant improvement in customer count and revenues, driven largely by increased sales of higher margin front store merchandise. Management expects this trend to continue, however there can be no assurance that similar improvements will be achieved in each geographic market in which the Company operates. See "Cautionary Statement Concerning Forward-Looking Statements" below. Freestanding locations require properties of approximately 1 1/4 acres to support parking for 40-60 cars. As a result, site selection is also an important aspect of the Company's relocation program.

The Company believes that achieving a critical mass in terms of store count and locating stores in desirable geographic markets is essential to competing effectively in the context of the current managed care environment described more fully above. As a result, management believes that the Company's store development program is an important element of its ability to maintain its leadership position in the chain drugstore industry.

INFORMATION SYSTEMS

CVS has made significant investments in information systems to enable the Company to deliver an exceptional level of customer service, while lowering costs and increasing operating efficiency. The Company's client-server based systems permit rapid and flexible system development to meet changing business needs, enabling the integration of CVS systems with those of other healthcare providers, including many of the Company's managed care customers. With a scaleable technical architecture, CVS can efficiently expand its network and add stores.

In the Company's pharmacy business, the RX2000 computer system enables CVS pharmacists to manage their prescription filling duties more efficiently, giving them more time to spend with customers. The RX2000 system, which includes one of the largest data warehouses in the country, facilitates the management of third party healthcare plans and provides a warehouse of pharmacy data that can be analyzed by both CVS and its managed care customers for a variety of healthcare- and business-related applications. In addition, during 1997 the Company implemented CVS Rapid Refill, an interactive voice response system that enables customers to place refill orders by telephone 24 hours a day.

In the front store business, the Company has developed an advanced "Retail Data Warehouse" that enables a quick analysis of point-of-sale ("POS") data on a store-by-store basis to develop targeted marketing and merchandising strategies. The Company has also implemented a "Field Management System" that uses POS data to identify areas to improve operational execution on a store-by-store basis. In addition, the Company is in the process of a major supply chain initiative to reengineer its entire warehouse and merchandising network, which is intended to enable the more efficient and effective control of merchandise flow to CVS stores.

5

SUPPLIERS

The Company centrally purchases most of its merchandise, including prescription drugs, directly from manufacturers, allowing it to take advantage of the promotional and volume discount programs that certain manufacturers offer to retailers. During 1997, approximately 85% of the merchandise purchased by the Company was received at one of the Company's distribution centers for redistribution to its stores. The balance of store merchandise is shipped directly to CVS stores from manufacturers and distributors at prices negotiated at the corporate level.

The Company believes that the loss of any one supplier or group of suppliers under common control would not have a material effect on its business.

CUSTOMER SERVICE

CVS strives to provide the highest levels of service to its customers and partners. As a result, the Company devotes considerable time and attention to people, systems and high service standards. The Company places an emphasis on attracting and training friendly and helpful associates to work both in CVS stores and throughout the CVS organization. Each CVS store receives a formal customer service evaluation twice per year, based on a mystery shopper program, customer letters and calls, and market research. CVS' priority on customer service extends into the managed care portion of its business as well. In every market, a Managed Care Service Team is responsible for ensuring that managed care partners are receiving high levels of service. CVS pharmacists consistently rank at the top of the industry on measurements of trust, relationship-building and accessibility. This high level of service and expertise has played a key role in enabling the growth of CVS' pharmacy operations.

REGULATION

The Company's pharmacies and pharmacists are required to be licensed by the appropriate state boards of pharmacy. The Company's pharmacies and its distribution centers are also registered with the Federal Drug Enforcement Agency. By virtue of these licensing and registration requirements, the Company is required to comply with various statutes, rules and regulations, a violation of which could result in a suspension or revocation of such licenses or registrations. Under the Omnibus Budget Reconciliation Act of 1990, the Company's pharmacists are required to offer counseling, without charge, to customers covered by Medicare about medication, dosage, delivery system, potential side effects, and other information deemed significant by such pharmacists. The Company's pharmacists in fact routinely offer such counseling to consumers.

COMPETITION

The retail drugstore business is highly competitive. The Company believes that it competes principally on the basis of: (i) store location and convenience, (ii) customer service and satisfaction, (iii) product selection and variety and (iv) price. The Company experiences active competition not only from independent and other chain drugstores, but also from health maintenance organizations, hospitals, mail order organizations, supermarkets, discount drugstores and discount general merchandisers. The deep discount drug segment has experienced significant growth over the past several years as drug chains, food, discount and specialty retailers have entered the business. Major retail companies now operate deep discount drugstores in the most competitive retailing markets. "Combo" stores, which consist of grocery, drugstore and several other operations under the same roof, have also experienced significant growth over the past several years as consumers have become more attracted to one-stop shopping. Retail mass merchandisers with prescription departments have also grown in popularity. The Company is among the nation's largest chain drugstores, in terms of both store count and annual sales volume.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

This report (as well as other public filings, press releases and discussions with Company management) contains and incorporates by reference certain forward-looking statements that are subject to risks and uncertainties. Forward-looking statements include the information concerning future results of operations, cost savings and synergies of the Company following the Revco merger and the Arbor acquisition; the information concerning the Company's ability to continue to achieve significant sales growth; the information concerning the

6

ability of the Company to elevate the performance level of Revco stores following the Revco merger; the information concerning the Company's belief that it can continue to improve operating performance by relocating existing in-line stores to freestanding locations; and the information concerning the Company's ability to continue to reduce selling, general and administrative expenses as a percentage of net sales; as well as those preceded by, followed by or that otherwise include the words "believes", "expects", "anticipates", "intends", "estimates" or similar expressions. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. You should understand that the following important factors, in addition to those discussed elsewhere in this report and in the documents which are incorporated by reference, and in our other public filings, press releases and discussions with Company management, could affect the future results of CVS and could cause those results to differ materially from those expressed in the forward-looking statements: materially adverse changes in economic conditions in the markets served by the Company; future regulatory and legislative actions affecting the Company and/or the chain-drug industry; competition from other drugstore chains, from alternative distribution channels such as supermarkets, membership clubs, other retailers and mail order companies and from other third party plans; and the continued efforts of health maintenance organizations, managed care organizations, pharmacy benefit management companies and other third party payors to reduce prescription drug costs. The forward looking statements referred to above are also subject to uncertainties and assumptions relating to the operations and results of operations of the Company following the Revco merger and the Arbor acquisition, including: risks relating to the Company's ability to combine the businesses of CVS, Revco and Arbor and maintain current operating performance levels during the integration period(s) and the challenges inherent in diverting the Company's management focus and resources from other strategic opportunities and from operational matters for an extended period of time during the integration process(es); the Company's ability to continue to secure suitable new store locations on favorable lease terms as it seeks to open new stores and relocate a portion of its existing store base to freestanding locations; the Company's ability to continue to purchase inventory on favorable terms; the Company's ability to attract, hire and retain suitable pharmacists and management personnel; the ability of the Company and its key vendors to successfully manage Year 2000 issues; relationships with suppliers; and the impact of inflation.

ITEM 2. DESCRIPTION OF PROPERTY

Most CVS stores are occupied pursuant to long-term leases that vary as to rental amounts and payments, expiration dates, renewal options and other rental provisions. The Company does not deem any individual store lease to be significant in relation to its overall business. For information as to the amount of the Company's rental obligations for retail store leases, see Note 9 of Notes to Consolidated Financial Statements.

The Company owns its corporate headquarters, located in two buildings in Woonsocket, Rhode Island which contain an aggregate of approximately 312,000 square feet. Additionally, the Company recently announced plans to begin construction of a third headquarters building, expected to contain in excess of 200,000 square feet, on a site adjacent to its corporate headquarters. The Company also owns distribution centers located in Rhode Island, New Jersey, Virginia, Indiana, Alabama, Pennsylvania, Tennessee, North Carolina and South Carolina, which contain an aggregate of approximately 4,944,000 square feet, and leases additional space near its distribution centers which contain an aggregate of approximately 1,189,000 square feet. In addition, the Company owns an office building located in Woonsocket, Rhode Island which contains approximately 33,000 square feet. The Company also leases approximately 41,000 square feet in an office building in Lincoln, Rhode Island and four "satellite" store support buildings located in Rhode Island and Massachusetts which contain an aggregate of approximately 146,000 square feet. The Company also owns Revco's former corporate headquarters, located in Twinsburg, Ohio, which contains approximately 108,000 square feet, and leases an additional 151,000 square feet in Twinsburg formerly used for Revco store support. All of the Company's Twinsburg facilities are expected to be consolidated or closed in 1998.

In addition, in connection with certain dispositions of divisions completed between 1991 and 1997, CVS continues to guaranty certain lease obligations for store leases that had been entered into and guaranteed by the Company prior to the time of disposition for approximately 2,000 former stores. The Company is indemnified for these guarantee obligations by the respective purchasers. These guarantees generally remain in effect for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. See Note 8 of Notes to Consolidated Financial Statements.

7

ITEM 3. LEGAL PROCEEDINGS

From time to time the Company and its subsidiaries are involved in the assertion of claims and in litigation incidental to the normal course of business. Management does not believe that any existing claims or litigation will have a material adverse effect on the consolidated financial condition or results of operations of the Company.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No matters were submitted to a vote of security holders during the fourth quarter of the year ended December 31, 1997.

EXECUTIVE OFFICERS OF THE REGISTRANT

The following is included as an unnumbered item in Part I of this Report.

                                                                                                             DATE FIRST
                                                                                            DATE APPOINTED   APPOINTED
                                                                                              TO PRESENT     OFFICER OF
                                                                                            OFFICE OF THE       THE
NAME/OFFICE                                                                        AGE         COMPANY        COMPANY
-----------------------------------------------------------------------------      ---      --------------  ------------

Charles C. Conaway
  Executive Vice President and Chief Financial Officer,
  CVS Corporation and CVS Pharmacy, Inc .....................................          37       07/10/96       07/10/96

Stanley P. Goldstein
  Chairman of the Board and Chief Executive Officer,
  CVS Corporation............................................................          63       01/01/87       04/13/71

Rosemary Mede
  Vice President, CVS Corporation
  Senior Vice President--Human Resources, CVS Pharmacy, Inc..................          51       10/01/97       10/01/97

Larry J. Merlo
  Vice President, CVS Corporation
  Senior Vice President--Stores, CVS Pharmacy, Inc...........................          42       10/09/96       10/09/96

Daniel C. Nelson
  Vice President, CVS Corporation
  Executive Vice President--Marketing, CVS Pharmacy, Inc.....................          48       10/09/96       10/09/96

Thomas M. Ryan
  Vice Chairman and Chief Operating Officer, CVS Corporation
  President and Chief Executive Officer, CVS Pharmacy, Inc...................          45       10/09/96       01/01/94

Douglas A. Sgarro
  Vice President, CVS Corporation
  Senior Vice President--Administration and Chief Legal Officer,
  CVS Pharmacy, Inc..........................................................          38       09/10/97       09/10/97

Larry D. Solberg
  Vice President, CVS Corporation
  Senior Vice President--Finance and Controller, CVS Pharmacy, Inc...........          50       10/09/96       10/09/96

In each case the term of office extends to the date of the board of directors meeting following the next annual meeting of stockholders of the Company. In addition to the office(s) which they hold in CVS

8

Corporation and CVS Pharmacy, Inc. as shown above, each of the individuals listed holds various offices in certain CVS subsidiaries. Previous positions and responsibilities held by each of the above officers over the past five years are indicated below:

CHARLES C. CONAWAY, Executive Vice President and Chief Financial Officer of CVS Corporation since July 1996; Executive Vice President and Chief Financial Officer of CVS Pharmacy, Inc. since February 1995; from September 1992 to February 1995, Senior Vice President--Pharmacy of CVS Pharmacy, Inc.; director of Linens 'n Things, Inc.

STANLEY P. GOLDSTEIN, Chairman of the Board and Chief Executive Officer of CVS Corporation since January 1987; director of Bell Atlantic Corporation, Linens 'n Things, Inc. and Footstar, Inc. Additionally, the Company recently announced that Mr. Goldstein will step down as Chief Executive Officer of CVS Corporation effective May 13, 1998, at the time of the Company's Annual Meeting of Stockholders. He will be succeeded as Chief Executive Officer by Thomas M. Ryan (see below). Mr. Goldstein will remain Chairman of the Board.

ROSEMARY MEDE, Vice President of CVS Corporation and Senior Vice President--Human Resources of CVS Pharmacy, Inc. since October 1997; from December 1995 to September 1997, Vice President/General Manager of Business Services, Becton Dickinson & Co.; from 1988 to November 1995, held various management positions in human resources, Becton Dickinson & Co.

LARRY J. MERLO, Vice President of CVS Corporation since October 1996; Senior Vice President--Stores of CVS Pharmacy, Inc. since January 1994; from March 1993 to December 1993, Area Vice President of CVS Pharmacy, Inc.; from March 1991 to March 1993, Area Vice President of Peoples Drug Stores, Inc.

DANIEL C. NELSON, Vice President of CVS Corporation since October 1996; Executive Vice President--Marketing of CVS Pharmacy, Inc. since September 1993; from June 1990 to September 1993, Senior Vice President of Dominicks Finer Foods, Inc.

THOMAS M. RYAN, Vice Chairman of the Board and Chief Operating Officer of CVS Corporation since October 1996; President and Chief Executive Officer of CVS Pharmacy, Inc. since January 1994; from January 1990 to January 1994, Executive Vice President--Stores of CVS Pharmacy, Inc.; director of Fleet Financial Group and Reebok International Ltd. Additionally, the Company recently announced that Mr. Ryan has been elected President and Chief Executive Officer of CVS Corporation effective May 13, 1998, at the time of the Company's Annual Meeting of Stockholders.

DOUGLAS A. SGARRO, Vice President of CVS Corporation and Senior Vice President--Administration and Chief Legal Officer of CVS Pharmacy, Inc. since September 1997; from January 1993 to August 1997, partner in the New York City office of the law firm of Brown & Wood LLP; from September 1984 to December 1992, associate in the New York City office of Brown & Wood LLP.

LARRY D. SOLBERG, Vice President of CVS Corporation since October 1996; Senior Vice President--Finance and Controller of CVS Pharmacy, Inc. since March 1996; Vice President and Controller of CVS Pharmacy, Inc. from October 1994 to March 1996; from September 1993 to October 1994, Senior Vice President of PIMMS Corp.; prior to September 1993, various offices with National Car Rental Corp., most recently as Executive Vice President and Chief Financial Officer.

PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

The number of holders of the Company's Common Stock, based upon the number of record holders according to the records of the Company's transfer agent, was approximately 10,200 as of December 31, 1997. The Company's Common Stock is listed on the New York Stock Exchange ("NYSE"), under the ticker symbol "CVS." The following table sets forth, for the calendar quarters indicated, the reported high and low sale prices of the Company's Common Stock as reported on the NYSE Composite Transaction Tape, and the cash dividends declared by the Company per share of Common Stock.

9

                                                                                                            CASH
                                                                                                          DIVIDENDS
                                                                                     HIGH        LOW      DECLARED
                                                                                   ---------  ---------  -----------

1996

First Quarter....................................................................  $  36 3/8  $  27 1/4   $    0.11

Second Quarter...................................................................  $  44 1/2  $  35 1/4   $    0.11

Third Quarter(1).................................................................  $   46.00  $  36 5/8   $    0.11

Fourth Quarter...................................................................  $  44 3/4  $  36 3/8   $    0.11

1997

First Quarter....................................................................  $   48.00  $   39.00   $    0.11

Second Quarter...................................................................  $  53 3/4  $  44 1/4   $    0.11

Third Quarter....................................................................  $   60.00  $  50 7/8   $    0.11

Fourth Quarter...................................................................  $   70.00  $  54 5/8   $    0.11


On March 2, 1998, the closing sale price of the Common Stock as reported by the New York Stock Exchange was $73 9/16.

(1) On October 12, 1996, the Company completed the distribution of 100% of the common stock of Footstar, Inc. ("Footstar"), formerly a wholly owned subsidiary of the Company, in the form of a stock dividend to the Company's stockholders. The stock prices shown in the table are actual trading prices and do not reflect any adjustments for the when issued price of Footstar prior to October 16, 1996 (the date on which Footstar common stock commenced trading regular way on the NYSE).

UNREGISTERED SALES OF SECURITIES

The Company did not sell any equity securities during the period covered by this Annual Report on Form 10-K that were not registered under the Securities Act of 1933.

ITEM 6. SELECTED FINANCIAL DATA

The information required by this item is included in the Registrant's Annual Report to Shareholders for the year ended December 31, 1997 on page 66 and is incorporated herein by reference.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The information required by this item is included in the Registrant's Annual Report to Shareholders for the year ended December 31, 1997 on pages 36 through 44 and is incorporated herein by reference.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Management does not believe that there is any material market risk exposure with respect to derivative or other financial instruments which would require disclosure under this Item.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The information required by this item is included in the Registrant's Annual Report to Shareholders for the year ended December 31, 1997 on pages 46 through 65, and is incorporated herein by reference.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

During the Registrant's two most recent fiscal years and subsequent interim period, no event occurred which would require disclosure under this Item.

10

PART III

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

The information required by this item, with the exception of the information relating to executive officers of the Registrant (which is presented under the caption "Executive Officers of the Registrant" in Part I, Item 4, above), is included in the Registrant's Proxy Statement for the 1998 Annual Meeting of Stockholders under the captions "Directors" and "Section
16(a) Beneficial Ownership Reporting Compliance" and is incorporated herein by reference.

ITEM 11. EXECUTIVE COMPENSATION

The information required by this item is included in the Registrant's Proxy Statement for the 1998 Annual Meeting of Stockholders under the caption "Executive Compensation" and is incorporated herein by reference.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The information required by this item is included in the Registrant's Proxy Statement for the 1998 Annual Meeting of Stockholders under the captions "Share Ownership Information of Directors and Named Executive Officers" and "Share Ownership Information of Certain Principal Stockholders" and is incorporated herein by reference.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

The information required by this item is included in the Registrant's Proxy Statement for the 1998 Annual Meeting of Stockholders under the caption "Certain Relationships and Related Transactions" and is incorporated herein by reference.

PART IV

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K

ITEM 14(A) THE FOLLOWING DOCUMENTS ARE FILED AS PART OF THIS ANNUAL REPORT ON FORM 10-K.

Item 14(a)(1) and (2) The consolidated financial statements of CVS
Corporation incorporated herein by reference to the Annual Report to Shareholders for the year ended December 31, 1997 and the related consolidated financial statement schedule are listed in the Index to Consolidated Financial Statements and Schedule on page 16 hereof. Other financial statement schedules have not been included because they are not applicable or the information is included in the financial statements or notes thereto.

ITEM 14(A)(3) EXHIBITS

The following is a list of exhibits filed as part of this Annual Report on Form 10-K.

EXHIBIT                                                   DESCRIPTION
------------  ----------------------------------------------------------------------------------------------------

           3.1        Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to
                      Exhibit 3.1 of CVS Corporation's Annual Report on Form 10-K for the fiscal year ended December 31,
                      1996).

           3.2        Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 of CVS Corporation's Annual
                      Report on Form 10-K for the fiscal year ended December 31, 1996).

                                      11

             4        Pursuant to Regulation S-K, Item 601(b)(4)(iii)(A), no instrument which defines the rights of
                      holders of long-term debt of the Registrant ant its subsidiaries is filed herewith. The Registrant
                      hereby agrees to furnish a copy of any such instrument to the Securities and Exchange Commission
                      upon request.

           4.1        Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Registration
                      Statement of the Registrant on Form 8-B dated November 4, 1996 and filed under the Securities
                      Exchange Act of 1934 on November 5, 1996).

      10(i)(1)        Stock Purchase Agreement dated as of October 14, 1995 between The TJX Companies, Inc. and Melville
                      Corporation, as amended November 17, 1995 (incorporated by reference to Exhibits 2.1 and 2.2 to
                      Melville's Current Report on Form 8-K dated December 4, 1995).

      10(i)(2)        Stock Purchase Agreement dated as of March 25, 1996 between Melville Corporation and Consolidated
                      Stores Corporation, as amended May 3, 1996 (incorporated by reference to Exhibits 2.1 and 2.2 to
                      Melville's Current Report on Form 8-K dated May 5, 1996).

      10(i)(3)        Distribution Agreement dated as of September 24, 1996 among Melville Corporation, Footstar, Inc. and
                      Footstar Center, Inc. (incorporated by reference to Exhibit 99.1 to Melville's Current Report on
                      Form 8-K dated October 28, 1996).

      10(i)(4)        Tax Disaffiliation Agreement dated as of September 24, 1996 among Melville Corporation, Footstar,
                      Inc. and certain subsidiaries named therein (incorporated by reference to Exhibit 99.2 to Melville's
                      Current Report on Form 8-K dated October 28, 1996).

      10(i)(5)        Agreement and Plan of Merger dated as of February 8, 1998, as amended as of March 2, 1998, among the
                      Registrant, Arbor Drugs, Inc. and Red Acquisition, Inc. (incorporated by reference to Exhibit 2 to
                      the Registrant's Registration Statement on Form S-4 filed March 2, 1998).

      10(i)(6)        Stockholder Agreement dated as of December 2, 1996 between the Registrant, Nashua Hollis CVS, Inc.
                      and Linens 'n Things, Inc.

      10(i)(7)        Tax Disaffiliation Agreement dated as of December 2, 1996 between the Registrant and Linens 'n
                      Things, Inc. and certain of their respective affiliates.

      10(i)(8)        Five Year Credit Agreement dated as of May 23, 1997 by and among the Registrant, the Lenders party
                      thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities, Inc., as Syndication
                      Agent and The Bank of New York, as Administrative Agent.

      10(i)(9)        Note Purchase Agreement dated as of June 7, 1989 by and among The Melville Corporation and Subsidiaries
                      Employee Stock Ownership Plan Trust, as Issuer, Melville Corporation, as Guarantor, and the Purchasers
                      named therein.

                                       12

    10(iii)(A)      1973 Stock Option Plan (incorporated by reference to Exhibit (10)(iii)(A)(i) to Melville

                 (i)  Corporation's Annual Report on Form 10-K for the fiscal year ended December 31, 1987).

                (ii)  1987 Stock Option Plan (incorporated by reference to Exhibit (10)(iii)(A)(iii) to Melville
                      Corporation's Annual Report on Form 10-K for the fiscal year ended December 31, 1987).

               (iii)  1989 Directors Stock Option Plan (incorporated by reference to Exhibit B to Melville Corporation's
                      Annual Report on Form 10-K for the fiscal year ended December 31, 1988).

                (iv)  Melville Corporation Omnibus Stock Incentive Plan (incorporated by reference to Exhibit B to
                      Melville Corporation's Annual Report on Form 10-K for the fiscal year ended December 31, 1989 and
                      Exhibit A to Melville's definitive Proxy Statement dated March 7, 1995).

                 (v)  Profit Incentive Plan of Melville Corporation (incorporated by reference to Exhibit A to Melville
                      Corporation's definitive Proxy Statement dated March 14, 1994).

                (vi)  Supplemental Retirement Plan for Select Senior Management of Melville Corporation I as amended
                      through July 1995 (incorporated by reference to Exhibit 10(iii)(A)(vii) to Melville's Annual Report
                      on Form 10-K for the fiscal year ended December 31, 1995).

               (vii)  Supplemental Retirement Plan for Select Senior Management of Melville Corporation II as amended
                      through July 1995 (incorporated by reference to Exhibit 10(iii)(A)(viii) to Melville's Annual Report
                      on Form 10-K for the fiscal year ended December 31, 1995).

              (viii)  Income Continuation Policy for Select Senior Executives of Melville Corporation as amended through
                      May 12, 1988 (incorporated by reference to Exhibit 10 (viii) to Melville's Annual Report on Form
                      10-K for the fiscal year ended December 31, 1994).

                (ix)  Melville Corporation 1996 Directors Stock Plan (incorporated by reference to Exhibit A to Melville's
                      definitive Proxy Statement dated March 7, 1996).

                 (x)  Form of Employment Agreements between the Registrant and each of Messrs. Ryan, Conaway, Nelson and
                      Merlo (incorporated by reference to the Registrant's Annual Report on Form 10-K/A for the fiscal year
                      ended December 31, 1996).

                (xi)  Deferred Stock Compensation Plan.

         11           Statement re: Computation of Earnings per Common Share.

         12           Statement re: Computation of Ratio of Earnings to Fixed Charges.

         13           1997 Annual Report to Shareholders (Sections entitled "Management's Discussion and Analysis of
                      Financial Condition and Results of Operations," "Management's Responsibility for Financial
                      Reporting," "Independent Auditors' Report," "Consolidated Statements of Operations," "Consolidated
                      Balance Sheets," "Consolidated Statements of Cash Flows," "Consolidated Statements of Shareholders'
                      Equity," "Notes to Consolidated Financial Statements," and "Five-Year Financial Summary").

         21           Subsidiaries of the Registrant.

         23           Consent of KPMG Peat Marwick LLP.

         27.1         Financial Data Schedule.

         27.2         Restated Financial Data Schedule -- Fiscal Year 1996.

         27.3         Restated Financial Data Schedule -- Fiscal Year 1995.

ITEM 14(B) REPORTS ON FORM 8-K

During the quarter ended December 31, 1997, the Company filed did not file any Reports on Form 8-K.

13

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

CVS CORPORATION

DATE: March 30 , 1998               BY: /S/ Stanley P. Goldstein
                                    --------------------------------------
                                    Stanley P. Goldstein,
                                    Chairman of the Board and
                                    Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

          SIGNATURE                          TITLE                   DATE
------------------------------  -----------------------------  ----------------


                                Chairman of the Board,
   /s/ STANLEY P. GOLDSTEIN       Chief Executive Officer
------------------------------    and Director (Principal      March 30, 1998
     Stanley P. Goldstein         Executive Officer)

                                Executive Vice President
    /s/ CHARLES C. CONAWAY        and Chief Financial
------------------------------    Officer (Principal           March 30, 1998
      Charles C. Conaway          Financial Officer)

     /s/ LARRY D. SOLBERG       Vice President (Principal
------------------------------    Accounting Officer)          March 30, 1998
       Larry D. Solberg

    /s/ ALLAN J. BLOOSTEIN      Director
------------------------------                                 March 30, 1998
      Allan J. Bloostein

     /s/ W. DON CORNWELL        Director
------------------------------                                 March 30, 1998
       W. Don Cornwell

    /s/ THOMAS P. GERRITY       Director
------------------------------                                 March 30, 1998
      Thomas P. Gerrity

     /s/ WILLIAM H. JOYCE       Director
------------------------------                                 March 30, 1998
       William H. Joyce

   /s/ TERRY R. LAUTENBACH      Director
------------------------------                                 March 30, 1998
     Terry R. Lautenbach

14

          SIGNATURE                        TITLE                    DATE
------------------------------  ---------------------------  -------------------


     /s/ TERRENCE MURRAY        Director
------------------------------                                 March 30, 1998
       Terrence Murray

    /s/ SHELI Z. ROSENBERG      Director
------------------------------                                 March 30, 1998
      Sheli Z. Rosenberg


      /s/ THOMAS M. RYAN        Vice Chairman, Chief
------------------------------    Operating Officer and        March 30, 1998
        Thomas M. Ryan            Director

    /s/ IVAN G. SEIDENBERG      Director
------------------------------                                 March 30, 1998
      Ivan G. Seidenberg

  /s/ PATRICIA CARRY STEWART    Director
------------------------------                                 March 30, 1998
    Patricia Carry Stewart

    /s/ THOMAS O. THORSEN       Director
------------------------------                                 March 30, 1998
      Thomas O. Thorsen

 /s/ M. CABELL WOODWARD, JR.    Director
------------------------------                                 March 30, 1998
   M. Cabell Woodward, Jr.

15

CVS CORPORATION AND SUBSIDIARY COMPANIES

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND SCHEDULE

The consolidated financial statements of CVS Corporation together with the report on such consolidated financial statements of KPMG Peat Marwick LLP dated February 9, 1998 which appear on the pages listed below of the Annual Report to Shareholders for the year ended December 31, 1997, are incorporated by reference in this Annual Report on Form 10-K.

                                                                                                    PAGE NUMBER IN
                                                                                                      1997 ANNUAL
                                                                                                       REPORT TO
                                                                                                     SHAREHOLDERS
                                                                                                   -----------------
Management's Responsibility for Financial Reporting..............................................             45
Independent Auditors' Report.....................................................................             45
Consolidated Statements of Operations for the years ended December 31, 1997, 1996 and 1995.......             46
Consolidated Balance Sheets as of December 31, 1997 and 1996.....................................             47
Consolidated Statements of Shareholders' Equity for the years ended December 31, 1997, 1996 and
  1995...........................................................................................             48
Consolidated Statements of Cash Flows for the years ended December 31, 1997, 1996 and 1995.......             49
Notes to Consolidated Financial Statements.......................................................          50-65
Five-Year Financial Summary......................................................................             66

                                                                                                                PAGE
                                                                                                                -----
Included in Part IV of this report:
Independent Auditors' Report on Consolidated Financial Statements..........................................         F-1
Consolidated Financial Statement Schedule of CVS Corporation for the years ended December 31, 1997, 1996
  and 1995:
Schedule II -- Valuation and Qualifying Accounts...........................................................         S-1

16

INDEPENDENT AUDITORS' REPORT

The Board of Directors and Shareholders
of CVS Corporation:

Under date of February 9, 1998, we reported on the consolidated balance sheets of CVS Corporation and subsidiaries as of December 31, 1997 and 1996, and related consolidated statements of operations, shareholders' equity and cash flows for each of the years in the three-year period ended December 31, 1997, as contained in the 1997 annual report to shareholders. These consolidated financial statements and our report thereon are incorporated by reference in the annual report on Form 10-K for the year 1997. In connection with our audits of the aforementioned consolidated financial statements, we also audited the related consolidated financial statement schedule as listed in the accompanying index. This financial statement schedule is the responsibility of the Company's management. Our responsibility is to express an opinion on this financial statement schedule based on our audits.

In our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein.

/s/ KPMG PEAT MARWICK LLP
----------------------------
KPMG PEAT MARWICK LLP

Providence, Rhode Island
February 9, 1998

F-1

SCHEDULE II

CVS CORPORATION

VALUATION AND QUALIFYING ACCOUNTS

                                           BALANCE AT        ADDITIONS CHARGED TO                          BALANCE AT
IN MILLIONS                             BEGINNING OF YEAR  COSTS & EXPENSES (1) (3)    DEDUCTIONS (2)    END OF YEAR (3)
--------------------------------------  -----------------  -------------------------  -----------------  ---------------
Accounts Receivable Allowance
for Doubtful Accounts:
Year Ended December 31, 1997..........      $    36.0              $     7.3              $     5.3         $    38.0
Year Ended December 31, 1996..........           58.6                   11.2                   33.8              36.0
Year Ended December 31, 1995..........           45.4                   43.6                   30.4              58.6


(1) 1995 includes a charge of $21.3 million that relates to certain receivables of former operating businesses that were retained by the Company subsequent to the sale of the related operating businesses.

(2) 1996 includes a deduction of $21.2 million that relates to the actual write-off of the receivables discussed in Note (1) above.

(3) 1997 amounts are consistent with the historical results of the Company's continuing operations.

S-1

STOCKHOLDER AGREEMENT

STOCKHOLDER AGREEMENT dated as of December 2, 1996 (the "Agreement") between CVS Corporation, a Delaware corporation ("CVS"), Nashua Hollis CVS, Inc., a New Hampshire corporation ("Nashua Hollis"), and Linens 'n Things, Inc. ("Linens"), a Delaware corporation.

W I T N E S S E T H:

WHEREAS, Linens is presently a wholly owned Subsidiary of CVS;

WHEREAS, after the sale on the date hereof of Common Stock, $0.01 par value per share (the "Common Stock"), of Linens to the public in an initial public offering (the "Initial Public Offering") registered under the Securities Act of 1933, as amended, CVS will own approximately 32.5% of the outstanding Common Stock of Linens;

WHEREAS, CVS and Linens are concurrently herewith entering into the Transitional Services Agreement and the Tax Disaffiliation Agreement;

WHEREAS, the parties hereto desire to set forth herein certain matters relating to the relationship and the respective rights and obligations of the parties following the Initial Public Offering;

NOW, THEREFORE, the parties hereto agree as follows:

ARTICLE I

DEFINITIONS

Section 1.01. Definitions. The following terms, as used herein, have the following meanings:

"Action" means any claim, suit, action, arbitration, investigation or other proceeding by or before any court, governmental or other regulatory or administrative agency or commission or any other tribunal.

"Affiliate" means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under common control with, such Person. For the purposes of


this definition, "control" means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise; and the terms "controlling" and "controlled" have meanings correlative to the foregoing; provided that, for purposes hereof, CVS and Linens will be deemed not to be Affiliates of each other.

"Applicable CVS Number" has the meaning assigned to such term in the Linens Charter.

"Commission" means the Securities and Exchange Commission.

"Common Stock" has the meaning assigned thereto in the recitals above.

"CVS Group" means CVS and its Subsidiaries (other than any Subsidiary or member of, or other entity in, the Linens Group).

"CVS Liabilities" means all (i) Liabilities of the CVS Group under this Agreement and (ii) except as otherwise specifically provided herein or in the Tax Disaffiliation Agreement, other Liabilities that arise from or in connection with a Third Party Claim, whether arising before, on or after the Initial Public Offering Date, and that are of or relate to the CVS Group or arise from or in connection with the conduct of the businesses of the CVS Group (other than the Linens Business) or the ownership or use of assets in connection therewith. Notwithstanding the foregoing, "CVS Liabilities" shall exclude (x) any Liabilities for Taxes (since such Liabilities shall be governed by the Tax Disaffiliation Agreement) and (y) any Liabilities specifically retained or assumed by Linens pursuant to this Agreement.

"Environmental Laws" means any and all federal, state, local and foreign statutes, laws, judicial decisions, regulations, ordinances, rules, judgments, orders, decrees, codes, plans, permits, licenses and governmental restrictions, whether now or hereafter in effect, relating to the environment, the effect of the environment on human health or to emissions, discharges, releases, manufacturing, storage, processing, distribution, use, treatment, disposal, transportation or handling of pollutants, contaminants, petroleum or petroleum products, chemicals or industrial, toxic, radioactive or hazardous substances or wastes or the clean-up or other remediation thereof.

"Finally Determined" means, with respect to any Action

2

or other matter, that the outcome or resolution of such Action or matter has been judicially determined by judgment or order not subject to further appeal or discretionary review.

"Group" means, as the context requires, the Linens Group or the CVS Group.

"Guaranteed Lease" has the meaning assigned to such term in Section 3.01.

"Indemnified Party" has the meaning set forth in Section 2.04.

"Indemnifying Party" has the meaning set forth in Section 2.04.

"Initial Public Offering Date" means the date on which the closing of the Initial Public Offering is consummated.

"Lease Guarantee" has the meaning assigned to such term in Section 3.01.

"Liabilities" means any and all claims, debts, liabilities and obligations, absolute or contingent, matured or not matured, liquidated or unliquidated, accrued or unaccrued, known or unknown, whenever arising, including all costs and expenses relating thereto, and including, without limitation, those debts, liabilities and obligations arising under this Agreement, any law, rule, regulation, any action, order, injunction or consent decree of any governmental agency or entity, or any award of any arbitrator of any kind, and those arising under any agreement, commitment or undertaking.

"Linens Business" means the businesses and operations (including, without limitation, the home textiles and housewares-related purchasing, distribution and sales operations and activities) associated with Linens or otherwise of the Linens Group, in each case whether conducted prior to, on or after the Initial Public Offering Date.

"Linens Charter" means the Amended and Restated Certificate of Incorporation of Linens in effect as of the date hereof.

"Linens Group" means Linens and its Subsidiaries as of (and, except where the context clearly indicates otherwise, after) the Initial Public Offering Date (including all predecessors to such Persons).

"Linens Liabilities" means all (i) Liabilities of the

3

Linens Group under this Agreement and (ii) except as otherwise specifically provided herein or in the Tax Disaffiliation Agreement, other Liabilities that arise from or in connection with a Third Party Claim, whether arising before, on or after the Initial Public Offering Date, and that are of or relate to the Linens Group or arise from or in connection with the conduct of the Linens Business or the ownership or use of assets in connection therewith, including without limitation any such Liabilities that arise under or relate to Environmental Laws. Notwithstanding the foregoing, "Linens Liabilities" shall exclude: (x) any Liabilities for Taxes (since such Liabilities shall be governed by the Tax Disaffiliation Agreement), (y) any Liabilities arising from shareholder derivative lawsuits against CVS, and (z) any Liabilities specifically retained or assumed by CVS pursuant to this Agreement.

"Losses" means, with respect to any Person, any and all damage, loss, liability and expense incurred or suffered by such Person (including, without limitation, reasonable expenses of investigation and reasonable attorneys' fees and expenses in connection with any and all Actions or threatened Actions).

"1933 Act" means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

"1934 Act" means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

"Person" means an individual, corporation, limited liability company, partnership, association, trust or other entity or organization, including a governmental or political subdivision or an agency or instrumentality thereof.

"Principal Stockholder" has the meaning assigned to such term in the Linens Charter.

"Prospectus" means the prospectus relating to the Registration Statement in the form first used to confirm the sale of shares of Common Stock in the Initial Public Offering.

"Registration Statement" means the registration statement on Form S-1 filed with the Commission relating to the offering and sale of the shares of Common Stock of Linens in the Initial Public Offering.

"Stockholder Documents" means all of the agreements and other documents entered into between Linens and CVS in connection with the Initial Public Offering as contemplated hereby, including, without limitation, this Agreement, the Transitional Services Agreement and the Tax Disaffiliation Agreement.

4

"Subsidiary" means, with respect to any Person, any other entity of which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions are at the time directly or indirectly owned by such Person.

"Tax" means Tax as such term is defined in the Tax Disaffiliation Agreement.

"Tax Disaffiliation Agreement" means the Tax Disaffiliation Agreement dated as of the date hereof between CVS and Linens.

"Third-Party Claim" has the meaning set forth in Section 2.05.

ARTICLE II

INDEMNIFICATION

Section 2.01. Linens Indemnification of the CVS Group. (a) Subject to Section 2.03, on and after the Initial Public Offering Date, Linens shall indemnify, defend and hold harmless the CVS Group and the respective directors, officers and Affiliates of each Person in the CVS Group (the "CVS Indemnitees") from and against any and all Losses incurred or suffered by any of the CVS Indemnitees arising out of, or due to the failure of any Person in the Linens Group to pay, perform or otherwise discharge, any of the Linens Liabilities.

(b) Subject to Section 2.03, Linens shall indemnify, defend and hold harmless each of the CVS Indemnitees and each Person, if any, who controls any CVS Indemnitee within the meaning of either Section 15 of the 1933 Act or
Section 20 of the 1934 Act from and against any and all Losses caused by any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any amendment thereof, any preliminary prospectus or the Prospectus (as amended or supplemented if Linens shall have furnished any amendments or supplements thereto), or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such Losses are caused by any such untrue statement or omission or alleged untrue statement or omission based upon information furnished to Linens in writing by CVS expressly for use therein.

(c) Subject to Section 2.03, on and after the Initial Public Offering Date, Linens shall indemnify, defend and hold

5

harmless each of the CVS Indemnitees and each Person, if any, who controls any CVS Indemnitee from and against any and all Losses incurred or suffered by any of the CVS Indemnitees (i) due to the failure of any Person in the Linens Group to pay, perform or otherwise discharge its obligations under any of the Guaranteed Leases or (ii) otherwise arising out of or with respect to any of the Guaranteed Leases or Lease Guarantees, except in the case of this clause (ii), to the extent Losses are attributable to any breach of any agreement or covenant by the CVS Group under any Lease Guarantee.

Section 2.02. CVS Indemnification of Linens Group. (a) Subject to
Section 2.03, on and after the Initial Public Offering Date, CVS shall indemnify, defend and hold harmless the Linens Group and the respective directors, officers and Affiliates of each Person in the Linens Group (the "Linens Indemnitees") from and against any and all Losses incurred or suffered by any of the Linens Indemnitees and arising out of, or due to the failure of any Person in the CVS Group to pay, perform or otherwise discharge, any of the CVS Liabilities.

(b) Subject to Section 2.03, CVS shall indemnify, defend and hold harmless each of the Linens Indemnities and each Person, if any, who controls any Linens Indemnitee within the meaning of either Section 15 of the 1933 Act or
Section 20 of the 1934 Act from and against any and all Losses caused by any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any amendment thereof, any preliminary prospectus or the Prospectus (as amended or supplemented if Linens shall have furnished any amendments or supplements thereto), or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such Losses are caused by any such untrue statement or omission or alleged untrue statement or omission based upon information furnished to Linens in writing by CVS expressly for use therein.

(c) The parties agree that, for purposes of Sections 2.01(b) and 2.02(b) hereof, the only information furnished to Linens in writing by CVS expressly for use in the Registration Statement or any amendment thereof, any preliminary prospectus or the Prospectus (as amended or supplemented if Linens shall have furnished any amendments or supplements thereto) is the information contained therein under the following captions: "Risk Factors--Control of the Company by CVS" and "Relationship with CVS and Related Party Transactions".

6

Section 2.03. Insurance; Third Party Obligations; Tax Benefits. Any indemnification pursuant to Sections 2.01 or 2.02 shall be paid net of the amount of any insurance or other amounts that would be payable by any third party to the Indemnified Party (as defined below) in the absence of this Agreement (irrespective of time of receipt of such insurance or other amounts) and net of any tax benefit to the Indemnified Party attributable to the relevant payment or Liability. It is expressly agreed that no insurer or any other third party shall be (i) entitled to a benefit it would not be entitled to receive in the absence of the foregoing indemnification provisions, (ii) relieved of the responsibility to pay any claims to which it is obligated or (iii) entitled to any subrogation rights with respect to any obligation hereunder.

Section 2.04. Notice and Payment of Claims. If any CVS Indemnitee or Linens Indemnitee (the "Indemnified Party") determines that it is or may be entitled to indemnification by any party (the "Indemnifying Party") under Article II (other than in connection with any Action subject to Section 2.05), the Indemnified Party shall deliver to the Indemnifying Party a written notice specifying, to the extent reasonably practicable, the basis for its claim for indemnification and the amount for which the Indemnified Party reasonably believes it is entitled to be indemnified. Within 30 days after receipt of such notice, the Indemnifying Party shall pay the Indemnified Party such amount in cash or other immediately available funds unless the Indemnifying Party objects to the claim for indemnification or the amount thereof. If the Indemnifying Party does not give the Indemnified Party written notice objecting to such indemnity claim and setting forth the grounds therefore within such 30-day period, the Indemnifying Party shall be deemed to have acknowledged its liability for such claim and the Indemnified Party may exercise any and all of its rights under applicable law to collect such amount. In the event of such a timely objection by the Indemnifying Party, the amount, if any, that is Finally Determined to be required to be paid by the Indemnifying Party in respect of such indemnity claim shall be paid by the Indemnifying Party to the Indemnified Party in cash within 15 days after such indemnity claim has been so Finally Determined.

Section 2.05. Notice and Defense of Third-Party Claims. Promptly following the earlier of (i) receipt of notice of the commencement by a third party of any Action against or otherwise involving any Indemnified Party or (ii) receipt of information from a third party alleging the existence of a claim against an Indemnified Party, in either case, with respect to which indemnification may be sought pursuant to this Agreement (a "Third-Party Claim"), the Indemnified Party shall give the Indemnifying Party written notice thereof. The failure of the

7

Indemnified Party to give notice as provided in this Section 2.05 shall not relieve the Indemnifying Party of its obligations under this Agreement, except to the extent that the Indemnifying Party is prejudiced by such failure to give notice. Within 30 days after receipt of such notice, the Indemnifying Party may
(i) by giving written notice thereof to the Indemnified Party, acknowledge liability for such indemnification claim and at its option elect to assume the defense of such Third-Party Claim at its sole cost and expense or (ii) object to the claim for indemnification set forth in the notice delivered by the Indemnified Party pursuant to the first sentence of this Section 2.05; provided that if the Indemnifying Party does not within such 30-day period give the Indemnified Party written notice objecting to such indemnification claim and setting forth the grounds therefor, the Indemnifying Party shall be deemed to have acknowledged its liability for such indemnification claim. If the Indemnifying Party has elected to assume the defense of a Third-Party Claim, (x) the defense shall be conducted by counsel retained by the Indemnifying Party and reasonably satisfactory to the Indemnified Party, provided that the Indemnified Party shall have the right to participate in such proceedings and to be represented by counsel of its own choosing at the Indemnified Party's sole cost and expense; and (y) the Indemnifying Party may settle or compromise the Third Party Claim without the prior written consent of the Indemnified Party so long as such settlement includes an unconditional release of the Indemnified Party from all claims that are the subject of such Third Party Claim, provided that the Indemnifying Party may not agree to any such settlement pursuant to which any remedy or relief, other than monetary damages for which the Indemnifying Party shall be responsible hereunder, shall be applied to or against the Indemnified Party, without the prior written consent of the Indemnified Party, which consent shall not be unreasonably withheld. If the Indemnifying Party does not assume the defense of a Third-Party Claim for which it has acknowledged liability for indemnification hereunder, the Indemnified Party may require the Indemnifying Party to reimburse it on a current basis for its reasonable expenses of investigation, reasonable attorney's fees and reasonable out-of-pocket expenses incurred in defending against such Third-Party Claim and the Indemnifying Party shall be bound by the result obtained with respect thereto by the Indemnified Party; provided that the Indemnifying Party shall not be liable for any settlement effected without its consent, which consent shall not be unreasonably withheld. The Indemnifying Party shall pay to the Indemnified Party in cash the amount, if any, for which the Indemnified Party is entitled to be indemnified hereunder within 15 days after such Third Party Claim has been Finally Determined, in the case of an indemnity claim as to which the Indemnifying Party has acknowledged liability or, in the case of any indemnity claim as to which the Indemnifying

8

Party has not acknowledged liability, within 15 days after such Indemnifying Party's objection to liability hereunder has been Finally Determined.

Section 2.06. Certain Limitations on Claims. Notwithstanding anything else contained in this Agreement, no claim may be made under Section 2.01(a), 2.01 (b), 2.02(a) or 2.02(b): (a) in respect of any single Loss claim or item of $500 or less, provided that this clause (a) shall not preclude a claim under any such Section in an amount in excess of $500 that is made up of several related claims or items that individually are less than $500 in amount, or (b) if the Loss giving rise to such claim is incurred after the fifth anniversary of the date hereof.

Section 2.07. Contribution. If for any reason the indemnification provided for in Section 2.01 or 2.02 is unavailable to any Indemnified Party, or insufficient to hold it harmless, then, subject to the provisions of the Underwriting Agreement relating to the Initial Public Offering, the Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses in such proportion as is appropriate to reflect all relevant equitable considerations.

Section 2.08. Non-Exclusivity of Remedies. The remedies provided for in this Article II are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Party at law or in equity.

ARTICLE III

CERTAIN AGREEMENTS RELATING TO LEASES; OTHER AGREEMENTS

Section 3.01. Continuity of Existing Lease Guarantees. With respect to each real estate lease under which any Person in the Linens Group is a lessee or sublessee and that is in effect prior to the date hereof (including, without limitation, the leases set forth in Schedule 3.01 hereto (the "Scheduled Leases")) and that remains in effect following the date hereof (i) without any renewal option having been exercised or (ii) except in the case of the Scheduled Leases (which will be guaranteed only through the initial term thereof), by reason of the exercise of any renewal option provided for in the terms of such lease as in effect as of the date hereof (collectively, the "Guaranteed Leases"), any lease guarantee of such Guaranteed Lease provided by CVS or any of its Affiliates and in effect as of the date hereof (a "Lease Guarantee") will remain in effect after the date hereof for the duration of the term of such lease

9

and, except in the case of the Scheduled Leases (which will be guaranteed only through the initial term thereof), any extension thereof pursuant to the exercise of any such renewal option. CVS and its Affiliates shall be indemnified against any Losses arising from such Guaranteed Leases or Lease Guarantees, as provided in Section 2.01(c).

Section 3.02. No New CVS Lease Guarantees To be Furnished After The Initial Public Offering. Except as expressly provided otherwise in Section 3.01, to the extent that any guarantee is required to be provided after the date hereof with respect to any real estate or other lease entered into by a Person in the Linens Group, such guarantee shall not be furnished by any Person in the CVS Group.

Section 3.03. Intercompany Accounts. All intercompany receivable, payable and loan balances in existence as of the date hereof between the CVS Group and Linens Group will be eliminated in the manner described in the Registration Statement.

Section 3.04. Certain Rights Upon a Third Party Obtaining Above a Specified Ownership Level of Linens Common Stock. (a) No Person or group (within the meaning of Section 13(d) under the 1934 Act) of Persons shall become the beneficial owner (within the meaning of Rule 13d-3 under the 1934 Act) of a majority of the Common Stock (such beneficial ownership level being "Majority Beneficial Ownership") unless (i) CVS shall have received prior written notice that such Person or group proposes to acquire Majority Beneficial Ownership and
(ii) prior to such acquisition such Person or group provides to CVS (unless waived by CVS in writing) a guarantee, in form and substance acceptable to CVS, of the obligations of Linens under Section 2.01(c) of this Agreement. In addition, upon any such Person or group acquiring Majority Beneficial Ownership, CVS may, at its election, forthwith terminate its provision of any or all of the Services under the Transitional Services Agreement.

(b) As soon as Linens is aware or has reason to believe that any Person or group proposes to acquire (or is considering acquiring) Majority Beneficial Ownership, (i) Linens shall promptly provide written notice thereof to CVS and (ii) Linens shall promptly inform such Person or group in writing of the provisions of this Section 3.04. So long as (x) Linens has a class of its capital stock registered under Section 12 of the 1934 Act and (y) the aggregate future minimum lease payments under the Guaranteed Leases is greater than $50 million, Linens shall disclose the provisions of this Section 3.04 in each Linens' Annual Report on Form 10-K filed under the 1934 Act.

Section 3.05. Intellectual Property Rights and

10

Licenses. Neither Group shall have any right or license in or to any technology, software, intellectual property (including any trademark, service mark, patent or copyright), know-how or other proprietary right owned, licensed or held for use by the other Group.

ARTICLE IV

REGISTRATION RIGHTS

Section 4.01. General. Linens grants to CVS and each other Person in the CVS Group that agrees to be bound by the terms of Appendix A hereto the registration rights set forth in Appendix A hereto. CVS, Nashua Hollis and Linens hereby agree to the terms and provisions set forth in Appendix A hereto.

ARTICLE V

ACCESS TO INFORMATION

Section 5.01. Provision of Corporate Records. Immediately prior to or as soon as practicable following the Initial Public Offering Date, each Group shall provide to the other Group all documents, contracts, books, records and data (including but not limited to minute books, stock registers, stock certificates and documents of title) in its possession relating to such other Group or such other Group's business and affairs; provided that if any such documents, contracts, books, records or data relate to both Groups or the business and operations of both Groups, each such Group shall provide to the other Group true and complete copies of such documents, contracts, books, records or data.

Section 5.02. Access to Information. From and after the Initial Public Offering Date until the later of (a) two years after the date hereof and
(b) the date CVS ceases to be a Principal Stockholder, each Group shall afford promptly to the other Group and its accountants, counsel and other designated representatives reasonable access during normal business hours to all documents, contracts, books, records, computer data and other data in such Group's possession relating to such other Group or the business and affairs of such other Group (other than data and information subject to an attorney/client or other privilege), insofar as such access is reasonably required by such other Group, including, without limitation, for audit, accounting, litigation and disclosure and reporting purposes.

11

Section 5.03. Litigation Cooperation. Each Group shall use reasonable efforts to make available to the other Group and its accountants, counsel, and other designated representatives, upon written request, its directors, officers, employees and representatives as witnesses, and shall otherwise cooperate with the other Group, to the extent reasonably required in connection with any legal, administrative or other proceedings arising out of either Group's business and operations prior to the Initial Public Offering Date in which the requesting party may from time to time be involved.

Section 5.04. Reimbursement. Each Group providing information or witnesses to the other Group, or otherwise incurring any expense in connection with cooperating, under Sections 5.01, 5.02 or 5.03 shall be entitled to receive from the recipient thereof, upon the presentation of invoices therefor, payment for all out-of-pocket costs and expenses (excluding charges for employee time) as may be reasonably incurred in providing such information, witnesses or cooperation.

Section 5.05. Retention of Records. Except as otherwise required by law or agreed to in writing, each party shall, and shall cause the members of its respective Group to, retain all information relating to the other Group's business and operations in accordance with the past practice of such party. Notwithstanding the foregoing, any party may destroy or otherwise dispose of any such information at any time, provided that, prior to such destruction or disposal, (i) such party shall provide not less than 90 days' prior written notice to the other party, specifying the information proposed to be destroyed or disposed of, and (ii) if the recipient of such notice shall request in writing prior to the scheduled date for such destruction or disposal that any of the information proposed to be destroyed or disposed of be delivered to such requesting party, the party proposing the destruction or disposal shall promptly arrange for the delivery of such of the information as was requested at the expense of the requesting party.

Section 5.06. Confidentiality. Each party shall hold and shall cause its directors, officers, employees, agents, consultants and advisors ("Representatives") to hold in strict confidence all information (other than any such information relating solely to the business or affairs of such party) concerning the other party unless (i) such party is compelled to disclose such information by judicial or administrative process or, in the opinion of its counsel, by other requirements of law or (ii) such information can be shown to have been (A) in the public domain through no fault of such party or (B) lawfully acquired after the date hereof on a non-confidential basis from other sources. Notwithstanding the foregoing, such party may

12

disclose such information to its Representatives so long as such Persons are informed by such party of the confidential nature of such information and are directed by such party to treat such information confidentially. If such party or any of its Representatives becomes legally compelled to disclose any documents or information subject to this Section, such party will promptly notify the other party so that the other party may seek a protective order or other remedy or waive such party's compliance with this Section. If no such protective order or other remedy is obtained or waiver granted, such party will furnish only that portion of the information which it is advised by counsel is legally required and will exercise its reasonable efforts to obtain reliable assurance that confidential treatment will be accorded such information. Such party agrees to be responsible for any breach of this Section by it and its Representatives.

Section 5.07. Inapplicability of Article V to Tax Matters. Notwithstanding anything to the contrary in Article V, Article V shall not apply with respect to information, records and other matters relating to Taxes, all of which shall be governed by the Tax Disaffiliation Agreement.

ARTICLE VI

EMPLOYEE MATTERS

Section 6.01. Employee Matters. With respect to employee matters and employee benefit arrangements, the parties hereto agree as set forth in Schedule 6.01.

13

ARTICLE VII

CVS' GOVERNANCE RIGHTS

Section 7.01. Appointment of Outside Directors. Within three months after the date hereof, the Board of Directors of Linens (the "Linens Board") shall fill two of the vacancies on the Linens Board with individuals who are not officers or employees of any entity in the CVS Group or the Linens Group.

Section 7.02. CVS Designated Directors. CVS shall have the right to designate the Applicable CVS Number of directors to the Linens Board and the right to designate the class of the Linens Board to which each such CVS designee shall be elected. In connection with each election of directors, Linens shall nominate each of the Applicable CVS Number of individuals designated by CVS (each, a "CVS Designee") as a director to the Board of Directors and shall recommend to the stockholders the election of each CVS Designee as a director (in the class so designated by CVS). Within three months after the date hereof, the Linens Board shall fill one or more vacancies on the Linens Board with individuals who are CVS Designees so that, after giving effect thereto, the Applicable CVS Number of CVS Designees shall serve as directors on the Linens Board.

Section 7.03. Removal of CVS Designees. In the event of a decrease in the Applicable CVS Number at any time, (i) one or more (as appropriate) CVS Designees (selected by CVS as provided in clause (ii)) shall automatically be deemed removed from the Board effective at such time, and (ii) CVS shall have the right to select the individual to be removed if any CVS Designee is to remain as a director after giving effect to such decrease; provided that if after giving effect to such decrease the Applicable CVS Number is zero, one CVS Designee (selected by CVS) shall continue to serve as a director until the next annual meeting of stockholders. Except as aforesaid or as provided in clause (g) of Article FIFTH of the Linens Charter, no CVS Designee may be removed from the Linens Board except with the written consent of CVS. CVS shall have the right to remove any CVS Designee at any time (such removal to be effective upon delivery of notice thereof to Linens), and the vacancy resulting from such removal shall be filled as provided in Section 7.04.

Section 7.04. Filling of Vacancy of CVS Designee. In the event that
(i) there occurs at any time a vacancy in the Linens Board by reason of the death, retirement, resignation, removal or other departure of any CVS Designee and (ii) after giving effect to such vacancy the number of CVS Designees on the Linens Board is less than the Applicable CVS Number at such time, the Linens Board will act as promptly as practicable to fill such

14

vacancy with a CVS Designee (and will so fill multiple vacancies, if necessary) so that, after giving effect to the election of such CVS Designee as a director, the Applicable CVS Number of CVS Designees shall serve as directors on the Linens Board.

ARTICLE VIII

MISCELLANEOUS

Section 8.01. Notices. All notices and other communications to any party hereunder shall be in writing (including telex, telecopy or similar writing) and shall be deemed given when received addressed as follows:

If to CVS, to:

CVS Corporation
1 CVS Drive
Woonsocket, Rhode Island 02895

Telecopy:   (401) 765-4128
Attention:  Chief Financial Officer and
            General Counsel

With a copy to:

Davis Polk & Wardwell
450 Lexington Avenue
New York, New York 10017 Telecopy: (212) 450-4800 Attention: Dennis S. Hersch

If to Linens, to:

Linens 'n Things, Inc.
6 Brighton Road
Clifton, New Jersey 07015

Telecopy: (201) 778-1300 Attention:

With a copy to:

Davis Polk & Wardwell
450 Lexington Avenue
New York, New York 10017 Telecopy: (212) 450-4800 Attention: Dennis S. Hersch

Any party may, by written notice so delivered to the other parties, change the address to which delivery of any notice shall

15

thereafter be made.

Section 8.02. Amendments; No Waivers. (a) Any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by CVS and Linens, or in the case of a waiver, by the party against whom the waiver is to be effective.

(b) No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.

Section 8.03. Expenses. Except as specifically provided otherwise in this Agreement, the Transitional Services Agreement or the Tax Disaffiliation Agreement (including, without limitation, in Article II, Sections 3.03, 5.04, 5.05 and 8.08(c) and Schedule 6.01 of this Agreement), all costs and expenses incurred in connection with the preparation, execution and delivery of the Stockholder Documents and the consummation of the Initial Public Offering (including the fees and expenses of all counsel, accountants and financial and other advisors of both Groups in connection therewith, and all expenses in connection with preparation, filing and printing of the Registration Statement relating to the Initial Public Offering) shall be paid by CVS; provided that Linens shall be responsible for and pay the fees, expenses and other amounts payable to the lenders under Linens's credit facilities and all other fees and expenses incurred in connection therewith (including the fees and expenses of Linens's counsel in connection with the preparation and negotiation of all documentation relating to such credit facilities).

Section 8.04. Successor and Assigns. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns; provided that no party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other parties hereto.

Section 8.05. Governing Law. This Agreement shall be construed in accordance with and governed by the law of the State of New York (except for Article VII, which shall be construed in accordance with and governed by the law of the State of Delaware), without regard to the conflicts of laws rules of either such State.

16

Section 8.06. Counterparts; Effectiveness. This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each party hereto shall have received a counterpart hereof signed by the other parties hereto.

Section 8.07. Entire Agreement. This Agreement and the other Stockholder Documents constitute the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements, understandings and negotiations, both written and oral, between the parties with respect to the subject matter hereof and thereof. No representation, inducement, promise, understanding, condition or warranty not set forth herein or in the other Stockholder Documents has been made or relied upon by any party hereto. Neither this Agreement nor any provision hereof is intended to confer upon any Person other than the parties hereto any rights or remedies hereunder.

Section 8.08. Tax Disaffiliation Agreement; Set-Off. (a) Except as otherwise provided herein and not inconsistent with the Tax Disaffiliation Agreement, this Agreement shall not govern any Tax, and any and all claims, losses, damages, demands, costs, expenses or liabilities relating to Taxes shall be exclusively governed by the Tax Disaffiliation Agreement.

(b) If, at the time Linens is required to make any payment to CVS under this Agreement, CVS owes Linens any amount under this Agreement or the Tax Disaffiliation Agreement, then such amounts shall be offset and the excess shall be paid by the party liable for such excess. Similarly, if at the time CVS is required to make any payment to Linens under this Agreement, Linens owes CVS any amount under this Agreement or the Tax Disaffiliation Agreement, then such amounts shall be offset and the excess shall be paid by the party liable for such excess.

(c) If, pursuant to a Final Determination, any amount paid by CVS, Linens or their respective Post-Distribution Affiliates pursuant to this Agreement results in any increased Tax liability or reduction of any Tax Asset of any member of the Linens Group, Linens or its Post-Distribution Affiliates, or the CVS Group, CVS or its Post-Distribution Affiliates, respectively, then CVS or Linens, as the case may be, shall indemnify the other party and hold it harmless from any interest or penalty attributable to such increased Tax liability or the reduction of such Tax asset and shall pay to the other party, in addition to amounts otherwise owed, 100 percent of the After-Tax Amount. All capitalized terms used in this Section 8.08(c) and not otherwise

17

defined in this Agreement are used as defined in the Tax Disaffiliation Agreement.

Section 8.09. Jurisdiction. Any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby may be brought in the United States District Court for the Southern District of New York or the United States District Court for the District of Delaware or any other New York State court sitting in New York County or any other court of the State of Delaware, and each of the parties hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding which is brought in any such court has been brought in an inconvenient form. Process in any such suit, action or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each party agrees that service of process on such party as provided in Section 8.01 shall be deemed effective service of process on such party.

Section 8.10. Existing Arrangements. Except as otherwise contemplated hereby, all prior agreements and arrangements, including those relating to goods, rights or services provided or licensed, between the Linens Group and the CVS Group shall be terminated effective as of the Initial Public Offering Date, if not theretofore terminated. No such agreements or arrangements shall be in effect after the Initial Public Offering Date unless embodied in the Stockholder Documents.

Section 8.11. Further Assurances. In addition to the actions specifically provided for elsewhere in the Stockholder Documents, each of the parties hereto shall use its reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things, reasonably necessary, proper or advisable under applicable laws, regulations and agreements or otherwise to consummate and make effective the transactions contemplated by the Stockholder Documents.

Section 8.12. Effective Date. This Agreement shall become effective upon the closing of the Initial Public Offering.

Section 8.13. Captions. The captions herein are included for convenience of reference only and shall be ignored in the construction or interpretation hereof.

18

IN WITNESS WHEREOF the parties hereto have caused this Stockholder Agreement to be duly executed by their respective authorized officers as of the date first above written.

CVS CORPORATION

By

Name:

Title:

LINENS 'N THINGS, INC.

By

Name:

Title:

NASHUA HOLLIS CVS, INC.

By

Name:

Title:


SCHEDULE 6.01

EMPLOYEE MATTERS

Section 1. General. Except as otherwise set forth in this Schedule 6.01, (a) CVS shall retain (i) any and all liabilities relating to or arising out of any employee benefit or compensation arrangement (a "Plan") in respect of any employee or former employee of CVS and any Affiliate of CVS who is not a Transferred Employee (as hereinafter defined), and (ii) any and all liabilities relating to or arising out of any Plan in respect of all Transferred Employees that were incurred or are otherwise related to any period prior to and including the Initial Public Offering Date and (b) CVS shall have no liability relating to or arising out of any Plan in respect of Transferred Employees to the extent that any such liability is incurred or otherwise relates to any period after the Initial Public Offering Date.

Section 2. Employees. With respect to Terrence Grossman or each individual who, as of the Initial Public Offering Date, is employed (including persons absent from active service by reason of Short Term Disability or Long Term Disability, as hereinafter defined, or absence not relating to disability, whether paid or unpaid) in the Linens Business ("Transferred Employees"), Linens shall cause the employment of each Transferred Employee to be continued on the Initial Public Offering Date, provided that nothing stated herein shall limit the right of Linens or any Subsidiary to terminate the employment of any Transferred Employee following the Initial Public Offering Date or to reduce or otherwise modify the position, responsibilities, compensation or benefits of any Transferred Employee at any time, and provided further that an individual who is employed as of the Initial Public Offering Date by Linens or any of its Subsidiaries, but on such date is absent from active service and (i) is receiving Long Term Disability Benefits (as hereinafter defined) or (ii) is absent by reason of Short Term Disability but subsequently begins to receive Long Term Disability Benefits shall not be considered a Transferred Employee for purposes of the CVS Long Term Disability Plan. The employee benefit plans and arrangements maintained by Linens shall give full service credit for purposes of eligibility and vesting (and in connection with any such severance or vacation plan or policy, for purposes of determining the level of benefit) for any service on or prior to the Initial Public Offering Date of a Transferred Employee with CVS and its Subsidiaries. For purposes of this Agreement, (i) "Short Term Disability" shall mean a condition with respect to which an employee is receiving

20

benefits, as of the Initial Public Offering Date, under either the CVS Short Term Disability Plan or the CVS Salary Continuation Plan, and (ii) "Long Term Disability Benefits" shall mean benefits under the CVS Long Term Disability Plan.

Section 3. Qualified Plans. (a) CVS shall retain all liabilities and obligations in respect to benefits accrued by Transferred Employees under CVS's ESOP. CVS shall cause each Transferred Employee to become 100% vested in the employee's account in CVS's ESOP as of the Initial Public Offering Date. As soon as practicable after the Initial Public Offering Date, CVS shall take such action as may be necessary, if any, to permit each Transferred Employee to exercise his rights under CVS's ESOP to effect an immediate distribution of such Transferred Employee's full account balances under CVS's ESOP or to effect a tax-free rollover of the taxable portion of the account balances into an eligible retirement plan (within the meaning of Section 401(a)(31) of the Internal Revenue Code ("Code"), a "Direct Rollover") maintained by Linens (the "Linens Plan") or to an individual retirement account. CVS and Linens shall work together in order to facilitate any such distribution or rollover and to effect a Direct Rollover for those participants who elect to roll over their account balances directly into the Linens Plan; provided that nothing contained herein shall obligate the Linens Plan to accept a Direct Rollover in a form other than cash.

(b) On the Initial Public Offering Date, or as soon as practicable thereafter, Linens shall establish or designate the Linens Plan in order to accommodate the Direct Rollovers described above and shall take all action necessary, if any, to qualify the Linens Plan under the applicable provisions of the Code and shall make any and all filings and submissions to the appropriate governmental authorities required to be made by it in connection with any Direct Rollover.

(c) As soon as practicable after the Initial Public Offering Date, Linens shall establish or designate an individual account plan (the "Successor Individual Account Plan"), which may be the same plan as the Linens Plan, for the benefit of Transferred Employees, shall take all necessary action, if any, to qualify such plan under the applicable provisions of the Code and shall make any and all filings and submissions to the appropriate governmental agencies required to be made by it in connection with the transfer of assets described below. CVS shall cause each Transferred Employee to be 100% vested in the employee's account balance under CVS's 401(k) Profit Sharing Plan as of the Initial Public Offering Date. No later than the date of the transfer described herein, Linens shall make all applicable 401(k), profit sharing, matching contributions and

21

qualified non-elective contributions payable under CVS's 401(k) Profit Sharing Plan with respect to Transferred Employees for periods on or prior to the Initial Public Offering Date and shall be entitled to retain any applicable reserves or accruals relating thereto. As soon as practicable following the Initial Public Offering Date, CVS shall cause the trustee of CVS's 401(k) Profit Sharing Plan to transfer in the form of cash or, to the extent applicable, notes representing outstanding loans made to Transferred Employees under CVS's 401(k) Profit Sharing Plan (or such other form as may be agreed to by CVS and Linens) the full account balances of Transferred Employees (and beneficiaries thereof) under CVS's 401(k) Profit Sharing Plan (which account balances will have been credited with appropriate earnings attributable to the period from the Initial Public Offering Date to the date of transfer described herein), reduced by any necessary benefit or withdrawal payments to or in respect of Transferred Employees occurring during the period from the Initial Public Offering Date to the date of transfer described herein, to the appropriate trustee as designed by Linens under the trust agreement forming a part of the Successor Individual Account Plan, it being understood that CVS is under no obligation to effect a distribution, payment or loan under CVS's 401(k) Profit Sharing Plan in respect of a Transferred Employee who either requests a loan or terminates employment after the Initial Public Offering Date but prior to the date of transfer described herein if the required distribution, payment or loan, as the case may be, forms have not been received by CVS prior to the last day of the month preceding the month in which the transfer described herein occurs. CVS and Linens agree to take such actions and enter into such agreements, if any, that may be necessary to effect the transfer described herein. In consideration for the transfer of assets described herein, Linens shall, effective as of the date of transfer described herein, assume all of the obligations of CVS in respect of the account balances accumulated by Transferred Employees under CVS's 401(k) Profit Sharing Plan (exclusive of any portion of such account balances which are paid or otherwise withdrawn prior to the date of transfer described herein) with respect to the account balances transferred to the Successor Individual Account Plan. CVS hereby indemnifies Linens, the Company and the Subsidiaries against and agrees to hold them harmless from any liabilities or claims (including claims for benefits or for breach of fiduciary duties, but excluding claims for benefits to the extent of the assets transferred hereunder) relating to CVS's
401(k) Profit Sharing Plan (or the qualified status of that Plan) which arose prior to the transfer of assets described herein or which relate to the operation or administration of that Plan prior to the transfer of assets. Linens hereby indemnifies CVS against and agrees to hold it harmless from any liabilities or claims relating to the qualified status of the Successor Individual Account Plan or the

22

operation or administration of that Plan following the transfer of assets described herein.

Section 4. Welfare Plans and Worker Compensation. (a) Linens and its Affiliates shall each establish or designate welfare benefit plans, within the meaning of Section 3(2) of the Employee Retirement Income Security Act of 1974, as amended, and applicable workers compensation plans, for the benefit of their respective Transferred Employees (the "Replacement Welfare Plans"). The Replacement Welfare Plans shall be effective as of the Initial Public Offering Date, provided, that at the request of Linens, CVS shall continue to provide, to the extent applicable, services for (i) Transferred Employees (and eligible spouses and dependents) and (ii) former employees of the Linens Business and their qualified beneficiaries who as of the Initial Public Offering Date are covered pursuant to Title X of the Consolidated Omnibus Budget Reconciliation Act of 1985 and Section 4980B of the Code under its Plans which provide medical, dental, life insurance, accidental death and dismemberment, pharmacy, eyecare and disability benefits for such period of time from the Initial Public Offering Date to not later than May 1, 1997 as Linens shall specify in such request (the "Benefit Transition Period"). Linens shall pay the claim and claims processing cost of such services during the Benefit Transition Period (including claims runout in respect of claims incurred both before and after the Initial Public Offering Date) and shall directly fund all medical and dental claims through a bank account set up solely for such purposes. In addition, Linens shall be entitled to retain any applicable reserves or accruals relating to such benefits. Linens and its designated Affiliates shall retain or assume all of the obligations for any retiree benefits under any welfare plan provided Transferred Employees (and dependents) and retirees (and dependents) terminated while employed by Linens and any Affiliate or while employed in the Linens Business prior to the Initial Public Offering Date. Linens and its Affiliates shall assume as of the end of the Benefit Transition Period all obligations to provide coverage and benefits for Transferred Employees and former employees of the Linens Business and their qualified beneficiaries under the Title X of the Consolidated Omnibus Budget Reconciliation Act of 1985 and Section 4980B of the Code.

(b) Linens shall be responsible for all workers compensation claims, whether arising before or after the Initial Public Offering Date, with respect to any employee or former employee of the Linens Business, including, but not limited to, any Transferred Employee. In addition, Linens shall be entitled to retain any applicable reserves or accruals relating thereto.

Section 5. Stock Options. Except as otherwise

23

provided in any agreement with a Transferred Employee, as of the Initial Public Offering Date all outstanding options issued to Transferred Employees to purchase CVS Common Stock that have heretofore been granted under any employee stock option plan of CVS and are exercisable on the Initial Public Offering Date shall be exercisable for a period of 90 days from the Initial Public Offering Date.

Section 6. Bonus and Profit Incentive Plans. Except as otherwise provided in any agreement with a Transferred Employee, CVS shall have no liability for any bonus or profit incentive awards and Linens shall be responsible for all such awards relating to the period beginning on the Initial Public Offering Date.

Section 7. Severance. The continued employment by Linens and its Affiliates of Transferred Employees after the Initial Public Offering Date shall not be deemed a severance of employment of such Transferred Employees from CVS for purposes of any policy, Plan, program or agreement of CVS or any of its Subsidiaries that provides for the payment of severance, salary continuation or similar benefits.

Section 8. Supplemental Retirement Benefits and Deferred Compensation. (a) Linens and its Affiliates shall assume as of the Initial Public Offering Date all of the obligations and liabilities of CVS and any of its Affiliates for any Transferred Employee under the Deferred Compensation Plan of CVS Corporation and Affiliated Companies and any reserve or accrual in respect of such Transferred Employees shall be retained by Linens.

(b) CVS shall have no liability for any obligation relating to Transferred Employees under the Supplemental Retirement Plans I and II for Select Senior Management of CVS Corporation and any Linens reserve or accrual in respect of such Transferred Employees shall be transferred to CVS.

Section 9. No Third Party Beneficiaries. Neither Transferred Employees nor any current, former or retired employee of CVS or its affiliates shall be entitled to enforce the provisions of this Schedule 6.01 against the respective parties as third party beneficiaries thereof.

24

TAX DISAFFILIATION AGREEMENT

between

CVS CORPORATION,
on behalf of itself and its
Post-Deconsolidation Affiliates

and

LINENS `N THINGS, INC.,
on behalf of itself and its
Post-Deconsolidation Affiliates


1. Definitions

2.Federal and State Taxes--Administrative and Compliance Matters.

(a)     Sole Tax Sharing Agreement.................................8
(b)     Designation of Agent.......................................9
(c)     Pre-Deconsolidation Period Returns........................10

3.Consolidated Federal, Consolidated State and Unitary State Taxes -- Allocation of Taxes.

(a)     General...................................................10
(b)     Estimated Payments........................................11
(c)     Payment of Taxes at Year-End..............................11
(d)     Carrybacks and Certain Other Matters......................14

                                 4. Other Taxes

                              5. Certain Covenants.

(a)     Linens Covenants..........................................18
(b)     CVS Covenants.............................................19
(c)     Linens and CVS Covenant...................................20

                                 6. Indemnities.

(a)(I)  Linens Indemnity .........................................20
(a)(II) Linens Additional Indemnity ..............................21
(b)     CVS Indemnity.............................................21
(c)     Discharge of Indemnity....................................23
(d)     Tax Benefits..............................................24
(e)     Refunds...................................................25
(f)     Clerical Errors...........................................25
(g)     Method of Calculation.....................................25

                        7. Communication and Cooperation.

(a)     Consult and Cooperate.....................................26
(b)     Provide Information.......................................27
(c)     Tax Attribute Matters.....................................28

i

8. Audits and Contest.

9. Payments.

10. Notices.

11. Costs and Expenses.

12. Effectiveness; Termination and Survival.

13. Section Headings.

14. Entire Agreement; Amendments and Waivers.

(a) Entire Agreement. ........................................33
(b) Waiver....................................................34

15.Governing Law and Interpretation.

16. Dispute Resolution.

17. Counterparts.

18. Assignments; Third Party Beneficiaries.

Exhibit A

ii

Exhibit B

TAX DISAFFILIATION AGREEMENT

This Agreement is entered into as of the seond day of December, 1996 between CVS Corporation ("CVS"), a Delaware corporation, on behalf of itself and its Post-Deconsolidation Affiliates, and Linens 'n Things, Inc. ("Linens"), a Delaware corporation, on behalf of itself and its Post-Deconsolidation Affiliates.

W I T N E S S E T H:

WHEREAS CVS and Linens intend to offer shares of Linens Common Stock to the public pursuant to which Linens will cease to be a member of the CVS Consolidated Group, as defined below.

WHEREAS, CVS and Linens desire to set forth their agreement on the rights and obligations of CVS, Linens and their respective Affiliates with respect to the handling and allocation of federal, state, local and foreign Taxes incurred in Taxable periods beginning prior to the Deconsolidation Date and various other Tax matters;

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, the parties agree as follows:

1

1. Definitions

(a) As used in this Agreement:

"Affiliate" of any person shall mean any individual, corporation, partnership or other entity directly or indirectly owning more than 50 percent of, owned more than 50 percent by, or under more than 50 percent common ownership with, such person.

"After-Tax Amount" shall mean an additional amount necessary to reflect the hypothetical Tax consequences of the receipt or accrual of any payment, using the maximum statutory rate (or rates, in the case of an item that affects more than one Tax) applicable to the recipient of such payment for the relevant year, reflecting for example, the effect of the deductions available for interest paid or accrued and for Taxes such as state and local income Taxes.

"CVS Consolidated Group" shall mean, with respect to any Taxable period, (i) with respect to Consolidated Federal Taxes, the affiliated group of corporations of which CVS or Melville Corporation ("Melville") (or a successor of either) was or is the common parent (within the meaning of Section 1504 of the Code), (ii) with respect to Consolidated State Taxes and Unitary State Taxes, the consolidated, combined or unitary group of which CVS or Melville (or a successor of either) or any of their Affiliates was or is a member, and (iii) with respect to any Other Tax payable with respect to a group which includes or included at least one member of the CVS Group and at least one member of the Linens Group, such group.

2

"CVS Group" shall mean, with respect to any Taxable period, CVS, Melville and their Affiliates (including their predecessors and successors) at any time prior to the Deconsolidation (including, without limitation, the Non-Chain Corporations) other than those Affiliates comprising the Linens Group.

"Code" shall mean the Internal Revenue Code of 1986, as amended, or any successor thereto.

"Consolidated Federal Tax" shall mean the consolidated Federal Tax liability of the CVS Consolidated Group for any period as to which a consolidated Federal Tax Return was or is filed by CVS or Melville, or any successor to either, for such group.

"Consolidated State Tax" shall mean with respect to each State, any income or franchise Tax payable with respect to a group of at least two corporations, other than a Unitary State Tax.

"Deconsolidation" shall mean any event pursuant to which Linens ceases to be a subsidiary corporation includible in a consolidated tax return of CVS for Federal Tax purposes, or in a consolidated, combined or unitary return with a member of the CVS Group.

"Deconsolidation Date" shall mean the date on which the Deconsolidation shall be effected.

"Federal Tax" shall mean any Tax imposed under Subtitle A of the Code and any related penalty imposed under Subtitle F of the Code.

3

"Final Determination" shall mean (i) with respect to Federal Taxes, (A) a "determination" as defined in Section 1313(a) of the Code, or (B) the date of acceptance by or on behalf of the Internal Revenue Service of Form 870-AD (or any successor form thereto), as a final resolution of Tax liability for any Taxable period, except that a Form 870-AD (or successor form thereto) that reserves the right of the taxpayer to file a claim for refund and/or the right of the Internal Revenue Service to assert a further deficiency shall not constitute a Final Determination with respect to the item or items so reserved;
(ii) with respect to Taxes other than Federal Taxes, any final determination of liability in respect of a Tax provided for under applicable law; (iii) any final disposition by reason of the expiration of the applicable statute of limitations; and (iv) the payment of Tax by CVS, Linens, or any Affiliate of CVS or Linens, whichever is responsible for payment of such Tax under applicable law, with respect to any item disallowed or adjusted by a Taxing Authority, provided that the provisions of Section 8 hereof have been complied with, or, if such section is inapplicable, that the party responsible under the terms of this Agreement for such Tax is notified by the party paying such Tax that it has determined that no action should be taken to recoup such disallowed item, and the other party agrees with such determination.

"Linens Group" shall mean Linens and its Affiliates immediately after the Deconsolidation Date, including any predecessors thereto, and any corporation that would have been an Affiliate of Linens immediately after

4

the Deconsolidation Date if it had not been previously sold, liquidated or otherwise disposed of.

"Non-Chain Corporations" shall mean Computer Development, Inc., Melville Equipment Leasing Corporation, MC Retail, Inc., Melville Realty Company and their direct and indirect subsidiaries.

"Other Taxes" is defined in Section 4.

"Post-Deconsolidation Affiliate" shall mean with regard to CVS, any person that is or that will be an Affiliate of CVS or a successor to CVS after the Deconsolidation and, with regard to Linens, any person that is or that will be an Affiliate of Linens or a successor to Linens after the Deconsolidation.

"Post-Deconsolidation Period" shall mean any taxable period (or portion thereof) beginning after the close of business on the Deconsolidation Date.

"Pre-Deconsolidation Period" shall mean any Taxable period ending on or before the close of business on the Deconsolidation Date; provided that if a Taxable period ending after the Deconsolidation Date contains any days which fall prior to or on the Deconsolidation Date, any portion of such Taxable period up to or including the Deconsolidation Date shall also be included in the Pre-Deconsolidation Period.

"Pre-Deconsolidation Tax Liability" shall mean (i) the Consolidated Federal Tax, and (ii) the Consolidated State Tax liability of any group that includes at least one member of the CVS Group and at least one member of the Linens Group, (iii) the Unitary State Tax liability of any group which includes at least one member of the CVS Group and at least one

5

member of the Linens Group, and (iv) any Other Taxes, in each case for any Pre-Deconsolidation Period.

"Prime" shall mean the rate announced from time to time as "prime" by Morgan Guaranty Trust Company as its prime rate.

"Referee" is defined in Section 16.

"Return" shall mean any Tax return, statement, report or form (including estimated Tax returns and reports, extension requests and forms, and information returns and reports) required to be filed with any Taxing Authority.

"Tax" (and the correlative meaning, "Taxes," "Taxing" and "Taxable") shall mean (A) any tax imposed under Subtitle A of the Code, any net income, gross income, gross receipts, alternative or add-on minimum, sales, use, value-added, goods and services, ad valorem, franchise, profits, license, withholding, payroll, employment, excise, transfer, recording, severance, stamp, occupation, premium, property, environmental, custom duty, or other tax, governmental fee or other like assessment or charge of any kind whatsoever, together with any interest and any penalty, addition to tax or additional amount imposed by a Taxing Authority; (B) any liability of a member of the CVS Group or the Linens Group, as the case may be, for the payment of any amounts of the type described in clause (A) for any Taxable period resulting from the application of Treasury Regulation Section 1.1502-6 or any similar

6

provision applicable under state, local or foreign law; and (C) any liability of a member of the CVS Group or the Linens Group for the payment of any amounts described in clause (A) as a result of any express or implied obligation to indemnify any other party.

"Tax Asset" shall mean any net operating loss, net capital loss, investment Tax credit, foreign Tax credit, target jobs Tax credit, low income housing credit, research and experimentation credit, charitable deduction or any other credit or Tax attribute, including additions to basis of property, which could reduce any Tax, including, without limitation, deductions, credits, or alternative minimum net operating loss carryforwards related to alternative minimum Taxes.

"Tax Packages" shall mean one or more packages of information, including but not limited to the Corptax file and the divisional reconciliation, that are (i) reasonably necessary for the purpose of preparing Federal Tax, Consolidated State Tax, Unitary State Tax Returns or Other Tax returns of the CVS Consolidated Group with respect to a Pre-Deconsolidation Period and (ii) completed in all material respects in accordance with the standards that CVS has established for its subsidiaries with respect to the relevant Pre-Deconsolidation Period.

"Tax Proceeding" shall mean any Tax audit, dispute or proceeding (whether administrative or judicial).

7

"Taxing Authority" shall mean any governmental authority (domestic or foreign) responsible for the imposition of any Tax.

"Unitary State Tax" shall mean, with respect to each State, any income or franchise Tax payable with respect to a group of at least two corporations and based upon a group apportionment percentage.

(b) Any term used in this Agreement which is not defined in this Agreement shall, to the extent the context requires, have the meaning assigned to it in the Code or the applicable Treasury regulations thereunder and, in the case of Consolidated State Taxes, Unitary State Taxes, and Other Taxes, in comparable provisions of applicable law.

2. Federal and State Taxes--Administrative and Compliance Matters.

(a) Sole Tax Sharing Agreement. The parties acknowledge that there has not been a Final Determination of the Pre-Deconsolidation Tax Liability, and that members of the Linens Group are includible in the CVS Consolidated Group for the Pre-Deconsolidation Period. This Agreement shall constitute the sole Tax sharing agreement between CVS and its Post-Deconsolidation Affiliates, on one hand, and Linens and its Post-Deconsolidation Affiliates, on the other hand, and, to the extent there is any inconsistency between this Agreement and any existing Tax sharing agreements or arrangements, written or unwritten, between CVS and its Post-

8

Deconsolidation Affiliates, on one hand, and Linens and its Post-Deconsolidation Affiliates, on the other hand, this Agreement shall govern.

(b) Designation of Agent. Linens and each member of the Linens Group, with respect to Consolidated Federal Taxes, each hereby irrevocably designate CVS or Melville (to the extent required by applicable law) or a successor of either as its agent, coordinator, and administrator, and, with respect to Consolidated State Taxes, Unitary State Taxes and any Other Taxes payable with respect to a group which includes at least one member of the CVS Group and at least one member of the Linens Group, each hereby irrevocably authorize CVS to designate a member of the CVS Group, or a successor of such member, as its agent, coordinator, and administrator, for the purpose of taking any and all actions (including the execution of waivers of applicable statutes of limitation) necessary or incidental to the filing of any Return, any amended Return, or any claim for refund (even where an item or Tax Asset giving rise to an amended Return or refund claim arises in a Post-Deconsolidation Period), credit or offset of Tax or any other proceedings, and for the purpose of making payments to, or collecting refunds from, any Taxing Authority, in each case relating to any Pre-Deconsolidation Period. CVS or the member of the CVS Group, as the case may be, as agent, covenants to Linens that it shall be responsible to see that all such administrative matters relating thereto shall be handled promptly and appropriately. CVS shall inform and consult with Linens

9

prior to taking any action on behalf of, or which will have any material impact on the Tax liability of the Linens Group.

(c) Pre-Deconsolidation Period Returns. CVS and its Post-Deconsolidation Affiliates will prepare, with the assistance of Linens and its Post-Deconsolidation Affiliates, and file the Consolidated Federal Tax Returns and the Consolidated State and Unitary State Tax Returns for all Pre-Deconsolidation Periods. With respect to the 1996 year, Linens and its Post-Deconsolidation Affiliates shall prepare and deliver to CVS all Tax Packages within 120 days after the Deconsolidation Date.(1)

3. Consolidated Federal, Consolidated State and Unitary State Taxes -- Allocation of Taxes.

(a) General. For the 1995 and 1996 Taxable years of the CVS Consolidated Group,(2) Linens shall pay, or cause to be paid, to CVS or Melville, with respect to 1995) an amount equal to (i) the Linens Group's share of the CVS Consolidated Group's Consolidated Federal Tax and Consolidated State Tax liability, determined in accordance with Exhibit A to this Agreement, and
(ii) the Linens Group's share of the CVS Consolidated Group's Unitary State Tax liability, determined in accordance with Exhibit B to this Agreement.


(1) Provide for 1997 if offering occurs in 1997 or if CVS continues to hold at least 50% of Linens at any time in 1997.

(2) Provide for 1997 if offering occurs in 1997 or if CVS continues to hold at least 50% of Linens at any time in 1997.

10

(b) Estimated Payments. Promptly after CVS, Melville or any of their Affiliates makes an estimated Tax payment with respect to the 1996 Taxable year (other than a payment which relates solely to minimum Taxes due), whether or not such payment is made prior to the Deconsolidation, CVS shall (i) in good faith determine the amount of the Linens Group's share of such estimated Tax payment (X) in accordance with the principles of Exhibit A to this Agreement, in the case of an estimated Tax payment in respect of the Consolidated Federal Tax or any Consolidated State Tax liability of the CVS Consolidated Group, and (Y) in accordance with the principles of Exhibit B to this Agreement using 1995 apportionment factors, adjusted for significant dispositions or transfers of assets, in the case of an estimated Tax payment in respect of any Unitary State Tax liability of the CVS Consolidated Group and (ii) deliver a written statement to Linens reflecting the determination described above. Linens shall pay to CVS or CVS shall pay to Linens, as appropriate, the amount so determined in accordance with Section 9 hereof.

(c) Payment of Taxes at Year-End.

(i) Promptly after CVS, Melville or any of their Affiliates files an application to extend the due date of a Return for the 1995 or 1996 Taxable year, whether or not such application is filed prior to the Deconsolidation, CVS shall (a) in good faith determine the estimated amount of the Linens Group's share of the CVS Consolidated Group's Consolidated Federal Tax or Consolidated State Tax liability for such

11

Return in accordance with the principles of Exhibit A to this Agreement or, in the case of a Unitary State Tax Return, in accordance with the principles of Exhibit B to this Agreement using 1994 and 1995 apportionment factors for 1995 and 1996, respectively, adjusted for significant dispositions or transfers of assets, and (b) deliver a written statement to Linens reflecting the determination described above. Linens shall pay to CVS, or CVS shall pay to Linens, as appropriate, in accordance with Section 9 hereof, an amount equal to the difference, if any, between (x) the amounts so determined and (y) the aggregate amount of estimated installments paid with respect to the Linens Group's share of such Tax liability for such year made pursuant to Section 3(b), adjusted to take into account amounts previously paid or received by Linens or any Affiliate in connection with any previous extension payments made either before or after the Deconsolidation.

(ii) Promptly after CVS or a member of the CVS Consolidated Group files a Consolidated Federal Tax Return, Consolidated State Tax Return or Unitary State Tax Return, as the case may be, for which payments are to be made under this Agreement, whether or not such Return is filed prior to the Deconsolidation, CVS shall deliver to Linens a written statement setting forth the difference between (x) the Linens Group's share of the CVS Consolidated Group's Consolidated Federal Tax, Consolidated State Tax or Unitary State Tax liability for such

12

Return, determined in accordance with the principles of Exhibit A or B to this Agreement, as the case may be, and (y) the aggregate amount of payments with respect to the Linens Group's share of such Tax liability for such year made pursuant to Section 3(b) or Section 3(c)(i). Linens shall pay to CVS, or CVS shall pay to Linens, as appropriate, in accordance with Section 9 hereof, an amount equal to such difference, if any.

(iii) If the determination of the Linens Group's share of the CVS Consolidated Group's Consolidated Federal Tax, Consolidated State Tax or Unitary State Tax reflects a Tax Asset that may under applicable law be used to reduce a Federal Tax, Consolidated State Tax or Unitary State Tax liability, as the case may be, of any member of the CVS Group for any Tax period, CVS shall pay to Linens, in accordance with Section 9 hereof, the actual Tax saving produced by such Tax Asset; provided, however, that such payment shall be made within 30 days of the receipt by CVS or any CVS Affiliate of any refund, credit or other offset attributable thereto from the relevant Taxing Authority. The amount of any such tax saving for any tax period shall be the amount of the reduction in Taxes payable to a Taxing Authority (or the increase in any Tax refund) with respect to such period as compared to the Taxes that would have been payable to a Taxing Authority (or the Tax refund that would have been received) with respect to such period in the

13

absence of such Tax Asset; provided, however, that in the event that the use in a Pre-Deconsolidation Period of a Tax Asset attributable to any member of the Linens Group, gives rise to, or increases, any alternative minimum Tax liability, CVS shall pay to Linens, or Linens shall pay to CVS, as the case may be, an amount equal to the difference between (i) the maximum hypothetical Tax savings that could result from the use of such Tax Asset determined using the maximum applicable regular tax rate in effect for such Taxable year (or, in the case of a credit, 100 percent) and (ii) the Linens Group's share of the alternative minimum Tax liability or increase in alternative minimum Tax liability, as the case may be, determined in accordance with Exhibit A to this Agreement.

(d) Carrybacks and Certain Other Matters.

(i) Subject to the provisions of Exhibit A hereto, CVS agrees to pay Linens the actual benefit received by the CVS Consolidated Group in any Tax period from the use in any Pre-Deconsolidation Period of any Tax Asset arising in a Post-Deconsolidation Period. Such benefit shall be considered equal to the excess of the amount of Tax that would have been payable (or of the Tax refund that would have been receivable) by the CVS Consolidated Group in such Tax period in the absence of such carryback over the amount of Tax actually payable (or of the Tax refund actually receivable) by the CVS Consolidated Group in such period; provided, however, that in the event that the use in a Pre-

14

Deconsolidation Period of a Tax Asset, attributable to any member of the Linens Group, gives rise to, or increases, any alternative minimum Tax liability, CVS shall pay to Linens, or Linens shall pay to CVS, as the case may be, an amount equal to the difference between (i) the maximum hypothetical Tax savings that could result from the use of such Tax Asset determined using the maximum applicable regular tax rate in effect for such Taxable year and (ii) the Linens Group's share of the alternative minimum Tax liability or increase in alternative minimum Tax liability, as the case may be, determined in accordance with Exhibit A to this Agreement. Payment of the amount of such benefit shall be made in accordance with Section 9 hereof; provided, however, that any such payment shall be made within 30 days of the receipt by any member of the CVS Consolidated Group of any refund, credit or other offset attributable thereto from the relevant Taxing Authority.

(ii) If, subsequent to the payment by CVS to Linens of any amount referred to in Section 3(d)(i) above, there shall be (A) a Final Determination which results in a disallowance or a reduction of the Tax Asset so carried back or (B) a reduction in the amount of the benefit realized by the CVS Consolidated Group from such carryback as a result of a Final Determination or the use by the CVS Consolidated Group of a Tax Asset of the CVS Group, Linens shall repay to CVS the amount which would not have been payable to Linens pursuant to Section 3(d)(i)

15

had the amount of the benefit been determined in light of such event. In addition, Linens shall hold CVS and each of its Post-Deconsolidation Affiliates harmless for any penalty or interest payable by any member of the CVS Consolidated Group as a result of any such event referred to in the preceding sentence. Any amounts payable under this Section 3(d)(ii) shall be paid by Linens to CVS in accordance with Section 9 hereof. To the extent Linens' repayment obligation arises due to the use by the CVS Consolidated Group of a Tax asset of a member of the CVS Group, Linens shall pay CVS interest on the amount repaid to CVS from the date such amount was paid by CVS to Linens until such repayment at Prime.

(iii) The parties hereto acknowledge that, in connection with the disposition or deconsolidation of certain members of the CVS Group, CVS or Melville has entered into, and intends to enter into, agreements similar to this Agreement (the "CVS Group Agreements") relating to Tax matters involving such members. Notwithstanding anything to the contrary in this Agreement, to the extent that (i) CVS would be required under Section 3 of this Agreement to make a payment to Linens in respect of a Tax saving or Tax benefit attributable to a Tax Asset of the Linens Group and (ii) CVS would be required under a CVS Group Agreement or Agreements to make a similar payment to a member or

16

members of the CVS Group in respect of the same Tax saving or Tax benefit, then the portion of such Tax saving or benefit attributable to a Tax Asset of the Linens Group shall be calculated in accordance with Treasury Regulation Section 1502-21A and any successor thereto.

4. Other Taxes

(a) Liability for all Taxes other than Consolidated Federal Taxes or Consolidated State or Unitary Taxes ("Other Taxes") attributable to the Linens Group shall be the sole responsibility of Linens and its Post-Deconsolidation Affiliates. Liability for all Other Taxes attributable to the CVS Group shall be the sole responsibility of CVS and its Post-Deconsolidation Affiliates. The responsibility for preparing and filing all Returns, and for making all payments to any Taxing Authority, relating solely to Other Taxes attributable to the Linens Group shall be the sole responsibility of Linens and its Post-Deconsolidation Affiliates. The responsibility for preparing and filing all other Returns, and for making all payments to any Taxing Authority, relating to Other Taxes for any Pre-Deconsolidation Period shall be the sole responsibility of CVS and its Post-Deconsolidation Affiliates. Promptly after a payment of Other Taxes by CVS, or any of its Post-Deconsolidation Affiliates on one hand, or Linens or any of its Post-Deconsolidation Affiliates, on the other hand, the paying party shall notify the non-paying party of the amount of such Other Taxes, if any, which is attributable to the non-paying party, in accordance with

17

Section 4(c). The non-paying party shall pay to the paying party, in accordance with Section 9 hereof, such amount.

(b) Linens shall be entitled to all refunds and credits of Other Taxes attributable to the Linens Group, and CVS shall be entitled to all refunds and credits of Other Taxes attributable to the CVS Group.

(c) The determination of whether Other Taxes are attributable to the CVS Group, on one hand, or the Linens Group, on the other hand, shall be made in accordance with past practices.

5. Certain Covenants.

(a) Linens Covenants. Linens covenants to CVS that during the period beginning on the Deconsolidation Date and ending upon the expiration of the statute of limitations period applicable to the Taxable year in which the Deconsolidation occurs (after giving effect to any extension, mitigation or waiver thereof), Linens will not, nor will it permit any of its Post-Deconsolidation Affiliates to make or change any accounting method, amend any Tax Return or take any Tax position on any Tax Return, change the manner in which it conducts its business, take any other action, omit to take any action or enter into any transaction that results in any increased Tax liability with respect to a Pre-Deconsolidation Period, or reduction of any Tax Asset which was created in a Pre-Deconsolidation Period, of the CVS Group or any member thereof without first obtaining the written consent of an authorized representative of CVS; provided, however, that if a change in law (including the

18

enactment of any statute or the issuance of any proposed, temporary or final regulations, or administrative pronouncement or judicial decision) would have a material adverse effect on the aggregate Tax liability of Linens and its Post-Deconsolidation Affiliates, then, notwithstanding anything to the contrary in this Section 5(a), Linens shall be entitled to take, or to permit its Post-Deconsolidation Affiliates to take, such minimum action as is necessary to eliminate or mitigate the effect of the change in law. Linens agrees to notify CVS of any action taken under the proviso contained in the preceding sentence.

(b) CVS Covenants. CVS covenants to Linens that (i) it will not change its year-end for any Tax year beginning prior to January 1, 1997 and (ii) during the period beginning on the Deconsolidation Date and ending upon the expiration of the statute of limitations period applicable to the Taxable year in which the Deconsolidation occurs (after giving effect to any extension, mitigation or waiver thereof), CVS will not, nor will it permit any of its Post-Deconsolidation Affiliates to make or change any accounting method, amend any Tax Return or take any Tax position on any Tax Return, change the manner in which it conducts its business, take any other action, omit to take any action or enter into any transaction that results in any increased Tax liability with respect to a Pre-Deconsolidation Period, or reduction of any Tax Asset which was created in a Pre-Deconsolidation Period, of the Linens Group or any member thereof without first obtaining the written consent of an authorized representative of Linens; provided, however, that if a change in law (including

19

the enactment of any statute or the issuance of any proposed, temporary or final regulations, or administrative pronouncement or judicial decision) would have a material adverse effect on the aggregate Tax liability of CVS and its Post-Deconsolidation Affiliates, then, notwithstanding anything to the contrary in this clause (ii), CVS shall be entitled to take, or to permit its Post-Deconsolidation Affiliates to take, such minimum action as is necessary to eliminate or mitigate the effect of the change in law. CVS agrees to notify Linens of any action taken under the proviso contained in the preceding sentence.

(c) Linens and CVS Covenant. The parties hereto agree to act in good faith in complying with the terms of this Agreement.

6. Indemnities.

(a)(I) Linens Indemnity. Linens and each corporation that is a Post-Deconsolidation Affiliate of Linens will jointly and severally indemnify CVS and its Post-Deconsolidation Affiliates against and hold them harmless from

(i) any Pre-Deconsolidation Tax Liability assessed pursuant to a Final Determination, to the extent attributable to an adjustment of any item of income, gain, gross receipts, loss, credit, deduction or other Tax attribute of any member of the Linens Group; and

(ii) any liability or damage resulting from a breach by Linens or any of its Post-Deconsolidation Affiliates of any covenant made by Linens herein.

20

(iii) any liability or damage under the securities laws or otherwise resulting from information furnished by Linens in connection with the Deconsolidation.

If a Post-Deconsolidation Affiliate of Linens ceases to be an Affiliate of Linens as a result of a sale of its stock to a third party (whether or not treated as a sale of stock for Tax purposes), such Post-Deconsolidation Affiliate shall be released from its obligations under this Agreement upon such sale and neither Linens nor any of its other Post-Deconsolidation Affiliates shall have any obligation to indemnify CVS or any of its Post-Deconsolidation Affiliates under Section 6(a)(I)(ii) for any liability or damage attributable to actions taken after such sale by such Post-Deconsolidation Affiliates. Notwithstanding anything in this Agreement to the contrary, the preceding sentence shall have no effect on Linens' obligation to indemnify CVS and its Post-Deconsolidation Affiliates pursuant to Section 6(a)(II) of this Agreement.

(a)(II) Linens Additional Indemnity. Linens and each of its Post-Deconsolidation Affiliates agree to continue to be bound by the terms of the Tax Disaffiliation Agreement between Melville and Footstar, Inc. dated as of September 24, 1996 (the "Footstar Tax Disaffiliation Agreement") after the Deconsolidation. Linens will indemnify CVS and its Post-Deconsolidation Affiliates for any liability incurred by CVS or any of its Post-Deconsolidation Affiliates pursuant to Section 6(b)(iii) of the Footstar Tax Disaffiliation

21

Agreement resulting from any action taken after the Deconsolidation by Linens or any of its Post-Deconsolidation Affiliates.

(b) CVS Indemnity. CVS and each corporation that is a Post-Deconsolidation Affiliate of CVS will jointly and severally indemnify Linens and its Post-Deconsolidation Affiliates against and hold them harmless from

(i) any Pre-Deconsolidation Tax Liability, or Tax liability resulting from the Deconsolidation, other than any such liabilities described in Section 6(a);

(ii) any Tax liability allocable to a member of the CVS Group which is a liability of the Linens Group under clause (B) of the definition of Tax with respect to any pre-Deconsolidation Period or any Tax year of the CVS Consolidated Group which includes (but does not end on) the Deconsolidation Date; and

(iii) any liability or damage resulting from a breach by CVS or any of its Post-Deconsolidation Affiliates of any covenant made by CVS herein.

(iv) any liability of damage under the securities laws or otherwise resulting from information furnished by CVS in connection with the Deconsolidation.

For the purpose of avoiding ambiguity, the parties agree that CVS and its Post-Deconsolidation Affiliates shall be responsible under this Agreement for any Tax for a Pre-Deconsolidation Period attributable to (x) the corporations

22

(domestic or foreign) comprising the CVS, Bob's, Footstar (including Footaction, Meldisco, Melville (Europe) Purchasing Ltd. and Thom McAn), Wilsons, Kay-Bee, Marshalls, This End Up, Prints Plus, Chess King, Foxmoor and Accessory Lady retail chains, (y) the Non-Chain Corporations and (z) to any business activity conducted by CVS or any of its Affiliates (domestic or foreign) which is or was directly related to the businesses conducted by the corporations specified in clauses (x) and (y). If a Post-Deconsolidation Affiliate of CVS ceases to be an Affiliate of CVS as a result of a sale of its stock to a third party (whether or not treated as a sale of stock for Tax purposes), such Post-Deconsolidation Affiliate shall be released from its obligations under this Agreement upon such sale and neither CVS nor any of its other Post-Deconsolidation Affiliates shall have any obligation to indemnify Linens or any of its Post-Deconsolidation Affiliates under Section 6(b)(iii) for any liability or damage attributable to actions taken after such sale by such Post-Deconsolidation Affiliates.

(c) Discharge of Indemnity. Linens, CVS and their respective Post-Deconsolidation Affiliates shall discharge their obligations under Section 6(a) and 6(b) hereof, respectively, by paying the relevant amount within 30 days of demand therefor. After a Final Determination of an obligation of Linens or any of its Post-Deconsolidation Affiliates under Section 6(a), CVS shall send a statement to Linens showing the amount due thereunder. After a Final Determination of an obligation of CVS or any of its Post-Deconsolidation

23

Affiliates under Section 6(b), Linens shall send a statement to CVS showing the amount due thereunder. Calculation mechanics relating to items described in
Section 6(a)(i) are set forth in Section 3(c). Notwithstanding the foregoing, if either Linens, CVS or any of their respective Post-Deconsolidation Affiliates disputes in good faith the fact or the amount of its obligation under Section 6(a) or Section 6(b), then no payment of the amount in dispute shall be required until any such good faith dispute is resolved in accordance with Section 16 hereof; provided, however, that any amount not paid within 30 days of demand therefor shall bear interest as provided in Section 9.

(d) Tax Benefits. If an indemnification obligation of CVS, Linens or any of their respective Post-Deconsolidation Affiliates under this Section 6 arises in respect of an adjustment that makes allowable to CVS or its Affiliates, or Linens or its Affiliates, respectively, any deduction, amortization, exclusion from income or other allowance (a "Tax Benefit") which would not, but for such adjustment, be allowable, then any payment by CVS, Linens or any of their respective Post-Deconsolidation Affiliates, as the case may be, pursuant to this Section 6 shall be an amount equal to (X) the amount otherwise due but for this subsection (d), minus (Y) the present value of the product of the Tax Benefit multiplied (i) by the maximum federal or state, as the case may be, corporate tax rate in effect at the time such Tax Benefit becomes allowable to CVS or its Affiliates, or Linens or its Affiliates (as the case may be) or (ii) in the case of a credit, by 100 percent. The present value of such product shall be

24

determined by discounting such product from the time the Tax Benefit becomes allowable at a rate equal to Prime.

(e) Refunds. Any refunds of Tax received by CVS or any of its Post-Deconsolidation Affiliates relating to a Post-Deconsolidation Period, to the extent attributable to any item of income, loss, credit, deduction or other tax attribute of any member of the Linens Group shall be paid by CVS to Linens within 30 days of receipt. Any amount not paid when due shall bear interest as provided in Section 9.

(f) Clerical Errors If, as a result of a correction of a clerical error made by booking any item at one member of the CVS Consolidated Group instead of another, (i) the Pre-Deconsolidation Tax Liability allocable to the Linens Group or the CVS Group, as the case may be, is increased, (ii) the Pre-Deconsolidation Tax Liability allocable to the other group is decreased by an offsetting amount, and (iii) no Tax payment is required to be made to a Taxing Authority in respect of the correction of the clerical error, then the group referred to in clause (ii) of this Section 6(f) shall be treated as having made a Tax payment in an amount equal to the increased Pre-Deconsolidation Tax Liability described in clause (i) of this Section 6(f) and shall be entitled to indemnification therefor under this Section 6 without regard to Section 6(d).

(g) Method of Calculation. (i) Except as otherwise provided, the amount of any liability of Linens and its Post-Deconsolidation Affiliates or of CVS and its Post-Deconsolidation Affiliates under this Section 6 shall be

25

calculated pursuant to the method described in Exhibit A hereto; provided, however, that the calculation of any party's share of Unitary State Tax shall be calculated pursuant to the method described in Exhibit B hereto.

(ii) For purposes of this Section 6, in the case of Taxes that are imposed on a periodic basis and are payable for a Tax period that includes (but does not end on) the Deconsolidation Date, the portion of such Tax related to the portion of such Tax period ending on the Deconsolidation Date shall (x) in the case of any Taxes other than Taxes based upon or related to income, sales, gross receipts, wages, capital expenditures or expenses, be deemed to be the amount of such Tax for the entire Tax period multiplied by a fraction the numerator of which is the number of days in the Tax period ending on the Deconsolidation Date and the denominator of which is the number of days in the entire Tax period, and (y) in the case of any Tax based upon or related to income, sales, gross receipts, wages, capital expenditures or expenses, be deemed equal to the amount which would be payable if the relevant Tax period ended on the Deconsolidation Date and applying the weighted average 1996 Tax rate for the relevant Tax applicable to the corporation subject to such Tax.

7. Communication and Cooperation.

(a) Consult and Cooperate. Linens and CVS shall consult and cooperate (and shall cause each of their Post-Deconsolidation Affiliates to cooperate) fully at such time and to the extent reasonably requested by the other

26

party in connection with all matters subject to this Agreement. Such cooperation shall include, without limitation,

(i) the retention and provision on reasonable request of any and all information including all books, records, documentation or other information pertaining to Tax matters relating to the CVS Group and the Linens Group, any necessary explanations of information, and access to personnel, until the expiration of the applicable statute of limitation (giving effect to any extension, waiver, or mitigation thereof);

(ii) the execution of any document that may be necessary or helpful in connection of any required Return or in connection with any audit, proceeding, suit or action;

(iii) reporting to the other party, on a quarterly basis, on the status of any Tax audit relating to a Pre-Deconsolidation Period; and

(iv) the use of the parties' best efforts to obtain any documentation from a governmental authority or a third party that may be necessary or helpful in connection with the foregoing.

(b) Provide Information. CVS and Linens shall keep each other fully informed with respect to any material development relating to the matters subject to this Agreement. CVS shall provide to Linens copies of all Information Document Requests relating to a Pre-Deconsolidation Period issued by the Internal Revenue Services on Form 4564 or any successor thereto and any analogous requests issued by any other Tax Authority (collectively,

27

"Requests"), and (to the extent practicable in light of the relevant Taxing Authority's requirements) shall use reasonable efforts to provide copies of the response to each Request more than two business days prior to filing such response; provided, however, that CVS's failure to deliver a copy of a response to a Request before such two-day period shall not relieve Linens of its obligations under this Agreement. CVS shall not be required to provide Linens with copies of any Requests or the responses thereto unless specifically related to the Linens group; provided, however, Linens shall not be entitled to review or receive the portion of any response which does not specifically relate to the Linens Group.

(c) Tax Attribute Matters. CVS and Linens shall advise and consult with each other with respect to any proposed Tax adjustments relating to the CVS Consolidated Group or, with respect to Other Taxes, any group which includes at least one member of the CVS Group and at least one member of the Linens Group, which are the subject of an audit or investigation, or are the subject of any proceeding or litigation, and which may affect any Tax attribute of CVS, Linens, the CVS Group, the Linens Group or any Post-Deconsolidation Affiliate of CVS or Linens (including, but not limited to, basis in an asset or the amount of earnings and profits).

8. Audits and Contest.

(a) Notwithstanding anything in this Agreement to the contrary, CVS shall have full control over all matters relating to any Federal Tax return

28

filed by the CVS Consolidated Group, any Consolidated State or Unitary State Tax Return, any Other Tax Return (other than one relating solely to the Linens Group), or any Tax Proceeding relating to any Tax matters of at least one member of the CVS Group. Except as provided in Section 8(b), CVS shall have absolute discretion with respect to any decisions to be made, or the nature of any action to be taken, with respect to any matter described in the preceding sentence.

(b) No settlement of any Tax Proceeding relating to any matter which would cause a payment obligation under Sections 6(a) or 6(b) shall be accepted or entered into by or on behalf of the party entitled to receive a payment under either Section 6(a) or Section 6(b), whichever is applicable, unless the party ultimately responsible for such payment under either Section 6(a) or Section
6(b), whichever is applicable (the "Indemnitor"), consents thereto in writing (which consent shall not be unreasonably withheld). If such consent is unreasonably withheld, all expenses relating to the contest of such matter shall be borne by the Indemnitor, and otherwise they shall be borne equally by the Indemnitor and the indemnified party. If the Indemnitor does not respond to the indemnified party's request for consent within 30 days, the Indemnitor will be deemed to have consented to the settlement. Notwithstanding anything to the contrary herein, the indemnified party shall have the right, without the consent of the Indemnitor, to settle any Tax Proceeding relating to any matter which would cause a payment obligation under Sections 6(a) or 6(b),

29

provided, however, that in such event the Indemnitor shall have no liability under Section 6(a) or (b), as the case may be, with respect to such matter.

(c) The indemnified party agrees to give prompt notice to the Indemnitor of the assertion of any claim, or the commencement of any suit, action or proceeding in respect of which indemnity may be sought hereunder. The failure of the indemnified party to give notice as provided in this Section 8(c) shall not relieve the Indemnitor of its obligations under this Agreement, except to the extent that the Indemnitor is materially prejudiced by such failure to give notice.

(d) With respect to Returns relating to Other Taxes solely attributable to the Linens Group, Linens and its Post-Deconsolidation Affiliates shall have full control over all matters relating to any Tax Proceeding in connection therewith. Linens and its Post-Deconsolidation Affiliates shall have absolute discretion with respect to any decisions to be made, or the nature of any action to be taken, with respect to any matter described in the preceding sentence.

9. Payments.

All payments to be made hereunder shall be made in immediately available funds. Except as otherwise provided, all payments required to be made pursuant to this Agreement will be due 30 days after the receipt of notice of such payment or, where no notice is required, 30 days after the fixing of liability or the resolution of a dispute. Payments shall be deemed made when

30

received. Any payment that is not made when due shall bear interest at the rate per annum determined, from time to time, under the provision of Section 6621(a)(2) of the Code for each day until paid; provided, however, that, if an obligation or the amount thereof is being disputed in good faith, any payment required after resolution of such dispute shall bear interest at Prime until and including the thirtieth day after such resolution. If, pursuant to a Final Determination, any amount paid by CVS, Linens or their respective Post-Deconsolidation Affiliates pursuant to this Agreement results in any increased Tax liability or reduction of any Tax Asset of any member of the Linens Group, Linens or its Post-Deconsolidation Affiliates, or the CVS Group, CVS or its Post-Deconsolidation Affiliates, respectively, then CVS or Linens, as the case may be, shall indemnify the other party and hold it harmless from any interest or penalty attributable to such increased Tax liability or the reduction of such Tax asset and shall pay to the other party, in addition to amounts otherwise owed, 50 percent of the After-Tax Amount; provided, however, that with respect to any amount paid pursuant to Section 3(d)(ii) (other than as a result of the use by the CVS Consolidated Group of a Tax Asset of the CVS Group), Section 6(a)(ii) or (iii) or Section 6(b)(iii) or (iv), CVS or Linens, as the case may be, shall pay to the other party 100 percent of the After-Tax Amount.

10. Notices.

Any notice, demand, claim, or other communication under this Agreement shall be in writing and shall be deemed to have been given upon the

31

delivery or mailing thereof, as the case may be, if delivered personally or sent by certified mail, return receipt requested, postage prepaid, to the parties at the following addresses (or at such other address as a party may specify by notice to the other):

If to CVS, to:

Charles Conaway
1 CVS Drive
Woonsocket, RI 02895

James E. Alward
Michael Golub
67 Millbrook Street
Worcester, MA 01606

If to Linens, to:

James Tomaszewski
William Giles
David Dick
6 Brighton Road
Clifton, NJ 07015

11. Costs and Expenses.

Except as expressly set forth in this Agreement, each party shall bear its own costs and expenses incurred pursuant to this Agreement. For purposes of this Agreement, "out-of-pocket" expenses shall include reasonable attorney fees, accountant fees and other related professional fees and disbursements.

32

12. Effectiveness; Termination and Survival.

This Agreement shall become effective upon the consummation of the Deconsolidation. Notwithstanding anything in this Agreement to the contrary, this Agreement shall remain in effect and its provisions shall survive for the full period of all applicable statutes of limitation (giving effect to any extension, waiver or mitigation thereof).

13. Section Headings.

The headings contained in this Agreement are inserted for convenience only and shall not constitute a part hereof or in any way affect the meaning or interpretation of this Agreement.

14. Entire Agreement; Amendments and Waivers.

(a) Entire Agreement. This Agreement contains the entire understanding of the parties hereto with respect to the subject matter contained herein. No alteration, amendment, modification, or waiver of any of the terms of this Agreement shall be valid unless made by an instrument signed by an authorized officer of CVS and Linens, or in the case of a waiver, by the party against whom the waiver is to be effective.

(b) Waiver. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver hereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power or privilege.

33

15. Governing Law and Interpretation. This Agreement has been made in and shall be construed and enforced in accordance with the laws of the Commonwealth of Massachusetts.

16. Dispute Resolution. If the parties hereto are unable to resolve any disagreement or dispute relating to this Agreement within 20 days, such disagreement or dispute shall be resolved by a nationally recognized law firm or accounting firm expert in Tax matters that is mutually acceptable to the parties hereto (a "Referee"). A Referee so chosen shall resolve any such disagreement pursuant to such procedures as it may deem advisable. Any such resolution shall be binding on the parties hereto without further recourse. Except as otherwise provided herein, the costs of any Referee shall be apportioned between CVS and Linens as determined by such Referee in such manner as the Referee deems reasonable, taking into account the circumstances of the dispute, the conduct of the parties and the result of the dispute.

17. Counterparts.

This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

18. Assignments; Third Party Beneficiaries.

Except as provided below, this Agreement shall be binding upon and shall inure only to the benefit of the parties hereto and their respective successors and assigns. This Agreement is not intended to benefit any person other than the

34

parties hereto and such successors and assigns, and no such other person shall be a third party beneficiary hereof. If, during the period beginning on the Deconsolidation Date and ending upon the expiration of all statute of limitations periods applicable to Pre-Deconsolidation Periods, any corporation becomes an Affiliate of either CVS or Linens, as the case may be, then upon the request of either Linens or CVS, as the case may be, the other party shall provide evidence of such Affiliate's agreement to be bound by the terms of this Agreement. During the period beginning on the Deconsolidation Date and ending upon the expiration of all statute of limitations periods applicable to Pre-Deconsolidation Periods, no entity shall be entitled to acquire a controlling interest in CVS or Linens unless such entity agrees to be bound by the terms of this Agreement.

35

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the day and year first written above.

CVS on its own behalf and on behalf of its Post-Deconsolidation Affiliates

By:__________________________

Title:_______________________

Linens on its own behalf and on behalf of its Post-Deconsolidation Affiliates

By:___________________________

Title:________________________

LNT, Inc., Divisional Agent for the Linens Group

By: __________________________

Title: _______________________

36

Exhibit A

1. The Linens Group's share of any Pre-Deconsolidation Consolidated Federal or Consolidated State Tax liability shall be, with respect to such Federal or Consolidated State Taxes, as applicable, calculated as if Linens were the parent of a group filing its own consolidated return for all Pre-Deconsolidation Periods; provided, however, that (i) income, deductions, credits and losses shall be computed in a manner consistent with past practices, (ii) the applicable Tax rate shall be the appropriate maximum statutory rate in effect during the relevant year, (iii) in no event shall the Linens Group's share of any Consolidated Federal or Consolidated State Tax liability exceed the amount that would have constituted the Linens Group's share of such liability if such share had been calculated in accordance with the allocation principles set forth in Treas. Reg.ss.1.1552-1(a)(2) and Treas. Reg.ss. 1.1502-33(d)(2)(ii) as in effect prior to Treasury Decision 8597, except to the extent consistent with past practice, and (iv) notwithstanding anything to the contrary in this Agreement, any deduction attributable to the exercise of an option to acquire CVS stock by a person who is an employee of a member of the Linens Group at the time of such exercise shall be treated as a deduction allocable to the member of the Linens Group employing such person.

2. For purposes of paragraph 1 above, "Tax liability" (1) shall exclude any liability for the payment of alternative minimum tax; and (2) shall refer to an actual out-of-pocket payment to any Taxing Authority, after taking into account the utilization of net operating losses and any other Tax Assets.

3. Any alternative minimum Tax liability (and any Tax Assets attributable to such liability) and any environmental Tax imposed under Section 59A of the Code shall be allocated among the members of the CVS Consolidated Group in accordance with the formulas referenced in Proposed Treasury Regulation
Section 1.1502-5(b)(6).

4. For all Pre-Deconsolidation Periods, CVS or Melville (as appropriate) shall have the right, in its sole discretion, to elect (in an original or an amended return) to deduct currently any Taxes of foreign countries and of possessions of the United States. In the event that CVS or Melville, as the case may be, elects not to deduct currently such Taxes but instead to elect to take a foreign tax credit under the provisions of Part III of Subchapter N of the Code, any consolidated unused foreign tax credit of

37

the CVS Consolidated Group shall be apportioned to the members of such group pursuant to Treas. Reg.ss. 1.1502-79(d).

5. Any interest imposed in connection with any Tax liability shall be allocated in the same manner as the underlying Tax liability, as provided above.

6. Any penalty imposed in connection with any Tax liability shall be the responsibility of the party whose action or inaction resulted in the imposition of such penalty; provided, however, that if such a determination cannot be made, the penalty shall be allocated in the same manner as the underlying Tax liability, as provided above.

38

Exhibit B

1. The Linens Group's share of any Pre-Deconsolidation Unitary State Tax Liability shall be, with respect to each State, the aggregate amount of Unitary State Tax Liability of all members of the Linens Group that are members of the relevant CVS Consolidated Group. A member's liability for its share of Pre-Deconsolidation Unitary State Tax shall be determined in accordance with paragraph 3 of this Exhibit B; provided, however, that (i) income, deductions, credits and losses shall be computed in a manner consistent with past practices, (ii) credits and any minimum taxes shall be allocated to the member responsible for the generation of such credit or taxes, and (iii) notwithstanding anything to the contrary in this Agreement, any deduction attributable to the exercise of an option to acquire CVS stock by a person who is an employee of a member of the Linens Group at the time of such exercise shall be treated as a deduction allocable to the member of the Linens Group employing such person.

2. The Linens Group's share of any Pre-Deconsolidation Unitary State Tax Assets shall be, with respect to each State, the aggregate amount of Unitary State Tax Assets of all members of the Linens Group. A member's share of such Unitary State Tax Assets shall be determined in accordance with paragraph 3 of this Exhibit B.

3. A member of the Linens Group's share of any Pre-Deconsolidation Unitary State Tax Liability or Pre-Deconsolidation Unitary State Tax Asset shall be the product of (i) such Unitary State Tax Liability or Unitary State Tax Asset, as the case may be, and (ii) the percentage of the numerator used in determining the apportionment percentage of the CVS Consolidated Group for such Unitary State which is attributable to such member of the Linens Group.

4. Any interest imposed in connection with any Tax liability shall be allocated in the same manner as the underlying Tax liability, as provided above.

5. Any penalty imposed in connection with any Tax liability shall be the responsibility of the party whose action or inaction resulted in the imposition of such penalty; provided, however, that if such a determination cannot be made, the penalty shall be allocated in the same manner as the underlying Tax liability, as provided above.

39


FIVE YEAR CREDIT AGREEMENT

Dated as of May 23, 1997

by and among

CVS CORPORATION,

THE LENDERS PARTY THERETO,

FLEET NATIONAL BANK,
as Documentation Agent,

JP MORGAN SECURITIES INC.,
as Syndication Agent,

and

THE BANK OF NEW YORK,
as Administrative Agent,


$670,000,000


Effective Date: May 30, 1997

CLOSING DOCUMENTS


EMMET, MARVIN & MARTIN, LLP
120 BROADWAY
NEW YORK, N.Y. 10271


INDEX

Five Year Credit Agreement
Dated as of May 23, 1997,
by and among
CVS Corporation,
the Lenders party thereto,
Fleet National Bank,
as Documentation Agent,
JP Morgan Securities Inc.,
as Syndication Agent,
and
The Bank of New York,
as Administrative Agent

Capitalized terms used herein which are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

1. FIVE YEAR CREDIT AGREEMENT, dated as of May 23, 1997, by and among CVS CORPORATION, (the "Borrower"), the Lenders party thereto, FLEET NATIONAL BANK, as documentation agent (the "Documentation Agent"), JP MORGAN SECURITIES INC. as syndication agent (the "Syndication Agent"), and THE BANK OF NEW YORK, as administrative agent (the "Administrative Agent"), and arranged by BNY CAPITAL MARKETS, INC.

2. Revolving Credit Notes, Competitive Bid Notes, and Swing Line Note.*

3. Certificate, dated May 30, 1997, of the Secretary of the Borrower, certifying as to the incumbency of its officers who may sign the Loan Documents and all other documents in connection therewith, including therein a signature specimen of such officers, and attaching:

(a) a true and complete copy of its Certificate of Incorporation;

(b) a true and complete copy of its By-Laws;

(c) a certificate of good standing of the Secretary of State of the State of Delaware; and


* previously delivered to each applicable Lender

(d) a true and complete copy of the resolutions of its Board of Directors.

4. Good Standing Telegram from the Secretary of State of the State of Delaware.

5. Certificate, dated May 30, 1997, of the Treasurer of the Borrower, certifying (i) as to the consummation of the CVS/Revco Merger, (ii) that the representations and warranties contained in the Credit Agreement are correct and that no Default or Event of Default exists, and (iii) that immediately before and after giving effect to the consummation of the CVS/ Revco Merger, the Borrower is Solvent, and attaching:

(a) the CVS/Revco Merger Documents.*

6. Opinion of Davis Polk & Wardwell, special New York Counsel to the Borrower, dated May 30, 1997.

7. Opinion of Zenon Lankowsky, General Counsel to the Borrower, dated May 30, 1997.

8. Opinion of Special Counsel, dated May 30, 1997.


* lodged with the Administrative Agent

- 2 -

FIVE YEAR CREDIT AGREEMENT

by and among

CVS CORPORATION,

THE LENDERS PARTY HERETO,

FLEET NATIONAL BANK,
as Documentation Agent,

JP MORGAN SECURITIES INC.,
as Syndication Agent,

and

THE BANK OF NEW YORK,
as Administrative Agent,


$670,000,000


Dated as of May 23, 1997

Arranged by: BNY CAPITAL MARKETS, INC.


                                TABLE OF CONTENTS

1. DEFINITIONS AND PRINCIPLES OF CONSTRUCTION .............................. 1
     1.1 Definitions ....................................................... 1
     1.2 Principles of Construction ....................................... 15

2. AMOUNT AND TERMS OF LOANS .............................................. 16
     2.1 Revolving Credit Loans ........................................... 16
     2.2 Swing Line Loans ................................................. 17
     2.3 Notice of Borrowing-Revolving Credit Loans and Swing
         Line Loans ....................................................... 19
     2.4 Competitive Bid Loans and Procedure .............................. 20
     2.5 Use of Proceeds .................................................. 22
     2.6 Termination or Reduction of Commitments .......................... 22
     2.7 Prepayments of Loans ............................................. 23
     2.8 Letter of Credit Sub-facility .................................... 24
     2.9 Letter of Credit Participation ................................... 25
     2.10 Absolute Obligation with respect to Letter of
          Credit Payments ................................................. 26

3. PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD
   PROTECTION AND FEES .................................................... 26
     3.1 Disbursement of the Proceeds of the Loans ........................ 26
     3.2 Payments ......................................................... 27
     3.3 Conversions; Other Matters ....................................... 28
     3.4 Interest Rates and Payment Dates ................................. 29
     3.5 Indemnification for Loss ......................................... 30
     3.6 Reimbursement for Costs, Etc. .................................... 31
     3.7 Illegality of Funding ............................................ 32
     3.8 Option to Fund; Substituted Interest Rate ........................ 32
     3.9 Certificates of Payment and Reimbursement ........................ 33
     3.10 Taxes; Net Payments ............................................. 33
     3.11 Facility Fee .................................................... 34
     3.12 Letter of Credit Participation Fee .............................. 35
     3.13 Replacement of Lender ........................................... 35

4. REPRESENTATIONS AND WARRANTIES ......................................... 36
     4.1 Existence and Power .............................................. 36
     4.2 Authority ........................................................ 36
     4.3 Binding Agreement ................................................ 37
     4.4 Litigation ....................................................... 37
     4.5 No Conflicting Agreements ........................................ 37
     4.6 Taxes ............................................................ 38
     4.7 Compliance with Applicable Laws; Filings ......................... 38
     4.8 Governmental Regulations ......................................... 38
     4.9 Federal Reserve Regulations; Use of Proceeds ..................... 38
     4.10 No Misrepresentation ............................................ 39
     4.11 Plans ........................................................... 39

     4.12 Environmental Matters ........................................... 39
     4.13 Financial Statements ............................................ 40

5. CONDITIONS OF LENDING - FIRST LOANS AND LETTERS OF CREDIT
   ON THE FIRST BORROWING DATE ............................................ 41
     5.1 Evidence of Corporate Action ..................................... 41
     5.2 Notes ............................................................ 41
     5.3 Opinion of Special Counsel ....................................... 41
     5.4 Opinion of Counsel to the Borrower ............................... 41
     5.5 CVS/Revco Merger ................................................. 41
     5.6 Existing Credit Agreements ....................................... 42

6. CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT ................ 42
     6.1 Compliance ....................................................... 42
     6.2 Requests ......................................................... 42
     6.3 Loan Closings .................................................... 43

7. AFFIRMATIVE COVENANTS .................................................. 43
     7.1 Legal Existence .................................................. 43
     7.2 Taxes ............................................................ 43
     7.3 Insurance ........................................................ 43
     7.4 Performance of Obligations ....................................... 43
     7.5 Condition of Property ............................................ 44
     7.6 Observance of Legal Requirements ................................. 44
     7.7 Financial Statements and Other Information ....................... 44
     7.8 Records .......................................................... 45
     7.9 Authorizations ................................................... 46
     7.10 Revco 10 1/8% Indenture Debt .................................... 46

8. NEGATIVE COVENANTS ..................................................... 46
     8.1 Subsidiary Indebtedness .......................................... 46
     8.2 Liens ............................................................ 46
     8.3 Dispositions ..................................................... 47
     8.4 Merger or Consolidation, Etc. .................................... 47
     8.5 Acquisitions ..................................................... 47
     8.6 Restricted Payments .............................................. 48
     8.7 Limitation on Upstream Dividends by Subsidiaries ................. 48
     8.8 Limitation on Negative Pledges ................................... 49
     8.9 CVS/Revco Merger Documents ....................................... 49
     8.10 Ratio of Consolidated Indebtedness to Total
          Capitalization .................................................. 49

9. DEFAULT ................................................................ 49
     9.1 Events of Default ................................................ 49
     9.2 Remedies ......................................................... 51

10. AGENT ................................................................. 52
     10.1 Appointment ..................................................... 52
     10.2 Delegation of Duties ............................................ 53
     10.3 Exculpatory Provisions .......................................... 53

- ii -

     10.4 Reliance by Administrative Agent ................................ 53
     10.5 Notice of Default ............................................... 54
     10.6 Non-Reliance .................................................... 54
     10.7 Indemnification ................................................. 55
     10.8 Administrative Agent in Its Individual Capacity ................. 55
     10.9 Successor Administrative Agent .................................. 55
     10.10 Documentation Agent and Syndication Agent ...................... 56

11. OTHER PROVISIONS ...................................................... 56
     11.1 Amendments, Waivers, Etc. ....................................... 56
     11.2 Notices ......................................................... 57
     11.3 No Waiver; Cumulative Remedies .................................. 59
     11.4 Survival of Representations and Warranties ...................... 59
     11.5 Payment of Expenses and Taxes; Indemnified
          Liabilities ..................................................... 59
     11.6 Lending Offices ................................................. 60
     11.7 Successors and Assigns .......................................... 60
     11.8 Counterparts .................................................... 61
     11.9 Set-off and Sharing of Payments ................................. 62
     11.10 Indemnity ...................................................... 63
     11.11 Governing Law .................................................. 63
     11.12 Severability ................................................... 64
     11.13 Integration .................................................... 64
     11.14 Treatment of Certain Information ............................... 64
     11.15 Acknowledgments ................................................ 65
     11.16 Consent to Jurisdiction ........................................ 65
     11.17 Service of Process ............................................. 65
     11.18 No Limitation on Service or Suit ............................... 66
     11.19 WAIVER OF TRIAL BY JURY ........................................ 66
     11.20 Effective Date ................................................. 66

EXHIBITS

Exhibit     A        List of Commitments and Lending and Notice Offices
Exhibit     B-1      Form of Revolving Credit Note
Exhibit     B-2      Form of Competitive Bid Note
Exhibit     B-3      Form of Swing Line Note
Exhibit     C        Form of Borrowing Request
Exhibit     D        Form of Opinion of counsel to the Borrower
Exhibit     E        Form of Opinion of Special Counsel
Exhibit     F        Form of Assignment and Acceptance Agreement
Exhibit     G        Form of Competitive Bid Request
Exhibit     H        Form of Invitation to Bid
Exhibit     I        Form of Competitive Bid
Exhibit     J        Form of Competitive Bid Accept/Reject Letter
Exhibit     K        Form of Letter of Credit Request

- iii -

SCHEDULES

Schedule 4.4 List of Litigation
Schedule 8.2 List of Liens

- iv -

FIVE YEAR CREDIT AGREEMENT, dated as of May 23, 1997, by and among CVS CORPORATION, a Delaware corporation (the "Borrower"), the Lenders party hereto from time to time (each a "Lender" and, collectively, the "Lenders"), FLEET NATIONAL BANK, as documentation agent (in such capacity, the Documentation Agent"), JP MORGAN SECURITIES INC. as syndication agent (in such capacity, the "Syndication Agent"), and THE BANK OF NEW YORK ("BNY"), as administrative agent for the Lenders (in such capacity, the "Administrative Agent"), and arranged by BNY CAPITAL MARKETS, INC.

1. DEFINITIONS AND PRINCIPLES OF CONSTRUCTION

1.1 Definitions

When used in any Loan Document (as defined below), each of the following terms shall have the meaning ascribed thereto unless the context otherwise specifically requires:

"ABR Advances": the Revolving Credit Loans (or any portions thereof) at such time as they (or such portions) are made or are being maintained at a rate of interest based upon the Alternate Base Rate.

"Accumulated Funding Deficiency": as defined in Section 302 of ERISA.

"Acquisition": with respect to any Person, the purchase or other acquisition by such Person, by any means whatsoever (including by devise, bequest, gift, through a dividend or otherwise), of (a) stock of, or other equity securities of, any other Person if, immediately thereafter, such other Person would be either a consolidated subsidiary of such Person or otherwise under the control of such Person, (b) any business, going concern or division or segment thereof, or (c) the Property of any other Person other than in the ordinary course of business, provided that (i) no acquisition of substantially all of the assets, or any division or segment, of such other Person shall be deemed to be in the ordinary course of business and (ii) no redemption, retirement, purchase or acquisition by any Person of the stock or other equity securities of such Person shall be deemed to constitute an Acquisition.

"Administrative Agent": as defined in the preamble.

"Affected Advance": as defined in Section 3.8(b).

"Affiliate": with respect to any Person at any time and from time to time, any other Person (other than a wholly-owned subsidiary of such Person) which, at such time (a) controls such Person, (b) is controlled by such Person or (c) is under common control with such Person. The term "control", as used in this definition with respect to any Person, means the power, whether direct or indirect through one or more intermediaries, to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or other interests, by contract or otherwise.

"Aggregate Commitment Amount": at any time, the sum of the Commitment Amounts of the Lenders at such time under this Agreement.


"Aggregate Credit Exposure": at any time, the sum at such time of (a) the aggregate Committed Credit Exposure of the Lenders at such time under this Agreement and (b) the aggregate outstanding principal balance of all Competitive Bid Loans at such time under this Agreement.

"Agreement": this Credit Agreement, as the same may be amended, supplemented or otherwise modified from time to time.

"Alternate Base Rate": for any day, a rate per annum equal to the greater of (a) the BNY Rate in effect on such day, or (b) 0.50% plus the Federal Funds Effective Rate (rounded, if necessary, to the nearest 1/100th of 1% or, if there is no nearest 1/100 of 1%, then to the next higher 1/100 of 1%) in effect on such day.

"Applicable Margin": (i) with respect to the unpaid principal balance of ABR Advances, the applicable percentage set forth below in the column entitled "ABR Advances", (ii) with respect to the unpaid principal balance of Eurodollar Advances, the applicable percentage set forth below in the column entitled "Eurodollar Advances", (iii) with respect to the Facility Fee, the applicable percentage set forth below in the column entitled "Facility Fee" and (iv) with respect to the Letter of Credit Participation Fee, the applicable percentage set forth below in the column entitled "Letters of Credit", in each case opposite the applicable Pricing Level:

--------------------------------------------------------------------------------
                        ABR              Eurodollar    Facility      Letters of
Pricing Level           Advances         Advances      Fee           Credit
-------------           --------         --------      ---           ------

Pricing Level I            0%            0.130%        0.060%        0.130%
Pricing Level II           0%            0.135%        0.065%        0.135%
Pricing Level III          0%            0.145%        0.065%        0.145%
Pricing Level IV           0%            0.155%        0.070%        0.155%
Pricing Level V            0%            0.185%        0.090%        0.185%
Pricing Level VI           0%            0.225%        0.125%        0.225%
Pricing Level VII          0%            0.2625%       0.1875%       0.2625%
--------------------------------------------------------------------------------

Decreases in the Applicable Margin resulting from a change in Pricing Level shall become effective upon the delivery by the Borrower to the Administrative Agent of a notice pursuant to Section 7.7(d). Increases in the Applicable Margin resulting from a change in Pricing Level shall become effective on the effective date of any downgrade or withdrawal in the rating by Moody's or S&P of the senior unsecured long term debt rating of the Borrower.

"Assignment": as defined in Section 11.7(c).

"Assignment and Acceptance Agreement": an assignment and acceptance agreement executed by an assignor and an assignee pursuant to which, subject to the terms and conditions hereof and thereof, the assignor assigns to the assignee all or any portion of such assignor's Loans, Notes and Commitment, substantially in the form of Exhibit F.

"Assignment Fee": as defined in Section 11.7(c).

-2-

"Benefited Lender": as defined in Section 11.9(b).

"BNY": as defined in the preamble.

"BNY Rate": a rate of interest per annum equal to the rate of interest publicly announced in New York City by BNY from time to time as its prime commercial lending rate, such rate to be adjusted automatically (without notice) on the effective date of any change in such publicly announced rate.

"Borrower": as defined in the preamble.

"Borrower Audited Financial Statements": as defined in Section 4.13.

"Borrower Pro Forma Financial Statements": as defined in Section 4.13.

"Borrowing Date": (i) in respect of Revolving Credit Loans, any Business Day on which the Lenders shall make Revolving Credit Loans pursuant to a Borrowing Request or pursuant to a Mandatory Borrowing, (ii) in respect of Competitive Bid Loans, any Business Day on which a Lender shall make a Competitive Bid Loan pursuant to a Competitive Bid Request, (iii) in respect of Swing Line Loans, any Business Day on which the Swing Line Lender shall make a Swing Line Loan pursuant to a Borrowing Request and (iv) in respect of Letters of Credit, any Business Day on which the Issuer shall issue a Letter of Credit pursuant to a Letter of Credit Request.

"Borrowing Request": a request for Revolving Credit Loans or Swing Line Loans in the form of Exhibit C.

"Change of Control": any of the following:

(i) any Person or group (as such term is used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, (a) shall have or acquire beneficial ownership of securities having 30% or more of the ordinary voting power of the Borrower or (b) shall possess, directly or indirectly, the power to direct or cause the direction of the management and policies of the Borrower, whether through the ownership of voting securities, by contract or otherwise; or

(ii) the Continuing Directors shall cease for any reason to constitute a majority of the board of directors of the Borrower then in office.

"Commitment": in respect of any Lender, such Lender's undertaking to make Revolving Credit Loans, subject to the terms and conditions hereof, in an aggregate outstanding principal amount not to exceed the Commitment Amount of such Lender.

"Commitment Amount": at any time and with respect to any Lender, the amount set forth adjacent to such Lender's name under the heading "Commitment Amount" in Exhibit A at such time or, in the event that such Lender is not listed on Exhibit A, the "Commitment Amount" which such Lender shall have assumed from another Lender in accordance with Section 11.7 on or prior to such time, as the same may be adjusted from time to time pursuant to Sections 2.6 and 11.7(c).

-3-

"Commitment Percentage": at any time and with respect to any Lender, a fraction the numerator of which is such Lender's Commitment Amount at such time, and the denominator of which is the Aggregate Commitment Amount at such time.

"Commitment Period": the period commencing on the Effective Date and ending on the Commitment Termination Date, or on such earlier date as all of the Commitments shall have been terminated in accordance with the terms hereof.

"Commitment Termination Date": the earlier of the fifth anniversary of the Effective Date and the date on which the Loans shall become due and payable, whether by acceleration, notice of intention to prepay or otherwise.

"Committed Credit Exposure": with respect to any Lender at any time, the sum at such time of (a) the outstanding principal balance of such Lender's Revolving Credit Loans, (b) the Swing Line Exposure of such Lender and (c) the Letter of Credit Exposure of such Lender.

"Competitive Bid": an offer by a Lender, in the form of Exhibit I, to make one or more Competitive Bid Loans.

"Competitive Bid Accept/Reject Letter": a notification made by the Borrower pursuant to Section 2.4(d) in the form of Exhibit J.

"Competitive Bid Loan": as defined in Section 2.4(a).

"Competitive Bid Note": as defined in Section 2.4(h).

"Competitive Bid Rate": as to any Competitive Bid made by a Lender pursuant to Section 2.4(b), the fixed rate of interest (which shall be expressed in the form of a decimal to no more than four decimal places) offered by such Lender and accepted by the Borrower.

"Competitive Bid Request": a request by the Borrower, in the form of Exhibit G, for Competitive Bids.

"Competitive Interest Period": as to any Competitive Bid Loan, the period commencing on the date of such Competitive Bid Loan and ending on the date requested in the Competitive Bid Request with respect thereto, which shall not be earlier than 3 days after the date of such Competitive Bid Loan or later than 180 days after the date of such Competitive Bid Loan; provided that if any Competitive Interest Period would end on a day other than a Domestic Business Day, such Interest Period shall be extended to the next succeeding Domestic Business Day, unless such next succeeding Domestic Business Day would be a date on or after the Commitment Termination Date, in which case such Competitive Interest Period shall end on the next preceding Domestic Business Day. Interest shall accrue from and including the first day of a Competitive Interest Period to but excluding the last day of such Competitive Interest Period.

"Consolidated": the Borrower and the Subsidiaries on a consolidated basis in accordance with GAAP.

-4-

"Contingent Obligation": as to any Person (the "secondary obligor"), any obligation of such secondary obligor (a) guaranteeing or in effect guaranteeing any return on any investment made by another Person, or (b) guaranteeing or in effect guaranteeing any Indebtedness, lease, dividend or other obligation ("primary obligation") of any other Person (the "primary obligor") in any manner, whether directly or indirectly, including any obligation of such secondary obligor, whether or not contingent, (i) to purchase any such primary obligation or any Property constituting direct or indirect security therefor,
(ii) to advance or supply funds (A) for the purchase or payment of any such primary obligation or (B) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (iii) to purchase Property, securities or services primarily for the purpose of assuring the beneficiary of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation,
(iv) otherwise to assure or hold harmless the beneficiary of such primary obligation against loss in respect thereof, and (v) in respect of the Indebtedness of any partnership in which such secondary obligor is a general partner, except to the extent that such Indebtedness of such partnership is nonrecourse to such secondary obligor and its separate Property; provided that the term "Contingent Obligation" shall not include the indorsement of instruments for deposit or collection in the ordinary course of business.

"Continuing Director": any member of the board of directors of the Borrower who (i) is a member of that board of directors on the Effective Date or
(ii) was nominated for election by the board of directors a majority of whom were directors on the Effective Date or whose election or nomination for election was previously approved by one or more of such directors.

"Control Person": as defined in Section 3.6.

"Convert", "Conversion" and "Converted": each, a reference to a conversion pursuant to Section 3.3 of one Type of Revolving Credit Loan into another Type of Revolving Credit Loan.

"Costs": as defined in Section 3.6.

"CVS Existing Credit Agreement": the Credit Agreement, dated as of July 10, 1996, by and among the Borrower, the lenders party thereto and The Bank of New York, as agent.

"CVS/Revco Merger": the merger of Revco into and with CVS Sub, with Revco as the surviving corporation.

"CVS/Revco Merger Date": the date on which the CVS/Revco Merger shall be consummated.

"CVS/Revco Merger Documents": the S-4 Registration Statement of the Borrower, as filed with the Securities and Exchange Commission on March 28, 1997, and the Agreement and Plan of Merger, dated as of February 6, 1997, among the Borrower, Revco and CVS Sub, as amended by the First Amendment, dated as of March 19, 1997, in each case as the same may be amended, supplemented or otherwise modified from time to time in accordance with Section 8.9.

-5-

"CVS Sub": North Acquisition Corp., a Delaware corporation and a wholly-owned Subsidiary of the Borrower formed for the purpose of effecting the CVS/Revco Merger. Prior to the CVS/Revco Merger, CVS Sub shall have no assets (other than as required by law) and no liabilities (other than liabilities arising under, or pursuant to, the CVS/Revco Merger Documents).

"Default": any of the events specified in Section 9.1, whether any requirement for the giving of notice, the lapse of time, or both, or any other condition, has been satisfied.

"Disposition": with respect to any Person, any sale, assignment, transfer or other disposition by such Person by any means, of:

(a) the Stock of, or other equity interests of, any other Person,

(b) any business, operating entity, division or segment thereof, or

(c) any other Property of such Person, other than (i) the sale of inventory (other than in connection with bulk transfers), (ii) the disposition of equipment and (iii) the sale of cash investments.

"Dividend Restrictions": as defined in Section 8.7.

"Documentation Agent": as defined in the preamble.

"Dollar or "$": lawful currency of the United States of America.

"Domestic Business Day": any day (other than a Saturday, Sunday or legal holiday in the State of New York) on which banks are open for business in New York City.

"Effective Date": as defined in Section 11.20.

"Employee Benefit Plan": an employee benefit plan, within the meaning of
Section 3(3) of ERISA, maintained, sponsored or contributed to by the Borrower, any Subsidiary or any ERISA Affiliate.

"ERISA": the Employee Retirement Income Security Act of 1974, as amended from time to time, or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.

"ERISA Affiliate": when used with respect to an Employee Benefit Plan, ERISA, the PBGC or a provision of the Internal Revenue Code pertaining to employee benefit plans, any Person that is a member of any group of organizations within the meaning of Sections 414(b) or (c) of the Internal Revenue Code or, solely with respect to the applicable provisions of the Internal Revenue Code, Sections 414(m) or (o) of the Internal Revenue Code, of which the Borrower or any Subsidiary is a member.

"ESOP Guaranty": the guaranty of the 8.52% ESOP Note maturing 2008 in the aggregate unpaid principal amount, as of December 31, 1996, of $309,400,000.

-6-

"Eurodollar Advance": a portion of the Revolving Credit Loans selected by the Borrower to bear interest during a Eurodollar Interest Period selected by the Borrower at a rate per annum based upon a Eurodollar Rate determined with reference to such Interest Period, all pursuant to and in accordance with
Section 2.1 or 3.3.

"Eurodollar Business Day": any Domestic Business Day, other than a Domestic Business Day on which banks are not open for dealings in Dollar deposits in the interbank eurodollar market.

"Eurodollar Interest Period": the period commencing on any Eurodollar Business Day selected by the Borrower in accordance with Section 2.1 or Section 3.3 and ending one, two, three or six months thereafter, as selected by the Borrower in accordance with either such Sections, subject to the following:

(i) if any Interest Period would otherwise end on a day which is not a Eurodollar Business Day, such Interest Period shall be extended to the immediately succeeding Eurodollar Business Day unless the result of such extension would be to carry the end of such Interest Period into another calendar month, in which event such Interest Period shall end on the Eurodollar Business Day immediately preceding such day; and

(ii) if any Interest Period shall begin on the last Eurodollar Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period), such Interest Period shall end on the last Eurodollar Business Day of such latter calendar month.

"Eurodollar Rate": with respect to each Eurodollar Advance and as determined by the Administrative Agent, the rate of interest per annum (rounded, if necessary, to the nearest 1/100 of 1% or, if there is no nearest 1/100 of 1%, then to the next higher 1/100 of 1%) equal to a fraction, the numerator of which is the rate per annum quoted by BNY at approximately 11:00 A.M. (or as soon thereafter as practicable) two Eurodollar Business Days prior to the first day of such Interest Period to leading banks in the interbank eurodollar market as the rate at which BNY is offering Dollar deposits in an amount approximately equal to its Commitment Percentage of such Eurodollar Advance and having a period to maturity approximately equal to the Interest Period applicable to such Eurodollar Advance, and the denominator of which is an amount equal to 1.00 minus the aggregate of the then stated maximum rates during such Interest Period of all reserve requirements (including marginal, emergency, supplemental and special reserves), expressed as a decimal, established by the Board of Governors of the Federal Reserve System and any other banking authority to which BNY and other major United States money center banks are subject, in respect of eurocurrency liabilities.

"Event of Default": any of the events specified in Section 9.1, provided that any requirement for the giving of notice, the lapse of time, or both, or any other condition has been satisfied.

"Existing Credit Agreements": the CVS Existing Credit Agreement and the Revco Existing Credit Agreement.

-7-

"Expiration Date": the first date, occurring after the Commitments shall have terminated or been terminated in accordance herewith, upon which there shall be no Loans or Letters of Credit outstanding.

"Facility Fee": as defined in Section 3.11.

"Federal Funds Effective Rate": for any period, a fluctuating interest rate per annum equal for each day during such period to the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers, as published for such day (or, if such day is not a Domestic Business Day, for the next preceding Domestic Business Day) by the Federal Reserve Bank of New York, or, if such rate is not so published for any day which is a Domestic Business Day, the average (rounded, if necessary, to the nearest 1/100 of 1% or, if there is no nearest 1/100 of 1%, then to the next higher 1/100 of 1%) of the quotations for such day on such transactions received by the Administrative Agent from three Federal funds brokers of recognized standing selected by the Administrative Agent.

"Fees": as defined in Section 3.2.

"Financial Statements": as defined in Section 4.13.

"GAAP": generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or such other principles as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination, consistently applied.

"Governmental Authority": any foreign, federal, state, municipal or other government, or any department, commission, board, bureau, agency, public authority or instrumentality thereof, or any court or arbitrator.

"Highest Lawful Rate": as to any Lender, the maximum rate of interest, if any, which at any time or from time to time may be contracted for, taken, charged or received on the Loans or the Notes or which may be owing to such Lender pursuant to this Agreement under the laws applicable to such Lender and this Agreement.

"Indebtedness": as to any Person at a particular time, all items of such Person which constitute, without duplication, (a) indebtedness for borrowed money or the deferred purchase price of Property (other than trade payables and accrued expenses incurred in the ordinary course of business), (b) indebtedness evidenced by notes, bonds, debentures or similar instruments, (c) indebtedness with respect to any conditional sale or other title retention agreement, (d) indebtedness arising under acceptance facilities and the amount available to be drawn under all letters of credit (excluding for purposes of Sections 8.1 and 8.10 letters of credit obtained in the ordinary course of business by the Borrower or any Subsidiary) issued for the account of such Person and, without duplication, all drafts drawn thereunder to the extent such Person shall not have reimbursed the issuer in respect of the issuer's payment of such drafts,
(e) that portion of any obligation of such Person, as lessee, which in accordance with GAAP is required to be capitalized on a balance sheet of such Person, (f) all indebtedness described in (a) - (e) above secured by

-8-

any Lien on any Property owned by such Person even though such Person shall not have assumed or otherwise become liable for the payment thereof (other than carriers', warehousemen's, mechanics', repairmen's or other like non-consensual Liens arising in the ordinary course of business), and (g) Contingent Obligations in respect of any indebtedness described in items (a) - (f) above; provided that, for purposes of this definition, Indebtedness shall not include Intercompany Debt and obligations in respect of interest rate caps, collars, exchanges, swaps or other, similar agreements.

"Indemnified Liabilities": as defined in Section 11.5.

"Indemnified Person": as defined in Section 11.10.

"Intercompany Debt": (i) Indebtedness of the Borrower to one or more of the Subsidiaries of the Borrower and (ii) demand Indebtedness of one or more of the Subsidiaries of the Borrower to the Borrower or any one or more of the other Subsidiaries of the Borrower.

"Intercompany Disposition": a Disposition by the Borrower or any of the Subsidiaries of the Borrower to the Borrower or to any of the other Subsidiaries of the Borrower.

"Interest Payment Date": (i) as to any ABR Advance, the last day of each March, June, September and December, commencing on the first of such days to occur after such ABR Advance is made or any Eurodollar Advance is converted to an ABR Advance, (ii) as to any Swing Line Loan, the day on which the outstanding principal balance of such Swing Line Loan shall become due and payable in accordance with Section 2.2(a), (iii) as to any Eurodollar Advance in respect of which the Borrower has selected a Eurodollar Interest Period of one, two or three months, the last day of such Eurodollar Interest Period, (iv) as to any Competitive Bid Loan in respect of which the Borrower has selected a Competitive Interest Period of 90 days or less the last day of such Competitive Interest Period and (v) as to any Eurodollar Advance or Competitive Bid Loan in respect of which the Borrower has selected an Interest Period greater than three months or 90 days, as the case may be, the last day of the third month or the 90th day, as the case may be, of such Interest Period and the last day of such Interest Period.

"Interest Period": a Eurodollar Interest Period, a Swing Line Interest Period or a Competitive Interest Period, as the case may be.

"Internal Revenue Code": the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.

"Invitation to Bid": an invitation by the Administrative Agent to the Lenders to make Competitive Bids in the form of Exhibit H.

"Issuer": BNY.

"Lender": as defined in the preamble; such term to also include the Swing Line Lender and the Issuer where the context hereof requires or permits such inclusion.

-9-

"Letter of Credit": as defined in Section 2.8.

"Letter of Credit Commitment": the commitment of the Issuer to issue Letters of Credit in accordance with the terms hereof in an aggregate outstanding face amount not exceeding $50,000,000 (or, if less, the Aggregate Commitment Amount) at any time, as the same may be reduced pursuant to Section 2.6.

"Letter of Credit Exposure": at any time, (a) in respect of all Lenders, the sum, without duplication, of (i) the maximum aggregate amount which may be drawn under all unexpired Letters of Credit at such time (whether the conditions for drawing thereunder have or may be satisfied), (ii) the aggregate amount, at such time, of all unpaid drafts (which have not been dishonored) drawn under all Letters of Credit, and (iii) the aggregate unpaid principal amount of the Reimbursement Obligations at such time, and (b) in respect of any Lender, an amount equal to such Lender's Commitment Percentage at such time multiplied by the amount determined under clause (a) of this definition.

"Letter of Credit Participation": with respect to each Lender, its obligations to the Issuer under Section 2.9.

"Letter of Credit Participation Fee": as defined in Section 3.12.

"Letter of Credit Request": a request in the form of Exhibit K.

"Lien": any mortgage, pledge, hypothecation, assignment, lien, deposit arrangement, charge, encumbrance or other security arrangement or security interest of any kind, or the interest of a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement.

"Loan": a Revolving Credit Loan, a Competitive Bid Loan or a Swing Line Loan, as the case may be.

"Loan Documents": this Agreement and, upon the execution and delivery thereof, the Notes and the Reimbursement Agreements.

"Loans": the Revolving Credit Loans, the Competitive Bid Loans and the Swing Line Loans.

"Mandatory Borrowing": as defined in Section 2.2(c).

"Margin Stock": any "margin stock", as said term is defined in Regulation U of the Board of Governors of the Federal Reserve System, as the same may be amended or supplemented from time to time.

"Material Adverse": with respect to any change or effect, a material adverse change in, or effect on, as the case may be, (i) the financial condition, operations, business, or Property of the Borrower and the Subsidiaries taken as a whole, (ii) the ability of the Borrower to perform its obligations under the Loan Documents, or (iii) the ability of the Administrative Agent, the Issuer or any Lender to enforce the Loan Documents.

"Moody's": Moody's Investors Service, Inc.

-10-

"Multiemployer Plan": a Pension Plan which is a multiemployer plan as defined in Section 4001(a)(3) of ERISA.

"Negotiated Rate": with respect to each Swing Line Loan, the rate per annum agreed to in writing by the Borrower and the Swing Line Lender as the interest rate which such Swing Line Loan shall bear.

"Net Worth": at any date of determination, the sum of all amounts which would be included under shareholders' equity on a Consolidated balance sheet of the Borrower and the Subsidiaries determined in accordance with GAAP as at such date.

"Note": a Revolving Credit Note, a Competitive Bid Note or the Swing Line Note, as the case may be.

"Other Credit Agreement": the 364 Day Credit Agreement, dated as of May 23, 1997, by and among the Borrower, the lenders party thereto, Fleet National Bank, as documentation agent, JP Morgan Securities Inc., as syndication agent, and The Bank of New York, as administrative agent, as the same may be amended, supplemented or otherwise modified from time to time.

"PBGC": the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV of ERISA, or any Governmental Authority succeeding to the functions thereof.

"Pension Plan": at any time, any Employee Benefit Plan (including a Multiemployer Plan) subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, the funding requirements of which are, or at any time within the six years immediately preceding the time in question, were in whole or in part, the responsibility of the Borrower, any Subsidiary or an ERISA Affiliate.

"Person": any individual, firm, partnership, limited liability company, joint venture, corporation, association, business trust, joint stock company, unincorporated association, trust, Governmental Authority or any other entity, whether acting in an individual, fiduciary, or other capacity, and for the purpose of the definition of "ERISA Affiliate", a trade or business.

"Pricing Level": Pricing Level I, Pricing Level II, Pricing Level III, Pricing Level IV, Pricing Level V, Pricing Level VI or Pricing Level VII, as the case may be.

"Pricing Level I": any time when the senior unsecured long term debt rating of the Borrower by (x) S&P is AA- or higher or (y) Moody's is Aa3 or higher.

"Pricing Level II": any time when (i) the senior unsecured long term debt rating of the Borrower by (x) S&P is A+ or higher or (y) Moody's is A1 or higher and (ii) Pricing Level I does not apply.

"Pricing Level III": any time when (i) the senior unsecured long term debt rating of the Borrower by (x) S&P is A or higher or (y) Moody's is A2 or higher and (ii) neither Pricing Level I nor II applies.

-11-

"Pricing Level IV": any time when (i) the senior unsecured long term debt rating of the Borrower by (x) S&P is A- or higher or (y) Moody's is A3 or higher and (ii) none of Pricing Level I, II or III applies.

"Pricing Level V": any time when (i) the senior unsecured long term debt rating of the Borrower by (x) S&P is BBB+ or higher or (y) Moody's is Baa1 or higher and (ii) none of Pricing Level I, II, III or IV applies.

"Pricing Level VI": any time when (i) the senior unsecured long term debt rating of the Borrower by (x) S&P is BBB or higher or (y) Moody's is Baa2 or higher and (ii) none of Pricing Level I, II, III, IV or V applies.

"Pricing Level VII": any time when none of Pricing Level I, II, III, IV, V or VI applies.

Notwithstanding each definition of Pricing Level set forth above, if at any time the senior unsecured long term debt ratings of the Borrower by S&P and Moody's differ by more than one equivalent rating level, then the applicable Pricing Level shall be determined based upon the lower such rating adjusted upwards to the next higher rating level.

"Principal Office": from time to time, the principal office of BNY, located on the date hereof in New York, New York.

"Prohibited Transaction": a transaction that is prohibited under Section 4975 of the Internal Revenue Code or Section 406 of ERISA and not exempt under
Section 4975 of the Internal Revenue Code or Section 408 of ERISA.

"Property": in respect of any Person, all types of real, personal or mixed property and all types of tangible or intangible property owned or leased by such Person.

"Regulatory Change": (a) the introduction or phasing in of any law, rule or regulation after the date hereof, (b) the issuance or promulgation after the date hereof of any directive, guideline or request from any central bank or United States or foreign Governmental Authority (whether or not having the force of law), or (c) any change after the date hereof in the interpretation of any existing law, rule, regulation, directive, guideline or request by any central bank or United States or foreign Governmental Authority charged with the administration thereof, in each case applicable to the transactions contemplated by this Agreement.

"Reimbursement Agreement": as defined in Section 2.8(b).

"Reimbursement Obligations": all obligations and liabilities of the Borrower due and to become due (a) under the Reimbursement Agreements and (b) hereunder in respect of Letters of Credit.

"Replaced Lender": as defined in Section 3.13.

"Replacement Lender": as defined in Section 3.13.

-12-

"Reportable Event": with respect to any Pension Plan, (a) any event set forth in Sections 4043(b) (other than a Reportable Event as to which the 30 day notice requirement is waived by the PBGC under applicable regulations), 4062(e) or 4063(a) of ERISA, or the regulations thereunder, (b) an event requiring the Borrower, any Subsidiary or any ERISA Affiliate to provide security to a Pension Plan under Section 401(a)(29) of the Internal Revenue Code, or (c) the failure to make any payment required by Section 412(m) of the Internal Revenue Code.

"Required Lenders": (a) at any time prior to the Commitment Termination Date or such earlier date as all of the Commitments shall have terminated or been terminated in accordance herewith, Lenders having Commitment Amounts equal to or more than 51% of the Aggregate Commitment Amount, and (b) at all other times, Lenders holding Notes having an unpaid principal balance equal to or more than 51% of all Loans outstanding.

"Restricted Payment": with respect to any Person, any of the following, whether direct or indirect: (a) the declaration or payment by such Person of any dividend or distribution on any class of Stock of such Person, other than a dividend payable solely in shares of that class of Stock to the holders of such class, (b) the declaration or payment by such Person of any distribution on any other type or class of equity interest or equity investment in such Person, and
(c) any redemption, retirement, purchase or acquisition of, or sinking fund or other similar payment in respect of, any class of Stock of, or other type or class of equity interest or equity investment in, such Person.

'Restrictive Agreement": as defined in Section 8.7.

"Revco": Revco D.S., Inc., a Delaware corporation.

"Revco Audited Financial Statements": as defined in Section 4.13.

"Revco Existing Credit Agreement": collectively, the Amended and Restated Credit Agreement dated as of July 27, 1995 among Revco, the financial institutions party thereto, as revolving lenders, Banque Paribas and Bank of America Illinois, as managing agents, and Bank of America National Trust and Savings Association, as administrative agent, as amended, and the Credit Agreement (364 Day Facility) dated as of November 15, 1996 among Revco, Banque Paribas and Bank of America Illinois, as lenders, and Bank of America National Trust and Savings Association, as administrative agent.

"Revco 9 1/8% Indenture Debt": the Indebtedness of Revco under the 9 1/8% senior notes due 2000 issued under the Indenture, dated as of January 1, 1993, between Revco and First Fidelity Bank, National Association, New Jersey, as trustee, as amended by the First Amendment to Indenture, dated as of April 20, 1994.

"Revco 10 1/8% Indenture Debt": the Indebtedness of Hook SupeRx, Inc. (a wholly-owned subsidiary of Revco), as issuer, and Revco, as guarantor, under the 10 1/8% senior notes due 2002 issued under the Indenture, dated as of June 1, 1992, between Hook SupeRx, Inc. and Star Bank, National Association, as trustee.

"Revolving Credit Loans": as defined in Section 2.1(a).

"Revolving Credit Note": as defined in Section 2.1(b).

-13-

"S&P": Standard and Poor's Ratings Group, a division of McGraw-Hill, Inc.

"Solvent": with respect to any Person on a particular date, the condition that on such date, (i) the fair value of the Property of such Person is greater than the total amount of liabilities, including, without limitation, contingent liabilities, of such Person, (ii) the present fair salable value of the assets of such Person is not less than the amount that will be required to pay the probable liability of such Person on its debts as they become absolute and matured, (iii) such Person does not intend to, and does not believe that it will, incur debts or liabilities beyond such Person's ability to pay as such debts and liabilities mature, and (iv) such Person is not engaged in business or a transaction, and is not about to engage in business or a transaction, for which such Person's Property would constitute an unreasonably small amount of capital. For purposes of this definition, the amount of any contingent liability at any time shall be computed as the amount that, in light of all the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability after taking into account probable payments by co-obligors.

"Special Counsel": Emmet, Marvin & Martin, LLP.

"Subsidiary": at any time and from time to time, any corporation, association, partnership, limited liability company, joint venture or other business entity of which the Borrower and/or any Subsidiary of the Borrower, directly or indirectly at such time, either (a) in respect of a corporation, owns or controls more than 50% of the outstanding stock having ordinary voting power to elect a majority of the board of directors or similar managing body, irrespective of whether a class or classes shall or might have voting power by reason of the happening of any contingency, or (b) in respect of an association, partnership, limited liability company, joint venture or other business entity, is entitled to share in more than 50% of the profits and losses, however determined.

"Swing Line Commitment": the commitment of the Swing Line Lender to make Swing Line Loans in accordance with the terms hereof in an aggregate outstanding principal amount not exceeding $50,000,000 (or, if less, the Aggregate Commitment Amount) at any time, as the same may be reduced pursuant to Section 2.6.

"Swing Line Commitment Period": the period from the Effective Date to, but excluding, the Swing Line Termination Date.

"Swing Line Exposure": at any time, in respect of any Lender, an amount equal to the aggregate principal balance of Swing Line Loans at such time multiplied by such Lender's Commitment Percentage at such time.

"Swing Line Interest Period": as to any Swing Line Loan, the period commencing on the date of such Swing Line Loan and ending on the date set forth by the Borrower in the Borrowing Request with respect to such Swing Line Loan; provided that the last day of any Swing Line Interest Period shall not be earlier than one day after the date of such Swing Line Loan or later than 7 days after the date of such Swing Line Loan and in no event later than the Swing Line Termination Date; and provided further that if any Swing Line Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day.

-14-

"Swing Line Lender": BNY.

"Swing Line Loan" and "Swing Line Loans": as defined in Section 2.2(a).

"Swing Line Maturity Date": as defined in Section 2.2(a).

"Swing Line Note": as defined in Section 2.2(b).

"Swing Line Participation Amount": as defined in Section 2.2(d).

"Swing Line Termination Date": the date which is 7 Domestic Business Days prior to the Commitment Termination Date.

"Syndication Agent": as defined in the preamble.

"Tangible Net Worth": at any date of determination, Net Worth less all assets of the Borrower and its Subsidiaries included in such Net Worth, determined on a Consolidated basis at such date, that would be classified as intangible assets in accordance with GAAP.

"Termination Event": with respect to any Pension Plan, (a) a Reportable Event, (b) the termination of a Pension Plan under Section 4041(c) of ERISA, or the filing of a notice of intent to terminate a Pension Plan under Section 4041(c) of ERISA, or the treatment of a Pension Plan amendment as a termination under Section 4041(e) of ERISA (except an amendment made after such Pension Plan satisfies the requirement for a standard termination under Section 4041(b) of ERISA), (c) the institution of proceedings by the PBGC to terminate a Pension Plan under Section 4042 of ERISA, or (d) the appointment of a trustee to administer any Pension Plan under Section 4042 of ERISA.

"Total Capitalization": at any date, the sum of the Borrower's Consolidated Indebtedness and shareholders' equity on such date, determined in accordance with GAAP.

"Type": with respect to any Revolving Credit Loan, the characteristic of such Loan as an ABR Advance or a Eurodollar Advance, each of which constitutes a Type of Revolving Credit Loan.

"Unqualified Amount": as defined in Section 3.4(c).

"Upstream Dividends": as defined in Section 8.7.

1.2 Principles of Construction

(a) All capitalized terms defined in this Agreement shall have the meanings given such capitalized terms herein when used in the other Loan Documents or in any certificate, opinion or other document made or delivered pursuant hereto or thereto, unless otherwise expressly provided therein.

(b) Unless otherwise expressly provided herein, the word "fiscal" when used herein shall refer to the relevant fiscal period of the Borrower. As used in the Loan

-15-

Documents and in any certificate, opinion or other document made or delivered pursuant thereto, accounting terms not defined in Section 1.1, and accounting terms partly defined in Section 1.1, to the extent not defined, shall have the respective meanings given to them under GAAP.

(c) The words "hereof", "herein", "hereto" and "hereunder" and similar words when used in each Loan Document shall refer to such Loan Document as a whole and not to any particular provision of such Loan Document, and Section, schedule and exhibit references contained therein shall refer to Sections thereof or schedules or exhibits thereto unless otherwise expressly provided therein.

(d) All references herein to a time of day shall mean the then applicable time in New York, New York, unless otherwise expressly provided herein.

(e) Section headings have been inserted in the Loan Documents for convenience only and shall not be construed to be a part thereof. Unless the context otherwise requires, words in the singular number include the plural, and words in the plural include the singular.

(f) Whenever in any Loan Document or in any certificate or other document made or delivered pursuant thereto, the terms thereof require that a Person sign or execute the same or refer to the same as having been so signed or executed, such terms shall mean that the same shall be, or was, duly signed or executed by (i) in respect of any Person that is a corporation, any duly authorized officer thereof, and (ii) in respect of any other Person (other than an individual), any analogous counterpart thereof.

(g) The words "include" and "including", when used in each Loan Document, shall mean that the same shall be included "without limitation", unless otherwise specifically provided.

2. AMOUNT AND TERMS OF LOANS

2.1 Revolving Credit Loans

(a) Subject to the terms and conditions hereof, each Lender severally (and not jointly) agrees to make loans under this Agreement (each a "Revolving Credit Loan" and, collectively with each other Revolving Credit Loan of such Lender and/or with each Revolving Credit Loan of each other Lender, the "Revolving Credit Loans") to the Borrower from time to time during the Commitment Period, during which period the Borrower may borrow, prepay and reborrow in accordance with the provisions hereof. Immediately after making each Revolving Credit Loan and after giving effect to all Swing Line Loans and Competitive Bid Loans repaid and all Reimbursement Obligations paid on the same date, the Aggregate Credit Exposure will not exceed the Aggregate Commitment Amount. With respect to each Lender, at the time of the making of any Revolving Credit Loan, the sum of (I) the principal amount of such Lender's Revolving Credit Loan constituting a part of the Revolving Credit Loans to be made, (II) the aggregate principal balance of all other Revolving Credit Loans (exclusive of Revolving Credit Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the Revolving Credit Loans to be made) then outstanding from such Lender and (III) the product of (A) such Lender's Commitment Percentage and (B) the sum of (1) the aggregate principal

-16-

balance of all Swing Line Loans (exclusive of Swing Line Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the respective Revolving Credit Loans) then outstanding and (2) the Letter of Credit Exposure of all Lenders, will not exceed the Commitment of such Lender at such time. During the Commitment Period, the Borrower may borrow, prepay in whole or in part and reborrow Revolving Credit Loans under the Commitments, all in accordance with the terms and conditions hereof. At the option of the Borrower, indicated in a Borrowing Request, Revolving Credit Loans may be made as ABR Advances or Eurodollar Advances.

(b) Revolving Credit Loans made by each Lender shall be evidenced by a promissory note of the Borrower, substantially in the form of Exhibit B-1 (each, as indorsed or modified from time to time, a "Revolving Credit Note"), payable to the order of such Lender, dated the first Borrowing Date, and in the maximum stated principal amount equal to such Lender's Commitment Amount and evidencing the obligation of the Borrower to pay such Commitment Amount, or, if less, the aggregate unpaid principal balance of the Revolving Credit Loans made by such Lender, with interest thereon as provided herein.

(c) The aggregate outstanding principal balance of all Revolving Credit Loans shall be due and payable on the Commitment Termination Date or on such earlier date upon which all of the Commitments shall have been voluntarily terminated by the Borrower in accordance with Section 2.6.

2.2 Swing Line Loans

(a) Subject to the terms and conditions hereof, the Swing Line Lender agrees to make loans under this Agreement (each a "Swing Line Loan" and, collectively, the "Swing Line Loans") to the Borrower from time to time during the Swing Line Commitment Period. Swing Line Loans (i) may be repaid and reborrowed in accordance with the provisions hereof, (ii) shall not, immediately after giving effect thereto, result in the Aggregate Credit Exposure exceeding the Aggregate Commitment Amount, and (iii) shall not, immediately after giving effect thereto, result in the aggregate outstanding principal balance of all Swing Line Loans exceeding the Swing Line Commitment. The Swing Line Lender shall not be obligated to make any Swing Line Loan at a time when any Lender shall be in default of its obligations under this Agreement unless the Swing Line Lender has entered into arrangements satisfactory to it and the Borrower to eliminate the Swing Line Lender's risk with respect to such defaulting Lender's participation in such Swing Line Loan. The Swing Line Lender will not make a Swing Line Loan if the Administrative Agent, or any Lender by notice to the Swing Line Lender and the Borrower no later than one Business Day prior to the Borrowing Date with respect to such Swing Line Loan, shall have determined that the conditions set forth in Sections 5 and 6 have not been satisfied and such conditions remain unsatisfied as of the requested time of the making of such Loan. Each Swing Line Loan shall be due and payable on the day (the "Swing Line Maturity Date") being the earliest of the last day of the Swing Line Interest Period applicable thereto, the date on which the Swing Line Commitment shall have been voluntarily terminated by the Borrower in accordance with Section 2.6, and the date on which the Loans shall become due and payable pursuant to the provisions hereof, whether by acceleration or otherwise. Each Swing Line Loan shall bear interest at the Negotiated Rate applicable thereto. The Swing Line Lender shall disburse the proceeds of Swing Line

-17-

Loans at its office designated in Section 11.2 by crediting such proceeds to an account of the Borrower maintained with the Swing Line Lender.

(b) Swing Line Loans shall be evidenced by a promissory note of the Borrower, substantially in the form of Exhibit B-3 (as indorsed or modified from time to time, the "Swing Line Note"), payable to the order of the Swing Line Lender, dated the first Borrowing Date, and in the maximum stated principal amount equal to the Swing Line Commitment and evidencing the obligation of the Borrower to pay the amount of the Swing Line Commitment or, if less, the aggregate unpaid principal balance of the Swing Line Loans made by the Swing Line Lender which shall not have been funded by a Mandatory Borrowing, together with interest thereon as provided herein.

(c) On any Business Day on which a Swing Line Loan shall be due and payable and shall remain unpaid, the Swing Line Lender may, in its sole discretion, give notice to the Lenders and the Borrower that such outstanding Swing Line Loan shall be funded with a borrowing of Revolving Credit Loans (provided that such notice shall be deemed to have been automatically given upon the occurrence of a Default or an Event of Default under Sections 9.1(h) or
(i)), in which case a borrowing of Revolving Credit Loans made as ABR Advances (each such borrowing, a "Mandatory Borrowing"), shall be made by all Lenders pro rata based on each such Lender's Commitment Percentage on the Business Day immediately succeeding the giving of such notice. The proceeds of each Mandatory Borrowing shall be remitted directly to the Swing Line Lender to repay such outstanding Swing Line Loan. Each Lender irrevocably agrees to make a Revolving Credit Loan pursuant to each Mandatory Borrowing in the amount and in the manner specified in the preceding sentence and on the date specified in writing by the Swing Line Lender notwithstanding: (i) whether the amount of such Mandatory Borrowing complies with the minimum amount for Loans otherwise required hereunder, (ii) whether any condition specified in Section 6 is then unsatisfied, (iii) whether a Default or an Event of Default then exists, (iv) the Borrowing Date of such Mandatory Borrowing, (v) the aggregate principal amount of all Loans then outstanding, (vi) the Aggregate Credit Exposure at such time and (vii) the amount of the Commitments at such time.

(d) Upon each receipt by a Lender of notice of an Event of Default from the Administrative Agent pursuant to Section 10.5, such Lender shall purchase unconditionally, irrevocably, and severally (and not jointly) from the Swing Line Lender a participation in the outstanding Swing Line Loans (including accrued interest thereon) in an amount equal to the product of its Commitment Percentage and the outstanding balance of the Swing Line Loans (each, a "Swing Line Participation Amount"). Each Lender shall also be liable for an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to this Section that are subsequently rescinded or avoided, or must otherwise be restored or returned. Such liabilities shall be unconditional and without regard to the occurrence of any Default or Event of Default or the compliance by the Borrower with any of its obligations under the Loan Documents.

(e) In furtherance of Section 2.2(d), upon each receipt by a Lender of notice of an Event of Default from the Administrative Agent pursuant to
Section 10.5, such Lender shall promptly make available to the Administrative Agent for the account of the Swing Line Lender its Swing Line Participation Amount at the office of the Administrative Agent specified in Section 11.2, in lawful money of the United States and in immediately available funds. The Administrative Agent shall deliver the payments made

-18-

by each Lender pursuant to the immediately preceding sentence to the Swing Line Lender promptly upon receipt thereof in like funds as received. Each Lender hereby indemnifies and agrees to hold harmless the Administrative Agent and the Swing Line Lender from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and expenses resulting from any failure on the part of such Lender to pay, or from any delay in paying the Administrative Agent any amount such Lender is required by notice from the Administrative Agent to pay in accordance with this Section upon receipt of notice of an Event of Default from the Administrative Agent pursuant to Section 10.5 (except in respect of losses, liabilities or other obligations suffered by the Administrative Agent or the Swing Line Lender, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or the Swing Line Lender, as the case may be), and such Lender shall pay interest to the Administrative Agent for the account of the Swing Line Lender from the date such amount was due until paid in full, on the unpaid portion thereof, at a rate of interest per annum, whether before or after judgment, equal to (i) from the date such amount was due until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate plus 2%, payable upon demand by the Swing Line Lender. The Administrative Agent shall distribute such interest payments to the Swing Line Lender upon receipt thereof in like funds as received.

(f) Whenever the Administrative Agent is reimbursed by the Borrower for the account of the Swing Line Lender for any payment in connection with Swing Line Loans and such payment relates to an amount previously paid by a Lender pursuant to this Section, the Administrative Agent will promptly remit such payment to such Lender.

2.3 Notice of Borrowing-Revolving Credit Loans and Swing Line Loans

The Borrower agrees to notify the Administrative Agent (and with respect to a Swing Line Loan, the Swing Line Lender), which notification shall be irrevocable, no later than (a) 12:00 Noon on the proposed Borrowing Date in the case of Swing Line Loans, (b) 10:00 A.M. on the proposed Borrowing Date in the case of Revolving Credit Loans to consist of ABR Advances and (c) 10:00 A.M. at least two Eurodollar Business Days prior to the proposed Borrowing Date in the case of Revolving Credit Loans to consist of Eurodollar Advances. Each such notice shall specify (i) the aggregate amount requested to be borrowed under the Commitments or the Swing Line Commitment, (ii) the proposed Borrowing Date,
(iii) whether a borrowing of Revolving Credit Loans is to be of ABR Advances or Eurodollar Advances, and the amount of each thereof (iv) the Interest Period for such Eurodollar Advances and (v) the Swing Line Interest Period for, and the amount of, each Swing Line Loan. Each such notice shall be promptly confirmed by delivery to the Administrative Agent (and, with respect to a Swing Line Loan, the Swing Line Lender) of a Borrowing Request. Each Eurodollar Advance to be made on a Borrowing Date, when aggregated with all amounts to be Converted to Eurodollar Advances on such date and having the same Interest Period as such Eurodollar Advance, shall equal no less than $10,000,000, or an integral multiple of $1,000,000 in excess thereof. Each ABR Advance made on each Borrowing Date shall equal no less than $5,000,000 or an integral multiple of $500,000 in excess thereof. Each Swing Line Loan made on each Borrowing Date shall equal no less than $1,000,000 or an integral multiple of $500,000 in excess thereof. The Administrative Agent shall promptly notify each Lender (by telephone or otherwise, such notification to be confirmed by fax or other writing) of each such Borrowing Request. Subject to its receipt of each such notice from the Administrative Agent and

-19-

subject to the terms and conditions hereof, (A) each Lender shall make immediately available funds available to the Administrative Agent at the address therefor set forth in Section 11.2 not later than 1:00 P.M. on each Borrowing Date in an amount equal to such Lender's Commitment Percentage of the Revolving Credit Loans requested by the Borrower on such Borrowing Date and/or (B) the Swing Line Lender shall make immediately available funds available to the Borrower on such Borrowing Date in an amount equal to the Swing Line Loan requested by the Borrower.

2.4 Competitive Bid Loans and Procedure

(a) Subject to the terms and conditions hereof, the Borrower may request competitive bid loans under this Agreement (each a "Competitive Bid Loan") during the Commitment Period. In order to request Competitive Bids, the Borrower shall deliver by hand or fax to the Administrative Agent a duly completed Competitive Bid Request not later than 11:00 A.M., one Domestic Business Day before the proposed Borrowing Date therefor. A Competitive Bid Request that does not conform substantially to the format of Exhibit G may be rejected by the Administrative Agent in the Administrative Agent's reasonable discretion, and the Administrative Agent shall promptly notify the Borrower of such rejection by fax and telephone. Each Competitive Bid Request shall specify
(x) the proposed Borrowing Date for the Competitive Bid Loans then being requested (which shall be a Domestic Business Day) and the aggregate principal amount thereof and (y) the Competitive Interest Period or Interest Periods (which shall not exceed ten different Interest Periods in a single Competitive Bid Request), with respect thereto (which may not end after the Domestic Business Day immediately preceding the Commitment Termination Date). Promptly after its receipt of each Competitive Bid Request that is not rejected as aforesaid, the Administrative Agent shall invite by fax (in the form of Exhibit
H) the Lenders to bid, on the terms and conditions of this Agreement, to make Competitive Bid Loans pursuant to such Competitive Bid Request.

(b) Each Lender, in its sole and absolute discretion, may make one or more Competitive Bids to the Borrower responsive to a Competitive Bid Request. Subject to subsection (f) below, each Competitive Bid by a Lender must be received by the Administrative Agent not later than 10:00 A.M. on the proposed Borrowing Date for the relevant Competitive Bid Loan. Multiple bids will be accepted by the Administrative Agent. Bids to make Competitive Bid Loans that do not conform substantially to the format of Exhibit I may be rejected by the Administrative Agent after conferring with, and upon the instruction of, the Borrower, and the Administrative Agent shall notify the Lender making such nonconforming bid of such rejection as soon as practicable. Each Competitive Bid shall be irrevocable and shall specify (x) the principal amount (which (1) shall be in a minimum principal amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof, and (2) may equal the entire principal amount requested by the Borrower) of the Competitive Bid Loan or Competitive Bid Loans that the Lender is willing to make to the Borrower, (y) the Competitive Bid Rate or Rates at which the Lender is prepared to make such Competitive Bid Loan or Competitive Bid Loans, and (z) the Competitive Interest Period with respect to each such Competitive Bid Loan and the last day thereof. If any Lender shall elect not to make a Competitive Bid, such Lender shall so notify the Administrative Agent by fax not later than 10:00 A.M. on the proposed Borrowing Date therefor, provided that the failure by any Lender to give any such notice shall not obligate such Lender to make any Competitive Bid Loan in connection with the relevant Competitive Bid Request.

-20-

(c) With respect to each Competitive Bid Request, the Administrative Agent shall (i) notify the Borrower by fax by 11:00 A.M. on the proposed Borrowing Date with respect thereto of each Competitive Bid made, the Competitive Bid Rate applicable thereto and the identity of the Lender that made such Competitive Bid, and (ii) send a list of all Competitive Bids to the Borrower for its records as soon as practicable after completion of the bidding process. Each notice and list sent by the Administrative Agent pursuant to this
Section 2.4(c) shall list the Competitive Bids in ascending yield order.

(d) The Borrower may in its sole and absolute discretion, subject only to the provisions of this Section 2.4(d), accept or reject any Competitive Bid made in accordance with the procedures set forth in this Section 2.4, and the Borrower shall notify the Administrative Agent by telephone, confirmed by fax in the form of a Competitive Bid Accept/Reject Letter, whether and to what extent it has decided to accept or reject any or all of such Competitive Bids not later than 12:00 Noon on the proposed Borrowing Date therefor, provided that the failure by the Borrower to give such notice shall be deemed to be a rejection of all such Competitive Bids. In connection with each acceptance of one or more Competitive Bids by the Borrower:

(1) the Borrower shall not accept a Competitive Bid made at a particular Competitive Bid Rate if the Borrower has decided to reject a Competitive Bid made at a lower Competitive Bid Rate unless the acceptance of such lower Competitive Bid would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents, in which case the Borrower may reject such lower Competitive Bid,

(2) the aggregate amount of the Competitive Bids accepted by the Borrower shall not exceed the principal amount specified in the Competitive Bid Request therefor,

(3) if the Borrower shall desire to accept a Competitive Bid made at a particular Competitive Bid Rate, it must accept all other Competitive Bids at such Competitive Bid Rate, except for any such Competitive Bid the acceptance of which would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents, provided that if the acceptance of all such other Competitive Bids would cause the aggregate amount of all such accepted Competitive Bids to exceed the amount requested, then such acceptance shall be made pro rata in accordance with the amount of each such Competitive Bid at such Competitive Bid Rate,

(4) except pursuant to clause (3) above, no Competitive Bid shall be accepted unless the Competitive Bid Loan with respect thereto shall be in a minimum principal amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof, and

(5) no Competitive Bid shall be accepted and no Competitive Bid Loan shall be made, if immediately after giving effect thereto, the Aggregate Credit Exposure would exceed the Aggregate Commitment Amount.

-21-

(e) The Administrative Agent shall promptly fax to each bidding Lender (with a copy to the Borrower) a Competitive Bid Accept/Reject Letter advising such Lender whether its Competitive Bid has been accepted (and if accepted, in what amount and at what Competitive Bid Rate), and each successful bidder so notified will thereupon become bound, subject to the other applicable conditions hereof, to make the Competitive Bid Loan in respect of which each of its Competitive Bids has been accepted by making immediately available funds available to the Administrative Agent at its address set forth in Section 11.2 not later than 1:00 P.M. on the Borrowing Date for such Competitive Bid Loan in the amount thereof.

(f) Anything herein to the contrary notwithstanding, if the Administrative Agent shall elect to submit a Competitive Bid in its capacity as a Lender, it shall submit such bid directly to the Borrower not later than 9:30
A.M. on the relevant proposed Borrowing Date.

(g) All notices required by this Section shall be given in accordance with Section 11.2.

(h) The Competitive Bid Loans made by each Lender shall be evidenced by a promissory note of the Borrower, substantially in the form of Exhibit B-2 (each, as indorsed or modified from time to time, a "Competitive Bid Note"), payable to the order of such Lender, dated the first Borrowing Date evidencing the obligation of the Borrower to pay the aggregate unpaid principal balance of all Competitive Bid Loans made by such Lender to the Borrower, together with interest thereon as provided herein. Each Competitive Bid Loan shall be due and payable on the last day of the Interest Period applicable thereto or on such earlier date upon which the Loans shall become due and payable hereunder, whether by acceleration or otherwise.

2.5 Use of Proceeds

The Borrower agrees that the proceeds of the Loans and Letters of Credit shall be used solely for its general corporate purposes not inconsistent with the provisions hereof, including as a backup for the Borrower's commercial paper and to refinance all outstanding Indebtedness (excluding letters of credit issued under the Revco Existing Credit Agreement) under the Existing Credit Agreements. Notwithstanding anything to the contrary contained in any Loan Document, the Borrower further agrees that no part of the proceeds of any Loan or Letter of Credit will be used, directly or indirectly, for a purpose which violates any law, rule or regulation of any Governmental Authority, including the provisions of Regulations G, U or X of the Board of Governors of the Federal Reserve System, as amended or any provision of this Agreement, including, without limitation, the provisions of Section 4.9.

2.6 Termination or Reduction of Commitments

(a) Voluntary Termination or Reductions. At the Borrower's option and upon at least three Domestic Business Days' prior irrevocable notice to the Administrative Agent, the Borrower may (i) terminate the Commitments, the Swing Line Commitment and the Letter of Credit Commitment, at any time, or (ii) permanently reduce the Aggregate Commitment Amount, the Swing Line Commitment or the Letter of Credit Commitment, in part at any time and from time to time, provided that (1) each such partial

-22-

reduction shall be in an amount equal to at least (i) in the case of the Aggregate Commitment Amount, $10,000,000 or an integral multiple of $1,000,000 in excess thereof, (ii) in the case of the Swing Line Commitment, $1,000,000, or an integral multiple of $1,000,000 in excess thereof, and (iii) in the case of the Letter of Credit Commitment, $1,000,000, or an integral multiple of $1,000,000 in excess thereof, and (2) immediately after giving effect to each such reduction, (i) the Aggregate Commitment Amount shall equal or exceed the sum of the aggregate outstanding principal balance of all Loans and the Letter of Credit Exposure, (ii) the Swing Line Commitment shall equal or exceed the aggregate outstanding principal balance of all Swing Line Loans and (iii) the Letter of Credit Commitment shall equal or exceed the Letter of Credit Exposure of all Lenders, and provided further that a notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitment delivered by the Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities (such notice to specify the proposed effective date), in which case such notice may be revoked by the Borrower (by notice to the Administrative Agent on or prior to such specified effective date) if such condition is not satisfied and the Borrower shall indemnify the Lenders in accordance with Section 3.5.

(b) In General. Each reduction of the Aggregate Commitment Amount shall be made by reducing each Lender's Commitment Amount by a sum equal to such Lender's Commitment Percentage of the amount of such reduction.

2.7 Prepayments of Loans

(a) Voluntary Prepayments. The Borrower may prepay Revolving Credit Loans, Competitive Bid Loans and Swing Line Loans, in whole or in part, without premium or penalty, but subject to Section 3.5 at any time and from time to time, by notifying the Administrative Agent, which notification shall be irrevocable, at least two Eurodollar Business Days, in the case of a prepayment of Eurodollar Advances, two Business Days, in the case of Competitive Bid Loans, or one Domestic Business Day, in the case of a prepayment of Swing Line Loans and ABR Advances, prior to the proposed prepayment date specifying (i) the Loans to be prepaid, (ii) the amount to be prepaid, and (iii) the date of prepayment. Upon receipt of each such notice, the Administrative Agent shall promptly notify each Lender thereof. Each such notice given by the Borrower pursuant to this
Section shall be irrevocable, provided that, if a notice of prepayment is given in connection with a conditional notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitment as contemplated by
Section 2.6, then such notice of prepayment may be revoked if such notice of termination is revoked in accordance with Section 2.6, and the Borrower shall indemnify the Lenders in accordance with Section 3.5. Each partial prepayment under this Section shall be in a minimum amount of $1,000,000 ($500,000 in the case of ABR Advances and Swing Line Loans) or an integral multiple of $1,000,000 ($100,000 in the case of ABR Advances and Swing Line Loans) in excess thereof.

(b) In General. Simultaneously with each prepayment hereunder, the Borrower shall prepay all accrued interest on the amount prepaid through the date of prepayment and indemnify the Lenders in accordance with Section 3.5.

-23-

2.8 Letter of Credit Sub-facility

(a) Subject to the terms and conditions hereof and the payment by the Borrower to the Issuer of such fees as the Borrower and the Issuer shall have agreed in writing, the Issuer agrees, in reliance on the agreement of the other Lenders set forth in Section 2.9, to issue standby letters of credit (each a "Letter of Credit" and, collectively, the "Letters of Credit") during the Commitment Period for the account of the Borrower, provided that immediately after the issuance of each Letter of Credit (i) the Letter of Credit Exposure of all Lenders shall not exceed the Letter of Credit Commitment, and (ii) the Aggregate Credit Exposure shall not exceed the Aggregate Commitment Amount. Each Letter of Credit shall have an expiration date which shall be not later than the earlier to occur of one year from the date of issuance thereof or 5 days prior to the Commitment Termination Date. No Letter of Credit shall be issued if the Administrative Agent, or any Lender by notice to the Administrative Agent and the Issuer no later than 3:00 P.M. one Domestic Business Day prior to the requested date of issuance of such Letter of Credit, shall have determined that the conditions set forth in Sections 5 and 6 have not been satisfied.

(b) Each Letter of Credit shall be issued for the account of the Borrower in support of an obligation of the Borrower in favor of a beneficiary who has requested the issuance of such Letter of Credit as a condition to a transaction entered into in connection with the Borrower's ordinary course of business. The Borrower shall give the Administrative Agent a Letter of Credit Request for the issuance of each Letter of Credit by 12:00 Noon at least two Domestic Business Days prior to the requested date of issuance. Such Letter of Credit Request shall be accompanied by the Issuer's standard Application and Agreement for Standby Letter of Credit (each a "Reimbursement Agreement") executed by the Borrower, and shall specify (i) the beneficiary of such Letter of Credit and the obligations of the Borrower in respect of which such Letter of Credit is to be issued, (ii) the Borrower's proposal as to the conditions under which a drawing may be made under such Letter of Credit and the documentation to be required in respect thereof, (iii) the maximum amount to be available under such Letter of Credit, and (iv) the requested date of issuance. Upon receipt of such Letter of Credit Request from the Borrower, the Administrative Agent shall promptly notify the Issuer and each other Lender thereof. The Issuer shall, on the proposed date of issuance and subject to the other terms and conditions of this Agreement, issue the requested Letter of Credit. Each Letter of Credit shall be in form and substance reasonably satisfactory to the Issuer, with such provisions with respect to the conditions under which a drawing may be made thereunder and the documentation required in respect of such drawing as the Issuer shall reasonably require. Each Letter of Credit shall be used solely for the purposes described therein.

(c) Each payment by the Issuer of a draft drawn under a Letter of Credit shall give rise to the obligation of the Borrower to immediately reimburse the Issuer for the amount thereof. The Issuer shall promptly notify the Borrower of such payment by the Issuer of a draft drawn under a Letter of Credit, but any failure to so notify shall not in any manner affect the obligation of the Borrower to make reimbursement when due. In lieu of such notice, if the Borrower has not made reimbursement prior to the end of the Business Day when due, the Borrower hereby authorizes the Issuer to deduct the amount of any such reimbursement from such account(s) as the Borrower may from time to time designate in writing to the Issuer, upon which the Issuer shall apply the amount of such deduction to such reimbursement. If all or any portion of any reimbursement obligation in

-24-

respect of a Letter of Credit shall not be paid when due (whether at the stated maturity thereof, by acceleration or otherwise), such overdue amount shall bear interest, payable upon demand, at a rate per annum equal to the Alternate Base Rate plus the Applicable Margin applicable to ABR Advances plus 2%, from the date of such nonpayment until paid in full (whether before or after the entry of a judgment thereon).

2.9 Letter of Credit Participation

(a) Each Lender hereby unconditionally and irrevocably, severally (and not jointly) takes an undivided participating interest in the obligations of the Issuer under and in connection with each Letter of Credit in an amount equal to such Lender's Commitment Percentage of the amount of such Letter of Credit. Each Lender shall be liable to the Issuer for its Commitment Percentage of the unreimbursed amount of any draft drawn and honored under each Letter of Credit. Each Lender shall also be liable for an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to Sections 2.8 and 2.10 that are subsequently rescinded or avoided, or must otherwise be restored or returned. Such liabilities shall be unconditional and without regard to the occurrence of any Default or Event of Default or the compliance by the Borrower with any of its obligations under the Loan Documents.

(b) The Issuer shall promptly notify the Administrative Agent, and the Administrative Agent shall promptly notify each Lender (which notice shall be promptly confirmed in writing), of the date and the amount of each draft paid under each Letter of Credit with respect to which full reimbursement payment shall not have been made by the Borrower as provided in Section 2.8(c), and forthwith upon receipt of such notice, such Lender shall promptly make available to the Administrative Agent for the account of the Issuer its Commitment Percentage of the amount of such unreimbursed draft at the office of the Administrative Agent specified in Section 11.2 in lawful money of the United States and in immediately available funds. The Administrative Agent shall distribute the payments made by each Lender pursuant to the immediately preceding sentence to the Issuer promptly upon receipt thereof in like funds as received. Each Lender shall indemnify and hold harmless the Administrative Agent and the Issuer from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and expenses (including, without limitation, reasonable attorneys' fees and expenses) resulting from any failure on the part of such Lender to provide, or from any delay in providing, the Administrative Agent with such Lender's Commitment Percentage of the amount of any payment made by the Issuer under a Letter of Credit in accordance with this clause (b) above (except in respect of losses, liabilities or other obligations suffered by the Administrative Agent or the Issuer, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or the Issuer, as the case may be). If a Lender does not make available to the Administrative Agent when due such Lender's Commitment Percentage of any unreimbursed payment made by the Issuer under a Letter of Credit, such Lender shall be required to pay interest to the Administrative Agent for the account of the Issuer on such Lender's Commitment Percentage of such payment at a rate of interest per annum equal to (i) from the date such Lender should have made such amount available until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate plus 2%, in each case payable upon demand by the Issuer. The Administrative Agent shall distribute such interest payments to the Issuer upon receipt thereof in like funds as received.

-25-

(c) Whenever the Administrative Agent is reimbursed by the Borrower, for the account of the Issuer, for any payment under a Letter of Credit and such payment relates to an amount previously paid by a Lender in respect of its Commitment Percentage of the amount of such payment under such Letter of Credit, the Administrative Agent (or the Issuer, if such payment by a Lender was paid by the Administrative Agent to the Issuer) will promptly pay over such payment to such Lender.

2.10 Absolute Obligation with respect to Letter of Credit Payments

The Borrower's obligation to reimburse the Administrative Agent for the account of the Issuer for each payment under or in respect of each Letter of Credit shall be absolute and unconditional under any and all circumstances and irrespective of any set-off, counterclaim or defense to payment which the Borrower may have or have had against the beneficiary of such Letter of Credit, the Administrative Agent, the Issuer, the Swing Line Lender, any Lender or any other Person, including, without limitation, any defense based on the failure of any drawing to conform to the terms of such Letter of Credit, any drawing document proving to be forged, fraudulent or invalid, or the legality, validity, regularity or enforceability of such Letter of Credit, provided, however, that, with respect to any Letter of Credit, the foregoing shall not relieve the Issuer of any liability it may have to the Borrower for any actual damages sustained by the Borrower arising from a wrongful payment (or failure to pay) under such Letter of Credit made as a result of the Issuer's gross negligence or willful misconduct.

3. PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD PROTECTION AND FEES

3.1 Disbursement of the Proceeds of the Loans

The Administrative Agent shall disburse the proceeds of the Loans (other than the Swing Line Loans) at its office specified in Section 11.2 by crediting to the Borrower's general deposit account with the Administrative Agent the funds received from each Lender. Unless the Administrative Agent shall have received prior notice from a Lender (by telephone or otherwise, such notice to be confirmed by fax or other writing) that such Lender will not make available to the Administrative Agent such Lender's Commitment Percentage of the Revolving Credit Loans, or the amount of any Competitive Bid Loan, to be made by it on a Borrowing Date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on such Borrowing Date in accordance with this Section, provided that, in the case of a Revolving Credit Loan, such Lender received notice thereof from the Administrative Agent in accordance with the terms hereof, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrower on such Borrowing Date a corresponding amount. If and to the extent such Lender shall not have so made such amount available to the Administrative Agent, such Lender and the Borrower severally agree to pay to the Administrative Agent, forthwith on demand, such corresponding amount (to the extent not previously paid by the other), together with interest thereon for each day from the date such amount is made available to the Borrower until the date such amount is paid to the Administrative Agent, at a rate per annum equal to, in the case of the Borrower, the applicable interest rate set forth in Section 3.4(a) and, in the case of such Lender, the Federal Funds Effective Rate from the date such payment is due until the third day after such date and, thereafter, at the Federal Funds Effective Rate plus 2%. Any such payment by

-26-

the Borrower shall be without prejudice to its rights against such Lender. If such Lender shall pay to the Administrative Agent such corresponding amount, such amount so paid shall constitute such Lender's Loan as part of such Loans for purposes of this Agreement, which Loan shall be deemed to have been made by such Lender on the Borrowing Date applicable to such Loans.

3.2 Payments

(a) Each borrowing of Revolving Credit Loans by the Borrower from the Lenders, any Conversion of Revolving Credit Loans from one Type to another, and any reduction in the Commitments shall be made pro rata according to the Commitment Percentage of each Lender. Each payment, including each prepayment, of principal and interest on the Loans and of the Facility Fee and the Letter of Credit Participation Fee (collectively, together with all of the other fees to be paid to the Administrative Agent, the Lenders, the Issuer and the Swing Line Lender in connection with the Loan Documents, the "Fees"), and of all of the other amounts to be paid to the Administrative Agent and the Lenders in connection with the Loan Documents shall be made by the Borrower to the Administrative Agent at its office specified in Section 11.2 in funds immediately available in New York by 3:00 P.M. on the due date for such payment. The failure of the Borrower to make any such payment by such time shall not constitute a default hereunder, provided that such payment is made on such due date, but any such payment made after 3:00 P.M. on such due date shall be deemed to have been made on the next Domestic Business Day or Eurodollar Business Day, as the case may be, for the purpose of calculating interest on amounts outstanding on the Loans. If the Borrower has not made any such payment prior to 3:00 P.M., the Borrower hereby authorizes the Administrative Agent to deduct the amount of any such payment from such account(s) as the Borrower may from time to time designate in writing to the Administrative Agent, upon which the Administrative Agent shall apply the amount of such deduction to such payment. Promptly upon receipt thereof by the Administrative Agent, each payment of principal and interest on the: (i) Revolving Credit Loans shall be remitted by the Administrative Agent in like funds as received to each Lender (a) first, pro rata according to the amount of interest which is then due and payable to the Lenders, and (b) second, pro rata according to the amount of principal which is then due and payable to the Lenders, (ii) Competitive Bid Loans shall be remitted by the Administrative Agent in like funds as received to each applicable Lender and (iii) Swing Line Loans shall be remitted by the Administrative Agent in like funds as received to the Swing Line Lender. Each payment of the Fees payable to the Lenders shall be promptly transmitted by the Administrative Agent in like funds as received to each Lender pro rata according to such Lender's Commitment Amount or, if the Commitments shall have terminated or been terminated, according to the outstanding principal amount of such Lender's Revolving Credit Loans.

(b) If any payment hereunder or under the Loans shall be due and payable on a day which is not a Domestic Business Day or Eurodollar Business Day, as the case may be, the due date thereof (except as otherwise provided in the definition of Eurodollar Interest Period or Competitive Interest Period) shall be extended to the next Domestic Business Day or Eurodollar Business Day, as the case may be, and (except with respect to payments in respect of the Facility Fee and in respect of the Letter of Credit Participation Fee) interest shall be payable at the applicable rate specified herein during such extension.

-27-

3.3 Conversions; Other Matters

(a) The Borrower may elect at any time and from time to time to Convert one or more Eurodollar Advances to an ABR Advance by giving the Administrative Agent at least one Domestic Business Day's prior irrevocable notice of such election, specifying the amount to be so Converted. In addition, the Borrower may elect at any time and from time to time to Convert an ABR Advance to any one or more new Eurodollar Advances or to Convert any one or more existing Eurodollar Advances to any one or more new Eurodollar Advances by giving the Administrative Agent at least two Eurodollar Business Days' prior irrevocable notice, in the case of a Conversion to Eurodollar Advances, of such election, specifying the amount to be so Converted and the initial Interest Period relating thereto, provided that any Conversion of an ABR Advance to Eurodollar Advances shall only be made on a Eurodollar Business Day. The Administrative Agent shall promptly provide the Lenders with notice of each such election. ABR Advances and Eurodollar Advances may be Converted pursuant to this
Section in whole or in part, provided that the amount to be Converted to each Eurodollar Advance, when aggregated with any Eurodollar Advance to be made on such date in accordance with Section 2.1 and having the same Interest Period as such first Eurodollar Advance, shall equal no less than $10,000,000 or an integral multiple of $1,000,000 in excess thereof.

(b) Notwithstanding anything in this Agreement to the contrary, upon the occurrence and during the continuance of a Default or an Event of Default, the Borrower shall have no right to elect to Convert any existing ABR Advance to a new Eurodollar Advance or to Convert any existing Eurodollar Advance to a new Eurodollar Advance. In such event, such ABR Advance shall be automatically continued as an ABR Advance or such Eurodollar Advance shall be automatically Converted to an ABR Advance on the last day of the Interest Period applicable to such Eurodollar Advance. The foregoing shall not affect any other rights or remedies that the Administrative Agent or any Lender may have under this Agreement or any other Loan Document.

(c) Each Conversion shall be effected by each Lender by applying the proceeds of each new ABR Advance or Eurodollar Advance, as the case may be, to the existing Advance (or portion thereof) being Converted (it being understood that such Conversion shall not constitute a borrowing for purposes of Sections 4, 5 or 6).

(d) Notwithstanding any other provision of any Loan Document:

(i) if the Borrower shall have failed to elect a Eurodollar Advance under Section 2.3 or this Section 3.3, as the case may be, in connection with any borrowing of new Revolving Credit Loans or expiration of an Interest Period with respect to any existing Eurodollar Advance, the amount of the Revolving Credit Loans subject to such borrowing or such existing Eurodollar Advance shall thereafter be an ABR Advance until such time, if any, as the Borrower shall elect a new Eurodollar Advance pursuant to this Section 3.3,

(ii) the Borrower shall not be permitted to select a Eurodollar Advance the Interest Period in respect of which ends later than the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been voluntarily terminated by the Borrower in accordance with Section 2.6, and

-28-

(iii) the Borrower shall not be permitted to have more than 10 Eurodollar Advances and Competitive Bid Loans, in the aggregate, outstanding at any one time, it being understood and agreed that each borrowing of Eurodollar Advances or Competitive Bid Loans pursuant to a single Borrowing Request or Competitive Bid Request, as the case may be, shall constitute the making of one Eurodollar Advance or Competitive Bid Loan for the purpose of calculating such limitation.

3.4 Interest Rates and Payment Dates

(a) Prior to Maturity. Except as otherwise provided in Sections 3.4(b) and 3.4(c), the Loans shall bear interest on the unpaid principal balance thereof at the applicable interest rate or rates per annum set forth below:

--------------------------------------------------------------------------------
      LOANS                            RATE

      Revolving Credit Loans           Alternate Base Rate applicable
      constituting ABR Advances        thereto plus the Applicable Margin.

      Revolving Credit Loans           Eurodollar Rate applicable
      constituting Eurodollar          thereto
      Advances                         plus the Applicable Margin.

      Competitive Bid                  Fixed rate of interest applicable
      Loans                            thereto accepted by the Borrower
                                       pursuant to Section 2.4(d).

      Swing Line Loans                 Negotiated Rate applicable
                                       thereto as provided in Section 2.2(a).
--------------------------------------------------------------------------------

(b) After Maturity, Late Payment Rate. After maturity, whether by acceleration, notice of intention to prepay or otherwise, the outstanding principal balance of the Loans shall bear interest at the Alternate Base Rate plus 2% per annum until paid (whether before or after the entry of any judgment thereon). Any payment of principal, interest or any Fees not paid on the date when due and payable shall bear interest at the Alternate Base Rate plus 2% per annum from the due date thereof until the date such payment is made (whether before or after the entry of any judgment thereon).

(c) Highest Lawful Rate. Notwithstanding anything to the contrary contained in this Agreement, at no time shall the interest rate payable to any Lender on any of its Loans, together with the Fees and all other amounts payable hereunder to such Lender to the extent the same constitute or are deemed to constitute interest, exceed the Highest Lawful Rate. If in respect of any period during the term of this Agreement, any amount paid to any Lender hereunder, to the extent the same shall (but for the provisions of this Section 3.4) constitute or be deemed to constitute interest, would exceed the maximum amount of interest permitted by the Highest Lawful Rate during such period (such amount being hereinafter referred to as an "Unqualified Amount"), then
(i) such Unqualified

-29-

Amount shall be applied or shall be deemed to have been applied as a prepayment of the Loans of such Lender, and (ii) if, in any subsequent period during the term of this Agreement, all amounts payable hereunder to such Lender in respect of such period which constitute or shall be deemed to constitute interest shall be less than the maximum amount of interest permitted by the Highest Lawful Rate during such period, then the Borrower shall pay to such Lender in respect of such period an amount (each a "Compensatory Interest Payment") equal to the lesser of (x) a sum which, when added to all such amounts, would equal the maximum amount of interest permitted by the Highest Lawful Rate during such period, and (y) an amount equal to the aggregate sum of all Unqualified Amounts less all other Compensatory Interest Payments.

(d) General. Interest shall be payable in arrears on each Interest Payment Date, on the Commitment Termination Date and, to the extent provided in
Section 2.7(b), upon each prepayment of the Loans. Any change in the interest rate on the Loans resulting from an increase or a decrease in the Alternate Base Rate or any reserve requirement shall become effective as of the opening of business on the day on which such change shall become effective. The Administrative Agent shall, as soon as practicable, notify the Borrower and the Lenders of the effective date and the amount of each change in the BNY Rate, but any failure to so notify shall not in any manner affect the obligation of the Borrower to pay interest on the Loans in the amounts and on the dates set forth herein. Each determination by the Administrative Agent of the Alternate Base Rate, the Eurodollar Rate and the Competitive Rate pursuant to this Agreement shall be conclusive and binding on the Borrower absent manifest error. The Borrower acknowledges that to the extent interest payable on the Loans is based on the Alternate Base Rate, such rate is only one of the bases for computing interest on loans made by the Lenders, and by basing interest payable on ABR Advances on the Alternate Base Rate, the Lenders have not committed to charge, and the Borrower has not in any way bargained for, interest based on a lower or the lowest rate at which the Lenders may now or in the future make extensions of credit to other Persons. All interest (other than interest calculated with reference to the BNY Rate) shall be calculated on the basis of a 360-day year for the actual number of days elapsed, and all interest determined with reference to the BNY Rate shall be calculated on the basis of a 365/366-day year for the actual number of days elapsed.

3.5 Indemnification for Loss

Notwithstanding anything contained herein to the contrary, if: (i) the Borrower shall fail to borrow a Eurodollar Advance or if the Borrower shall fail to Convert a Eurodollar Advance after it shall have given notice to do so in which it shall have requested a Eurodollar Advance pursuant to Section 2.3 or 3.3, as the case may be, (ii) the Borrower shall fail to borrow a Competitive Bid Loan after it shall have accepted any offer with respect thereto in accordance with Section 2.4 or a Swing Line Loan after it shall have agreed to a Negotiated Rate with respect thereto in accordance with Section 2.2(a), (iii) a Eurodollar Advance, Competitive Bid Loan or Swing Line Loan shall be terminated for any reason prior to the last day of the Interest Period applicable thereto,
(iv) any repayment or prepayment of the principal amount of a Eurodollar Advance, Competitive Bid Loan or Swing Line Loan is made for any reason on a date which is prior to the last day of the Interest Period applicable thereto, or (v) the Borrower shall have revoked a notice of prepayment or notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitments that was conditioned upon the effectiveness of other credit facilities pursuant to Section 2.6 or 2.7, the Borrower agrees

-30-

to indemnify each Lender (or the Swing Line Lender, as applicable) against, and to pay on demand directly to such Lender the amount (calculated by such Lender using any method chosen by such Lender which is customarily used by such Lender for such purpose) equal to any loss or expense suffered by such Lender as a result of such failure to borrow or Convert, or such termination, repayment, prepayment or revocation, including any loss, cost or expense suffered by such Lender in liquidating or employing deposits acquired to fund or maintain the funding of such Eurodollar Advance, Competitive Bid Loan or Swing Line Loan, as the case may be, or redeploying funds prepaid or repaid, in amounts which correspond to such Eurodollar Advance, Competitive Bid Loan or Swing Line Loan, as the case may be, and any reasonable internal processing charge customarily charged by such Lender in connection therewith.

3.6 Reimbursement for Costs, Etc.

If at any time or from time to time there shall occur a Regulatory Change and the Issuer or any Lender shall have reasonably determined that such Regulatory Change (i) shall have had or will thereafter have the effect of reducing (A) the rate of return on the Issuer's or such Lender's capital or the capital of any Person directly or indirectly owning or controlling the Issuer or such Lender (each a "Control Person"), or (B) the asset value (for capital purposes) to the Issuer or such Lender or such Control Person, as applicable, of the Reimbursement Obligations, or any participation therein, or the Loans, or any participation therein, in any case to a level below that which the Issuer or such Lender or such Control Person could have achieved or would thereafter be able to achieve but for such Regulatory Change (after taking into account the Issuer's, such Lender's or such Control Person's policies regarding capital),
(ii) will impose, modify or deem applicable any reserve, asset, special deposit or special assessment requirements on deposits obtained in the interbank eurodollar market in connection with the Loan Documents (excluding, with respect to any Eurodollar Advance, any such requirement which is included in the determination of the rate applicable thereto), (iii) will subject the Issuer, or such Lender or such Control Person, as applicable, to any tax (documentary, stamp or otherwise) with respect to this Agreement, any Note, or any Reimbursement Agreement, or (iv) will change the basis of taxation of payments to the Issuer or such Lender or such Control Person, as applicable, of principal, interest or fees payable under the Loan Documents (except, in the case of clauses (iii) and (iv) above, for any tax or changes in the rate of tax on the Issuer's, or such Lender's or such Control Person's net income) then, in each such case, within ten days after demand by the Issuer or such Lender, as applicable, the Borrower shall pay to the Issuer, such Lender or such Control Person, as the case may be, such additional amount or amounts as shall be sufficient to compensate the Issuer, such Lender or such Control Person, as the case may be, for any such reduction, reserve or other requirement, tax, loss, cost or expense (excluding general administrative and overhead costs) (collectively, "Costs") attributable to the Issuer's, such Lender's or such Control Person's compliance during the term hereof with such Regulatory Change. The Issuer and each Lender may make multiple requests for compensation under this Section.

Notwithstanding the foregoing, the Borrower will not be required to compensate any Lender for any Costs under this Section 3.6 arising prior to 45 days preceding the date of demand, unless the applicable Regulatory Change giving rise to such Costs is imposed retroactively. In the case of retroactivity, such notice shall be provided to the Borrower not later than 45 days from the date that such Lender learned of such

-31-

Regulatory Change. The Borrower's obligation to compensate such Lender shall be contingent upon the provision of such timely notice (but any failure by such Lender to provide such timely notice shall not affect the Borrower's obligations with respect to (i) Costs incurred from the date as of which such Regulatory Change became effective to the date that is 45 days after the date such Lender reasonably should have learned of such Regulatory Change and (ii) Costs incurred following the provision of such notice).

3.7 Illegality of Funding

Notwithstanding any other provision hereof, if any Lender shall reasonably determine that any law, regulation, treaty or directive, or any change therein or in the interpretation or application thereof, shall make it unlawful for such Lender to make or maintain any Eurodollar Advance as contemplated by this Agreement, such Lender shall promptly notify the Borrower and the Administrative Agent thereof, and (a) the commitment of such Lender to make such Eurodollar Advances or Convert ABR Advances to such Eurodollar Advances shall forthwith be suspended, (b) such Lender shall fund its portion of each requested Eurodollar Advance as an ABR Advance and (c) such Lender's Loans then outstanding as such Eurodollar Advances, if any, shall be Converted automatically to an ABR Advance on the last day of the then current Interest Period applicable thereto or at such earlier time as may be required. If the commitment of any Lender with respect to Eurodollar Advances is suspended pursuant to this Section and such Lender shall have obtained actual knowledge that it is once again legal for such Lender to make or maintain Eurodollar Advances, such Lender shall promptly notify the Administrative Agent and the Borrower thereof and, upon receipt of such notice by each of the Administrative Agent and the Borrower, such Lender's commitment to make or maintain Eurodollar Advances shall be reinstated. If the commitment of any Lender with respect to Eurodollar Advances is suspended pursuant to this Section, such suspension shall not otherwise affect such Lender's Commitment.

3.8 Option to Fund; Substituted Interest Rate

(a) Each Lender has indicated that, if the Borrower requests a Swing Line Loan, a Eurodollar Advance or a Competitive Bid Loan, such Lender may wish to purchase one or more deposits in order to fund or maintain its funding of its Commitment Percentage of such Eurodollar Advance or its Swing Line Loan or Competitive Bid Loan during the Interest Period with respect thereto; it being understood that the provisions of this Agreement relating to such funding are included only for the purpose of determining the rate of interest to be paid in respect of such Swing Line Loan, Eurodollar Advance or Competitive Bid Loan and any amounts owing under Sections 3.5 and 3.6. The Swing Line Lender and each Lender shall be entitled to fund and maintain its funding of all or any part of each Swing Line Loan, Eurodollar Advance and Competitive Bid Loan in any manner it sees fit, but all such determinations hereunder shall be made as if such Lender had actually funded and maintained its Commitment Percentage of each Eurodollar Advance or its Swing Line Loan or Competitive Bid Loan, as the case may be, during the applicable Interest Period through the purchase of deposits in an amount equal to the amount of its Commitment Percentage of such Eurodollar Advance or the amount of such Swing Line Loan or Competitive Bid Loan, as the case may be, and having a maturity corresponding to such Interest Period. Each Lender may fund its Loans from or for the account of any branch or office of such Lender as such Lender may choose from time to time, subject to Section 3.10.

-32-

(b) In the event that (i) the Administrative Agent shall have determined in good faith (which determination shall be conclusive and binding upon the Borrower) that by reason of circumstances affecting the interbank eurodollar market either adequate and reasonable means do not exist for ascertaining the Eurodollar Rate applicable pursuant to Section 2.3 or Section 3.3, or (ii) the Required Lenders shall have notified the Administrative Agent that they have in good faith determined (which determination shall be conclusive and binding on the Borrower) that the applicable Eurodollar Rate will not adequately and fairly reflect the cost to such Lenders of maintaining or funding loans bearing interest based on such Eurodollar Rate with respect to any portion of the Loans that the Borrower has requested be made as Eurodollar Advances or any Eurodollar Advance that will result from the requested conversion of any portion of the Loans into Eurodollar Advances (each, an "Affected Advance"), the Administrative Agent shall promptly notify the Borrower and the Lenders (by telephone or otherwise, to be promptly confirmed in writing) of such determination on or, to the extent practicable, prior to the requested Borrowing Date or conversion date for such Affected Advances. If the Administrative Agent shall give such notice, (A) any Affected Advances shall be made as ABR Advances (or, subject to the terms and conditions hereof, Competitive Bid Loans), (B) the Loans (or any portion thereof) that were to have been Converted to Affected Advances shall be Converted to or continued as ABR Advances (or, subject to the terms and conditions hereof, Competitive Bid Loans), and (C) any outstanding Affected Advances shall be Converted, on the last day of the then current Interest Period with respect thereto, to ABR Advances (or, subject to the terms and conditions hereof, Competitive Bid Loans). Until any notice under clauses
(i) or (ii), as the case may be, of this Section 3.8(b) has been withdrawn by the Administrative Agent (by notice to the Borrower) promptly upon either (x) the Administrative Agent having determined that such circumstances affecting the relevant market no longer exist and that adequate and reasonable means do exist for determining the Eurodollar Rate pursuant to Section 2.3 or Section 3.3, or
(y) the Administrative Agent having been notified by such Required Lenders that circumstances no longer render the Loans (or any portion thereof) Affected Advances, no further Eurodollar Advances shall be required to be made by the Lenders nor shall the Borrower have the right to Convert all or any portion of the Loans to Eurodollar Advances.

3.9 Certificates of Payment and Reimbursement

Each of the Issuer and each Lender agrees, in connection with any request by it for payment or reimbursement pursuant to Section 3.5 or 3.6, to provide the Borrower with a certificate, signed by an officer of the Issuer or such Lender, as the case may be, setting forth a description in reasonable detail of any such payment or reimbursement. Each determination by the Issuer and each Lender of such payment or reimbursement shall be conclusive absent manifest error.

3.10 Taxes; Net Payments

(a) All payments made by the Borrower under the Loan Documents shall be made free and clear of, and without reduction for or on account of, any taxes required by law to be withheld from any amounts payable under the Loan Documents. In the event that the Borrower is prohibited by law from making such payments free of deductions or withholdings, then the Borrower shall pay such additional amounts to the Administrative Agent, for the benefit of the Issuer and the Lenders, as may be necessary

-33-

in order that the actual amounts received by the Issuer and the Lenders in respect of interest and any other amounts payable under the Loan Documents after deduction or withholding (and after payment of any additional taxes or other charges due as a consequence of the payment of such additional amounts) shall equal the amount that would have been received if such deduction or withholding were not required. In the event that any such deduction or withholding can be reduced or nullified as a result of the application of any relevant double taxation convention, the Lenders, the Issuer and the Administrative Agent will, at the expense of the Borrower, cooperate with the Borrower in making application to the relevant taxing authorities seeking to obtain such reduction or nullification, provided that the Lenders, the Issuer and the Administrative Agent shall have no obligation to (i) engage in any litigation, hearing or proceeding with respect thereto or (ii) disclose any tax return or other confidential information. If the Borrower shall make any payment under this
Section or shall make any deduction or withholding from amounts paid under any Loan Document, the Borrower shall forthwith forward to the Administrative Agent original or certified copies of official receipts or other evidence acceptable to the Administrative Agent establishing each such payment, deduction or withholding, as the case may be, and the Administrative Agent in turn shall distribute copies thereof to the Issuer and each Lender. If any payment to the Issuer or any Lender under any Loan Document is or becomes subject to any withholding, the Issuer or such Lender, as the case may be, shall (unless otherwise required by a Governmental Authority or as a result of any law, rule, regulation, order or similar directive applicable to the Issuer or such Lender, as the case may be) designate a different office or branch to which such payment is to be made from that initially selected thereby, if such designation would avoid such withholding and would not be otherwise disadvantageous to the Issuer or such Lender, as the case may be, in any respect. In the event that the Issuer or any Lender determines that it received a refund or credit for taxes paid by the Borrower under this Section, the Issuer or such Lender, as the case may be, shall promptly notify the Administrative Agent and the Borrower of such fact and shall remit to the Borrower the amount of such refund or credit applicable to the payments made by the Borrower in respect of the Issuer or such Lender, as the case may be, under this Section.

(b) So long as it is lawfully able to do so, each Lender not incorporated under the laws of the United States or any State thereof shall deliver to the Borrower such certificates, documents, or other evidence as the Borrower may reasonably require from time to time as are necessary to establish that such Lender is not subject to withholding under Section 1441, 1442 or 3406 of the Internal Revenue Code or as may be necessary to establish, under any law imposing upon the Borrower, hereafter, an obligation to withhold any portion of the payments made by the Borrower under the Loan Documents, that payments to the Administrative Agent on behalf of such Lender are not subject to withholding. Notwithstanding any provision herein to the contrary, the Borrower shall have no obligation to pay to the Issuer, the Swing Line Lender or any Lender any amount which the Borrower is liable to withhold due to the failure of the Issuer, the Swing Line Lender or such Lender, as the case may be, to file any statement of exemption required by the Internal Revenue Code.

3.11 Facility Fee

The Borrower agrees to pay to the Administrative Agent for the pro rata account of each Lender a fee (the "Facility Fee") during the period commencing on the Effective Date and ending on the Expiration Date, payable quarterly in arrears on the last

-34-

day of each March, June, September and December of each year, commencing on the last day of the calendar quarter in which the Effective Date shall have occurred, and on the Expiration Date, at a rate per annum equal to the Applicable Margin of (a) prior to the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been voluntarily terminated by the Borrower in accordance with Section 2.6, the Commitment Amount of such Lender (whether used or unused), and (b) thereafter, the sum of (i) the outstanding principal balance of all Revolving Credit Loans of such Lender, (ii) such Lender's Swing Line Exposure and (iii) such Lender's Letter of Credit Exposure. Notwithstanding anything to the contrary contained in this Section, on and after the Commitment Termination Date, the Facility Fee shall be payable upon demand. In addition, upon each reduction of the Aggregate Commitment Amount, the Borrower shall pay the Facility Fee accrued on the amount of such reduction through the date of such reduction. The Facility Fee shall be computed on the basis of a 360-day year for the actual number of days elapsed.

3.12 Letter of Credit Participation Fee

The Borrower agrees to pay to the Administrative Agent for the pro rata account of each Lender a fee (the "Letter of Credit Participation Fee") with respect to the Letters of Credit during the period commencing on the Effective Date and ending on the Commitment Termination Date or, if later, the date when the Letter of Credit Exposure of all Lenders is $0, payable quarterly in arrears on the last day of each March, June, September and December of each year, commencing on the last day of the calendar quarter in which the Effective Date shall have occurred, and on the last date of such period, at a rate per annum equal to the Applicable Margin of the average daily aggregate amount which may be drawn under the Letters of Credit during such period (whether or not the conditions for drawing thereunder have or may be satisfied) multiplied by such Lender's Commitment Percentage. The Letter of Credit Participation Fee shall be computed on the basis of a 360-day year for the actual number of days elapsed.

3.13 Replacement of Lender

If the Borrower is obligated to pay to any Lender any amount under
Section 3.6 or 3.10, the Borrower shall have the right within 90 days thereafter, in accordance with the requirements of Section 11.7(c), if no Default or Event of Default shall exist, to replace such Lender (the "Replaced Lender") with one or more other assignees (each a "Replacement Lender"), reasonably acceptable to the Swing Line Lender and the Issuer, provided that (i) at the time of any replacement pursuant to this Section, the Replacement Lender shall enter into one or more Assignment and Acceptance Agreements pursuant to
Section 11.7(c) (with the Assignment Fee payable pursuant to said Section 11.7(c) to be paid by the Replacement Lender) pursuant to which the Replacement Lender shall acquire the Commitment, the outstanding Loans, the Swing Line Exposure and the Letter of Credit Exposure of the Replaced Lender and, in connection therewith, shall pay the following: (a) to the Replaced Lender, an amount equal to the sum of (A) an amount equal to the principal of, and all accrued interest on, all outstanding Loans and Swing Line Participation Amounts of the Replaced Lender, (B) an amount equal to all drawings on all Letters of Credit that have been funded by (and not reimbursed to) such Replaced Lender, together with all then unpaid interest with respect thereto at such time, and
(C) an amount equal to all accrued, but unpaid, fees owing to the Replaced Lender, (b) to the Issuer, an amount equal to such Replaced Lender's Commitment Percentage of all drawings (which at such time remain

-35-

unpaid drawings) to the extent such amount was not funded by such Replaced Lender, (c) to the Swing Line Lender, an amount equal to such Replaced Lender's Commitment Percentage of any Mandatory Borrowing to the extent such amount was not funded by such Replaced Lender, and (d) to the Administrative Agent an amount equal to all amounts owed by such Replaced Lender to the Administrative Agent under this Agreement, including, without limitation, an amount equal to the principal of, and all accrued interest on, all outstanding Loans of the Replaced Lender, a corresponding amount of which was made available by the Administrative Agent to the Borrower pursuant to Section 3.1 and which has not been repaid to the Administrative Agent by such Replaced Lender or the Borrower, and (ii) all obligations of the Borrower owing to the Replaced Lender (other than those specifically described in clause (i) above in respect of which the assignment purchase price has been, or is concurrently being, paid) shall be paid in full to such Replaced Lender concurrently with such replacement. Upon the execution of the respective Assignment and Acceptance Agreements and the payment of amounts referred to in clauses (i) and (ii) of this Section 3.13, the Replacement Lender shall become a Lender hereunder and the Replaced Lender shall cease to constitute a Lender hereunder, except with respect to indemnification provisions under this Agreement that are intended to survive the termination of the Commitments.

4. REPRESENTATIONS AND WARRANTIES

In order to induce the Administrative Agent, the Lenders and the Issuer to enter into this Agreement, the Lenders to make the Loans and the Issuer to issue Letters of Credit, the Borrower hereby makes the following representations and warranties to the Administrative Agent, the Lenders and the Issuer:

4.1 Existence and Power

Each of the Borrower and the Subsidiaries is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation (except, in the case of the Subsidiaries, where the failure to be in such good standing could not reasonably be expected to have a Material Adverse effect), has all requisite corporate power and authority to own its Property and to carry on its business as now conducted, and is qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which it owns or leases real Property or in which the nature of its business requires it to be so qualified (except those jurisdictions where the failure to be so qualified or to be in good standing could not reasonably be expected to have a Material Adverse effect).

4.2 Authority

The Borrower has full corporate power and authority to enter into, execute, deliver and perform the terms of the Loan Documents and to consummate the CVS/Revco Merger in accordance with the CVS/Revco Merger Documents, all of which have been duly authorized by all proper and necessary corporate action and are not in contravention of any applicable law or the terms of its Certificate of Incorporation and By-Laws. No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with the

-36-

execution, delivery, and performance by the Borrower of the Loan Documents or in connection with the consummation of the CVS/Revco Merger, or is required as a condition to the enforceability of the Loan Documents against the Borrower or as a condition to the CVS/Revco Merger.

4.3 Binding Agreement

The Loan Documents and the CVS/Revco Merger Documents constitute the valid and legally binding obligations of the Borrower, enforceable in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors' rights generally and by equitable principles relating to the availability of specific performance as a remedy.

4.4 Litigation

Except as set forth on Schedule 4.4, there are no actions, suits, arbitration proceedings or claims (whether purportedly on behalf of the Borrower, any Subsidiary or otherwise) pending or, to the knowledge of the Borrower, threatened against the Borrower or any Subsidiary or any of their respective Properties, or maintained by the Borrower or any Subsidiary, at law or in equity, before any Governmental Authority which could reasonably be expected to have a Material Adverse effect. There are no proceedings pending or, to the knowledge of the Borrower, threatened against the Borrower or any Subsidiary (a) which call into question the validity or enforceability of any Loan Document, or otherwise seek to invalidate, any Loan Document or invalidate or prevent the consummation of the CVS/Revco Merger, or (b) which might, individually or in the aggregate, materially and adversely affect any of the transactions contemplated by any Loan Document or materially and adversely affect the CVS/Revco Merger.

4.5 No Conflicting Agreements

(a) Neither the Borrower nor any Subsidiary is in default under any agreement to which it is a party or by which it or any of its Property is bound the effect of which could reasonably be expected to have a Material Adverse effect. No notice to, or filing with, any Governmental Authority is required for the due execution, delivery and performance by the Borrower of the Loan Documents or to effect the CVS/Revco Merger, except for notices and filings required in connection with the CVS/Revco Merger which have been given and made.

(b) No provision of any existing material mortgage, material indenture, material contract or material agreement or of any existing statute, rule, regulation, judgment, decree or order binding on the Borrower or any Subsidiary or affecting the Property of the Borrower or any Subsidiary conflicts with, or requires any consent which has not already been obtained under, or would in any way prevent the execution, delivery or performance by the Borrower of the terms of, any Loan Document or the CVS/Revco Merger. The execution, delivery or performance by the Borrower of the terms of each Loan Document and the consummation of the CVS/Revco Merger will not constitute a default under, or result in the creation or imposition of, or obligation to create, any Lien upon the Property of the Borrower or any Subsidiary pursuant to the terms of any such mortgage, indenture, contract or agreement.

-37-

4.6 Taxes

The Borrower and each Subsidiary has filed or caused to be filed all tax returns, and has paid, or has made adequate provision for the payment of, all taxes shown to be due and payable on said returns or in any assessments made against them, the failure of which to file or pay could reasonably be expected to have a Material Adverse effect, and no tax Liens (other than Liens permitted under Section 8.2) have been filed against the Borrower or any Subsidiary and no claims are being asserted with respect to such taxes which are required by GAAP to be reflected in the Financial Statements and are not so reflected, except for taxes which have been assessed but which are not yet due and payable. The charges, accruals and reserves on the books of the Borrower and each Subsidiary with respect to all federal, state, local and other taxes are considered by the management of the Borrower to be adequate, and the Borrower knows of no unpaid assessment which (a) could reasonably be expected to have a Material Adverse effect, or (b) is or might be due and payable against it or any Subsidiary or any Property of the Borrower or any Subsidiary, except such thereof as are being contested in good faith and by appropriate proceedings diligently conducted, and for which adequate reserves have been set aside in accordance with GAAP or which have been assessed but are not yet due and payable.

4.7 Compliance with Applicable Laws; Filings

Neither the Borrower nor any Subsidiary is in default with respect to any judgment, order, writ, injunction, decree or decision of any Governmental Authority which default could reasonably be expected to have a Material Adverse effect. The Borrower and each Subsidiary is complying with all applicable statutes, rules and regulations of all Governmental Authorities, a violation of which could reasonably be expected to have a Material Adverse effect. The Borrower and each Subsidiary has filed or caused to be filed with all Governmental Authorities all reports, applications, documents, instruments and information required to be filed pursuant to all applicable laws, rules, regulations and requests which, if not so filed, could reasonably be expected to have a Material Adverse effect.

4.8 Governmental Regulations

Neither the Borrower nor any Subsidiary nor any corporation controlling the Borrower or any Subsidiary or under common control with the Borrower or any Subsidiary is subject to regulation under the Investment Company Act of 1940, as amended, or is subject to any statute or regulation which regulates the incurrence of Indebtedness.

4.9 Federal Reserve Regulations; Use of Proceeds

The Borrower is not engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System, as amended. No part of the proceeds of the Loans or the Letters of Credit has been or will be used, directly or indirectly, for a purpose which violates any law, rule or regulation of any Governmental Authority, including, without limitation, the provisions of Regulations G, T, U or X of the Board of Governors of the Federal Reserve System, as amended. Anything in this Agreement to the contrary notwithstanding, neither

-38-

the Issuer nor any Lender shall be obligated to extend credit to or on behalf of the Borrower in violation of any limitation or prohibition provided by any applicable law, regulation or statute, including said Regulation U. Following application of the proceeds of each Loan and the issuance of each Letter of Credit, not more than 25% (or such greater or lesser percentage as is provided in the exclusions from the definition of "Indirectly Secured" contained in said Regulation G and Regulation U as in effect at the time of the making of such Loan or issuance of such Letter of Credit) of the value of the assets of the Borrower and the Subsidiaries on a Consolidated basis that are subject to
Section 8.2 will be Margin Stock.

4.10 No Misrepresentation

No representation or warranty contained in any Loan Document and no certificate or written report furnished by the Borrower to the Administrative Agent or any Lender contains or will contain, as of its date, a misstatement of material fact, or omits or will omit to state, as of its date, a material fact required to be stated in order to make the statements therein contained not misleading in the light of the circumstances under which made.

4.11 Plans

Each Employee Benefit Plan of the Borrower, each Subsidiary and each ERISA Affiliate is in compliance with ERISA and the Internal Revenue Code, where applicable, except where the failure to so comply would not be material. The Borrower, each Subsidiary and each ERISA Affiliate have complied with the material requirements of Section 515 of ERISA with respect to each Pension Plan which is a Multiemployer Plan, except where the failure to so comply would not be material. The Borrower, each Subsidiary and each ERISA Affiliate has, as of the date hereof, made all contributions or payments to or under each such Pension Plan required by law or the terms of such Pension Plan or any contract or agreement. No liability to the PBGC has been, or is reasonably expected by the Borrower, any Subsidiary or any ERISA Affiliate to be, incurred by the Borrower, any Subsidiary or any ERISA Affiliate. Liability, as referred to in this Section 4.11, includes any joint and several liability, but excludes any liability for premiums under Section 4007 of ERISA. Each Employee Benefit Plan which is a group health plan within the meaning of Section 5000(b)(1) of the Internal Revenue Code is in material compliance with the continuation of health care coverage requirements of Section 4980B of the Internal Revenue Code.

4.12 Environmental Matters

Neither the Borrower nor any Subsidiary (a) has received written notice or otherwise learned of any claim, demand, action, event, condition, report or investigation indicating or concerning any potential or actual liability which individually or in the aggregate could reasonably be expected to have a Material Adverse effect, arising in connection with (i) any non-compliance with or violation of the requirements of any applicable federal, state or local environmental health or safety statute or regulation, or (ii) the release or threatened release of any toxic or hazardous waste, substance or constituent, or other substance into the environment, (b) to the best knowledge of the Borrower, has any threatened or actual liability in connection with the release or threatened release of any toxic or hazardous waste, substance or constituent, or other substance into the environment which individually or in the aggregate could reasonably be expected to have a Material Adverse effect,
(c) has received notice of any federal or state investigation evaluating whether any remedial action is needed to respond to a release or threatened release of any

-39-

toxic or hazardous waste, substance or constituent or other substance into the environment for which the Borrower or any Subsidiary is or would be liable, which liability would reasonably be expected to have a Material Adverse effect, or (d) has received notice that the Borrower or any Subsidiary is or may be liable to any Person under the Comprehensive Environmental Response, Compensation and Liability Act, as amended, 42 U.S.C. Section 9601 et seq., or any analogous state law, which liability would reasonably be expected to have a Material Adverse effect. The Borrower and each Subsidiary is in compliance with the financial responsibility requirements of federal and state environmental laws to the extent applicable, including those contained in 40 C.F.R., parts 264 and 265, subpart H, and any analogous state law, except in those cases in which the failure so to comply would not reasonably be expected to have a Material Adverse effect.

4.13 Financial Statements

The Borrower has heretofore delivered to the Lenders through the Administrative Agent copies of (i) the audited Consolidated Balance Sheet of the Borrower and its Subsidiaries as of December 31, 1996, and the related Consolidated Statement of Income and Retained Earnings, and Consolidated Statement of Cash Flows, for the fiscal year then ended (the "Borrower Audited Financial Statements"), (ii) the audited consolidated Balance Sheet of Revco and its subsidiaries as of December 31, 1996, and the related consolidated Statements of Income and Retained Earnings, and consolidated Statement of Cash Flows, for the fiscal year then ended (the "Revco Audited Financial Statements") and (iii) the unaudited pro-forma (after giving effect to the CVS/Revco Merger) Consolidated Balance Sheet of the Borrower as of the proposed CVS/Revco Merger Date, and the related pro-forma (after giving effect to the CVS/Revco Merger) Consolidated Statement of Income and Retained Earnings for the period from January 1, 1997 to the proposed CVS/Revco Merger Date (the "Borrower Pro Forma Financial Statements") and, together with the Borrower Audited Statements and the Revco Audited Statements, including any related notes and schedules, the "Financial Statements"). The Borrower Audited Financial Statements fairly present the Consolidated financial condition and results of the operations of the Borrower and the Subsidiaries, and the Borrower Pro Forma Financial Statements fairly present, on a pro forma basis after giving effect to the consummation of the CVS/Revco Merger, the Consolidated financial condition and results of the operations of the Borrower and the Subsidiaries, in each case as of the dates and for the periods indicated therein and, except as noted therein, have been prepared in conformity with GAAP as then in effect. Neither the Borrower nor any of the Subsidiaries, with respect to the Borrower Audited Financial Statements, and neither the Borrower nor any of the Subsidiaries (after giving effect to the CVS/Revco Merger), with respect to the Borrower Pro Forma Financial Statements, has any obligation or liability of any kind (whether fixed, accrued, contingent, unmatured or otherwise) which, in accordance with GAAP as then in effect, should have been disclosed in the Financial Statements and was not. During the period from December 31, 1996 to and including the Effective Date there has been no Material Adverse change, including as a result of any change in law, in the consolidated financial condition, operations, business or Property of the Borrower and the Subsidiaries taken as a whole (after giving effect to the CVS/Revco Merger).

-40-

5. CONDITIONS OF LENDING - FIRST LOANS AND LETTERS OF CREDIT ON THE FIRST BORROWING DATE

In addition to the requirements set forth in Section 6, the obligation of each Lender on the first Borrowing Date to make one or more Revolving Credit Loans, the Swing Line Lender to make one or more Swing Line Loans, the Issuer to issue one or more Letters of Credit and any Lender to make a Competitive Bid Loan are subject to the fulfillment of the following conditions precedent prior to or simultaneously with the Effective Date:

5.1 Evidence of Corporate Action

The Administrative Agent shall have received a certificate, dated the Effective Date, of the Secretary or an Assistant Secretary of the Borrower
(i) attaching a true and complete copy of the resolutions of its Board of Directors and of all documents evidencing all other necessary corporate action
(in form and substance reasonably satisfactory to the Administrative Agent) taken by the Borrower to authorize the Loan Documents, the CVS/Revco Merger and the transactions contemplated thereby, (ii) attaching a true and complete copy of its Certificate of Incorporation and By-Laws, (iii) setting forth the incumbency of the officer or officers of the Borrower who may sign the Loan Documents and any other certificates, requests, notices or other documents now or in the future required thereunder, including therein a signature specimen of such officers, and (iv) attaching a certificate of good standing of the Secretary of State of the State of Delaware.

5.2 Notes

The Borrower shall have delivered to the Administrative Agent (for delivery to the Lenders) the Notes, executed by the Borrower.

5.3 Opinion of Special Counsel

The Administrative Agent shall have received from Special Counsel an opinion, dated the Effective Date, and in the form of Exhibit E.

5.4 Opinion of Counsel to the Borrower

The Administrative Agent shall have received an opinion of Davis Polk & Wardwell, special counsel to the Borrower, and Zenon Lankowsky, counsel to the Borrower, dated the Effective Date, and in the form of Exhibit D.

5.5 CVS/Revco Merger

The CVS/Revco Merger shall have been consummated substantially in accordance with the CVS/Revco Merger Documents, with no amendment or waiver of any term or condition thereto which would have a Material Adverse effect with respect to the Borrower and the Subsidiaries taken as a whole (after giving effect to the CVS/Revco Merger) since December 31, 1996 or which would materially and adversely affect the interest of the Administrative Agent or the Lenders under the Loan Documents and in connection therewith: the Administrative Agent shall have received a certificate from the Treasurer of the Borrower stating that (i) the CVS/Revco Merger has been consummated

-41-

substantially in accordance with the CVS/Revco Merger Documents, with no amendment or waiver of any term or condition thereto which would have a Material Adverse effect with respect to the Borrower and the Subsidiaries taken as a whole (after giving effect to the CVS/Revco Merger) since December 31, 1996 or which would materially and adversely affect the interest of the Administrative Agent or the Lenders under the Loan Documents, (ii) the CVS/Revco Merger has become effective, (iii) all representations and warranties contained in this Agreement shall be true and correct and no Default or Event of Default shall exist, in each case immediately before and after giving effect to the consummation of the CVS/Revco Merger, and attaching a true and complete copy of the CVS/Revco Merger Documents, and (iv) immediately before and after giving effect to the consummation of the CVS/Revco Merger, the Borrower is Solvent.

5.6 Existing Credit Agreements

All commitments to lend under the Existing Credit Agreements shall have been terminated, all letters of credit issued thereunder (other than letters of credit issued under the Revco Existing Credit Agreement) shall have been cancelled and all loans, interest, fees and other amounts owing thereunder shall have been paid in full. In order to facilitate the satisfaction of the condition set forth in this Section 5.6, each Lender hereunder which is a party to the Existing CVS Credit Agreement waives the requirement in Section 2.6 thereof that a notice terminating the commitments of the lenders thereunder must be given by the Borrower at least three Domestic Business Days prior to such termination, and agrees that the termination of the commitments thereunder shall be contingent upon, and effective upon, the occurrence of the Effective Date hereunder, provided that, if for any reason such termination shall not occur on the date proposed by the Borrower as the Effective Date hereunder, the Borrower shall indemnify the Lenders in accordance with Section 3.5 thereof.

6. CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT

The obligation of each Lender on any Borrowing Date to make each Revolving Credit Loan (other than a Revolving Credit Loan constituting a Mandatory Borrowing), the Swing Line Lender to make each Swing Line Loan, the Issuer to issue each Letter of Credit and any Lender to make a Competitive Bid Loan are subject to the fulfillment of the following conditions precedent:

6.1 Compliance

On each Borrowing Date, and after giving effect to the Loans to be made or the Letters of Credit to be issued on such Borrowing Date, (a) there shall exist no Default or Event of Default, and (b) the representations and warranties contained in this Agreement shall be true and correct with the same effect as though such representations and warranties had been made on such Borrowing Date, except those which are expressly specified to be made as of an earlier date.

6.2 Requests

The Administrative Agent shall have received either or both, as applicable, of a Borrowing Request or a Letter of Credit Request from the Borrower.

-42-

6.3 Loan Closings

All documents required by the provisions of this Agreement to have been executed or delivered by the Borrower to the Administrative Agent, any Lender or the Issuer on or before the applicable Borrowing Date shall have been so executed or delivered on or before such Borrowing Date.

7. AFFIRMATIVE COVENANTS

The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums payable under the Loan Documents, the Borrower will:

7.1 Legal Existence

Except as may otherwise be permitted by Sections 8.3 and 8.4, maintain, and cause each Subsidiary to maintain, its corporate existence in good standing in the jurisdiction of its incorporation or formation and in each other jurisdiction in which the failure so to do could reasonably be expected to have a Material Adverse effect, except that the corporate existence of Subsidiaries operating closing or discontinued operations may be terminated.

7.2 Taxes

Pay and discharge when due, and cause each Subsidiary so to do, all taxes, assessments, governmental charges, license fees and levies upon or with respect to the Borrower and such Subsidiary, and upon the income, profits and Property thereof unless, and only to the extent, that either (i)(a) such taxes, assessments, governmental charges, license fees and levies shall be contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Subsidiary, and (b) such reserve or other appropriate provision as shall be required by GAAP shall have been made therefor, or (ii) the failure to pay or discharge such taxes, assessments, governmental charges, license fees and levies could not reasonably be expected to have a Material Adverse effect.

7.3 Insurance

Keep, and cause each Subsidiary to keep, insurance with responsible insurance companies in such amounts and against such risks as is usually carried by the Borrower or such Subsidiary.

7.4 Performance of Obligations

Pay and discharge promptly when due, and cause each Subsidiary so to do, all lawful Indebtedness, obligations and claims for labor, materials and supplies or otherwise which, if unpaid, could reasonably be expected to (a) have a Material Adverse effect, or (b) become a Lien on the Property of the Borrower or any Subsidiary, except

-43-

those Liens permitted under Section 8.2, provided that neither the Borrower nor such Subsidiary shall be required to pay or discharge or cause to be paid or discharged any such Indebtedness, obligation or claim so long as (i) the validity thereof shall be contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Subsidiary, and (ii) such reserve or other appropriate provision as shall be required by GAAP shall have been made therefor.

7.5 Condition of Property

Except for ordinary wear and tear, at all times, maintain, protect and keep in good repair, working order and condition, all material Property necessary for the operation of its business (other than Property which is replaced with similar Property) as then being operated, and cause each Subsidiary so to do.

7.6 Observance of Legal Requirements

Observe and comply in all material respects, and cause each Subsidiary so to do, with all laws, ordinances, orders, judgments, rules, regulations, certifications, franchises, permits, licenses, directions and requirements of all Governmental Authorities, which now or at any time hereafter may be applicable to it or to such Subsidiary, a violation of which could reasonably be expected to have a Material Adverse effect.

7.7 Financial Statements and Other Information

Maintain, and cause each Subsidiary to maintain, a standard system of accounting in accordance with GAAP, and furnish to each Lender:

(a) As soon as available and, in any event, within 120 days after the close of each fiscal year, a copy of (x) the Borrower's 10-K in respect of such fiscal year, and (y) (i) the Borrower's Consolidated Balance Sheet as of the end of such fiscal year, and (ii) the related Consolidated Statements of Earnings, Shareholders' Equity and Cash Flows, as of and through the end of such fiscal year, setting forth in each case in comparative form the corresponding figures in respect of the previous fiscal year, all in reasonable detail, and accompanied by a report of the Borrower's auditors, which report shall state that (A) such auditors audited such financial statements, (B) such audit was made in accordance with generally accepted auditing standards in effect at the time and provides a reasonable basis for such opinion, and (C) said financial statements have been prepared in accordance with GAAP;

(b) As soon as available, and in any event within 60 days after the end of each of the first three fiscal quarters of each fiscal year, a copy of
(x) the Borrower's 10-Q in respect of such fiscal quarter, and (y) (i) the Borrower's Consolidated Balance Sheet as of the end of such quarter and (ii) the related Consolidated Statements of Earnings, Shareholders' Equity and Cash Flows for (A) such quarter and (B) the period from the beginning of the then current fiscal year to the end of such quarter, in each case in comparable form with the prior fiscal year, all in reasonable detail and prepared in accordance with GAAP (without footnotes and subject to year-end adjustments);

(c) Simultaneously with the delivery of the financial statements required by clauses (a) and (b) above, a certificate of the chief financial officer or treasurer of the

-44-

Borrower certifying that no Default or Event of Default shall have occurred or be continuing or, if so, specifying in such certificate all such Defaults and Events of Default, and setting forth computations in reasonable detail demonstrating compliance with Sections 8.1 and 8.10.

(d) Prompt notice upon the Borrower becoming aware of any change in a Pricing Level;

(e) Promptly upon becoming available, copies of all regular or periodic reports (including, without limitation, current reports on Form 8-K) which the Borrower or any Subsidiary may now or hereafter be required to file with or deliver to the Securities and Exchange Commission, or any other Governmental Authority succeeding to the functions thereof, and copies of all material news releases sent to all stockholders;

(f) Prompt written notice of: (i) any citation, summons, subpoena, order to show cause or other order naming the Borrower or any Subsidiary a party to any proceeding before any Governmental Authority which could reasonably be expected to have a Material Adverse effect, and include with such notice a copy of such citation, summons, subpoena, order to show cause or other order, (ii) any lapse or other termination of any license, permit, franchise or other authorization issued to the Borrower or any Subsidiary by any Governmental Authority, (iii) any refusal by any Governmental Authority to renew or extend any license, permit, franchise or other authorization, and (iv) any dispute between the Borrower or any Subsidiary and any Governmental Authority, which lapse, termination, refusal or dispute, referred to in clause (ii), (iii) or
(iv) above, could reasonably be expected to have a Material Adverse effect;

(g) Prompt written notice of the occurrence of (i) each Default (ii) each Event of Default and (iii) each Material Adverse change;

(h) Promptly upon receipt thereof, copies of any audit reports and management letters delivered in connection with the statements referred to in
Section 7.7(a); and

(i) From time to time, such other information regarding the financial position or business of the Borrower and the Subsidiaries as the Administrative Agent, at the request of any Lender, may reasonably request.

7.8 Records

Upon reasonable notice and during normal business hours, permit representatives of the Administrative Agent and each Lender to visit the offices of the Borrower and each Subsidiary, to examine the books and records (other than tax returns and work papers related to tax returns) thereof and auditors' reports relating thereto, to discuss the affairs of the Borrower and each Subsidiary with the respective officers thereof, and to meet and discuss the affairs of the Borrower and each Subsidiary with the Borrower's auditors.

-45-

7.9 Authorizations

Maintain and cause each Subsidiary to maintain, in full force and effect, all copyrights, patents, trademarks, trade names, franchises, licenses, permits, applications, reports, and other authorizations and rights, which, if not so maintained, would individually or in the aggregate have a Material Adverse effect.

7.10 Revco 10 1/8% Indenture Debt

Within three Business Days of the Effective Date, notify (or request the trustee to notify) the holders of the Revco 10 1/8% Indenture Debt of Revco's election to redeem all of the Revco 10 1/8% Indenture Debt on a redemption date no later than 60 days from the Effective Date.

8. NEGATIVE COVENANTS

The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums which are payable under the Loan Documents, the Borrower will not:

8.1 Subsidiary Indebtedness

Permit the Indebtedness of all Subsidiaries (excluding the ESOP Guaranty, the Revco 9 1/8% Indenture Debt and the Revco 10 1/8% Indenture Debt) to exceed (on a combined basis) 10% of Tangible Net Worth.

8.2 Liens

Create, incur, assume or suffer to exist any Lien against or on any Property now owned or hereafter acquired by the Borrower or any of the Subsidiaries, or permit any of the Subsidiaries so to do, except any one or more of the following types of Liens: (a) Liens in connection with workers' compensation, unemployment insurance or other social security obligations (which phrase shall not be construed to refer to ERISA or the minimum funding obligations under Section 412 of the Code), (b) Liens to secure the performance of bids, tenders, letters of credit, contracts (other than contracts for the payment of Indebtedness), leases, statutory obligations, surety, customs, appeal, performance and payment bonds and other obligations of like nature, in each such case arising in the ordinary course of business, (c) mechanics', workmen's, carriers', warehousemen's, materialmen's, landlords' or other like Liens arising in the ordinary course of business with respect to obligations which are not due or which are being contested in good faith and by appropriate proceedings diligently conducted, (d) Liens for taxes, assessments, fees or governmental charges the payment of which is not required by Section 7.2, (e) easements, rights of way, restrictions, leases of Property to others, easements for installations of public utilities, title imperfections and restrictions, zoning ordinances and other similar encumbrances affecting Property which in the aggregate do not materially impair its use for the operation of the business of the Borrower or such Subsidiary, (f) Liens on Property as set forth on Schedule 8.2 and any renewals thereof, provided that any such renewals attach only to such Property, (g) Liens on Property of the Subsidiaries under capital leases

-46-

and Liens on Property of the Subsidiaries acquired (whether as a result of purchase, capital lease, merger or other acquisition) and either existing on such Property when acquired, or created contemporaneously with or within 12 months of such acquisition to secure the payment or financing of the purchase price of such Property (including the construction, development, substantial repair, alteration or improvement thereof), and any renewals thereof, provided that such Liens attach only to the Property so purchased or acquired (including any such construction, development, substantial repair, alteration or improvement thereof) and provided further that the Indebtedness secured by such Liens is permitted by Section 8.1, (h) statutory Liens in favor of lessors arising in connection with Property leased to the Borrower or any of the Subsidiaries, (i) Liens of attachments, judgments or awards against the Borrower or any of the Subsidiaries with respect to which an appeal or proceeding for review shall be pending or a stay of execution or bond shall have been obtained, or which are otherwise being contested in good faith and by appropriate proceedings diligently conducted, and in respect of which adequate reserves shall have been established in accordance with GAAP on the books of the Borrower or such Subsidiary, (j) Liens securing Indebtedness of a Subsidiary to the Borrower or another Subsidiary, (k) Liens (other than Liens permitted by any of the foregoing clauses) arising in the ordinary course of its business which do not secure Indebtedness and do not, in the aggregate, materially detract from the value of the business of the Borrower and its Subsidiaries, taken as a whole, and (l) additional Liens securing Indebtedness of the Borrower and the Subsidiaries in an aggregate outstanding Consolidated principal amount not exceeding 10% of Tangible Net Worth.

8.3 Dispositions

Make any Disposition, or permit any of its Subsidiaries so to do, of all or substantially all of the assets of the Borrower and the Subsidiaries on a Consolidated basis.

8.4 Merger or Consolidation, Etc.

The Borrower will not consolidate with, be acquired by, or merge into or with any Person unless (x) immediately after giving effect thereto no Default or Event of Default shall or would exist and (y) either (i) the Borrower or (ii) a corporation organized and existing under the laws of one of the States of the United States of America shall be the survivor of such consolidation or merger, provided that if the Borrower is not the survivor, the corporation which is the survivor shall expressly assume, pursuant to an instrument executed and delivered to the Administrative Agent, and in form and substance satisfactory to the Administrative Agent, all obligations of the Borrower under the Loan Documents and the Administrative Agent shall have received such documents, opinions and certificates as it shall have reasonable requested in connection therewith.

8.5 Acquisitions

Make any Acquisition, or permit any of the Subsidiaries so to do, except any one or more of the following: (a) Intercompany Dispositions permitted by Section 8.3, (b) Acquisitions by the Borrower or any of the Subsidiaries, provided that immediately before and after giving effect to each such Acquisition no Default or Event of Default shall or would exist, and (c) the CVS/Revco Merger.

-47-

8.6 Restricted Payments

Make any Restricted Payment or permit any of the Subsidiaries so to do, except any one or more of the following Restricted Payments: (a) any direct or indirect Subsidiary may make dividends or other distributions to the Borrower or to any other direct or indirect Subsidiary, and (b) the Borrower may make Restricted Payments provided that, in the case of this clause (b), immediately before and after giving effect thereto, no Event of Default shall or would exist. Nothing in this Section 8.6 shall prohibit or restrict the declaration or payment of dividends in respect of the Series One ESOP Convertible Preferred Stock of the Borrower.

8.7 Limitation on Upstream Dividends by Subsidiaries

Permit or cause any of the Subsidiaries to enter into or agree, or otherwise be or become subject, to any agreement, contract or other arrangement (other than this Agreement and the indenture with respect to the Revco 10 1/8% Indenture Debt) with any Person (each a "Restrictive Agreement") pursuant to the terms of which (a) such Subsidiary is or would be prohibited from declaring or paying any cash dividends on any class of its stock owned directly or indirectly by the Borrower or any of the other Subsidiaries or from making any other distribution on account of any class of any such stock (herein referred to as "Upstream Dividends"), or (b) the declaration or payment of Upstream Dividends by a Subsidiary to the Borrower or another Subsidiary, on an annual or cumulative basis, is or would be otherwise limited or restricted ("Dividend Restrictions"). Notwithstanding the foregoing, nothing in this Section 8.7 shall prohibit:

(i) Dividend Restrictions set forth in any Restrictive Agreement in effect on the date hereof and any extensions, refinancings, renewals or replacements thereof; provided that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced;

(ii) Dividend Restrictions existing with respect to any Person acquired by the Borrower or any Subsidiary and existing at the time of such acquisition, which Dividend Restrictions are not applicable to any Person or the property or assets of any Person other than such Person or its property or assets acquired, and any extensions, refinancings, renewals or replacements of any of the foregoing; provided that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced; or

(iii) Dividend Restrictions consisting of customary net worth, leverage and other financial covenants, customary covenants regarding the merger of or sale of assets of a Subsidiary, customary restrictions on transactions with affiliates, and customary subordination provisions governing Indebtedness owed to the Borrower or any Subsidiary contained in, or required by, any agreement governing Indebtedness owed to the Borrower or any Subsidiary contained in, or required by, any agreement governing Indebtedness incurred by a Subsidiary in accordance with Section 8.1.

-48-

8.8 Limitation on Negative Pledges

Enter into any agreement, other than (i) this Agreement and (ii) purchase money mortgages or capital leases permitted by this Agreement (in which cases, any prohibition or limitation shall only be effective against the assets financed thereby), or permit any Subsidiary so to do, which prohibits or limits the ability of the Borrower or such Subsidiary to create, incur, assume or suffer to exist any Lien upon any of its Property or revenues, whether now owned or hereafter acquired.

8.9 CVS/Revco Merger Documents

Amend, modify or otherwise change any of the CVS/Revco Merger Documents if such change would have a Material Adverse effect with respect to the Borrower and the Subsidiaries taken as a whole (after giving effect to the CVS/Revco Merger) since December 31, 1996 or would materially and adversely affect the interest of the Administrative Agent or the Lenders under the Loan Documents.

8.10 Ratio of Consolidated Indebtedness to Total Capitalization

Permit its ratio of Consolidated Indebtedness to Total Capitalization at the end of any fiscal quarter to exceed 0.6:1.0.

9. DEFAULT

9.1 Events of Default

The following shall each constitute an "Event of Default" hereunder:

(a) The failure of the Borrower to make any payment of principal on any Loan or any reimbursement payment in respect of any Letter of Credit when due and payable; or

(b) The failure of the Borrower to make any payment of interest on any Loan or of any Fee on any date when due and payable and such default shall continue unremedied for a period of 5 Domestic Business Days after the same shall be due and payable; or

(c) The failure of the Borrower to observe or perform any covenant or agreement contained in Sections 2.5 and 7.1 or in Section 8; or

(d) The failure of the Borrower to observe or perform any other covenant or agreement contained in this Agreement, and such failure shall have continued unremedied for a period of 30 days after the Borrower shall have become aware of such failure; or

(e) An Event of Default (as defined in any Reimbursement Agreement) shall occur under any Reimbursement Agreement; or

-49-

(f) Any representation or warranty of the Borrower (or of any of its officers on its behalf) made in any Loan Document, or made in any certificate, report, opinion (other than an opinion of counsel) or other document delivered on or after the date hereof shall in any such case prove to have been incorrect or misleading (whether because of misstatement or omission) in any material respect when made; or

(g) (i) Obligations in an aggregate Consolidated amount in excess of $25,000,000 of the Borrower (other than its obligations hereunder and under the Notes) and the Subsidiaries, whether as principal, guarantor, surety or other obligor, for the payment of any Indebtedness or any net liability under interest rate swap, collar, exchange or cap agreements, (A) shall become or shall be declared to be due and payable prior to the expressed maturity thereof, or (B) shall not be paid when due or within any grace period for the payment thereof, or (ii) any holder of any such obligations shall have the right to declare the Indebtedness evidenced thereby due and payable prior to its stated maturity; or

(h) The Borrower or any Subsidiary shall (i) suspend or discontinue its business (except for store closings in the ordinary course of business and except in connection with a permitted Disposition under Section 8.3 and as may otherwise be expressly permitted herein), or (ii) make an assignment for the benefit of creditors, or (iii) generally not be paying its debts as such debts become due, or (iv) admit in writing its inability to pay its debts as they become due, or (v) file a voluntary petition in bankruptcy, or (vi) become insolvent (however such insolvency shall be evidenced), or (vii) file any petition or answer seeking for itself any reorganization, arrangement, composition, readjustment of debt, liquidation or dissolution or similar relief under any present or future statute, law or regulation of any jurisdiction (including under any law applicable to insurance companies), or (viii) petition or apply to any tribunal, or any other Governmental Authority, for any receiver, custodian or any trustee for any substantial part of its Property, or (ix) be the subject of any proceeding specified in clause (vii) or (viii) filed against it which remains undismissed for a period of 60 consecutive days, or (x) file any answer admitting or not contesting the material allegations of any such petition filed against it, or of any order, judgment or decree approving such petition in any such proceeding, or (xi) seek, approve, consent to, or acquiesce in any such proceeding, or in the appointment of any trustee, receiver, custodian, liquidator, or fiscal agent for it, or any substantial part of its Property, or an order is entered appointing any such trustee, receiver, custodian, liquidator or fiscal agent and such order remains unstayed and in effect for 60 consecutive days, or (xii) take any formal action for the purpose of effecting any of the foregoing (except as may otherwise be expressly permitted herein); or

(i) An order for relief is entered under the United States bankruptcy laws or any other decree or order is entered by a court or other Governmental Authority having jurisdiction and continues unstayed and in effect for a period of 60 consecutive days (i) adjudging the Borrower or any Subsidiary bankrupt or insolvent, or (ii) approving as properly filed a petition seeking reorganization, liquidation, arrangement, adjustment or composition of, or in respect of the Borrower or any Subsidiary under the United States bankruptcy laws or any other applicable Federal or state law, or (iii) appointing a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) of the Borrower or any Subsidiary or of substantially all of the Property of any thereof, or (iv) ordering the winding up or liquidation of the affairs of the Borrower or any Subsidiary; or

-50-

(j) Judgments or decrees in an aggregate Consolidated amount in excess of $25,000,000 against the Borrower and the Subsidiaries shall remain unpaid, unstayed on appeal, undischarged, unbonded or undismissed for a period of 60 days; or

(k) After the Effective Date a Change of Control shall occur; or

(l) (i) Any Termination Event shall occur (x) with respect to any Pension Plan (other than a Multiemployer Plan) or (y) with respect to any other retirement plan subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, which plan, during the five year period prior to such Termination Event, was the responsibility in whole or in part of the Borrower, any Subsidiary or any ERISA Affiliate, provided that this clause (y) shall only apply if, in connection with such Termination Event, it is reasonably likely that liability under Section 4069 of ERISA in an aggregate Consolidated amount in excess of $25,000,000 will be imposed upon the Borrower, any Subsidiary or any ERISA Affiliate; (ii) any Accumulated Funding Deficiency, whether or not waived, in an aggregate Consolidated amount in excess of $25,000,000 shall exist with respect to any Pension Plan with respect to any Pension Plan (other than a Multiemployer Plan); (iii) any Person shall engage in any Prohibited Transaction involving any Employee Benefit Plan; (iv) the Borrower, any Subsidiary or any ERISA Affiliate shall fail to pay when due an amount which is payable by it to the PBGC or to a Pension Plan (including a Multiemployer Plan) under Title IV of ERISA; (v) the imposition of any tax under Section 4980(B)(a) of the Internal Revenue Code; or (vi) the assessment of a civil penalty with respect to any Employee Benefit Plan under Section 502(c) of ERISA; in each case, to the extent such event or condition would have a Material Adverse effect.

9.2 Remedies

(a) Upon the occurrence of an Event of Default or at any time thereafter during the continuance of an Event of Default, the Administrative Agent, at the written request of the Required Lenders, shall notify the Borrower that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment have been terminated and/or that all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other amounts owing under the Loan Documents have been declared immediately due and payable, provided that upon the occurrence of an Event of Default under
Section 9.1(h) or (i) with respect to the Borrower, the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall automatically terminate and all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other amounts owing under the Loan Documents shall become immediately due and payable without declaration or notice to the Borrower. To the fullest extent not prohibited by law, except for the notice provided for in the preceding sentence, the Borrower expressly waives any presentment, demand, protest, notice of protest or other notice of any kind in connection with the Loan Documents and its obligations thereunder. To the fullest extent not prohibited by law, the Borrower further expressly waives and covenants not to assert any appraisement, valuation, stay, extension, redemption or similar law, now or at any time hereafter in force which might delay, prevent or otherwise impede the performance or enforcement of the Loan Documents.

(b) In the event that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall have been terminated or all of the Loans, the Notes

-51-

and the Reimbursement Obligations shall have been declared due and payable pursuant to the provisions of this Section, (i) the Borrower shall forthwith deposit an amount equal to the Letter of Credit Exposure in a cash collateral account with and under the exclusive control of the Administrative Agent, and
(ii) the Administrative Agent, the Issuer and the Lenders agree, among themselves, that any funds received from or on behalf of the Borrower under any Loan Document by the Issuer or any Lender (except funds received by the Issuer or any Lender as a result of a purchase from the Issuer or such Lender, as the case may be, pursuant to the provisions of Section 11.9) shall be remitted to the Administrative Agent, and shall be applied by the Administrative Agent in payment of the Loans, the Reimbursement Obligations and the other obligations of the Borrower under the Loan Documents in the following manner and order: (1) first, to reimburse the Administrative Agent, the Issuer and the Lenders, in that order, for any expenses due from the Borrower pursuant to the provisions of
Section 11.5 and the Reimbursement Agreements, (2) second, to the payment of the Fees, (3) third, to the payment of any expenses or amounts (other than the principal of and interest on the Loans and the Notes and the Reimbursement Obligations) payable by the Borrower to the Administrative Agent, the Issuer or any of the Lenders under the Loan Documents, (4) fourth, to the payment, pro rata according to the outstanding principal balance of the Loans and the Letter of Credit Exposure of each Lender, of interest due on the Loans and the Reimbursement Obligations, (5) fifth, to the payment, pro rata according to the sum of (A) the aggregate outstanding principal balance of the Loans plus (B) the aggregate outstanding balance of the Reimbursement Obligations, of the aggregate outstanding principal balance of the Loans and the aggregate outstanding balance of the Reimbursement Obligations, and (6) sixth, any remaining funds shall be paid to whosoever shall be entitled thereto or as a court of competent jurisdiction shall direct.

(c) In the event that the Loans and the Notes and the Reimbursement Obligations shall have been declared due and payable pursuant to the provisions of this Section 9.2, the Administrative Agent upon the written request of the Required Lenders, shall proceed to enforce the Reimbursement Obligations and the rights of the holders of the Notes by suit in equity, action at law and/or other appropriate proceedings, whether for payment or the specific performance of any covenant or agreement contained in the Loan Documents. In the event that the Administrative Agent shall fail or refuse so to proceed, the Issuer and each Lender shall be entitled to take such action as the Required Lenders shall deem appropriate to enforce its rights under the Loan Documents.

10. AGENT

10.1 Appointment

Each Lender hereby irrevocably designates and appoints BNY as the Administrative Agent of such Lender under the Loan Documents and each Lender irrevocably authorizes the Administrative Agent to take such action on its behalf under the provisions of the Loan Documents and to exercise such powers and perform such duties as are expressly delegated to the Administrative Agent by the terms of the Loan Documents, together with such other powers as are reasonably incidental thereto. Notwithstanding any provision to the contrary contained in the Loan Documents, the Administrative Agent shall not have any duties or responsibilities except those expressly set forth in the Loan Documents, or any fiduciary relationship with any Lender, and no implied covenants,

-52-

functions, responsibilities, duties, obligations or liabilities shall be read into the Loan Documents or otherwise exist against the Administrative Agent.

10.2 Delegation of Duties

The Administrative Agent may execute any of its duties under the Loan Documents by or through agents or attorneys-in-fact and shall be entitled to rely upon the advice of counsel concerning all matters pertaining to such duties, and shall not be liable for any action taken or omitted to be taken in good faith upon the advice of such counsel.

10.3 Exculpatory Provisions

None of the Administrative Agent or any of its officers, directors, employees, agents, attorneys-in-fact or Affiliates shall be (i) liable for any action lawfully taken or omitted to be taken by the Administrative Agent or such Person under or in connection with the Loan Documents (except the Administrative Agent for its own gross negligence or willful misconduct), or (ii) responsible in any manner to any of the Lenders for any recitals, statements, representations or warranties made by any party contained in the Loan Documents or in any certificate, report, statement or other document referred to or provided for in, or received by the Administrative Agent under or in connection with, the Loan Documents or for the value, validity, effectiveness, genuineness, enforceability or sufficiency of any of the Loan Documents or for any failure of the Borrower or any other Person to perform its obligations thereunder. The Administrative Agent shall not be under any obligation to any Lender to ascertain or to inquire into the observance or performance of any of the covenants or agreements contained in, or conditions of, the Loan Documents, or to inspect the Property, books or records of the Borrower or any Subsidiary. The Administrative Agent shall not be under any liability or responsibility to the Borrower or any other Person as a consequence of any failure or delay in performance, or any breach, by any Lender of any of its obligations under any of the Loan Documents. The Lenders acknowledge that the Administrative Agent shall not be under any duty to take any discretionary action permitted under the Loan Documents unless the Administrative Agent shall be requested in writing to do so by the Required Lenders.

10.4 Reliance by Administrative Agent

The Administrative Agent shall be entitled to rely, and shall be fully protected in relying, upon any writing, resolution, notice, request, consent, certificate, affidavit, opinion, letter, cablegram, telegram, fax, telex or teletype message, statement, order or other document or conversation reasonably believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (including counsel to the Borrower), independent accountants and other experts selected by the Administrative Agent. The Administrative Agent may treat each Lender, or the Person designated in the last notice filed under
Section 11.7, as the holder of all of the interests of such Lender in its Loans and Notes until written notice of transfer, signed by such Lender (or the Person designated in the last notice filed with the Administrative Agent) and by the Person designated in such written notice of transfer, in form and substance satisfactory to the Administrative Agent, shall have been filed with the Administrative Agent and all requirements of Section 11.7 have been satisfied. The Administrative Agent shall not be under any duty to examine or pass upon the validity, effectiveness or genuineness of the Loan Documents or any instrument,

-53-

document or communication furnished pursuant thereto or in connection therewith, and the Administrative Agent shall be entitled to assume that the same are valid, effective and genuine, have been signed or sent by the proper parties and are what they purport to be. The Administrative Agent shall be fully justified in failing or refusing to take any action not expressly required under the Loan Documents unless it shall first receive such advice or concurrence of the Required Lenders as it deems appropriate. The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under the Loan Documents in accordance with a request of the Required Lenders or, if required by Section 11.1, all Lenders, and such request and any action taken or failure to act pursuant thereto shall be binding upon the Borrower, all the Lenders and all future holders of the Notes.

10.5 Notice of Default

The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default unless the Administrative Agent shall have received written notice thereof from a Lender or the Borrower referring to this Agreement, describing such Default or Event of Default and stating such notice is a "Notice of Default." In the event that the Administrative Agent receives such a notice, the Administrative Agent shall promptly give notice thereof to the Lenders. The Administrative Agent shall take such action with respect to such Default or Event of Default as shall be reasonably directed by the Required Lenders, provided that unless and until the Administrative Agent shall have received such directions, the Administrative Agent may (but shall not be obligated to) take such action or give such directions, or refrain from taking such action or giving such directions, with respect to such Default or Event of Default as it shall deem to be in the best interests of the Lenders.

10.6 Non-Reliance

Each Lender expressly acknowledges that neither the Administrative Agent nor any of its officers, directors, employees, agents, attorneys-in-fact or Affiliates has made any representations or warranties to such Lender and that no act by the Administrative Agent hereafter, including any review of the affairs of the Borrower or the Subsidiaries, shall be deemed to constitute any representation or warranty by the Administrative Agent to any Lender. Each Lender represents to the Administrative Agent that such Lender has, independently and without reliance upon the Administrative Agent or any other Lender, and based on such documents and information as it has deemed appropriate, made its own evaluation of and investigation into the business, operations, Property, financial and other condition and creditworthiness of the Borrower and the Subsidiaries and has made its own decision to enter into this Agreement. Each Lender also represents that it will, independently and without reliance upon the Administrative Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, evaluations and decisions in taking or not taking action under the Loan Documents, and to make such investigation as it deems necessary to inform itself as to the business, operations, Property, financial and other condition and creditworthiness of the Borrower and the Subsidiaries. Each Lender acknowledges that a copy of this Agreement and all exhibits and schedules hereto have been made available to it and its individual counsel for review, and each Lender acknowledges that it is satisfied with the form and substance thereof. Except for notices, reports and other documents expressly required to be furnished to the Lenders by the

-54-

Administrative Agent hereunder, the Administrative Agent shall have no duty or responsibility to provide any Lender with any credit or other information concerning the business, operations, Property, financial and other condition or creditworthiness of the Borrower or the Subsidiaries which may come into the possession of the Administrative Agent or any of its officers, directors, employees, agents, attorneys-in-fact or Affiliates.

10.7 Indemnification

Each Lender agrees to indemnify the Administrative Agent in its capacity as such (to the extent not promptly reimbursed by the Borrower and without limiting the obligation of the Borrower to do so), pro rata according to
(i) at any time when no Loans are outstanding, its Commitment Percentage, or if no Commitments then exist, its Commitment Percentage on the last day on which Commitments did exist, and (ii) at any time when Loans are outstanding (x) if the Commitments then exist, its Commitment Percentage or (y) if the Commitments have been terminated or otherwise no longer exist, the percentage equal to the fraction (A) the numerator of which is such Lender's share of the Aggregate Credit Exposure and (B) the denominator of which is the Aggregate Credit Exposure, from and against any and all liabilities, obligations, claims, losses, damages, penalties, actions, judgments, suits, costs, expenses and disbursements of any kind whatsoever, including any amounts paid to the Lenders by or for the account of the Borrower pursuant to the terms of the Loan Documents that are subsequently rescinded or avoided (or must otherwise be restored or returned), which may at any time (including at any time following the payment of the Loans and the Notes) be imposed on, incurred by or asserted against the Administrative Agent in any way relating to or arising out of the Loan Documents or any other document contemplated by or referred to therein or the transactions contemplated thereby or any action taken or omitted to be taken by the Administrative Agent under or in connection therewith; provided that no Lender shall be liable for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements to the extent resulting solely from the gross negligence or willful misconduct of the Administrative Agent. The agreements in this Section shall survive the payment of the Loans and the Notes and all other amounts payable under the Loan Documents. If the Administrative Agent is subsequently reimbursed by the Borrower for such amounts, the Administrative Agent shall remit to the Lenders their pro rata shares of such reimbursement to the extent they previously paid such amounts.

10.8 Administrative Agent in Its Individual Capacity

BNY and each Affiliate thereof, may make loans to, accept deposits from, issue letters of credit for the account of and generally engage in any kind of business with the Borrower and the Subsidiaries as though it were not the Administrative Agent. With respect to the Commitment made or renewed by BNY and each Note issued to BNY, BNY shall have the same rights and powers under the Loan Documents as any Lender and may exercise the same as though it were not the Administrative Agent, the Issuer and the Swing Line Lender, and the term "Lender" shall include BNY.

10.9 Successor Administrative Agent

If at any time the Administrative Agent deems it advisable, in its sole discretion, it may submit to each Lender a written notification of its resignation as

-55-

Administrative Agent under the Loan Documents, such resignation to be effective on the earlier to occur of (a) the thirtieth day after the date of such notice, and (b) the date upon which any successor to the Administrative Agent, in accordance with the provisions of this Section, shall have accepted in writing its appointment as successor Administrative Agent. Upon any such resignation, the Required Lenders shall have the right to appoint from among the Lenders a successor Administrative Agent, which successor Administrative Agent, provided that no Default or Event of Default shall then exist, shall be reasonably satisfactory to the Borrower. If no such successor Administrative Agent shall have been so appointed by the Required Lenders and accepted such appointment within 30 days after the retiring Administrative Agent's giving of notice of resignation, then the retiring Administrative Agent may, on behalf of the Lenders, appoint a successor Administrative Agent, which successor Administrative Agent shall be a commercial bank organized and licensed under the laws of the United States of America or of any State thereof and having a combined capital and surplus of at least $500,000,000. Upon the written acceptance of any appointment as Administrative Agent hereunder by a successor Administrative Agent, such successor Administrative Agent shall automatically become a party to this Agreement and shall thereupon succeed to and become vested with all the rights, powers, privileges and duties of the retiring Administrative Agent, and the retiring Administrative Agent's rights, powers, privileges and duties as Administrative Agent under the Loan Documents shall be terminated. The Borrower and the Lenders shall execute such documents as shall be necessary to effect such appointment. After any retiring Administrative Agent's resignation as Administrative Agent, the provisions of this Section 10 shall inure to its benefit as to any actions taken or omitted to be taken by it while it was the Administrative Agent. If at any time there shall not be a duly appointed and acting Administrative Agent, upon notice duly given, the Borrower agrees to make each payment when due under the Loan Documents directly to the Lenders entitled thereto during such time.

10.10 Documentation Agent and Syndication Agent

The Documentation Agent and Syndication Agent shall have no duties or obligations under the Loan Documents in their capacity as Documentation Agent and Syndication Agent.

11. OTHER PROVISIONS

11.1 Amendments, Waivers, Etc.

With the written consent of the Required Lenders, the Administrative Agent and the Borrower may, from time to time, enter into written amendments, supplements or modifications of the Loan Documents and, with the written consent of the Required Lenders, the Administrative Agent on behalf of the Lenders may execute and deliver to any such parties a written instrument waiving or consenting to the departure from, on such terms and conditions as the Administrative Agent may specify in such instrument, any of the requirements of the Loan Documents or any Default or Event of Default and its consequences, provided that no such amendment, supplement, modification, waiver or consent shall, without the consent of all of the Lenders (i) increase the Commitment Amount of any Lender (provided that no waiver of a Default or Event of Default shall be deemed to constitute such an increase), (ii) extend the Commitment Period, (iii) reduce the amount, or extend the time of payment, of the Fees,
(iv) reduce the rate,

-56-

or extend the time of payment of, interest on any Revolving Credit Loan, any Revolving Credit Note or any Reimbursement Obligation (other than the applicability of any post-default increase in such rate of interest), (v) reduce the amount, or extend the time of payment of any payment of any Reimbursement Obligation or principal on any Revolving Credit Loan or any Revolving Credit Note, (vi) decrease or forgive the principal amount of any Revolving Credit Loan, any Revolving Credit Note or any Reimbursement Obligation, (vii) consent to any assignment or delegation by the Borrower of any of its rights or obligations under any Loan Document, (viii) change the provisions of this
Section 11.1, (ix) change the definition of Required Lenders, (x) change the several nature of the obligations of the Lenders, (xi) change the sharing provisions among Lenders, or (xii) extend the expiration date of a Letter of Credit beyond the Commitment Termination Date. Notwithstanding the foregoing, no such amendment, supplement, modification, waiver or consent shall (A) amend, modify or waive any provision of Section 10 or otherwise change any of the rights or obligations of the Administrative Agent, the Issuer or the Swing Line Lender under any Loan Document without the written consent of the Administrative Agent, the Issuer or the Swing Line Lender, as the case may be, (B) change the Letter of Credit Commitment, change the amount or the time of payment of the Letter of Credit Commissions, or change any other term or provision which relates to the Letter of Credit Commitment or the Letters of Credit without the written consent of the Issuer, (C) change the Swing Line Commitment, change the amount or the time of payment of the Swing Line Loans or interest thereon or change any other term or provision which relates to the Swing Line Commitment or the Swing Line Loans without the written consent of the Swing Line Lender or (D) change the amount or the time of payment of any Competitive Bid Loan or interest thereon without the written consent of the Lender holding such Competitive Bid Loan. Any such amendment, supplement, modification, waiver or consent shall apply equally to each of the Lenders and shall be binding upon the parties to the applicable Loan Document, the Lenders, the Administrative Agent and all future holders of the Notes and the Reimbursement Obligations. In the case of any waiver, the Borrower, the Lenders and the Administrative Agent shall be restored to their former position and rights under the Loan Documents, but any Default or Event of Default waived shall not extend to any subsequent or other Default or Event of Default, or impair any right consequent thereon.

11.2 Notices

Except as otherwise expressly provided herein, all notices, requests and demands to or upon the respective parties hereto to be effective shall be in writing and, if in writing, shall be deemed to have been duly given or made (a) when delivered by hand, (b) one Domestic Business Day after having been sent by overnight courier service at the cost of the sender, (c) five Domestic Business Days after having been deposited in the mail, first-class postage prepaid, or
(d) in the case of fax notice, when sent, addressed as follows in the case of the Borrower, the Administrative Agent, the Issuer and the Swing Line Lender, and as set forth in Exhibit A in the case of each of the Lenders, or to such other addresses as to which the Administrative Agent may be hereafter notified by the respective parties hereto or any future holders of the Notes:

-57-

The Borrower:

CVS Corporation
1 CVS Drive
Woonsocket, Rhode Island 02895

Attention: Philip C. Galbo, Vice President and Treasurer Facsimile: (401) 769-2211 Telephone: (401) 765-1500

with a copy, in the case of a notice of Default or Event of Default, to:

CVS Corporation
1 CVS Drive
Woonsocket, Rhode Island 02895 Attention: Legal Department Facsimile: (401) 765-7887 or 9304 Telephone: (401) 765-1500

The Administrative Agent, the Swing Line Lender and the Issuer:

in the case of each Borrowing Request, each notice of prepayment under Section 2.7, each Letter of Credit Request, each Competitive Bid Request, each Competitive Bid, and each Competitive Bid Accept/Reject Letter:

The Bank of New York
One Wall Street
New York, New York 10286 Attention: Carol Surles, Agency Function Administration Facsimile: (212) 635-6365,6366 or 6367 Telephone: (212) 635-4695,

in all other cases:

The Bank of New York
Retailing Industry Division 8th Floor
One Wall Street
New York, New York 10286 Attention: Howard F. Bascom, Vice President Facsimile: (212) 635-1481 Telephone: (212) 635-7894,

-58-

except that any notice, request or demand by the Borrower to or upon the Administrative Agent or the Lenders pursuant to Sections 2.3, 2.4, 2.6, 2.7, 2.8, 2.9 or 3.3 shall not be effective until received. Any party to a Loan Document may rely on signatures of the parties thereto which are transmitted by fax or other electronic means as fully as if originally signed.

11.3 No Waiver; Cumulative Remedies

No failure to exercise and no delay in exercising, on the part of the Administrative Agent, any Lender or the Issuer, any right, remedy, power or privilege under any Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege under any Loan Document preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges under the Loan Documents are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.

11.4 Survival of Representations and Warranties

All representations and warranties made in the Loan Documents and in any document, certificate or statement delivered pursuant thereto or in connection therewith shall survive the execution and delivery of the Loan Documents.

11.5 Payment of Expenses and Taxes; Indemnified Liabilities

The Borrower agrees, promptly upon presentation of a statement or invoice therefor setting forth in reasonable detail the items thereof, and whether any Loan is made or Letter of Credit is issued, (a) to pay or reimburse the Administrative Agent and its Affiliates for all its reasonable costs and expenses actually incurred in connection with the development, syndication, preparation and execution of, and any amendment, waiver, consent, supplement or modification to, the Loan Documents, any documents prepared in connection therewith and the consummation of the transactions contemplated thereby, whether such Loan Documents or any such amendment, waiver, consent, supplement or modification to the Loan Documents or any documents prepared in connection therewith are executed and whether the transactions contemplated thereby are consummated, including the reasonable fees and disbursements of Special Counsel,
(b) to pay, indemnify, and hold the Administrative Agent, the Lenders and the Issuer harmless from any and all recording and filing fees and any and all liabilities and penalties with respect to, or resulting from any delay (other than penalties to the extent attributable to the negligence of the Administrative Agent, the Lenders or the Issuer, as the case may be, in failing to pay such fees or other liabilities when due) in paying, stamp, excise and other similar taxes, if any, which may be payable or determined to be payable in connection with the execution and delivery of, or consummation of any of the transactions contemplated by, or any amendment, supplement or modification of, or any waiver or consent under or in respect of, the Loan Documents and any such other documents, and (c) to pay, reimburse, indemnify and hold each Indemnified Person harmless from and against any and all other liabilities, obligations, claims, losses, damages, penalties, actions, judgments, suits, costs, expenses and disbursements of any kind or nature whatsoever (including reasonable counsel fees and disbursements of counsel (including the allocated costs of internal counsel) and such local counsel as may be required) actually incurred with respect to the

-59-

enforcement, performance of, and preservation of rights under, the Loan Documents (all the foregoing, collectively, the "Indemnified Liabilities") and, if and to the extent that the foregoing indemnity may be unenforceable for any reason, the Borrower agrees to make the maximum payment permitted under applicable law; provided that the Borrower shall have no obligation hereunder to pay Indemnified Liabilities to an Indemnified Person to the extent arising from its gross negligence or willful misconduct. The agreements in this Section shall survive the termination of the Commitments and the payment of the Loans and the Notes and all other amounts payable under the Loan Documents.

11.6 Lending Offices

Each Lender shall have the right at any time and from time to time to transfer any Loan to a different office of such Lender, subject to Section 3.10.

11.7 Successors and Assigns

(a) The Loan Documents shall be binding upon and inure to the benefit of the Borrower, the Lenders, the Administrative Agent, the Issuer, all future holders of the Notes and the Reimbursement Obligations and their respective successors and assigns; provided that the Borrower shall not assign, transfer or delegate any of its rights or obligations under the Loan Documents without the prior consent of the Administrative Agent, the Issuer and all of the Lenders.

(b) Notwithstanding Section 11.7(c), but subject to Section 11.7(e), each Lender may at any time assign all or any portion of its rights under any Loan Document to any Federal Reserve Bank.

(c) In addition to its rights under Section 11.7(b), each Lender shall have the right, at any time, upon written notice to the Administrative Agent of its intent to do so, to sell, assign, transfer or negotiate (each an "Assignment") all or any portion of all of its Loans, its Commitment and its Notes and its interest in the Loan Documents to any subsidiary or Affiliate of such Lender, to any other Lender or, with the prior written consent of the Borrower, the Swing Line Lender and the Issuer (which consents shall not be unreasonably withheld and shall not be required of the Borrower if, at the time of such Assignment, an Event of Default shall exist), to any other bank, insurance company, pension fund, mutual or other similar fund or other financial institution, provided that (i) the assigning Lender shall simultaneously assign to the same assignee the same percentage of its interest under the Other Credit Agreement, unless otherwise consented to by the Borrower, (ii) each such Assignment shall be of a constant, and not varying, percentage of all of the assigning Lender's rights and obligations under the Loan Documents and be in a minimum amount (together with the simultaneous assignment made under the Other Credit Agreement) of $5,000,000 (which minimum amount shall not be applicable to an Assignment by a Lender to a subsidiary or Affiliate of such Lender) or the full amount of such Lender's Commitment, and (iii) the parties to each such Assignment (excluding the Borrower if the Borrower is a party to such assignment) shall execute and deliver to the Administrative Agent an Assignment and Acceptance Agreement, together with a fee (the "Assignment Fee"), payable to the Administrative Agent, of $1,750 ($3,500 if no simultaneous assignment is being made by such parties under the Other Credit Agreement). Upon receipt of each such executed Assignment and Acceptance Agreement together with the Assignment Fee therefor, the Administrative Agent shall execute the

-60-

same and, in the event that either the assignee thereunder is a Lender (or a subsidiary or Affiliate thereof) or the Borrower shall have consented to such assignment (to the extent that such consent was not unreasonably withheld and is required as aforesaid), (i) record the same and execute two copies of such Assignment and Acceptance Agreement in the appropriate place, deliver one copy to the assignor and one copy to the assignee, and (ii) request the Borrower to execute and deliver (1) to such assignee, one or more Notes, in an aggregate principal amount equal to the Loans assigned to, and Commitment assumed by, such assignee, and (2) to such assignor, in the event that such assignor shall retain any Loans and Commitment, one or more Notes in an aggregate principal amount equal to the balance of such assignor Lender's Loans and Commitment, in each case against receipt of such assignor Lender's existing Note or Notes, as the case may be, appropriately marked to indicate their substitution. The Borrower agrees that it shall, upon each such request of the Administrative Agent, execute and deliver such new Notes at its own cost and expense. Upon such delivery, acceptance and recording by the Administrative Agent, from and after the effective date specified in such Assignment and Acceptance Agreement, the assignee thereunder shall be a party hereto and shall for all purposes of the Loan Documents be deemed a "Lender" and, to the extent provided in such Assignment and Acceptance Agreement, the assignor Lender thereunder shall be released from its obligations under the Loan Documents.

(d) In addition to the participations provided for in Section 11.9(b), each Lender may grant participations in all or any part of its Loans, its Notes and its Commitment to one or more banks, insurance companies, pension funds, mutual funds or other financial institutions, provided that (i) such Lender's obligations under the Loan Documents shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties to the Loan Documents for the performance of such obligations, (iii) the Borrower, the Administrative Agent, the Issuer and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lender's rights and obligations under the Loan Documents, (iv) no sub-participations shall be permitted, and (v) the voting rights of any holder of any participation shall be limited to decisions that in accordance with Section 11.1 require the consent of all of the Lenders. The Borrower acknowledges and agrees that any such participant shall for purposes of Section 3.5, 3.6, 3.10 and 11.5 be deemed to be a "Lender", provided that in no event shall the Borrower be liable for any amounts under said Sections in excess of the amounts for which it would be liable but for such participation.

(e) No Lender shall, as between and among the Borrower, the Administrative Agent, the Issuer, the Swing Line Lender and such Lender, be relieved of any of its obligations under the Loan Documents as a result of any assignment of or granting of participations in, all or any part of its Loans, its Commitment and its Notes, except that a Lender shall be relieved of its obligations to the extent of any such assignment of all or any part of its Loans, its Commitment or its Notes pursuant to Section 11.7(c).

11.8 Counterparts

Each of the Loan Documents (other than the Notes) may be executed on any number of separate counterparts and all of said counterparts taken together shall be deemed to constitute one and the same agreement. It shall not be necessary in making proof of any Loan Document to produce or account for more than one counterpart signed

-61-

by the party to be charged. A set of the copies of this Agreement signed by all of the parties hereto shall be lodged with each of the Borrower and the Administrative Agent. Any party to a Loan Document may rely upon the signatures of any other party thereto which are transmitted by fax or other electronic means to the same extent as if originally signed.

11.9 Set-off and Sharing of Payments

(a) In addition to any rights and remedies of the Lenders and the Issuer provided by law, upon the occurrence of an Event of Default under Section 9.1(a) or (b) or upon the acceleration of the payment of the Notes, each Lender and the Issuer shall have the right, without prior notice to the Borrower, any such notice being expressly waived by the Borrower, to set-off and apply against any indebtedness or other liability, whether matured or unmatured, of the Borrower to such Lender or the Issuer arising under the Loan Documents, any amount owing from such Lender or the Issuer to the Borrower. To the extent permitted by applicable law, the aforesaid right of set-off may be exercised by such Lender or the Issuer against the Borrower or against any trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receiver, or execution, judgment or attachment creditor of the Borrower, or against anyone else claiming through or against the Borrower or such trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receivers, or execution, judgment or attachment creditor, notwithstanding the fact that such right of set-off shall not have been exercised by such Lender or the Issuer prior to the making, filing or issuance of, service upon such Lender or the Issuer of, or notice to such Lender or the Issuer of, any petition, assignment for the benefit of creditors, appointment or application for the appointment of a receiver, or issuance of execution, subpoena, order or warrant. Each Lender and the Issuer agree promptly to notify the Borrower and the Administrative Agent after each such set-off and application made by such Lender or the Issuer, provided that the failure to give such notice shall not affect the validity of such set-off and application.

(b) If any Lender or the Issuer (each a "Benefited Lender") shall obtain any payment (whether voluntary, involuntary, through the exercise of any right of set-off, or otherwise) on account of its Loans or its Notes or the Reimbursement Obligations in excess of its pro rata share (in accordance with the outstanding principal balance of all Loans or the Reimbursement Obligations ) of payments then due and payable on account of the Loans and Notes received by all the Lenders or the Reimbursement Obligations, such Lender or the Issuer, as the case may be, shall forthwith purchase, without recourse, for cash, from the other Lenders such participations in their Loans and Notes or the Reimbursement Obligations as shall be necessary to cause such purchasing Lender or the Issuer to share the excess payment with each of them according to their pro rata share (in accordance with the outstanding principal balance of all Loans or the Reimbursement Obligations), provided that if all or any portion of such excess payment is thereafter recovered from such purchasing Lender or the Issuer, such purchase from each Lender shall be rescinded and each such Lender shall repay to the purchasing Lender or the Issuer the purchase price to the extent of such recovery, together with an amount equal to such Lender's pro rata share (according to the proportion of (i) the amount of such Lender's required repayment to (ii) the total amount so recovered from the purchasing Lender or the Issuer) of any interest or other amount paid or payable by the purchasing Lender in respect of the total amount so recovered. The Borrower agrees, to the fullest extent permitted by law, that any Lender or the Issuer so purchasing a participation from another

-62-

Lender pursuant to this Section may exercise such rights to payment (including the right of set-off) with respect to such participation as fully as if such Lender or the Issuer were the direct creditor of the Borrower in the amount of such participation.

11.10 Indemnity

The Borrower agrees to indemnify and hold harmless each of the Administrative Agent, the Issuer, each Lender and their respective Affiliates, officers, directors, employees, agents and representatives (each an "Indemnified Person") from and against any loss, cost, liability, damage or expense, including the reasonable fees and disbursements of counsel (including the allocated costs of internal counsel) and such local counsel as may be required to represent such Indemnified Person actually incurred by such Indemnified Person in preparing for, defending against, or providing evidence, producing documents or taking any other action in respect of, any litigation, administrative proceeding or investigation under any federal securities law or any other statute of any jurisdiction, or any regulation, or at common law or otherwise, which is alleged to arise out of or is based upon (1) any untrue statement or alleged untrue statement of any material fact by or on behalf of the Borrower or any Subsidiary, in any document or schedule executed or filed with any Governmental Authority by or on behalf of the Borrower or any Subsidiary which relates to the transactions contemplated by the Loan Documents,
(2) any omission or alleged omission by or on behalf of the Borrower or any Subsidiary to state any material fact required to be stated in such document or schedule, or necessary to make the statements made therein, in light of the circumstances under which made, not misleading, (3) any acts, practices or omissions or alleged acts, practices or omissions of the Borrower or its agents relating to the use of the proceeds of any Loan or Letter of Credit which is alleged to be in violation of Section 2.5, or in violation of any federal securities law or of any other statute, regulation or other law of any jurisdiction applicable thereto, or (4) any Loan Document or any other document contemplated by or referred to therein or the transactions contemplated thereby or any action taken or omitted to be taken by such Indemnified Person under or in connection with any of the foregoing. Notwithstanding the above, the Borrower shall have no liability under clause (4) of this Section to indemnify or hold harmless any Indemnified Person for any loss, cost, liability, damage or expense relating to income or withholding taxes or any tax in lieu of such taxes. The indemnity set forth herein shall be in addition to any other obligations or liabilities of the Borrower to each Indemnified Person hereunder or at common law or otherwise, shall include the reasonable fees and disbursements of counsel (including the allocated costs of internal counsel) and such local counsel as may be required in connection with establishing liability under this Section or collecting amounts payable under this Section and shall survive any termination of this Agreement, the expiration of the Commitments and the payment of all indebtedness of the Borrower under the Loan Documents, provided that the Borrower shall not have any liability under this Section to any Indemnified Person with respect to indemnified liabilities which are determined by a final and nonappealable judgment of a court of competent jurisdiction to have arisen primarily from the gross negligence or willful misconduct of such Indemnified Person.

11.11 Governing Law

The Loan Documents and the rights and obligations of the parties thereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York, without regard to principles of conflict of laws.

-63-

11.12 Severability

Every provision of the Loan Documents is intended to be severable, and if any term or provision thereof shall be invalid, illegal or unenforceable for any reason, the validity, legality and enforceability of the remaining provisions thereof shall not be affected or impaired thereby, and any invalidity, illegality or unenforceability in any jurisdiction shall not affect the validity, legality or enforceability of any such term or provision in any other jurisdiction.

11.13 Integration

All exhibits to the Loan Documents shall be deemed to be a part thereof. Each Loan Document embodies the entire agreement and understanding between or among the parties thereto with respect to the subject matter thereof and supersedes all prior agreements and understandings between or among the parties thereto with respect to the subject matter thereof.

11.14 Treatment of Certain Information

Each Lender, the Issuer and the Administrative Agent agrees to maintain as confidential and not to disclose, publish or disseminate to any third parties any financial or other information relating to the business, operations and condition, financial or otherwise, of the Borrower provided to it, except if and to the extent that:

(a) such information is in the public domain at the time of disclosure;

(b) such information is required to be disclosed by subpoena or similar process or applicable law or regulations;

(c) such information is required or requested to be disclosed to any regulatory or administrative body or commission to whose jurisdiction it may be subject;

(d) such information is disclosed to its counsel, auditors or other professional advisors;

(e) such information is disclosed to (and, unless and until it receives written objection from the Borrower, the Borrower shall be deemed to have consented to disclosure of such information to) its affiliates; provided that such information shall be used in connection with this Agreement and the transactions contemplated hereby;

(f) such information is disclosed to its officers, directors and employees;

(g) such information is disclosed with the prior written consent of the party furnishing the information;

(h) such information is disclosed in connection with any litigation or dispute involving the Borrower and/or it;

-64-

(i) such information is disclosed in connection with the sale of a participation or other disposition by it of any of its interest in this Agreement, provided that such information shall not be disclosed unless and until the party to whom it shall be disclosed shall have agreed to keep such information confidential as set forth herein;

(j) such information was in its possession or in its affiliate's possession as shown by clear and convincing evidence prior to any of the Borrower and/or any or the Borrower's representatives or agents furnishing such information to it; or

(k) such information is received by it, without restriction as to its disclosure or use, from a Person who, to its knowledge or reasonable belief, was not prohibited from disclosing such information by any duty of confidentiality.

Except to the extent prohibited or restricted by law or Governmental Authority, each Lender shall notify the Borrower promptly of any disclosures of information made by it as permitted pursuant to (h) above.

11.15 Acknowledgments

The Borrower acknowledges that (a) it has been advised by counsel in the negotiation, execution and delivery of the Loan Documents, (b) by virtue of the Loan Documents, none of the Administrative Agent, the Issuer, or any Lender has any fiduciary relationship to the Borrower, and the relationship between the Administrative Agent, the Issuer, and the Lenders, on the one hand, and the Borrower, on the other hand, is solely that of debtor and creditor, and (c) by virtue of the Loan Documents, no joint venture exists among the Lenders or among the Borrower and the Lenders.

11.16 Consent to Jurisdiction

The Borrower irrevocably submits to the non-exclusive jurisdiction of any New York State or Federal Court sitting in the City of New York over any suit, action or proceeding arising out of or relating to the Loan Documents. The Borrower irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of the venue of any such suit, action or proceeding brought in such a court and any claim that any such suit, action or proceeding brought in such a court has been brought in an inconvenient forum. The Borrower agrees that a final judgment in any such suit, action or proceeding brought in such a court, after all appropriate appeals, shall be conclusive and binding upon it.

11.17 Service of Process

The Borrower agrees that process may be served against it in any suit, action or proceeding referred to in Section 11.16 by sending the same by first class mail, return receipt requested or by overnight courier service, with receipt acknowledged, to the address of the Borrower set forth in Section 11.2. The Borrower agrees that any such service (i) shall be deemed in every respect effective service of process upon it in any such suit, action, or proceeding, and (ii) shall to the fullest extent enforceable by law, be taken and held to be valid personal service upon and personal delivery to it.

-65-

11.18 No Limitation on Service or Suit

Nothing in the Loan Documents or any modification, waiver, or amendment thereto shall affect the right of the Administrative Agent, the Issuer or any Lender to serve process in any manner permitted by law or limit the right of the Administrative Agent, the Issuer or any Lender to bring proceedings against the Borrower in the courts of any jurisdiction or jurisdictions.

11.19 WAIVER OF TRIAL BY JURY

THE ADMINISTRATIVE AGENT, THE ISSUER, THE LENDERS AND THE BORROWER KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE ANY RIGHT THEY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION ARISING OUT OF, UNDER OR IN CONNECTION WITH THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY. FURTHER, THE BORROWER HEREBY CERTIFIES THAT NO REPRESENTATIVE OR AGENT OF THE ADMINISTRATIVE AGENT, THE ISSUER, OR THE LENDERS, OR COUNSEL TO THE ADMINISTRATIVE AGENT, THE ISSUER, OR THE LENDERS, HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT THE ADMINISTRATIVE AGENT, THE ISSUER, OR THE LENDERS WOULD NOT, IN THE EVENT OF SUCH LITIGATION, SEEK TO ENFORCE THIS WAIVER OF RIGHT TO JURY TRIAL PROVISION. THE BORROWER ACKNOWLEDGES THAT THE ADMINISTRATIVE AGENT, THE ISSUER, AND THE LENDERS HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, INTER ALIA, THE PROVISIONS OF THIS SECTION.

11.20 Effective Date

This Agreement shall be effective at such time (the "Effective Date") as the Administrative Agent shall have received executed counterparts hereof by the Borrower, the Administrative Agent, the Issuer, and each Lender and the conditions set forth in Sections 5.1 through 5.6 have been or simultaneously will be satisfied, provided that this Agreement shall not become effective or be binding on any party hereto unless all of such conditions are satisfied not later than June 15, 1997.

-66-

CVS CORPORATION
Five Year Credit Agreement

AS EVIDENCE of the agreement by the parties hereto to the terms and conditions herein contained, each such party has caused this Agreement to be executed on its behalf.

CVS CORPORATION

By: /s/ Philip C. Galbro
    ---------------------------------------

Name: Philip C. Galbro
      -------------------------------------

Title: Vice President and Treasurer
       ------------------------------------


CVS CORPORATION
Five Year Credit Agreement

THE BANK OF NEW YORK, in its capacity
as a Lender and in its capacity
as the Administrative Agent

By: /s/ Howard F. Bascom, Jr.
    ---------------------------------------

Name: Howard F. Bascom, Jr.
      -------------------------------------

Title: Vice President
       ------------------------------------

- 2 -

CVS CORPORATION
Five Year Credit Agreement

MORGAN GUARANTY TRUST COMPANY
OF NEW YORK

By: /s/ Robert L. Barrett
    ---------------------------------------

Name: Robert L. Barrett
      -------------------------------------

Title: Vice President
       ------------------------------------

- 3 -

CVS CORPORATION
Five Year Credit Agreement

FLEET NATIONAL BANK

By: /s/ Thomas J. Bullard
    ---------------------------------------

Name: Thomas J. Bullard
      -------------------------------------

Title: Vice President
       ------------------------------------

- 4 -

CVS CORPORATION
Five Year Credit Agreement

BANKBOSTON, N.A.

By: /s/ Peter L. Griswold
    ---------------------------------------

Name: Peter L. Griswold
      -------------------------------------

Title: Director
       ------------------------------------

- 5 -

CVS CORPORATION
Five Year Credit Agreement

BANK OF TOKYO-MITSUBISHI TRUST COMPANY

By: /s/ Patrick D. Bonebrake
    ---------------------------------------

Name: Patrick D. Bonebrake
      -------------------------------------

Title: Assistant Vice President
       ------------------------------------

- 6 -

CVS CORPORATION
Five Year Credit Agreement

BANCA POPOLARE DI MILANO

By: /s/ Anthony Franco
    ---------------------------------------

Name: Anthony Franco
      -------------------------------------

Title: Executive Vice President
          & General Manager
       ------------------------------------

By: /s/ [ILLEGIBLE]
    ---------------------------------------

Name: [ILLEGIBLE]
      -------------------------------------

Title: First Vice President
       ------------------------------------

- 7 -

CVS CORPORATION
Five Year Credit Agreement

BANK OF AMERICA ILLINOIS

By: /s/ Dale Robert Mason
    ---------------------------------------

Name: Dale Robert Mason
      -------------------------------------

Title: Vice President
       ------------------------------------

- 8 -

CVS CORPORATION
Five Year Credit Agreement

THE BANK OF NOVA SCOTIA

By: /s/ [ILLEGIBLE]
    ---------------------------------------

Name: [ILLEGIBLE]
      -------------------------------------

Title: Authorized Signatory
       ------------------------------------

- 9 -

CVS CORPORATION
Five Year Credit Agreement

THE CHASE MANHATTAN BANK

By: /s/ Neil R. Boylan
    ---------------------------------------

Name: Neil R. Boylan
      -------------------------------------

Title: Vice President
       ------------------------------------

- 10 -

CVS CORPORATION
Five Year Credit Agreement

CORESTATES BANK, N.A.

By: /s/ Thomas I. McDonnell
    ---------------------------------------

Name: Thomas I. McDonnell
      -------------------------------------

Title: Vice President
       ------------------------------------

- 11 -

CVS CORPORATION
Five Year Credit Agreement

CREDIT LYONNAIS NEW YORK BRANCH

By: /s/ Robert Ivosevich
    ---------------------------------------

Name: Robert Ivosevich
      -------------------------------------

Title: Authorized Signature
       ------------------------------------

- 12 -

CVS CORPORATION
Five Year Credit Agreement

CREDIT SUISSE FIRST BOSTON

By: /s/ Joel Glodowski
    ---------------------------------------

Name: Joel Glodowski
      -------------------------------------

Title: Managing Director
       ------------------------------------


By: /s/ Chris Hargan
    ---------------------------------------

Name: Chris Hargan
      -------------------------------------

Title: Vice President
       ------------------------------------

- 13 -

CVS CORPORATION
Five Year Credit Agreement

FIRST UNION NATIONAL BANK OF NORTH CAROLINA

By: /s/ Mark M. Harden
    ---------------------------------------

Name: Mark M. Harden
      -------------------------------------

Title: Vice President
       ------------------------------------

- 14 -

CVS CORPORATION
Five Year Credit Agreement

KEY BANK NATIONAL ASSOCIATION

By: /s/ Marianne T. Mail
    ---------------------------------------

Name: Marianne T. Mail
      -------------------------------------

Title: Vice President
       ------------------------------------

- 15 -

CVS CORPORATION
Five Year Credit Agreement

PNC BANK, N.A.

By: /s/ Patrick H. Kinzler
    ---------------------------------------

Name: Patrick H. Kinzler
      -------------------------------------

Title: Vice President
       ------------------------------------

- 16 -

CVS CORPORATION
Five Year Credit Agreement

THE SUMITOMO BANK, LIMITED

By: /s/ John C. Kissinger
    ---------------------------------------

Name: John C. Kissinger
      -------------------------------------

Title: Joint General Manager
       ------------------------------------

- 17 -

CVS CORPORATION
Five Year Credit Agreement

WACHOVIA BANK OF GEORGIA, N.A.

By: /s/ Henry H. Hagan
    ---------------------------------------

Name: Henry H. Hagan
      -------------------------------------

Title: SVP
       ------------------------------------

- 18 -

CVS CORPORATION
Five Year Credit Agreement

CRESTAR BANK

By: /s/ Julian N. Holland, Jr.
    ---------------------------------------

Name: Julian N. Holland, Jr.
      -------------------------------------

Title: Vice President
       ------------------------------------

- 19 -

CVS CORPORATION
Five Year Credit Agreement

THE DAI-ICHI KANGYO BANK, LTD.,
New York Branch

By: /s/ Kim P. Leary
    ---------------------------------------

Name: Kim P. Leary
      -------------------------------------

Title: Vice President
       ------------------------------------

- 20 -

CVS CORPORATION
Five Year Credit Agreement

FIRST HAWAIIAN BANK

By: /s/ Scott Nahme
    ---------------------------------------

Name: Scott Nahme
      -------------------------------------

Title: Assistant Vice President
       ------------------------------------

- 21 -

CVS CORPORATION
Five Year Credit Agreement

THE FUJI BANK, LIMITED

By: /s/ Kazuaki Kirabatake
    ---------------------------------------

Name: Kazuaki Kirabatake
      -------------------------------------

Title: Senior Vice President
       ------------------------------------

- 22 -

CVS CORPORATION
Five Year Credit Agreement

MELLON BANK, N.A.

By: /s/ Maribeth Donnelly
    ---------------------------------------

Name: Maribeth Donnelly
      -------------------------------------

Title: Vice President
       ------------------------------------

- 23 -

CVS CORPORATION
Five Year Credit Agreement

THE SAKURA BANK, LIMITED

By: /s/ Yasumasa Kikuchi
    ---------------------------------------

Name: Yasumasa Kikuchi
      -------------------------------------

Title: Senior Vice President
       ------------------------------------

- 24 -

CVS CORPORATION
Five Year Credit Agreement

SUNTRUST BANK, ATLANTA

By: /s/ James D. McQueen, III
    ---------------------------------------

Name: James D. McQueen, III
      -------------------------------------

Title: Banking Officer
       ------------------------------------


By:   /s/ [ILLEGIBLE]
      [ILLEGIBLE]
      Vice President & Manager

- 25 -

CVS CORPORATION
Five Year Credit Agreement

THE SANWA BANK, LIMITED

By: /s/ Yutaka Higashino
    ---------------------------------------

Name: Yutaka Higashino
      -------------------------------------

Title: Senior Vice President
       ------------------------------------

- 26 -

EXHIBIT A

LIST OF COMMITMENTS, APPLICABLE LENDING OFFICES
AND ADDRESSES FOR NOTICES

A. LIST OF COMMITMENTS

      Lender                                        Commitment Amount
-----------------                                   -----------------

THE BANK OF NEW YORK                                  $ 50,250,000

MORGAN GUARANTY TRUST COMPANY                           41,875,000
 OF NEW YORK

FLEET NATIONAL BANK                                     41,875,000

BANKBOSTON, N.A.                                        26,800,000

BANK OF TOKYO-MITSUBISHI TRUST COMPANY                  26,800,000

BANCA POPOLARE DI MILANO                                26,800,000

BANK OF AMERICA ILLINOIS                                26,800,000

THE BANK OF NOVA SCOTIA                                 26,800,000

THE CHASE MANHATTAN BANK                                26,800,000

CORESTATES BANK, N.A.                                   26,800,000

CREDIT LYONNAIS NEW YORK BRANCH                         26,800,000

CREDIT SUISSE FIRST BOSTON                              26,800,000

FIRST UNION NATIONAL BANK OF
  NORTH CAROLINA                                        26,800,000

KEY BANK NATIONAL ASSOCIATION                           26,800,000

PNC BANK, N.A.                                          26,800,000

THE SUMITOMO BANK, LIMITED                              26,800,000

WACHOVIA BANK OF GEORGIA, N.A.                          26,800,000

CRESTAR BANK                                            20,100,000

THE DAI-ICHI KANGYO BANK, LTD.,                         20,100,000
 NEW YORK BRANCH

FIRST HAWAIIAN BANK                                     20,100,000

THE FUJI BANK, LIMITED                                  20,100,000

MELLON BANK, N.A.                                       20,100,000

THE SAKURA BANK, LIMITED                                20,100,000

SUNTRUST BANK, ATLANTA                                  20,100,000

THE SANWA BANK, LIMITED                                 20,100,000

                                  TOTAL               $670,000,000


B. LIST OF APPLICABLE LENDING OFFICES AND ADDRESSES FOR NOTICES

THE BANK OF NEW YORK

Applicable Lending Office for each Eurodollar Advance :

The Bank of New York
One Wall Street
New York, NY 10286

Applicable Lending Office for all other Advances:

The Bank of New York
One Wall Street
New York, NY 10286

Address for Notices:

The Bank of New York
One Wall Street
22nd Floor
New York, NY 10286
Attention: Howard F.Bascom,
Vice President
Telephone: (212) 635-7894
Facsimile: (212) 635-1481


MORGAN GUARANTY TRUST COMPANY
OF NEW YORK

Applicable Lending Office for each Eurodollar Advance :

Morgan Guaranty Trust Company
of New York
Nassau Bahamas Office
c/o J.P. Morgan Services, Inc.
Loan Operations - 3rd Floor
500 Stanton Christiana Road
Newark, Delaware 19713

Applicable Lending Office for all other Advances:

Morgan Guaranty Trust Company
of New York
60 Wall Street
New York, New York 10260-0060

Address for Notices:

Morgan Guaranty Trust Company
of New York
Nassau Bahamas Office
c/o J.P. Morgan Services, Inc.
Loan Operations - 3rd Floor
500 Stanton Christiana Road
Newark, Delaware 19713
Attention: Victoria A. Fedele
Telephone: (302) 634-4225
Facsimile: (302) 634-1852


FLEET NATIONAL BANK

Applicable Lending Office for each Eurodollar Advance:

Fleet National Bank
One Federal Street
Boston, Massachusetts 02211
Attn: Christopher Kampe
Telephone: (617) 346-0238
Facsimile: (617) 346-0689

Applicable Lending Office for all other Advances:

Fleet National Bank
One Federal Street
Boston, Massachusetts 02211
Attn: Christopher Kampe
Telephone: (617) 346-0238
Facsimile: (617) 346-0689

Address for Notices:

Fleet National Bank
One Federal Street
Boston, Massachusetts 02211
Attention: Thomas Bullard
Telephone: (617) 346-0146
Facsimile: (617) 346-0580


BANKBOSTON , N.A.

Applicable Lending Office for each Eurodollar Advance :

BankBoston, N.A.
100 Federal Street, 01-09-05
Boston, Massachusetts 02100

Applicable Lending Office for all other Advances:

BankBoston, N.A.
100 Federal Street, 01-09-05
Boston, Massachusetts 02100

Address for Notices:

BankBoston, N.A.
100 Federal Street, 01-09-05
Boston, Massachusetts 02100
Attention: Judith C.E. Kelly
Telephone: (617) 434-5280
Facsimile: (617) 434-0630


BANK OF TOKYO-MITSUBISHI TRUST COMPANY

Applicable Lending Office for each Eurodollar Advance :

Bank of Tokyo-Mitsubishi Trust Company
1251 Avenue of the Americas
New York, New York 10020

Applicable Lending Office for all other Advances:

Bank of Tokyo-Mitsubishi Trust Company
1251 Avenue of the Americas
New York, New York 10020

Address for Notices:

Bank of Tokyo-Mitsubishi Trust Company
125 Summer Street, Suite 1170
Boston, Massachusetts 02110
Attention: Patrick Bonebrake
Telephone: (617) 330-7437
Facsimile: (617) 330-7422


BANCA POPOLARE DI MILANO

Applicable Lending Office for each Eurodollar Advance :

Banca Popolare Di Milano
375 Park Avenue
New York, New York 10152

Applicable Lending Office for all other Advances:

Banca Popolare Di Milano
375 Park Avenue
New York, New York 10152

Address for Notices:

Banca Popolare Di Milano
375 Park Avenue
New York, New York 10152
Attention: Fulvio Montanari
Telephone: (212) 758-5040
Facsimile: (212) 838-1077


BANK OF AMERICA ILLINOIS

Applicable Lending Office for each Eurodollar Advance :

Bank of America Illinois
231 S. LaSalle Street
Chicago, Illinois 60697

Applicable Lending Office for all other Advances:

Bank of America Illinois
231 S. LaSalle Street
Chicago, Illinois 60697

Address for Notices:

Bank of America Illinois
231 S. LaSalle Street
Chicago, Illinois 60697
Attention: Jody Pritchard
Telephone: (312) 828-5258
Facsimile: (312) 974-0732


THE BANK OF NOVA SCOTIA

Applicable Lending Office for each Eurodollar Advance :

The Bank of Nova Scotia
Atlanta Agency
600 Peachtree Street, Suite 2700
Atlanta, Georgia 30308

Applicable Lending Office for all other Advances:

The Bank of Nova Scotia
Atlanta Agency
600 Peachtree Street, Suite 2700
Atlanta, Georgia 30308

Address for Notices:

The Bank of Nova Scotia
101 Federal Street, 16th Floor
Boston, Massachusetts 02100
Attention: Michael Bradley
Telephone: (617) 737-6312
Facsimile: (617) 951-2177


THE CHASE MANHATTAN BANK

Applicable Lending Office for each Eurodollar Advance:

The Chase Manhattan Bank
270 Park Avenue
New York, New York 10017

Applicable Lending Office for all other Advances:

The Chase Manhattan Bank
270 Park Avenue
New York, New York 10017

Address for Notices:

The Chase Manhattan Bank
270 Park Avenue
New York, New York 10017
Attention: Neil Boylan
Telephone: (212) 270-1410
Facsimile: (212) 270-1474


CORESTATES BANK, N.A.

Applicable Lending Office for each Eurodollar Advance :

Corestates Bank, N.A.
P.O. Box 7618
Philadelphia, PA 19101

Applicable Lending Office for all other Advances:

Corestates Bank, N.A.
P.O. Box 7618
Philadelphia, PA 19101

Address for Notices:

Corestates Bank, N.A.
1345 Chestnut Street
Philadelphia, PA 19102
Attention: Thomas J. McDonnell
Telephone: (215) 973-7667
Facsimile: (215) 973-7820


CREDIT LYONNAIS NEW YORK BRANCH

Applicable Lending Office for each Eurodollar Advance :

Credit Lyonnais New York Branch
1301 Avenue of the Americas
New York, New York 10019

Applicable Lending Office for all other Advances:

Credit Lyonnais New York Branch
1301 Avenue of the Americas
New York, New York 10019

Address for Notices:

Credit Lyonnais New York Branch
1301 Avenue of the Americas
New York, New York 10019
Attention: Heidi Rosen
Telephone: (212) 261-7241
Facsimile: (212) 459-3179


CREDIT SUISSE FIRST BOSTON

Applicable Lending Office for each Eurodollar Advance :

Credit Suisse First Boston
11 Madison Avenue, 19th Floor
New York, New York 10010

Applicable Lending Office for all other Advances:

Credit Suisse First Boston
11 Madison Avenue, 19th Floor
New York, New York 10010

Address for Notices:

Credit Suisse First Boston
11 Madison Avenue, 19th Floor
New York, New York 10010
Attention: Joel Glodowski
Telephone: (212) 325-9171
Facsimile: (212) 325-8309


FIRST UNION NATIONAL BANK OF NORTH CAROLINA

Applicable Lending Office for each Eurodollar Advance :

First Union National Bank of North Carolina One First Union Center
301 South College Street, DC5
Charlotte, North Carolina 28288-0745

Applicable Lending Office for all other Advances:

First Union National Bank of North Carolina One First Union Center
301 South College Street, DC5
Charlotte, North Carolina 28288-0745

Address for Notices:

First Union National Bank of North Carolina One First Union Center
301 South College Street, DC5
Charlotte, North Carolina 28288-0745
Attention: Chris Klos
Telephone: (704) 383-7629
Facsimile: (704) 383-0634


KEY BANK NATIONAL ASSOCIATION

Applicable Lending Office for each Eurodollar Advance :

Key Bank National Association
127 Public Square
Cleveland, Ohio 44114

Applicable Lending Office for all other Advances:

Key Bank National Association
127 Public Square
Cleveland, Ohio 44114

Address for Notices:

Key Bank National Association
127 Public Square
Cleveland, Ohio 44114
Attention: Marianne Meil
Telephone: (216) 689-3549
Facsimile: (216) 689-4981


PNC BANK, N.A.

Applicable Lending Office for each Eurodollar Advance :

PNC Bank, N.A.
Two Tower Center Boulevard
East Brunswick, New Jersey 08816

Applicable Lending Office for all other Advances:

PNC Bank, N.A.
Two Tower Center Boulevard
East Brunswick, New Jersey 08816

Address for Notices:

PNC Bank, N.A.
2 Tower Center
East Brunswick, New Jersey 08816
Attention: Michael Richards
Telephone: (908) 220-3228
Facsimile: (908) 220-3231


THE SUMITOMO BANK, LIMITED, NEW YORK BRANCH

Applicable Lending Office for each Eurodollar Advance :

The Sumitomo Bank, Limited, New York Branch 277 Park Avenue
New York, New York 10172

Applicable Lending Office for all other Advances:

The Sumitomo Bank, Limited, New York Branch 277 Park Avenue
New York, New York 10172

Address for Notices:

The Sumitomo Bank, Limited, New York Branch 277 Park Avenue
New York, New York 10172
Attention: Thomas Miressi
Telephone: (212) 224-____
Facsimile: (212) 224-5188


WACHOVIA BANK OF GEORGIA, N.A.

Applicable Lending Office for each Eurodollar Advance :

Wachovia Bank of Georgia, N.A.
191 Peachtree Street, N.E.
Atlanta, Georgia 30303

Applicable Lending Office for all other Advances:

Wachovia Bank of Georgia, N.A.
191 Peachtree Street, N.E.
Atlanta, Georgia 30303

Address for Notices:

Wachovia Bank of Georgia, N.A.
191 Peachtree Street, N.E.
Atlanta, Georgia 30303
Attention: Jeffrey S. Nurkiewiez
Telephone: (404) 332-1288
Facsimile: (404) 332-6898


CRESTAR BANK

Applicable Lending Office for each Eurodollar Advance :

Crestar Bank
919 E. Main Street, 22nd Floor
Richmond, Virginia 23219

Applicable Lending Office for all other Advances:

Crestar Bank
919 E. Main Street, 22nd Floor
Richmond, Virginia 23219

Address for Notices:

Crestar Bank
919 E. Main Street, 22nd Floor
Richmond, Virginia 23219
Attention: Julian N. Holland, Jr.
Telephone: (804) 782-7346
Facsimile: (804) 782-5413


THE DAI-ICHI KANGYO BANK, LTD., NEW YORK BRANCH

Applicable Lending Office for each Eurodollar Advance :

The Dai-Ichi Kangyo Bank, Ltd.,
New York Branch
One World Trade Center
Suite 4911
New York, New York 10048

Applicable Lending Office for all other Advances:

The Dai-Ichi Kangyo Bank, Ltd.,
New York Branch
One World Trade Center
Suite 4911
New York, New York 10048

Address for Notices:

The Dai-Ichi Kangyo Bank, Ltd.,
New York Branch
One World Trade Center
Suite 4911
New York, New York 10048
Attention: Kim Leary
Telephone: (212) 432-6641
Facsimile: (212) 912-1879


FIRST HAWAIIAN BANK

Applicable Lending Office for each Eurodollar Advance :

First Hawaiian Bank
999 Bishop Street, 11th Floor
Honolulu, Hawaii 96813

Applicable Lending Office for all other Advances:

First Hawaiian Bank
999 Bishop Street, 11th Floor
Honolulu, Hawaii 96813

Address for Notices:

First Hawaiian Bank
999 Bishop Street, 11th Floor
Honolulu, Hawaii 96813
Attention: Scott R. Nahme
Telephone: (808) 525-8781
Facsimile: (808) 525-6372


THE FUJI BANK, LIMITED

Applicable Lending Office for each Eurodollar Advance :

The Fuji Bank, Limited
New York Branch
Two World Trade Center
New York, New York 10048

Applicable Lending Office for all other Advances:

The Fuji Bank, Limited
New York Branch
Two World Trade Center
New York, New York 10048

Address for Notices:

The Fuji Bank, Limited
New York Branch
Two World Trade Center
New York, New York 10048
Attention: Chigusa Tada
Telephone: (212) 898-2067
Facsimile: (212) 912-0516


MELLON BANK, N.A.

Applicable Lending Office for each Eurodollar Advance :

Mellon Bank, N.A.
Three Mellon Bank Center, Room 305
Pittsburgh, PA 15259

Applicable Lending Office for all other Advances:

Mellon Bank, N.A.
Three Mellon Bank Center, Room 305
Pittsburgh, PA 15259

Address for Notices:

Mellon Bank, N.A.
Three Mellon Bank Center, Room 305
Pittsburgh, PA 15259
Attention: Manuel Burgueno
Telephone: (412) 234-6798
Facsimile: (412) 236-1914


THE SAKURA BANK, LIMITED

Applicable Lending Office for each Eurodollar Advance :

The Sakura Bank, Ltd
New York Branch
277 Park Avenue - 46th Floor
New York, New York 10172

Applicable Lending Office for all other Advances:

The Sakura Bank, Ltd
New York Branch
277 Park Avenue - 46th Floor
New York, New York 10172

Address for Notices:

The Sakura Bank, Ltd
New York Branch
277 Park Avenue - 46th Floor
New York, New York 10172
Attention: Takehiro Matsamoto
Telephone: (212) 756-6745
Facsimile: (212) 888-7651


SUNTRUST BANK, ATLANTA

Applicable Lending Office for each Eurodollar Advance :

SunTrust Bank, Atlanta
25 Park Place
Atlanta, Georgia 30303
Attention: Kathy Dorsey
Telephone: (404) 588-8375
Facsimile: (404) 658-4905

Applicable Lending Office for all other Advances:

SunTrust Bank, Atlanta
25 Park Place
Atlanta, Georgia 30303
Attention: Kathy Dorsey
Telephone: (404) 588-8375
Facsimile: (404) 658-4905

Address for Notices:

SunTrust Bank, Atlanta
711 Fifth Avenue - 16th Floor
New York, New York 10022
Attention: Jamie McQueen
Telephone: (212) 583-2611
Facsimile: (212) 371-9386


THE SANWA BANK, LIMITED

Applicable Lending Office for each Eurodollar Advance :

The Sanwa Bank, Limited
Park Avenue Plaza
55 East 52nd Street
New York, New York 10055

Applicable Lending Office for all other Advances:

The Sanwa Bank, Limited
Park Avenue Plaza
55 East 52nd Street
New York, New York 10055

Address for Notices:

The Sanwa Bank, Limited
One Financial Center, Suite 2812
Boston, MA 02111
Attention: Dale C. Edmunds
Telephone: (617) 654-1430
Facsimile: (617) 350-7212


EXHIBIT B-1

FORM OF REVOLVING CREDIT NOTE

$______________. _________ __, 1997 New York, New York

FOR VALUE RECEIVED, the undersigned, CVS CORPORATION, a Delaware corporation (the "Borrower"), hereby promises to pay to the order of _________________________ (the "Lender") the lesser of $_________________ or the outstanding principal balance of the Lender's Revolving Credit Loans, together with interest thereon, at the rate or rates, in the amounts and at the time or times set forth in the Five Year Credit Agreement (as the same may be amended, supplemented or otherwise modified from time to time, the "Credit Agreement"), dated as of __________, 1997, by and among the Borrower, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as the administrative agent (in such capacity, the "Administrative Agent"), in each case at the office of the Administrative Agent located at One Wall Street, New York, New York, or at such other place as the Administrative Agent may specify from time to time, in lawful money of the United States of America in immediately available funds.

Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

The Revolving Credit Loans evidenced by this Revolving Credit Note are prepayable in the amounts, and on the dates, set forth in the Credit Agreement. This Revolving Credit Note is one of the Revolving Credit Notes under the Credit Agreement, and is subject to, and shall be construed in accordance with, the provisions thereof, and is entitled to the benefits set forth in the Loan Documents.

The Lender is hereby authorized to record on the schedule annexed hereto, and any continuation sheets which the Lender may attach thereto (a) the date and amount of each Revolving Credit Loan made by the Lender, (b) the character of each Revolving Credit Loan as one or more ABR Advances, one or more Eurodollar Advances, or a combination thereof, (c) the Interest Period and Eurodollar Rate applicable to each Eurodollar Advance, and (d) the date and amount of each Conversion of, and each payment or prepayment of principal of, each Revolving Credit Loan. The failure to so record or any error in so recording shall not affect the obligation of the Borrower to repay the Revolving Credit Loans, together with interest thereon, as provided in the Credit Agreement.

Except as specifically otherwise provided in the Credit Agreement, the Borrower hereby waives presentment, demand, notice of dishonor, protest, notice of protest and all other demands, protests and notices in connection with the execution, delivery, performance, collection and enforcement of this Revolving Credit Note.

This Revolving Credit Note is being delivered in, is intended to be performed in, shall be construed and interpreted in accordance with, and be governed


by the internal laws of, the State of New York, without regard to principles of conflict of laws.

This Revolving Credit Note may only be amended by an instrument in writing executed pursuant to the provisions of Section 11.1 of the Credit Agreement.

CVS CORPORATION

By:

Name:

Title:

- 2 -

SCHEDULE TO REVOLVING CREDIT NOTE

                      Type of                                     Amount of
                      Advance         Interest      Eurodollar    Conversion
        Amount of     (Eurodollar     Period (If    Rate (If      or Principal
        Revolving     or ABR          Eurodollar    Eurodollar    Payment or       Notation
Date    Credit Loan   Advance)        Advance)      Advance)      Prepayment       Made by
----    -----------   -----------     ----------    ----------    ------------     --------


EXHIBIT B-2

FORM OF COMPETITIVE BID NOTE

_________ __, 1997
New York, New York

FOR VALUE RECEIVED, the undersigned, CVS CORPORATION, a Delaware corporation (the "Borrower"), hereby promises to pay to the order of _________________________ (the "Lender") the outstanding principal balance of the Lender's Competitive Bid Loans, together with the interest due thereon, in the amounts, at the rate or rates, and at the time or times set forth in the Five Year Credit Agreement (as the same may be amended, supplemented or otherwise modified from time to time, the "Credit Agreement"), dated as of __________, 1997, by and among the Borrower, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as administrative agent (in such capacity, the "Administrative Agent"), in each case at the office of the Administrative Agent located at One Wall Street, New York, New York, or at such other place as the Administrative Agent may specify from time to time, in lawful money of the United States of America in immediately available funds.

Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

This Competitive Bid Note is one of the Competitive Bid Notes under the Credit Agreement, and is subject to, and shall be construed in accordance with, the provisions thereof, and is entitled to the benefits set forth in the Loan Documents.

The Lender is hereby authorized to record on the schedule annexed hereto, and any continuation sheets which the Lender may attach thereto (a) the date and amount of each Competitive Bid Loan made by the Lender, (b) the Competitive Interest Period and the Competitive Bid Rate applicable to each such Competitive Bid Loan, and (c) the date and amount of each payment or prepayment of principal of each Competitive Bid Loan. The failure to so record or any error in so recording shall not affect the obligation of the Borrower to repay the Competitive Bid Loans, together with interest thereon, as provided in the Credit Agreement.

Except as specifically otherwise provided in the Credit Agreement, the Borrower hereby waives presentment, demand, notice of dishonor, protest, notice of protest and all other demands, protests and notices in connection with the execution, delivery, performance, collection and enforcement of this Competitive Bid Note.

This Competitive Bid Note is being delivered in, is intended to be performed in, shall be construed and interpreted in accordance with, and be governed by the internal laws of, the State of New York, without regard to principles of conflict of laws.


This Competitive Bid Note may only be amended by an instrument in writing executed pursuant to the provisions of Section 11.1 of the Credit Agreement.

CVS CORPORATION

By:

Name:

Title:

- 2 -

SCHEDULE TO COMPETITIVE BID NOTE

                                                         Amount of
         Amount of         Competitive                   Principal
         Competitive       Interest       Competitive    Payment or    Notation
Date     Bid Loan          Period         Bid Rate       Prepayment    Made by
----     -----------       -----------    -----------    ----------    --------


EXHIBIT B-3

FORM OF SWING LINE NOTE

$50,000,000.                                                  _________ __, 1997
                                                              New York, New York


            FOR VALUE RECEIVED, the undersigned, CVS CORPORATION, a Delaware

corporation (the "Borrower"), hereby promises to pay to the order of THE BANK OF NEW YORK (the "Lender") the lesser of $50,000,000 or the outstanding principal balance of the Lender's Swing Line Loans, together with interest thereon, at the rate or rates, in the amounts and at the time or times set forth in the Five Year Credit Agreement (as the same may be amended, supplemented or otherwise modified from time to time, the "Credit Agreement"), dated as of __________, 1997, by and among the Borrower, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as administrative agent (in such capacity, the "Administrative Agent"), in each case at the office of the Administrative Agent located at One Wall Street, New York, New York, or at such other place as the Administrative Agent may specify from time to time, in lawful money of the United States of America in immediately available funds.

Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

The Swing Line Loans evidenced by this Swing Line Note are prepayable in the amounts, and on the dates, set forth in the Credit Agreement. This Swing Line Note is the Swing Line Note under the Credit Agreement, and is subject to, and shall be construed in accordance with, the provisions thereof, and is entitled to the benefits set forth in the Loan Documents.

The Lender is hereby authorized to record on the schedule annexed hereto, and any continuation sheets which the Lender may attach thereto (a) the date and amount of each Swing Line Loan made by the Lender, (b) the Swing Line Interest Period and Negotiated Rate applicable to each Swing Line Loan, and (c) the date and amount of each payment or prepayment of principal of each Swing Line Loan. The failure to so record or any error in so recording shall not affect the obligation of the Borrower to repay the Swing Line Loans, together with interest thereon, as provided in the Credit Agreement.

Except as specifically otherwise provided in the Credit Agreement, the Borrower hereby waives presentment, demand, notice of dishonor, protest, notice of protest and all other demands, protests and notices in connection with the execution, delivery, performance, collection and enforcement of this Swing Line Note.

This Swing Line Note is being delivered in, is intended to be performed in, shall be construed and interpreted in accordance with, and be governed by the internal laws of, the State of New York, without regard to principles of conflict of laws.


This Swing Line Note may only be amended by an instrument in writing executed pursuant to the provisions of Section 11.1 of the Credit Agreement.

CVS CORPORATION

By:

Name:

Title:

- 2 -

SCHEDULE TO SWING LINE NOTE

            Amount of
            Swing                Interest         Negotiated        Notation
Date        Line Loan            Period           Rate              Made by
----        ---------            --------         ----------        --------


EXHIBIT C

FORM OF BORROWING REQUEST

[Date]

The Bank of New York, as Administrative Agent One Wall Street
New York, New York 10286
Attention: ______________,

Re: Five Year Credit Agreement, dated as of ___________, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement")

Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

Pursuant to Section 2.3 of the Credit Agreement, the Borrower hereby gives notice of its intention to borrow Revolving Credit Loans in the aggregate sum of $____________ on ____________, and/or a Swing Line Loan in the sum of $____________ on ____________, which borrowing shall consist of the following type or types of Advances:

Type of
Advance(s) (ABR,
Eurodollar or
Swing Line)                        Amount              Interest Period
----------------                   ------              ---------------

The Borrower hereby certifies that on the Borrowing Date set forth above, and after giving effect to the Loans requested hereby:

(a) The Borrower shall be in compliance with all of the terms, covenants and conditions of each Loan Document.

(b) There shall exist no Default or Event of Default.


(c) The representations and warranties contained in the Credit Agreement shall be true and correct, except those which are expressly specified to be made as of an earlier date.

IN EVIDENCE of the foregoing, the undersigned has caused this Borrowing Request to be duly executed on its behalf.

CVS CORPORATION

By:

Name:

Title:

- 2 -

EXHIBIT D

FORM OF OPINION OF
COUNSEL TO THE BORROWER

In connection with the Five Year Credit Agreement, dated as of ____________, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (the "Credit Agreement"), set forth below are the opinions to be included in the opinion letter referred to in Section 5.4 of the Credit Agreement (collectively, the "Opinions"). Capitalized terms used in the Opinions and which are not otherwise defined therein shall have the respective meanings ascribed thereto in the Credit Agreement.

Opinions:

1. Each of the Borrower and the Subsidiaries is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation (except, in the case of the Subsidiaries, where the failure to be in such good standing could not reasonably be expected to have a Material Adverse effect), has all requisite corporate power and authority to own its Property and to carry on its business as now conducted, and is qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which it owns or leases real Property or in which the nature of its business requires it to be so qualified (except those jurisdictions where the failure to be so qualified or to be in good standing could not reasonably be expected to have a Material Adverse effect).

2. The Borrower has full corporate power and authority to enter into, execute, deliver and perform the terms of the Loan Documents and to consummate the CVS/Revco Merger in accordance with the CVS/Revco Merger Documents, all of which have been duly authorized by all proper and necessary corporate action and are not in contravention of its Certificate of Incorporation and By-Laws. No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with the execution, delivery and performance by the Borrower, of the Loan Documents or in connection with the consummation of the CVS/Revco Merger, or is required as a condition to the enforceability of the Loan Documents against the Borrower or as a condition to the CVS/Revco Merger.

3. The Loan Documents constitute the valid and legally binding obligations of the Borrower, enforceable in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization or similar laws affecting the enforcement of creditors' rights generally and by equitable principles, whether considered in a proceeding at law or in equity, and except to the extent that indemnification obligations may be limited by federal or state securities laws or public policy relating thereto.


4. Except as set forth on Schedule 4.4 to the Credit Agreement, to the best of my/our knowledge, there are no actions, suits, arbitration proceedings or claims (whether purportedly on behalf of the Borrower, any Subsidiary or otherwise) pending or threatened against the Borrower or any Subsidiary or any of their respective Properties, or maintained by the Borrower or any Subsidiary, at law or in equity, before any Governmental Authority which could reasonably be expected to have a Material Adverse effect. To the best of my/our knowledge, there are no proceedings pending or threatened against the Borrower or any Subsidiary (a) which call into question the validity or enforceability of, or otherwise seek to invalidate, any Loan Document or invalidate or prevent the consummation of the CVS/Revco Merger, or (b) which might, individually or in the aggregate, materially and adversely affect any of the transactions contemplated by any Loan Document or materially and adversely affect the CVS/Revco Merger.

5. To the best of my/our knowledge, neither the Borrower nor any Subsidiary is in default under any agreement to which it is a party or by which it or any of its Property is bound the effect of which could reasonably be expected to have a Material Adverse effect. No notice to, or filing with, any Governmental Authority is required for the due execution, delivery and performance by the Borrower of the Loan Documents or to effect the CVS/Revco Merger, except for notices and filings required in connection with the CVS/Revco Merger which have been given and made.

6. No provision of any statute, rule, regulation, or, to the best of my/our knowledge, any existing material mortgage, material indenture, material contract, material agreement, judgment, decree or order, in each case binding on the Borrower or any Subsidiary or affecting the Property of the Borrower or any Subsidiary conflicts with, or requires any consent which has not already been obtained under, or would in any way prevent the execution, delivery or performance by the Borrower of the terms of, any Loan Document or the CVS/Revco Merger. To the best of my/our knowledge, the execution, delivery or performance by the Borrower of the terms of each Loan Document and the consummation of the CVS/Revco Merger will not constitute a default under, or result in the creation or imposition of, or obligation to create, any Lien upon the Property of the Borrower or any Subsidiary pursuant to the terms of any such mortgage, indenture, contract or agreement.

7. To the best of my/our knowledge, neither the Borrower nor any Subsidiary is in default with respect to any judgment, order, writ, injunction, decree or decision of any Governmental Authority which default could reasonably be expected to have a Material Adverse effect. To the best of my/our knowledge, the Borrower and each Subsidiary is complying with all applicable statutes, rules and regulations of all Governmental Authorities, a violation of which could reasonably be expected to have a Material Adverse effect. To the best of my/our knowledge, the Borrower and each Subsidiary has filed or caused to be filed with all Governmental Authorities all reports, applications, documents, instruments and information required to be filed pursuant to all applicable laws, rules, regulations and requests which, if not so filed, could reasonably be expected to have a Material Adverse effect.

8. Neither the Borrower or any Subsidiary, nor any corporation controlling the Borrower or any Subsidiary or under common control with the Borrower or any Subsidiary, is subject to regulation under the Investment Company Act of 1940, as

- 2 -

amended, or is subject to any statute or regulation which regulates the incurrence of Indebtedness.

9. The Borrower is not engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System, as amended. If used in accordance with
Section 2.5 of the Credit Agreement, no part of the proceeds of the Loans or the Letters of Credit will be used, directly or indirectly, for a purpose which violates the provisions of Regulations G, T, U or X of the Board of Governors of the Federal Reserve System, as amended.

- 3 -

EXHIBIT E

FORM OF OPINION OF
COUNSEL TO THE ADMINISTRATIVE AGENT

____________, 1997

TO THE LENDERS PARTY TO THE CREDIT
AGREEMENT (AS DEFINED BELOW)

Re: Five Year Credit Agreement, dated as of ________, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (the "Agreement")

We have acted as Special Counsel to the Administrative Agent in connection with the Agreement. Capitalized terms used herein that are not defined herein shall have the respective meanings ascribed thereto in the Agreement.

We have examined originals or copies certified to our satisfaction of the documents required to be delivered pursuant to the provisions of Section 5 of the Agreement. In conducting such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, and the conformity to originals of all documents submitted to us as copies.

Based upon the foregoing examination, and (1) assuming with your permission the accuracy of the opinion of _________________, _________ counsel to the Borrower and (2) relying with your permission upon the representations and warranties of the Borrower contained in the Agreement, we are of the opinion that all legal preconditions to the effectiveness of the Agreement have been satisfactorily met.

This opinion is rendered solely for your benefit in connection with the transactions referred to herein and may not be relied upon by any other Person.

We express no opinion as to laws other than the laws of the State of New York and the federal laws of the United States of America.

Very truly yours,


EXHIBIT F

FORM OF ASSIGNMENT AND ACCEPTANCE AGREEMENT

Assignment and Acceptance Agreement (as the same may be amended, supplemented or otherwise modified from time to time, this "Agreement"), dated as of ____________, by and between ____________ (the "Assignor") and ____________ (the "Assignee").

RECITALS

I. Reference is made to the Five Year Credit Agreement, dated as of ___________, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (as the same may be amended, supplemented or otherwise modified from time to time, the "Credit Agreement").

II. The Assignor wishes to assign and delegate to the Assignee, and the Assignee wishes to purchase and assume from the Assignor, some or all of the Assignor's rights and obligations under the Loan Documents upon the terms, and subject to the conditions, contained herein.

Therefore, in consideration of the Recitals, the terms and conditions herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Assignor and the Assignee hereby agree as follows:

1. Defined Terms

(a) Each capitalized term used herein that is not defined herein shall have the meaning ascribed thereto in the Credit Agreement.

(b) When used in this Agreement, each of the following capitalized terms shall have the meaning ascribed thereto unless the context hereof otherwise specifically requires:

"Assigned Percentage": _____%.

"Assignment Effective Date": as defined in Section 5.

"Assignor Rights and Obligations": as of the Assignment Effective Date, the Assigned Percentage of all of the Assignor's rights and obligations under the Loan Documents, including, without limitation, such percentage of its Loans, its Commitment and its Notes.

"Purchase Price": an amount equal to the Assigned Percentage of the aggregate unpaid principal amount of the Assignor's Loans as of the Assignment Effective Date.


2. Assignment; Payment by Assignee

The Assignor hereby assigns and delegates to the Assignee, and the Assignee hereby purchases and assumes from the Assignor, without recourse or, except as otherwise specifically provided herein, representation or warranty, the Assignor Rights and Obligations. The Assignee agrees to pay to the Assignor the Purchase Price on the Assignment Effective Date.

3. Representations and Warranties

(a) Assignor. The Assignor hereby represents and warrants to the Assignee as follows:

(i) the aggregate unpaid principal amount of its Revolving Credit Loans is $___________, and such Revolving Credit Loans are composed of the following ABR Advances and Eurodollar Advances: (1) ABR Advances:
$__________, and (2) Eurodollar Advances: (A) $__________ for [length of Interest Period], the last day of which is _______________, (B) $__________ for [length of Interest Period], the last day of which is _______________,

(ii) the aggregate unpaid principal amount of its Swing Line Loans is $___________, and such Swing Line Loans are composed of the following:
(A) $__________ for [length of Swing Line Interest Period], the last day of which is _______________, (B) $__________ for [length of Swing Line Interest Period], the last day of which is _______________,

(iii) the aggregate unpaid principal amount of its Competitive Bid Loans is $_________, and such Competitive Bid Loans are composed of the following: (A) $__________ for [length of Competitive Interest Period], the last day of which is _______________, (B) $__________ for [length of Competitive Interest Period], the last day of which is _______________, and

(iv) its Commitment Amount is $_______.

The Assignor makes no representation or warranty with respect to the validity or enforceability of the Credit Agreement or any other Loan Document or the financial condition or creditworthiness of the Borrower.

(b) Assignee. The Assignee hereby represents and warrants to the Assignor that (i) it is legally authorized to enter into this Agreement, (ii) it is an "accredited investor" within the meaning of Regulation D, as amended, promulgated under the Securities Act of 1933, as amended, [and] (iii) it has, independently and without reliance upon the Assignor or the Administrative Agent, and based on such documents and information as it has deemed appropriate, made its own evaluation of, and investigation into, the business, operations, Property, financial and other condition and creditworthiness of the Borrower and made its own decision to enter into this Agreement [, and (iv) it is a Lender or a subsidiary or Affiliate of a Lender].

4. Covenants of the Assignee

The Assignee hereby covenants and agrees that it will, independently and without reliance upon the Assignor or Administrative Agent, and based on such

- 2 -

documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, evaluations and decisions in taking or not taking action under the Loan Documents, and to make such investigation as it deems necessary to inform itself as to the business, operations, Property, financial and other condition and creditworthiness of the Borrower. The Assignee further agrees to provide to the Administrative Agent any forms required by Section 3.10 of the Credit Agreement and any administrative questionnaire reasonably required by the Administrative Agent.

5. Effectiveness of this Agreement

(a) Section 2 of this Agreement shall not become effective until such date (the "Assignment Effective Date") as all of the following conditions shall have been fulfilled:

(i) The Administrative Agent shall have executed a copy of this Agreement and shall have received duly executed counterparts hereof by each of the Assignor, the Assignee and, if required by the Credit Agreement, the Borrower;

(ii) The Assignor shall have delivered to the Assignee (with a copy to the Administrative Agent) a duly completed letter in the form of Annex A hereto;

(iii) The Assignee shall have confirmed in writing to the Assignor (with a copy to the Administrative Agent) that, on or before the Assignment Effective Date, it shall have transferred (in accordance with
Section 6 hereof) the Purchase Price to the Assignor. At the time of such confirmation, the Assignee shall be deemed to have remade the representations and warranties contained in Section 3(b)(i), (ii) [and]
(iii) [, and (iv)] hereof on and as of the date of such confirmation;

(iv) The Administrative Agent shall have received, for its own account, the assignment fee required to be paid pursuant to Section 11.7 of the Credit Agreement; and

(v) The Administrative Agent shall have received any forms required by Section 3.10 of the Credit Agreement and any administrative questionnaire reasonably required by the Administrative Agent.

(b) Upon the Assignment Effective Date, (i) the Administrative Agent shall record the assignment contemplated hereby, (ii) the Assignee shall be a Lender, and (iii) the Assignor, to the extent of the assignment provided for herein, shall be released from its obligations under the Loan Documents.

(c) The Assignee hereby appoints and authorizes the Administrative Agent to take such action, on and after the Assignment Effective Date, as agent on its behalf and to exercise such powers under the Loan Documents as are delegated to the Administrative Agent by the terms thereof, together with such powers as are reasonably incidental thereto.

(d) From and after the Assignment Effective Date, the Administrative Agent shall make all payments in respect of the interest assigned hereby (including payments of principal, interest, fees and other amounts) to the Assignee. The Assignor

- 3 -

and the Assignee shall make all appropriate adjustments with respect to amounts under the Loan Documents which accrued prior to the Assignment Effective Date, and which were paid thereafter, directly between themselves.

6. Payment Instructions

All payments to be made to the Assignor by the Assignee hereunder shall be made by wire transfer of immediately available funds to the Assignor at: [Wire Instructions].

7. Notices

All notices, requests and demands to or upon the Assignee in connection with this Agreement and the Loan Documents are to be sent or delivered to the place set forth adjacent to its name on the signature page(s) hereof.

8. Miscellaneous

(a) For purposes of this Agreement, all calculations and determinations with respect to the outstanding principal amount of the Assignor's Loans, the Assignor's Commitment Amount and all other similar calculations and determinations, shall be made and shall be deemed to be made as of the commencement of business on the date of such calculation or determination, as the case may be.

(b) Section headings have been inserted herein for convenience only and shall not be construed to be a part hereof.

(c) This Agreement embodies the entire agreement and understanding among the parties hereto with respect to the subject matter hereof and supersedes all other prior arrangements and understandings among the parties hereto with respect to the subject matter hereof.

(d) This Agreement may be executed in any number of separate counterparts and all of said counterparts taken together shall be deemed to constitute one and the same agreement. It shall not be necessary in making proof of this Agreement to produce or account for more than one counterpart signed by the party to be charged.

(e) Every provision of this Agreement is intended to be severable, and if any term or provision hereof shall be invalid, illegal or unenforceable for any reason, the validity, legality and enforceability of the remaining provisions hereof shall not be affected or impaired thereby, and any invalidity, illegality or unenforceability in any jurisdiction shall not affect the validity, legality or enforceability of any such term or provision in any other jurisdiction.

(f) This Agreement shall be binding upon and inure to the benefit of the Assignor and the Assignee and their respective successors and permitted assigns, except that neither party may assign or transfer any of its rights or obligations hereunder (i) without the prior written consent of the other party, and (ii) in contravention of the Credit Agreement.

- 4 -

(g) This Agreement and the rights and obligations of the parties hereunder shall be governed by, and construed and interpreted in accordance with, the internal laws of the State of New York without regard to principles of conflicts of law.

- 5 -

AS EVIDENCE of the agreement by the parties hereto to the terms and conditions herein contained, each such party has caused this Agreement to be duly executed on its behalf.

[NAME OF ASSIGNOR]

By:

Name:

Title:

Address for notices:                      [NAME OF ASSIGNEE]


----------------------------              By:
                                              -------------------------------

----------------------------              Name:
                                                -----------------------------

----------------------------              Title:
                                                 ----------------------------
Attention: _________

Telephone:_____________
Facsimile:_____________


Consented to and Accepted this __ day
of __________, ____

THE BANK OF NEW YORK, as Administrative Agent

By:

Name:

Title:

[Consented to this __ day
of __________, ____

CVS CORPORATION

By:

Name:

Title: ]

- 6 -

ANNEX A TO ASSIGNMENT AND
ACCEPTANCE AGREEMENT

FORM OF LETTER

[Assignment Effective Date]

[Name and Address of Assignee]
Attention: _______________,

Re: Assignment and Acceptance Agreement, dated as of _______________, by and between _______________ and _______________ (as the same may be amended, supplemented or otherwise modified from time to time, the "Agreement")

Ladies and Gentlemen:

This letter is being delivered pursuant to Section 5(a)(ii) of the Agreement. Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Agreement.

The Assignor hereby represents and warrants to the Assignee as follows:

(i) the aggregate unpaid principal amount of its Revolving Credit Loans is $___________, and such Revolving Credit Loans are composed of the following ABR Advances and Eurodollar Advances: (1) ABR Advances:
$__________, and (2) Eurodollar Advances: (A) $__________ for [length of Interest Period], the last day of which is _______________, (B) $__________ for [length of Interest Period], the last day of which is _______________,

(ii) the aggregate unpaid principal amount of its Swing Line Loans is $___________, and such Swing Line Loans are composed of the following:
(A) $__________ for [length of Swing Line Interest Period], the last day of which is _______________, (B) $__________ for [length of Swing Line Interest Period], the last day of which is _______________,

(iii) the aggregate unpaid principal amount of its Competitive Bid Loans is $_________, and such Competitive Bid Loans are composed of the following: (A) $__________ for [length of Competitive Interest Period], the last day of which is _______________, (B) $__________ for [length of Competitive Interest Period], the last day of which is _______________,

(iv) its Commitment Amount is $_______, and


(v) it is the legal and beneficial owner of the Assignor Rights and Obligations free and clear of any adverse claim created by it.

Very truly yours,

[NAME OF ASSIGNOR]

By:

Name:

Title:

cc: [Name and title
of Administrative Agent contact]

- 2 -

EXHIBIT G

FORM OF COMPETITIVE BID REQUEST

[Date]

The Bank of New York, as Administrative Agent One Wall Street
New York, New York 10286
Attention: ______________,

Re: Five Year Credit Agreement, dated as of ___________, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement")

Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

Pursuant to Section 2.4 of the Credit Agreement, the Borrower hereby gives notice of its request to borrow Competitive Bid Loans in the aggregate sum of $____________ on ____________, which borrowing shall consist of the following:

                       Competitive
Amount                 Interest Period
------                 ---------------

The Borrower hereby certifies that on the Borrowing Date set forth above, and after giving effect to the Competitive Bid Loans requested hereby:

(a) The Borrower shall be in compliance with all of the terms, covenants and conditions of each Loan Document.

(b) There shall exist no Default or Event of Default.


(c) The representations and warranties contained in the Credit Agreement shall be true and correct, except those which are expressly specified to be made as of an earlier date.

IN EVIDENCE of the foregoing, the undersigned has caused this Competitive Bid Request to be duly executed on its behalf.

CVS CORPORATION

By:

Name:

Title:

- 2 -

EXHIBIT H

FORM OF INVITATION TO BID

[Date]

To the Lenders party
from time to time to the
captioned Credit Agreement

Re: Five Year Credit Agreement, dated as of ___________, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (as amended, supplemented or otherwise modified from time to time, "Credit Agreement")

Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

Pursuant to a Competitive Bid Request, the Borrower gave notice of its request to borrow Competitive Bid Loans in the aggregate sum of $____________ on ____________, which borrowing would consist of the following type or types of Competitive Advances:

                             Competitive
Amount                       Interest Period
------                       ---------------

The Lenders are hereby invited to bid, pursuant to the terms and conditions of the Credit Agreement, on such requested Competitive Bid Loans.

THE BANK OF NEW YORK,
as Administrative Agent

By:

Name:

Title:

EXHIBIT I

FORM OF COMPETITIVE BID

[Date]

The Bank of New York, as Administrative Agent One Wall Street
New York, New York 10286
Attention: _________________,

Re: Five Year Credit Agreement, dated as of ___________, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement")

Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

In response to a Competitive Bid Request, the undersigned Lender hereby offers to make Competitive Loan(s) in the aggregate sum of $____________

on ____________:

                       Comptetitive
                       Interest                 Competitive
      Amount           Period                   Bid Rate
      ------           ------------             -----------

                                                [fixed rate]


                                          [LENDER]


                                          By:
                                              -------------------------------

                                          Name:
                                                -----------------------------

                                          Title:
                                                 ----------------------------


EXHIBIT J

FORM OF COMPETITIVE BID ACCEPT/REJECT LETTER

[Date]

The Bank of New York, as Administrative Agent One Wall Street
New York, New York 10286
Attention: ______________,

Re: Five Year Credit Agreement, dated as of ___________, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement")

Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

Pursuant to Section 2.4(d) of the Credit Agreement, the Borrower hereby gives notice of its acceptance of the following Competitive Bids:


------------- ---------------,

and its rejection of all other Competitive Bids, in each case made pursuant to the Competitive Bid Request, dated _______________.

IN EVIDENCE of the foregoing, the undersigned has caused this Competitive Bid Accept/Reject Letter to be duly executed on its behalf.

CVS CORPORATION

By:

Name:

Title:

EXHIBIT K

FORM OF LETTER OF CREDIT REQUEST

[Date]

The Bank of New York, as Administrative Agent One Wall Street
New York, New York 10286
Attention: ______________,

Re: Five Year Credit Agreement, dated as of ___________, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement")

Capitalized terms used herein that are not otherwise defined herein shall have the respective meanings ascribed thereto in the Credit Agreement.

Pursuant to Section 2.8(b) of the Credit Agreement, the Borrower hereby gives notice of its intention to have issued by the Issuer a Letter of Credit for the account of the Borrower and for the benefit of ______________________ on ____________ in connection with ___________________________ in the maximum amount of $_______________. A drawing may be made under such Letter of Credit under the following conditions:
_______________________________________________.

The Borrower hereby certifies that on the above requested date of issuance of such Letter of Credit, and after giving effect to the issuance of such Letter of Credit:

(a) The Borrower shall be in compliance with all of the terms, covenants and conditions of each Loan Document.

(b) There shall exist no Default or Event of Default.

(c) The representations and warranties contained in the Credit Agreement shall be true and correct, except those which are expressly specified to be made as of an earlier date.


IN EVIDENCE of the foregoing, the undersigned has caused this Letter of Credit Request to be duly executed on its behalf.

CVS CORPORATION

By:

Name:

Title:

- 2 -

SCHEDULE 4.4

LIST OF LITIGATION

NONE


SCHEDULE 8.2

LIST OF LIENS

NONE


PREVIOUSLY DELIVERED TO EACH APPLICABLE LENDER


CERTIFICATE OF SECRETARY

I, Zenon P. Lankowsky, Secretary of CVS Corporation, a Delaware corporation (the "Borrower"), do hereby certify, in my capacity as Secretary of the Borrower (and not in my individual capacity) pursuant to Section 5.I of the Five Year Credit Agreement by and among the Borrower, the lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent and The Bank of New York, as Administrative Agent dated as of May 23, 1997 (the "Credit Agreement") that:

1. Attached hereto as Exhibit A is a true and complete copy of the Certificate of Incorporation of the Borrower as in full force and effect on the date hereof.

2. Attached hereto as Exhibit B is a true and complete copy of the By-Laws of the Borrower as in full force and effect on the date hereof.

3. Attached hereto as Exhibit C is a certificate of good standing of the Secretary of State of the State of Delaware with respect to the Borrower as of May 20, 1997.

4. Attached hereto as Exhibit D is a true and complete copy of resolutions duly adopted by the Board of Directors of the Borrower at a meeting duly called and held on May 27, 1997 at which meeting a quorum of said board was at all times present in person and acting. All such resolutions are in full force and effect on the date hereof in the form in which adopted and no other resolutions have been adopted by the Board of Directors of the Borrower or any committee thereof relating to the Credit Agreement, the CVS/Revco Merger and the transactions referred to in such resolutions.

5. The following persons are duly qualified and acting officers of the Borrower duly elected or appointed to the offices set forth opposite their respective names, and each such person who, as an officer of the Borrower, signed (i) the Credit Agreement, (ii) the Notes and (iii) any other document delivered prior hereto or on the date hereof in connection with the borrowings under the Credit Agreement, was duly elected or appointed, qualified and acting as such


officer at the respective times of such signing and delivery, and the signatures of such persons appearing on such documents are their genuine signatures.

             Name                                      Office
------------------------------------    ---------------------------------------

Stanley P. Goldstein                    Chairman and Chief Executive Officer

Thomas M. Ryan                          Vice Chairman and Chief Operating
                                        Officer

Charles C. Conaway                      Executive Vice President and Chief
                                        Financial Officer

Philip C. Galbo                         Vice President and Treasurer

Terms used in this Certificate and not defined have the meanings assigned to them in the Credit Agreement.

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the Borrower.

May 30, 1997

/s/ Zenon P. Lankowsky
------------------------------
Name: Zenon P. Lankowsky
Title: Secretary

2

State of Delaware

Office of the Secretary of State PAGE 1

I, EDWARD J. FREEL, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF INCORPORATION OF "CVS CORPORATION", FILED IN THIS OFFICE ON THE TWENTY-SECOND DAY OF AUGUST, A.D. 1996, AT 4 O'CLOCK P.M.

                                  [seal]     -----------------------------------
                                             Edward J. Freel, Secretary of State

2656078 B100                                 AUTHENTICATION: B474574
971164349
                                                       DATE: 5-20-97

                                                         STATE OF DELAWARE
                                                         SECRETARY OF STATE
                                                      DIVISION OF CORPORATIONS
                                                      FILED 04:00 PM 08/22/1996
                                                      960245972 - 2656079

CERTIFICATE OF INCORPORATION

OF

CVS CORPORATION


FIRST: The name of the Corporation is CVS Corporation.

SECOND: The address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, City of Wilmington, County of New Castle, Delaware 19801. The name of its registered agent at such address is The Corporation Trust Company.

THIRD: The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended ("Delaware Law").

FOURTH: The total number of shares of stock which the Corporation shall have authority to issue is 100, and the par value of each such share is $1.00, amounting in the aggregate to $100.

FIFTH: The name and mailing address of the incorporator are:

Name                   Mailing Address
----                   ---------------

Carol F. Crossdale     450 Lexington Avenue
                       New York, New York 10017

The power of the incorporator as such shall terminate upon the filing of this Certificate of Incorporation.

SIXTH: The names and mailing addresses of the persons who are to serve as directors until the first annual meeting of stockholders or until their successors are elected and qualified are:

Name                   Mailing Address
----                   ---------------

Stanley Goldstein      One CVS Drive
                       Woonsocket, RI 02895

Thomas Ryan            One CVS Drive
                       Woonsocket, RI 02895

SEVENTH: The Board of Directors shall have the power to adopt, amend or repeal the bylaws of the Corporation.

EIGHTH: Election of directors need not be by written ballot unless the bylaws of the Corporation so provide.

NINTH: (1) A director of the Corporation shall not be liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director to the fullest extent permitted by Delaware Law.

(2)(a) Each person (and the heirs, executors or administrators of such person) who was or is a party or is threatened to be made a party to, or is involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director or officer of the Corporation or is or was serving at the request of the Corporation as director or officer of another corporation, partnership, joint venture, trust or other enterprise, shall be indemnified and held harmless by the Corporation to the fullest extent permitted by Delaware Law. The right to indemnification conferred in this ARTICLE NINTH shall also include the right to be paid by the Corporation the expenses incurred in connection with any such proceeding in advance of its final disposition to the fullest extent authorized by Delaware law. The right to indemnification conferred in this ARTICLE NINTH shall be a contract right.

(b) The Corporation may, by action of its Board of Directors, provide indemnification to such of the employees and agents of the Corporation to such extent and to such effect as the Board of Directors shall determine to be appropriate and authorized by Delaware Law.

(3) The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss incurred by such person in any such capacity or arising out of his status as such, whether or not the Corporation would have the power to indemnify him against such liability under Delaware Law.

(4) The rights and authority conferred in this ARTICLE NINTH shall not be exclusive of any other right which any person may otherwise have or hereafter acquire.

(5) Neither the amendment nor repeal of this ARTICLE NINTH, nor the adoption of any provision of this Certificate of Incorporation or the bylaws of the

2

Corporation, nor, to the fullest extent permitted by Delaware Law, any modification of law, shall eliminate or reduce the effect of this ARTICLE NINTH in respect of any acts or omissions occurring prior to such amendment, repeal, adoption or modification.

TENTH: The Corporation reserves the right to amend this Certificate of Incorporation in any manner permitted by Delaware Law and, with the sole exception of those rights and powers conferred under the above ARTICLE NINTH, all rights and powers conferred herein on stockholders, directors and officers, if any, are subject to this reserved power.

IN WITNESS WHEREOF, I have hereunto signed my name this 22nd day of August, 1996.

/s/ Carol F. Crossdale
---------------------------
Carol F. Crossdale

3

State of Delaware

Office of the Secretary of State PAGE 1

I, EDWARD J. FREEL, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE RESTATED CERTIFICATE OF "CVS CORPORATION", FILED IN THIS OFFICE ON THE FIFTEENTH DAY OF NOVEMBER, A.D.
1996, AT 12:30 O'CLOCK P.M.

                                  [seal]     -----------------------------------
                                             Edward J. Freel, Secretary of State

2656078 B100                                 AUTHENTICATION: B74575
971164349
                                                       DATE: 5-20-97

   STATE OF DELAWARE
   SECRETARY OF STATE

DIVISION OF CORPORATIONS
FILED 12:30 PM 11/15/1996
960333880 - 2656079

AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

CVS CORPORATION

CVS Corporation, a corporation organized and existing under the laws of the State of Delaware (the "Corporation"), hereby certifies as follows:

1. The name of the Corporation is "CVS Corporation" and the name under which the Corporation was originally formed is "CVS Corporation." The original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on August 2, 1996.

2. This Amended and Restated Certificate of Incorporation (this "Restated Certificate") has been duly adopted by the Board of Directors of the Corporation in accordance with Sections 241 and 245 of the General Corporation Law of the State of Delaware.

3. Pursuant to Sections 241 and 245 of the General Corporation Law of the State of Delaware, this Amended and Restated Certificate of Incorporation restates and integrates and further amends the provisions of the Certificate of Incorporation of the Corporation.

4. The text of the Certificate of Incorporation as heretofore amended is hereby restated and further amended to read in its entirety as hereinafter set forth:

FIRST: The name of the Corporation is "CVS Corporation".

SECOND: The address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, City of Wilmington, County of New Castle, Delaware 19801. The name of its registered agent at such address is The Corporation Trust Company.

THIRD: The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended ("Delaware Law").

FOURTH: The authorized capital stock of the corporation consists of (i) 300,000,000 shares of Common Stock, par value $.01 per share ("Common Stock"),

(ii)

120,619 shares of Cumulative Preferred Stock, par value $.01 per share ("Preferred Stock"), and (iii) 50,000,000 shares of Preference Stock, par value $1 per share ("Preference Stock").

All the designations, preferences, privileges and voting powers of the shares of each class, and the restrictions or qualifications thereof, shall be as follows:

I. Provisions Generally Applicable to Capital Stock

I.A. Voting Rights of Common Stock

Each holder of Common Stock shall be entitled to one vote for each share thereof held of record by such holder.

I.B. Ranking of Capital Stock

The Preferred Stock shall be senior to the Preference Stock and the Common Stock, and the Preference Stock and the Common Stock shall be subject to all the rights and preferences of the Preferred Stock as hereafter set forth. The Preference Stock shall be senior to the Common Stock, and the Common Stock shall be subject to all the rights and preferences of the Preference Stock as hereafter set forth.

I.C. No Preemptive Rights

No stockholder of the Corporation shall be entitled as such, as a matter of right, to subscribe for or purchase any part of any new or additional issue of stock of any class or series whatsoever, any rights or options to purchase stock of any class or series whatsoever, whether now or hereafter authorized and whether issued for cash or other consideration or by way of dividend.

I.D. Fractional Interests

In case any person shall become entitled to a fractional interest in a share of Preferred Stock, of Preference Stock or of Common Stock, the Corporation may deliver a scrip certificate representing such fractional interest, which together with other similar scrip certificates aggregating a whole share, may be surrendered in exchange for a stock certificate representing one full share of Preferred Stock, Preference Stock or Common Stock as the case may be; provided, however, that the rights of the holders of such scrip certificates shall be subject to any conditions and limitations prescribed by the Board of Directors, which may include a provision that after a specified date the scrip certificate shall become absolutely void.

2

II. Preferred Stock

II.A. Provisions Generally Applicable to Preferred Stock

II.A.(i) The Preferred Stock may be issued from time to time in one or more series, the shares of each series to have such designations, preferences, privileges, and voting powers, and the restrictions or qualifications thereof, as are stated and expressed herein or in a resolution or resolutions providing for the issue of such series adopted by the Board of Directors as hereafter provided.

II.A.(ii) Authority is hereby expressly granted to the Board of Directors, subject to the provisions of this Certificate and Delaware Law, to authorize the issue of one or more series of Preferred Stock and with respect to each such series to fix by resolution or resolutions providing for the issue of such series:

(1) The number of shares of Preferred Stock which shall comprise such series and the distinctive designation thereof;

(2) The dividend rate on the shares of such series (not exceeding $6 a share per annum) and the date or dates from which dividends shall accumulate;

(3) Whether or not the shares of such series shall be subject to purchase and to redemption and the amount of premium, if any (not exceeding $7 a share), which the holders of shares of such series shall be entitled to receive over and above $100 a share and any accrued dividends thereon upon the redemption thereof or upon the voluntary liquidation, dissolution or winding up of the Corporation;

(4) Whether or not the shares of such series shall be subject to the operation of a sinking fund to be applied to the purchase or redemption of the shares of such series for retirement and, if such sinking fund be established, the terms and provisions relative to the operation thereof;

(5) Whether or not the shares of such series shall be made convertible into or exchangeable for any other class or classes or for any other series of the same class of stock of the Corporation and, if made so convertible or exchangeable, the conversion price or prices or rates of exchange at which such conversion or exchange may be made and the method, if any, of adjusting the same;

(6) The restrictions, if any, on the payment of dividends upon, and the making of distributions to, any class of stock ranking junior to the shares of Preferred Stock, and the restrictions, if any, on the purchase or redemption of the shares of any such junior class; and

3

(7) The voting rights, if any, of the shares of such series other than those voting rights provided for in Section II.A. (viii) of this Article Fourth.

II.A.(iii) All shares of any one series of Preferred Stock shall be identical with each other in all respects except that shares of any one series issued at different times may differ as to the dates from which dividends thereon shall accumulate; and all series shall rank equally and be identical in all respects except as permitted in the foregoing provisions of Section
II.A.(ii) of this Article Fourth.

II.A.(iv) The holders of shares of Preferred Stock of each series shall be entitled to receive, when and as declared by the Board of Directors, dividends payable in cash in, but not exceeding, the amount fixed for such series. Such dividends shall be cumulative, so that if dividends on all outstanding Preferred Stock of each series in the amount fixed therefor shall not have been paid or declared and set apart for payment for all past dividend periods, and for the dividend period current at the time, the deficiency shall be fully paid, or dividends equal thereto declared and set apart for payment, but without interest thereon, before any dividends on any class of stock of the Corporation junior to the Preferred Stock shall be paid or declared and set apart for payment.

Dividends shall not be declared or paid on the Preferred Stock of any one series for any dividend period unless dividends have been or are contemporaneously paid or declared and set apart for payment on the Preferred Stock of all series of the dividend periods terminating on the same and all earlier dates.

Any dividend paid in an amount less than full cumulative dividends accrued or in arrears on all Preferred Stock then outstanding shall be divided between the outstanding Preferred Stock in proportion to the amounts which would be distributable per share to the Preferred Stock if full cumulative dividends were declared and paid thereon.

After full cumulative dividends as aforesaid upon the Preferred Stock of all series then outstanding shall have been paid for all past dividend periods, and full dividends on the Preferred Stock then outstanding for the current dividend period shall have been declared and paid or set apart for payment, and after complying with all the provisions with respect to any sinking fund or funds for any one or more series of Preferred Stock, then, and not otherwise, dividends may be declared and paid upon any class of stock of the Corporation junior to the Preferred Stock.

II.A.(v) In the event of any liquidation, dissolution or winding up of the Corporation the Preferred Stock shall be preferred as to assets as well as dividends and upon any such dissolution, liquidation or winding up, the holders of the Preferred Stock of each series shall be entitled to receive and be paid for each share thereof out of the assets of the Corporation (whether capital or surplus) $100, together with an amount equal to the accrued and unpaid dividends thereon computed to the date of payment, plus a premium of such additional

4

amount per share as shall have been fixed for such series in the event the dissolution, liquidation or winding up is voluntary, before any distribution of the assets shall be made to the holders of any class of stock of the Corporation junior to the Preferred Stock. All assets remaining after such distribution to the Preferred Stock shall then be distributed exclusively among the holders of any class or classes of stock of the Corporation junior to the Preferred Stock. If, upon any such dissolution, liquidation or winding up, the assets of the Corporation distributable among the holders of Preferred Stock shall be insufficient to pay in full the preferential amount aforesaid, then such assets or the proceeds thereof shall be distributed ratably among the holders of Preferred Stock then outstanding until there shall have been paid in full and in order, first, the sum of $100 in respect of each share; second, an amount ratably in proportion to the amounts to which they are respectively entitled by reason of accrued and unpaid dividends computed to the date of distribution; and third, the balance ratably in proportion to the amounts to which they are respectively entitled by way of premium.

II.A.(vi) The Corporation, at its option to be exercised by its Board of Directors, may redeem the whole or any part of any series of Preferred Stock which by its terms is subject to redemption, at the time or times provided in the terms of such series, at a redemption price per share for each series thereof, equal to: $100 plus a premium, if any, of such additional amount as shall have been fixed as payable in case of redemption in respect of each share of such series and an amount equal to any accrued and unpaid dividends thereon computed to the date of redemption. If at any time less than all of the Preferred Stock then outstanding and subject to redemption shall be called for redemption, the Board of Directors may select the series of such Preferred Stock to be redeemed and if less than all the Preferred Stock of any series is to be called for redemption, the shares to be redeemed may be selected by lot or by such other equitable method as the Board of Directors in its discretion may determine. Notice of every such redemption, stating the redemption date, the redemption price, and the place of payment thereof, shall be given by mailing a copy of such notice at least thirty (30) days and not more than sixty (60) days prior to the date fixed for redemption to the holders of record of the Preferred Stock to be redeemed at their respective addresses as the same appear on the books of the Corporation. A similar notice shall be published at least once in a daily newspaper printed in the English language and published and of general circulation in the Borough of Manhattan, the City of New York. At any time after notice of redemption has been given in the manner prescribed by the Board of Directors to the holders of stock so to be redeemed the Corporation may deposit with a bank or trust company having capital, surplus and undivided profits of at least $5,000,000 named in such notice, the redemption price, in trust, for payment on or before the date fixed for redemption, as aforesaid, to the respective orders of the holders of the shares so to be redeemed, on such endorsement to the Corporation or its nominee or otherwise, as may be required, and upon surrender of the certificates for such shares. Upon the deposit of the said redemption price as aforesaid, or, if no such deposit is made, upon the said redemption date (unless the Corporation shall default in making payment of the redemption price as set forth in such notice), such holders shall cease to be stockholders with respect to the said shares, and from and after the making of the said deposit, or, if no such deposit is made, after the redemption date (the Corporation

5

not having defaulted in making payment of the redemption price as set forth in such notice), the said shares shall not longer be transferable on the books of the Corporation, and the said holders shall have no interest in or claim against the Corporation with respect to the said shares but shall be entitled only to such conversion rights (if any) on or before the date fixed for redemption as may be provided with respect to such shares or to receive payment of the redemption price without interest thereon, upon endorsement, provided, that any funds so deposited by the Corporation and unclaimed at the end of one year from the date fixed for such redemption shall be repaid to the Corporation upon its request, after which repayment the holders of such shares so called for redemption shall look only to the Corporation for the payment of the redemption price thereof. Any funds so deposited, which shall not be required for such redemption because of the exercise of any right of conversion or otherwise subsequently to the date of such deposit, shall be returned to the Corporation forthwith. Any interest accrued on any funds so deposited shall belong to the Corporation and shall be paid to it from time to time.

In order to facilitate the redemption of any shares of Preferred Stock, the Board of Directors is authorized to cause the transfer books of the Corporation to be closed as to the shares to be redeemed.

The Corporation shall have the right, provided full cumulative dividends on the Preferred Stock shall have been paid for past dividend periods and the Corporation shall not then be in default as to any payment required for any sinking fund created with respect to any series of Preferred Stock, to purchase Preferred Stock of any series which is subject to purchase by the terms of such series, at prices not in excess of the then redemption price thererof, either for the purpose of redemption or retirement or to be held, used and disposed of as treasury shares.

II.A.(vii) If at any time the Corporation shall have failed to pay dividends in full on the Preferred Stock, thereafter and until dividends in full, including all accrued and unpaid dividends, on Preferred Stock outstanding shall have been paid, or declared and set aside for payment, the Corporation shall not redeem any Preferred Stock except as a whole and shall not purchase any Preferred Stock except in accordance with a purchase offer made in writing or by publication (as determined by the Board of Directors) to all holders of the Preferred Stock upon the same terms as to any series, and shall not purchase or redeem any other shares of any class ranking on a parity with or junior to the Preferred Stock as to dividends or as to assets.

II.A.(viii) Special Voting Rights of Preferred Stock.

(1) The Corporation shall not, without the affirmative vote at a meeting, or the written consent with or without a meeting, of the holders of at least two-thirds of the then outstanding Preferred Stock of all series;

6

(a) Change the express terms and provisions applicable to all series of the Preferred Stock in any material respect prejudicial to the holders thereof; or

(b) Create any class of stock which shall be preferred as to dividends or as to assets over the Preferred Stock.

(2) The Corporation shall not, without the affirmative vote at a meeting, or the written consent with or without a meeting, of the holders of at least two-thirds of the outstanding Preferred Stock of any particular series, change the express terms of the special provisions fur such series as provided in this Certificate or in the resolution or resolutions of the Board of Directors providing for the issue of such series in any material respect prejudicial to the holders of shares of such series.

(3) The Corporation shall not without the affirmative vote at a meeting, or the written consent with or without a meeting, of the holders of at least a majority of the then outstanding Preferred Stock of all series, increase the authorized number of shares of Preferred Stock or create any class of stock which shall rank on a parity with the Preferred Stock as to dividends or as to assets.

(4) If the Corporation shall have failed to pay dividends upon the Preferred Stock in an aggregate amount equal to four full quarterly dividends on any series of the Preferred Stock at the time outstanding, the holders of Preferred Stock shall have the right, voting separately as a class at the annual meeting of stockholders, to elect one-third (or the nearest number thereto) of the members of the Board of Directors of the Corporation until such time as all dividends accumulated on the Preferred Stock shall have been paid in full; and upon such payment in full of all dividends accumulated on the Preferred Stock, such special voting rights of holders thereof shall cease, subject to re-vesting in the event of each and every subsequent default of the character above mentioned.

III. Preference Stock

III.A. Provisions Generally Applicable to Preference Stock

III.A.(i) The Preference Stock may be issued from time to time by the Board of directors as shares of one or more series. Subject to the provisions hereof and the limitations prescribed by law, the Board of Directors is expressly authorized, prior to issuance, by adopting resolutions providing for the issuance of shares of any particular series and, if and to the extent from time to time required by law, by filing a certificate pursuant to the Delaware Law (or other laws hereafter in effect relating to the same or substantially similar subject matter), to establish the number of shares to be included in each such series and to fix the designations, relative rights, preferences and limitations of the shares of each such series. The authority of the Board of Directors with respect to each series shall include, but not be limited to, determination of the following:

7

(1) the distinctive serial designation of such series and the number of shares constituting such series (provided that the aggregate number of shares constituting all series of Preference Stock shall not exceed 50,000,000);

(2) the dividend rate, or basis for determining such rate, if any, on shares of such series, whether dividends shall be cumulative and, if so, from which date or dates;

(3) whether the shares of each series shall be redeemable and, if so, the terms and conditions of such redemption, including the date or dates upon and after which such shares shall be redeemable, and the amount per share payable in case of redemption, which amount may vary under different conditions and at different redemption dates;

(4) the obligation, if any, of the Corporation to retire shares of such series pursuant to a sinking fund;

(5) whether shares of such series shall be convertible into, or exchangeable for, shares of stock of any other class or classes or any other series of the same class of stock and, if so, the terms and conditions of such conversion or exchange, including the price or prices or the rate or rates of conversion or exchange and the terms of adjustment, if any;

(6) whether the shares of such series shall have voting rights, in addition to the voting rights provided by law, and, if so, the terms of such voting rights;

(7) the rights of the shares of such series in the event of voluntary or involuntary liquidation, dissolution or winding up of the Corporation;

(8) the restrictions, if any, on the payment of dividends upon, and the making of distributions to, any class of stock ranking junior to the shares of Preference Stock, and the restrictions, if any, on the purchase or redemption of the shares of any such junior class; and

(9) any other designations, relative rights, preferences and limitations of such series.

8

III.B. Series One ESOP Convertible Preference Stock

The number of shares, the designation, the relative rights, the preferences and the limitations of the Series One ESOP Convertible Preference Stock of the Corporation are as follows:

III.B.(i) Designation and Amount; Special Purpose Restricted Transfer Issue

(1) The shares of this series of Preference Stock shall be designated as Series One ESOP Convertible Preference Stock ("Series One Preference Stock") and the number of shares constituting such series shall be 6,688,494.

(2) Shares of Series One Preference Stock shall be issued only to a trustee acting on behalf of an employee stock ownership plan or other employee benefit plan of the Corporation. In the event of any transfer of shares of Series One Preference Stock to any person other than (a) the issuance of Series One Preference Stock to any such plan trustee or (b) a distribution of Series One Preference Stock by any such plan trustee to a participant in any such plan in satisfaction of the distribution requirements of any such plan or any investment elections provided to participants pursuant to any such plan, the shares of Series One Preference Stock so transferred, upon such transfer and without any further action by the Corporation or the holder, shall be automatically converted into shares of Common Stock on the terms otherwise provided for the conversion of shares of Series One Preference Stock into shares of Common Stock pursuant to Section III.B.(v) hereof and no such transferee shall have any of the voting powers, preferences and relative, participating, optional or special rights ascribed to shares of Series One Preference Stock hereunder but, rather, only the powers and rights pertaining to the Common Stock into which such shares of Series One Preference Stock shall be so converted. Certificates representing shares of Series One Preference Stock shall be legended to reflect such restrictions on transfer. Notwithstanding the foregoing provisions of this Section III.B.(i)(2), shares of Series One Preference Stock
(a) may be converted into shares of Common Stock as provided by Section
III.B.(v) hereof and the shares of Common Stock issued upon such conversion may be transferred by the holder thereof as permitted by law and (b) shall be redeemable by the Corporation upon the terms and conditions provided by Sections
III.B.(vi), (vii) and (viii) hereof.

III.B.(ii) Dividends and Distributions

(1) Subject to the provisions of adjustment hereinafter set forth, the holders of shares of Series One Preference Stock shall be entitled to receive, when, as and if declared by the Board of Directors out of funds legally available therefor, cash dividends ("Preference Dividends") in an amount per share equal to the greater of (a) the sum of the aggregate amounts of regular cash dividends paid during the periods ending on December 31, 1989, October 31, 1990, October 31, 1991, October 31, 1992 and December 31, 1993 in each year thereafter (each a "Dividend Payment Date") on the number of shares of Common Stock into

9

which one share of Series One Preference Stock could be converted pursuant to
Section III.B.(v) hereof, calculated on the basis of the Conversion Price (as defined in Section III.B.(v) hereof and as adjusted from time to time pursuant to Section III.B.(ix) hereof) in effect on each record date for any such regular quarterly cash dividends on Common Stock paid during such one year period, and
(b) $3.90 per share per annum, and no more; provided that the first dividend on the Series One Preference Stock shall be $3.63. For purposes of this Section
III.B.(ii)(1), "regular cash dividends" on the Common Stock shall mean any cash dividends on the Common Stock which are not "Extraordinary Distributions" as defined in Section III.B.(ix)(7). Preference Dividends shall be payable annually, on each Dividend Payment Date, commencing on the Dividend Payment Date in 1989, to holders of record at the start of business on such Dividend Payment Date. Preference Dividends shall begin to accrue on outstanding shares of Series One Preference Stock from the date of issuance of such shares of Series One Preference Stock. The amount of Preference Dividends accrued as of any date on each share of Series One Preference Stock shall be equal to the greater of (x) the sum of the aggregate amounts of regular cash dividends paid during the period beginning on the most current previous Dividend Payment Date and ending on the date as of which accrual is being determined on the number of shares of Common Stock into which one share of Series One Preference Stock could be converted pursuant to Section III.B.(v) hereof, calculated as provided in clause
(a) above, and (y) $3.90 per annum accrued on a daily basis (whether or not the Corporation shall have surplus at the time) for the period beginning on the most recent previous Dividend Payment Date and ending on the date as of which accrual is being determined, computed for any period less than a full annual period between Dividend Payment Dates on the basis of a 360 day year of 30 day months; provided that a total dividend payment of $3.63 per share shall accrue for the period from the date of issuance of the Series One Preference Stock until December 31, 1989. Accumulated but unpaid Preference Dividends shall cumulate as of the Dividend Payment Date on which they first become payable, but no interest shall accrue on accumulated but unpaid Preference Dividends.

(2) So long as any Series One Preference Stock shall be outstanding, no dividend shall be declared or paid or set apart for payment on any other series of stock ranking on a parity with the Series One Preference Stock as to dividends, unless there shall also be or have been declared and paid or set apart for payment on the Series One Preference Stock, like dividends for all dividend payment periods of the Series One Preference Stock ending on or before the dividend payment date of such parity stock, ratably in proportion to the respective amounts of dividends accumulated and unpaid through such dividend payment period on the Series One Preference Stock and accumulated and unpaid or payable on such parity stock through the dividend payment period on such parity stock next preceding such dividend payment date. In the event that full cumulative dividends on the Series One Preference Stock have not been declared and paid or set apart for payment when due, the Corporation shall not declare or pay or set apart for payment any dividends or make any other distributions on, or make any payment on account of the purchase, redemption or other retirement of any other class of stock or series thereof of the Corporation ranking, as to dividends or as to distributions in the event of a liquidation, dissolution or winding-up of the Corporation, junior

10

to the Series One Preference Stock until full cumulative dividends on the Series One Preference Stock shall have been paid or declared and provided for, provided, however, that the foregoing shall not apply to (a) any dividend payable solely in any shares of any stock ranking, as to dividends or as to distributions in the event of a liquidation, dissolution or winding-up of the Corporation, junior to the Series One Preference Stock, or (b) the acquisition of shares of any stock ranking, as to dividends or as to distributions in the event of a liquidation, dissolution or winding-up of the Corporation, junior to the Series One Preference Stock either (x) pursuant to any employee or director incentive or benefit plan or arrangement (including any employment, severance or consulting agreement) of the Corporation or any subsidiary of the Corporation heretofore or hereafter adopted or (y) in exchange solely for shares of any other stock ranking junior to the Series One Preference Stock.

III.B.(iii) Voting Rights

The holders of shares of Series One Preference Stock shall have the following voting rights:

(1) The holders of Series One Preference Stock shall be entitled to vote on all matters submitted to a vote of the holders of Common Stock of the Corporation, voting together with the holders of Common Stock as one class. Each share of the Series One Preference Stock shall be entitled to the number of votes equal to the number of shares of Common Stock into which such share of Series One Preference Stock could be converted on the record date for determining the stockholders entitled to vote, rounded to the nearest one-tenth of a vote; it being understood that whenever the "Conversion Price" (as defined in Section III.B.(v) hereof) is adjusted as provided in Section III.B.(ix) hereof, the voting rights of the Series One Preference Stock shall also be similarly adjusted.

(2) Except as otherwise required by law or set forth herein, holders of Series One Preference Stock shall have no special voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock as set forth herein) for the taking of any corporate action; provided, however, that the vote of at least 66 2/3% of the outstanding shares of Series One Preference Stock, voting separately as a series, shall be necessary to adopt any alteration, amendment or repeal of any provision of the Certificate of Incorporation of the Corporation, as amended (including any such alteration, amendment or repeal effected by any merger or consolidation in which the Corporation is the surviving or resulting corporation), if such amendment, alteration or repeal would alter or change the powers, preferences or special rights of the shares of Series One Preference Stock so as to affect them adversely. The authorization or issuance of additional Common Stock, Preference Stock or Preferred Stock shall be deemed not to affect the powers, preferences and special rights of the Series One Preference Stock adversely for purposes of the preceding sentence.

11

III.B.(iv) Liquidation, Dissolution or Winding Up

(1) Upon any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holders of Series One Preference Stock shall be entitled to receive out of assets of the Corporation which remain after satisfaction in full of all valid claims of creditors of the Corporation and which are available for payment to stockholders and subject to the rights of the holders of any stock of the Corporation ranking senior to or on a parity with the Series One Preference Stock in respect of distributions upon liquidation, dissolution or winding up of the Corporation, before any amount shall be paid or distributed among the holders of Common Stock or any other shares ranking junior to the Series One Preference Stock in respect of distributions upon liquidation, dissolution or winding up of the Corporation, liquidating distributions in the amount of $53.45 per share, plus an amount equal to all accrued and unpaid dividends thereon to the date fixed for distribution, and no more. If upon any liquidation, dissolution or winding up of the Corporation, the amounts payable with respect to the Series One Preference Stock and any other stock ranking as to any such distribution on a parity with the Series One Preference Stock are not paid in full, the holders of the Series One Preference Stock and such other stock shall share ratably in any distribution of assets in proportion to the full respective preferential amounts to which they are entitled. After payment of the full amount to which they are entitled as provided by the foregoing provisions of Section III.B.(iv)(1), the holders of shares of Series One Preference Stock shall not be entitled to any further right or claim to any of the remaining assets of the Corporation.

(2) Neither the merger or consolidation of the Corporation with or into any other corporation, nor the merger or consolidation of any other corporation with or into the Corporation, nor the sale, transfer or lease of all or any portion of the assets of the Corporation, shall be deemed to be a dissolution, liquidation or winding up of the affairs of the Corporation for purposes of this
Section III.B.(iv), but the holders of Series One Preference Stock shall nevertheless be entitled in the event of any such merger or consolidation to the rights provided by Section III.B.(viii) hereof.

(3) Written notice of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, stating the payment date or dates when, and the place or places where, the amounts distributable to holders of Series One Preference Stock in such circumstances shall be payable, shall be given by first-class mail, postage prepaid, mailed not less than twenty (20) days prior to any payment date stated therein, to the holders of Series One Preference Stock, at the address shown on the books of the Corporation or any transfer agent for the Series One Preference Stock.

III.B.(v) Conversion into Common Stock

(1) A holder of shares of Series One Preference Stock shall be entitled, at any time prior to the close of business on the date fixed for redemption of such shares pursuant to Sections III.B.(vi), (vii) or (viii) hereof, to cause any or all of such shares to be converted into

12

shares of Common Stock, initially at a conversion rate equal to the ratio of $53.45 to the amount which initially shall be $53.45 and which shall be adjusted as hereinafter provided (and, as so adjusted, is hereinafter sometimes referred to as the "Conversion Price") (that is, a conversion rate initially equivalent to one share of Common Stock for each share of Series One Preference Stock so converted but that is subject to adjustment as the Conversion Price is adjusted as hereinafter provided.)

(2) Any holder of shares of Series One Preference Stock desiring to convert such shares into shares of Common Stock shall surrender the certificate or certificates representing the shares of Series One Preference Stock being converted, duly assigned or endorsed for transfer to the Corporation (or accompanied by duly executed stock powers relating thereto), at the principal executive office of the Corporation or the offices of the transfer agent for the Series One Preference Stock or such office or offices in the continental United States of an agent for conversion as may from time to time be designated by notice to the holders of the Series One Preference Stock by the Corporation or the transfer agent for the Series One Preference Stock, accompanied by written notice of conversion. Such notice of conversion shall specify (a) the number of shares of Series One Preference Stock to be converted and the name or names in which such holder wishes the certificate or certificates for Common Stock and for any shares of Series One Preference Stock not to be so converted to be issued, and (b) the address to which such holder wishes delivery to be made of such new certificates to be issued upon such conversion.

(3) Upon surrender of a certificate representing a share or shares of Series One Preference Stock for conversion, the Corporation shall prepare and send by hand delivery (with receipt to be acknowledged) or by first class mail, postage prepaid, to the holder thereof or to such holder's designee, at the address designated by such holder, a certificate or certificates for the number of shares of Common Stock to which such holder shall be entitled upon conversion. In the event that there shall have been surrendered a certificate or certificates representing shares of Series One Preference Stock, only part of which are to be converted, the Corporation shall issue and deliver to such holder or such holder's designee a new certificate or certificates representing the number of shares of Series One Preference Stock which shall not have been converted.

(4) The conversion into Common Stock of shares of Series One Preference Stock at the option of the holder thereof shall be effective as of the earlier of (a) the delivery to such holder or such holder's designee of the certificates representing the shares of Common Stock deliverable upon conversion thereof or
(b) the commencement of business on the second business day after the surrender of the certificate or certificates for the shares of Series One Preference Stock to be converted, duly assigned or endorsed for transfer to the Corporation (or accompanied by duly executed stock powers relating thereto) as provided by this
Section III.B.(v). On and after the effective day of conversion, the person or persons entitled to receive the Common Stock deliverable upon such conversion shall be treated for all purposes as the record holder or holders of such shares of Common Stock, but no allowance or

13

adjustment shall be made in respect of dividends payable to holders of Common Stock in respect of any period prior to such effective date. The Corporation shall not be obligated to pay any dividends which shall have been declared and shall be payable to holders of shares of Series One Preference Stock on a Dividend Payment Date if such Dividend Payment Date for such dividend shall coincide with or be on or subsequent to the effective date of conversion of such shares.

(5) The Corporation shall not be obligated to deliver to holders of Series One Preference Stock any fractional share or shares of Common Stock deliverable upon any conversion of such shares of Series One Preference Stock, but in lieu thereof may make a cash payment in respect thereof in any manner permitted by law.

(6) The Corporation shall at all times reserve and keep available out of its authorized and unissued Common Stock, or out of Common Stock held in its treasury, solely for delivery upon the conversion of shares of Series One Preference Stock as herein provided, free from any preemptive rights, such number of shares of Common Stock as shall from time to time be deliverable upon the conversion of all the shares of Series One Preference Stock then outstanding. The Corporation shall prepare and shall use its best efforts to obtain and keep in force such governmental or regulatory permits or other authorizations as may be required by law, and shall comply with all requirements as to registration or qualification of the Common Stock, in order to enable the Corporation lawfully to deliver to each holder of record of Series One Preference Stock such number of shares of its Common Stock as shall from time to time be sufficient to effect the conversion of all shares of Series One Preference Stock then outstanding and convertible into shares of Common Stock.

III.B.(vi) Redemption At the Option of the Corporation

(1) The Series One Preference Stock shall be redeemable, in whole or in part, at the option of the Corporation at any time at the following redemption prices per share, except that no such redemption at the option of the Corporation may be made prior to June 23, 1991 unless the Fair Market Value of the Common Stock as of the date on which notice of redemption is first mailed pursuant to Section III.B.(vi)(2) below shall be at least 130% of the then current Conversion Price. The Fair Market Value of the Common Stock shall be determined as provided in Section III.B.(ix)(7), except that for purposes of this Section III.B.(vi)(1) the Adjustment Period used in calculating such Fair Market Value shall be deemed to be the twenty (20) consecutive trading days ending upon but excluding the date on which notice of redemption is first mailed:

14

During the Twelve-Month
Period Beginning June 23       Price Per Share
-----------------------       ---------------
       1989                     $57.35
       1990                     $56.96
       1991                     $56.57
       1992                     $56.18
       1993                     $55.79
       1994                     $55.40
       1995                     $55.01
       1996                     $54.62
       1997                     $54.23
       1998                     $53.84

and thereafter at $53.45 per share, plus, in each case, an amount equal to all accrued and unpaid dividends thereon to the date fixed for redemption. Payment of the redemption price shall be made by the Corporation in cash or shares of Common Stock or a combination thereof, as permitted by Section III.B.(vi)(4). From and after the date fixed for redemption, dividends on Series One Preference Stock called for redemption will cease to accrue, such shares will no longer be deemed to be outstanding and all rights in respect of such shares of the Corporation shall cease, except the right to receive the redemption price. If less than all of the outstanding shares of Series One Preference Stock are to be redeemed, the Corporation shall either redeem a portion of the shares of each holder determined pro rata based on the number of shares held by each holder or shall select the shares to be redeemed by lot, as may be determined by the Board of Directors of the Corporation.

(2) Unless otherwise required by law, notice of redemption will be sent to the holders of Series One Preference Stock at the address shown on the books of the Corporation or any transfer agent for the Series One Preference Stock by first class mail, postage prepaid, mailed not less than twenty (20) days nor more than sixty (60) days prior to the redemption date. Each such notice shall state: (a) the redemption date; (b) the total number of shares of the Series One Preference Stock to be redeemed and, if fewer than all the shares held by such holder are to be redeemed, the number of such shares to be redeemed from such holder; (c) the redemption price and the form of payment thereof; (d) the place or places where certificates for such shares are to be surrendered for payment of the redemption price; (e) that dividends on the shares to be redeemed will cease to accrue on such redemption date; and (f) the conversion rights of the shares to be redeemed, the period within which conversion rights may be exercised, and the Conversion Price and number of shares of Common Stock issuable upon conversion of a share of the Series One Preference Stock at the time. Upon surrender of the certificates for any shares so called for redemption and not previously converted (properly endorsed or assigned for transfer if the Board of Directors of the Corporation shall so require and the notice shall so state), such shares shall be redeemed by the Corporation on the date fixed for redemption and at the redemption price set forth in this Section III.B.(vi).

15

(3) Notwithstanding anything to the contrary contained in Section
III.B.(vi)(1), the Corporation may from time to time, in its sole discretion, elect to redeem, upon notice as required in Section III.B.(vi)(2), all or part of the shares of Series One Preference Stock at a price equal to the amount payable in respect of such shares upon liquidation of the Corporation pursuant to Section III.B.(iv) hereof (except that any redemption pursuant to clause (d) below shall be at a price equal to the price payable upon redemption at the option of the Corporation pursuant to Section III.B.(vi)(1) plus all accrued and unpaid dividends to the date fixed for redemption) upon any of the following:

(a) In the event of a change in the federal tax law of the United States of America which has the effect of precluding the Corporation from claiming any of the tax deductions for dividends paid on the Series One Preference Stock when such dividends are used as provided under Section 404(k)(2) of the Internal Revenue code of 1986, as amended (the "Code") and in effect on the date the shares of Series One Preference Stock are initially issued; provided that notice of any redemption pursuant to this clause (a) shall be given not more than 90 days following the later of the effectiveness or the adoption of any such change in the federal tax law of the United States of America; or

(b) In the event of a determination by the Internal Revenue Service that the Melville Corporation and Subsidiaries Employee Stock Ownership Plan, dated as of January 1, 1989, as amended, or any successor plan ("the Plan"), as the same may be amended, is not qualified within the meaning of
Section 401(a) or is not an employee stock ownership plan within the meaning of Section 4975(e)(7) of the Code; or

(c) If the exclusion of interest received by any lender on any borrowings by the trustee of the Plan from the lender's income pursuant to Section 133 or any successor provision of the Code is reduced to a percentage amount less than fifty percent (50%); provided that notice of any redemption pursuant to this clause (c) shall be given not more than 90 days following the later of the effectiveness or the adoption of any such reduction; or

(d) If the Corporation terminates the Plan or terminates future contributions to the Plan; or

(e) If any shares of Series One Preference Stock are transferred to a participant in the Plan, but only any such shares so transferred may be redeemed pursuant to this clause (e); or

(f) In the event and to the extent that redemption of Series One Preference Stock is necessary or appropriate to provide for satisfaction of any investment election provided to participants in accordance with the Plan; or

16

(g) In the event and to the extent that redemption of Series One Preference Stock is necessary or appropriate to provide for distributions to be made to participants under the Plan.

(4) the Corporation, at its option, may make payment of the redemption price required upon redemption of shares of Series One Preference Stock pursuant to Section III.B.(vi)(1) above or clauses (a) through (f) of Section
III.B.(vi)(3) above in cash or in shares of Common Stock, or in a combination of such shares and cash. The Corporation shall make payment of the redemption price required upon redemption of shares of Series One Preference Stock pursuant to clause (g) of Section III.B.(vi)(3) above in shares of Common Stock, except that cash shall be paid in lieu of delivery of fractional shares. Any shares of Common Stock delivered in payment of the redemption price pursuant to this
Section III.B.(vi) shall be valued for such purpose at their Fair Market Value (as defined in Section III.B.(ix)(7) hereof, provided, however, that in calculating their Fair Market Value the Adjustment Period shall be deemed to be the five (5) consecutive trading days ending with, and including, the date of redemption).

III.B.(vii) Other Redemption Rights

Shares of Series One Preference Stock shall be called for redemption by the Corporation, through notice as required by Section III.B.(vi)(2), for cash or, if the Corporation so elects, in shares of Common Stock, or a combination of such shares and cash, any such shares of Common Stock to be valued for such purpose as provided by Section III.B.(vi)(4), at a redemption price of $53.45 per share plus accrued and unpaid dividends thereon to the date fixed for redemption, at any time and from time to time when and to the extent necessary to provide for payment of principal, interest or premium due and payable (whether as scheduled or upon acceleration) on the 8.60% ESOP Notes Due 2008 of the trust under the Plan or an indebtedness incurred by the trustee for the benefit of the Plan.

III.b.(viii) Consolidation, Merger, etc.

(1) In the event that the Corporation shall consummate any consolidation or merger or similar transaction, however named, pursuant to which the outstanding shares of Common Stock are by operation of law exchanged solely for or changed, reclassified or converted solely into stock of any successor or resulting corporation (including the Corporation) that constitutes "qualifying employer securities" with respect to a holder of Series One Preference Stock within the meaning of Section 409(l) of the Code and Section 407(c)(5) of the Employee Retirement Income Security Act of 1974, as amended, or any successor provisions of law, and, if applicable, for a cash payment in lieu of fractional shares, if any, the shares of Series One Preference Stock of such holder shall be assumed by and shall become preferred stock of such successor or resulting corporation, having in respect of such corporation insofar as possible the same powers, preferences and relative, participating, optional or other special rights (including the redemption rights provided by Sections III.B.(vi), (vii) and (viii) hereof),

17

and the qualifications, limitations or restrictions thereon, that the Series One Preference Stock had immediately prior to such transaction, except that after such transaction each share of the Series One Preference Stock shall be convertible, otherwise on the terms and conditions provided by Section III.B.(v) hereof, into the qualifying employer securities so receivable by a holder of the number of shares of Common Stock into which such shares of Series One Preference Stock could have been converted immediately prior to such transaction if such holder of Common Stock failed to exercise any rights of election to receive any kind or amount of stock, securities, cash or other property (other than such qualifying employer securities and a cash payment, if applicable, in lieu of fractional shares) receivable upon such transaction (provided that, if the kind or amount of qualifying employer securities receivable upon such transaction is not the same for each non-electing share, then the kind and amount of qualifying employer securities receivable upon such transaction for each non-electing share shall be the kind and amount so receivable per share by a plurality of the non-electing shares). The rights of the Series One Preference Stock as preferred stock of such successor or resulting company shall successively be subject to adjustments pursuant to Section III.B.(ix) hereof after any such transaction as nearly as possible equivalent to the adjustments provided for by such section prior to such transaction. The Corporation shall not consummate any such merger, consolidation or similar transaction unless all then outstanding shares of the Series One Preference Stock shall be assumed and authorized by the successor or resulting company as aforesaid.

(2) In the event that the Corporation shall consummate any consolidation or merger or similar transaction, however named, pursuant to which the outstanding shares of Common Stock are by operation of law exchanged for or changed, reclassified or converted into other stock or securities or cash or any other property, or any combination thereof, other than any such consideration which is constituted solely of qualifying employer securities (as referred to in
Section III.B.(viii)(1)) and cash payments, if applicable, in lieu of fractional shares, then the corporation shall, at least twenty (20) days before consummation of such transaction, give notice of such agreement and the material terms thereof to each holder of Series One Preference Stock and the Corporation shall simultaneously call for redemption, through notice as required by Section
III.B.(vi)(2), for cash at a redemption price equal to the amount payable in respect of such shares upon liquidation of the Corporation pursuant to Section
III.B.(iv), all of the then outstanding shares of Series One Preference Stock.

III.B.(ix) Anti-dilution Adjustments

(1) In the event the Corporation shall, at any time or from time to time while any of the shares of the Series One Preference Stock are outstanding, (a) pay a dividend or make a distribution in respect of the Common Stock in shares of Common Stock, (b) subdivide the outstanding shares of Common Stock, or (c) combine the outstanding shares of Common Stock into a smaller number of shares, in each case whether by reclassification of shares, recapitalization of the Corporation (including a recapitalization effected by a merger or consolidation to which Section III.B.(viii) hereof does not apply), or otherwise, the

18

Conversion Price in effect immediately prior to such action shall be adjusted by multiplying such Conversion Price by the fraction the numerator of which is the number of shares of Common Stock outstanding immediately before such event and the denominator of which is the number of shares of Common Stock outstanding immediately after such event. An adjustment made pursuant to this Section
III.B.(ix)(1) shall be given effect, upon payment of such a dividend or distribution, as of the record date for the determination of stockholders entitled to receive such dividend or distribution (on a retroactive basis) and in the case of a subdivision or combination shall become effective immediately as of the effective date thereof.

(2) In the event that the Corporation shall, at any time or from time to time while any of the shares of Series One Preference Stock are outstanding, issue to holders of shares of Common Stock as a dividend or distribution, including by way of a reclassification of shares or a recapitalization of the Corporation, any right or warrant to purchase shares of Common Stock (but not including as such a right or warrant any security convertible into or exchangeable for shares of Common Stock) at a purchase price per share less than the Fair Market Value (as hereinafter defined) of a share of Common Stock on the date of issuance of such right or warrant, then, subject to the provisions of Sections III.B.(ix)(5) and III.B.(ix)(6), the Conversion Price shall be adjusted by multiplying such Conversion Price by the fraction the numerator of which shall be the number of shares of Common Stock outstanding immediately before such issuance of rights or warrants plus the number of shares of Common Stock which could be purchased at the Fair Market Value of a share of Common Stock at that time of such issuance for the maximum aggregate consideration payable upon exercise in full of all such rights or warrants and the denominator of which shall be the number of shares of Common Stock outstanding immediately before such issuance of rights or warrants plus the number of shares of Common Stock that could be acquired upon exercise in full of all such rights and warrants.

(3) In the event the Corporation shall, at any time or from time to time while any of the shares of Series One Preference Stock are outstanding, issue, sell or exchange shares of Common Stock (other than pursuant to any right or warrant to purchase or acquire shares of Common Stock (including as such a right or warrant any security convertible into or exchangeable for shares of Common Stock) and other than pursuant to any employee or director incentive or benefit plan or arrangement, including any employment, severance or consulting agreement, of the Corporation or any subsidiary of the Corporation heretofore or hereafter adopted) for a consideration having a Fair Market Value on the date of such issuance, sale or exchange less than the Fair Market Value of such shares on the date of such issuance, sale or exchange, then, subject to the provisions of Sections III.B.(ix)(5) and III.B.(ix)(6), the Conversion Price shall be adjusted by multiplying such Conversion Price by the fraction the numerator of which shall be the sum of (a) the Fair Market Value of all the shares of Common Stock outstanding on the day immediately preceding the first public announcement of such issuance, sale or exchange plus (b) the Fair Market Value of the consideration received by the Corporation in respect of such issuance, sale or exchange of shares of Common Stock, and the denominator of which shall be the product of (a) the Fair

19

Market Value of a share of Common Stock on the day immediately preceding the first public announcement of such issuance, sale or exchange multiplied by (b) the sum of the number of shares of Common Stock outstanding on such day plus the number of shares of Common Stock so issued, sold or exchanged by the Corporation. In the event the Corporation shall, at any time or from time to time while any shares of Series One Preference Stock are outstanding, issue, sell or exchange any right or warrant to purchase or acquire shares of Common Stock (including as such a right or warrant any security convertible into or exchangeable for shares of Common Stock), other than any such issuance to holders of shares of Common Stock as a dividend or distribution (including by way of reclassification of shares or a recapitalization of the Corporation) and other than pursuant to any employee or director incentive or benefit plan or arrangement (including any employment, severance or consulting agreement) of the Corporation or any subsidiary of the Corporation heretofore or hereafter adopted, for a consideration having a Fair Market Value on the date of such issuance, sale or exchange less than the Non-Dilutive Amount (as hereinafter defined), then, subject to the provisions of Sections III.B(ix)(5) and
III.B.(ix)(6), the Conversion Price shall be adjusted by multiplying such Conversion Price by a fraction the numerator of which shall be the sum of (a) the Fair Market Value of all the Shares of Common Stock outstanding on the day immediately preceding the first public announcement of such issuance, sale or exchange plus (b) the Fair Market Value of the consideration received by the Corporation in respect of such issuance, sale or exchange of such right or warrant plus (c) the Fair Market Value at the time of such issuance of the consideration which the Corporation would receive upon exercise in full of all such rights or warrants, and the denominator of which shall be the product of
(a) the Fair Market Value of a share of Common Stock on the day immediately preceding the first public announcement of issuance, sale or exchange multiplied by (b) the sum of the number of shares of Common Stock outstanding on such day plus the maximum number of shares of Common Stock which could be acquired pursuant to such right or warrant at the time of the issuance, sale or exchange of such right or warrant (assuming shares of Common Stock could be acquired pursuant to such right or warrant at such time).

(4) In the event the Corporation shall, at any time or from time to time while any of the shares of Series One Preference Stock are outstanding, make an Extraordinary Distribution (as hereinafter defined) in respect of the Common Stock whether by dividend, distribution, reclassification of shares or recapitalization of the Corporation (including a recapitalization or reclassification effected by a merger or consolidation to which Section
III.B.(viii) hereof does not apply) or effect a Pro Rata Repurchase (as hereinafter defined) of Common Stock, the Conversion Price in effect immediately prior to such Extraordinary Distribution or Pro Rata Repurchase shall, subject to Sections III.B.(ix)(5) and III.B.(ix)(6), be adjusted by multiplying such Conversion Price by the fraction the numerator of which is (a) the product of
(x) the number of shares of Common Stock outstanding immediately before such Extraordinary Distribution or Pro Rata Repurchase multiplied by (y) the Fair Market Value (as herein defined) of a share of Common Stock on the record date with respect to an Extraordinary Distribution, or on the applicable expiration date (including all extensions thereof) of any tender offer which is a Pro Rata Repurchase, or on the date of purchase with

20

respect to any Pro Rata Repurchase which is not a tender offer, as the case may be, minus (b) the Fair Market Value of the Extraordinary Distribution or the aggregate purchase price of the Pro Rata Repurchase, as the case may be, and the denominator of which shall be the product of (x) the number of shares of Common Stock outstanding immediately before such Extraordinary Distribution or Pro Rata Repurchase minus, in the case of a Pro Rata Repurchase, the number of shares of Common Stock repurchased by the Corporation multiplied by (y) the Fair Market Value of a share of Common Stock on the record date with respect to an Extraordinary Distribution or on the applicable expiration date (including all extensions thereof) of any tender offer which is a Pro Rata Repurchase or on the date of purchase with respect to any Pro Rata Repurchase which is not a tender offer, as the case may be. The Corporation shall send each holder of Series One Preference Stock (a) notice of its intent to make any dividend or distribution and (b) notice of any offer by the Corporation to make a Pro Rata Repurchase, in each case at the same time as, or as soon as practicable after, such offer is first communicated (including by announcement of a record date in accordance with the rules of any stock exchange on which the Common Stock is listed or admitted to trading) to holders of Common Stock. Such notice shall indicate the intended record date and the amount and nature of such dividend or distribution, or the number of shares subject to such offer for a Pro Rata Repurchase and the purchase price payable by the Corporation pursuant to such offer, as well as the Conversion Price and the number of shares of Common Stock into which a share of Series One Preference Stock may be converted at such time.

(5) Notwithstanding any other provisions of this Section III.B.(ix), the Corporation shall not be required to make any adjustment of the Conversion Price unless such adjustment would require an increase or decrease of at least one percent (1%) in the Conversion Price. Any lesser adjustment shall be carried forward and shall be made no later than the time of, and together with, the next subsequent adjustment which, together with any adjustment or adjustments so carried forward, shall amount to an increase or decrease of at least one percent (1%) in the Conversion Price.

(6) If the Corporation shall make any dividend or distribution on the Common Stock or issue any Common Stock, other capital stock or other security of the Corporation or any rights or warrants to purchase or acquire any such security, which transaction does not result in an adjustment to the Conversion Price pursuant to the foregoing provisions of this Section III.B.(ix), the Board of Directors of the Corporation shall consider whether such action is of such a nature that an adjustment to the Conversion price should equitably be made in respect of such transaction. If in such case the Board of Directors of the Corporation determines that an adjustment to the Conversion Price should be made, an adjustment shall be made effective as of such date as is determined by the Board of Directors of the Corporation. The determination of the Board of Directors of the Corporation as to whether an adjustment to the Conversion Price should be made pursuant to the foregoing provisions of this Section
III.B.(ix)(6), and, if so, as to what adjustment should be made and when, shall be final and binding on the Corporation and all stockholders of the Corporation. The Corporation shall be entitled to make such additional adjustments in the Conversion Price, in addition to those

21

required by the foregoing provisions of this Section III.B.(ix), as shall be necessary in order that any dividend or distribution in shares of capital stock of the Corporation, subdivision, reclassification or combination of shares of stock of the Corporation or any recapitalization of the Corporation shall not be taxable to holders of the Common Stock.

(7) For purposes of this Section III.B.(ix), the following definitions shall apply:

"Extraordinary Distribution" shall mean any dividend or other distribution (effected while any of the shares of Series One Preference Stock are outstanding) (a) of cash, where the aggregate amount of such cash dividend or distribution together with the amount of all cash dividends and distributions made during the preceding period of 12 months, when combined with the aggregate amount of all Pro Rata Repurchases (for this purpose, including only that portion of the aggregate purchase price of such Pro Rata Repurchase which is in excess of the Fair Market Value of the Common Stock repurchased as determined on the applicable expiration date (including all extensions thereof) of any tender offer or exchange offer which is a Pro Rata Repurchase, or the date of purchase with respect to any other Pro Rata Repurchase which is not a tender offer or exchange offer made during such period), exceeds twelve and one-half percent (12-1/2%) of the aggregate Fair Market Value of all shares of Common Stock outstanding on the record date for determining the stockholders entitled to receive such Extraordinary Distribution and (b) of any shares of capital stock of the Corporation (other than shares of Common Stock), other securities of the Corporation (other than securities of the type referred to in Section
III.B.(ix)(2)), evidences of indebtedness of the Corporation or any other person or any other property (including shares of any subsidiary of the Corporation), or any combination thereof. The Fair Market Value of an Extraordinary Distribution for purposes of Section III.B.(ix)(4) shall be the sum of the Fair Market Value of such Extraordinary Distributions made during such twelve month period and not previously included in the calculation of an adjustment pursuant to Section III.B.(ix)(4).

"Fair Market Value" shall mean, as to shares of Common Stock or any other class of capital stock or securities of the Corporation or any other issuer which are publicly traded, the average of the Current Market Prices (as hereinafter defined) of such shares or securities for each day of the Adjustment Period (as hereinafter defined). "Current Market Price" of publicly traded shares of Common Stock or any other class of capital stock or other security of the Corporation or any other issuer for a day shall mean the last reported sales price, regular way, or, in case no sale takes place on such day, the average of the reported closing bid and asked prices, regular way, in either case as reported on the New York Stock Exchange Composite Tape or, if such security is not listed or admitted to trading on the New York Stock Exchange, on the principal national securities exchange on which such security is listed or admitted to trading or, if not listed or admitted to trading on any national securities exchange on the NASDAQ National Market System or, if such security is not quoted on such National Market System, the average of the closing bid and asked prices on each such day in the over-the-counter market as reported by NASDAQ or, if bid and asked prices for such

22

security on each such day shall not have been reported through NASDAQ, the average of the bid and asked prices for such day as furnished by any New York Stock Exchange member firm regularly making a market in such security selected for such purpose by the Board of Directors of the Corporation or a committee thereof on each trading day during the Adjustment Period. "Adjustment Period" shall mean the period of five (5) consecutive trading days, selected by the Board of Directors of the Corporation or a committee thereof, during the 20 trading days ending with, and including, the date as of which the Fair Market Value of a security is to be determined; provided that such period of five consecutive trading days shall end prior to the date on which such security begins to trade "ex dividend" with respect to any dividend or distribution giving rise to an adjustment under this Section III.B.(ix). The "Fair Market Value" of any security which is not publicly traded or of any other property shall mean the fair value thereof as determined by an independent investment banking or appraisal firm experienced in the valuation of such securities or property selected in good faith by the Board of Directors of the Corporation or a committee thereof, or, if no such investment banking or appraisal firm is in the good faith judgment of the Board of Directors or such committee available to make such determination, as determined in good faith by the Board of Directors of the Corporation or such committee.

"Non-Dilutive Amount" in respect of an issuance, sale or exchange by the Corporation of any right or warrant to purchase or acquire shares of Common Stock (including any security convertible into or exchangeable for shares of Common Stock) shall mean the remainder of (a) the product of the Fair Market Value of a share of Common Stock on the day preceding the first public announcement of such issuance, sale or exchange multiplied by the maximum number of shares of Common Stock which could be acquired on such date upon the exercise in full of such rights and warrants (including upon the conversion or exchange of all such convertible or exchangeable securities), whether or not exercisable (or convertible or exchangeable) at such date, minus (b) the aggregate amount payable pursuant to such right or warrant to purchase or acquire such maximum number of shares of Common Stock; provided, however, that in no event shall the Non-Dilutive Amount be less than zero. For purposes of the foregoing sentence, in the case of a security convertible into or exchangeable for shares of Common Stock, the amount payable pursuant to a right or warrant to purchase or acquire shares of Common Stock shall be the Fair Market Value of such security on the date of the issuance, sale or exchange of such security by the Corporation.

"Pro Rata Repurchase" shall mean any purchase of shares of Common Stock by the Corporation or any subsidiary thereof, whether for cash, shares of capital stock of the Corporation, other securities of the Corporation, evidences of indebtedness of the Corporation or any other person or any other property (including shares of a subsidiary of the Corporation), or any combination thereof, effected while any of the shares of Series One Preference Stock are outstanding, pursuant to any tender offer or exchange offer subject to Section 13(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or any successor provision of law, or pursuant to any other offer available to substantially all holders of Common Stock; provided, however, that no purchase of shares by the Corporation

23

or any subsidiary thereof shall be deemed a Pro Rata Repurchase if made (a) in open market transactions or (b) pursuant to a single tender offer subject to
Section 13(e) of the Securities Exchange Act commenced prior to December 31, 1989, but any purchase made in such a tender offer shall only be deemed not to be a Pro Rata Repurchase to the extent that the aggregate amount used to purchase Common Stock in such tender offer does not exceed $357,500,000. For purposes of this subsection (ix)(7), shares shall be deemed to have been purchased by the Corporation or any subsidiary thereof "in open market transactions" if they have been purchased substantially in accordance with the requirements of Rule 10b-18 as in effect under the Exchange Act, on the date shares of Series One Preference Stock are initially issued by the Corporation or on such other terms and conditions as the Board of Directors of the Corporation or a committee thereof shall have determined are reasonably designed to prevent such purchases from having a material effect on the trading market for the Common Stock.

(8) Whenever an adjustment to the Conversion Price and the related voting rights of the Series One Preference Stock is required pursuant to this Section
III.B.(ix), the Corporation shall forthwith place on file with the transfer agent for the Common Stock and the Series One Preference Stock if there be one, and with the Secretary of the Corporation, a statement signed by two officers of the Corporation stating the adjusted Conversion Price determined as provided herein and the resulting conversion ratio, and the voting rights (as appropriately adjusted), of the Series One Preference Stock. Such statement shall set forth in reasonable detail such facts as shall be necessary to show the reason and the manner of computing such adjustment, including any determination of Fair Market Value involved in such computation. Promptly after each adjustment to the Conversion Price and the related voting rights of the Series One Preference Stock, the Corporation shall mail a notice thereof and of the then prevailing conversion ratio to each holder of shares of the Series One Preference Stock.

III.B.(x) Banking: Retirement of Shares

(1) The Series One Preference Stock shall rank senior to the Common Stock as to the payment of dividends and the distribution of assets on liquidation, dissolution and winding up of the Corporation. The Series One Preference Stock shall rank on a parity with all other series of the Corporation's Preference Stock as to the payment of dividends and the distribution of assets on liquidation, dissolution and winding up of the Corporation. Unless otherwise provided in the Certificate of Incorporation of the Corporation, as amended, the Series One Preference Stock shall rank junior to all other series of the Corporation's Preferred Stock as to the payment of dividends and the distribution of assets on liquidation, dissolution or winding up of the Corporation.

(2) Any shares of Series One Preference Stock acquired by the Corporation by reason of the conversion or redemption of such shares as provided by this
Section III.B., or otherwise so acquired, shall be retired as shares of Series One Preference Stock and restored

24

to the status of authorized but unissued shares of preference stock, $1.00 par value, of the Corporation, undesignated as to series, and may thereafter be reissued as part of a new series of such Preference Stock as permitted by law.

III.B.(xi) Miscellaneous

(1) All notices referred to herein shall be in writing, and all notices hereunder shall be deemed to have been given upon the earlier of receipt thereof or three (3) business days after the mailing thereof if sent by registered mail (unless first-class mail shall be specifically permitted for such notice under the terms of this Resolution) with postage prepaid, addressed: (a) if to the Corporation, to its office as specified in its most recent Annual Report on Form 10-K (or any successor report or form) or to the transfer agent for the Series One Preference Stock, or other agent of the Corporation designated as permitted by this Section III.B. or (b) if to any holder of the Series One Preference Stock or Common Stock, as the case may be, to such holder at the address of such holder as listed in the stock record books of the Corporation (which may include the records of any transfer agent for the Series One Preference Stock or Common Stock, as the case may be) or (c) to such other address as the Corporation or any such holder, as the case may be, shall have designated by notice similarly given.

(2) The term "Common Stock" as used in this Section III.B. means the Corporation's Common Stock of par value $.01, as the same exists at the date of filing of this Certificate of Amendment of the Certificate of Incorporation of the Corporation relating to Series One Preference Stock or any other class of stock resulting from successive changes or reclassifications of such Common Stock consisting solely of changes in par value, or from par value to no par value, or from no par value to par value. In the event that, at any time as a result of an adjustment made pursuant to Section III.B.(ix), the holder of any shares of the Series One Preference Stock upon thereafter surrendering such shares for conversion shall become entitled to receive any shares or other securities of the Corporation other than shares of Common Stock, the Conversion Price in respect of such other shares or securities so receivable upon conversion of shares of Series One Preference Stock shall thereafter be adjusted, and shall be subject to further adjustment from time to time, in a manner and on terms as nearly equivalent as practicable to the provisions with respect to Common Stock contained in Section III.B.(ix) hereof, and the provisions of Sections (i) through (viii) and (x) and (xi) of this Article Fourth III.B. with respect to the Common Stock shall apply on like or similar terms to any such other shares or securities.

(3) The Corporation shall pay any and all stock transfer and documentary stamp taxes that may be payable in respect of any issuance or delivery of shares of Series One Preference Stock or shares of Common Stock or other securities issued on account of Series One Preference Stock pursuant hereto or certificates representing such shares or securities. The Corporation shall not, however, be required to pay any such tax which may be payable in respect of any transfer involved in the issuance or delivery of shares of Series One Preference

25

Stock or Common Stock or other securities in a name other than that in which the shares of Series One Preference Stock with respect to which such shares or other securities are issued or delivered were registered, or in respect of any payment to any person with respect to any such shares or securities other than a payment to the registered holder thereof, and shall not be required to make any such issuance, delivery or payment unless and until the person otherwise entitled to such issuance, delivery or payment has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid or is not payable.

(4) In the event that a holder of shares of Series One Preference Stock shall not by written notice designate the name in which shares of Common Stock to be issued upon conversion of such shares should be registered or to whom payment upon redemption of shares of Series One Preference Stock should be made or the address to which the certificate or certificates representing such shares, or such payment, should be sent, the Corporation shall be entitled to register such shares, and make such payment, in the name of the holder of such Series One Preference Stock as shown on the records of the Corporation and to send the certificate or certificates representing such shares, or such payment, to the address of such holder shown on the records of the Corporation.

(5) Unless otherwise provided in the Certificate of Incorporation, as amended, of the Corporation, all payments in the form of dividends, distributions on voluntary or involuntary dissolution, liquidation or winding-up or otherwise made upon the shares of Series One Preference Stock and any other stock ranking on a parity with the Series One Preference Stock with respect to such dividend or distribution shall be made pro rata, so that amounts paid per share on the Series One Preference Stock and such other stock shall in all cases bear to each other the same ratio that the required dividends, distributions or payments, as the case may be, then payable per share on the shares of the Series One Preference Stock and such other stock bear to each other.

(6) The Corporation may appoint, and from time to time discharge and change, a transfer agent for the Series One Preference Stock. Upon any such appointment or discharge of a transfer agent, the Corporation shall send notice thereof by first-class mail, postage prepaid, to each holder of record of Series One Preference Stock.

FIFTH: (i) In addition to any affirmative vote required by law or otherwise, the affirmative vote of the holders of at least 66 2/3% of the outstanding shares of Voting Stock, voting together as a single class, held by stockholders other than a Related Person shall be required for the approval, authorization or effectuation directly or indirectly, of any Business Combination with such Related Person (such affirmative vote being required notwithstanding the fact that no vote may be required or that a lesser percentage may be specified by law, this Certificate of Incorporation, any resolution or resolutions adopted by the Board of Directors pursuant to this Certificate of Incorporation, any agreement with any national securities

26

exchange or otherwise); provided, however, that such voting requirement shall not be applicable if:

(1) The Continuing Directors, by at least 66 2/3% vote of such continuing Directors, have expressly approved such Business Combination either in advance of or subsequent to such Related Person's having become a Related Person; or

(2) All of the following conditions shall have been satisfied:

(a) The Fair Market Value as of the date of consummation of the Business Combination of the consideration to be received per share by holders of shares of each class or series of Capital Stock (regardless of whether or not such Related Person is the Beneficial Owner of shares of any such class or series of Capital Stock) in the Business Combination is not less than the Highest Per Share Price;

(b) The form of consideration to be received by holders of shares of each class or series of Capital Stock in the Business Combination shall be United States currency or the form of consideration used by such Related Person in acquiring the largest aggregate number of shares of the Capital Stock which such Related Person has previously acquired;

(c) After such Related Person shall have first become a Related Person and prior to the consummation of such Business Combination:

(x) Except as approved by at least 66 2/3% of the Continuing Directors, there shall not have been any failure to declare and pay at the regular dates therefor the full amount of all dividends (whether or not cumulative) payable on the Preferred Stock, the Preference Stock or any other class or series of stock having a preference over the Common Stock as to dividends or upon liquidation;

(y) There shall not have been (A) any reduction in the annual rate of dividends paid on the Common Stock (except as necessary to reflect any subdivision of the Common Stock) except as approved by at least 66 2/3% of the Continuing Directors or (B) any failure to increase such annual rate of dividends, to the extent necessary to prevent any such reduction, in the event of any reclassification (including any reverse stock split), recapitalization, reorganization or any similar transaction that has the effect of reducing the number of outstanding shares of Common Stock, unless the failure so to increase such annual rate shall have been approved by at least 66 2/3% of the Continuing Directors; and

(z) Such Related Person shall not have become the Beneficial Owner of additional shares of Voting Stock, except as part of the transaction that results in such Related Person becoming a Related Person and except in a transaction that,

27

giving effect thereto, would not result in any increase in the percentage of Voting Stock of which such Related Person is the Beneficial Owner; and

(d) A proxy statement describing the proposed Business Combination and complying with the requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, or any acts, rules or regulations that at least 66 2/3% of the Continuing Directors determine are successors thereof, shall (whether or not such a proxy statement is required to be mailed pursuant to such acts, rules or regulations) have been mailed to all holders of Voting Stock at least 30 days prior to the date of the meeting called to consider such Business Combination and such statement shall have contained, at the front thereof, in a prominent place such recommendations and other information concerning the Business Combination as at least 66 2/3% of the Continuing Directors may determine so to include.

(ii) For purposes of this Article:

(1) The terms "Affiliate" and "Associate" shall have the same meaning as in Rule 12b-2 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended, as in effect on the date of this Restated Certificate (the term "registrant" in said Rule 12b-2 meaning in this case the Corporation), and shall include a Person that, giving effect to a Business Combination, would become such an Affiliate or Associate.

(2) The term "Beneficial Owner" shall mean any person which beneficially owns any Capital Stock within the meaning ascribed in Rule 13d-3 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended, as in effect on the date of this Restated Certificate, or who has the right to acquire any such beneficial ownership (whether or not such right is exercisable immediately, with the passage of time or subject to any condition) pursuant to any agreement, contract, arrangement or understanding or upon the exercise of any conversion, exchange or other right, warrant or option, or otherwise. A Person shall be deemed the Beneficial Owner of all Capital Stock of which any Affiliate or Associate of such Person is the Beneficial Owner.

(3) The term "Business Combination" shall mean (a) any merger or consolidation of the Corporation or a Subsidiary with or into a Related Person,
(b) any sale, lease, exchange, transfer or other disposition, including without limitation by way of a mortgage or any other security device, of any Substantial Amount of the assets of the Corporation, one or more Subsidiaries or the Corporation and one or more Subsidiaries to a Related Person, (c) the adoption of any plan or proposal for the liquidation or dissolution of the Corporation proposed by or on behalf of any Related Person, (d) any sale, lease, exchange, transfer or other disposition, including without limitation by way of a mortgage or any other security device, of any Substantial Amount of the assets of a Related Person to the Corporation, one or more Subsidiaries, or the Corporation and one or more Subsidiaries, (e) the issuance of any securities of the Corporation, one or more Subsidiaries or the Corporation and one or more

28

Subsidiaries to a Related Person or to a Person that giving effect thereto, would be a Related Person other than the issuance on a pro rata basis to all holders of stock of the same class pursuant to a stock split or stock dividend,
(f) any reclassification of securities, recapitalization of the Corporation, or any merger or consolidation of the Corporation with or into one or more Subsidiaries or any other transaction that would have the effect, directly or indirectly, of increasing the voting power or other equity interest of a Related Person in the Corporation, (g) any loan, advance, guaranty, pledge or other financial assistance by the Corporation, one or more Subsidiaries or the Corporation and one or more Subsidiaries to or for the benefit, directly or indirectly (except proportionately as a stockholder), of a Related Person, (h) any agreement, contract or other arrangement providing for any Business Combination and (i) any series of transactions that a majority of Continuing Directors determines are related and that, taken together, would constitute a Business Combination.

(4) For the purposes of Section (i)(2) of this Article FIFTH, the term "consideration to be received" shall include, without limitation, Capital Stock of the Corporation retained by its existing stockholders other than Related Persons in the event of a Business Combination that is a merger and in which the Corporation is the surviving corporation.

(5) The term "Continuing Director" shall mean a Director of the Corporation who is not the Related Person, or an Affiliate or Associate of the Related Person (or a representative or nominee of the Related Person or such Affiliate or Associate), that is involved in the relevant Business Combination and (a) who was a member of the Board of Directors of the Corporation immediately prior to the time that such Related Person became a Related Person or (b) whose initial election as a Director of the Corporation was recommended by the affirmative vote of a least 66 2/3% of the Continuing Directors then in office, provided that, in either such case, such Continuing Director has continued in office after becoming a Continuing Director.

(6) The term "Fair Market Value" shall mean (a) in the case of United States currency, the amount thereof, (b) in the case of stock, (x) the closing sale price per share thereof on the last trading day preceding the date as of which the determination thereof is to be made, or the highest closing sale price per share thereof during the specified period, on the Composite Tape for New York Stock Exchange--Listed Stocks or, if such stock is not quoted on the Composite Tape, on the New York Stock Exchange, or if such stock is not listed on such exchange, on the United States securities exchange registered as a national securities exchange under the Securities Exchange Act of 1934, as amended, on which such stock is listed or principally traded, (y) if such stock is not so listed, the closing bid quotation per share thereof on the last trading day preceding the date as of which the determination thereof is to be made, or the highest closing bid quotation per share thereof during the specified period, on the National Association of Securities Dealers Inc. Automated Quotation System, or any system then in use or (z) if no such quotations are then available, the fair market value thereof, as of the date of which the determination thereof is to be made, as determined by at least 66 2/3% of the Continuing Directors and (c) in the case of securities, property or assets

29

other than such currency or stock, the fair market value thereof, as of the date of which the determination thereof is made, as determined by at least 66 2/3% of the Continuing Directors.

(7) The term "Highest Per Share Price" shall mean with respect to any class or series of Capital Stock the highest of (a) the highest price per share that can be determined to have been paid at any time by the Related Person involved in the relevant Business Combination for any share or shares of such class or series of Capital Stock, or if such Related Person has not acquired any Capital Stock of such class or series, the highest equivalent, as determined by at least 66 2/3% of the Continuing Directors for a share of such class or series of such highest price for any other class or series of Capital Stock, (b) the highest preferential amount, if any, per share payable to shares of such class or series of Capital Stock in the event of a voluntary or involuntary liquidation of the Corporation, or the highest redemption price, if any, to which the holders of shares of such class or series of Capital Stock would be entitled, whichever is the highest, and (c) the Fair Market Value per share of such Capital Stock during the period of twenty (20) trading days immediately preceding the time the relevant Business Combination is first publicly announced, or during the period of twenty (20) trading days immediately preceding the time at which the Related Person became a Related Person, whichever is higher. In determining Highest Per Share Price, (x) all purchases by the Related Person shall be taken into account regardless of whether the share were purchased before or after the Related Person became a Related Person and (y) the Highest Per Share Price shall include any brokerage commissions, transfer taxes and soliciting dealers' fees or other value paid in connection with such purchases.

A Related Person shall be deemed to have acquired a share of Capital Stock at the time when such Related Person became the Beneficial Owner thereof. The price deemed to have been paid by a Related Person for Capital Stock of which an Affiliate or Associate is the Beneficial Owner shall be priced that is the highest of (a) the price paid upon the acquisition thereof by the relevant Affiliate or Associate (if any, and whether or not such Affiliate or Associate was a Affiliate or Associate at the time of such acquisition), and (b) the Fair Market Value per share of such Capital Stock during the 20 trading days immediately preceding the time at which the Related Person became the Beneficial Owner thereof.

In any determination of the price or prices paid or deemed to have been paid by any Person, and in any determination of the Highest Per Share Price or Fair Market Value, appropriate adjustment shall be made to reflect the effect of any stock dividends, splits and distributions and any combination of Capital Stock.

(8) The Term "Related Person" shall mean (a) any Person (other than the Corporation or any wholly owned Subsidiary) that, alone or together with any Affiliate or Associate, is or becomes the Beneficial Owner of an aggregate of 10% or more of the outstanding Voting Stock, and (b) any Affiliate or Associate of any such Person, provided, however, that the term "Related Person" shall not include (x) a Person whose acquisition of such aggregate

30

percentage of Voting Stock was approved in advance by at least 66 2/3% of the Continuing Directors or (y) any pension, profit sharing, employee stock ownership or other employee benefit plan of the Corporation or any Subsidiary, all of the capital stock of or equity interest in which Subsidiary is owned by the Corporation, one or more Subsidiaries or the Corporation and one or more Subsidiaries, or any trustee or fiduciary when acting in such capacity with respect to any such plan. The term "Person" shall mean any individual, corporation, partnership or other entity, including any group comprised of any Person and any other Person, or any Affiliate or Associate thereof, with whom such Person, or any Affiliate or Associate thereof, has any agreement, arrangement or understanding, directly or indirectly, for the purpose of acquiring holding, voting or disposing of Voting Stock and each Person, and any Affiliate or Associate thereof, that is a member of the group.

(9) The term "Subsidiary" shall mean any Person a majority of the capital stock of or other equity interest in which is owned by the Corporation, one or more Subsidiaries or the Corporation and one or more Subsidiaries.

(10) The term "Substantial Amount" shall mean an amount of stock, securities or other property having a Fair Market Value equal to 10% or more of the Fair Market Value of the total consolidated assets of the Corporation and its Subsidiaries taken as a whole, as of the end of the Corporation's most recent fiscal year ended prior to the time as of which the determination is being made.

(11) The term "Voting Stock" shall mean all outstanding Common Stock and all other outstanding Capital Stock of the Corporation, if any, entitled to vote on each matter on which the holders of record of Common Stock shall be entitled to vote, and each reference to a proportion of shares of Voting Stock shall refer to such proportion of the votes entitled to be cast by the holders of such Common Stock and other Capital Stock, if any, and the term "Capital Stock" shall mean all outstanding capital stock of the Corporation issued pursuant to this Certificate of Incorporation or any resolution or resolutions of the Board of Directors of the Corporation adopted pursuant to this Certificate of Incorporation.

(12) The Continuing Directors by at least 66 2/3% vote, shall have the power to make any and all determinations provided for in this Article FIFTH and to interpret the provisions and definitions in this article FIFTH, which determinations and interpretations shall, to the fullest extent permitted by law, be conclusive.

(iii) In addition to the requirements of law and any other provisions of this Certificate of Incorporation or any resolution or resolutions of the Board of Directors of the Corporation adopted pursuant to this Certificate of Incorporation (and notwithstanding the fact that a lesser percentage may be specified by law, this Certificate of Incorporation, any such resolution or resolutions or otherwise), the affirmative vote of the holders of at least 66 2/3% of the outstanding shares of Voting Stock held by stockholders other than any Related Person

31

shall be required to amend, alter or repeal, or adopt any provision inconsistent with the provisions of this Article FIFTH.

SIXTH: The number of directors of the Corporation shall not be less than three nor more than eighteen as determined by action of the Board of Directors.

SEVENTH: (i) A Director of the Corporation shall not be liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director to the fullest extent permitted by Delaware Law.

(ii)(1) Each person (and the heirs, executors or administrators of such person) who was or is a party or is threatened to be made a party to, or is involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact than such person is or was a director or officer of the Corporation or is or was serving at the request of the Corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise, shall be indemnified and held harmless by the Corporation to the fullest extent permitted by Delaware Law. The right to indemnification conferred in this ARTICLE SEVENTH shall also include the right to be paid by the Corporation the expenses incurred in connection with any such proceeding in advance of its final disposition to the fullest extent authorized by Delaware Law. The right to indemnification conferred in this ARTICLE SEVENTH shall be a contract right.

(2) The Corporation may, by action of its Board of Directors, provide indemnification to such of the employees and agents of the Corporation to such extent and to such effect as the Board of Directors shall determine to be appropriate and authorized by Delaware Law.

(iii) The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss incurred by such person in any such capacity or arising out of his status as such, whether or not the Corporation would have the power to indemnify him against such liability under Delaware Law.

(iv) The right and authority conferred in this ARTICLE SEVENTH shall not be exclusive of any other right which any person may otherwise have or hereafter acquire.

(v) Neither the amendment nor repeal of this ARTICLE SEVENTH, nor the adoption of any provision of this Certificate of Incorporation or the bylaws of the Corporation, nor, to the fullest extent permitted by Delaware Law, any modification of law, shall eliminate or reduce the effect of this ARTICLE SEVENTH in respect of any acts or omissions occurring prior to such amendment, repeal, adoption or modification.

32

EIGHTH: Any action required or permitted to be taken at any annual or special meeting of shareholders may be taken without a meeting on written consent, setting forth the holders of all outstanding shares entitled to vote thereon. Written consent thus given by the shareholders of all outstanding shares entitled to vote shall have the same effect as a unanimous vote of stockholders.

NINTH: Special meetings of the shareholders may be called by the Board of Directors, the Chairman of the Board of Directors or the President of the Corporation and may not be called by any other person. Notwithstanding the foregoing, whenever holders of one or more classes or series of Preferred Stock shall have the right, voting separately as a class or series, to elect directors, such holders may call, to the extent provided in Article FOURTH (or pursuant to the terms of the resolution or resolutions adopted by the Board of Directors pursuant to ARTICLE FOURTH hereof), special meetings of holders of such Preferred Stock or Preference Stock.

TENTH: The Corporation's bylaws or any of them, may be altered, amended or repealed, or new bylaws may be made, by the shareholders entitled to vote thereon at any annual or special meeting thereof or by the Board of Directors.

ELEVENTH: The Corporation reserves the right to amend this Certificate of Incorporation in any manner permitted by Delaware Law and, with the sole expectation of those rights and powers conferred under the above ARTICLE SEVENTH, all rights and powers conferred herein on stockholders, directors and officers, if any, are subject to this reserved power.

[Remainder of this page intentionally left blank.]

33

IN WITNESS WHEREOF, the Corporation has caused this Restated Certificate to be executed by its Chief Executive Officer and attested by its Secretary on this 15th day of November, 1996.

CVS Corporation

                                        By: /s/ Stanley P. Goldstein
                                            ----------------------------
                                            Name:   Stanley P. Goldstein
                                            Title:  Chairman of the Board and
                                                    Chief Executive Officer

Attest: /s/ Zenon Lankowsky
        ----------------------
Name:   Zenon Lankowsky
Secretary: Secretary

34

to that effect. If the notice is mailed, it shall be directed to a stockholder at his address as it appears on the record of stockholders unless he shall have filed with the Secretary of the corporation a written request that notices intended for him be mailed to some other address, in which case it shall be mailed to the address designated in such request.

Notice of a meeting need not be given to any stockholder who submits a signed waiver of notice, in person or by proxy, whether before or after the meeting. The attendance of a stockholder at a meeting, in person or by proxy, without protesting prior to the conclusion of the meeting the lack of notice of such meeting, shall constitute a waiver of notice by him.

Section 4. QUORUM. At any meeting of the stockholders the holders of a majority of the shares entitled to vote and being present in person or represented by proxy shall constitute a quorum for all purposes, unless the representation of a different number shall be required by law or by another provision of these by-laws, and in that case the representation of the number so required shall constitute a quorum.

If the holders of the amount of shares necessary to constitute a quorum shall fail to attend in person or by proxy, the holders of a majority of the shares present in person or represented by proxy at the meeting may adjourn from time to time without further notice other than by an announcement made at the meeting. At any such adjourned meeting at which a quorum is present, any business may be transacted which might have been transacted at the meeting as originally called.

Section 5. ORGANIZATION. The Chairman of the Board of Directors or, in his absence, the President or, in his absence, any Executive Vice President, Senior Vice President or Vice President in the order of their seniority or in such other order as may be designated by the Board of Directors, shall call meetings of the stockholders to order and shall act as chairman of such meetings. The Board of Directors or the Executive Committee may appoint any stockholder to act as chairman of any meeting in the absence of any of such officers and in the event of such absence and the failure of such board or committee to appoint a chairman, the stockholders present at such meeting may nominate and appoint any stockholder to act as chairman.

The Secretary of the corporation, or, in his absence, an Assistant Secretary, shall act as secretary of all meetings of stockholders, but, in the absence of said officers, the chairman of the meeting may appoint any person to act as secretary of the meeting.

Section 6. VOTING. At each meeting of the stockholders every stockholder of record having the right to vote shall be entitled to vote either in person or by proxy.

2

Section 7. ACTION BY WRITTEN CONSENT. Any action required or permitted to be taken at any annual or special meeting of stockholders may be taken without a meeting on written consent, setting forth the action so taken, signed by the holders of all outstanding share entitled to vote thereon. Written consent thus given by the holders of all outstanding shares entitled to vote shall have the same effect as a unanimous vote of the stockholders.

Section 8. INSPECTORS OF ELECTION. The Board of Directors, in advance of any stockholders' meeting may appoint one or more inspectors to act at the meeting or any adjournment thereof. If inspectors are not so appointed, the person presiding at a stockholders' meeting may, and on the request of any stockholder entitled to vote thereat, shall appoint one or more inspectors. In case any person appointed fails to appear or act, the vacancy may be filled by appointment made by the Board in advance of the meeting or at the meeting by the person presiding thereat. Inspectors shall be sworn.

Section 9. CONDUCT OF ELECTION. At each meeting of the stockholders, votes, proxies, consents and ballots shall be received, and all questions touching the qualification of voters, the validity of proxies and the acceptance or rejection of votes, shall be decided by the Inspectors of Election.

ARTICLE II

BOARD OF DIRECTORS

Section 1. NUMBER OF DIRECTORS. The number of directors of the Corporation shall be not less than three nor more than eighteen, as determined by action of the Board of Directors.

Section 2. TERM AND VACANCIES. Directors shall be elected at the annual meeting of stockholders to hold office until the next annual meeting and until their respective successors have been duly elected and have qualified.

Vacancies in the Board of Directors occurring between annual meetings, from any cause whatsoever including vacancies created by an increase in the number of directors, shall be filled by the vote of a majority of the remaining directors, though less than a quorum.

Directors need not be stockholders.

Section 3. GENERAL POWERS OF DIRECTORS. The business of the corporation shall be managed under the direction of its Board of Directors subject to the restrictions imposed by law, by the corporation's certificate of incorporation and amendments thereto, or by these by-laws.

3

Section 4. MEETINGS OF DIRECTORS. The directors may hold their meetings and may keep an office and maintain the books of the corporation, except as otherwise provided by statute, in such place or places in the State of Delaware or outside the State of Delaware as the Board may, from time to time, determine.

Any action required or permitted to be taken by the Board of Directors may be taken without a meeting if all of the directors consent in writing to the adoption of a resolution authorizing the action, and in such event the resolution and the written consent of all directors thereto shall be filed with the minutes of the proceedings of the Board of Directors.

Any one or more directors may participate in a meeting of the Board of Directors by means of a conference telephone or similar communications equipment allowing all persons participating in the meeting to hear each other at the same time, and participation by such means shall constitute presence in person at a meeting.

Section 5. REGULAR MEETINGS. Regular meetings of the Board of Directors shall be held at the principal office of the corporation in the County of Providence, Town of Woonsocket, State of Rhode Island, or at such other place within or without the State of Delaware as shall be designated in the notice of the meeting as follows: One meeting shall be held immediately following the annual meeting of stockholders and further meetings shall be held at such intervals or on such dates as may from time to time be fixed by the directors, all of which meetings shall be held upon not less than four days' notice served upon each director by mailing such notice to him at his address as the same appears upon the records of the corporation, except the meeting which shall be held immediately following the annual meeting of stockholders which meeting shall be held without notice.

Section 6. SPECIAL MEETINGS. Special meetings of the Board of Directors shall be held whenever called by the direction of the Chairman of the Board of Directors, or of the President of the corporation, or of one-third of the directors at the time in office. The Secretary shall give notice of each special meeting by mailing such notice nor less than four days, or by telegraphing or telecopying such notice nor less than two days, before the date set for a special meeting, to each director.

Section 7. WAIVER. Notice of a meeting need nor be given to any director who submits a signed waiver of notice whether before or after the meeting, or who attends the meeting without protesting, prior thereto or at its commencement, the lack of notice to him.

Section 8. QUORUM. One-third of the total number of directors shall constitute a quorum for the transaction of business, but if at any meeting of the Board

4

there be less than a quorum present the majority of those present may adjourn the meeting from time to time.

Section 9. ORDER OF BUSINESS. At meetings of the Board of Directors business shall be transacted in such order as the Board may fix and determine.

At all meetings of the Board of Directors, the Chairman of the Board of Directors, or in his absence, the President, or in the absence of both, the Executive Vice-President or any Vice-President (provided such person be a member of the Board) shall preside.

Section 10. ELECTION OF CHAIRMAN, OFFICERS AND COMMITTEES. At the first regular meeting of the Board of Directors in each year, at which a quorum shall be present, held next after the annual meeting of the stockholders, the Board of Directors shall proceed to the election of a Chairman of the Board, of the executive officers of the corporation and of the Executive Committee, if the Board of Directors shall provide for such committee under the provisions of Article III hereof.

The Board of Directors from time to time may fill any vacancies among the executive officers, members of the Executive Committee and members of other committees, and may appoint additional executive officers and additional members of such Executive Committee or other committees.

Section 11. COMPENSATION. Directors who are not officers or employees of the corporation or any of its subsidiaries may receive such remuneration as the Board may fix, in addition to a fixed sum for attendance at each regular or special meeting of the Board or a Committee of the Board; provided, however, that nothing herein contained shall be construed to preclude any director from serving the corporation in any other capacity or receiving compensation therefor. In addition, each director shall be entitled to reimbursement for expenses incurred in attending any meeting of the Board or Committee thereof.

ARTICLE III

COMMITTEES

Section 1. EXECUTIVE COMMITTEE. The Board of Directors by resolution adopted by a majority of the entire Board, may designate from the Directors an Executive Committee consisting of three or more, to serve at the pleasure of the Board. At all times when the Board of Directors is not in session, the Executive Committee so designated shall have and exercise the powers of the Board of Directors, except that such committee shall have no authority as to the matters set out in Section 3 of this Article III.

5

Meetings of the Executive Committee shall be called by any member of the same, on three days' mailed notice, or one day's telegraphed or telecopied notice to each of the other members, starting therein the purpose for which such meeting is to be held. Notice of meeting may be waived, in writing, by any member of the Executive Committee.

All action by the Executive Committee shall be recorded in its minutes and reported from time to time to the Board of Directors.

The Executive Committee shall fix its own rules of procedure shall meet where and as provided by such rules or by resolution of the Board of Directors.

Any action required or permitted to be taken by the Executive Committee may be taken without a meeting if all of the members of the Executive Committee consent in writing to the adoption of a resolution authorizing the action, and in such event the resolution and the written consent of all members of the Executive Committee thereto shall be filed with the minutes of the proceedings of the Executive Committee.

Any one or more members of the Executive Committee may participate in a meeting of the Executive Committee by means of a conference telephone or similar communications equipment allowing all persons participating in the meeting to hear each other at the same time, and participation by such means shall constitute presence in person at a meeting.

Section 2. OTHER COMMITTEES. The Board of Directors may appoint such other committees, of three or more, as the Board shall, from time to time, deem advisable, which committees shall have and may exercise such powers as shall be prescribed, from time to time, by resolution of the Board of Directors, except that such committees shall have no authority as to the matters set out in
Section 3 hereof.

Actions and recommendations by each committee which shall be appointed pursuant to this section shall be recorded and reported from time to time to the Board of Directors.

Each such committee shall fix its own rules of procedure and shall meet where and as provided by such rules or by resolution of the Board of Directors.

Any action required or permitted to be taken by any such committee may be taken without a meeting if all of the members of such committee consent in writing to the adoption of a resolution authorizing the action, and in such event the resolution and the written consent of all members of such committee thereto shall be filed with the minutes of the proceedings of such committee.

6

Any one or more members of any such committee may participate in a meeting of such committee by means of a conference telephone or similar communications equipment allowing all persons participating in the meeting to hear each other at the same time, and participation by such means shall constitute presence in person at a meeting.

Section 3. LIMITATIONS. No committee shall have authority as to the following matters.

(1) The submission to stockholders of any action that needs stockholders' authorization.

(2) The filling of vacancies in the Board of Directors or in any committee.

(3) The fixing of compensation of the directors for serving on the Board or on any committee.

(4) The amendment or repeal of the by-laws, or the adoption of new by-laws.

(5) The amendment or repeal of any resolution of the Board which by its terms shall not be so amendable or repealable.

Section 4. ALTERNATES. The Board may designate one or more directors as alternate members of any such committees, who may replace any absent member or members at any meeting of such committees.

Section 5. COMPENSATION. Members of special or standing committees may receive such salary for their services as the Board of Directors may determine; provided, however, that nothing herein contained shall be construed to preclude any member of any such committee from serving the corporation in any other capacity or receiving compensation therefor.

ARTICLE IV

OFFICERS

Section 1. TITLES AND TERMS OF OFFICE. The executive officers of the corporation shall be the Chairman of the Board of Directors and a Vice Chairman, each of whom shall be a member of the Board of Directors, and may include a President, such number of Executive Vice Presidents, Senior Vice Presidents and/or Vice Presidents, a Controller, a Treasurer and/or a Secretary, as the Board of Directors shall determine, all of whom shall be chosen by the Board of Directors.

7

The Board of Directors may also appoint one or more Assistant secretaries and one or more Assistant Treasurers, and such other junior officers as it shall deem necessary, who shall have such authority and shall perform such duties as from time to time may be prescribed by the Board of Directors.

One person may hold more than one of the above offices except the offices of President and Secretary.

The officers of the Corporation shall each hold office for one year and until their successors are chosen and qualified, and shall be subject to removal at any time by the affirmative vote of the majority of the entire Board of Directors.

Section 2. CHAIRMAN OF THE BOARD OF DIRECTORS. The Chairman of the Board of Directors shall be the chief executive officer of the corporation. He shall have general management and control over the policy, business and affairs of the corporation and shall have such other authority and perform such other duties as usually appertain to a chief executive officer of a business corporation. He shall preside at meetings of the Board of Directors and of the stockholders.

Section 3. VICE CHAIRMAN. The Vice Chairman shall have such authority and perform such duties as the Board of Directors, the Executive Committee, or the Chairman of the Board of Directors may from time to time determine. In the event that at any time no President of the Corporation is in office, all powers of the President shall vest in the Vice Chairman and the Vice Chairman may exercise all powers of the President set forth in these by-laws.

Section 4. PRESIDENT. The President, if any, shall have such authority and shall perform such duties as the Board of Directors, the Executive Committee, or the Chairman of the Board of Directors may from time to time determine. He shall exercise the powers of the Chairman of the Board of Directors during his absence or inability to act.

Section 5. EXECUTIVE VICE PRESIDENTS, SENIOR VICE PRESIDENTS AND VICE
PRESIDENTS. The Executive Vice Presidents, Senior Vice Presidents and Vice Presidents, if any, shall be designated and shall have such powers and perform such duties as may be assigned to them by the Board of Directors, the Executive Committee, the Chairman of the Board of Directors or the President. They shall, in order of their seniority or in such other order as may be designated by the Board of Directors, the Executive Committee, the Chairman of the Board of Directors or the President exercise the powers of the Chairman of the Board of Directors during the absence or inability to act of the Chairman of the Board of Directors and the President.

8

Section 6. PRINCIPAL FINANCIAL OFFICER. An officer designated by the Board of Directors shall be the principal financial officer of the Corporation. He shall render to the Board of Directors, whenever the Board may require, an account of the financial condition of the corporation, and shall do and perform such other duties as from time to time may be assigned to him by the Board of Directors, the Executive Committee, the Chairman of the Board of Directors or the President.

Section 7. PRINCIPAL ACCOUNTING OFFICER. A Controller or other officer designated by the Board of Directors shall be the principal accounting officer and subject to the direction of the principal financial officer, he shall have supervision over all the accounts and account books of the corporation. He shall have such other powers and perform such other duties as from time to time may be assigned to him by the principal financial officer, and shall exercise the powers of the principal financial officer during his absence or inability to act.

Section 8. TREASURER. The Treasurer shall have custody of the funds and securities of the corporation which come into his hands. When necessary or proper, he may endorse on behalf of the corporation for collection, checks, notes, and other instruments and obligations and shall deposit the same to the credit of the corporation in such bank or banks or depositaries as the Board of Directors or the Executive Committee shall designate; whenever required by the Board of Directors or the Executive Committee, he shall render a statement of his cash account; he shall keep, or cause to be kept, books of account, in which shall be entered and kept full and accurate accounts of all monies received and paid out on account of the corporation; he shall perform all acts incident to the position of Treasurer, subject to the control of the Board of Directors, the Executive Committee, the Chairman of the Board of Directors, the President and the principal financia1 officer; he shall give bond for the faithful discharge of his duties, if, as, and when the Board of Directors or the Executive Committee may require. He shall perform such other duties as from time to time may be assigned to him by the Board of Directors, the Executive Committee, the Chairman of the Board of Directors, the President or the principal financial officer.

Section 9. ASSISTANT TREASURER. Each Assistant Treasurer shall have such powers and perform such duties as may be delegated to him, and the Assistant Treasurers shall, in the order of their seniority, or in such other order as may be designated by the Board of Directors, the Executive Committee, the Chairman of the Board of Directors, the President or the principal financial officer, exercise the powers of the Treasurer during his absence or inability to act.

Section 10. SECRETARY. The Secretary shall keep the minutes of all meetings of the Board of Directors and the minutes of all meetings of the stockholders and of the Executive Committee, in books provided for that purpose; he shall attend to the giving and serving of all notices of the corporation; and be shall have charge of

9

the certificate books, transfer books and records of stockholders and such other books and records as the Board of Directors or Executive Committee may direct, all of which shall at all reasonable times be open to the inspection of any director upon application during the usual business hours.

He shall keep at the office of the corporation, or at the office of the transfer agent or registrar of the corporation's capital stock, a record containing the names, alphabetically arranged, of all persons who are stockholders of the corporation, showing their places of residence, the number of shares held by them, respectively, the time when they respectively became the owners thereof, and the amount paid thereon, and such record shall be open for inspection as prescribed by Section 220 of the General Corporate Law of the State of Delaware. He shall in general perform all the duties incident to the office of Secretary, subject to the control of the Board of Directors, the Executive Committee, the Chairman of the Board of Directors and the President.

Section 11. ASSISTANT SECRETARIES. Each Assistant Secretary shall have such powers and perform such duties as may be delegated to him, and the Assistant Secretaries shall, in the order of their seniority, or in such other order as may be designated by the Board of Directors, the Executive Committee, the Chairman of the Board of Directors or the President, exercise the powers of the Secretary during his absence or inability to act.

Section 12. VOTING UPON STOCKS. Unless otherwise ordered by the Board of Directors or by the Executive Committee, the Chairman of the Board of Directors of the corporation, or one designated in a proxy executed by him, and in the absence of either, the President, or a person designated in a proxy executed by him, and in the absence of all such, the Executive Vice-Presidents or the Vice-Presidents of the corporation in the order of their seniority, shall have full power and authority on behalf of the corporation to attend, and to act, and to vote at meetings of stockholders of any corporation in which this corporation may hold stock, and each such officer of the corporation shall have power to sign a proxy deputizing others to vote the same; and all such who shall be so authorized to vote shall possess and may exercise any and all rights and powers incident to the ownership of such stock and which, as the owner thereof, the corporation might have possessed and exercised, if present.

The Board of Directors or the Executive Committee may, by resolution from time to time, confer like powers on any other person or persons which shall supersede the powers of those designated in the foregoing paragraph.

Section 13. EXECUTION OF CHECKS, ETC. All checks, notes, drafts or other instruments for the payment of money shall be signed on behalf of this

10

corporation by such person or persons and in such manner as the Board of Directors or Executive Committee may prescribe by resolution from time to time.

ARTICLE V

STOCK; RECORD DATE

Section 1. CERTIFICATES FOR STOCK. The certificates for shares of the stock of the corporation shall be in such form as shall be proper or approved by the Board of Directors. Each certificate shall state (i) that the corporation is formed under the laws of the State of Delaware, (ii) the name of the person or persons to whom issued, (iii) the number and class of shares and the designation of the series, if any, which such certificate represents and (iv) the par value, if any, of each share represented by such certificate. Each certificate shall be signed by the Chairman of the Board of Directors, the President, an Executive Vice-President or a Vice-President, and also by the Treasurer or an Assistant Treasurer or the Secretary or an Assistant Secretary and sealed with the corporation's seal; provided, however, that if such certificates are signed by a transfer agent or transfer clerk and by a registrar the signature of the Chairman of the Board of Directors, the President, the Executive Vice President, Vice-President, Treasurer, Assistant Treasurer, Secretary and Assistant Secretary and the seal of the corporation upon such certificates may be facsimiles, engraved or printed.

Section 2. TRANSFER OF SHARES. Shares of the stock of the corporation may be transferred on the record of stockholders of the corporation by the holder thereof in person or by his duly authorized attorney upon surrender of a certificate therefor properly endorsed.

Section 3. AUTHORITY FOR ADDITIONAL RULES REGARDING TRANSFER. The Board of Directors and the Executive Committee shall have power and authority to make all such rules and regulations as respectively they may deem expedient concerning the issue, transfer and registration of such certificates for shares of the stock of the corporation as well as for the issuance of new certificates in lieu of those which may be lost or destroyed, and may require of any stockholder requesting replacement of lost or destroyed certificates, bond in such amount and in such form as they may deem expedient to indemnify the corporation, and/or the transfer agents, and/or the registrars of its stock against any claims arising in connection therewith.

Section 4. TRANSFER AGENTS AND REGISTRARS. The Board of Directors or Executive Committee may appoint one or more transfer agents and one or more registrars of transfer and may require all stock certificates to be countersigned by such transfer agent and registered by such registrar of transfers. One person or organization may serve as both transfer agent and registrar.

11

Section 5. RECORD DATE. For the purpose of determining the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or to express consent to or dissent from any proposal without a meeting, or for the purpose of determining stockholders entitled to receive payment of any dividend or the allotment of any rights, or for the purpose of any other action, the Board of Directors shall fix in advance a date as the record date for any such determination of stockholders. Such date shall not be more than sixty nor less than ten days before the date of such meeting, nor more than sixty days prior to any other action.

Section 6. LIST OF STOCKHOLDERS AS OF RECORD DATE. The Secretary of the corporation or the transfer agent of its stock shall make and certify a list of the stockholders as of the record date and number of shares of each class of stock of record in the name of each stockholder and such list shall be present at every meeting of stockholders. If the right to vote at any meeting is challenged, the inspectors of elections, or person presiding the thereat, shall require such list of stockholders to be produced as evidence of the right of the persons challenged to vote at such meeting, and all persons who appear from such list to be stockholders entitled to vote thereat, may vote at such meeting.

Section 7. DIVIDENDS. Dividends may be declared and paid out of the surplus of the corporation as often and at such times and to such extent as the Board of Directors may determine, consistent with the provisions of the certificate of incorporation of the corporation.

ARTICLE VI

CORPORATE SEAL

The Board of Directors shall provide a suitable seal containing the name of the corporation and of the state under the laws of which the corporation was incorporated; and the Secretary shall have the custody thereof.

ARTICLE VII

AMENDMENTS

Section 1. These by-laws or any of them, may be altered, amended or repealed, or new bylaws may be made by the stockholders entitled to vote thereon at any annual or special meeting thereof or by the Board of Directors.

12

State of Delaware

Office of the Secretary of State


PAGE 1

I, EDWARD J. FREEL, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THAT "CVS CORPORATION" IS DULY INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE AND IS IN GOOD STANDING AND HAS A LEGAL CORPORATE EXISTENCE NOT HAVING BEEN CANCELLED OR DISSOLVED SO FAR AS THE RECORDS OF THIS OFFICE SHOW AND IS DULY AUTHORIZED TO TRANSACT BUSINESS.

THE FOLLOWING DOCUMENTS HAVE BEEN FILED:

CERTIFICATE OF INCORPORATION, FILED THE TWENTY-SECOND DAY OF AUGUST, A.D.

1996, AT 4 O'CLOCK P.M.

RESTATED CERTIFICATE, FILED THE FIFTEENTH DAY OF NOVEMBER, A.D. 1996, AT

12:30 O'CLOCK P.M.

AND I DO HEREBY FURTHER CERTIFY THAT THE AFORESAID CERTIFICATES ARE THE

ONLY CERTIFICATES ON RECORD OF THE AFORESAID CORPORATION.

AND I DO HEREBY FURTHER CERTIFY THAT THE ANNUAL REPORTS HAVE BEEN FILED TO

DATE.

AND I DO HEREBY FURTHER CERTIFY THAT THE FRANCHISE TAXES HAVE BEEN PAID TO

DATE.

                               [Seal]      /s/  Edward J. Freel
                                           -------------------------------------
                                           Edward J. Freel, Secretary of State

2656078 8310                               AUTHENTICATION:       8473712

971164260                                            DATE:       05-20-97


CVS CORPORATION

RESOLVED, that the Chairman, Vice Chairman, Secretary or any Vice President or the Treasurer of the Corporation be, and they and each of them, acting alone, hereby is, authorized and empowered, in the name and on behalf of the Corporation, to enter into a commercial paper program providing for proceeds to the Corporation in an aggregate principal amount of up to $1,500,000,000 on such terms and condition as such officer shall approve, such approval to be conclusively evidenced by execution of definitive documentation with respect to such program; and further

RESOLVED, that the Chairman, Vice Chairman, Secretary or any Vice President or the Treasurer of the Corporation be, and they and each of them, acting alone, hereby is, authorized and empowered, in the name and on behalf of the Corporation, to execute and deliver a credit agreement or other credit facility (or an amendment or extension of any existing credit agreement or other existing credit faci1ity) providing for financing to the Corporation in an aggregate principal amount of up to $1,500,000,000 on such terms and conditions as such officer shall approve, such approval to be conclusively evidenced by such execution, to arrange for loans thereunder and to execute and deliver to the lenders thereunder notes evidencing the borrowings thereunder; and further


RESOLVED, that the Chairman, Vice Chairman, Secretary or any Vice President or the Treasurer of the Corporation be, and they and each of them, acting in each instance with the expressed concurrence of the Corporation's Chief Financial Officer, hereby is, authorized and empowered, in the name and on behalf of the Corporation, to enter into derivatives transactions exclusively for risk management purposes, in the case of each transaction on such terms and conditions as such officer and the Chief Financial Officer shall approve, such approval to be conclusively evidenced by execution of definitive documentation with respect thereto; and further

RESOLVED, that the Chairman, Vice Chairman, Secretary or any Vice President or the Treasurer of the Corporation be, and each of them hereby is, authorized to take any and all action, to execute any and all documents, agreements and instruments and to take any and all steps deemed by them necessary or desirable to carry out the purpose and intent of each of the foregoing resolutions and the transactions contemplated thereby.


APPROVAL OF MERGER

RESOLVED, that the Board of Directors of CVS Corporation ("CVS") deems it desirable and in the best interest of CVS and its stockholders to acquire Revco D.S., Inc., a Delaware corporation ("Revco"); and

FURTHER RESOLVED, that the form, terms and provisions of, and the transactions contemplated in, the Agreement and Plan of Merger (together with the exhibits thereto, the "Merger Agreement") between Revco, CVS and North Acquisition Corp. (a newly formed wholly owned subsidiary of CVS) ("Merger Sub"), substantially in the form presented to this meeting and filed with the records of CVS, providing for the merger or Merger Sub with and into Revco, with Revco being the surviving entity (the "Merger"), pursuant to the applicable laws of the State of Delaware and upon the terms and conditions contained in the Merger Agreement, which provide, among other things, for the issuance by CVS of that number of shares of common stock of CVS as described in the Merger Agreement in exchange for all the issued and outstanding shares of Revco common stock, be, and the same hereby are, in all respects authorized and approved, with such changes or additions as the person or persons hereinafter authorized to execute the Merger Agreement on behalf of CVS may approve, the execution and delivery thereof to be conclusive evidence of such approval; and

FURTHER RESOLVED, that the Chairman of the Board and Chief Executive Officer, the Vice Chairman and Chief Operating Officer, and any other officer of CVS (the "Authorized Officers") be, and each of them hereby is, authorized, empowered and directed, in the name and on behalf of CVS to execute and deliver the Merger


Agreement, substantially in the form presented to this meeting and filed with the records of CVS, with such changes or additions to any of the terms and provisions of said Merger Agreement as such persons, or any one or more of them, executing the same shall approve, the execution and delivery thereof to be conclusive evidence of such approval; and

FURTHER RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized, in the name and on behalf of CVS, to execute and deliver all such certificates of merger, articles of merger or plans of merger as may be required to effectuate the Merger; and

FURTHER RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized, in the name and on behalf of CVS, to do and perform all such further acts and things, to execute and deliver in the name and on behalf of CVS, and where necessary or appropriate, to file with the appropriate governmental authorities, all such further certificates, instruments, applications, notices, affidavits, powers of attorney, consents to service of process, certified copies of minutes of stockholders' and directors' meetings, bonds, agreements and other writings and documents as may be required, and to make all such payments, and to take all such other actions as in the judgment of any one or more of them shall be deemed necessary or advisable in order to carry out and effectuate the intent and purposes of the foregoing resolutions (or any of them), and any or all of the transactions contemplated therein or thereby, the authority therefor to be conclusively evidenced by the taking of such action or the execution of such documents; and

ISSUANCE OF SHARES

FURTHER RESOLVED, that CVS is hereby authorized to issue such number of shares of common stock of CVS, par value $.01 per share, necessary to consummate the transactions contemplated by the Merger Agreement, and, when issued in accordance with the Merger Agreement, such shares of common stock of CVS shall be duly authorized, validly issued, fully paid and non-assessable; and


FURTHER RESOLVED, that the Chairman of the Board and Chief Executive Officer is hereby authorized, in the name and on behalf of CVS, to convene a Meeting of Stockholders of CVS, and shall convene such meeting, to be held on such date and at such place, and subject to such record date, as may be selected by the Chairman of the Board and Chief Executive Officer whereat the share issuance required by the Merger Agreement shall be submitted, with the recommendations of this Board of Directors for approval thereof, to a vote of the stockholders of CVS; and

PROXY STATEMENT AND REGISTRATION STATEMENT

FURTHER RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized in the name and on behalf of CVS, to prepare or caused to be prepared and to execute and file with the Securities and Exchange Commission (the "Commission") preliminary and final proxy materials required by the rules and regulations of the Commission for use in connection with the Meeting of Stockholders of CVS referred to above; and

FURTHER RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized, in the name and on behalf of CVS, to prepare, execute and filed, or cause to be prepared and filed, with the Commission a Registration statement, including a form of prospectus/proxy statement on Form S-4, under the Securities Act of 1933, as amended (the "Securities Act") relating to, and providing for, the registration of shares of common stock of CVS, par value $.01 per share, to be issued in the Merger pursuant to the Merger Agreement, together with all amendments thereto (including, without limitation, all pre-effective amendments) and all documents required as exhibits to the Registration Statement and any other certificates, documents, instruments and papers which may be required or desirable to be filed with the Commission, in such form as the Authorized Officers executing the same may approve, such approval to be conclusively evidenced by the execution thereof, and to take any and all other actions that any such Authorized Officer shall deem necessary or proper in order that the Registration Statement, as it hereafter may be amended or supplemented, may become effective pursuant to the provisions of the Securities Act


and the rules and regulations of the Commission promulgated thereunder; and

FURTHER RESOLVED, that Charles Conaway, the Executive Vice President and Chief Financial Officer, be, and hereby is, designated as the agent of CVS for service, who is hereby authorized to receive all notices and communications from the Commission with respect to the Registration Statement and any and all further amendments and supplements thereto, and to exercise the powers and rights conferred upon such agent by the Securities Act and the rules and regulations of the Commission thereunder; and

FURTHER RESOLVED, that each officer and director who has executed or may be required to execute the Registration Statement or any amendments thereto, whether on behalf of CVS or as an officer or director thereof or by attesting the seal of CVS or otherwise, be, and each of them acting individually hereby is, authorized, empowered and directed to execute a power of attorney in customary form, appointing Thomas M. Ryan, Charles Conaway and Zenon P. Lankowsky, each of them, with full power to act without the other, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities (until revoked in writing to sign the Registration Statement and any and all amendments (including post-effective amendments and other amendments thereto) to the Registration statement and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary fully to all intents and purposes as he or she might or could do in person, thereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue thereof, and the form, terms and provisions of such Power of Attorney are hereby, in all respects approved; and


"BLUE SKY" MATTERS

            FURTHER RESOLVED, that the Authorized Officers be, and each of them
            hereby is, authorized, in the name and on behalf of CVS, to take any
            and all action which they may deem necessary, advisable or
            appropriate in order to effect the registration or qualification (or
            exemption therefrom) of the shares of common stock of CVS to be
            issued in the Merger for offer or sale under the Blue Sky or
            securities laws of any of the states, districts, territories or
            commonwealths of the United States of America or any other
            jurisdiction and in connection therewith to determine in which of
            such jurisdictions appropriate action shall be taken to qualify or
            register for sale all or such part of such shares as said officers
            may deem advisable; that the Authorized Officers be, and each of
            them hereby is, authorized to perform in the name of and on behalf
            of CVS any and all such action as such officer may deem necessary,
            advisable or appropriate in order to comply with the applicable laws
            of regulations of any such jurisdictions, and in connection
            therewith to execute and file all requisite papers and documents,
            including, but not limited to, applications, reports, surety bonds,
            irrevocable consents and appointments of attorneys for service of
            process; and the execution by any of such officers of any such paper
            or document or the doing by any of them of any act in connection
            with the foregoing matters shall conclusively establish such
            officer's authority therefor from CVS and the approval and
            ratification of CVS of the papers and documents so executed and the
            action so taken and any resolution which is required or appropriate
            in connection therewith shall be deemed to have been adopted hereby
            and may so be certified by the Secretary of CVS; and

            FURTHER RESOLVED, that the form of any resolution or resolutions
            required by any agency or authority of the jurisdictions referred to
            in the preceding resolution to be filed in connection with the
            qualification or registration of such shares of common stock of CVS,
            are hereby adopted, provided that in the opinion of any Authorized
            Officer the adoption of such resolution or resolutions is in the
            best interests of CVS, which resolution or resolutions will
            thereupon be deemed to be adopted by this Board of Directors with
            the same force and effect as if fully set forth herein, and the
            Secretary of CVS is authorized to certify as

            to the adoption of any and all such resolutions, a copy of each such
            resolution (if any) to be annexed to these resolutions in the minute
            books of CVS; and

EXCHANGE LISTING

FURTHER RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized, in the name and on behalf of CVS, to prepare, execute and file, or cause to be prepared and filed, a supplemental listing application with the New York Stock Exchange, Inc. (the "NYSE"), providing for listing on the NYSE, upon official notice issuance, of the shares of common stock of CVS to be issued in the Merger, in such form as such officer or officers approve, together with all amendments thereto and all documents required as exhibits to such supplemental listing application and any other filings which may be desirable to be made with the NYSE with respect to the listing of such shares, and if required or requested, to affix the corporate seal thereto, duly attested, and to appear, if requested, before officials of the NYSE with authority to make such changes to any such applications or any agreements relative thereto as may be necessary to conform to the listing requirements of the NYSE, and to take any and all actions that any such Authorized Officer shall deem necessary or proper in connection with the foregoing; and

FURTHER RESOLVED, that the form of any resolution or resolutions required to be filed by the NYSE in connection with the listing of the shares of common stock of CVS are hereby adopted, provided that in the opinion of any Authorized Officer the adoption of such resolution or resolutions is in the best interests of CVS, which resolution or resolutions will thereupon be deemed to be adopted by this Board of Directors with the same force and effect as if fully set forth herein, and the Secretary of CVS is authorized to certify as to the adoption of any and all such resolutions, a copy of each such resolution (if any) to be annexed to these resolutions in the minute books of CVS; and

HART-SC0TT-RODINO FILING

FURTHER RESOLVED, that the Authorized Officers and agents designated by such officers be, and each of them


hereby is, authorized and directed to prepare the filings required by the Hart-Scott-Rodino Antitrust Improvement Act of 1976 (the "HSR Act") with respect to the Merger, to execute and file such documents with the Federal Trade Commission (the "FTC") and the Department of Justice (the "DOJ"); to supply, in their discretion, any additional information that may be requested by the FTC and the DOJ in connection with the Merger and to cooperate with Revco with regard to its preparation of any filings required by the HSR Act with respect to the Merger; and

EXCHANGE AGENT

FURTHER RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized in the name and on behalf of CVS, to appoint an Exchange Agent, in accordance with the Merger Agreement, for the purpose of, among other things, exchanging certificates representing shares of common stock of Revco for shares of common stock of CVS to be issued in the Merger. The Exchange Agent shall act under the direction and supervision of the Authorized Officers in all matters arising out of or pertaining to the exchanging of such shares; and

FURTHER RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized, in the name and on behalf of CVS, to execute and deliver an agreement or such other documents in connection with the foregoing resolution, on such terms as such Authorized Officers deem necessary, advisable or appropriate, and that CVS is authorized to pay any and all expenses and fees arising in connection therewith; and

ADVISORS

FURTHER RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized, in the name and on behalf of CVS, to retain such legal, financial, accounting or other advisors, including, without limitation, proxy solicitors, with respect to the Merger as such officers shall deem necessary, advisable or appropriate and to execute, deliver and enter into agreements or such other documents with advisors on such terms as such Authorized Officers deem necessary, advisable or appropriate, and that CVS is


authorized to pay any and all expenses and fees arising in connection therewith; and

GENERAL

FURTHER RESOLVED, that CVS is hereby authorized to pay any and all fees, costs and expenses arising in connection with the registration of the shares of common stock of CVS under the Securities Act and under the securities or Blue Sky laws of various jurisdictions, and otherwise in connection with these resolutions; and

FURTHER RESOLVED, that a11 actions heretofore taken by any officer or director of CVS in connection with any matter referred to in any of the foregoing resolutions are hereby approved, ratified and confirmed in all respects as fully as if such actions had been presented to this Board of Directors for its approval prior to such actions being taken; and

FURTHER RESOLVED, that the Authorized Officers be, and each of them hereby is, authorized, empowered and directed, in the name and on behalf of CVS, to do and perform all such further acts and things including, but not limited to, making all necessary filings with the SEC, preparing and publishing newspaper advertisements or press releases, and executing and delivering, and where necessary or appropriate, filing with the appropriate governmental authorities, a11 such certificates, contracts, bonds, agreements, documents, instruments, receipts or other papers, and making all such payments including payments of all fees and expenses, as in the judgment of such officer shall be necessary, desirable or appropriate to effectuate the Merger, the issuance of the shares of the common stock of CVS pursuant to the Merger Agreement and the transactions contemplated by each of the foregoing resolutions.

RESOLVED, that the authorization (pursuant to the resolution of this Board of Directors, adopted on July 1O, 1996) of CVS Corporation to repurchase, from time to time, in the open market up to two million shares of its common stock, $.01 par value, is hereby revoked and rescinded.


                                    [LOGO]

             [LETTERHEAD OF STATE OF DELAWARE DEPARTMENT OF STATE]

                            GOODSTANDING TELEGRAM

DATE:    MAY 29, 1997

TO:      KAREN COUGHLIN

C/O:     ACCESS INFORMATION SERVICES INC

FAX:     800-388-1599

CORPORATION(S) CVS CORPORATION [26560-76]

IS A DELAWARE CORPORATION IN GOODSTANDING AS OF

____ BEGINNING OF
BUSINESS

X TODAY'S DATE

____ CLOSE OF
BUSINESS

____ AND HAS NO TAXES ASSESSED TO DATE

____ AND HAS PAID TAXES TO DATE

X AND HAS FILED ANNUAL REPORTS AND PAID TAXES

SlGNATURE LINE: EDWARD J. FREEL, SECRETARY OF STATE OF DELAWARE


CERTIFICATE OF TREASURER

I. Philip C. Galbo, Vice President and Treasurer of CVS Corporation, a Delaware corporation (the "Borrower"), do hereby certify, in my capacity as Vice President and Treasurer of the Borrower (and not in my individual capacity) pursuant to Section 5.5 of the Five Year Credit Agreement by and among the Borrower, the lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent and The Bank of New York, as Administrative Agent dated as of May 23, 1997 (the "Credit Agreement") that:

1. The CVS/Revco Merger has been consummated substantially in accordance with the CVS/Revco Merger Documents, with no amendment or waiver of any term or condition thereto.

2. The CVS/Revco Merger has become effective.

3. All representations and warranties contained in the Credit Agreement are true and correct and no Default or Event of Default exists, in each case immediately before and after giving effect to the consummation of the CVS/Revco Merger.

4 Attached hereto is a true and complete copy of the CVS/Revco Merger Documents.

5. Immediately before and after giving effect to the consummation of the CVS/Revco Merger, the Borrower is Solvent.


Terms used in this Certificate and not defined have the meanings assigned to them in the Credit Agreement.

                                                 /s/ Philip C. Galbo
                                                 --------------------------
                                                 Philip C. Galbo
                                                 Vice President and Treasurer

May 30, 1997
-------

2

LODGED WITH THE ADMINISTRATIVE AGENT


[LETTERHEAD OF DAVIS POLK & WARDWELL]

May 30, 1997

The Lenders, the Documentation Agent,
the Syndication Agent and
the Administrative Agent Referred to Below c/o The Bank of New York,
as Administrative Agent
One Wall Street
New York, New York 10286

Ladies and Gentlemen:

We have acted as special New York counsel for CVS Corporation, a Delaware corporation (the "Borrower") in connection with the Five Year Credit Agreement by and among the Borrower, the lenders party thereto (the "Lenders"), Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent and The Bank of New York, as Administrative Agent dated as of May 23, 1997 (the "Credit Agreement"). Capitalized terms not otherwise defined herein shall have the meanings assigned to them in the Credit Agreement.

We have examined originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials and other instruments and have conducted such other investigations of fact and law as we have deemed necessary or advisable for purposes of this opinion. In rendering our opinions set forth below, we have assumed (i) that the Credit Agreement has been duly authorized, executed and delivered by all parties thereto (other than the Borrower), (ii) that the CVS/Revco Merger Documents have been duly authorized, executed and delivered by all parties thereto, (iii) that the CVS/Revco Merger Documents constitute valid and binding obligations of each party thereto and are enforceable in accordance with their respective terms, (iv) the authenticity of all documents submitted to us as originals, (v) the conformity to original documents of all documents submitted to us as copies and (vi) the truth of all factual representations and warranties made by the Borrower in the Credit Agreement.


Based upon the foregoing, and subject to the qualifications set forth below, we are of the opinion that:

1. The Borrower is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware. The Borrower has all requisite corporate power and authority to own its Property and to carry on its business as now conducted.

2. The execution, delivery and performance by the Borrower of the Credit Agreement and the Notes are within the Borrower's corporate powers and have been duly authorized by all necessary corporate action.

3. The execution, delivery and performance by the Borrower of the Credit Agreement and the Notes do not require any action or approval on the part of the shareholders of the Borrower or any action by or in respect of, or filing with, any governmental body, agency or official under United States federal law, New York state law or the Delaware General Corporation Law, and do not contravene, or constitute a default under, any provision of (i) United States federal law, New York State law or the Delaware General Corporation Law, (ii) the Certificate of Incorporation or bylaws of the Borrower or (iii) any agreement listed on Schedule I.

4. The Credit Agreement and the Notes delivered by the Borrower on or prior to the date hereof have been duly executed and delivered by the Borrower and each constitutes the valid and binding agreement of the Borrower, in each case enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or similar laws from time to time in effect affecting the enforcement of creditors' rights generally and to general principles of equity.

5. The consummation of the CVS/Revco Merger does not require any action by or in respect of, or filing with, any governmental body, agency or official under United States federal or New York State law or Delaware General Corporation Law, other than any such actions which have been taken and any such filings which have been made, in each case on or prior to the date hereof and which in each case are in full force and effect on the date hereof.

6. The CVS/Revco Merger has been consummated in accordance with the terms of the CVS/Revco Merger Documents.

7. The Borrower is not an "investment company" (as such term is defined in the Unites States Investment Company Act of 1940, as amended).

The foregoing opinion is subject to the following qualifications:

2

(a) We express no opinion as to the effect (if any) of any law of any jurisdiction (except the State of New York) in which any Lender is located which may limit the rate of interest that such Lender may charge or collect.

(b) We express no opinion as to provisions in the Credit Agreement which purport to create rights of set-off in favor of participants or which provide for set-off to be made otherwise than in accordance with applicable laws.

(c) We note that public policy considerations or court decisions may limit the rights of any party to obtain indemnification under the Credit Agreement.

We are members of the bar of the State of New York and the foregoing opinion is limited to the laws of the State of New York, the federal laws of the United States of America and the Delaware General Corporation Law.

This opinion is rendered solely to you in connection with the above matter. This opinion may not be relied upon by you for any other purpose or relied upon by any other person without our prior written consent, except that any person that becomes a Lender in accordance with the provisions of the Credit Agreement may rely upon this opinion as if it were specifically addressed and delivered to such person on the date hereof.

Very truly yours,

/s/ Davis Polk & Wardwell

3

SCHEDULE I

1. The Other Credit Agreement

2. The Note Purchase Agreement dated as of June 7, 1989 among The Melville Corporation and Subsidiaries Employee Stock Ownership Plan Trust, The Bank of New York, as Trustee and Melville Corporation ("Melville"), as guarantor, as amended by the Amendment thereto dated as of June 23, 1989.

3. Credit Agreement dated as of August 13, 1996 among Footstar, Inc., ("Footstar") the Banks listed on the signature pages thereof, The Bank of New York, as Issuing Bank, and Morgan Guaranty Trust Company of New York, as Administrative Agent and Swingline Lender.

4. Distribution Agreement dated as of September 24, 1996 between Melville, Footstar and Footaction Center, Inc.

5. Tax Disaffiliation Agreement between Melville and Footstar.

6. Transitional Services Agreement dated as of December 2, 1996 between the Borrower and Linens `n Things, Inc. ("Linens").

7. Stockholders Agreement dated as of December 2, 1996 between the Borrower, Nashua Hollis CVS, Inc., and Linens.

8. Tax Disaffiliation Agreement dated as of December 2, 1996 between the Borrower and Linens.

9. Indenture dated as of January 1, 1993 between Revco D.S., Inc. and First Fidelity Bank, National Association, New Jersey, as trustee, as amended by the First Amendment to Indenture dated as of April 20, 1994.

10. Indenture dated as of June 1, 1992 between Hook SupeRx, Inc., and Star Bank, National Association, as trustee.

4

May 30, 1997

The Lenders, the Documentation Agent,
the Syndication Agent and
the Administrative Agent Referred to Below c/o The Bank of New York,
as Administrative Agent
One Wall Street
New York, New York 10286

Ladies and Gentlemen:

I am general counsel of CVS Corporation, a Delaware corporation (the "Borrower"), and have acted as such in connection with the Five Year Credit Agreement by and among the Borrower, the lenders party thereto, Fleet National Bank. as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent and The Bank of New York, as Administrative Agent dated as of May 23, 1997 (the "Credit Agreement"). Capitalized terms not otherwise defined herein shall have the meanings assigned to them in the Credit Agreement.

I have examined originals or copies, certified or otherwise identified to my satisfaction, of such documents, corporate records, certificates of public officials and other instruments and have conducted such other investigations of fact and law as I have deemed necessary or advisable for purposes of this opinion. In rendering my opinions set forth below, I have assumed (i) the authenticity of all documents submitted to me as originals and
(ii) the conformity to original documents of all documents submitted to me as copies.

Based upon the foregoing, I am of the opinion that:

1. The Borrower is qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which it owns or leases real Property or in which the nature of its business requires it to be so qualified (except those jurisdictions where the failure to be so qualified or to be in good standing could not reasonably be expected to have a Material Adverse effect).

2. Except as set forth on Schedule 4.4 to the Credit Agreement, to the best of my knowledge, there are no actions, suits, arbitration proceedings or claims


(whether purportedly on behalf of the Borrower, any Subsidiary or otherwise)
pending or threatened against the Borrower or any Subsidiary or any of their respective Properties, or maintained by the Borrower or any Subsidiary, at law or in equity, before any Governmental Authority which could reasonably be expected to have a Material Adverse effect. To the best of my know1edge, there are no proceedings pending or threatened against the Borrower or any Subsidiary
(a) which call into question the validity or enforceability of, or otherwise seek to invalidate, any Loan Document or invalidate or prevent the consummation of the CVS/Revco Merger, or (b) which might, individually or in the aggregate, materially and adversely affect any of the transactions contemplated by any Loan Document or materially and adversely affect the CVS/Revco Merger.

3. To the best of my knowledge, the Borrower is not in default under any agreement to which it is a party or by which it or any of its Property is bound the effect of which could reasonably be expected to have a Material Adverse effect.

4. To the best of my knowledge, no provision of any judgment, decree or order, in each case binding on the Borrower or any Subsidiary or affecting the Property of the Borrower or any Subsidiary conf1icts with, or requires any consent which has not already been obtained under, or would in any way prevent the execution, delivery or performance by the Borrower of the terms of, any Loan Document.

I am a member of the bar of the Commonwealth of Massachusetts and the foregoing opinion is limited to the laws of the Commonwealth of Massachusetts.

This opinion is rendered solely to you in connection with the above matter. This opinion may not be relied upon by you for any other purpose or relied upon by any other person without our prior written consent, except that any person that becomes a Lender in accordance with the provisions of the Credit Agreement may rely upon this opinion as if it were specifically addressed and delivered to such person on the date hereof.

Very truly yours,

/s/ [illegible]

2

[LETTERHEAD OF EMMET, MARVIN & MARTIN, LLP]

May 30, 1997

TO THE LENDERS PARTY TO THE CREDIT
AGREEMENT (AS DEFINED BELOW)

Re: Five Year Credit Agreement, dated as of May 30, 1997, by and among CVS Corporation, the Lenders party thereto, Fleet National Bank, as Documentation Agent, JP Morgan Securities Inc., as Syndication Agent, and The Bank of New York, as Administrative Agent (the Agreement")

We have acted as Special Counsel to the Administrative Agent in connection with the Agreement. Capitalized terms used herein that are not defined herein shall have the respective meanings ascribed thereto in the Agreement.

We have examined originals or copies certified to our satisfaction of the documents required to be delivered pursuant to the provisions of Section 5 of the Agreement. In conducting such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, and the conformity to originals of all documents submitted to us as copies.

Based upon the foregoing examination, and (1) assuming with your permission the accuracy of the opinions of Zenon Lankowsky, General Counsel to the Borrower, and Davis Polk & Wardwell, special New York counsel to the Borrower, and (2) relying with your permission upon the representations and warranties of the Borrower contained in the Agreement, we are of the opinion that all legal preconditions to the effectiveness of the Agreement have been satisfactorily met.

This opinion is rendered solely for your benefit in connection with the transactions referred to herein and may not be relied upon by any other Person.

We express no opinion as to laws other than the laws of the State of New York and the federal laws of the United States of America.

Very truly yours,

/s/ Emmet Marvin & Martin LLP


CONFORMED COPY


THE MELVILLE CORPORATION AND SUBSIDIARIES EMPLOYEE

STOCK OWNERSHIP PLAN TRUST, As Issuer

MELVILLE CORPORATION, As Guarantor


NOTE PURCHASE AGREEMENT

8.60% ESOP Notes Due 2008

($357,500,000)


Dated as of June 7, 1989


TABLE OF CONTENTS

(Not Part of Agreement)

                                                                                  Page
                                                                                  ----
1.   Authorization of Notes. . . . . . . . . . . . . . . . . . . . . . . . . . . . .1

2.   Purchase and Sale of Notes; Closing . . . . . . . . . . . . . . . . . . . . . .2

3.   Conditions to Closing . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2
     3A.  Opinions of Counsel. . . . . . . . . . . . . . . . . . . . . . . . . . . .3
     3B.  Representations and Warranties; No Default . . . . . . . . . . . . . . . .3
     3C.  Purchase Permitted by Applicable Laws. . . . . . . . . . . . . . . . . . .3
     3D.  ESOT Transaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
     3E.  Compliance with Securities Laws. . . . . . . . . . . . . . . . . . . . . .4
     3F.  Approvals and Consents . . . . . . . . . . . . . . . . . . . . . . . . . .4
     3G.  Proceedings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5
     3H.  Sale of Notes to Other Purchasers. . . . . . . . . . . . . . . . . . . . .5

4.   Payments. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5
     4A.  Required Installment Payments. . . . . . . . . . . . . . . . . . . . . . .5
     4B.  Optional Prepayment. . . . . . . . . . . . . . . . . . . . . . . . . . . .5
     4C.  Notice of Prepayments. . . . . . . . . . . . . . . . . . . . . . . . . . .6
     4D.  Acquisition or Retirement of Notes . . . . . . . . . . . . . . . . . . . .6

5.   Affirmative Covenants . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6
     5A.  Financial Statements and Other Reports . . . . . . . . . . . . . . . . . .7
     5B.  Inspection of Property . . . . . . . . . . . . . . . . . . . . . . . . . .9
     5C.  Payment of Taxes and Claims. . . . . . . . . . . . . . . . . . . . . . . 10
     5D.  Corporate Existence. . . . . . . . . . . . . . . . . . . . . . . . . . . 10
     5E.  Maintenance of Properties. . . . . . . . . . . . . . . . . . . . . . . . 10
     5F.  Determination Letter . . . . . . . . . . . . . . . . . . . . . . . . . . 11
     5G.  Plan Existence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
     5H.  Application of Proceeds. . . . . . . . . . . . . . . . . . . . . . . . . 12

6.   Negative Covenants. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
     6A.  Restrictions on Senior Funded Debt . . . . . . . . . . . . . . . . . . . 12
     6B.  Restrictions upon Secured Debt . . . . . . . . . . . . . . . . . . . . . 13
     6C.  Restrictions upon Sale and Leaseback Transactions. . . . . . . . . . . . 15
     6D.  Restrictions on Funded Debt of Restricted Subsidiaries . . . . . . . . . 15
     6E.  Permitted Financing Transactions . . . . . . . . . . . . . . . . . . . . 16
     6F.  Consolidation, Merger, Conveyance, Transfer or Lease . . . . . . . . . . 16


                                          i

                                  TABLE OF CONTENTS (cont'd)

                                                                                  Page
                                                                                  ----

7.   Income Taxation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
     7A.  Additional Payments. . . . . . . . . . . . . . . . . . . . . . . . . . . 17
     7B.  Supplemental Payments. . . . . . . . . . . . . . . . . . . . . . . . . . 19
     7C.  Payment Dates. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
     7D.  Interest Rate Adjustment . . . . . . . . . . . . . . . . . . . . . . . . 20
     7E.  Refunds. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
     7F.  Contest of Disallowance of Section 133 Exclusion . . . . . . . . . . . . 22
     7G.  Request for Qualifying Opinion of Counsel. . . . . . . . . . . . . . . . 24

8.   Company Guarantee and Purchase Obligation . . . . . . . . . . . . . . . . . . 25
     8A.  Guarantee by the Company . . . . . . . . . . . . . . . . . . . . . . . . 25
     8B.  Purchases of Notes by the Company. . . . . . . . . . . . . . . . . . . . 28
     8C.  Issuance of Notes by the Company . . . . . . . . . . . . . . . . . . . . 30
     8D.  Excess Allocation and Note Exchange. . . . . . . . . . . . . . . . . . . 31

9.   Events of Default . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
     9A.  Default; Acceleration. . . . . . . . . . . . . . . . . . . . . . . . . . 32
     9B.  Other Remedies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
     9C.  Rescission of Acceleration . . . . . . . . . . . . . . . . . . . . . . . 37
     9D.  Limited Recourse . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38

10. Representations and Warranties . . . . . . . . . . . . . . . . . . . . . . . . 38
     10A. Organization; Corporate Authority. . . . . . . . . . . . . . . . . . . . 38
     10B. Financial Statements; SEC Reports. . . . . . . . . . . . . . . . . . . . 39
     10C. Actions Pending. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
     10D. Taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
     10E. Title to Property. . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
     10F. Conflicting Agreements and Other Matters . . . . . . . . . . . . . . . . 42
     10G. Offering of Notes. . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
     10H. Broker's or Finder's Commissions . . . . . . . . . . . . . . . . . . . . 42
     10I. Margin Regulations . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
     10J. Investment Company Act . . . . . . . . . . . . . . . . . . . . . . . . . 43
     10K. Public Utility Holding Company Act . . . . . . . . . . . . . . . . . . . 43
     10L. Governmental Consents, etc.. . . . . . . . . . . . . . . . . . . . . . . 43
     10M. ERISA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
     10N. The Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
     10O. Representations as to the Trustee. . . . . . . . . . . . . . . . . . . . 46
     10P. Pollution and Other Regulations. . . . . . . . . . . . . . . . . . . . . 47


                                          ii

                                  TABLE OF CONTENTS (cont'd)

                                                                                  Page
                                                                                  ----

11.  Representations of Purchaser. . . . . . . . . . . . . . . . . . . . . . . . . 47

12. Definitions and Accounting Matters, etc. . . . . . . . . . . . . . . . . . . . 48
     12A. Yield-Maintenance Terms. . . . . . . . . . . . . . . . . . . . . . . . . 48
     12B. Other Defined Terms. . . . . . . . . . . . . . . . . . . . . . . . . . . 51
     12C. Accounting Terms and Determinations. . . . . . . . . . . . . . . . . . . 63

13. Judicial Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
     13A. Consent to Jurisdictions . . . . . . . . . . . . . . . . . . . . . . . . 63
     13B. Enforcement of Judgements. . . . . . . . . . . . . . . . . . . . . . . . 63
     13C. Service of Process . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
     13D. No Limitation on Service or Suit . . . . . . . . . . . . . . . . . . . . 64

14. Miscellaneous. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
     14A. Note Payments. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
     14B. Expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
     14C. Consent to Amendments. . . . . . . . . . . . . . . . . . . . . . . . . . 66
     14D. Form, Registration, Transfer and Exchange of Notes; Lost Notes . . . . . 67
     14E. Persons Deemed Owners; Participations  . . . . . . . . . . . . . . . . . 68
     14F. Survival of Representations and Warranties; Entire Agreement . . . . . . 68
     14G. Successors and Assigns . . . . . . . . . . . . . . . . . . . . . . . . . 68
     14H. Disclosure to Other Persons. . . . . . . . . . . . . . . . . . . . . . . 68
     141. Notices. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
     14J. Descriptive Headings . . . . . . . . . . . . . . . . . . . . . . . . . . 69
     14K. Satisfaction Requirement . . . . . . . . . . . . . . . . . . . . . . . . 69
     14L. Governing Law. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
     14M. Counterparts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
     14N. Reproduction of Documents. . . . . . . . . . . . . . . . . . . . . . . . 70
     14O. Trustee Liability. . . . . . . . . . . . . . . . . . . . . . . . . . . . 70

PURCHASER SCHEDULE

EXHIBIT A-1  - Form of Note
EXHIBIT A-2  - Amortization of Principal
EXHIBIT B-1  - [Intentionally left blank]
EXHIBIT B-2  - Form of Opinion of Company Counsel
EXHIBIT B-3  - Form of Opinion of Counsel to the ESOT
EXHIBIT B-4  - Form of Opinion of Willkie Farr & Gallagher
EXHIBIT C  - Form of Company Note

iii

THE MELVILLE CORPORATION AND SUBSIDIARIES EMPLOYEE
STOCK OWNERSHIP PLAN TRUST
The Bank Of New York, as Trustee
48 Wall Street
New York, New York 10528

MELVILLE CORPORATION
3000 Westchester Avenue
Harrison, New York 10528

June 7,1989

To the Purchaser accepting this Agreement on the signature page hereof

Ladies and Gentlemen:

The undersigned, Melville Corporation, a New York corporation (the "Company"), and the trust established by the Melville Corporation and Subsidiaries Employee Stock Ownership Plan Trust Agreement (the "ESOT") of the Melville Corporation and Subsidiaries Employee Stock Ownership Plan, an employee stock ownership plan under section 407(d)(5) of ERISA and Section 4975(e) of the Code (the "Plan"), hereby agree with you as follows:

1. AUTHORIZATION OF NOTES. The ESOT will authorize the issuance, sale and delivery of $357,500,000 aggregate principal amount of its 8.60% ESOP Notes (herein, together with any such notes that may be issued pursuant to any provision of this Agreement and any such notes that may be issued hereunder in substitution or exchange therefor, collectively called the "Notes" and individually called a "Note") to be dated the date of issue thereof, to bear interest on the unpaid principal balance thereof from the date thereof until the principal balance thereof shall become due and payable at the rate of 8.60% per annum (subject to the provisions of paragraph 7) and on overdue principal, premium and interest at the rate specified therein, which Notes, when issued, sold and delivered pursuant to this Agreement, will be substantially in the form of Exhibit A-1. Interest on the Notes will be payable on December 31, 1989, October 31, 1990, October 31, 1991 and October 31, 1992 and December 31, 1993 and each December 31 thereafter until the principal amount of the Notes shall have been paid in full and will be computed based on a 360-day year comprised of 12 months of 30 days each.

Certain capitalized terms used in this Agreement are defined in paragraph 12; references to a paragraph are, unless otherwise specified, to one of the


paragraphs of this Agreement and references to an "Exhibit" are, unless otherwise specified, to one of the exhibits attached to this Agreement.

2. PURCHASE AND SALE OF NOTES; CLOSING. The ESOT hereby agrees to sell to you and, subject to the terms and conditions herein set forth, you agree to purchase from the ESOT, Notes in the principal amount set forth opposite your name in the Purchaser Schedule attached hereto, in the form of one or more Notes registered in your name or that of your nominee, as you shall request, and in such denominations as you shall request, for an aggregate purchase price of 100% of the principal amount thereof.

The issuance, sale and delivery of the Notes to be purchased by you shall take place at 10:00 A.M., New York time, on June 23, 1989, at the offices of Willkie Farr & Gallagher, 153 East 53rd Street, New York, New York, or on such other date as the Company, the ESOT, you and the Other Purchasers may agree (the "Closing"). At the Closing, the ESOT will deliver to you the Notes to be purchased by you, against payment of the purchase price therefor (and fulfillment of the requirements of paragraph 3H as to the Other Purchasers) by wire transfer of immediately available funds to The Bank of New York, as Trustee (ABA No. 021000018) for credit to the account of Melville Corporation and Subsidiaries Employee Stock Ownership Trust. If at the Closing the ESOT shall fail to tender to you the Notes to be purchased by you as provided above in this paragraph 2, or any of the conditions specified in paragraph 3 shall not have been satisfied or waived by you, you shall, at your election, be relieved of all further obligations under this Agreement, without thereby waiving any other rights you may have by reason of such failure or such non-fulfillment.

Concurrently with the execution and delivery of this Agreement, the ESOT and the Company are entering into other Note Purchase Agreements (herein called the "Other Note Agreements") identical to this Agreement (except as to the identity of the purchaser and the principal amount of Notes to be purchased) with the other purchasers (herein called the "Other Purchasers") named in the Purchaser Schedule attached hereto. The sale of the Notes to you and to the Other Purchasers are to be separate and several sales.

3. CONDITIONS TO CLOSING. Your obligation to purchase and pay for the Notes to be purchased by you at the Closing is subject to the satisfaction or waiver, prior to or simultaneously and concurrently with the Closing, of the following conditions:

3A. OPINIONS OF COUNSEL. You shall have received from (i) Davis Polk & Wardwell, counsel for the Company, a favorable opinion satisfactory in form and substance to you in your sole discretion, (ii)(a) the General Attorney or

2

Assistant General Attorney of the Company, (b) Winthrop, Stimson, Putnam & Roberts, counsel to the ESOT and (c) Willkie Farr & Gallagher, your special counsel in connection with the transactions contemplated by this Agreement, favorable opinions substantially in the forms set forth in Exhibits B-2, B-3 and B-4, respectively, each dated the date of the Closing and addressed to you. To the extent that any opinion referred to above in this paragraph 3A is rendered in reliance upon the opinion of any other counsel, you shall have received a copy of the opinion of such other counsel, dated the date of the Closing and addressed to you, or a letter from such other counsel, dated the date of the Closing and addressed to you, authorizing you to rely on such other counsel's opinion.

3B. REPRESENTATIONS AND WARRANTIES; NO DEFAULT. The representations and warranties of the ESOT and the Company contained in this Agreement shall be true when made and at the time of the Closing in all material respects, and there shall exist at the time of the Closing and after giving effect to the transactions contemplated hereby, no Event of Default, Default, Purchase Event or ESOT Event. The Company shall have delivered to you an Officer's Certificate, dated the date of the Closing, to all such effects and further as to the satisfaction of the conditions (other than any condition that any matters or documents be in form and substance satisfactory to you) set forth in paragraph 3D and the ESOT shall have delivered to you a certificate, dated the date of the Closing, to the same effect as such Officer's Certificate, but limited to matters pertaining to the ESOT.

3C. PURCHASE PERMITTED BY APPLICABLE LAWS. The purchase of and payment for the Notes to be purchased by you on the date of Closing on the terms and conditions herein provided (including the use of the proceeds of such Notes by the ESOT) shall not violate any applicable law or governmental regulation (including, without limitation, section 5 of the Securities Act or Regulation G, T, U or X of the Board of Governors of the Federal Reserve System) or result in a violation of any order of any court or governmental body applicable to you (or any of your employees, directors or affiliates) and shall not subject you to any tax, penalty, liability or other onerous condition under or pursuant to any applicable law or governmental regulation or order, and you shall have received such certificates or other evidence as you may request to establish compliance with this condition.

3D. ESOT TRANSACTION. Prior to the Closing you shall have received complete and correct copies of the Plan Documents and all other documents and instruments having the legal effect of governing the terms or administration of the Plan or the ESOT, and all the terms and provisions thereof shall be satisfactory to you in form and substance (including schedules and exhibits thereto); all such agreements, documents and instruments shall be in full force and effect and no

3

term or condition thereof shall have been amended, modified or waived except with your prior consent; the Trustee shall have made appropriate determinations satisfactory to you establishing that neither the sale of the Notes to you nor the purchase of the Employer Capital Stock as contemplated by the Stock Purchase Agreement nor the consummation of the transactions contemplated by this Agreement is or will constitute a "prohibited transaction" as such term is defined in section 406 of ERISA or section 4975 of the Code; and the purchase of Employer Capital Stock in the ESOT Transaction shall be duly and validly consummated concurrently with the Closing hereunder. Except as affected by the transactions contemplated hereby, all conditions precedent to the consummation of the transactions contemplated by the Plan Documents shall have occurred, all governmental authorizations, consents, approvals, exemptions or other actions required in connection with such transactions shall have been duly received (except for the determination letter from the IRS described in paragraph 5F) and such transactions shall have been consummated substantially in accordance with the terms of such documents. All material matters relating to the ESOT, including, without limitation, the amount and the deductibility of contributions by the Company to the ESOT, the use and sufficiency of such contributions to pay the Notes and the excludibility of 50% of the interest paid by the ESOT on the Notes from your Federal Gross Income, shall be satisfactory to you.

3E. COMPLIANCE WITH SECURITIES LAWS. The issuance, sale and delivery of the Notes under this Agreement and of the Employer Capital Stock in the ESOT Transaction shall have complied in all material respects with all applicable requirements of Federal and state securities laws, and you shall have received evidence of such compliance in form and substance reasonably satisfactory to you.

3F. APPROVALS AND CONSENTS. The ESOT and the Company shall each have duly received all authorizations, consents, approvals, licenses, franchises, permits and certificates by or of all Federal, state and local governmental authorities necessary for the issuance, sale and delivery of the Notes pursuant to this Agreement and of the Employer Capital Stock in the ESOT Transaction ("Approvals and Consents"), and all Approvals and Consents shall be in full force and effect at the time of Closing and shall be effective to permit each such issuance, sale and delivery, and you shall have received such certificates or other evidence as you may reasonably request to establish compliance with this condition.

3G. PROCEEDINGS. All corporate and other proceedings taken or to be taken in connection with the transactions contemplated hereby, and all documents incident thereto shall be satisfactory in form and substance to you and your special counsel, and you and your special counsel shall have received all such

4

counterpart originals or certified or other copies of such documents as you or they may reasonably request.

3H. SALE OF NOTES TO OTHER PURCHASERS. The ESOT shall, concurrently with your purchase of Notes hereunder, sell to the Other Purchasers the Notes to be purchased by them at the Closing as provided in the Other Note Agreements on terms which are identical to the terms for your purchase hereunder and shall receive payment in full therefor.

4. PAYMENTS. The Notes shall be subject to payment with respect to the Required Installment Payments specified in paragraph 4A and shall be subject to prepayment under the circumstances set forth in paragraph 4B.

4A. REQUIRED INSTALLMENT PAYMENTS. The principal amount of the Notes will be due and payable in installment payments, as set forth on Exhibit A-2. Each such installment payment is herein called a "Required Installment Payment". Upon any partial prepayment of Notes pursuant to paragraph 4B, or any partial retirement, purchase or other acquisition of Notes by the ESOT or the Company, its Subsidiaries or Affiliates (whether pursuant to paragraph 4D or paragraph
8), the amount of each subsequent Required Installment Payment applicable to the Notes shall be reduced by an amount equal to the product obtained by multiplying
(x) the aggregate principal amount of the Notes so prepaid, retired, purchased or acquired by (y) a fraction the numerator of which is the amount of such Required Installment Payment and the denominator of which is the unpaid principal balance of the Notes immediately prior to such prepayment, retirement, purchase or acquisition, as the case may be. Each Required Installment Payment shall be allocated and applied to all Notes at the time outstanding in proportion to the respective outstanding principal amounts thereof and shall be set forth in the amortization schedule appended to each Note as provided in Exhibit A-2.

4B. OPTIONAL PREPAYMENT. The Notes shall be subject to prepayment, at any time in whole, or from time to time in part (in a minimum aggregate principal amount of $1,000,000), at the option of the ESOT, at 100% of the principal amount thereof to be prepaid, together with accrued interest thereon to the prepayment date and the Yield-Maintenance Premium, if any, with respect to the amount so prepaid. Upon any partial prepayment of the Notes pursuant to this paragraph 4B, the principal amount so prepaid shall be allocated to all Notes at the time outstanding in proportion to the respective outstanding principal amounts thereof.

4C. NOTICE OF PREPAYMENTS. The ESOT shall give each holder of Notes irrevocable written notice of any prepayment of the Notes pursuant to

5

paragraph 4B not less than 30 days prior to the prepayment date, specifying such prepayment date and the principal amounts of the Notes and of the Notes held by such holder to be prepaid on such date and stating that such prepayment is being made pursuant to paragraph 4B, whereupon the principal amount of the Notes to be prepaid, together with interest accrued thereon to the prepayment date and the Yield-Maintenance Premium, if any, with respect to each Note, shall become due and payable on such prepayment date.

4D. ACQUISITION OR RETIREMENT OF NOTES. The Company will not, and will not permit any of its Subsidiaries or Affiliates to, and the ESOT will not, retire in whole or in part prior to their stated maturity, or purchase or otherwise acquire, directly or indirectly, (other than by payment pursuant to paragraph 4A, prepayment pursuant to paragraph 4B or purchase or exchange pursuant to paragraph 8B, 8C or 8D or upon acceleration pursuant to paragraph 9A), Notes held by any holder unless the Company or such Subsidiary or Affiliate or the ESOT shall have offered in writing to retire or purchase or otherwise acquire, as the case may be, the same proportion of the aggregate principal amount of Notes held by each other holder of Notes at the time outstanding upon the same terms and conditions. To the extent that any holder of the Notes declines such offer (or shall fail to accept such offer within the time period specified therein, which shall be not less than 10 Business Days), the Company or such Subsidiary or Affiliate or the ESOT may purchase or otherwise acquire Notes (again pro rata and on the same terms as aforesaid) from other holders of Notes. Any Notes retired, purchased or otherwise acquired by the Company or any of its Subsidiaries or Affiliates or the ESOT shall not be deemed to be outstanding for any purpose under this Agreement.

5. AFFIRMATIVE COVENANTS. The provisions of this paragraph 5 shall remain in effect from the date hereof and thereafter so long as any Note shall remain outstanding.

5A. FINANCIAL STATEMENTS AND OTHER REPORTS. The Company covenants that it will deliver to each Significant Holder of a Note in quadruplicate:

(i) as soon as is practicable and in any event within 45 days after the end of each quarterly period (other than the last quarterly period) in each fiscal year commencing with the first such quarter ending after the date of the Closing, consolidated statements of income and of cash flow of the Company and its Subsidiaries for such quarterly period, and a consolidated balance sheet of the Company and its Subsidiaries as at the end of such quarterly period, setting forth in each case in comparative form, figures for the corresponding quarter in the preceding fiscal year, all

6

in reasonable detail and certified as complete and correct and prepared in accordance with generally accepted accounting principles by an authorized financial officer of the Company, subject to changes resulting from year-end adjustments; provided, however, that delivery of substantially the same financial statement information that is required by a Quarterly Report on Form 10-Q of the Company for such quarterly period as such form is in effect on the date hereof under the Exchange Act shall be deemed to satisfy the requirements of this clause (i);

(ii) as soon as practicable and in any event within 90 days after the end of each fiscal year, consolidated statements of income and of cash flow of the Company and its Subsidiaries for such year, and a consolidated balance sheet of the Company and its Subsidiaries as at the end of such year, setting forth in each case in comparative form, corresponding consolidated figures from the preceding annual audited financial statements, all in reasonable detail and reasonably satisfactory in scope to the Required Holder(s), and accompanied by an opinion addressed to the Company of independent public accountants of recognized national standing selected by the Company whose opinion shall be in scope and substance reasonably satisfactory to the Required Holder(s) (it being agreed that the form of opinion included in the Historical Financial Statements is satisfactory); provided, however, that delivery of substantially the same financial statement information that is required by an Annual Report on Form 10-K (including all incorporated documents) of the Company for such fiscal year as such form is in effect on the date hereof under the Exchange Act shall be deemed to satisfy the requirements of this clause (ii);

(iii) promptly upon transmission thereof, copies of all such financial statements, proxy statements, notices and reports as it shall send to its public stockholders and copies of all registration statements (without exhibits), other than on Form S-8 or any similar successor form (except to the extent any such registration statement on Form S-8 relates to any offer or sale of securities held by the Plan), and all public reports which it files with the Commission;

(iv) promptly upon its becoming available and in any event within 30 days after such time as such reports are required to be filed with the IRS, a copy of the annual report of the Plan on Form 5500;

(v) promptly upon their becoming available, copies of the Annual Report on Form 11-K of the Plan as filed with the Commission;

7

(vi) promptly following the Company's obtaining knowledge thereof, a notice of the occurrence of any event that could, in the reasonable judgment of the Company, be expected to give rise to a change in the interest rate applicable to the Notes or the payment of any amount by the ESOT pursuant to paragraph 7;

(vii) promptly upon receipt thereof by the Company or any of its Subsidiaries, copies of all reports submitted to the Company or any of its Subsidiaries by independent public accountants in connection with each annual, interim or special audit of the books of the Company or any of its Subsidiaries made by such accountants, including, without limitation, any comment letter submitted by such accountants to management in connection with their annual audit, but only if such report or letter refers to material weakness in the Company's accounting procedures or controls;

(viii) with reasonable promptness, such other financial data with respect to the Company or any of its Subsidiaries as from time to time may be reasonably requested by such Significant Holder.

Together with each delivery of financial statements required by clauses (i) and (ii) above, the Company will deliver to each holder of Notes an Officer's Certificate demonstrating (with computations in reasonable detail) compliance by the Company and its Subsidiaries with the provisions of paragraphs 6A, 6B, 6C, 6D and 6E and stating that there exists no Event of Default, Default, ESOT Event or Purchase Event, or, if any Event of Default, Default, ESOT Event or Purchase Event exists, specifying the nature and period of existence thereof and what action the Company has taken or proposes to take with respect thereto. Together with each delivery of financial statements required by clause (ii) above, the Company will deliver to each holder of Notes a certificate of such accountants stating that, in conducting the audit necessary to certify such financial statements, they have obtained no knowledge of any Default, Event of Default, ESOT Event or Purchase Event, or, if they have obtained knowledge of any Default, Event of Default, ESOT Event or Purchase Event, specifying the nature and period of existence thereof. Such accountants, however, shall not be liable to anyone by reason of their failure to obtain knowledge of any Default, Event of Default, ESOT Event or Purchase Event which would not be disclosed in the course of an audit conducted in accordance with generally accepted auditing standards. The Company also covenants that forthwith upon the chief executive officer, chief operating officer, principal financial officer, principal accounting officer or treasurer of the Company obtaining actual knowledge of any Default, Event of Default, ESOT Event or Purchase Event, it will deliver to each holder of Notes an Officer's Certificate specifying the nature and period of existence thereof and what action the Company proposes to take with respect thereto.

8

5B. INSPECTION OF PROPERTY. The Company covenants that it will permit any authorized representative designated by you or any other Significant Holder, at such Significant Holder's expense, to visit and inspect any of the properties of the Company, including its financial and accounting records, and to make copies and take extracts therefrom, and to discuss the affairs, finances and accounts of the Company and its Subsidiaries with the Company's officers and, in or outside of the presence of any officers or employees of the Company, with the independent public accountants of the Company, all upon reasonable notice and at such reasonable times during normal business hours and as often as may be reasonably requested.

5C. PAYMENT OF TAXES AND CLAIMS. The Company covenants that it will pay or discharge, or cause to be paid or discharged, before the same shall become delinquent (i) all taxes, assessments and governmental charges (including claims of the IRS and the PBGC and claims made at the instance of the PBGC) levied or imposed upon it or its Subsidiaries or upon its or their income, profits or property, except where non-payment would not (either individually or in the aggregate) have a material adverse effect on the Company and its Subsidiaries taken as a whole or the ability of the Company to perform and satisfy its obligations under this Agreement, (ii) all lawful claims for labor, materials and supplies, which, if unpaid, might by law become a lien upon its or its Subsidiaries properties, except where non-payment would not (either individually or in the aggregate) have a material adverse effect on the Company and its Subsidiaries taken as a whole or the ability of the Company to perform and satisfy its obligations under this Agreement and (iii) all required installments under section 412(m) of the Code and all other required payments under section 412 of the Code with respect to any pension plan maintained by the Company or a Code Affiliate; provided, however, that the Company shall not be required to pay or discharge or cause to be paid or discharged any such tax, assessment, charge or claim whose amount, applicability or validity is being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance with generally accepted accounting principles.

5D. CORPORATE EXISTENCE. Subject to paragraph 6F, the Company covenants that it will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence, rights (charter and statutory) and franchises; provided, however, that the Company shall not be required to preserve any such right or franchise if the Board of Directors shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Company and that the loss thereof is not disadvantageous in any material respect to the holders of the Notes.

9

5E. MAINTENANCE OF PROPERTIES. The Company covenants that it will cause all properties of material value used or useful in the conduct of its business or the business of any Subsidiary to be maintained and kept in good condition, repair and working order and supplied with all necessary equipment and will cause to be made all necessary repairs, renewals, replacements, betterments and improvements thereof, all as in the judgment of the Company may be necessary so that the business carried on in connection therewith may be properly and advantageously conducted at all times; provided, however, that nothing in this paragraph 5E shall prevent the Company from discontinuing the operation or maintenance of any of such properties if such discontinuance is, in the judgment of the Company, desirable in the conduct of its business or the business of any Subsidiary and not disadvantageous in any material respect to the holders of the Notes.

5F. DETERMINATION LETTER. The Company covenants that it will promptly (and in no event later than August 31, 1989) apply for, and use its best efforts to obtain and deliver to each holder of Notes as promptly as practicable, a determination letter from the IRS to the effect that the Plan meets the requirements for qualification under sections 401(a) and 4975(e)(7) of the Code and the ESOT meets the requirements for tax exemption under section 501(a) of the Code and that it will comply with any reasonable request from any Indemnitee for assistance in establishing the status of the Plan as an "employee stock ownership plan" under Section 4975(e)(7) of the Code or the status of any Note as a "securities acquisition loan" under section 133 of the Code.

5G. PLAN EXISTENCE. (a) Unless and until the Board of Directors of the Company shall have determined, by resolution, that it is no longer in the best interests of the Company to maintain the ESOT, each of the Company and the ESOT covenants that it will:

(i) do all things necessary to comply with the requirements for an "exempt loan" to the ESOT as defined in Treasury Regulation sections 54.4975-7 and 54.4975-11 and the requirements, if any, that may be promulgated from time to time with respect to section 133 of the Code;

(ii) do all things necessary to maintain and keep in full force and effect the Plan as an "employee stock ownership plan", within the meaning of section 4975(e)(7) of the Code and section 407(d)(6) of ERISA;

(iii) cause the Plan and the ESOT to be operated and administered at all times and be amended as necessary so as to remain qualified under sections 401(a) and 4975(e)(7) of the Code and the ESOT to remain tax-exempt under section 501(a) of the Code;

10

(iv) cause all other actions to be taken which are necessary for the Plan and the ESOT to be in material compliance with all applicable requirements of ERISA including Titles I and II thereof) and the Code and the regulations thereunder as from time to time in effect and applicable to the Plan and the ESOT; and

(v) take no action to amend or otherwise modify any Plan Document in a manner, or take any other action, that would result in the extension of credit represented by the Notes ceasing to qualify as a "securities acquisition loan" within the meaning of section 133(b) of the Code.

(b) From and after such time as the Board of Directors of the Company shall have determined that it is no longer in the best interests of the Company to maintain the ESOT, the Company shall forthwith terminate the ESOT in accordance with the requirements of ERISA, the Code, the rules and regulations promulgated thereunder, and all other requirements of law.

5H. APPLICATION OF PROCEEDS. The Company and the ESOT covenant that the ESOT will apply the entire proceeds of the issuance and sale of the Notes to acquire, at not more than adequate consideration (within the meaning of Section 3(18) of ERISA), Employer Capital Stock from the Company. The ESOT and the Company will furnish to you, if required in connection with your purchase of the Notes hereunder, a statement in conformity with applicable margin requirements of the Federal Reserve under Regulation G or U.

6. NEGATIVE COVENANTS. The provisions of this paragraph 6 shall remain in effect from the date hereof and thereafter so long as any Note shall remain outstanding.

6A. RESTRICTIONS ON SENIOR FUNDED DEBT. The Company may not, nor may it permit any Restricted Subsidiary to, create, issue, incur, assume or guarantee any Senior Funded Debt (otherwise than in connection with renewals, extensions or refundings of Senior Funded Debt at the time outstanding which do not increase the aggregate outstanding principal amount thereof) or sell, transfer or otherwise dispose of any Senior Funded Debt of a Restricted Subsidiary, unless, after giving effect thereto and to the retirement of any Senior Funded Debt to be retired substantially concurrently therewith, the aggregate amount of Senior Funded Debt of the Company and its Restricted Subsidiaries outstanding, determined on a consolidated basis, is less than or equal to 50% of Long-Term Capitalization of the Company and its Restricted Subsidiaries.

11

6B. RESTRICTIONS UPON SECURED DEBT. Except as expressly permitted by paragraph 6E, the Company will not, nor will it permit any Restricted Subsidiary to, create, issue, incur, assume or guarantee any Debt secured by a Mortgage upon any Principal Property of the Company or any Restricted Subsidiary or on any shares of stock or indebtedness of any Restricted Subsidiary (whether such Principal Property, shares of stock or indebtedness is now owned or hereafter acquired); without, in any such case effectively providing, concurrently with the issuance, assumption or guarantee of any such Debt, that the Company's obligations under paragraph 8 (the "Company Obligations") and any outstanding Company Notes (together with, if the Company shall so determine, any other Debt of or guaranteed by the Company or such Restricted Subsidiary then existing or thereafter created ranking equally with the Company Obligations) shall be secured equally and ratably with such Debt provided, however, that the foregoing restrictions shall not apply to:

(i) Mortgages on property, shares of stock or indebtedness existing at the time of the acquisition thereof by the Company or such Restricted Subsidiary;

(ii) Mortgages on property of a corporation existing at the time such corporation is merged into or consolidated with the Company or a Restricted Subsidiary or at the time of a purchase, lease or other acquisition of the property of a corporation or an operating division thereof as an entirety or substantially as an entirety by the Company or a Restricted Subsidiary;

(iii) Mortgages on property, shares of stock or indebtedness of (or guaranteed by) any corporation existing at the time such corporation becomes a Restricted Subsidiary;

(iv) Mortgages securing Debt of a Restricted Subsidiary owing to the Company or to another Restricted Subsidiary;

(v) Mortgages on property (not to exceed the fair market value of such property) to secure the payment of all or any part of the purchase price of such property upon the acquisition of such property by the Company or a Restricted Subsidiary or to secure any Debt incurred or guaranteed by the Company or a Restricted Subsidiary, or as to which a binding commitment to lend has been secured by the Company or such Restricted Subsidiary, prior to, at the time of, or within 12 months after the later of the acquisition, completion of construction development, substantial repair, alteration or improvement of the property, or commencement or placing in operation of such property, which Debt is

12

incurred or guaranteed for the purpose of financing all or any part of the purchase price thereof or construction; development, substantial repair, alteration or improvement thereof; provided, however, that in the case of any such acquisition, construction or improvement the Mortgage shall not apply to any property theretofore owned by the Company or a Restricted Subsidiary, other than, in the case of any such construction or improvement, any theretofore unimproved real property on which the property so constructed, or the improvement, is located;

(vi) liens for taxes, assessments or governmental charges or levies not yet delinquent or which are being actively contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance with generally accepted accounting principles.

(vii) liens of mechanics, materialmen and warehousemen and other mortgages incidental to the conduct of the business of the Company and its Subsidiaries or the ownership of its or their property and assets which were not incurred in connection with the borrowing of money or the obtaining of advances or credit and which do not, in the aggregate, materially detract from the value of such property or assets or materially impair the use thereof in the operation of such business.

(viii) any extension, renewal or replacement (or successive extensions, renewals or replacements) in whole or in part of any Mortgage referred to in the foregoing clauses (i) to (vii), inclusive; provided, however, that the principal amount of Debt secured thereby shall not exceed the principal amount of Debt so secured at the time of such extension, renewal or replacement, and that such extension, renewal or replacement shall be limited to all or part of the property encumbered by the Mortgage so extended, renewed or replaced (plus improvements and construction on such property).

6C. RESTRICTIONS UPON SALE AND LEASEBACK TRANSACTIONS. Except as expressly permitted by paragraph 6E, and except for any transactions which, if recast in the form of a secured loan, would be permitted by the provisions of paragraph 6B, the Company will not, nor will it permit any Restricted Subsidiary to, enter into any Sale and Lease-Back Transaction with respect to any Principal Property, whether such Principal Property is now owned or hereafter acquired (except for Sale and Lease-Back Transactions that involve leases for a term, including renewals, of not more than three years, and except for Sale and Lease-Back Transactions that involve leases between the Company and a Restritcted Subsidiary or between Restricted Subsidiaries), if the purchaser's commitment in respect thereof is obtained more

13

than 12 months after the later of the acquisition or completion or the placing in operation of such Principal Property as acquired, constructed or developed or substantially repaired, altered or improved, unless the Company shall apply an amount in cash equal to the greater of (i) the net proceeds, or (ii) the fair value (as determined by the Company's Board of Directors) of such Principal Property to the retirement (other than any mandatory retirement or by way of payment at maturity), within 180 days of the effective date of any such Sale and Leaseback Transaction, of Senior Funded Debt of the Company or any Restricted Subsidiary (other than Debt owned by the Company or any Restricted Subsidiary); provided, however, that the amount to be applied to such retirement of Senior Funded Debt shall be reduced by an amount equal to the principal amount, of other Senior Funded Debt voluntarily retired by the Company within 180 days after the effective date of such Sale and Lease-Back Transaction, excluding in each case retirements pursuant to mandatory sinking fund or prepayment provisions and payments at maturity.

6D. RESTRICTIONS ON FUNDED DEBT OF RESTRICTED SUBSIDIARIES. Except as expressly permitted by paragraph 6E, the Company will not permit any Restricted Subsidiary to create, issue, incur, assume or guarantee any Senior Funded Debt other than Funded Debt (i) secured by a Mortgage permitted under any of clauses
(i) through (viii) of Section 6B, (ii) of a corporation existing at the time such corporation is merged into or consolidated with, or sells or otherwise transfers substantially all its assets (or those of a division thereof) to, a Restricted Subsidiary, (iii) of a corporation existing at the time such corporation first becomes a Restricted Subsidiary or (iv) held by the Company or another Restricted Subsidiary, and except for any extension, renewal or replacement of any Senior Funded Debt referred io in clauses (i) through (iv) of this paragraph 6D, provided that the aggregate principal amount thereof or the aggregate preference on involuntary liquidation thereof, as the case may be, shall not be increased. The Company may not, and may not permit any Restricted Subsidiary to sell or transfer (except to the Company or a Restricted Subsidiary) any Senior Funded Debt of a Restricted Subsidiary, other than Senior Funded Debt secured by a Mortgage permitted under any of clauses (i) through
(viii) of paragraph 6B or in a transaction otherwise permitted by paragraph 6E.

6E. PERMITTED FINANCING TRANSACTIONS. Notwithstanding anything to the contrary contained in Sections 6B, 6C and 6D, the Company and its Restricted Subsidiaries may (i) create, issue, incur, assume or guarantee Debt secured by a Mortgage in addition to the Mortgages permitted by clauses (i) through (viii) of paragraph 6B, (ii) enter into Sale and Leaseback Transactions without applying funds to the retirement of Senior Funded Debt as provide in paragraph 6C, and
(iii) permit Restricted Subsidiaries to create, issue, incur, assume, suffer to exist or guarantee Senior Funded Debt in addition to Senior

14

Funded Debt permitted by clauses (i) through (iv) of Section 6D if the aggregate amount of all Debt secured by Mortgages, Attributable Debt in respect of Sale and Leaseback Transactions and Senior Funded Debt, in each case permitted by clauses (i), (ii) and (iii) of this paragraph 6E, does not exceed 10% of the Long-Term Capitalization of the Company and its Restricted Subsidiaries, as computed as of the time of becoming liable with respect to such obligation.

6F. CONSOLIDATION, MERGER, CONVEYANCE, TRANSFER OR LEASE. (i) The Company shall not consolidate with or merge into any other corporation or sell, convey, transfer or lease all or substantially all of its properties and assets to any Person, unless:

(a) the corporation formed by such consolidation or into which the Company is merged or the Person which acquires by conveyance or transfer, or which leases, the properties and assets of the Company substantially as an entirety shall be a corporation organized and existing under the laws of the United States of America, any State thereof or the District of Columbia and shall expressly assume, by an agreement supplemental hereto, executed and delivered to the holders of the Notes, the due and punctual performance of the obligations and covenants of the Company hereunder; and

(b) immediately after giving effect to such transaction and treating any indebtedness which becomes an obligation of the Company or a Subsidiary as a result of such transaction as having been incurred by the Company or such Subsidiary at the time of such transaction, (1) no Event of Default, and no event which, after notice or lapse of time or both, would become an Event of Default, shall have occurred and be continuing and (2) paragraph 6A shall permit the incurrence by the Company of no less than $1.00 of additional Senior Funded Debt; and

(c) in the case of a sale, conveyance, transfer or lease of assets, the Company shall have received full and fair consideration as determined by the Board of Directors of the Company by resolution for the properties or assets so sold, conveyed, transferred or leased.

(ii) Upon any consolidation by the Company with or merger by the Company into any other corporation or any conveyance, transfer or lease of the properties and assets of the Company substantially as an entirety in accordance with paragraph 6D(i), the successor corporation formed by such consolidation or into which the Company is merged or to which such conveyance, transfer or lease is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Agreement (including, without limitation,

15

those provided for in paragraph 8) with the same effect as if such successor corporation had been named as the Company herein, and thereafter, except in the case of a lease, the predecessor corporation shall be relieved of all obligations and covenants under this Agreement.

7. INCOME TAXATION.

7A. ADDITIONAL PAYMENTS. In the event that at any time (whether before or after payment of the Notes) a Gross-Up Event shall occur with respect to any Indemnitee, the ESOT will pay to such Indemnitee as additional interest in immediately available funds at the time or times specified in paragraph 7C:

(i) an amount equal to the excess of:

(a) the amount of interest which would have been payable on the unpaid principal amount of such Indemnitee's Note during the Additional Payment Period if such Note had borne interest at a rate per annum equal to the Gross-Up Rate (appropriately reduced if the amount of interest on such Indemnitee's Note included in its Federal Gross Income shall exceed the Inclusion Rate but shall be less than 100%) over

(b) the amount of interest actually paid or payable under the terms of such Indemnitee's Note during the Additional Payment Period (excluding any additional interest on overdue amounts paid or payable as provided in the Notes); and

(ii) the sum of

(a) the amount of any interest and of any penalties, additions to tax and additional amounts payable under the Code (such penalties, additions to tax and additional amounts being referred to as "Additions to Tax") which are deductible for Federal income tax purposes and are payable (or have been paid) to the United States by the Indemnitee as a consequence of the failure to include more than the Inclusion Rate of the interest referred to in paragraph 7AW(b) in the Federal Gross Income of such Indemnitee, and

(b) an amount which, after giving effect to all taxes attributable to the inclusion of such amount in the Federal Gross Income of such Indemnitee (such taxes to be calculated at the maximum statutory rate, applicable to such Indemnitee during the relevant taxable period, after taking into account deductions attributable to the imposition of Federal taxes), shall be equal to the amount of any interest or Additions to Tax which are not deductible for Federal income tax purposes and which are payable (or have

16

been previously paid) to the United States by the Indemnitee as a consequence of the failure to include more than the Inclusion Rate of the interest referred to in paragraph 7A(i)(b) in the Federal Gross Income of such Indemnitee;

provided, however, that as to any Gross-Up Event, no payment shall be required pursuant to paragraph 7A(ii) on account of any interest and Additions to Tax with respect to periods after all amounts due under paragraph 7A have been paid with respect to such Gross-Up Event.

7B. SUPPLEMENTAL PAYMENT S. (a) In the event that at any time (whether or not any Notes remain outstanding) a Change of Law shall occur with respect to any Indemnitee, the ESOT will pay to such Indemnitee as additional interest in immediately available funds at the time or times specified in paragraph 7C an amount with respect to the applicable Supplemental Payment Period which, after giving effect to all taxes attributable to the inclusion of such amount in Federal Gross Income of such Indemnitee shall be equal to any new or additional Federal tax related to the acquisition, ownership or disposition of such Indemnitee's Note which arises (and for this purpose tax arises, among other events, as a result of a reduction in any Tax Allowance) as a result of such Change of Law (all such Federal taxes to be calculated at the maximum statutory rate applicable to such Indemnitee) and adjusted to reflect any increased deductions or credits available to the Indemnitee related to the acquisition, ownership or disposition of such Indemnitee's Note which arise as a result of such Change of Law.

(b) Rules Governing Alternative Minimum Tax. If the alternative minimum tax is amended to classify any portion of the Statutory Exclusion as a "preference" or "adjustment (excluding preferences or adjustments relating to sections 56(f) and 56(g) of the Code, and successor provisions), the following rules shall apply. The amount payable to the Indemnitee under this Section 7B shall equal the product of (A) the lesser of (i) the AMT Increase and (ii) the AMT Liability multiplied by (B) the Proration Fraction. For this purpose, the following definitions shall apply:

"AMT Increase" = Preference Increase x 20% Rate x Total Section 133 Exclusions.

7C. PAYMENT DATES. (i) If the ESOT becomes obligated to make payments to any Indemnitee pursuant to paragraph 7A, the Indemnitee shall from time to time notify the ESOT and the Company of the amount that is payable in respect of such portion of the Additional Payment Period (a) as had elapsed prior to the occurrence of a Gross-Up Event, which amount shall be due and payable (1)

17

in the case such notice is given prior to payment in full of the Notes, on the first date thereafter on which any interest on the Notes is due and payable (or, if later, 10 days after the date of such notice), or (2) in the case such notice is given after payment in full of the Notes, within 10 days after the date of such notice, and (b) as had elapsed on and after the occurrence of a Gross-Up Event, which amount will be payable on each date thereafter on which any interest on the Notes is due and payable (each notice under this clause (b) shall be given at least 10 days prior to such interest payment date) provided, however, that if the Gross-Up Event occurs solely as a result of the occurrence of the event described in clause (b)(i) of the definition of Gross-Up Event, the ESOT and the Company may elect not to make any payments due hereunder during the period of any contest under paragraph 7F, unless the Indemnitee makes a payment
(including reducing any available refund, offset or credit otherwise available)
of the increased Federal tax arising from the Gross-Up Event, in which event the amount of such increased Federal tax (including any interest and Additions to Tax) shall be paid by the ESOT to the Indemnitee promptly upon its receipt of notice of such payment from the Indemnitee.

(ii) If the ESOT becomes obligated to make payments to any Indemnitee pursuant to paragraph 7B, such Indemnitee shall notify the ESOT and the Company
(a) of the amount that is payable in respect of such portion of the Supplemental Payment Period as had elapsed prior to the date such notice is given, which amount shall be due and payable within 10 days after the date of such notice, and (b) at least annually, of the amount that will be payable on such date or dates thereafter as set forth in such notice (each of which shall be at least 10 days after the date of such notice), which amount shall become due and payable on the dates specified.

(iii) The computation of any amount payable under paragraph 7A, 7B, 7D or 7E shall be made in good faith by the Indemnitee and shall be explained in writing to the ESOT and the Company, but neither the ESOT nor the Company shall have any right to examine the Indemnitee's Federal income tax returns or any other returns, documents or records of the Indemnitee. At the Company's or the ESOT's request and at the Company's expense, the Indemnitee will cause the Indemnitee's independent auditors to review such computation and certify to the Company or the ESOT, as the case may be, that such computation is accurate in all material respects.

(iv) If the ESOT shall fail to pay any amount payable under paragraphs 7A or 7B on the due date pursuant to this paragraph 7C, the ESOT shall also pay, to the extent lawful, interest on such unpaid amount at the rate payable on overdue payments of principal on the Notes, as set forth therein.

18

7D. INTEREST RATE ADJUSTMENT. In the event that at any time after the date hereof there is for any reason a change in the Federal Tax Rate or the Inclusion Rate, then, in that event, the interest rate on the Notes held by each Qualified Holder shall be automatically adjusted (but not higher than the Gross-Up Rate nor lower than Fully Tax-Exempt Rate), effective as of the effective date of change for each such change, to the rate per annum determined by multiplying the original interest rate applicable to the Notes by the Adjustment Fraction. Each Qualified Holder shall determine the adjusted interest rate on its Notes in accordance with the foregoing, subject to the procedures described in paragraph 7C(iii). The ESOT unconditionally promises to pay interest on such Notes from the date of each such change at the rate as so adjusted from time to time. If for any reason (e.g., a retroactive effective date) the effective date of change for any such change is prior to one or more payment dates for which payments were due and payable on such Notes, adjustments to payments are required under this paragraph 7D, (i) the ESOT shall promptly upon demand by such Qualified Holder pay the amount by which interest computed at such rate or rates exceeds the amount of interest actually theretofore paid by the ESOT on the Notes or
(ii) such Qualified Holder shall promptly upon demand for refund by the ESOT pay the amount by which the interest computed at such rate or rates is exceeded by the amount of interest theretofore paid by the ESOT on the Notes.

7E. REFUNDS. (i) If the ESOT or the Company shall make any payment to any Indemnitee pursuant to paragraph 7A or 7B and such Indemnitee shall thereafter receive a refund, offset or credit of tax of Federal Tax for any taxable year to which such payment related in respect of a claim that part of the interest on the Notes to which such payment related was excludable from its Federal Gross Income (or if it is otherwise subsequently determined that payments pursuant to paragraph 7A or 7B exceeded the amounts necessary to compensate the Indemnitee for a Gross-up Event or Change of Law, in which event, for purposes of this paragraph 7E(i), the Indemnitee shall be treated as receiving a refund in the amount of such excess) such Indemnitee shall pay to the ESOT or the Company, as the case may be, the sum of:

(a) an amount equal to the amount previously paid to such Indemnitee pursuant to paragraph 7AM or 7B with respect to the interest on such Notes for such taxable year to which such claim for refund, offset, or credit related (the "Disputed Interest") multiplied by a fraction the numerator of which is the amount of the refund or credit received of tax paid with respect to the Disputed Interest and the denominator of which is the amount of tax paid by such Indemnitee with respect to such Disputed Interest; and

19

(b) the amount of any refunded, offset or credited interest or Additions to Tax that had been paid with respect to such Disputed Interest and with respect to which such Indemnitee had been paid pursuant to paragraph 7A(ii) or 7B.

For purposes of this paragraph 7E(i), in the caise of a Gross-Up Event occurring solely as a result of the failure to provide a Qualifying Opinion of Counsel, the Indemnitee shall be treated as receiving a refund if and when it files a federal income tax return excluding interest on the Indemnitee's Note, in an amount equal to the portion of the amount paid pursuant to paragraph 7A that was determined with reference to the interest excluded on the return.

(ii) If the ESOT or the Company shall make any payment to an Indemnitee pursuant to paragraph 7B and if, in the Federal income tax return of such Indemnitee or after any adjustment of such return, the amount of the Tax Allowance or other amount by reference to which the amount of the supplemental payments is determined differs from the amount used to compute the amount of such payment, the ESOT or the Company, as the case may be, shall pay to such Indemnitee promptly on written demand any additional amount computed pursuant to paragraph 7B, and the Indemnitee shall promptly refund to the ESOT or the Company, as the case may be, any excess amount paid pursuant to paragraph 7B, attributable to such difference.

7F. CONTEST OF DISALLOWANCE OF SECTION 133 EXCLUSION. (i) If an Indemnitee anticipates receiving or actually receives an IRS Notice asserting a claim which, if successful, could result in a Gross-Up Event (an "Exclusion Claim"), the Indemnitee agrees to notify the ESOT and the Company in writing, as promptly as possible, of such Exclusion Claim and provide the ESOT and the Company with any relevant information relating to such Exclusion Claim that may be available to the Indemnitee.

(ii) The Indemnitee further agrees to contest any Exclusion Claim with diligence and in good faith, including appealing any adverse administrative or judicial determination and seeking a refund with respect to any Exclusion Claim if (in each instance) so requested by the ESOT or the Company; provided, however, that:

(a) within 30 days after notice by the Indemnitee to the ESOT and the Company of such Exclusion Claim, the ESOT or the Company shall request that such Exclusion Claim be contested;

(b) prior to the Indemnitee's taking any such requested action (including appealing any adverse decision), the Company (at the expense of

20

the Company and upon the written request of the Indemnitee) shall provide the Indemnitee with an opinion, reasonably satisfactory to the Indemnitee, of nationally recognized counsel, independent of the ESOT and the Company and reasonably satisfactory to the Indemnitee to the effect that there exists a reasonable basis for contesting such Exclusion Claim;

(c) the Company shall from time to time pay to the Indemnitee within 30 days after receipt by the ESOT and the Company of an itemized written demand therefor and explanation thereof an amount sufficient, on an after-tax basis, to reimburse the Indemnitee for all out-of-pocket expenses that the Indemnitee has incurred in connection with contesting or defending such Exclusion Claim or any appeal thereof, including, without limitation, expert witness, attorneys' and accountants' fees and disbursements; and

(d) the Indemnitee may, at any time, settle, compromise or otherwise terminate any contest with the consent of the ESOT and the Company, which consent shall not be unreasonably withheld.

(iii) Sole control over the conduct of any contest under subparagraph (ii) of this paragraph 7F shall be vested in the Indemnitee, but the Indemnitee shall consult with the ESOT, the Company and their counsel regarding all aspects of the contest, and shall consider and act on (or refrain from acting on) in good faith any recommendations of the ESOT, the Company, and their counsel as to conduct of the contest. The right of the Indemnitee to control the conduct of any contest shall not be construed to relieve the Indemnitee of its obligation to contest any Exclusion Claim in accordance with paragraph 7F(ii).

(iv) Notwithstanding anything to the contrary contained in subparagraph
(i), (ii) or (iii) of this paragraph 7F, the Indemnitee may in its sole discretion settle or compromise any Exclusion Claim, provided the Indemnitee gives the ESOT and the Company notice of its intention to settle or compromise the Exclusion Claim. If, after receiving the notice referred to in the preceding sentence and within 45 days of an agreement between the Company and the Indemnitee on the identity of counsel, the Company provides the Indemnitee with an opinion, reasonably satisfactory to the Indemnitee, of nationally recognized counsel, independent of the ESOT and the Company and reasonably satisfactory to the Indemnitee, that it is more likely than not that the Indemnitee would prevail in litigation with respect to such Exclusion Claim, then, to the extent payment was made by the ESOT or the Company under paragraph 7A, the Indemnitee shall be deemed to have received a refund in the amount of such payment, and shall immediately return such amount to the ESOT or the Company; to the extent payment was not made, the Gross-Up Event giving rise to the disallowance shall be deemed not to have occurred. Alternatively, if the Company provides the

21

Indemnitee with an opinion, reasonably satisfactory to the Indemnitee, of nationally recognized counsel, independent of the ESOT and the Company and reasonably satisfactory to the Indemnitee, that there is substantial authority (as defined in Section 6661 of the Code) for the position that the Indemnitee would prevail in litigation with respect to such Exclusion Claim, then if the amount paid by the ESOT or the Company exceeds 50% of the amount payable pursuant to paragraph 7A, the Indemnitee shall pay such excess to the ESOT or the Company, as appropriate; and if 50% of the amount payable pursuant to paragraph 7A exceeds the amount paid by the ESOT or the Company, the ESOT or the Company, as the case may be, shall pay the amount of such excess to the Indemnitee in complete accord and satisfaction of its obligations as to such issue under paragraph 7A.

For purposes of this subparagraph, an opinion will be "reasonably satisfactory" if such opinion considers authorities deemed relevant by such counsel (which will include authorities, which to the knowledge of such counsel are being relied upon by the IRS, such knowledge to include information obtained from discussions which the Indemnitee reasonably requests of such counsel) and does not assume any factual or legal conclusions that are being contested by the IRS (other than legal conclusions as to which such counsel properly opines) provided, however, that such opinion of counsel may rely on factual conclusions (even if contested by the IRS) contained in an opinion letter or appraisal or by a nationally recognized expert independent of the Company and the ESOT and reasonably satisfactory to the Indemnitee.

7G. REQUEST FOR QUALIFYING OPINION OF COUNSEL. If any Indemnitee determines, in good faith after consultation with independent nationally recognized counsel, that there is a substantial likelihood for any reason whatsoever that any Qualified Holder will be required to include more than that percentage of the interest on the Notes which is equal to the Inclusion Rate in its Federal Gross Income, such Indemnitee shall be entitled to request a Qualifying Opinion of Counsel at the Company's expense with respect to interest on the Notes for a period commencing with the date of issuance of the Notes and continuing through the date of such request or for any lesser period specified in such Indemnitee's request. If such a request is made, such Indemnitee shall supply the counsel rendering such opinion with such information as may be reasonably requested by such counsel in order for it to form a basis for rendering the opinion requested.

8. COMPANY GUARANTEE AND PURCHASE OBLIGATION.

8A. GUARANTEE BY THE COMPANY. (i) The Company, in consideration of the execution and delivery of this Agreement, hereby

22

unconditionally and irrevocably guarantees to you (together with your successors and assigns, hereinafter referred to as the "Purchaser") and to the holders from time to time of the Notes, the due and punctual payment of the principal of, premium, if any (including, without limitation, the Yield-Maintenance Premium, if any) and interest on the Notes when and as the same shall become due and payable, whether at the maturity thereof, by acceleration, by notice of prepayment or otherwise, according to the terms thereof and of this Agreement, and the due and punctual payment of any other amounts owing to the Purchaser and to such holders under or in respect of the Notes and all other payment obligations of the ESOT hereunder (including, without limitation, amounts payable by the ESOT pursuant to paragraph 7), whether absolute or contingent, liquidated or unliquidated. In the absence of the due observance and performance by the ESOT of any of its other obligations, undertakings and conditions contained in this Agreement the Company shall use its best efforts, to the extent practicable, to provide reasonably equivalent performance intended to achieve comparable results. If the ESOT shall not punctually pay any such principal, premium (including, without limitation, the Yield-Maintenance Premium, if any), interest or other amounts (regardless of whether the holders of the Notes have recourse against the ESOT), the Company shall make such payment forthwith thereafter. If the Purchaser or any of the holders of the Notes shall have the right to declare any or all of the Notes due and payable (or any such right shall be limited by operation of the last sentence of paragraph 9A or otherwise), and acceleration of the payment of such Notes is stayed, enjoined or otherwise prevented for any reason, including, without limitation, because of the provisions of Treasury Regulation section 54-4975-7 and 54.4975-11, the Company, upon demand therefor, shall pay to the Purchaser and each holder of Notes, the sums which would have been due to the Purchaser and such holders under this Agreement if such acceleration had occurred, all as permitted by applicable law.

(ii) The Company agrees that its obligations hereunder are absolute and unconditional, irrespective of the validity, regularity or enforceability of, or any change in or amendment to, any Note or this Agreement, the institution or absence of any action to enforce the same, the waiver or consent by the Purchaser or the holder of any Note with respect to the provisions thereof, the obtaining of any judgment against the ESOT or any action to enforce the same, the inability to recover from the ESOT because of any statute of limitations, laches or otherwise or any other circumstance which might otherwise constitute a legal or equitable discharge of or a defense to a guarantor, and that the provisions of this paragraph 8 constitute a guarantee of payment and not of collectibility.

(iii) The Company hereby unconditionally: (a) waives notice of acceptance hereof, of any action taken or omitted in reliance hereon and of any defaults in respect of the Notes or in the payment of any other amounts due in respect

23

thereof, diligence, protest, presentment, filing of claims with a court in the event of the bankruptcy of the ESOT subject to such filings as may be necessary to protect rights of subrogation, but only at the written instance and expense of the Company), any right to require a proceeding first against the ESOT, or that the ESOT be joined in any proceeding against the Company, any marshalling of assets of the Company or the ESOT, any notice of default with respect to any of the Notes or this Agreement or any other act or omission or thing or delay to do any other act or thing which might in any manner or to any extent vary the risk of the Company or which might otherwise operate as a discharge of the Company; (b) agrees that this guarantee shall remain in full force and effect without regard to, and shall not be affected or impaired by, any invalidity, irregularity or unenforceability in whole or in part of any of the Notes or this Agreement or any of the limitations of liability or payment conditions thereunder which may now or hereafter be caused or imposed in any manner whatsoever; (c) agrees that this guarantee shall not be subject to any counterclaim (other than those which are compulsory in nature), set-off, deduction or defense based upon any claim the Company may have against the ESOT or any holder of the Notes hereunder or otherwise; and (d) agrees that this guarantee shall be discharged only by complete performance of the undertakings in this paragraph 8. Nothing herein is intended to impair any rights of the Company to enforce any rights it may have against any Person by way of a separate proceeding or action.

(iv) The Company authorizes the Purchaser and the holders of the Notes, without notice or demand to the Company and without affecting its liability hereunder, from time to time (a) to exercise or refrain from exercising any rights against the ESOT or others; and (b) to apply any sums, by whomsoever paid or however realized, to the payment of the principal of, premium, if any, and interest on the Notes and any other obligation hereunder. The Company waives any right to require the Purchaser and the holders of the Notes to proceed against the ESOT or any other Person or to pursue any other remedy available to the Purchaser or to such holders.

(v) In the event the ESOT fails to observe or perform any of its obligations or undertakings under this Agreement (an "ESOT Default"), the Company will be subrogated and succeed to the rights of the Purchaser and the holders of the Notes which may be asserted against the ESOT by the Purchaser or such holders as a result of any such ESOT Default upon payment or performance of such obligations or undertakings; provided, however, that the Company will not exercise any rights which it may have acquired by way of subrogation under this Agreement, by any payment made hereunder or otherwise, or accept any payment on account of such subrogation rights, unless and until all of the obligations, undertakings or conditions then and thereafter to be performed or observed by the ESOT pursuant to the Notes and this Agreement at the time of the Company's

24

exercise of any such right shall have been performed, observed or paid in full by the ESOT or the Company. In the event that the Company receives any payment on account of such subrogation rights, it shall promptly apply such payment to the extent of its obligations hereunder. In the event that the Company pays or causes to be paid all amounts due under any of the Notes, the Purchaser or holder will assign and transfer such Notes to the Company or its designee. In no event shall such subrogation grant to the Company any right or power with respect to the ESOT which it is forbidden to exercise pursuant to ERISA or the Code or the regulations thereunder including but not limited to Treasury Regulation sections 54.4975-7 and 54.4975-11.

(vi) This guarantee shall continue to be effective or be reinstated, as the case may be, if at any time payment, or a part thereof, of the principal of, Yield Maintenance Premium, if any, or interest on any of the Notes or of any other obligations guaranteed hereby is rescinded or must otherwise be restored or returned by the Purchaser or any subsequent holder of Notes upon the insolvency, bankruptcy or reorganization of the ESOT, or otherwise, all as though such payment has not been made.

(vii) The Company may at any time elect to pay or otherwise perform any obligation of the ESOT under this Agreement or in respect of the Notes, which shall operate as a discharge and release of the ESOT from such obligation to the Purchaser or any subsequent holders of the Notes (but not to the Company as subrogee or as a successor Noteholder), provided that no such election shall release the ESOT from any of its other obligations hereunder and under the Notes.

8B. PURCHASES OF NOTES BY THE COMPANY. (i) At any time after the occurrence of a Purchase Event or, subject to the provisions of paragraph 8C, an ESOT Event, and prior to the expiration of the later of (x) 90 days after receipt of an Event Notice (as defined in subparagraph (iii) below) relating thereto and
(y) 15 days after receipt of an Other Holder Notice (as defined in subparagraph
(iii) below), but in no event later than one year after receipt of such Event Notice, any holder of a Note may deliver a notice to the Company (a) stating that it is electing to exercise its right to require the purchase by the Company pursuant to this paragraph 8B of the Notes then held by it (a "Purchase Notice") and (b) specifying the date on which, subject to the provisions of paragraph 8B(iv), if applicable, such purchase shall occur (which date shall not be less than 25 nor more than 35 days after the date on which such holder shall have delivered such Purchase Notice to the Company), and in any such event the Company, on such specified date, shall purchase or cause to be purchased the Note or Notes then held by such holder, without recourse, representation or warranty (other than as to the holder's full right, title and interest free of any adverse claim in such Note or Notes), and, subject to the provisions of paragraph

25

8B(iv), such holder shall sell such Note or Notes to or at the direction of the Company at a price, payable in immediately available funds by wire transfer to the accounts specified pursuant to paragraph 14A or to such other account as may be specified in such notice, equal to the then outstanding principal amount thereof, together with interest accrued on such principal amount to the date of purchase, plus a premium equal to the Yield-Maintenance Premium, if any, with respect to each Note purchased.

(ii) If either or both of Moody's or Standard & Poor's is not providing public ratings of Unsupported Company Debt, the Company may (subject to the approval of the Required Holder(s)) substitute another rating agency or other rating agencies of national reputation for Moody's and/or Standard & Poor's for the purpose of determining, by reference to the public ratings of two such rating agencies (which shall include Moody's or Standard & Poor's if one of them is providing public ratings of Unsupported Company Debt), whether the Company shall be obligated pursuant to subparagraph (i) of this paragraph 8B to purchase such holder's Note or Notes. If no rating agency of national reputation is providing public ratings of the Unsupported Company Debt, any holder of a Note may request that the Company obtain from each of Moody's and Standard & Poor's a private credit rating for the Unsupported Company Debt for the purpose of determining, by reference to the ratings of two such rating agencies, whether the Company shall be obligated pursuant to subparagraph (i) of this paragraph 8B to purchase such holder's Note or Notes. Upon receipt of any such request, the Company shall promptly, and in any event within 10 days after receiving such request, notify each other holder of a Note of such request and use its best efforts to obtain as promptly as practicable from each of Moody's and Standard Poor's (or, if either of them declines to provide a private credit rating, the other of them and one other rating agency of national reputation, and if both of them so decline, two other rating agencies of national reputation (subject to the approval of the Required Holders)) a private credit rating for such purpose. If the Company does not have any Unsupported Company Debt, the determination of whether the Company shall be obligated pursuant to subparagraph (i) of this paragraph 8B to purchase any holder's Note or Notes shall be made as aforesaid, but by reference to a credit rating of the Notes instead of Unsupported Company Debt. If the Company is required pursuant to this subparagraph (ii) of this paragraph 8B to seek a private credit rating and fails to obtain such private credit rating within 90 days of any holder's request therefor, such rating shall be deemed to be less than Baa3 or BBB- (or any comparable rating then in existence). In the event another rating agency of national reputation is substituted for Moody's or Standard & Poor's, such determination shall be made by reference to the rating of such substituted agency that is most nearly comparable to Baa3 of Moody's and BBB- of Standard & Poor's (or, in either case, the comparable ratings then in existence).

26

Suspension of a rating by a rating agency shall be deemed to have the effect of such agency providing no rating.

(iii) The Company covenants that it will deliver to each holder of a Note promptly, and in any event within 10 days following the occurrence thereof, (a) a notice of any change in the credit rating (whether public or private) of the Unsupported Company Debt or of the Notes (whether or not the Notes at the time benefit from any credit enhancement) by Moody's or Standard & Poor's, respectively, together, in the case of any such change, with a statement of the date of such occurrence and a reasonably detailed description of the facts and circumstances underlying such occurrence known to it, and (b) a notice of the occurrence of a Purchase Event, together with a statement of the date of occurrence of such Purchase Event and a reasonably detailed description of the facts and circumstances underlying such occurrence known to it, and which states that the Company is obligated, upon receipt of a Purchase Notice described in subparagraph (i) of this paragraph 8B, to purchase Notes pursuant to subparagraph (i) of this paragraph 8B (an "Event Notice"). Promptly, and in any event within 5 days following its receipt thereof, the Company will deliver to each holder of a Note a copy of any Purchase Notice received by it pursuant to subparagraph (i) of paragraph 8B of this Agreement or the Other Note Agreements (an "Other Holder Notice").

(iv) The Company's obligation to purchase Notes pursuant to any Purchase Notice given in respect of a Purchase Event shall be suspended for up to 60 days following the occurrence of such Purchase Event during such time as the Company is diligently seeking, and shall have notified each holder of a Note that it is seeking, a credit enhancement of the Notes which the Company reasonably believes will permit the Notes to be rated no less than Aal and AA+ by Moody's and Standard and Poor's, respectively (or, in either case, the comparable ratings then in existence). If, within such 60-day period, such a credit enhancement is legally and validly effected under arrangements to remain in place through the final maturity of the Notes and such ratings are duly obtained and written notice and evidence thereof is delivered to each holder of the Notes, then each Purchase Notice theretofore given in respect of such Purchase Event shall be deemed to be rescinded and of no further force or effect. If, at the end of such 60-day period, such ratings have not been obtained, the Company shall give prompt written notice to each holder of a Note, and the purchase and sale of any Note or Notes pursuant to each outstanding Purchase Notice shall occur on the later of the date specified in such Purchase Notice or the fifth Business Day following the expiration of such 60-day period, or on such other date as the holder of such Note shall specify by written notice to the Company.

27

8C. ISSUANCE OF NOTES BY THE COMPANY. The Company may elect to satisfy its obligation to pay for Notes tendered for purchase pursuant to any Purchase Notice in respect of an ESOT Event by delivery to such holder in exchange for such Notes of promissory notes of the Company, substantially in the form of Exhibit C (the "Company Notes"), with a maturity date, in principal amounts and with repayment schedules identical to the Notes so exchanged that were held by such holder together with accrued interest to the date of exchange. Company Notes issued pursuant to this paragraph 8C shall be dated the date of exchange of the Notes and shall bear interest from that date at the Gross-Up Rate. The holders of Company Notes shall be entitled to all of the benefits of this Agreement (other than the provisions of paragraph 7). Upon and after issuance of the Company Notes (whether pursuant to this paragraph 8C or pursuant to paragraph 8D), references to "Notes" herein shall be deemed to also include the Company Notes, except that the provisions of paragraph 7 shall not be applicable to the Company Notes. The issuance of Company Notes as aforesaid to any holder is subject to the satisfaction or waiver by such holder of each of the following conditions (the "Company Note Conditions"):

(i) no Event of Default or Default or Purchase Event shall have occurred and be continuing and paragraph 6A shall permit the incurrence by the Company of no less than $1.00 of additional Senior Funded Debt;

(ii) the Company Notes shall be legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors' rights generally and the application of general equitable principles;

(iii) the Company, at its expense, shall have delivered an opinion of counsel of national reputation addressed to the holders of the Notes to be exchanged for Company Notes and satisfactory to such holders to the foregoing effects and covering such other matters as may be reasonably requested by such holders;

(iv) the representations and warranties of the Company contained in this Agreement (other than those specifically relating to the ESOT) shall be repeated and true in all material respects as of the date of the Company's election to require such exchange and upon consummation of such exchange (except as otherwise specified in writing by the Company to such holder); and

(v) the Company shall have reimbursed and shall have agreed in writing in an instrument satisfactory in form and substance to such holder to hold harmless

28

such holder on an after-tax basis (as determined in good faith by such holder) for all taxes applicable to, or incurred in respect of, such exchange.

If any of the conditions set forth above shall not be met to the satisfaction to such holder (or if any of the exceptions described in clause
(iv) above shall be unacceptable to such holder) the Company shall pay for the Notes specified in such Purchase Notice in cash as provided in paragraph 8B.

8D. EXCESS ALLOCATION AND NOTE EXCHANGE. (i) In the event an Excess Allocation shall exist with respect to the Notes, the Company, at its option, may require that Notes having an aggregate principal amount equal to the amount of such Excess Allocation be exchanged by the holders thereof for Company Notes on the terms set forth in this Section (each an "Exchange"). Such Company Notes will be dated the date of such Exchange and will at the option of each holder of a Note subject to Exchange, (a) have a principal amount equal to the principal amount of the Notes so Exchanged, and bear interest at the Gross-up Rate or (b) have a principal amount equal to the principal amount of the Notes so Exchanged plus an amount equal to the Yield-Maintenance Premium at the time of Exchange applicable thereto and bear interest at the rate of 8.60% pet annum. The Company shall provide each Noteholder with no less than 30 days' prior written notice of the date of any proposed Exchange, and each holder of Notes shall specify its election pursuant to paragraph 8D(i)(a) or (b) no less than 5 days prior to the scheduled date of such Exchange.

(ii) In the case of an Exchange, the Notes (or portions thereof) to be Exchanged shall be selected by the ESOT by prorating the principal amount of the Notes to be Exchanged among the holders of Notes in proportion to the principal amount of the Notes registered in their respective names.

(iii) The right of the Company to require any Exchange is subject to the satisfaction or waiver by the holder of each of the Company Note Conditions (as well as such holder's satisfaction with any exceptions specified in clause (iv) of such conditions).

9. EVENTS OF DEFAULT.

9A. DEFAULT; ACCELERATION. If any of the following events shall occur and be continuing for any reason whatsoever (and whether such occurrence shall be voluntary or involuntary or come about or be effected by operation of law or otherwise):

(i) default in the payment of any principal (including any Required Installment Payment) of or Yield-Maintenance Premium on any Note

29

when the same shall become due, whether at maturity or at the times specified in paragraph 4A or 4B or otherwise, either by the terms thereof or otherwise as herein provided; or default which shall continue for more than 10 Business Days in the payment of any interest on any Note when the same shall become due; or

(ii) the Company states or otherwise claims in writing that any of its obligations under paragraph 8 is not enforceable in accordance with its terms; or

(iii) default in the performance or breach of any covenant of the Company or the ESOT contained in paragraph 7 or 8 or in the last sentence of paragraph 5A and continuance of such default or breach for a period of 15 Business Days after any of the chief executive officer, chief operating officer, principal financial officer, principal accounting officer or treasurer of the Company has obtained actual knowledge of such default or breach; or

(iv) default in the performance, or breach, of any covenant of the Company or the ESOT in this Agreement (other than as specified in the definition of ESOT Event and other than a covenant default in whose performance or whose breach is elsewhere in this paragraph 9A specifically dealt with), and continuance of such default or breach for a period of 45 days after the earlier of (x) the date the Company shall have given notice thereof to the holders of the Notes pursuant to the last sentence of paragraph 5A and (y) the date there shall have been given to the Company and the ESOT, by the Required Holders, a written notice specifiying such default or breach and requiring it to be remedied and stating that such notice is a "Notice of Default" hereunder; or

(v) any representation or warranty made by the Company or the ESOT herein or in any writing furnished pursuant to the requirements of paragraph 3 or paragraph 5A or 5B of this Agreement shall be false in any material respect on the date as of which made after the Required Holders have given written notice to the Company and the ESOT of such falsity; or

(vi) the Company or any Subsidiary defaults in any payment of principal of or interest on any other obligation for money borrowed (or any capitalized lease obligation, any obligation under a conditional sale or other title retention agreement, any obligation issued or assumed as full or partial payment for property whether or not secured by a purchase money mortgage or any obligation under notes payable or drafts accepted representing extensions of credit), other than the Notes, beyond any period

30

of grace provided with respect thereto, or the Company or any Subsidiary fails to perform or observe any other agreement, term or condition contained in any agreement (other than the Other Note Agreements) under which any such obligation is created (or if any other event thereunder or under any such agreement shall occur and be continuing) and such default, failure, or other event is not annulled or cured within 15 days after there shall have been given to the Company by the Required Holders a written notice specifying such default and requiring it to be remedied; provided that either (a) the aggregate amount of all obligations as to which such a payment default shall occur and be continuing or as to which such a default, failure or other event shall have caused, given any holder or holders of such obligations the right to cause or given any trustee on behalf of such holders the right to cause, such obligations to become due prior to any stated maturity, exceeds $35,000,000 or (b) such amount exceeds $25,000,000 and the effect of such default, failure or other event is to cause (without any action by or on behalf of the holder or holders of such obligation), or as a result thereof the holder or holders of such obligation (or a trustee on behalf of such holder or holders) shall have caused, such obligation to become due prior to any stated maturity; or

(vii) the Company or a Sigificant Subsidiary or Significant Group of Subsidiaries makes an assignment for the benefit of creditors or is generally not paying its debts as such debts become due; or

(viii) any decree or order for relief in respect of the Company or any Significant Subsidiary or Significant Group of Subsidiaries is entered under any bankruptcy, reorganization, compromise, arrangement, insolvency, readjustment of debt, dissolution or liquidation or similar law, whether now or hereafter in effect (herein called the "Bankruptcy Law"), of any jurisdiction; or

(ix) the Company or any Significant Subsidiary or Significant Group of Subsidiaries petitions or applies to any tribunal for, or consents to, the appointment of, or taking possession by, a trustee, receiver, custodian, liquidator or similar official of the Company or any Significant Subsidiary or Significant Group of Subsidiaries, or commences a voluntary case under the Bankruptcy Law of the United States or any proceedings (other than proceedings for the voluntary liquidation and dissolution of a significant subsidiary or Significant Group of Subsidiries) relating to the Company or any Significant Subsidiary or Significant Group of Subsidiaries under the Bankruptcy Law of any other jurisdiction; or

31

(x) any such petition or application is filed, or any such proceedings are commenced, against the Company or any Significant Subsidiary or Significant Group of Subsidiaries and the Company or such Significant Subsidiary or Significant Group of Subsidiaries by any corporate act, consents thereto or acquiesces therein, or an order, judgment or decree is entered appointing any such trustee, receiver, custodian, liquidator or similar official, or approving the petition in any such proceedings, and such order, judgment or decree remains unstayed and in effect for more than 30 days; or

(xi) any order, judgment or decree is entered in any proceedings against the Company or any Significant subsidiary or Significant Group of Subsidiaries decreeing the dissolution of the Company or any Significant Subsidiary or Significant Group of Subsidiaries and such order, judgment or decree remains unstayed and in effect for more than 60 days; or

(xii) any "reportable event" as such term is defined in section 4043 of ERISA occurs in connection with any ERISA Plan or trust created thereunder for which the thirty day notice requirement has not been waived under applicable regulations, or an event occurs requiring the Company or any ERISA Affiliate to provide security to an ERISA Plan under section 401(a)(29) of the Code; any "prohibited transaction" occurs, as such term is defined in section 4975 of the Code or in section 406 of ERISA, in connection with any ERISA Plan or any trust created thereunder; any notice of intent to terminate an ERISA Plan or ERISA Plans is filed under Title IV of ERISA by the Company or any ERISA Affiliate, any ERISA Plan administrator or any combination of the foregoing; any proceedings are instituted by the PBGC to terminate or to cause a trustee to be appointed to administer any ERISA Plan; any partial or complete withdrawal is made by the Company or an ERISA Affiliate from any Multiemployer Plan; any proceedings are instituted by a fiduciary of any ERISA Plan against the Company or any Code Affiliate to enforce section 515 of ERISA and such proceeding shall not have been dismissed within 30 days thereafter; the Company or a Code Affiliate fails to make a required installment under section 412(m) of the Code or to pay any amount or amounts which it shall have become liable to pay to the PBGC or to an ERISA Plan under Title IV of ERISA on or before the due date; any application is filed by the Company or a Code Affiliate for a waiver of the minimum funding, standard under section 412 of the Code or section 302 of ERISA; or any "reorganization" (as defined in section 418 of the Code or Title IV of ERISA) of any plan which is a Multiemployer Plan occurs; and each such instance individually, or any two or more such instances in the aggregate, would, in the reasonable judgment of the

32

Required Holder(s), more likely than not result in liability of the Company or any Code Affiliate or ERISA Affiliate to the IRS, the PBGC or an ERISA Plan in an aggregate amount exceeding $5,000,000; or

(xiii) any order, judgment or decree is entered in any proceeding by a court of competent jurisdiction decreeing that the Plan, the ESOT or the ESOT Transaction has not been properly established or consummated, as the case may be (other than as specified in clause (iii) of the definition of ESOT Event), in any material respect, and such order, judgment or decree remains unstayed and in effect for more than 60 days and no appeal is filed by the Company or the ESOT therefrom within 60 days of the time such order, judgment or decree first becomes appealable; or

(xiv) a final judgment in an amount in excess of $5,000,000 is rendered against the Company or any Significant Subsidiary or Significant Group of Subsidiries and, within 60 days after entry thereof, such judgment is not discharged or execution thereof stayed pending appeal, or within 60 days after the expiration of any such stay, such judgment is not discharged;

then (a) if such event is an Event of Default specified in clause (viii), (ix) or (x) of this paragraph 9A with respect to the Company, all of the Notes at the time outstanding shall automatically become immediately due and payable at the principal amount thereof together with interest accrued thereon, without presentment, demand, protest or notice of any kind, all of which are hereby waived by the Company and the ESOT, and (b) if such event is an Event of Default specified in any other clause of this paragraph 9A, the Required Holder(s) may at its or their option, by notice in writing to the Company and the ESOT, declare all of the Notes to be, and all of the Notes shall thereupon be and become (except that, if such event is an Event of Default specified in clause
(i) of this paragraph 9A with respect to any Note, the holder of such Note may at its option by notice in writing to the Company and the ESOT, declare such Note to be, and such Note shall thereupon be and become) immediately due and payable at the principal amount thereof together with interest accrued thereon and the Yield-Maintenance Premium, if any, with respect thereto without presentment, demand, protest or other notice of, any kind, all of which are hereby waived by the Company and the ESOT, provided that the Yield-Maintenance Premium, if any, with respect to each Note shall be due and payable upon such declaration only if (x) such event is an Event of Default specified in any of clauses (i) to (vii), inclusive and clauses (xii) to (xiv), inclusive (y) the holder or holders making such declaration shall have given to the Company and the ESOT, at least 10 Business Days before such declaration, written notice stating its or their intention so to declare the Notes to be immediately due and payable and identifying one or

33

more such Events of Default whose occurrence on or before the date of such notice permits such declaration and (z) one or more of the Events of Default so identified shall be continuing at the time of such declaration. Nothing in this Agreement shall permit (i) a transfer of assets of the ESOT to any Person in excess of the amount permitted under Treasury Regulation Section 54.4975-7(b)(6) or (ii) if a holder of any Note is a disqualified person within the meaning of
Section 4975 of the Code or the Regulations thereunder, the transfer of assets of the ESOT to.such holder except upon the failure of the ESOT to make payment of regularly scheduled payments of principal and interest on such Notes, and then only to the extent of such failure.

9B. OTHER REMEDIES. If any Event of Default or Default shall occur and be continuing, the holder of any Note may proceed to protect and enforce its rights under this Agreement and such Note by exercising such remedies as are available to such holder in respect thereof under applicable law, either by suit in equity or by action at law, or both, whether for specific performance of any covenant or other agreement contained in this Agreement or in aid of the exercise of any power granted in this Agreement. No remedy conferred in this Agreement upon you or any other holder of any Note is intended to be exclusive of any other remedy, and each and every such remedy shall be cumulative and shall be in addition to every other remedy conferred herein or now or hereafter existing at law or in equity or by statute or otherwise.

9C. RESCISSION OF ACCELERATION. At any time after any declaration of acceleration of any of the Notes shall have been made pursuant to paragraph 9A by any holder or holders of the Notes and before a judgment or decree for the payment of money due has been obtained by such holder or holders, the Required Holder(s) may, by written notice to the Company and the ESOT and to the other holders of the Notes, rescind and annul such declaration and its consequences, provided that (i) the principal of and interest on the Notes, which shall have become due otherwise than by such declaration of acceleration shall have been duly paid, and (ii) all Events of Default, other than the nonpayment of principal of and interest on the Notes which have become due solely by any such declaration of acceleration, shall have been cured or expressly waived by the Required Holder(s). No rescission or annulment referred to above shall affect any subsequent Default or any right, power or remedy arising out of such subsequent Default.

9D. LIMITED RECOURSE. Notwithstanding any other provision of this Agreement to the contrary, the only assets of the ESOT that may be given as collateral for the ESOT's obligations under this Agreement and the Notes are the shares of Employer Capital Stock purchased with the proceeds of the sale of the Notes. No person entitled to payment under this Agreement and the Notes shall

34

have any right to assets of the ESOT other than (i) collateral given for the ESOT's obligations under this Agreement and the Notes, (ii) contributions (other than contributions of Company securities) that are made pursuant to the Plan to enable the ESOT to meet its obligations under this Agreement and the Notes, and
(iii) earnings attributable to such collateral and the investment of such contributions. The payments made by the ESOT with respect to this Agreement and the Notes during a calendar year shall not exceed an amount equal to the sum of such contributions and earnings received during or prior to such year less such payments received in prior years.

10. REPRESENTATIONS AND WARRANTIES. The Company and, in the case of paragraph 100 (other than clause (ii) thereof), the ESOT, as to the ESOT, represent and warrant that:

10A. ORGANIZATION; CORPORATE AUTHORITY. The Company and each of its Restricted Subsidiaries are corporations duly organized and validly existing in good standing under the laws of their respective states of incorporation; have all requisite power, and have all material governmental licenses, authorizations, consents and approvals, necessary to own their assets and carry on their business as now being conducted, except where the failure to have such power, licenses, authorizations, consents and approvals would not, individually or in the aggregate, have a material adverse effect on the consolidated financial position, shareholders' equity or results of operations of the Company and its Subsidiaries taken as a whole; and are qualified to do business in all jurisdictions in which the nature of the business conducted by them makes such qualification necessary and where failure to do so would have a material adverse effect on the consolidated financial position, shareholders' equity or results of operations of the Company and its Subsidiaries taken as a whole. The execution, delivery and performance of this Agreement and the Plan Documents, and compliance with provisions hereof and the consummation of any other transactions contemplated hereby and by the Plan Documents, are within the corporate power of the Company, have been duly authorized by all necessary corporate action and constitute legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms (subject, as to enforceability, to the effect of bankruptcy, insolvency, reorganization, moratorium and similar laws affecting the enforcement of creditors' rights generally and the application of principles of equity.)

10B. FINANCIAL STATEMENTS; SEC REPORTS. The Company has furnished you with the audited consolidated balance sheets of the Company and its Subsidiaries at December 31, 1988 and December 31, 1987 and the related audited consolidated statements of earnings, shareholders' equity and cash flows for each of the three years in the period ended December 31, 1988 all reported on

35

by Peat Marwick Main & Co. (the "Historical Financial Statements"). The Historical Financial Statements (i) are complete and correct in all material respects, (ii) have been prepared in conformity with generally accepted accounting principles applied on a consistent basis, and (iii) present fairly, in all material respects, the consolidated financial position of the Company and its Subsidiaries at the dates indicated and their results of operations and cash flows for the periods indicated. The Company has furnished you with the following documents and financial statements: (a) copies of the Company's Annual Report filed with the Commission on Form 10-K for its 1988 fiscal year and its Quarterly Report on Form 10-Q for the quarter ended March 31, 1989 (collectively, the "SEC Reports"), and (b) the Confidential Direct Placement Memorandum submitted to you by The First Boston Corporation, dated April 1989 (together with all schedules and appendices thereto, the "Placement Memorandum"). The SEC Reports have been prepared in conformity with the rules and regulations of the Commission applicable thereto, and, in accordance with such rules and regulations, accurately describe the business conducted by the Company and its Subsidiaries and the properties owned and operated in connection therewith. The Historical Financial Statements, the SEC Reports, the Placement Memorandum and all other documents and reports delivered by or on behalf of the Company to you in connection with the transactions contemplated by this Agreement (which other documents and reports are described in the Company's letter to you dated the date hereof), are herein collectively called the "Disclosure Documents". The Disclosure Documents did not, as of their respective dates, and taken as a whole, and this Agreement does not as of the date hereof contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. There is no fact peculiar to the Company which materially adversely affects or in the future would reasonably be expected to (so far as the Company can now foresee) materially adversely affect the business or prospects or the consolidated financial position, shareholders' equity or results of operation of the Company and its Subsidiaries taken as a whole which has not been set forth in this Agreement or in the Disclosure Documents. Neither the Company nor any of its Subsidiaries has sustained since December 31, 1988 any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree which is material to the Company and its consolidated Subsidiaries considered as a whole, otherwise than as set forth or contemplated in the Disclosure Documents; and, since the respective dates as of which information is given in the Disclosure Documents, there has not been any material change in the capital stock or long-term or short-term debt of the Company or in any of its Restricted Subsidiaries or in the consolidated capitalization of the Company and its consolidated Subsidiaries, or any material adverse change, or any development which the Company has reasonable cause to believe will involve a prospective

36

material adverse change, in or affecting the general affairs, management, financial position, shareholders' equity or results of operations of the Company and its consolidated Subsidiaries considered as a whole, otherwise than as set forth or contemplated in the Disclosure Documents.

10C. ACTIONS PENDING. There are no actions or proceedings filed or investigations pending or (to the best knowledge of the Company) threatened against the Company or the ESOT which question the validity or legality of or seek damages in connection with this Agreement or any action taken or to be taken pursuant to this Agreement or any of the transactions contemplated hereby (including the ESOT Transaction) and no order or judgment has been issued or entered restraining or enjoining the Company or the ESOT from the consummation of the transactions contemplated by this Agreement (including the ESOT Transaction) or which affects the ESOT or the Company or any of the ESOT's or the Company's properties or rights, or any of the ESOT's or the Company's affiliates, associates, officers or directors in relation to such matters, nor is there any action or proceeding which involves a significant possibility of an adverse determination which would have any such effect. There are no legal or governmental proceedings pending to which the Company or any of its Subsidiaries is a party or of which any property of the Company or any of its Subsidiaries is the subject other than legal or governmental proceedings which, if determined adversely to the Company and its Subsidiaries, would not in the aggregate have a material adverse effect on the business or prospects or the financial position, shareholders' equity or results of operations of the Company and its Subsidiaries taken as a whole; and no such proceedings are known by the Company to be threatened or contemplated by governmental authorities or threatened by others.

10D. TAXES. The Company has and each of its Subsidiaries has filed all Federal, State and other income tax returns which are required to be filed, and each has paid all taxes as shown on such returns and on all assessments received by it to the extent that such taxes have become due, except such taxes as are being contested in good faith by appropriate proceedings for which adequate reserves have been recorded on the books of the Company and its Subsidiaries in accordance with generally accepted accounting principles. Federal income tax returns of the Company and its Subsidiaries have been examined and reported on by the taxing authorities or closed by applicable statutes and satisfied for all fiscal years prior to and including the fiscal year ended on December 31, 1986.

10E. TITLE TO PROPERTY. The Company and its Restricted Subsidiaries have good and marketable title to all real property and good title to all personal property owned by them, in each case free and clear of all liens, encumbrances and defects except such as are described in the Disclosure

37

Documents or such as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and its Restricted Subsidiaries; and any real property and buildings held under lease by the Company and its Restricted Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its Restricted Subsidiaries.

10F. CONFLICTING AGREEMENTS AND OTHER MATTERS. Neither the execution nor delivery of this Agreement, or the Plan Documents, nor the offering, issuance and sale of the Notes or the consummation of the ESOT Transaction, nor fulfillment of nor compliance with the terms and provisions hereof and thereof will conflict with, or result in a breach of the terms, conditions or provisions of, or constitute a default under, or result in any violation of, or result in the creation of any Mortgage upon any of the material properties or assets of the Company or any of its Subsidiaries pursuant to, the charter or by-laws of the Company or any of its Subsidiaries, any award of any arbitrator or any agreement, instrument, order, judgment or decree, to which the Company or any of its Subsidiaries or any of their respective properties is subject. The Company is not a party to, or otherwise subject to any contract or agreement (including its charter) which limits the amounts of, or otherwise imposes restrictions on the incurring of, obligations of the type to be evidenced by its obligations under paragraph 8. The Company does not have outstanding any Debt which is senior in right of payment to the Company's obligations under paragraph 8(a).

10G. OFFERING OF NOTES. Neither the Company, the ESOT nor The First Boston Corporation (the only Person authorized or employed by the Company as agent, broker, dealer or otherwise in connection with the offering or sale of Notes, or any similar security of the ESOT) has, directly or indirectly, offered any of the Notes, or any similar security of the ESOT for sale to, or solicited any offers to buy any of the Notes, or any similar security of the ESOT from, or otherwise approached or negotiated with respect thereto with, any Person or Persons other than you, the Other Purchasers and no more than 75 other institutional investors; and neither the Company, the ESOT nor any agent acting on their behalf has taken or will take any action which would subject the issuance or sale of any of the Notes to the provisions of section 5 of the Securities Act or violate the provisions of any securities or Blue Sky law of any applicable jurisdiction.

10H. BROKER'S OR FINDER'S COMMISSIONS. No broker's or finder's fee or commission will be payable by the Company or the ESOT with respect to the issuance and sale of the Notes or the transactions contemplated

38

hereby except for the fees paid to The First Boston Corporation, and the Company agrees that such fees shall be paid by it and that it will hold you harmless from any claim, demand or liability for broker's or finder's fees or commissions alleged to have been incurred in connection with this transaction.

10I. MARGIN REGULATIONS. Neither the Company nor the ESOT will, directly or indirectly, use any of the proceeds of the issue and sale of the Notes or otherwise take or permit to be taken any action which would result in the issue and sale of the Notes, or the carrying out of any of the other transactions contemplated hereby or by the ESOT Transaction, being violative of Regulations G, T, U or X of the Board of Governors of the Federal Reserve System.

10J. INVESTMENT COMPANY ACT. Neither the Company nor any of its Subsidiaries is an "investment company", or a company "controlled" by an "investment company", within the meaning of the Investment Company Act of 1940, as amended.

10K. PUBLIC UTILITY HOLDING COMPANY ACT. Neither the Company nor any of its Subsidiaries is a "holding company", or a "subsidiary company" of a "holding company", or an "affiliate" of a "holding company" or of a "subsidiary company" of a "holding company", as such terms are defined in the Public Utility Holding Company Act of 1935, as amended.

10L. GOVERNMENTAL CONSENTS, ETC. No consent, approval or authorization of, or the making of any declaration or filing with, any governmental authority is required as a condition to the valid execution or delivery of this Agreement or the Plan Documents or the consummation of the transactions contemplated hereby and thereby except the filing of the Plan Documents with the IRS as contemplated by paragraph 5F.

10M. ERISA. (i) Neither the Company nor any ERISA Affiliate has engaged in a transaction in connection with which the Company could be subject to a material liability for either a civil penalty assessed pursuant to section 502(i) of ERISA or a tax imposed by section 4975 of the Code.

(ii) There has been no termination of an ERISA Plan or trust created under any ERISA Plan that would give rise to a material liability to the PBGC on the part of the Company or an ERISA Affiliate. No material liability to the PBGC has been or is expected by the Company to be incurred with respect to any ERISA Plan by the Company or an ERISA Affiliate. The PBGC has not instituted proceedings to terminate any ERISA Plan which is maintained or is to be maintained by the Company or an ERISA Affiliate. There exists no condition or set of circumstances which presents a material risk of termination or partial

39

termination of any ERISA Plan by the PBGC or restoration of any ERISA Plan heretofore terminated. The Company and each Code Affiliate is current with all premiums to the PBGC.

(iii) Full payment has been made of all amounts which are required under the terms of each ERISA Plan to have been paid as contributions to such ERISA Plan as of the last day of the most recent fiscal year of such ERISA Plan ended on or before the date of this Agreement, and no accumulated funding deficiency (as defined in section 302 of ERISA and section 412 of the Code), whether or not waived, exists with respect to any ERISA Plan or any employee pension benefit plan maintained by the Company or a Code Affiliate. The Company and each Code Affiliate is current with all required installments under section 412(m) of the Code.

(iv) The current value of the benefit liabilities (as defined in section 4001(a)(16) of ERISA) of each ERISA Plan does not exceed the fair market value of the assets of such ERISA Plan. Neither the Company nor any Code Affiliate is required to provide security to an ERISA Plan or an employee pension benefit plan maintained by a Code Affiliate under section 401(a)(29) of the Code. No lien under section 412(n) of the Code or sections 312(f) or 4068 of ERISA has been or is reasonably expected by the Company to be imposed on the assets of the Company or any ERISA Affiliate.

(v) Neither the Company nor any ERISA Affiliate has made a complete or partial withdrawal (or a reduction in contribution base units which if continued would result in a partial withdrawal) from a Multiemployer Plan which has resulted in, or is reasonably expected by the Company to result in, a material withdrawal liability.

(vi) All employee pension benefit plans (as defined in section 3(2) of ERISA) maintained by the Company or an ERISA Affiliate which are intended to be "qualified" are "qualified" under section 401(a) of the Code. All employee benefit plans (as defined in section (3) of ERISA) maintained by the Company or an ERISA Affiliate have been administered substantially in compliance with ERISA and the applicable provisions of the Code. There are no pending issues before the IRS or any court of competent jurisdiction related to the qualification of the Plan except for the filing of the Plan and the ESOT with the IRS as contemplated by paragraph 5F. Neither the Company nor any Code Affiliate has any material liability under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.

(vii) The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby will not involve any transaction which is

40

subject to the prohibitions of section 406 of ERISA or in connection with which a tax could be imposed pursuant to section 4975 of the Code. The representation by the Company in the preceding sentence is made in reliance upon and subject to the accuracy of your representation in paragraph 11 as to the source of funds used to pay the purchase price of the Notes.

10N. THE PLAN. (i) The Plan is an "employee" stock ownership plan" within the meaning of section 4975(e)(7) of the Code and is qualified under section 401(a) of the Code. The ESOT has been duly constituted in accordance with the Trust Agreement, is validly existing and is tax-exempt under section 501(a) of the Code. The ESOT has all requisite power and authority to own its properties and assets. The execution, delivery and performance of this Agreement and the consummation of the ESOT Transaction by the parties thereto will not involve any transaction which is subject to the prohibitions of section 406 of ERISA and will not otherwise constitute a violation of, or give rise to any liability under, any other provision of Title I of ERISA or section 4975 of the Code. The Employer Capital Stock constitutes "employer securities" within the meaning of section 409(l) of the Code. The issuance and sale of the Notes hereunder to you by the ESOT qualifies as a "securities acquisition loan" within the meaning of section 133 of the Code and, as a result thereof, 50% of the interest on the Notes is excludible from the gross income of any holder of the Notes for Federal income tax purposes, assuming that such holder is a Qualified Holder.

(ii) Neither the Plan nor the ESOT has incurred any Debt and, as of the Closing, neither will have incurred any Debt other than Debt represented by the Notes. The Plan and the ESOT have been established by the Company for a valid corporate purpose. The Company has delivered to you true and correct copies of the Plan Documents and all other documents having the legal effect of governing the terms or administration of the Plan and the ESOT. The ESOT Transaction as of the date hereof has been, and after giving effect to the transactions contemplated hereby will be, duly and validly consummated and all Plan Documents are and will be legal, valid, binding and enforceable obligations of the respective parties thereto (subject, as to enforceability, to the effect of bankruptcy, insolvency, reorganization, moratorium and other similar laws affecting the enforcement of creditors' rights generally and the application of general equitable principles).

(iii) It is the present intention of the Company to establish and maintain the ESOT in full force and effect as "an employee stock ownership plan" within the meaning of section 4975(e)(7) of the Code and section 407(d)(b) of ERISA.

10O. REPRESENTATIONS AS TO THE TRUSTEE. (i) The Trustee has all requisite power and authority to execute and deliver and to perform all of the

41

obligations of the ESOT under this Agreement and the Notes and to carry out the ESOT Transaction; (ii) the execution, delivery and performance by the Trustee of this Agreement and the Notes and the consummation by the ESOT of the ESOT Transaction will not violate any provision of any law, rule, regulation (including, without limitation, Regulation X of the Board of Governors of the Federal Reserve System), order, writ, judgment, injunction, decree, determination or award presently in effect having applicability to the Trustee;
(iii) this Agreement constitutes, and the Notes when delivered hereunder will constitute, legal, valid and binding obligations of the ESOT enforceable against the ESOT in accordance with their terms (subject, as to enforceability, to the effect of bankruptcy, insolvency, moratorium and similar laws affecting the enforcement of creditors' rights generally and the application of principles of equity) and (iv) there are no actions, suits or proceedings pending or, to the best knowledge of the Company or the ESOT, threatened against or affecting the ESOT or its properties before any court or governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign, which (a) draw into question the validity of the Trust Agreement, this Agreement, the Notes or the ESOT Transaction or (b) if determined adversely to the ESOT, would materially adversely affect the ability of the Trustee to perform its obligations under the Trust Agreement or of the ESOT to perform its obligation under this Agreement or the Notes or of any of them to consummate the ESOT Transaction.

The following representations and warranties are made only by the Trustee in its individual capacity and not by the Company or the ESOT: The Trustee, in its individual capacity, represents and warrants that (1) the Trustee is a New York banking corporation with corporate trust powers duly organized, validly existing and in good standing under the laws of the State of New York and has all requisite power and authority, corporate and otherwise, to conduct its business and to execute and deliver, and to perform all its obligations under, the Trust Agreement; (2) the Trustee is not in default under any provision of any law, rule, regulation (including, without limitation, Regulation X of the Board of Governors of the Federal Reserve System), order, writ, judgment, injunction, decree, determination or award presently in effect having applicability to the Trustee or any indenture or loan or credit agreement or any other material agreement, lease or instrument to which the Trustee is a party or by which it or its properties are bound or affected, which default would materially affect the ability of the Trustee to perform its obligations under the Trust Agreement; and (3) the execution, delivery and performance by the Trustee of the Plan Documents, this Agreement and the Notes and the consummation by the ESOT of the ESOT Transaction do not and will not violate any provision of the articles of association or by-laws of the Trustee.

10P. POLLUTION AND OTHER REGULATIONS. Except as otherwise previously disclosed to you in writing, the Company is in compliance in all

42

material respects with all laws and regulations, including, without limitation, those relating to pollution and environmental control, equal employment opportunity and employee safety in all jurisdictions in which it is presently doing business except where the failure to do so would not have a material adverse effect on the consolidated financial position, shareholders' equity or results of operations of the Company and its Subsidiaries taken as a whole.

11. REPRESENTATIONS OF PURCHASER. You represent, and in making this sale to you it is specifically understood and agreed, that you (i) are an "accredited investor" within the meaning of Regulation 501(a) under the Securities Act, and
(ii) are not acquiring the Notes to be purchased by you hereunder with a view to or for sale in connection with any distribution or public offering thereof within the meaning of the Securities Act, provided that the disposition of your property shall at all times be and remain within your control.

You also represent that the funds being used by you to pay the purchase price of the Notes being purchased by you hereunder constitute either part of your general asset account (or your general assets if you are not an insurance company) or constitute assets allocated to (i) a separate account (as defined in section 3 of ERISA) which is a "guaranteed contract separate account" (as defined in Department of Labor ("DOL") Prohibited Transaction Exemption 81-82 issued September 18, 1981), in which case you further warrant that all requirements for an exemption under DOL Prohibited Transaction Exemption 81-82 are met with respect to the use of such funds to pay the purchase price of the Notes; (ii) a collective investment fund (as defined in section IV of DOL Prohibited Transaction Exemption 80-51 issued July 21, 1980) maintained by you, in which case you further warrant all requirements for an exemption under DOL Prohibited Transaction Exemption 80-51 are met with respect to use of such funds to pay the purchase price of the Notes; or (iii) an investment fund (as defined in Part V of DOL Prohibited Transaction Exemption 84-14, issued March 13, 1984), in which case you further warrant-that all requirements for an exemption under DOL Prohibited Transaction Exemption 84-14 are met with respect to the use of such funds to pay the purchase price of the Notes.

12. DEFINITIONS AND ACCOUNTING MATTERS, ETC. As used herein, the following terms shall have the following meanings (terms defined in the singular to have the same meanings when used in the plural and vice versa):

12A. YIELD-MAINTENANCE TERMS.

"AMT Liability" shall mean the amount of the addition to the Indemnitee's Federal income tax liability determined under Section 55(a) of the Code.

43

"Annualized Reinvestment Yield" shall mean the yield resulting from the following formula:

( 1 + Reinvestment Yield )2 - 1

2

"Called Principal" shall mean, with respect to any Note, the principal of such Note that is to be prepaid pursuant to paragraph 5B or purchased or exchanged pursuant to paragraph 8B, 8C or 8D or is declared to be immediately due and payable pursuant to paragraph 9A, as the context requires.

"Current AMT Preference" shall mean 50% for tax years beginning before January 1, 1990, and 75% for subsequent tax years.

"Discounted Value" shall mean, with respect to the Called Principal of any Note, the amount obtained by discounting all Remaining Scheduled Payments with respect to such Called Principal from their respective scheduled due dates to the Settlement Date with respect to such Called Principal, in accordance with accepted financial practice and at a discount factor (applied on an annual basis) equal to the Annualized Reinvestment Yield plus .25% per annum with respect to such Called Principal.

"Preference Increase" shall mean the excess, if any, of the percentage of the Statutory Exclusion that is treated as a preference or adjustment (other than pursuant to Section 56(f) or (g) of the Code, or any successor provision thereto) pursuant to the Change of Law over the Current AMT Preference.

"Proration Fraction" shall mean, for tax years of the Indemnitee beginning on or before June 7, 1992, a fraction, the numerator of which is the interest received by the Indemnitee on Notes held by the Indemnitee during the taxable year, multiplied by the Statutory Exclusion, and the denominator of which is the Total Section 133 Exclusions. For subsequent tax years, the same numerator shall be used but the denominator will be the excess of the Indemnitee's alternative minimum taxable income (as defined in Section 55(b)(2) of the Code) over the Indemnitee's federal taxable income as otherwise calculated.

"Reinvestment Yield" shall mean, with respect to the Called Principal of any Note, the yield to maturity implied by (i) the yields reported, as of 10:00
A.M. (New York City time) on the Business Day next preceding the Settlement Date with respect to such Called Principal, on the display designated as "Page 678" on the Telerate Service (or such other display as may replace Page 678 on the Telerate Service) for actively traded U.S. Treasury securities having a maturity equal to the Remaining Average Life of such Called Principal as of such

44

Settlement Date, or if such yields shall not be reported as of such time or the yields reported as of such time shall not be ascertainable, or (ii) the Treasury Constant Maturity Series yields reported, for the latest day for which such yields shall have been so reported as of the Business Day next preceding the Settlement Date with respect to such Called Principal, in Federal Reserve Statistical Release H.15 (519) (or any comparable successor publication) for actively traded U.S. Treasury securities having a constant maturity equal to the Remaining Average Life of such Called Principal as of such Settlement Date. Such implied yield shall be determined, if necessary, (a) by converting U.S. Treasury bill quotations to bond-equivalent yields in accordance with accepted financial practice and (b) by linear interpolation between reported yields.

"Remaining Average Life" shall mean, with respect to the Called Principal of any Note, the number of years (calculated to the nearest one-twelfth year) obtained by dividing (i) such Called Principal into (ii) the sum of the products obtained by multiplying (a) each Remaining Scheduled Payment of such Called Principal (but not of interest thdreon) by (b) the number of years (calculated to the nearest one-twelfth year) which will elapse between the Settlement Date with respect to such Called Principal and the scheduled due date of such Remaining Scheduled Payment.

"Remaining Scheduled Payments" shall mean, with respect to the Called Principal of any Note, all payments of such Called Principal and interest thereon calculated at the Gross-up Rate that would be due on or after the Settlement Date with respect to such Called Principal if no payment of such Called Principal were made prior to its scheduled due date.

"Settlement Date" shall mean, with respect to the Called Principal of any Note, the date on which such Called Principal is to be prepaid pursuant to paragraph 5B or purchased or exchanged pursuant to paragraph 8B, or 8C or exchanged pursuant to paragraph 8B, 8C or 8D or is declared to be immediately due and payable pursuant to paragraph 10A, as the context requires.

"Total Section 133 Exclusions" shall mean the total amount of interest excludable by the Indemnitee under Section 133(a) of the Code for the tax year in question.

"Yield-Maintenance Premium" shall mean, with respect to any Note, a premium equal to the excess, if any, of the Discounted Value of the Called Principal of such Note over the sum of (i) such Called Principal plus (ii) interest accrued thereon as of (including interest due) the Settlement Date with respect to such Called Principal. The Yield-Maintenance Premium shall in no event be less than zero.

45

12B. OTHER DEFINED TERMS.

"Additional Payment Period" shall mean, as to any Indemnitee, the period from and at all times after the earliest date as of which more than the then current Inclusion Rate of the interest on such Indemnitee's Note (or interest therein) is included in such Indemnitee's Federal Gross Income as a result of one or more Gross-Up Events until the earlier of (i) the latest date as of which the then current Inclusion Rate or less of the interest on such Indemnitee's Note (or interest thereon) is included in such Indemnitee's Federal Gross Income and (ii) payment in full of such Indemnitee's Note, together with accrued interest and premium (including Market Premium), if any, thereon.

"Additions to Tax" shall have the meaning specified in paragraph 7A.

"Adjustment Fraction" shall mean the following fraction resulting from the following formula:

(1 - (Xo x Fo)) x (1 - Fn)
(1 - (Xn x Fn)) x (1 - Fo)

where

Xo = 50% (the Inclusion Rate on the date hereof)

Fo = 34% (the Federal Tax Rate on the date hereof)

Xn = the new Inclusion Rate

Fn = the new Federal Tax Rate

The Adjustment Fraction will be rounded to three decimal places with rounding up if the fourth decimal place is .0005 or higher, and rounded down otherwise.

"Affiliate" shall mean, with respect to any Person, any Person directly or indirectly controlling, controlled by, or under direct or indirect common control with, such Person. The term "control" means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise, and the terms "controlling" and "controlled" have correlative meanings to the foregoing.

"Attributable Debt" in respect of any Sale and Lease-Back Transaction shall mean, as of the time of the determination, the lesser of (i) the sale price of

46

the Principal Property so leased muitiplied by a fraction the numerator of which is the remaining portion of the base term of the lease included in such transaction and the denominator of which is the base term of such lease, and
(ii) the total obligation (discounted to present value at the highest rate of interest specified by the terms of any Funded Debt of the Company then outstanding compounded semiannually) of the lessee for rental payments (other than amounts required to be paid on account of property taxes as well as maintenance, repairs, insurance, water rates and other items which do not constitute payments for property rights) during the remaining portion of the base term of the lease included in such transaction.

"Bankruptcy Law" shall have the meaning specified in paragraph 9A and shall include, but not be limited to, Title 11 of the United States Code.

"Board of Directors" shall mean either the board of directors of the Company or any duly authorized committee of that board.

"Business Day" shall mean any day which is not a Saturday or a Sunday or a bank holiday in New York, New York.

"Change of Law" shall mean, with respect to any Indemnitee, any amendment to the Code or the enactment of or amendment to any other statute enacted by the Congress of the United States of America, or any administrative or judicial interpretation thereof, or any temporary or final regulation promulgated by the Treasury Department, after the date hereof, which, in the written opinion of independent counsel for such Indemnitee reasonably satisfactory to the ESOT and the Company (and at the Company's expense), consider that it is more likely than not that such change,

(i) reduces any Tax Allowance allowable to such Indemnitee in computing any Federal tax, or

(ii) imposes any new or additional Federal tax (including, but not limited to, minimum, preference or excise taxes) upon, extends any such tax to or otherwise increases the liability for any such tax of such Indemnitee (including, without limitation, by changing the provisions of Section 812(g) of the Code),

in either case solely or specifically by reason of owning, acquiring or disposing of obligations the interest on which is partially exempt from Federal income taxation under Section 133 of the Code or any similar or successor provision; provided that a Change of Law does not include (a) any change in the Inclusion Rate or the Federal Tax Rate or the alternative minimum tax rate or
(b) any change of general application to all obligations.

47

"Closing" shall have the meaning specified in paragraph 2.

"Code" shall mean the Internal Revenue Code of 1986.

"Code Affiliate" shall mean each trade or business (whether or not incorporated) which together with the Company is treated as a "single employer" under subsection (b), (c), (m), (n) or (o) of section 414 of the Code.

"Commission" shall mean the United States Securities and Exchange Commission and any successor Federal agency having similar powers.

"Company" shall have the meaning specified in the introduction to this Agreement and shall include any successor thereto.

"Company Note Conditions" shall have the meaning specified in paragraph 8C.

"Company Notes" shall have the meaning specified in paragraph 8B.

"Company Obligations" shall have the meaning specified in paragraph 6B.

"Current Debt" shall mean any obligation for borrowed money and any notes payable and drafts accepted representing extensions of credit, whether or not representing obligations for borrowed money, payable on demand or within a period of one year from the date of the creation thereof.

"Debt" shall nean Funded Debt and Current Debt.

"Designated Event" shall mean (i) a merger, acquisition or consolidation as a result of which holders of the voting stock of the Company immediately prior to such merger, acquisition or consolidation hold less than 50% of the voting stock of the new or surviving entity; (ii) a recapitalization, including any special dividend and any other extraordinary distribution of assets or obligations of the Company or any of its Subsidiaries to shareholders of the Company in an amount aggregating, during any twelve-month period, [10%] or more of the Company's Tangible Stockholders Equity or (iii) any repurchase by the Company or any of its Subsidiaries of [10%] or more of the Company's outstanding Common Stock during any twelve-month period, excluding any repurchases of shares of Common Stock effectuated within twelve months of the date of this Agreement using the proceeds of the ESOT Transaction.

"Disclosure Documents" shall have the meaning specified in paragraph 10B.

48

"DOL" shall have the meaning specified in paragraph 11.

"Employer Capital Stock" shall mean the Company's Series One ESOP Convertible Preference Stock.

"ERISA" shall mean the Employee Retirement Income Security Act of 1974, as amended from time to time. Section references to ERISA are to ERISA, as in effect at the date of this Agreement and any subsequent provisions of ERISA, amendatory thereof, supplemental thereto or substituted therefor.

"ERISA Affiliate" shall mean each trade or business (whether or not incorporated) which together with the Company would be deemed to be a "single employer" within the meaning of section 414(b) or (c) of the Code.

"ERISA Plan" shall mean any employee pension benefit plan within the meaning of section 3(2) of ERISA maintained or contributed to by the Company or an ERISA Affiliate.

"ESOT" shall have the meaning specified in the introduction to this Agreement and shall include any successor thereto.

"ESOT Default" shall have the meaning specified in subparagraph (v) of paragraph 8A.

"ESOT Event" shall mean the occurrence for any reason whatsoever (and whether such occurrence shall be voluntary or come about or be effected by operation of law or otherwise) of any of the following events:

(i) the ESOT or the Plan shall have been terminated, the ESOT shall fail to hold "qualifying employer securities" or otherwise fail to satisfy any applicable condition necessary to provide that the indebtedness evidenced by the Notes constitutes a "securities acquisition loan" within the meaning of section 133 of the Code or the Company shall fail to obtain from the IRS by the Qualification Date a favorable written determination to the effect that the Plan is an "employee stock ownership plan" within the meaning of section 4975(e)(7) of the Code and is qualified under section 401(a) of the Code and that the ESOT meets the requirements for tax exemption under section 501(a) of the Code.

"ESOT Transaction" shall mean the execution and delivery of the Notes by the ESOT and the purchase by the ESOT of shares of Employer Capital Stock from the Company pursuant to the Stock Purchase Agreement for an aggregate purchase price of $357,500,000.

49

"Event of Default" shall mean any of the events specified in paragraph 9A, if any requirement in connection with such event for the giving of notice, or the lapse of time, or both, or the happening of any further condition, event or act has been satisfied, and "Default" shall mean any of such events, whether or not any such requirement has been satisfied.

"Excess Allocation" shall mean the excess of (i) the value of shares to be allocated to employees as required under the terms of the Plan during any given period over (ii) the amount which may be allocated pursuant to scheduled payments of principal and interest on the Notes.

"Exchange" shall have the meaning specified in paragraph 8D.

"Exchange Act" shall mean the Securities Exchange Act of 1934.

"Federal Gross Income" shall mean gross income within the meaning of the Code.

"Federal Reserve Board Statistical Release" shall mean the weekly Statistical Release H.15(519) of the Federal Reserve Board of Governors or any successor or substitute publication.

"Federal Tax Rate" shall mean, (i) in the case of a life insurance company, the maximum incremental percentage rate from time to time applicable to the taxable income of such company as determined under section 801 of the Code, or any successor thereto, (ii) in the case of any other insurance company, the maximum incremental percentage rate from time to time applicable to the taxable income of such company as determined under section 831 of the Code, or any successor provision, (iii) in the case of any other Person the maximum incremental percentage rate from time to time applicable to the taxable income of any ordinary business corporation imposed under section 11 of the Code, or any successor thereto and (iv) in the case of a "regulated investment company" (as defined in Section 851 of the Code) the maximum incremental percentage rate from time to time applicable to the taxable income of an individual imposed under Section 1 of the Code, or any successor thereto.

"Fully Tax-Exempt Rate" shall mean the rate of 7.10% per annum.

"Funded Debt" of any Person shall mean the principal of (i) all indebtedness of such Person which by its terms is not payable on demand and which matures by its terms, or which by its terms such Person has the right at its option to renew or extend to a date more than one year after the date of determination, whether outstanding on the date of execution of this Agreement or

50

thereafter created, incurred or assumed, and which is (a) for money borrowed or
(b) evidenced by a note or similar instrument given in connection with the acquisition of any business, properties or assets, including securities, or which constitutes the deferred purchase price of any such business, properties or assets (other than accounts payable, due within 12 months, incurred in the ordinary course of business), (ii) any indebtedness of others of the kinds described in the preceding clause (i) for the payment of which such Person is responsible or liable as guarantor or otherwise (including the Notes in the case of the Company), and (iii) amendments, renewals and refundings of any such indebtedness; provided, however, that such term shall not include any obligations under leases (other than capital leases) or any guarantees of obligations of others under leases (other than capital leases). It is understood that for the purposes of this definition the term "principal" when used at any date with respect to any indebtedness shall mean the amount of principal of such indebtedness that would be declared due and payable on that date pursuant to the terms of such indebtedness is such indebtedness could then be declared to be due and payable.

"Gross-Up Event" shall mean, with respect to any Indemnitee, (a) the failure by such Indemnitee to receive a Qualifying Opinion of Counsel, requested pursuant to paragraph 7G, within 45 days after the receipt by the Company of such request therefor and agreement by the Indemnitee and the Company as to the identity of such counsel, or (b) an increase in such Indemnitee's Federal income tax liability, a reduction of such Indemnitee's net operating loss, an offset liability against any Federal tax refund or other amount otherwise due such Indemnitee with respect to such Indemnitee's Federal tax liability, or a utilization of an amount otherwise available to such Indemnitee as a credit against Federal tax caused by and computed solely with reference to an inclusion in such Indemnitee's Federal Gross Income (other than by reason of a Change of Law) of a percentage of the interest received or accrued by such Indemnitee with respect to such Indemnitee's Note exceeding the then current Inclusion Rate following or as a consequence of any one or more of the events set forth below:

(i) the issuance of an IRS Notice to such Indemnitee;

(ii) the occurrence of a final decision, judgment, decree or other order by the Tax Court or by any other court of competent jurisdiction with respect to such Indemnitee or any other Indemnitee and the expiration of the period for appealing such decision without an appeal being docketed; or

(iii) the execution of a closing agreement by such Indemnitee under section 7121 of the Code.

51

"Gross-Up Rate" shall mean the rate of 10.75% per annum.

"Historical Financial Statements" shall have the meaning specified in paragraph 10B.

"Inclusion Rate" shall mean the percentage of interest income received or accrued by an entity which is a Qualified Holder on securities acquisition loans which may not be excluded from such entity's Federal Gross Income.

"Indemnitee" shall mean you and your direct and indirect successors and assigns in any of the Notes (or any interest therein), including any assignee, participant or other transferee of all or any portion of any Indemnitee's interest in the Notes (whether or not the Indemnitee has an interest in any Note at the time amounts are payable to such Indemnitee hereunder) and any affiliated group (within the meaning of section 1504 of the Code) of which any Indemnitee is a member; provided that, for purposes of paragraph 7A or 7B, the term "Indemnitee" shall not include any assignee, participant or other transferee that is not a Qualified Holder with respect to the Notes at the time the assignee, participant or other transferee acquires an interest in the Notes, and shall not include any Person that no longer qualifies as a Qualified Holder (other than by reason of a Change of Law) but only with respect to the period such Person owned or held an interest in the Notes while so disqualified.

"Indemnitee's Note" shall mean, with respect to any Indemnitee, the Note (or participation or other interest in the Note) held by such Indemnitee at any time.

"IRS" shall mean the United States Internal Revenue Service and any successor Federal agency having similar powers.

"IRS Notice" shall mean, with respect to any Indemnitee, a revenue agent's report or notice of proposed adjustment or a notice of deficiency issued by the IRS to such Indemnitee with respect to the inclusion in Federal Gross Income of a percentage of the interest on such Indemnitee's Note exceeding the Inclusion Rate.

"Long-Term Capitalization" of the Company and its Restricted Subsidiaries as of any date shall mean the aggregate of (a) Funded Debt of the Company and its Restricted Subsidiaries, (b) Tangible Stockholders' Equity and (c) the amount of the liability of the Company and its Restricted Subsidiaries in respect of deferred income taxes, all computed and consolidated as of such date in accordance with generally accepted accounting principles.

52

"Moody's" shall mean Moody's Investors Service, Inc. and any successor thereto which is a nationally recognized rating agency.

"Mortgage" shall mean any mortgage, pledge, security interest, lien or other encumbrance.

"Multiemployer Plan" shall mean "multiemployer plan" (as such term is defined in section 3(37) of ERISA and section 414(f) of the Code) to which contributions are or have been made by the Company or any of its Subsidiaries.

"Notes" shall have the meaning specified in paragraph 1 and paragraph 8C.

"Officer's Certificate" shall mean a certificate signed in the name of the Company by its Chief Executive Officer, Chief Operating Officer, Chief Financial and Administrative Officer, Vice President and Controller or Vice President and Treasurer or any other officer of the Company performing functions similar to the functions of such officers as of the date of this Agreement.

"Opinion of Counsel" shall mean a written opinion of counsel, who may be counsel for the Company, and who shall be acceptable to the Required Holder(s).

"Other Holder Notice" shall have the meaning specified in paragraph 8B(iii).

"Other Note Agreements" shall have the meaning specified in paragraph 2.

"Other Purchasers" shall have the meaning specified in paragraph 2.

"PBGC" shall mean the Pension Benefit Guaranty Corporation or any entity succeeding to any or all of its functions under ERISA.

"Person" shall mean and include an individual, an association, a partnership, a joint venture, a corporation, a joint-stock company, a trust, an unincorporated organization and a government or any department or agency or political subdivision thereof.

"Placement Memorandum" shall have the meaning specified in paragraph 10B.

"Plan" shall have the meaning specified in the introduction to this Agreement and shall include any successor thereto.

53

"Plan Documents" shall mean the Plan, the Trust Agreement and the Stock Purchase Agreement.

"Principal Property" shall mean real or tangible property owned by the Company or any Restricted Subsidiary constituting a part of any store, warehouse or distribution center located within the United States (excluding current assets, motor vehicles, mobile materials-handling equipment and other rolling stock, cash registers and other point of sale recording devices and related equipment and data processing and other office equipment), the net book value of which (including leasehold improvements and store fixtures constituting a part of such store, warehouse or distribution center) exceeds 0.50% of Long-Term Capitalization.

"Purchase Event" shall mean (i) the occurrence of a Designated Event, and such occurrences shall have been a significant factor leading to the Unsupported Company Debt's having received a rating of less than Baa3 by Moody's and less than BBB- from Standard & Poor's (or in either case, the comparable ratings then in existence) (as modified pursuant to paragraph 8B(ii)), or (ii), if a second credit enhancement shall have been provided in respect of the Notes pursuant to paragraph 8B(iv) or otherwise, the Notes shall have received a rating of less than Aal and AA+ by Moody's and Standard & Poor's, respectively (or in either case, the comparable ratings then in existence) (as modified pursuant to paragraph 8B(ii)).

"Purchase Notice" shall have the meaning specified in paragraph 8B.

"Purchaser" shall have the meaning specified in subparagraph (i) of paragraph 8A.

"Qualification Date" shall mean the earliest of the following dates: (i) the date on which the Company and the ESOT shall receive, after the exhaustion of all legal remedies, a final determination that the Plan fails to qualify under Section 401(a) of the Code or is not an "employee stock ownership plan" within the meaning of section 4975(e)(7) of the Code or that the ESOT fails to meet the requirements for tax exemption under section 501(a) of the Code; and
(ii) December 31, 1990.

"Qualified Holder" shall mean any entity described in section 133(a) of the Code which is not a member of the same controlled group of corporations, as such term is defined in section 133(b)(4) of the Code, as the Company.

"Qualifying Opinion of Counsel" shall mean a written opinion of recognized tax counsel, selected by the Company and satisfactory to the Indemnitee requesting such opinion, to the effect that interest on the Indemnitee's

54

Note in an amount equal to the excess over the then current Inclusion Rate is excludible from such Indemnitee's Federal Gross Income during the applicable period under paragraph 7G.

"Required Holder(s)" shall mean the holder or holders of at least a majority of the aggregate principal amount of the Notes from time to time outstanding.

"Required Installment Payment" shall have the meaning specified in paragraph 4A.

"Restricted Subsidiary" shall mean any Subsidiary of the Company or of a Restricted Subsidiary substantially all the operating assets of which are located and the principal business of which is carried on within the United States, Puerto Rico, United States' Virgin Islands and Canada and which the Company shall, by an Officer's Certificate delivered to the holders of the Notes, have designated as a Restricted Subsidiary (all those now existing being deemed to have been so designated) and the designation of which as a Restricted Subsidiary shall not have been cancelled by an Officer's Certificate delivered to the holders of the Notes; provided, however, that neither the designation of a Subsidiary as a Restricted Subsidiary nor the cancellation of such designation shall be operative if the effect of such designation or cancellation shall be to make Long-Term Capitalization less than 200% of Senior Funded Debt of the Company and its Restricted Subsidiaries on a pro forma basis (eliminating intercompany items), and provided, further, that any Officer's Certificate of the designation of a Subsidiary as a Restricted Subsidiary or the cancellation of such designation shall set forth the Long-Term Capitalization and Senior Funded Debt of the Company and its Restricted Subsidiaries on a pro forma basis and show compliance with the first proviso of this paragraph. Any such designation or cancellation of such designation may be made more than once with respect to any Subsidiary; provided, however, that no Subsidiary which has previously been a Restricted Subsidiary shall be redesignated a Restricted Subsidiary if during any period following cancellation of its previous designation as a Restricted Subsidiary such Subsidiary shall have entered into a Sale and Lease-Back Transaction which would have been prohibited under paragraph 6E had such Subsidiary been a Restricted Subsidiary at the time of such Transaction.

"Sale and Lease-Back Transaction" of a corporation shall mean any arrangement whereby (a) property has been or is to be sold or transferred by such corporation to any Person with the intention on the part of such corporation of taking back a lease of such property pursuant to which the rental payments are calculated to amortize the purchase price of such property substantially over the

55

useful life of such property and (b) such property is in fact so leased by such corporation.

"Securities Act" shall mean the Securities Act of 1933, as amended.

"Senior Funded Debt" of the Company shall mean any Funded Debt of the Company unless in any instrument or instruments evidencing or securing such Funded Debt or pursuant to which the same is outstanding, or in any amendment, renewal, extension or refunding of such Funded Debt it is provided that such Funded Debt shall be subordinate in right of payment to the Company Obligations and the Company Notes (i) in the event of any dissolution or winding-up or total or partial liquidation or reorganization of the Company, whether voluntary or involuntary, or any bankruptcy, insolvency, receivership or similar proceedings relative to the Company, (ii) in the event that any Subordinated Funded Debt of the Company is declared due and payable before its expressed maturity because of the occurrence of an event of default with respect to such Subordinated Funded Debt and (iii) in the event of any default in the payment of principal (including any required prepayments or amortization) of or interest on any Senior Funded Debt of the Company. "Senior Funded Debt" of a Restricted Subsidiary shall mean any Funded Debt of such Restricted Subsidiary and the aggregate preference on involuntary liquidation of any class of stock of such Restricted Subsidiary held by any person other than the Company or a Restricted Subsidiary ranking, either as to payment of dividends or distribution of assets, prior to any other class of stock of such Restricted Subsidiary.

"Significant Holder" shall mean any original holder of Notes or a holder or holders of Notes aggregating not less than 5% in aggregate unpaid principal amount of the Notes at the time outstanding, and at the time of and during the continuance of a Default or ESOT Event or Purchase Event shall mean the holder of any Notes.

"Significant Subsidiary or Significant Group of Subsidiaries" means any Restricted Subsidiary or group of Restricted Subsidiaries which, individually or in the aggregate, together with its or their consolidated Subsidiaries, accounts or account for more than 20% of the consolidated gross revenues or net income of the Company and its Subsidiaries for the fiscal year most recently ended or for more than 20% of the total assets or Tangible Stockholders' Equity of the Company and its Subsidiaries as of the end of such fiscal year.

"Standard & Poor's" shall mean Standard & Poor's Corporation and any successor thereto that is a nationally recognized rating agency.

56

"Stock Purchase Agreement" shall mean the Preference Stock Purchase Agreement between the Company and the ESOT, in the form delivered as contemplated by paragraph 3D.

"Subsidiary" shall mean a corporation more than 50% of the outstanding voting stock of which is owned, directly or indirectly, by the Company or by one or more other Subsidiaries, or by the Company and one or more other Subsidiaries. For the purposes of this definition, "voting stock" means stock which ordinarily has voting power for the election of directors, whether at all times or only so long as no senior class of stock has such voting power by reason of any contingency.

"Subordinated Funded Debt" of the Company shall mean Funded Debt of the Company which is not Senior Funded Debt.

"Supplemental Payment Period" as to any Indemnitee shall mean, with respect to any Change of Law, the period from the earliest date as of which such Change of Law is effective with respect to such Indemnitee until the earlier of (i) the payment in full of such Indemnitee's Note, together with all accrued interest and premium, if any, thereon and (ii) the last date as of which such Change of Law remains effective.

"Tangible Stockholders' Equity" as of any date shall mean the aggregate of
(i) capital (including all preferred stock, common stock and capital surplus) and (ii) retained earnings, after deducting intangibles (other than goodwill, net of accumulated amortization, existing as of December 31, 1988), any contra-equity account, and the cost of shares of capital stock held in treasury, all as would be shown on a consolidated balance sheet of the Company and its subsidiaries as of such date prepared in accordance with generally accepted accounting principles.

"Tax Allowance" shall mean any deduction, credit, exclusion or other allowance allowable in computing liability for any Federal tax.

"Transferee" shall mean any direct or indirect transferee of all or any part of any Note purchased by you under the Agreement.

"Trust Agreement" shall mean the Trust Agreement, effective as of June 7, 1989, by and between the Company and the Trustee, as from time to time in effect, pursuant to which the ESOT was created.

"Trust Company" shall mean The Bank of New York, as trustee of the ESOT, and its successors as such trustee.

57

"Unsupported Company Debt" shall mean the long-term senior unsecured indebtedness of the Company, the creditworthiness of which is not supported through defeasance, guarantees, credit enhancement or otherwise.

12C. ACCOUNTING TERMS AND DETERMINATIONS. References in this agreement to "generally accepted accounting principles" shall mean generally accepted accounting principles in effect in the United States of America as of the date of determination thereof.

13. JUDICIAL PROCEEDINGS.

13A. CONSENT TO JURISDICTION. Each of the Company and the ESOT irrevocably submits to the non-exclusive jurisdiction of any New York State or Federal court sitting in the City of New York, Borough of Manhattan, over any suit, action or proceeding arising out of or relating to this Agreement or the Notes. To the fullest extent it may effectively do so under applicable law, each of the Company and the ESOT irrevocably waives and agrees not to assert, by way of motion as a defense or otherwise, any claim that it is not subject to the subject-matter jurisdiction of any such court, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding brought in any such court and any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.

13B. ENFORCEMENT OF JUDGMENTS. Each of the Company and the ESOT agrees, to the fullest extent it may effectively do so under applicable law, that a judgment in any suit, action or proceeding of the nature referred to in paragraph 13A brought in any such court shall be conclusive and binding upon the Company or the ESOT, as the case may be, and may be enforced in the courts of the United States of America or the State of New York (or any other courts to the jurisdiction of which the Company or the ESOT, as the case may be, is or may be subject) by a suit upon such judgment.

13C. SERVICE OF PROCESS. Each of the Company and the ESOT consents to process being served in any suit, action or proceeding of the nature referred to in paragraph 13A by mailing a copy thereof by registered or certified mail, postage prepaid, return receipt requested, to the address of the Company or the ESOT, as the case may be, specified in or designated pursuant to paragraph 14I. The Company and the ESOT agree that such service (i) shall be deemed in every respect effective service of process upon the Company or the ESOT, as the case may be, in any such suit, action or proceeding and (ii) shall, to the fullest extent permitted by law, be taken and held to be valid personal service upon and personal delivery to the Company or the ESOT, as the case may be.

58

13D. NO LIMITATION ON SERVICE OR SUIT. Nothing in this paragraph 13 shall affect the right of you or any holder of a Note to serve process in any manner permitted by law, or limit any right that the holders of any Notes may have to bring proceedings against the Company or the ESOT in the courts of any jurisdiction or to enforce in any lawful manner a judgment obtained in one jurisdiction in any other jurisdiction.

14. MISCELLANEOUS.

14A. NOTE PAYMENTS. So long as you shall hold any Note, payments of principal of the Notes and interest and premium on the Notes, which comply with the terms of this Agreement shall be made by wire transfer of immediately available funds for credit to your account or accounts, as specified in the Purchaser Schedule attached hereto, or to such other account or accounts in the United States as you may designate in writing, notwithstanding any contrary provision herein or in any Note with respect to the place of payment. You agree that, before disposing of any Note, you will make a notation thereon (or on a schedule attached thereto) of all principal payments previously made thereon and of the date to which interest thereon has been paid. Each of the Company and the ESOT agrees to afford the benefits of this paragraph 14A to any Transferee which shall have made the same agreements as you have made in this paragraph 14A.

14B. EXPENSES. The Company agrees, whether or not the transactions hereby contemplated shall be consummated, to pay, and save you and any Transferee harmless against liability for the payment of, all out-of-pocket expenses arising in connection with this Agreement, the Notes, the Plan Documents and the transactions hereby and thereby contemplated, including, without limitation, (i) all such expenses incurred with respect to the enforcement of any provision of any such agreement or instrument or with respect to complying with any subpoena or other legal process or informal investigative order or other request by a governmental body for information served upon you or any Transferee or any of your or any Transferee's employees or agents in connection with this Agreement or the transactions contemplated hereby or by reason of your or any Transferee's having acquired any Note, any proposed modifications, consents, amendments or waivers (whether or not the same become effective) under or in respect of any such agreement or instrument, and all expenses incurred in connection with the preparation of such agreements and instruments, (ii) all stamp, documentary or other similar issuance or transaction taxes (together in each case with interest and penalties, if any, and any income tax payable by you or any Transferee in respect of any reimbursement therefor) which may be payable in respect of the execution and delivery of such agreements or instruments, or the issuance, delivery or purchase by you of any Note, including, without limitation, any excise taxes imposed under the Code by reason of the

59

failure of the ESOT Transaction to satisfy the requirements of section 4975 of the Code for exemption from the provisions thereof, and (iii) all document production and duplication charges and the fees and expenses of your or any Transferee's special counsel and all local counsel retained in connection with such agreements and instruments, and the transactions hereby and thereby contemplated, including the enforcement of any provision hereof or thereof, and any such proposed modifications, consents, amendments or waivers (whether or not the same become effective), including without limitation costs and expenses incurred in any bankruptcy case. The Company further agrees to indemnify and save harmless you and any Transferee and each of your and any Transferee's officers, directors, employees and agents (each herein called an "indemnified person") from and against any and all actions, causes of action, suits, losses, liabilities and damages, and expenses (including, without limitation, attorneys' fees and disbursements provided, in any related series of actions involving different Persons but with common interests and with no conflicting interests, only one counsel's fees and disbursements shall be so reimbursed) in connection therewith (herein called the "indemnified liabilities") incurred by any indemnified person as a result of, or arising out of, or relating to any of the transactions contemplated hereby, except for any indemnified liabilities arising on account of the gross negligence or willful misconduct of such indemnified person provided that, if and to the extent the Company's agreement to indemnify may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the indemnified liabilities which shall be permissible under applicable law. If the Closing does not occur, the Company's obligations to you shall be limited to those set forth in this Section 14B.

14C. CONSENT TO AMENDMENTS. (i) This Agreement may be amended with the consent of both the Company and the ESOT, and with such consent the Company or the ESOT, as the case may be, may take any action herein prohibited, or omit to perform any act herein required to be performed by it, but in any of the foregoing cases only if there shall have been obtained the written consent to such amendment, action or omission to act, of the Required Holder(s), except that, without the written consent of the holder or holders of all Notes at the time outstanding, no amendment to this Agreement shall change the maturity of any Note or the right of any holder of a Note to accelerate such Note pursuant to paragraph 9A, or change the principal of, or the rate or time of payment of interest or any premium payable with respect to any Note, or change any of the provisions of paragraph 7 or 8, or affect the time, amount or allocation of any Required Installment Payments, or change any of the provisions of paragraph 4B or 4D or reduce the proportion of the principal amount of the Notes required with respect to any consent. Each holder of a Note at the time or thereafter outstanding shall be bound by any consent authorized by this paragraph 14C, whether or not such Note shall have been marked to indicate such consent,

60

but any Notes issued thereafter may bear a notation referring to any such consent. No course of dealing between the ESOT or the Company and any holder of a Note nor any delay in exercising any rights hereunder or under any Note shall operate as a waiver of any rights of such holder of a Note. As used herein and in the Notes, the term "this Agreement" or references thereto shall mean this Agreement as it may from time to time be amended or supplemented.

(ii) Neither the ESOT nor the Company will solicit, request or negotiate for or with respect to any proposed waiver or amendment of any of the provisions of this Agreement or the Notes unless each holder of Notes (irrespective of the amount of Notes then held by it) shall be informed thereof by the ESOT or the Company, as the case may be, and shall be afforded an opportunity of considering the same and shall be supplied by the ESOT or the Company, as the case may be, with sufficient information to enable it to make an informed decision with respect thereto. Executed or true and correct copies of any waiver or consent effected pursuant to the provisions of this Agreement shall be delivered by the ESOT or the Company, as the case may be, to each holder of Notes forthwith following the date on which the same shall have been executed and delivered by the holder or holders of the requisite percentage of outstanding Notes. Neither the ESOT nor the Company will, directly or indirectly, pay or cause to be paid any remuneration, whether by way of supplemental or additional interest, fee or otherwise, to any holder of Notes as consideration for or as an inducement to the entering into by such holder of Notes of any waiver or amendment of any of the terms and provisions of this Agreement unless such remuneration is concurrently paid, on the same terms, ratably to all such holders of Notes.

14D. FORM, REGISTRATION, TRANSFER AND EXCHANGE OF NOTES; LOST NOTES. The Notes are issuable as registered Notes without coupons in denominations of at least $500,000, except as may be necessary to reflect any principal amount not evenly divisible by $500,000. The ESOT shall keep or cause to be kept at its principal office or at the offices of its designated agent (the "ESOT Agent"), which shall initially be the Trustee or such other ESOT Agent as the ESOT shall from time to time designate and so notify the holders of the Notes, a register in which it shall provide for the registration of Notes and of transfers of Notes. Any registered holder of a Note shall be entitled, upon its written request, to receive from the ESOT Agent a list of the registered holders of the Notes and the respective principal amounts of Notes held by such holders. Upon surrender for registration of transfer of any Note at the principal office of the ESOT Agent it shall, at its expense, execute and deliver one or more new Notes of like tenor and of a like aggregate principal amount, which Notes shall be registered in the name of such transferee or transferees. At the option of the holder of any Note, such Note may be exchanged for Notes of like tenor and of any authorized denominations, of a like aggregate principal amount, upon

61

surrender of the Note to be exchanged at the principal office of the ESOT Agent. Whenever any Notes are so surrendered for exchange, the ESOT shall, at its expense, execute and deliver the Notes which the holder making the exchange is entitled to receive. Every Note surrendered for registration of transfer or exchange shall be duly endorsed, or be accompanied by a written instrument of transfer duly executed, by the holder of such Note or such holder's attorney duly authorized in writing. Any Note or Notes issued in exchange for any Note or upon transfer thereof shall carry the rights to unpaid interest and interest to accrue which were carried by the Note so exchanged or transferred, so that neither gain nor loss of interest shall result from any such transfer or exchange and shall be accompanied by the amortization schedule required by paragraph 4A. Upon receipt of written notice from the holder of any Note of the loss, theft, destruction or mutilation of such Note and, in the case of any such loss, theft or destruction, upon receipt of such holder's unsecured indemnity agreement, or in the case of any such mutilation upon surrender and cancellation of such Note, the ESOT will make and deliver a new Note, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Note, which shall be accompanied by the amortization schedule required by paragraph 4A. In the case of Company Notes, references in this paragraph to "ESOT" shall be deemed to be references to the "Company".

14E. PERSONS DEEMED OWNERS; PARTICIPATIONS. Prior to due presentment for registration of transfer, the ESOT (or the Company, in the case of Company Notes) may treat the Person in whose name any Note is registered as the owner and holder of such Note for the purpose of receiving payment of principal of and premium, if any, and interest on, such Note and for all other purposes whatsoever, whether or not such Note shall be overdue, and the ESOT shall not be affected by notice to the contrary. Subject to the preceding sentence, the holder of any Note may from time to time grant participations in all or any part of such Note to any Person on such terms and conditions as may be determined by such holder in its sole and absolute discretion.

14F. SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT. All representations and warranties contained herein or made in writing by or on behalf of the parties hereto in connection herewith shall survive the execution and delivery of this Agreement and the Notes, the transfer by you of any Note or portion thereof or interest therein and the payment of any Note, and may be relied upon by any Transferee, regardless of any investigation made at any time by or on behalf of you or any Transferee. Subject to the preceding sentence, this Agreement and the Notes embody the entire agreement and understanding between you, the ESOT and the Company and supersede all prior agreements and understandings relating to the subject matter hereof. The obligations of the Company and/or the ESOT under paragraph 7, paragraph 8 and paragraph 14B shall survive the transfer, purchase or payment of any Note (in

62

whole or in part) and the rights of each Person arising under said paragraphs may not be changed without the consent of such Person.

14G. SUCCESSORS AND ASSIGNS. All covenants and other agreements in this Agreement made by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors and assigns of the parties hereto (including, without limitation, any Transferee) whether so expressed or not.

14H. DISCLOSURE TO OTHER PERSONS. Each of the Company and the ESOT acknowledges that the holder of any Note may deliver copies of any financial statements and other documents delivered to such holder, and disclose any other information disclosed to such holder, by or on behalf of the ESOT, the Company or any Subsidiary in connection with or pursuant to this Agreement to (i) such holder's directors, officers, employees, agents and professional consultants,
(ii) any other holder of any Note, (iii) any Person to which such holder offers to sell such Note or any part thereof, (iv) any Person to which such holder sells or offers to sell a participation in all or any part of such Note, (v) any Federal or state regulatory authority having jurisdiction over such holder, (vi) the National Association of Insurance Commissioners or any similar organization or (vii) any other Person to which such delivery or disclosure may be necessary or appropriate (a) in compliance with any law, rule, regulation or order applicable to such holder, (b) in response to any subpoena or other legal process or informal investigative order, (c) in connection with any litigation to which such holder is a party or (d) in order to protect such holder's investment in such Note.

14I. NOTICES. All communications provided for hereunder shall be sent by first class mail or nationwide overnight delivery service (with charges prepaid) and (i) if to you, addressed to you at the address specified for such communications in the Purchaser Schedule hereto attached, or at such other address as you may have designated to the other parties hereto in writing, (ii) if to any other holder of any Notes, addressed to such holder at the registered address of such holder as set forth in the register kept by the ESOT at its principal office as provided in paragraph 14D, or at such other address as such holder may have designated to the other parties hereto in writing, (iii) if to the Company, addressed to it at 3000 Westchester Avenue, Harrison, New York 10528, Attention: Vice President and Treasurer, and (iv) if to the ESOT addressed to it at the address set forth in the heading of this Agreement, Attention: DIVISION HEAD, INSTITUTIONAL TRUST DIVISION or to such other address or addresses as the Company or the ESOT may have designated in writing to you and each other holder of any of the Notes at the time outstanding; provided, however, that any such communication to the Company may also, at your option, be either delivered

63

to the Company at its address set forth above or to any principal executive or financial officer of the Company.

14J. DESCRIPTIVE HEADINGS. The descriptive headings of the several paragraphs of this Agreement are inserted for convenience only and do not constitute a part of this Agreement.

14K. SATISFACTION REQUIREMENT. If any agreement, certificate or other writing, or any action taken or to be taken, is by the terms of this Agreement required to be reasonably satisfactory to you or the Required Holder(s), the determination of such reasonable satisfaction shall be made by you or the Required Holder(s), as the case may be, in the sole and exclusive judgment (exercised in good faith) of the Person or Persons making such determination.

14L. GOVERNING LAW. THIS AGREEMENT AND THE NOTES SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE LAW OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO THE PRINCIPLES OF CONFLICT OF LAW THEREOF.

14M. COUNTERPARTS. This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, and it shall not be necessary in making proof of this Agreement to produce or account for more than one such counterpart.

14N. REPRODUCTION OF DOCUMENTS. This Agreement and all documents relating hereto, including, without limitation (i) consents, waivers and modifications which may hereafter be executed, (ii) documents received by any party at the closing (except the Notes themselves), and (iii) financial statements, certificates and other information previously or hereafter furnished to any party may be reproduced by such party by any photographic, photostatic, microfilm, micro-card, miniature photographic or other similar process and such party may destroy any original documents so reproduced. The parties hereto agree and stipulate that, to the extent permitted by applicable law, any such reproduction shall be admissible in evidence as the original itself in any judicial or administrative proceeding (whether or not the original is in existence) and that any enlargement, facsimile or further reproduction of such reproduction shall likewise be admissible in evidence.

14O. TRUSTEE LIABILITY. You acknowledge that the Trustee is executing this Agreement and the Notes solely in its capacity as trustee under the Trust Agreement and at the written direction of the Company. Notwithstanding anything contained elsewhere in this Agreement and the Notes, the Trustee shall

64

have no liability or obligation of any kind to you or your assigns or successors, or any other Person claiming by or through you, as a result of the execution of this Agreement or the Notes or in connection with any actions taken or not taken in connection herewith or therewith, including without limitation the carrying out of or the failure to carry out any of the covenants made herein or therein, except for damages suffered by you as a result of acts or omissions on the part of the Trustee constituting gross negligence or wilful misconduct.

If you are in agreement with the foregoing, please sign the form of acceptance on the enclosed counterpart of this letter and return the same to the undersigned, whereupon this letter shall become a binding agreement between you and the undersigned.

Very truly yours,
THE MELVILLE CORPORATION AND

SUBSIDIARIES EMPLOYEE STOCK
OWNERSHIP PLAN TRUST

By THE BANK OF NEW YORK,
as Trustee

By: _____________________
Title:

MELVILLE CORPORATION
By: _____________________
Title:

65

EXHIBIT A-1

[FORM OF NOTE]

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY BE SOLD, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION ONLY PURSUANT TO AN EXEMPTION THEREFROM.

THE MELVILLE CORPORATION
SUBSIDIARIES EMPLOYEE
STOCK OWNERSHIP PLAN TRUST OF
THE MELVILLE CORPORATION AND
SUBSIDIARIES EMPLOYEE STOCK
OWNERSHIP PLAN

8.60% ESOP NOTE DUE DECEMBER 31, 2008

No. _______ [DATE] $__________

FOR VALUE RECEIVED, the undersigned trust established by the Melville Corporation and Subsidiaries Employee Stock Ownership Plan Trust Agreement (the "ESOT") of the Melville Corporation and Subsidiaries Employee Stock Ownership Plan (the "Plan"), hereby promises to pay to or registered assigns, the principal sum of DOLLARS with interest (computed on the basis of a 360-day year of twelve 30-day months) from the date hereof (a) on the unpaid balance thereof at the rate of 8.60% per annum (subject to adjustment, as provided in the Note Agreements hereinafter referred to) until the principal hereof shall have become due and payable, and (b) on each overdue payment (including any overdue prepayment) of principal and premium, if any, and, to the extent permitted by applicable law, each overdue payment of interest (payable, at the option of the registered holder hereof, on demand), at a rate per annum from time to time equal to the greater of (i) the rate of interest on this Note in effect at the time such payment was due, plus 2% per annum, or (ii) the rate of interest publicly announced by Morgan Guaranty Trust Company of New York from time to time in New York City as its Prime Rate, until such overdue amount shall have been paid in full. Accrued interest is payable in arrears, commencing on December 31, 1989, and thereafter on October 31, 1990, October 31, 1991, October 31, 1992, and on December 31, 1993 and each December 31 thereafter up to and including December 31, 2008. The principal of this Note is payable in installment payments as set forth on the Amortization Schedule annexed hereto.


1. Place of Payment. Payments of both principal and interest are to be made at the office of Morgan Guaranty Trust Company of New York, or such other place as the holder hereof shall designate to the ESOT in writing, in lawful money of the United States of America.

2. ESOP. This note is one of a number of 8.60% ESOP Notes Due December 31, 2008 (herein called the "Notes") in an original agaregate principal amount of $357,500,000 issued by the ESOT pursuant to certain Note Purchase Agreements (the "Note Agreements"), dated as of June 7, 1989, among the ESOT, Melville Corporation (the "Company") and the purchasers named therein, and is entitled to the benefits thereof.

3. Registered Notes. The Notes are issuable only as registered Notes. As provided in the Note Agreements, upon surrender of this Note for registration of transfer, duly endorsed, or accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder's attorney duly authorized in writing, a new Note for a like principal amount will be issued to, and registered in the name of, the transferee. Prior to due presentment for registration of transfer, the ESOT may treat the person in whose name this Note is registered as the owner hereof for the purpose of receiving payment and for all other purposes, and the Trustee shall not be affected by any notice to the contrary.

4. Defaults. In case an Event of Default, as defined in the Agreements, shall occur and be continuing, the principal of this Note may be declared or otherwise become due and payable in the manner and with the effect provided in the Note Agreements.

5. No Recourse. The holder of this Note shall not have any recourse against the ESOT or its trustees, except to the extent of the assets of the ESOT that are permitted under Treasury Regulation section 54.4975-7(b)(5) and 54.4975-7(b)(6) and any successor thereto, to be used to repay the Notes.

6. Guarantee. Payments under this Note are guaranteed by the Company pursuant to the Note Agreements.

THE MELVILLE CORPORATION AND
SUBSIDIARIES EMPLOYEE STOCK
OWNERSHIP PLAN TRUST OF THE
MELVILLE CORPORATION AND
SUBSIDIARIES EMPLOYEE STOCK
OWNERSHIP PLAN

2

By: _______________________________ Trustee

[By: ______________________________ Trustee]

3

AMORTIZATION SCHEDULE

8.60% ESOP NOTES

Percent of original
Date principal amount

EXHIBIT A-3

AMORTIZATION OF PRINCIPAL

Payment
 Date                            Principal Amount
--------                         ----------------
                                         $


EXHIBIT B-2

[FORM OF OPINION OF COMPANY COUNSEL]

[Date of Closing]

To each of the Purchasers named in
Schedule I hereto

Ladies and Gentlemen:

As General Attorney of Melville Corporation (the "Company"), I am familiar with the several Note Purchase Agreements, each dated as of June 7, 1989, among the trust established by the Melville Corporation and Subsidiaries Employee Stock Ownership Plan Trust Agreement (the "ESOT") of the Melville Corporation and Subsidiaries Employee Stock Ownership Plan (the "Plan"), as issuer, the Company, as guarantor, and, respectively, each of you (the "Note Agreements"), pursuant to which the ESOT has today issued its Notes in the aggregate principal amount of $357,500,000. Capitalized terms used herein without definition are used as defined in the Note Agreements.

In rendering the opinions set forth below, I have examined the originals or photostatic or certified copies of certain of the corporate records and documents of the Company, copies of public documents, certificates of officers or reptesentatives of the Company and such other instruments and documents, and have made such inquiries as I have deemed relevant and necessary as a basis for such opinions. I have assumed the authenticity of all documents submitted to me as originals and the conformity to original documents of all documents submitted to me as certified or photostatic copies. As to questions of fact material to the opinions hereinafter expressed, I have relied upon the representations and warranties of the Company made in the Note Agreements and the Plan Documents and upon certain certificates of and representations from other empicyees of the Company (which reliance I believe to be reasonable based upon my general knowledge of the Company and its affairs).

Based upon the foregoing, I am of the opinion that:

1. The Company and each of its Subsidiaries are qualified to do business in every jurisdiction in which the nature of the business conducted by the Company or such Subsidiary, as the case may be, makes such qualification


necessary and where the failure so to qualify would have a material adverse effect on the business, financial condition or operations of the Company and its Subsidiaries taken as a whole.

2. The execution and delivery of the Plan Documents and the Note Agreements, the guarantee of the Notes, the authorization of the Company Notes, the consummation of the ESOT Transaction and the fulfillment of and compliance with the respective provisions of the Note Agreements, the Notes and the Plan Documents do not conflict with, or result in a breach of the terms, conditions or provisions of, or constitute a default under, or result in any violation of, or result in the creation of any Mortgage upon, any of the material properties or assets of the Company or any Subsidiary pursuant to, or require any authorization, consent, approval, exemption or other action by or notice to or filing with any court, administrative or governmental body or other Person (other than routine filings not relating to the validity of any of the foregoing) pursuant to, the charter or By-Laws of the Company or any Subsidiary, any law, regulation, award of any arbitrator or any agreement, instrument, order, judgment or decree to which the Company or a Subsidiary is a party or by which the Company or a Subsidiary or any of their respective properties is subject.

3. There are no actions, suits or proceedings at law or in equity or by or before any governmental instrumentality or other agency or regulatory authority now pending or, to the best of my knowledge, threatened against or affecting the Company or any of its Subsidiaries or the ESOT or any of their respective property or assets, which questions the legality or validity of, or seeks damages in connection with, the Note Agreements, the Plan Documents, the ESOT Transaction or any action taken or to be taken pursuant to the Note Agreements or the Plan Documents, or which, if determined adversely to the Company or any of its Subsidiaries, would individually or in the aggregate have a material adverse effect on the consolidated financial position, shareholders' equity or results of operation of the Company and its Subsidiaries taken as a whole. Neither the Company nor any of its Subsidiaries is in violation of any order, injunction or decree of any governmental instrumentality or regulatory authority, where such violation would have a material adverse effect on the business, condition, operations or prospects (financial or other) of the Company and its Subsidiaries, taken as a whole.

Very truly yours,

2

EXHIBIT B-3

[FORM OF OPINION OF COUNSEL TO THE ESOT]

[Date of Closing]

To Each of the Purchasers
Party to the Note Agreements
Referred to Below

The Melville Corporation and Subsidiaries Employee Stock Ownership Plan Trust 8.60% Guaranteed ESOP Notes due

Dear Purchaser:

We have acted as counsel to The Bank of New York ("BNY") in connection with the Melville Corporation and Subsidiaries Employee Stock Ownership Plan Trust Agreement, dated June 7, 1989 (the "Trust Agreement") establishing the trust (the "Trust") which forms part of the Melville Corporation and Subsidiaries Employee Stock Ownership Plan (the "Plan"). In addition, we have acted as counsel to BNY, not in its individual capacity but solely in its capacity as trustee under the Trust Agreement (the "Trustee"), in connection with (a) the separate identical Note Purchase Agreements (the "Note Agreements"), dated as of June 7, 1989, between the Trust (also known as the "ESOT" for purposes of the Note Agreements) and you and each of the other institutional ivestors named in the Purchaser Schedule thereto (the "Other Purchasers"), respectively, pursuant to which the ESOT has issued to you and the Other Purchasers today $357,500,000 aggregate principal amount of its 8.60% Guaranteed ESOP Notes due January 2, 2009 (the "Notes"); and (b) the Preference Stock Purchase Agreement, dated as of June 7, 1989, between the ESOT and Melville Corporation (the "Stock Purchase Agreement"). Capitalized terms used in this letter that are not otherwise defined shall have the meanings assigned to them in the Note Agreements.

For purposes of rendering the opinions contained in this letter, we have examined and reviewed the following:

(i) the Trust Agreement;

(ii) the ESOP plan document;

(iii) the form of Note Agreement;


(iv) the form of Note;

(v) the Stock Purchase Agreement;

(vi) the Trustee's Certificate dated June , 1989;

(vii) the Certificate of Incumbency, dated June , 1989, of BNY;

(viii) the Registration Rights Agreement;

(ix) the opinion to you dated as of the date hereof of Davis Polk &

        Wardwell;

(x)     the Letter to the ESOT of Duff & Phelps Financial Consulting
        Co., dated June     , 1989;

(xi)    [(other documents?]

In addition, we have examined applicable provisions of the Internal Revenue Code of 1986 (the "Code"), and of the Employee Retirement Income Security Act of 1974, as amended ("ERISA"), regulations issued thereunder by the Departments of Labor and the Treasury and such other authorities as we have deemed relevant.

In rendering the opinions set forth herein, we have assumed that (i) all signatures on the documents listed above are genuine, (ii) all copies submitted to us as certified, conformed or photostatic copies conform to the original documents, and (iii) all statements, representations and warranties and recitals of fact set forth in such documents are true and all covenants and other terms set forth therein will be observed by all parties in all respects. Accordingly, with your consent, we have relied upon such statements, representation and warranties and recitals of fact without further investigation or independent verification.

In rendering the opinions set forth in paragraphs 5 and 6 below, we have relied with your consent upon the opinions expressed in numbered paragraph 5 of the opinion letter of Davis Polk & Wardwell referred to above. We express no opinions as to the matters covered in such opinion except to the extent expressly provided herein. For purposes of rendering the opinions set forth in paragraph 6 below, we have also, with your consent, relied upon a certificate of the Trustee attached hereto, and we understand that in giving such certificate the Trustee has relied upon the opinion of Duff & Phelps Financial Consulting Co. as to matters of fairness and value.

2

The opinions set forth in paragraph 6 below are based on the provisions of the Code and ERISA as in effect on the date hereof. We express no opinion concerning the effect of pending legislation, proposed, temporary or final rules or regulations, or other authoritative guidance which is hereafter enacted, adopted or issued. New developments in administrative regulations, court decisions, legislative changes, rulings of any agency, or changes in the facts or other information upon which our opinions are based may have an adverse effect on the legal consequences described herein. Such developments have recently become commonplace in the field of employee benefits. Any such change could be retroactive so as to apply to any party to any of the documents listed above or any of the transactions contemplated thereby. Although our opinions represent our best legal judgment, they may be subject to challenge by any governmental agency and are not binding on any governmental agency or the courts.

We are members of the Bar of the State of New York and do not purport to be experts on, or to express any opinions concerning, any laws other than (i) the laws of the State of New York and (ii) the federal laws of the United States of America.

Based upon the foregoing, and subject to the limitations and qualifications set forth herein and having regard to the legal considerations we deem relevant, we are of the opinion that:

1. BNY is a New York banking association duly organized, validly existing and in good standing under the laws of New York. BNY has all requisite power and authority to execute, deliver and perform all of its obligations under the Trust Agreement.

2. The Note Agreements, the Notes, the Trust Agreement and the Stock Purchase Agreement (a) have been duly authorized, executed and delivered by BNY or the Trustee, as the case may be, and (b) constitute legal, valid and binding agreements of BNY or the ESOT, as the case may be, enforceable in accordance with their respective terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors' rights and remedies generally and subject to general principles of equity, including principles of commercial reasonableness, good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity).

3. The execution, delivery and performance of the Trust Agreement by BNY, and the execution, delivery and performance of the Note Agreements, the Notes and the Stock Purchase Agreement by the Trustee, will not violate the charter or the By-Laws of BNY, any order, writ, judgment, injunction, decree, determination or award presently in effect of which we have knowledge and

3

which is binding on the Trustee or the ESOT, or any provision of any indenture, agreement or other instrument to which the ESOT or the Trustee is a party, or by which the ESOT or the Trustee or any of their respective properties or assets are or may be bound.

4. The Plan and the ESOT are, and, from the date of their adoption or latest amendment and restatement, respectively, have been, in form, qualified and tax-exempt under section 401(a) and 501(a) of the Code. The ESOT is, and, from its date of adoption, has been, in form, an employee stock ownership plan within the definition of section 4975(e)(7) of the Code and section 407(d)(6) of ERISA.

5. The acquisition by the ESOT of the Employer Capital Stock pursuant to the terms of the Stock Purchase Agreement qualify for the prohibited transaction exemption provided by Section 408(e) of ERISA and Section 4975(d)(13) of the Code. The consummation of the transactions specifically provided for in the Note Agreements, the compliance by the ESOT with the terms of the Note Agreements and the Notes, and the receipt of the proceeds of the Notes by the ESOT qualify for the prohibited transactions exemption provided by Section 408(b)(3) of ERISA, Section 4975(d)(3) of the Code and Treasury Regulation Section 54.4975-7.

6. To the best of our knowledge, there are no actions, suits or proceedings at law or in equity or by or before any governmental instrumentality or other agency or regulatory authority now pending against the ESOT, which involve the ESOT Transaction, or which might individually or in the aggregate materially impair the ability of the ESOT to conduct its affairs substantially as now conducted or as proposed to be conducted, or materially and adversely affect the activities or financial condition of the ESOT, or impair in any material respect the validity or enforceability of, or the ability of the Trustee or the ESOT to perform their respective obligations under, the Plan Documents.

The foregoing opinions are based on and subject to the following assumptions and understandings:

(a) We render no opinion regarding Section 406(b)(3) of ERISA or Section 4975(c)(1)(F) of the Code.

(b) In connection with the opinion set forth in paragraph 5 above, we understand that the Plan will be communicated to employees of the Company on or shortly after the date of its adoption and that further employee communications are scheduled to commence shortly after the Closing. We have assumed that the Plan and the ESOT will be submitted by us, within the time limits described under section 401(b) and the regulations thereunder, to the appropriate District Director

4

of Internal Revenue together with an application requesting a determination that the Plan satisfies and that the ESOT continues to satisfy the requirements for qualifications and exemption from federal income taxation under sections 401(a) and 501(a) of the Code, respectively, and that the Plan satisfies the requirements for qualification as an "employee stock ownership plan" under section 4975(d)(7) of the Code. In instances where the Code has been amended to impose qualification requirements that are inconsistent with administrative regulations adopted prior to such amendment, we have drafted the Plan and the ESOT to comply with the requirements of the Code. Although the District Director may require certain technical changes to be adopted before issuing a favorable determination letter, we note that paragraph 5F of the Note Agreements includes broad affirmative covenants on the part of the Company to apply for and obtain a favorable determination letter, and to make whatever amendments are required to assure that the Plan and the ESOT meet the requirements for qualification and exemption from taxation under sections
401(a), 501(a) and 4975(e)(7) of the Code. We have assumed that whatever amendments are required to assure that the Plan and the ESOT meet the requirements for qualification and exemption from taxation under sections
401(a), 501(a) and 4975(e)(7) of the Code and to exempt the loan to the ESOT evidenced by the sale of the Notes from the prohibited transaction provisions of sections 4975(c) of the Code and 406 of ERISA by reason of sections 4975(d)(3) and 408(b)(3) of ERISA will in fact be adopted. We specifically note that we do not express an opinion as to the effect on the qualification of the Plan of its operation subsequent to the date of the Closing.

(c) Our opinions in paragraph 6 are conditioned on and subject to a determination by the appropriate Plan fiduciary that, in accordance with
Section 4975(d)(3) of the Code and Section 408(b)(3) of ERISA, (i) the Note Agreements and the Notes are primarily for the benefit of participants and beneficiaries of the Plan and (ii) the Notes bear a reasonable rate of interest. In particular, Treasury Regulation Sections 54.4975-7(b)(2), (3) and (7) describe the factual determinations that must be made by the Plan's fiduciaries in order to conclude that the Note Agreements and the Notes are primarily for the benefit of participants and beneficiaries and bear a reasonable rate of interest. We express no opinion regarding these factual determinations.

(d) Our opinions in paragraph 6 are conditioned on and subject to the determination by the appropriate Plan fiduciary that, in accordance with
Section 4975(d)(13) of the Code and Section 408(b) of ERISA, the ESOT's acquisition of Employer Capital Stock pursuant to the Stock Purchase Agreement will be for "adequate consideration" (as defined in Section 3(18) of ERISA). Because there is no generally recognized market for the
[ESOP Preference Shares], "adequate consideration" for this purpose will be the fair market value of the [ESOP Preference Shares] as determined in good faith by the Trustee. We note in this

5

regard that the Trustee has conducted such investigations and performed such analyses as it deemed appropriate and has concluded, according to the attached certificate, that the consideration to be paid by the [ESOT] for the
[ESOP Preference Shares] pursuant to the Stock Purchase Agreement does not exceed the fair market value of such [ESOP Preference Shares].

This opinion letter is furnished by us solely for the benefit of the addressees hereof. This opinion may not be relied upon by any other person, firm or corporation for any purpose without our prior written consent.

Very truly yours,

6

EXHIBIT C

[FORM OF COMPANY NOTE]

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY BE SOLD, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION ONLY PURSUANT TO AN EXEMPTION THEREFROM.

MELVILLE CORPORATION

PROMISSORY NOTE

No. ________ [DATE] $__________

FOR VALUE RECEIVED, the undersigned, MELVILLE CORPORATION (herein called the "Company"), a corporation organized and existing under the laws of the State New York, hereby promises to pay to , or registered assigns, the principal sum of DOLLARS with interest (computed on the basis of a 360-day year of twelve 30-day months) from the date hereof (a) on the unpaid balance thereof at the rate of 10.75% per annum until the principal hereof shall have become due and payable, and (b) on each overdue payment (including any overdue prepayment) of principal and premium, if any, and, to the extent permitted by applicable law, each overdue payment of interest (payable, at the option of the registered holder hereof, on demand), at a rate per annum from time to time equal to the greater of (i) the aforesaid annual rate of interest, plus 2% per annum or (ii) the rate of interest publicly announced by Morgan Guaranty Trust Company of New York from time to time in New York City as its Prime Rate, until such overdue amount shall have been paid in full. Accrued interest is payable in arrears, on each of the following dates occurring after the date of issuance hereof and if not so issued, commencing December 31, of the year following such issuance, and thereafter on each December 31, up to and including December 31, 2008. The principal of this Note is payable in installment payments as set forth on the Amortization Schedule annexed hereto.

1. Place of Payment. Payments of both principal and interest are to be made at the office of Morgan Guaranty Trust Company of New York, or such other place as the holder hereof shall designate to the Company in writing, in lawful money of the United States of America.


2. Company Notes. This note is one of a number of Promissory Notes (herein called the "Company Notes") issued by the Company pursuant to certain Note Purchase Agreements (the "Note Agreements"), dated as of June 7, 1989, among the Melville Corporation and Subsidiaries Employee Stock Ownership Trust of The Melville Corporation and Subsidiaries Employee Stock Ownership Plan, the Company and the purchasers named therein, and is entitled to the benefits thereof.

3. Registered Notes. The Company Notes are issuable only as registered notes. As provided in the Note Agreements, upon surrender of this Company Note for registration of transfer, duly endorsed, or accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder's attorney duly authorized in writing, a new Company Note for a like principal amount will be issued to, and registered in the name of, the transferee. Prior to due presentment for registration of transfer, the Company may treat the person in whose name this Company Note is registered as the owner hereof for the purpose of receiving payment and for all other purposes, and the Company shall not be affected by any notice to the contrary.

4. Defaults. In case an Event of Default, as defined in the Note Agreements, shall occur and be continuing, the principal of this Company Note may be declared or otherwise become due and payable in the manner and with the effect provided in the Note Agreements.

MELVILLE CORPORATION

By __________________________
Title:

2

AMORTIZATION SCHEDULE

8.60% COMPANY NOTES

                              Percent of Original
Payment Date                  Principal Amount
------------                  -------------------


MELVILLE CORPORATION

8.60% ESOP Notes Due 2008

Mandatory Redemption Schedule

(The following schedule assumes a closing as of June 1, 1989; an earlier closing may result in insignificant differences in the anticipated repayment schedule.)

     Date                               Principal Repayment
     ----                               -------------------
December 31, 1989                            $    6.4
October 31, 1990                                  1.7
October 31, 1991                                  0.1
October 31, 1992                                  3.4
December 31, 1993                                 3.2
December 31, 1994                                 7.4
December 31, 1995                                 10.8
December 31, 1996                                 14.3
December 31, 1997                                 18.1
December 31, 1998                                 22.3
December 31, 1999                                 14.5
December 31, 2000                                 17.2
December 31, 2001                                 20.9
December 31, 2002                                 25.7
December 31, 2003                                 31.3
December 31, 2004                                 22.0
December 31, 2005                                 26.5
December 31, 2006                                 31.4
December 31, 2007                                 36.9
December 31, 2008                                 43.5
                                                  ----

     Total                                   $    357.5 (1)
                                                  -----

The interest payment dates would match the highlighted repayment schedule dates.


(1) The average life is approximately 13.75 years.

PURCHASER SCHEDULE

Part I
List of Purchasers

                                  Principal Amount
                                     of Notes
                                  to be Purchased     Denominations
                                  ---------------     -------------

The Prudential Insurance           $148,450,000        148,450,000
     Company of America

John Hancock Mutual                $ 60,500,000        34,500,000
     Life Insurance Company                            26,000,000

Lincoln National Life              $38,500,000         See Purchase
     Insurance Company                                 Schedule Part II

Massachusetts Mutual Life          $ 33,000,000        11,000,000
     Insurance Company                                 22,000,000

The Variable Annuity Life          $ 27,500,000        27,500,000
     Insurance Company

Cigna Investments                  $ 22,000,000        22,000,000

American United Life               $ 8,800,000         2,000,000
     Insurance Company                                 2,000,000
                                                       2,000,000
                                                       2,800,000

Century Life Insurance Company     $ 2,000,000         2,000,000

Century Life of America            $ 3,000,000         3,000,000

Ohio National Life Insurance       $ 5,500,000         5,500,000
     Company

General American Life              $ 5,500,000         5,500,000
     Insurance Company

Provident Mutual Life              $ 2,750,000         2,750,000
     Insurance Company


If you are in agreement with the foregoing, please sign the form of acceptance on the enclosed counterpart of this letter and return the Vame to the undersigned, whereupon this letter shall become a binding agreement between you and the undersigned.

Very truly yours,

THE MELVILLE CORPORATION AND
SUBSIDIARIES EMPLOYEE STOCK
OWNERSHIP PLAN TRUST

By THE BANK OF NEW YORK,
as Trustee

By:  /s/ Glen A. Rothbart
     -------------------------------
     Title: Assistant Vice President

MELVILLE CORPORATION

By:  /s/ James A. Marcum
     -------------------------------
     Title: Treasurer


The foregoing Agreement is
hereby accepted as of the
date first above written.

THE PRUDENTIAL INSUAANCE COMPANY
OF AMERICA

By /s/ Richard B. Rogers
   ---------------------
   Title: Vice President


PURCHASER SCHEDULE

Part I
List of Purchasers

                                   Principal Amount
                                       of Notes
                                   to be Purchased          Denominations
                                   ---------------          -------------

The Prudential Insurance           $148,450,000             148,450,000
     Company of America

John Hancock Mutual                $ 60,500,000             34,500,000
     Life Insurance Company                                 26,000,000

Lincoln National Life              $38,500,000              See Purchase
   Insurance Company                                    Schedule Part II

Massachusetts Mutual Life          $ 33,000,000             11,000,000
     Insurance Company                                      22,000,000

The Variable Annuity Life          $ 27,500,000             27,500,000
     Insurance Company

Cigna Investments                  $ 22,000,000             22,000,000

American United Life               $ 8,800,000              2,000,000
     Insurance Company                                      2,000,000
                                                            2,000,000
                                                            2,800,000

Century Life Insurance Company     $ 2,000,000              2,000,000

Century Life of America            $ 3,000,000              3,000,000

Ohio National Life Insurance       $ 5,500,000              5,500,000
     Company

General American Life              $ 5,500,000              5,500,000
     Insurance Company

Provident Mutual Life              $ 2,750,000              2,750,000
     Insurance Company


PURCHASER SCHEDULE

                                       Part II
                            Notice and Payment Information

     Purchaser
     ---------

THE PRUDENTIAL INSURANCE           Melville Corporation ESOP
COMPANY OF AMERICA                 Notes due 2009
                                   $148,450,000

(1) All payments on account of Notes held by such purchaser shall be made by wire transfer of immediately available funds for credit to:

Account No. 050-54-460
Morgan Guaranty Trustee
of New York
23 Wall Street
New York, New York 10015

Each such wire transfer shall
set forth the name of the
Company, the full title
(including the coupon rate
and final maturity date)
of the Notes, a reference
to "Security No. 585745XA5",
and the due date and
application (as among principal,
premium and interest) of the
payment being made.

(2) Address for all notices relating to payments:

The Prudential Insurance
Company of America
c/o The Prudential Corporate
Finance Group

1

Four Gateway Center
100 Mulberry Street
Newark, New Jersey 07102-4007
Attention: Manager, Investment
Information Services

(3) Address for all other communications and notices:

The Prudential Insurance
Company of America
c/o The Prudential Corporate
Finance Group
Four Gateway Center
100 Mulberry Street
Newark, New Jersey 07102-4007

Attention: Senior Managing Director

(4) Tax Identification No.:

22-1211670

2

Name and Address of Purchaser
-----------------------------

JOHN HANCOCK MUTUAL LIFE INSURANCE     Melville Corporation ESOP
    COMPANY                            Notes 8.60%, due 2009
GUARANTEED BENEFIT SUB-ACCOUNT         $34,500,000

(1) Registered Securities in Name of John Hancock Mutual Life Insurance Company.

(2) All payments shall be made by bank wire transfer of immediately available funds not later than 12 noon, Boston time, to:

The First National Bank of Boston
100 Federal Street
Boston, Massachusetts 02110
Attention: Insurance Division
Account of: John Hancock Mutual Life Insurance Company GBSA Account
Account Number: 535-84164
On Order of: [Name of Issuer]

(3) Contemporaneous with the above wire transfer, advice setting forth (1) the full name, interest rate and maturity date of the Notes or other obligations; (2) allocation of payment between principal and interest and any special payment; and (3) name and address of Bank (or Trustee) from which wire transfer was sent, shall be delivered or mailed to:

John Hancock Mutual Life Insurance Company John Hancock Place
P.O. Box 111
Boston, Massachusetts 02117
Attention: Securities Administration T-56

(4) All other communications

John Hancock Mutual Life Insurance Company John Hancock Place
P.O. Box 111
Boston, Massachusetts 02117
Attention: Bond and Corporate Finance Department, T-57


(5) Tax Identification Number

04-1414660

2

Name and Address of Purchaser
-----------------------------
JOHN HANCOCK MUTUAL LIFE INSURANCE     Melville Corporation ESOP
    COMPANY                            Notes 8.60%, due 2009
GUARANTEED ACCOUNT                     $26,000,000

(1) All other communications shall be delivered or mailed to:

John Hancock Mutual Life Insurance Company John Hancock Place
P.O. Box 111
Boston, Massachusetts 02117
Attention: Bond and Corporate Finance Department T-57

(2) All securities shall be registered in the name of John Hancock Mutual Life Insurance Company.

(3) All payments shall be made by bank wire transfer of immediately available funds for credit, not later than 12 noon, Boston time, to:

The First National Bank of Boston
100 Federal Street
Boston, Massachusetts 02110
Attention: Insurance Division
Account of: John Hancock Mutual Life Insurance Company Account Number: 279-80008
On Order of: [Name of Issuer]

(4) Contemporaneous with the above wire transfer, advice setting forth (1) the full name, interest rate and maturity date of the Notes or other obligations; (2) allocation of payment between principal and interest and any special payment; and (3) name and address of Bank (or Trustee) from which wire transfer was sent, shall be delivered or mailed to:

John Hancock Mutual Life Insurance Company John Hancock Place
P.O. Box 111
Boston, Massachusetts 02117
Attention: Securities Administration T-56

(5) Tax Identification Number 04-1414660

3

Name and Address of Purchaser
-----------------------------
LINCOLN NATIONAL LIFE INSURANCE                   Melville Corporation ESOP
    COMPANY - (REO)                               Notes due 2009
                                                  $2,500,000

(1)  Registered Securities in Name of

     The Lincoln National Life
     Insurance Company

(2) All payments shall be made by bank wire transfer of immediately available funds to:

Bankers Trust Company
ABA # 021001033

Attention: 99-087-897
New York, NY
For Account of: Lincoln National Life Insurance Company - (REO)
Custody Acct Number: 98149

(3) Address for all communication and notice of payments:

Lincoln National Investment
Management Company
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Securities Investment
Division - 2R

(4) Send securities by registered/insured mail to:

Lincoln National Corporation
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Kenneth R. Hobson
Securities Custody Dept. - 1H

(5) Tax Identification Number 35-0472300

4

Name and Address of Purchaser
-----------------------------

LINCOLN NATIONAL LIFE INSURANCE        Melville Corporation ESOP
    COMPANY                            Notes due 2009
                                       $1,500,000

(1) Registered Securities in Name of

The Lincoln National Life
Reinsurance Company

(2) All payments shall be made by bank wire transfer of immediately available funds to:

Bankers Trust Company
ABA # 021001033

Attention: 99-087-897
New York, NY
For Account of: Lincoln National Life Reinsurance Company
Custody Acct Number: 98165

(3) Address for all communication and notice of payments:

Lincoln National Investment
Management Company
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Securities Investment
Division - 2R

(4) Send securities by registered/insured mail to:

Lincoln National Corporation
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Kenneth R. Hobson
Securities Custody Dept. - 1H

(5) Tax Identification Number 35-1679513

5

Name and Address of Purchaser
-----------------------------

LINCOLN NATIONAL LIFE INSURANCE        Melville Corporation ESOP
    COMPANY - (IAL)                    Notes due 2009
                                       $13,500,000

(1) Registered Securities in Name of

The Lincoln National Life
Insurance Company

(2) All payments shall be made by bank wire transfer of immediately available funds to:

Bankers Trust Company
ABA # 021001033

Attention: 99-087-897
New York, New York
For Account of: Lincoln National Life Insurance Company - (IAL)
Custody Acct. Number: 98194

(3) Address for all communication and notice of payments:

Lincoln National Investment
Management Company
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Securities Investment
Division - 2R

(4) Send securities by registered/insured mail to:

Lincoln National Corporation
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Kenneth R. Hobson
Securities Custody Dept. - 1H

(5) Tax Identification Number 35-0472300

6

Name and Address of Purchaser
-----------------------------

LINCOLN NATIONAL LIFE INSURANCE        Melville Corporation ESOP
    COMPANY SEPARATE ACCOUNT NO. 6     Notes due 2009
                                       $10,000,000


(1)  Registered Securities in Name of

     The Lincoln National Life
     Insurance Company Separate
     Account No. 6

(2) All payments shall be made by bank wire transfer of immediately available funds to:

Bankers Trust Company
ABA # 021001033

Attention: 99-087-897
New York, New York
For Account of: Lincoln National Life Insurance Company Separate Account No. 6 Custody Acct. Number: 98208

(3) Address for all communication and notice of payments:

Lincoln National Investment
Management Company
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Securities Investment
Division - 2R

(4) Send securities by registered/insured mail to:

Lincoln National Corporation
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Kenneth R. Hobson
Securities Custody Dept. - 1H

(5) Tax Identification Number 35-0472300

7

Name and Address of Purchaser
-----------------------------

LINCOLN NATIONAL LIFE                  Melville Corporation ESOP
   INSURANCE  COMPANY - (UIN)          Notes due 2009
                                       $5,000,000


(1)  Registered Securities in Name of

     The Lincoln National Life
     Insurance Company

(2) All payments shall be made by bank wire transfer of immediately available funds to:

Bankers Trust
ABA # 021001033

Attention: 99-087-897
New York, New York
For Account of: Lincoln National Life Insurance Company - (UIN)
Custody Acct. Number: 98127

(3) Address for all communication and notice of payments:

Lincoln National Investment
Management Company
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Securities Investment
Division - 2R

(4) Send securities by registered/insured mail to:

Lincoln National Corporation
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Kenneth R. Hobson
Securities Custody Dept. - 1H

(5) Tax Identification Number 35-0472300

8

Name and Address of Purchaser
------------------------------

FIRST PENN-PACIFIC LIFE INSURANCE      Melville Corporation ESOP
     COMPANY                           Notes due 2009
                                       $3,000,000


(1)  Registered Securities in Name of

     First Penn-Pacific Life
     Insurance Company in care of
     Mellon Bank, N.A.

(2) All payments shall be made by bank wire transfer of immediately available funds to:

Mellon Bank N.A.
Mellon Square, Pittsburg, PA
ABA #043000261
Attn. Collections/Mellon Pit/Trust/First Penn-Pacific Life Insurance Company/075-205


(with reference to security & payments)

(3) Address for all communication and notice of payments:

Lincoln National Investment
Management Company
1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Securities Investment Division 2-R

(4) Send securities by registered/insured mail to:

Mellon Securities Trust Company
120 Broadway, 33rd Floor
New York, New York 10271
Attn: Securities Teller Window -
Liz Fisher
For Acct. of: First Penn-Pacific
Life Ins. Co.

(5) Custody Acct. 075-205

9

(6) Tax Identification Number

23-2044248

10

Name and Address of Purchaser
-----------------------------

SECURITY-CONNECTICUT LIFE-             Melville Corporation ESOP
     (UNIVERSAL LIFE)                  Notes due 2009
                                       $3,000,000


(1)  Registered Securities in Name of

     Security-Connecticut Life
     Insurance Company - Universal Life

(2) All payments shall be made by bank wire transfer of immediately available funds to:

Connecticut National Bank
777 Main Street, Hartford, CT 06115 ABA Routing #: 011900445
For Account of: Security-Connecticut Life Ins. Co. - Universal Life
Custody Account No. 0156196

(with reference to security and payment)

(3) Address for all communication and notice of payments:

Lincoln National Investment Management Company 1300 South Clinton Street
Fort Wayne, IN 46801
Attention: Securities Investment Division 2-R

(4) Address for all notices with respect to payments:

Security-Connecticut Life
Insurance Company
20 Security Drive
Avon, CT 06001
Attentional: Brigid M. Webster

11

(5) Send securities by registered/insured mail to:

Security-Connecticut Life Insurance Company 20 Security Drive
Avon, CT 06001
Attention: Brigid M. Webster

(6) Tax Identification Number

35-1468921

12

Name and Address of Purchaser
-----------------------------

MASSACHUSETTS MUTUAL LIFE INSURANCE    Melville Corporation ESOP
COMPANY                                Notes 8.60% due 2009
                                       $33,000,000

Number and Denomination of Note(s):

Two (2) Notes as follows $11,000,000 $22,000,000

(1) All payments on or in respect of the Notes to be by bank wire transfer of Federal or other immediately available funds (identifying each payment as, principal or interest") to:

Chemical Bank
Institutional Custody Department
55 Water Street
North Building
3rd Floor
New York, New York 10041

(i) in the case of Note No. R-1, (11,000,000) for credit to Massachusetts Mutual Life Insurance Company's "Mass Mutual IPL Traditional Account" No. 321-029-852

(i) in the case of Note No. R-2, (22,000,000) for credit to Massachusetts Mutual Life Insurance Company's "Mass Mutual SPC Account" No. 3890-4953

with telephone advice to the
Financial Services Department of
Massachusetts Mutual Life Insurance Company

13

(2) Address for all communications and notice of payment:

Massachusetts Mutual Life Insurance Company 1295 State Street
Springfield, Massachusetts 01111
Attention: Securities Investment Division

(3) Send all securities by registered/ insured mail to:

Citibank, N.A.
20 Exchange Place
New York, New York 10005

None.

(4) Tax Identification Number

04-1590850

14

Name and Address of Purchaser
-----------------------------

THE VARIABLE ANNUITY LIFE INSURANCE    Melville Corporation ESOP
    COMPANY                            Notes 8.60% due 2009
                                       $27,500,000

(1) All payments to be by wire transfer of immediately available funds with sufficient information (including interest rate, maturity date, interest amount, principal amount and premium amount, if applicable) to identify the source and application of such funds, to:

State Street Bank and Trust Company
BOS/SPEC/O10O-0002-8

Mutual Fund - Maryanne Bertone
Re: American General/VALIC PA 54

(2) All Notices of Payments and written confirmation of such wire transfers:

American General/VALIC
P.O. Box 17416
Newark, NJ 07194

with duplicate notices to:

The Variable Annuity Life Insurance Company % American General Corporation
2929 Allen Parkway
Houston, Texas 77019
Attn: Private Placements, A37-01

(3) All other communications to:

The Variable Annuity Life Insurance Company % American General Corporation
2929 Allen Parkway
Houston, Texas 77019
Attn: Private Placements, A37-01

(4) Tax Identification Number:

74-1625348

15

Name and Address of Purchaser
-----------------------------

CONNECTICUT GENERAL LIFE INSURANCE     Melville Corporation ESOP
     COMPANY                           Notes 8.60% due 2009
                                       $22,000,000

(1) In the case of all payments on account of the Notes:

By crediting in the form of bank wire transfer of Federal or other immediately available funds, providing sufficient information to identify the source of the transfer, and the amount of interest and/or principal, to Connecticut General Life Insurance Company Account No.
201-012-7 at:

The Connecticut Bank and Trust Company, National Association
One Constitution Plaza
Hartford, Connecticut 06115

(2) In the case of all notices with respect to payments:

Connecticut General Life Insurance Company c/o CIGNA Investments, Inc.
Hartford, Connecticut 06152
Attention: Securities Accounting
Department

(3) In the case of other communications:

Connecticut General Life Insurance Company c/o CIGNA Investments, Inc.
Hartford, Connecticut 06152 *
Attention: Private Placement Department

16

* In the event that notices/communications are sent by courier (e.g., Federal Express, Airborne) or Express Mail rather than by regular U.S. Postal Service, substitute "900 Cottage Grove Road, Bloomfield, Connecticut 06002" in place of "Hartford, Connecticut 066152."

(4) Tax Identification Number

06-0303370

17

Name and Address of Purchaser
-----------------------------
AMERICAN UNITED LIFE INSURANCE                     Melville Corporation ESOP
     COMPANY                                       Notes 8.60% due 2009
                                                   $8,800,000

     Number and Denomination of Note(s):

          Four (4) Notes as follows:    $2,000,000
                                        $2,000,000
                                        $2,000,000
                                        $2,800,000

(1) Registered Securities in the name of American United Life Insurance Company

(2) All payments in immediately available funds by wire transfer to the following bank account:

Bank One Indianapolis
ABA #0740-0001-0
Account #32032-50
Securities Trust Area
8th Floor
101 Monument Circle
Indianapolis, IN 46277

(3) Address for all communications and Notice of payment:

Securities Department
American United Life Insurance Company Post Office Box 368
Indianapolis IN 46206

(4) Send all securities by registered/ insured mail to:

Bank One Indianapolis
101 Monument Circle
Indianapolis IN 46277
Attention: Safekeeping Dept.

18

(5) Tax Identification Number

35-0145825

19

Name and Address of Purchaser
-------------------------------
CENTRAL LIFE INSURANCE COMPANY               Melville Corporation ESOP
                                             Notes 8.60% due 2009
                                             $2,000,000

(1)  All payments by wire transfer
     of immediately available funds
     to:

     The Northern Trust Company
     50 South LaSalle Street
     Chicago, IL 60675 ABA#071000152

For credit to Century Life Insurance Co., Account #433-063
with sufficient information
to identify the source and application of such funds.

(2) All notices of payments and written confirmations of such wire transfers:

Century Life Insurance Company
ATTN: Cashier Department
Heritage Way
Waverly, IA 50677

(3) All other communications:

Century Life Insurance Company
ATTN: Securities Division
Heritage Way
Waverly, IA 50677

(4) Tax Identification Number

42-1153896

20

Name and Address of Purchaser
----------------------------------
CENTURY LIFE OF AMERICA                              Melville Corporation ESOP
                                                     Notes 8.60% due 2009
                                                     $3,000,000


(1)  All payments by wire transfer
     of immediately available
     funds to:

     The Northern Trust Company
     50 South LaSalle Street
     Chicago, IL 60675

For credit to Century Life of America, Account #842-869 with sufficient information to identify the source and application of such funds.

(2) All notices of payments and written confirmations of such wire transfers:

Century Life of America
ATTN: Cashier Department
Heritage Way
Waverly, IA 50677

(3) All other communications:

Century Life of America
ATTN: Securities Division
Heritage Way
Waverly, IA 50677

(4) Tax Identification Number

42-0388260

21

Name and Address of Purchaser
-------------------------------
THE OHIO NATIONAL LIFE INSURANCE                   Melville Corporation ESOP
     COMPANY                                       Notes 8.60% due 2009
                                                   $5,500,000

(1) Registered Securities in the Name of The Ohio National Life Insurance Company

(2) All payments of immediately available funds by bank wire transfer to:

STAR Bank N.A.
5th & Walnuts Streets
Cincinnati, Ohio 45202

Far Account of The Ohio
National Life Insurance Co.
Account Number: 910-275-7

(3) All other communications send to:

The Ohio National Life Insurance
Company
P.O. Box 237
Cincinnati, Ohio 45201
Attention: Investment Department

(4) Tax Identification Number

31-0397080

22

Name and Address of Purchaser
---------------------------------
GENERAL AMERICAN LIFE INSURANCE                     Melville Corporation ESOP
    COMPANY                                         Notes 8.60% due 2009
                                                    $5,500,000


(1)  Registration Security in the name of:
     GALICO

(2)  Wire Transfer Information
     --------------------------

     Boatmen's Bank
     One Boatman's Plaza
     St. Louis, MO 63101
     Account #: 100100000342
     Identify source and use of funds
     ABA #: 081000032
     Safekeeping #: 320618

(3)  Notices Regarding Payments
     ---------------------------

     General American Life Insurance Company
     P. O. Box 418
     St. Louis, MO 63166
     Attn: Investment Accounting

(4)  All Other Notices:
     -------------------

     General American Life Insurance Company
     P. O. Box 396
     St. Louis, MO 63166
     Attn: Securities Division
          4th Floor

(5)  Tax Identification Number
     ---------------------------

43-6168630

23

Name and Address of Purchaser
--------------------------------
PROVIDENT MUTUAL LIFE INSURANCE                      Melville Corporation
     COMPANY                                         Notes  ESOP8 due 2009
                                                     $2,750,000

(1)  Registered Securities in name of:
     Provident National Bank

(2)  All payments made by bank wire
     transfer of immediately available
     funds to:
     Provident National Bank
     Broad and Chestnut Street
     Philadelphia, PA 19101
     Account Number 200-049-0

(3) Address for all other communication and Notice of Payments:
Provident Mutual Life Insurance Co. 1600 Market Street, 4th Floor
Philadelphia, PA 19103
Attention: Treasurer

(4) Send all securities by registered/ insured mail to:
Provident National Bank
Broad and Chestnut Street
Philadelphia, PA 19107

(5) Tax Identification Number:

23-0990450


EXHIBIT 10(iii)(A)(xi)

CVS CORPORATION

Deferred Stock Compensation Plan


CVS CORPORATION

Deferred Stock Compensation Plan

                                                                     Page
                                                                     ----

1.   Purposes ......................................................   1

2.   Definitions ...................................................   1

3.   Administration ................................................   2

4.   Participation .................................................   3

5.   Deferrals .....................................................   3

6.   Deferral Accounts .............................................   4

7.   Settlement of Deferral Accounts ...............................   5

8.   Provisions Relating to Section 16 of the Exchange Act
     and Section 162(m) of the Code ................................   6

9.   Statements ....................................................   6

10.  Sources of Stock:  Limitation on Amount of
     Stock-Denominated Deferrals ...................................   6

11.  Amendment/Termination .........................................   6

12.  General Provisions ............................................   6

13.  Effective Date ................................................   8


CVS CORPORATION

Deferred Stock Compensation Plan


1. Purposes. The purposes of this Deferred Stock Compensation Plan (the "Plan") are to provide certain highly compensated employees of CVS Corporation (the "Company") and its subsidiaries with the opportunity to elect to defer receipt of shares of Stock under certain Stock-based compensation plans or arrangements.

2. Definitions. In addition to the terms defined in Section 1 above, the following terms used in the Plan shall have the meanings set forth below:

(a) "Administrator" shall mean the Deferred Stock Compensation Committee set forth in Section 3(b) to whom the Committee has delegated the authority to take action under the Plan, except as may be otherwise required under Section 8.

(b) "Beneficiary" shall mean any person (which may include trusts and is not limited to one person) who has been designated by the Participant in his or her most recent written beneficiary designation filed with the Company to receive the benefits specified under the Plan in the event of the Participant's death. If no Beneficiary has been designated who survives the Participant's death, then Beneficiary means any person(s) entitled by will or, in the absence thereof, the laws of descent and distribution to receive such benefits.

(c) "Change in Control" shall have the meaning given to such term in the CVS Corporation 1997 Incentive Compensation Plan.

(d) "Code" shall mean the Internal Revenue Code of 1986, as amended. References to any provision of the Code or regulation (including a proposed regulation) thereunder shall include any successor provisions or regulations.

(e) "Committee" shall mean the Compensation Committee of the Board of Directors of the Company or any other directors of the Company designated as the Committee. Except as may be otherwise required under Section 8 or by applicable law, any function of the Committee may be delegated to the Administrator.

(f) "Deferral Account" shall mean the account or subaccount established and maintained by the Company for Stock deferrals by a Participant, as described in Section 6. A Deferral Account will be maintained solely as a bookkeeping entry by the Company to evidence unfunded obligations of the Company.

(g) "Deferred Stock" shall mean a right to receive Stock at the end of a specified deferral period.

(h) "Disability" shall have the meaning given to such term in the Company's Long-Term Disability Plan.


(i) "Exchange Act" shall mean the Securities Exchange Act of 1934, as amended. References to any provision of the Exchange Act or rule thereunder shall include any successor provisions or rules.

(j) "Participant" shall mean any employee of the Company or any subsidiary who is designated by the Committee as an eligible Participant in the Plan and who participates or makes an election to participate in the Plan.

(k) "Retirement" shall mean a Participant's voluntary termination of employment (i) at or after attaining age 60 or (ii) at or after attaining age 55, but prior to attaining age 60, if such termination is approved in advance by the Committee.

(l) "Stock" shall mean CVS Corporation Common Stock, or any other equity securities of the Company designated by the Committee.

(m) "Trust" shall mean any trust or trusts established or designated by the Company to hold Stock or other assets in connection with the Plan; provided, however, that the assets of such trusts shall remain subject to the claims of the general creditors of the Company.

(n) "Trustee" shall mean the trustee of a Trust.

(o) "Trust Agreement" shall mean the agreement entered into between the Company and the Trustee to carry out the purposes of the Plan, as amended or restated from time to time.

3. Administration.

(a) Authority. Both the Committee and the Administrator (subject to the ability of the Committee to restrict the Administrator) shall administer the Plan in accordance with its terms, and shall have all powers necessary to accomplish such purpose, including the power and authority to construe and interpret the Plan, to define the terms used herein, to prescribe, amend and rescind rules and regulations, agreements, forms, and notices relating to the administration of the Plan, and to make all other determinations necessary or advisable for the administration of the Plan. Any actions of the Committee or the Administrator with respect to the Plan shall be conclusive and binding upon all persons interested in the Plan, except that any action of the Administrator will not be binding on the Committee. The Committee and Administrator may each appoint agents and delegate thereto powers and duties under the Plan, except as otherwise limited by the Plan.

(b) Administrator. The Deferred Stock Compensation Committee shall consist of such number of members as shall be determined by the Committee, each of whom shall be appointed by, shall remain in office at the will of, and may be removed, with or without cause, by the Committee. Any member of the Deferred Stock Compensation Committee may resign at any time. No member of the Deferred Stock Compensation Committee shall be entitled to act on or decide any matter relating solely to himself or herself or any of his or her rights or benefits under the Plan. The members of the Deferred Stock Compensation Committee shall not receive any special compensation for serving in their capacities as members of the Deferred Stock Compensation Committee but shall be reimbursed for any reasonable expenses incurred in connection therewith. No bond or other security need be required of the Deferred Stock Compensation Committee or any member thereof in any jurisdiction.

2

(c) Limitation of Liability. Each member of the Committee and the Administrator shall be entitled to, in good faith, rely or act upon any report or other information furnished to him or her by any officer or other employee of the Company or any subsidiary, the Company's independent certified public accountants, or any executive compensation consultant, legal counsel, or other professional retained by the Company to assist in the administration of the Plan. To the maximum extent permitted by law, no member of the Committee or the Administrator, nor any person to whom ministerial duties have been delegated, shall be liable to any person for any action taken or omitted in connection with the interpretation and administration of the Plan.

4. Participation. The Administrator will notify each person of his or her participation or eligibility to participate in the Plan not later than 15 days (or such lesser period as may be practicable in the circumstances) prior to any deadline for filing an election form.

5. Deferrals. To the extent authorized by the Committee, a Participant may elect to defer any award or other compensation which is in the form of Stock or units denominated in Stock to be received from the Company or a subsidiary, including shares issuable in connection with annual incentive awards, long term awards or stock option exercises; provided, however, that a Participant who is an employee of the Company or a subsidiary may defer, with respect to a given year, receipt of only that portion of the Participant's compensation that exceeds the FICA maximum taxable wage base plus the amount necessary to satisfy Medicare and all other payroll taxes (other than Federal, state or local income tax withholding) imposed on the wages of such Participant from the Company and its subsidiaries. In addition to such limitation, and any terms and conditions of deferral set forth under plans, programs or arrangements from which receipt of the Stock-denominated award or other compensation is deferred, the Committee may impose limitations on the amounts permitted to be deferred and other terms and conditions of deferrals under the Plan. Any such limitations, and other terms and conditions of deferral, shall be set forth in the rules relating to the Plan or election forms, other forms, or instructions published by the Committee and/or the Administrator.

(a) Elections. Once an election form, properly completed, is received by the Company, the elections of the Participant shall be irrevocable; provided, however, that the Committee and/or the Administrator may, in its discretion, permit a Participant to elect a further deferral of amounts credited to a Deferral Account by filing a later election form; provided, further, that, unless otherwise approved by the Committee, any election to further defer amounts credited to a Deferral Account must be made at least one (1) year prior to the date such amounts would otherwise be payable.

(b) Date of Election. An election to defer Stock-denominated awards or other compensation hereunder must be received by the Administrator prior to the date specified by the Administrator. Under no circumstances may a Participant defer Stock-denominated awards or other compensation to which the Participant has attained, at the time of deferral, a legally enforceable right to current receipt of such Stock-denominated awards or other compensation.

3

6. Deferral Accounts.

(a) Establishment; Crediting of Amounts Deferred. One or more Deferral Accounts will be established for each Participant, as determined by the Administrator. The amount of Stock-denominated awards or other compensation deferred with respect to each Deferral Account will be credited to such Account as of the date on which such amounts would have been paid to the Participant but for the Participant's election to defer receipt hereunder. Unless otherwise determined by the Administrator, shares will be credited to the Participant's Deferral Account as units of Deferred Stock (as opposed to cash amounts valued by reference to the market price of Stock). With respect to any fractional shares of Stock or Stock-denominated awards, the Administrator, in its sole discretion, shall either pay such fractional shares to the Participant in cash, credit the Deferral Account with cash in lieu of depositing fractional shares into the Deferral Account, or credit the Deferral Account with a fraction of a share calculated to at least three decimal places.

(b) Deferred Stock As Sole Investment Vehicle. Amounts credited as Deferred Stock to a Participant's Deferral Account may not be reallocated or deemed reinvested in any other investment vehicle, but shall remain as Deferred Stock until such time as the Deferral Account is settled in accordance with Section 7.

(c) Dividend Equivalents. Except as provided in Section 6(d), dividend equivalents will be credited on Deferred Stock credited to a Participant's Deferral Account as follows:

(i) Cash and Non-Stock Dividends. If the Company declares and pays a dividend on Stock in the form of cash or property other than shares of Stock, then a number of additional shares of Deferred Stock shall be credited to a Participant's Deferral Account as of the payment date for such dividend equal to (A) the number of shares of Deferred Stock credited to the Deferral Account as of the record date for such dividend, multiplied by (B) the amount of cash plus the fair market value of any property other than shares actually paid as a dividend on each share at such payment date, divided by (C) the fair market value of a share of Stock at such payment date.

(ii) Stock Dividends and Splits. If the Company declares and pays a dividend on Stock in the form of additional shares of Stock, or there occurs a forward split of Stock, then a number of additional shares of Deferred Stock shall be credited to the Participant's Deferral Account as of the payment date for such dividend or forward Stock split equal to (A) the number of shares of Deferred Stock credited to the Deferral Account as of the record date for such dividend or split, multiplied by (B) the number of additional shares actually paid as a dividend or issued in such split in respect of each share of Stock.

(d) Trusts. The Committee may, in its discretion, establish one or more Trusts (including sub-accounts under such Trusts), and deposit therein shares of Stock equal in number to the number of shares of Deferred Stock then credited to a Participant's Deferral Account (or a specified subaccount). In such case, the provisions of Section 6(c) notwithstanding, the dividend equivalents payable on the Participant's Deferred Stock shall be equal to the actual dividends paid on the shares deposited in such Trust (which dividends shall be reinvested by the Trustee in additional shares of Stock), and shares may be delivered in settlement of the Participant's Deferred Stock from the assets in such Trusts. The Participant's rights with respect to directing the voting of shares held in such Trust or otherwise relating to such shares shall be determined by the Administrator in its discretion.

4

(e) Cashless Exercise. If and to the extent permitted by the Committee, and subject to such terms and conditions as may be established by the Committee from time to time, a Participant may submit a request to the Administrator to surrender (or constructively surrender) Deferred Stock credited to his or her Deferral Account to pay the purchase price of any stock option granted to the Participant under another Company plan, program or arrangement, which request the Administrator may approve in its discretion.

7. Settlement of Deferral Accounts.

(a) Form of Payment. The Company shall settle a Participant's Deferral Account, and discharge all of its obligations to pay deferred compensation under the Plan with respect to such Deferral Account, by delivery of shares of Stock, including shares of Stock delivered out of the assets of the Trust.

(b) Forfeited Stock. To the extent that Stock (i) is deposited in a Trust pursuant to Section 6 in connection with a deferral of Stock or a Stock-denominated award under another plan, program, employment agreement or other arrangement and (ii) is forfeited pursuant to the terms of such plan, program, agreement or arrangement, the Participant shall not be entitled to the value of such Stock and other property related thereto (including without limitation, dividends thereon) or other award or amount, or proceeds thereof. Any Stock or Stock-denominated awards (and proceeds thereof) forfeited shall be returned to the Company.

(c) Timing of Payments. Payments in settlement of a Deferral Account shall be made as soon as practicable after the date or dates (including upon the occurrence of specified events), and in such number of installments, as may be directed by the Participant in his or her election relating to such Deferral Account, or earlier in the following circumstances:

(i) In the event of termination of employment for reasons other than Retirement or Disability, a single lump sum payment in settlement of any Deferral Account (including a Deferral Account with respect to which one or more installment payments have previously been made) shall be made as promptly as practicable following such termination, unless otherwise determined by the Administrator; or

(ii) In the event of a Change in Control, payments in settlement of any Deferral Account (including a Deferral Account with respect to which one or more installment payments have previously been made) shall be made within fifteen (15) business days following such Change in Control.

(d) Financial Emergency and Other Payments. Other provisions of the Plan (except Section 8) notwithstanding, if, upon the written application of a Participant, the Committee determines that the Participant has a financial emergency of such a substantial nature and beyond the individual's control that payment of amounts previously deferred under the Plan is warranted, the Committee may direct the payment to the Participant of all or a portion of the balance of a Deferral Account and the time and manner of such payment.

5

8. Provisions Relating to Section 16 of the Exchange Act and Section 162(m) of the Code.

(a) Compliance with Section 16. With respect to a Participant who is then subject to the reporting requirements of Section 16(a) of the Exchange Act, the Committee and Administrator shall implement transactions under the Plan and administer the Plan in a manner that will ensure that each transaction by such a Participant is exempt from or otherwise not subject to liability under Rule 16b-3, except that such a Participant may be permitted to engage in a non-exempt transaction under the Plan if written notice is given to the Participant regarding the non-exempt nature of such transaction.

(b) Compliance with Code Section 162(m). It is the intent of the Company that any compensation (including any award) deferred under the Plan by a person who is, with respect to the year of payout, deemed by the Committee to be a "covered employee" within the meaning of Code Section 162(m) and regulations thereunder, which compensation constitutes "qualified performance-based compensation" within the meaning of Code Section 162(m) and regulations thereunder, shall not, as a result of deferral hereunder, become compensation with respect to which the Company in fact would not be entitled to a tax deduction under Code Section 162(m). Accordingly, unless otherwise determined by the Committee, if any compensation would become so disqualified under Section 162(m) as a result of deferral hereunder, the terms of such deferral shall be automatically modified to the extent necessary to ensure that the compensation would not, at the time of payout, be so disqualified.

9. Statements. The Administrator will furnish statements to each Participant reflecting the amount credited to a Participant's Deferral Accounts and transactions therein not less frequently than once each calendar year.

10. Sources of Stock: Limitation on Amount of Stock-Denominated Deferrals. If shares of Stock are deposited under the Plan in a Trust pursuant to Section 6 in connection with a deferral of a Stock-denominated award under another plan, program, employment agreement or other arrangement that provides for the issuance of shares, the shares so deposited shall be deemed to have originated, and shall be counted against the number of shares reserved, under such other plan, program or arrangement. Shares of Stock actually delivered in settlement of Deferral Accounts shall be originally issued shares or treasury shares, in the discretion of the Committee.

11. Amendment/Termination. The Committee may, with prospective or retroactive effect, amend, alter, suspend, discontinue, or terminate the Plan at any time without the consent of Participants, stockholders, or any other person; provided, however, that, without the consent of a Participant, no such action shall materially and adversely affect the rights of such Participant with respect to any rights to payment of amounts credited to such Participant's Deferral Account. Notwithstanding the foregoing, the Committee may, in its sole discretion, terminate the Plan (in whole or in part) and distribute to Participants (in whole or in part) the amounts credited to their Deferral Accounts.

12. General Provisions.

(a) Limits on Transfer of Awards. Other than by will or the laws of descent and distribution, no right, title or interest of any kind in the Plan shall be transferable or assignable by a Participant or his or her Beneficiary or be subject to alienation, anticipation, encumbrance, garnishment, attachment, levy, execution or other legal or equitable process, nor subject to the debts, contracts, liabilities or engagements, or torts of any Participant or his or her

6

Beneficiary. Any attempt to alienate, sell, transfer, assign, pledge, garnish, attach or take any other action subject to legal or equitable process or encumber or dispose of any interest in the Plan shall be void.

(b) Receipt and Release. Payments (in any form) to any Participant or Beneficiary in accordance with the provisions of the Plan shall, to the extent thereof, be in full satisfaction of all claims for the awards or other compensation deferred and relating to the Deferral Account to which the payments relate against the Company or any subsidiary thereof, the Committee, or the Administrator, and the Administrator may require such Participant or Beneficiary, as a condition to such payments, to execute a receipt and release to such effect. In the case of any payment under the Plan of less than all amounts then credited to an account in the form of Stock, the amounts paid shall be deemed to relate to the Stock credited to the account at the earliest time.

(c) Unfunded Status of Awards; Creation of Trusts. The Plan is intended to constitute an "unfunded" plan for deferred compensation and Participants shall rely solely on the unsecured promise of the Company for payment hereunder. With respect to any payment not yet made to a Participant under the Plan, nothing contained in the Plan shall give a Participant any rights that are greater than those of a general unsecured creditor of the Company; provided, however, that the Committee may authorize the creation of Trusts, including but not limited to the Trusts referred to in Section 6 hereof, or make other arrangements to meet the Company's obligations under the Plan, which Trusts or other arrangements shall be consistent with the "unfunded" status of the Plan unless the Committee otherwise determines with the consent of each affected Participant.

(d) Compliance. A Participant in the Plan shall have no right to receive payment (in any form) with respect to his or her Deferral Account until legal and contractual obligations of the Company relating to establishment of the Plan and the making of such payments shall have been complied with in full. In addition, the Company shall impose such restrictions on Stock delivered to a Participant hereunder and any other interest constituting a security as it may deem advisable in order to comply with the Securities Act of 1933, as amended, the requirements of the New York Stock Exchange or any other stock exchange or automated quotation system upon which the Stock is then listed or quoted, any applicable state securities laws, any provision of the Company's Certificate of Incorporation or Bylaws, or any other law, regulation, or binding contract to which the Company is a party.

(e) Other Participant Rights. No Participant shall have any of the rights or privileges of a stockholder of the Company under the Plan, including as a result of the crediting of Stock-denominated units or other amounts to a Deferral Account, or the creation of any Trust and deposit of such Stock therein, except at such time as Stock may be actually delivered in settlement of a Deferral Account. No provision of the Plan or transaction hereunder shall confer upon any Participant any right to be employed by the Company or a subsidiary thereof, or to interfere in any way with the right of the Company or a subsidiary to increase or decrease the amount of any compensation payable to such Participant. Subject to the limitations set forth in Section 12(a) hereof, the Plan shall inure to the benefit of, and be binding upon, the parties hereto and their successors and assigns.

(f) Tax Withholding. The Company and any subsidiary shall have the right to deduct from amounts otherwise payable in settlement of a Deferral Account any sums that federal, state, local or foreign tax law requires to be withheld with respect to such payment. Shares may be withheld to satisfy such obligations in any case where taxation would be imposed upon the delivery of shares, except that shares issued or delivered under any plan, program, employment agreement or other arrangement may be withheld only in accordance with the terms

7

of such plan, program, employment agreement or other arrangement and any applicable rules, regulations, or resolutions thereunder.

(g) Governing Law. The validity, construction, and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of laws, and applicable provisions of federal law.

(h) Limitation. A Participant and his or her Beneficiary shall assume all risk in connection with any decrease in value of the Deferral Account and neither the Company, the Committee nor the Administrator shall be liable or responsible therefor.

(i) Adjustments. In the event that any dividend or other distribution (whether in the form of cash, Stock, or other property), recapitalization, forward or reverse split, reorganization, merger, consolidation, spin-off, combination, repurchase, share exchange, liquidation, dissolution or other similar corporate transaction or event affects the Stock such that an adjustment is determined by the Administrator or the Committee to be appropriate in order to prevent dilution or enlargement of a Participant's rights under the Plan, then the Administrator or the Committee shall, in such manner as it may deem equitable, adjust any or all of the number and kind of shares of Stock to be issued upon settlement of Deferred Stock then credited to a Deferral Account under the Plan.

(j) Construction. The captions and numbers preceding the sections of the Plan are included solely as a matter of convenience of reference and are not to be taken as limiting or extending the meaning of any of the terms and provisions of the Plan. Whenever appropriate, words used in the singular shall include the plural or the plural may be read as the singular.

(k) Severability. In the event that any provision of the Plan shall be declared illegal or invalid for any reason, said illegality or invalidity shall not affect the remaining provisions of the Plan but shall be fully severable, and the Plan shall be construed and enforced as if said illegal or invalid provision had never been inserted herein.

(l) Status. The establishment and maintenance of, or allocations and credits to, the Deferral Account of any Participant shall not vest in any Participant any right, title or interest in and to any Plan or Company assets or benefits except at the time or times and upon the terms and conditions and to the extent expressly set forth in the Plan and in accordance with the terms of the Trust.

13. Effective Date. The Plan shall be effective as of September 10, 1997.

8

Exhibit 11

CVS Corporation

Computation of Earnings Per Common Share

                                                                                            YEARS ENDED DECEMBER 31,
                                                                                         -------------------------------
IN MILLIONS, EXCEPT PER SHARE AMOUNTS                                                      1997       1996       1995
---------------------------------------------------------------------------------------  ---------  ---------  ---------
Basic earnings (loss) per common share:
  Net earnings (loss)................................................................... $    37.7  $   176.6  $  (572.8)
  Less: Preference dividends, net of tax benefits........................................     13.7       14.5        17.0
                                                                                         ---------  ---------  ---------
Net earnings (loss) available to common shareholders...................................  $    24.0  $   162.1  $  (589.8)
Weighted average number of shares outstanding..........................................      169.8      165.3       163.7
                                                                                         ---------  ---------  ---------
Basic earnings (loss) per common share.................................................  $    0.14  $    0.98  $   (3.60)
                                                                                         ---------  ---------  ---------
                                                                                         ---------  ---------  ---------
Diluted earnings (loss) per common share: (1)
Net earnings (loss)....................................................................  $    37.7  $   176.6  $  (572.8)
Less: Preference dividends, net of tax benefits........................................       13.7         --       17.0
                                                                                         ---------  ---------  ---------
Net earnings (loss) available to common shareholders...................................  $    24.0  $   176.6  $  (589.8)
Less:   Adjustments assuming conversion of the Series One ESOP
        Convertible Preference Stock, for the following: (i)
        additional contributions to the ESOP to cover the shortfall
        between the Series One ESOP Convertible Preference Stock and
        Common Stock dividends and (ii) reductions in incentive bonuses
        and profit sharing, net of tax benefits........................................         --        7.5         --
                                                                                         ---------  ---------  ---------

Adjusted net earnings (loss) available to common shareholders..........................  $    24.0  $   169.1  $  (589.8)
                                                                                         ---------  ---------  ---------
Weighted average number of shares outstanding..........................................      169.8      165.3      163.7
Add: Weighted average shares of Series One ESOP
Convertible Preference Stock assuming conversion.......................................         --        5.9         --
Add: Weighted average number of shares which could have been issued upon exercise of
  outstanding options..................................................................        3.2        2.0        0.6
Adjusted weighted average number of shares outstanding.................................      173.0      173.2      164.3
                                                                                         ---------  ---------  ---------
Diluted earnings (loss) per common share...............................................  $    0.14  $    0.98  $   (3.59)
                                                                                         ---------  ---------  ---------
                                                                                         ---------  ---------  ---------


(1) In 1995 and 1997, the assumed conversion of the Series One ESOP Convertible Preference Stock would have increased diluted earnings per common share and, therefore, was not considered.


EXHIBIT 12
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
CVS CORPORATION

DOLLARS IN MILLIONS                                                        1997       1996       1995       1994       1993
-----------------------------------------------------------------------  ---------  ---------  ---------  ---------  ---------
Fixed Charges: (1)
  Interest Expense.....................................................     $ 57.7     $ 83.2     $114.9     $ 89.3     $ 48.7
  Interest Capitalized.................................................        0.2        0.1        0.2        0.2        0.6
  Interest Portion of Net Rental Expense (2)...........................      128.7      119.6      112.2       99.8       76.0
  Amortization of Debt Expense.........................................        0.1        0.1       0 .1        0.1        0.1
                                                                         ---------  ---------  ---------  ---------  ---------
  Total Fixed Charges..................................................     $186.7     $203.0     $227.4     $189.4     $125.4
                                                                         ---------  ---------  ---------  ---------  ---------
Adjusted Fixed Charges:
  Total Fixed Charges..................................................     $186.7     $203.0     $227.4     $189.4     $125.4
  Interest Capitalized ................................................        0.2        0.1        0.2        0.2        0.6
                                                                         ---------  ---------  ---------  ---------  ---------
  Adjusted Fixed Charges...............................................     $186.5     $202.9     $227.2     $189.2     $124.8
                                                                         ---------  ---------  ---------  ---------  ---------
Earnings:
  Net earnings from continuing operations before
    income taxes and extraordinary item (3) (4) (5)....................     $155.0     $592.0     $116.2     $290.4     $240.3
  Adjusted Fixed Charges...............................................      186.5      202.9      227.2      189.2      124.8
                                                                         ---------  ---------  ---------  ---------  ---------
                                                                            $341.5     $794.9     $343.4     $479.6     $365.1
                                                                         ---------  ---------  ---------  ---------  ---------

Ratio of Earnings to Fixed Charges.....................................       1.83       3.92       1.51       2.54       2.93
                                                                         ---------  ---------  ---------  ---------  ---------
                                                                         ---------  ---------  ---------  ---------  ---------


Note: All periods presented exclude the results of the footwear, apparel and toys and home furnishing operating businesses, which have been classified as discontinued operations.

(1) The Company formed an Employee Stock Ownership Plan effective January 1, 1989. On June 23, 1989, the ESOP Trust borrowed $357.5 million from qualified lenders, the proceeds of which were used to purchase a new series of preference stock issued by the Company. The loan to the ESOP Trust has been guaranteed by the Company. Annualized dividends on preference stock totaled $20.8 million in 1997, $21.8 million in 1996, $24.3 million in 1995, $24.9 million in 1994 and $25.3 million in 1993. These amounts are not reflected in the calculation above.

(2) The interest portion of the net rental expense is estimated to be equal to one-third of the minimum rental expense for the year.

(3) Net earnings from continuing operations before income taxes for 1995 includes the effect of $165.5 million of restructuring and asset impairment charges and $49.4 million of non-recurring operating charges.

(4) Net earnings from continuing operations before income taxes for 1996 includes the effect of the $121.4 million gain on sale of securities and $12.8 million of non-recurring operating charges.

(5) Net earnings from continuing operations before income taxes for 1997 includes the effect of $486.7 million of merger-related charges and $31.0 million of restructuring charges.


Management's Discussion and Analysis of Financial Condition and Results of Operations

RECENT DEVELOPMENT-PENDING AGREEMENT
TO ACQUIRE ARBOR DRUGS, INC.

On February 8, 1998, CVS Corporation ("CVS") signed a definitive merger agreement to acquire Arbor Drugs, Inc. ("Arbor") in a stock-for-stock merger valued at approximately $1.48 billion.

The transaction would establish the combined enterprise as the nation's top chain drug retailer based on store count and prescriptions dispensed. The combined company is expected to have revenues of approximately $15 billion in 1998 and approximately 4,100 stores in 25 states and the District of Columbia, and is expected to dispense approximately 12% of the retail prescriptions in the United States.

Under the terms of the agreement, which was unanimously approved by the Boards of Directors of both companies, CVS would acquire Arbor in an exchange of stock that is expected to qualify as a pooling of interests transaction, tax free to Arbor shareholders. The exchange ratio will be calculated by dividing an Arbor common stock price of $23 by an average closing price of CVS common stock to be determined over a specified period prior to the Arbor shareholder meeting. For each share of Arbor common stock they own, Arbor shareholders will receive not less than 0.3182 shares of CVS common stock and not more than 0.3660 shares of CVS common stock.

The transaction is subject to approval by the shareholders of Arbor, expiration of the applicable Hart-Scott-Rodino waiting period and other customary closing conditions. Subject to satisfying applicable closing conditions, it is expected that the transaction will be completed by March 31, 1998.

CVS/REVCO MERGER

On May 29, 1997, CVS completed a merger with Revco D.S., Inc. ("Revco"), hereafter collectively referred to as the Company, pursuant to which approximately 60.3 million shares of CVS common stock were issued in exchange for all of the outstanding common stock of Revco (the "Merger"). Each outstanding share of Revco common stock was exchanged for 0.8842 of a share of CVS common stock. In addition, outstanding Revco employee stock options were converted at the same exchange ratio into options to purchase approximately 3.3 million shares of CVS common stock.

Subsequent to the Merger, and pursuant to a consent decree with the Federal Trade Commission entered into in connection with the Merger, the Company divested 120 Revco stores, primarily in Richmond and the Tidewater area of Virginia.

ACCOUNTING TREATMENT FOR THE
CVS/REVCO MERGER

The Merger, which constituted a tax-free reorganization, has been accounted for as a pooling of interests under Accounting Principles Board ("APB") Opinion No. 16, "Accounting For Business Combinations." Accordingly, all prior period financial statements presented have been restated to include the combined results of operations, financial position and cash flows of Revco as if it had always been part of CVS.

Prior to the Merger, Revco's fiscal year ended on the Saturday closest to May
31. In recording the business combination, Revco's consolidated financial statements for the fiscal years ended June 1, 1996 and June 3, 1995 have been restated to reflect a December 31 year-end, to conform with CVS' fiscal year-end.

Revco's cost of sales and inventories have been restated from the last-in, first-out method to the first-in, first-out method in order to conform to CVS' accounting method for inventories. The impact of the restatement was to increase earnings from continuing operations by $13.5 million in 1996 and $11.9 million in 1995.

There were no material transactions between CVS and Revco prior to the Merger. Certain reclassifications have been made to Revco's historical consolidated financial statements to conform to CVS' presentation.

In accordance with Emerging Issues Task Force ("EITF") Issue No. 94-3, "Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (Including Certain Costs Incurred in a Restructuring)," the Company recorded a charge to operating expenses of $411.7 million in the second quarter of 1997 for direct and other merger-related costs pertaining to the merger transaction and certain restructuring activities (the "CVS/Revco Restructuring Charge").

Following is a summary of the significant components of the CVS/Revco Restructuring Charge:

--------------------------------------------------------------------------------
                                 CVS/REVCO
                             RESTRUCTURING     UTILIZED IN     BALANCE AT
   IN MILLIONS                     CHARGE             1997       12/31/97
------------------          --------------     -----------     -----------------
Merger transaction costs           $ 35.0           $ 32.1          $ 2.9
Restructuring costs:
  Employee severance                 89.8             37.4           52.4
  Exit costs                        286.9            126.1          160.8
--------------------------------------------------------------------------------
                                   $411.7           $195.6         $216.1
--------------------------------------------------------------------------------

1

Merger transaction costs primarily include fees for investment bankers, attorneys, accountants, financial printing and other related charges. Restructuring activities primarily relate to the consolidation of administrative functions. These actions resulted in the reduction of approximately 1,000 employees, primarily in Revco's Twinsburg, Ohio headquarters, and will include the consolidation and closure of certain facilities. Exit costs primarily relate to activities such as the cancellation of lease agreements, closing of certain facilities and the write-down of unutilized fixed assets.

Asset write-offs included in the above charge totaled $53.7 million. The balance of the charge, $358.0 million, will require cash outlays of which $164.8 million had been incurred as of December 31, 1997. The remaining balance, $193.2 million, which primarily includes non-cancelable operating lease commitments and severance, is expected to be incurred in 1998 and beyond.

The Company also recorded a $75 million charge to cost of goods sold in the second quarter of 1997 to reflect markdowns on non-compatible Revco merchandise.

See Note 1 to the consolidated financial statements for further information about the CVS/Revco Merger.

REVCO INTEGRATION UPDATE

We are pleased to report that the integration of Revco is proceeding according to expectations. Specifically:

- We have completed the conversion of all of Revco's back- end systems to CVS' back-end systems, enabling all merchandising and purchasing decisions to be made from CVS' headquarters.

- We have completed the conversion of all of Revco's store systems, both point-of-sale and pharmacy, to CVS' store systems.

- We have remodeled approximately 700 Revco stores to "look and feel" like a CVS store. We expect to have the remaining Revco stores remodeled before the end of 1998.

- With the exception of cosmetics, we have converted the inventory in all Revco stores to the CVS merchandise mix. We expect to complete the conversion of cosmetics in the remodeled Revco stores during the first half of 1998, following the receipt of tailored cosmetics fixtures from vendors. We expect to complete the remaining Revco stores as they are remodeled during 1998.

- The former Revco headquarters in Twinsburg, Ohio has been reduced to approximately 125 employees. By March 1998, the facility will be essentially closed.

- We achieved the anticipated cost savings of $40 million in 1997 and believe we are on track to achieve annual cost savings of $100 million, beginning in 1998. The achievement of future cost savings is subject to the uncertainties discussed in the "Cautionary Statement Concerning Forward Looking Statements" section below.

ACQUISITION OF BIG B, INC.

In November 1996, the Company completed a cash tender offer (the "Offer") for the common stock of Big B, Inc. ("Big B") resulting in the Company owning approximately 85% of the Big B common stock. In December 1996, the Company completed a second step acquisition in which all of the remaining Big B shareholders received the same cash price paid in the Offer. The aggregate transaction value, including the assumption of $49.3 million of Big B debt, was $423.2 million.

The acquisition of Big B was accounted for as a purchase business combination under APB Opinion No. 16. The purchase price was allocated to assets acquired and liabilities assumed based on estimated fair values at the date of acquisition. This resulted in an excess of purchase price over net assets acquired ("Goodwill") of approximately $249 million, which is being amortized on a straight-line basis over 40 years. Big B's results of operations have been consolidated with the Company's results of operations beginning November 16, 1996.

See Note 5 to the consolidated financial statements for further information about the Big B acquisition.

2

CVS STRATEGIC RESTRUCTURING PROGRAM

In November 1997, the Company completed the final phase of its comprehensive strategic restructuring plan, first announced in October 1995 and subsequently refined in May 1996 and June 1997. The restructuring plan included, among other things:

- The sale of four operating businesses (completed during 1995 and 1996).

- The spin-off of Footstar, Inc. ("Footstar") (completed in October 1996).

- The initial public offering of 67.5% of the shares of common stock of Linens `n Things, Inc. (completed in December 1996).

- The sale of Bob's Stores (completed in November 1997).

- The elimination of certain corporate overhead costs (completed during 1995 and 1996).

In June 1997, the Company sold its remaining 32.5% ownership interest in Linens `n Things, Inc.

The CVS Strategic Restructuring Program was completed without significant changes to the Board approved plan. As part of completing this program, the Company recorded, as a component of discontinued operations, a pre-tax charge of approximately $35 million during the second quarter of 1997 to finalize certain liabilities accrued for in the 1996 Restructuring Charge (defined in the "1997 versus 1996" section below).

See Note 3 to the consolidated financial statements for further information about the CVS Strategic Restructuring Program.

RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the Company's consolidated financial statements as of December 31, 1997 and 1996 and for each of the years in the three-year period ended December 31, 1997.

As discussed above, the CVS/Revco Merger has been accounted for as a pooling of interests under APB Opinion No. 16. Accordingly, all prior period financial statements presented have been restated to include the combined results of operations, financial position and cash flows of Revco as if it had always been part of CVS.

The results of operations of the Company's former footwear, apparel and toys and home furnishings segments have been classified as discontinued operations in the accompanying consolidated statements of operations for all periods presented. See the "CVS Strategic Restructuring Program" section above and Note 3 to the consolidated financial statements for further information. The following discussion, therefore, focuses primarily on continuing operations.

1997 VERSUS 1996

NET SALES for 1997 increased $1.8 billion or 16.4% to $12.7 billion, compared to $10.9 billion in 1996. Same store sales rose 9.8%, with pharmacy same store sales increasing 16.7%. Pharmacy sales were 54% of total sales in 1997, compared to 51% of total sales in 1996.

The growth in front store sales was primarily driven by increases in categories such as greeting cards, film and photofinishing, beauty and cosmetics, convenience foods, private label and seasonal merchandise. Growth in pharmacy sales was primarily driven by (i) increased penetration into managed care markets, (ii) the purchase of prescription files from independent pharmacies and
(iii) favorable trends, including an aging American population, greater responsibility being borne by Americans for their healthcare, an increasing demand for retail formats that provide easy access and convenience, discovery of new and better drug therapies, and the need for cost effective healthcare solutions (collectively, the "Pharmacy Sales Factors"). Both front store and pharmacy sales were positively impacted by the Big B acquisition effective November 16, 1996. Excluding the positive impact of the Big B acquisition, net sales increased 11.1% in 1997, compared to 1996.

3

GROSS MARGIN for 1997 increased $387.6 million or 12.7% to $3.4 billion, compared to $3.1 billion in 1996. During the second quarter of 1997, the Company recorded a charge of $75.0 million to cost of goods sold to reflect markdowns on non-compatible Revco merchandise (the "Revco Inventory Markdown"). Excluding the effect of the Revco Inventory Markdown, gross margin increased $462.6 million or 15.2% to $3.5 billion.

Gross margin as a percentage of net sales for 1997 was 27.0%, compared to 27.9% of net sales in 1996. Excluding the effect of the Revco Inventory Markdown, gross margin as a percentage of net sales was 27.6% for 1997. The decline in comparable gross margin as a percentage of net sales was primarily due to the continued increase in lower gross margin third party prescription sales and the increase in pharmacy sales as a percentage of total sales (collectively, the "Pharmacy Gross Margin Factors").

In recent years, the Company has experienced a reduction in pharmacy gross margin due to the efforts of managed care organizations and other third party payors to reduce prescription drug costs. To address this trend, in certain circumstances, the Company has declined to participate in certain third party programs that failed to satisfy minimum profitability standards. In the event this trend continues and the Company decides to decline participation in additional third party programs and/or terminate programs that fall below minimum profitability standards, the Company may be unable to sustain its current rate of sales growth.

TOTAL OPERATING EXPENSES for 1997 were $3.2 billion or 25.4% of net sales, compared to $2.5 billion or 22.9% of net sales in 1996. In order to properly evaluate the Company's total operating expenses in these periods, it is important to note the following non-recurring charges:

- During the second quarter of 1997, the Company recorded the CVS/Revco Restructuring Charge. For further information about this charge, see the "Accounting Treatment For The CVS/Revco Merger" section above.

- During the first quarter of 1997, the Company recorded a $31.0 million charge for certain non-capitalizable costs associated with the restructuring of Big B, which the Company acquired in 1996 (the "Big B Restructuring Charge"). The significant components of this charge included: $5.3 million for store, distribution and system conversion costs, $18.7 million for store closing costs and $7.0 million for duplicate headquarters and administration costs. In accordance with EITF Issue No. 94-3, this charge includes accrued liabilities related to certain exit plans for identified stores and duplicate corporate facilities, such as the cancellation of lease agreements and the write-down of unutilized fixed assets. These exit plans do not benefit the future activities of the retained stores or corporate facilities.

- During the second quarter of 1996, the Company recorded a $12.8 million charge upon Rite Aid Corporation's announcement that it had withdrawn its tender offer to acquire Revco (the "Rite Aid Charge").

Excluding the CVS/Revco Restructuring Charge and the Big B Restructuring Charge in 1997 and the Rite Aid Charge in 1996, comparable operating expenses for 1997 were $2.8 billion or 22.0% of net sales, compared to $2.5 billion or 22.8% of net sales in 1996. The improvement in comparable operating expenses as a percentage of net sales was primarily due to the benefits derived from: (i) sales in the Company's existing store base growing at a faster rate than operating costs, (ii) the CVS Strategic Restructuring Program, (iii) the consolidation of CVS' and Revco's administrative functions, (iv) store operating improvements and (v) key technology investments such as the Company's RX 2000 Pharmacy System, CVS Rapid Refill System, Pharmacy Data Warehouse, Point-of-Sale System, Retail Data Warehouse and Field Management System.

OPERATING PROFIT for 1997 decreased $341.0 million to $199.8 million, compared to $540.8 million in 1996. Excluding the effect of the Revco Inventory Markdown, the CVS/Revco Restructuring Charge and the Big B Restructuring Charge in 1997 and the Rite Aid Charge in 1996 (collectively, the "Noted Charges"), comparable operating profit increased $163.9 million or 29.6% to $717.5 million in 1997, compared to $553.6 million in 1996. Comparable operating profit as a percentage of net sales was 5.6% for 1997, compared to 5.1% of net sales in 1996.

OTHER (EXPENSE) INCOME, NET for 1997 amounted to an expense of $44.8 million, compared to income of $51.3 in 1996. The decrease in 1997 was primarily due to the $121.4 million gain that was realized during 1996 upon the sale of certain equity securities that were received as part of the proceeds from the sale of Marshalls to The TJX Companies, Inc. (the "TJX Gain"). The effect of the TJX Gain in 1996 was offset, in part, by a $30.9 million decrease in net interest expense in 1997. The decrease in net interest expense was primarily due to lower average borrowing levels that resulted primarily from the Revco Debt Retirement (defined in the "Revco Debt Retirement" section below).

4

EARNINGS FROM CONTINUING OPERATIONS BEFORE EXTRAORDINARY ITEM for 1997 decreased $303.5 million to $37.3 million or $0.14 per diluted share, compared to $340.8 million or $1.92 per diluted share in 1996. Excluding the effect of the Noted Charges and the TJX Gain, comparable earnings from continuing operations before extraordinary item increased $104.8 million or 38.1% to $380.1 million or $2.12 per diluted share in 1997, compared to $275.2 million or $1.55 per diluted share in 1996.

DISCONTINUED OPERATIONS--During the second quarter of 1997, the Company sold its remaining investment in Linens `n Things, Inc. for total proceeds of approximately $147 million, which resulted in a pre-tax gain of approximately $65 million. This gain has been reflected in discontinued operations. In conjunction with recording this gain, the Company recorded a pre-tax charge of approximately $35 million in discontinued operations to finalize certain liabilities accrued for as part of the CVS Strategic Restructuring Program. During the second quarter of 1996, the Company recorded, as a component of discontinued operations, a pre-tax charge of $235.0 million (the "1996 Restructuring Charge") after receiving approval from its Board of Directors to implement: (i) a formal plan to separate Linens `n Things and Bob's Stores from the Company and (ii) a formal plan to convert 80-100 of Thom McAn's stores to the Footaction store format and to sell or close the remaining Thom McAn stores, and thereby exit the Thom McAn business by mid-1997. See the "CVS Strategic Restructuring Program" section above and Note 3 to the consolidated financial statements for further information about the CVS Strategic Restructuring Program.

EXTRAORDINARY ITEM represents a $17.1 million after-tax charge that was recorded in the second quarter of 1997 as a result of the Revco Debt Retirement (defined in the "Revco Debt Retirement" section below). This charge includes early retirement premiums and the write-off of unamortized finance costs. For further discussion, see the "Revco Debt Retirement" section below.

NET EARNINGS for 1997 were $37.7 million or $0.14 per diluted share, compared to $176.6 million or $0.98 per diluted share, in 1996.

1996 VERSUS 1995

NET SALES for 1996 increased $1.2 billion or 12.1% to $10.9 billion, compared to $9.8 billion in 1995. Same store sales rose 8.7%, with pharmacy same store sales increasing 13.3%. Pharmacy sales were 51% of total sales in both 1996 and 1995.

The growth in front store sales was primarily driven by increases in categories such as greeting cards, film and photofinishing, beauty and cosmetics, convenience foods, private label and seasonal merchandise. Growth in pharmacy sales was primarily driven by the Pharmacy Sales Factors defined in the "1997 versus 1996" section above.

GROSS MARGIN for 1996 increased $305.2 million or 11.1% to $3.1 billion, compared to $2.7 billion in 1995.

Gross margin as a percentage of net sales for 1996 was 27.9%, compared to 28.1% of net sales in 1995. The decline in 1996 was primarily due to the Pharmacy Gross Margin Factors defined in the "1997 versus 1996" section above.

TOTAL OPERATING EXPENSES for 1996 were $2.5 billion or 22.9% of net sales, compared to $2.5 billion or 25.8% of net sales in 1995. In order to properly evaluate the Company's total operating expenses in these periods, it is important to note the following non-recurring charges:

- During the second quarter of 1996, the Company recorded the $12.8 million Rite Aid Charge.

- During the fourth quarter of 1995, the Company recorded a pre-tax charge of $872.0 million when its Board of Directors approved the CVS Strategic Restructuring Program (the "1995 Restructuring Charge"). $160.6 million of this charge pertained to continuing operations. The amount recorded in continuing operations primarily included costs associated with (i) exiting certain geographic markets, (ii) closing duplicate warehouse facilities and
(iii) closing the Company's corporate headquarters in Rye, New York. These costs primarily included asset write-offs, closed store and warehouse lease liabilities and employee severance. The balance of the charge, $711.4 million, was reflected as a component of discontinued operations. See the "CVS Strategic Restructuring Program" section above and Note 3 to the consolidated financial statements for further information about the CVS Strategic Restructuring Program.

- During the fourth quarter of 1995, the Company changed its policy from capitalizing internally developed software costs to expensing the costs as incurred and recorded a pre-tax charge of $74.5 million (the "Accounting Change"), $37.8 million of which pertained to continuing operations. The effect of this change in accounting principle has been treated as a change in accounting principle that is inseparable from the effect of the change in accounting estimate. See the "Accounting Changes" section below and Note 2 to the consolidated financial statements for further information about this charge.

5

During the fourth quarter of 1995, the Company recorded, as a component of operating expenses, the following non-recurring charges: (i) $11.6 million related to outsourcing certain technology functions and retaining certain employees until their respective job functions were transitioned, and (ii) $5.0 million related to the write-down of certain fixed and intangible assets as a result of the Company's early adoption of Statement of Financial Accounting Standards ("SFAS") No. 121, "Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of" (collectively, the "Special Charges"). See the "Accounting Changes" section below and Note 2 to the consolidated financial statements for further information about these charges.

Excluding the Rite Aid Charge in 1996 and the 1995 Restructuring Charge, the Accounting Change and the Special Charges in 1995, comparable operating expenses for 1996 were $2.5 billion or 22.8% of net sales, compared to $2.3 billion or 23.6% of net sales in 1995. The improvement in comparable operating expenses as a percentage of net sales was primarily due to the benefits derived from: (i) sales in the Company's existing store base growing at a faster rate than operating costs, (ii) the CVS Strategic Restructuring Program, (iii) store operating improvements and (iv) key technology investments.

OPERATING PROFIT for 1996 increased $310.1 million to $540.8 million, compared to $230.7 million in 1995. Excluding the Rite Aid Charge in 1996 and the 1995 Restructuring Charge, the Accounting Change and the Special Charges in 1995, comparable operating profit increased $107.9 million or 24.2% to $553.6 million in 1996, compared to $445.7 million in 1995. Comparable operating profit as a percentage of net sales was 5.1% for 1996, compared to 4.6% of net sales in 1995.

OTHER (EXPENSE) INCOME, NET for 1996 amounted to income of $51.3 million, compared to an expense of $114.5 million in 1995. This increase was primarily due to the TJX Gain in 1996. In addition, net interest expense decreased $38.8 million in 1996 to $75.7 million, compared to $114.5 million in 1995. The decrease in net interest expense was primarily due to lower average borrowing levels.

EARNINGS FROM CONTINUING OPERATIONS for 1996 increased $283.0 million to $340.8 million, compared to $57.8 million in 1995. Excluding the Rite Aid Charge and the TJX Gain in 1996 and the 1995 Restructuring Charge, the Accounting Change and the Special Charges in 1995, comparable earnings from continuing operations increased $90.5 million or 49.0% to $275.2 million or $1.55 per diluted share in 1996, compared to $184.7 million or $1.02 per diluted share in 1995.

DISCONTINUED OPERATIONS--During the second quarter of 1996, the Company recorded the 1996 Restructuring Charge. During the fourth quarter of 1995, the Company recorded the 1995 Restructuring Charge. See the "CVS Strategic Restructuring Program" section above and Note 3 to the consolidated financial statements for further information.

NET EARNINGS for 1996 were $176.6 million or $0.98 per diluted share, compared to a net loss of $572.8 million or $3.59 per diluted share in 1995.

SEASONALITY

The Company's business normally generates higher revenue during the holiday season in its fourth quarter. In each of the fiscal years ended December 31, 1997, 1996 and 1995, the fourth quarter accounted for approximately 26%, 28% and 28% of the Company's net sales, respectively.

LIQUIDITY & CAPITAL RESOURCES

The following discussion should be read in conjunction with the Company's consolidated financial statements as of December 31, 1997 and 1996 and for each of the years in the three-year period ended December 31, 1997.

The Company's financial condition remained strong at the end of 1997. Management's aggressive focus on working capital combined with the proceeds received from: (i) the sale of the Company's 32.5% ownership interest in Linens `n Things, Inc., (ii) the sale of Bob's Stores, (iii) the sale of certain Revco stores, and (iv) the sale of certain notes receivable that were received as a portion of the proceeds from the sale of certain businesses, allowed the Company to reduce its total debt position by approximately $422.4 million during the year to $779.8 million at December 31, 1997.

6

REVCO DEBT RETIREMENT

Following the completion of the CVS/Revco Merger:

- On May 30, 1997, the Company repaid $600 million of bank debt outstanding under the Revco Bank Facility.

- On June 30, 1997, the Company redeemed all $144.9 million aggregate principal amount of the Revco 10.125% Senior Notes at 105% of the principal amount plus accrued interest.

- In July 1997, the Company completed a tender offer pursuant to which it repurchased $120.8 million of the $140.0 million aggregate principal amount of the Revco 9.125% Senior Notes at an average price of 104.61% of the principal amount plus accrued interest.

As a result of the above (collectively, the "Revco Debt Retirement"), the Company recorded an after-tax charge of $17.1 million during the second quarter of 1997. This charge, which includes early retirement premiums and the write-off of unamortized finance costs, has been classified as an extraordinary item in the accompanying consolidated statements of operations.

The Revco Debt Retirement was financed with cash on hand and borrowings under the Company's commercial paper program. See Note 7 to the consolidated financial statements for further information about the Revco Debt Retirement.

On January 15, 1998, the Company redeemed the remaining $19.2 million aggregate principal amount of the Revco 9.125% Senior Notes at 103% of principal plus accrued interest.

GOODWILL

In connection with certain acquisitions which were accounted for as purchase business combinations under APB Opinion No. 16, the Company recorded goodwill in the amount of $776.9 million, representing the excess of the cost of the net assets acquired over their fair value. Goodwill is being amortized on a straight-line basis generally over periods of 40 years. At December 31, 1997, the unamortized portion of goodwill totaled $711.3 million.

Although goodwill amortization has no impact on the Company's cash flows, the impact on annual earnings is approximately $19.4 million. This amount is included in depreciation and amortization.

The Company evaluates goodwill for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. In completing its evaluation, the Company compares estimated future cash flows to the carrying amount of the goodwill. If the carrying amount of the goodwill exceeds the expected future cash flows, the Company considers the goodwill to be impaired and records an impairment loss. Based on the Company's analysis of future cash flows, management believes that goodwill is not presently impaired.

SOURCES OF LIQUIDITY

The Company has three primary sources of liquidity: (i) cash provided by operations, (ii) commercial paper and (iii) uncommitted lines of credit.

The Company issues commercial paper to finance, in part, its seasonal inventory requirements and capital expenditures. The commercial paper program is supported by a $670 million, five year unsecured revolving credit facility which expires on May 30, 2002 (the "Credit Facility"). The Credit Facility contains customary financial and operating covenants. Management believes that the restrictions contained in these covenants do not materially affect the Company's financial flexibility.

The Company can also obtain up to $220 million of short-term financing through various uncommitted lines of credit.

Management believes that the Company's cash on hand and cash provided by operations, together with its ability to obtain additional short-term and long-term financing, will be sufficient to cover its working capital needs, capital expenditures, debt service requirements and future cash outlays associated with the CVS/Revco Merger and the acquisition of Arbor.

7

YEAR 2000

Since 1995, the Company has been actively addressing the nature and impact of issues presented by the Year 2000. Accordingly, management expects to identify and complete all modifications required to support the Year 2000 in a timely manner and believes that the cost of such modifications will not have a material impact on the Company's results of operations, liquidity or capital resources. The Company has also communicated with its key vendors and suppliers to identify the nature and potential impact of issues presented by the Year 2000 on the businesses of such vendors and suppliers. Management is not presently aware of any vendor or supplier-related issue presented by the Year 2000 that could have a material impact on the Company.

CAPITAL EXPENDITURES

Capital expenditures totaled $312.1 million, $297.5 million and $528.9 million in 1997, 1996 and 1995, respectively. These expenditures were primarily for: (i) new stores, (ii) improvements to existing stores, (iii) store equipment, (iv) information systems, (v) distribution and office facilities and (vi) remodeling completed in connection with the Revco integration.

During 1997, the Company opened 287 new stores (including relocations) and expects to open approximately 300 new stores (including relocations) in 1998. Relocations involve moving existing in-line shopping center stores to larger freestanding locations. Historically, relocating stores to more convenient locations and larger sizes has generated significant improvements in customer count and revenues, driven largely by increased sales of higher margin front store merchandise. Management believes that relocations offer a significant opportunity for future growth as less than 20% of the Company's existing stores are freestanding. However, it is unknown at this time whether such relocations in existing or new markets served by the Company will realize the same results as those historically achieved.

REVISED DIVIDEND

On January 10, 1996, the Board of Directors approved a reduction in the Company's quarterly dividend from $0.38 per common share to $0.11 per common share (the "Revised Dividend"). Management believes that the Revised Dividend is consistent with chain drug industry practice and the Company's anticipated capital requirements. Future dividends will be at the discretion of the Company's Board of Directors and subject to future operating performance and financial condition.

CERTAIN TAX MATTERS

As of December 31, 1997, the Company had federal net operating loss carryforwards ("NOLs") of approximately $33.9 million expiring in the years 2003 through 2009.

Substantially all of these NOLs are attributable to the time period prior to Revco's emergence from Chapter 11. As discussed in Note 2 to the consolidated financial statements, under Fresh Start Reporting, the benefits realized from these NOLs should reduce Reorganization Goodwill. Accordingly, the tax benefit of such NOLs utilized during the three years ended December 31, 1997 (approximately $69.4 million, $15.3 million and $18.8 million for 1997, 1996 and 1995, respectively), have not been included in the computation of the Company's income tax provision, but instead have been reflected as reductions of Reorganization Goodwill. When realized, the tax benefit of the remaining NOL carryforward will also reduce Reorganization Goodwill.

ACCOUNTING CHANGES

During the fourth quarter of 1997, the Company was required to retroactively adopt SFAS No. 128, "Earnings Per Share." This statement requires companies with complex capital structures to present basic and diluted earnings per common share in lieu of previously reported primary and fully diluted earnings per common share. See Notes 2 and 18 to the consolidated financial statements for further information about SFAS No. 128.

Effective January 1, 1996, the Company adopted SFAS No. 123, "Accounting for Stock-Based Compensation." While SFAS No. 123 established financial accounting and reporting standards for stock-based employee compensation plans using a fair value method of accounting, it allows companies to continue to measure compensation using the intrinsic value method of accounting as prescribed in APB Opinion No. 25, "Accounting for Stock Issued to Employees." The Company will continue to use its present APB Opinion No. 25 accounting treatment for stock-based compensation. See Notes 2 and 11 to the consolidated financial statements for further information about SFAS No. 123.

8

Effective October 1, 1995, the Company early adopted SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of" and recorded a pre-tax asset impairment charge of $110.4 million ($5.0 million of which pertained to continuing operations) in connection with the write-down of certain fixed and intangible assets. The above charge resulted when the Company began identifying and measuring impairment at a lower level under SFAS No. 121 than under its previous accounting policy. Under the Company's previous accounting policy, long lived assets were evaluated in total for impairment at the operating business level if the operating business was either incurring operating losses or was expecting to incur operating losses in the future. Since the expected future cash flows measured at the operating business level were in excess of the carrying value of the related assets, no previous impairment losses were recorded.

During the fourth quarter of 1995, the Company changed its policy from capitalizing internally developed software costs to expensing the costs as incurred and recorded a charge of $74.5 million ($37.8 million of which pertained to continuing operations). The effect of the change in accounting principle has been treated as a change in accounting principle that is inseparable from the effect of the change in accounting estimate. As a result, the entire amount has been treated as a change in accounting estimate. The effect of this charge was to reduce net earnings by $45.8 million or $0.28 per diluted common share in 1995.

CAUTIONARY STATEMENT CONCERNING FORWARD LOOKING STATEMENTS

We have made forward-looking statements in this Annual Report (as well as in other public filings, press releases and discussions with Company management) that are subject to risks and uncertainties. Forward-looking statements include the information concerning future results of operations, sales growth, cost savings and synergies of the Company following the CVS/Revco Merger and the Arbor acquisition; the information concerning the ability of the Company to elevate the performance level of Revco stores following the CVS/Revco Merger; the information concerning the ability of the Company to continue to achieve significant sales growth; the information concerning the Company's belief that it can continue to improve operating performance by relocating existing stores to freestanding locations; the information concerning the Company's belief that it can continue to reduce selling, general and administrative expenses as a percentage of net sales; and the information concerning the ability of the Company and its key vendors and suppliers to successfully manage issues presented by the Year 2000; as well as those preceded by, followed by or that otherwise include the words: "believes," "expects," "anticipates," "intends," "estimates" or other similar expressions. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. You should understand that the following important factors, in addition to those discussed elsewhere in this Annual Report (including in the notes to the consolidated financial statements included herein) and in our Annual Report on Form 10-K for the year ended December 31, 1997, could affect the future results of the Company and could cause those results to differ materially from those expressed in our forward-looking statements: materially adverse changes in economic conditions generally or in the markets served by the Company; future regulatory and legislative actions affecting the Company and/or the chain-drug industry; competition from other drugstore chains, from alternative distribution channels such as supermarkets, membership clubs, other retailers and mail order companies; and from third party plans; and the continued efforts of health maintenance organizations, managed care organizations, pharmacy benefit management companies and other third party payors to reduce prescription drug costs. The forward-looking statements referred to above are also subject to uncertainties and assumptions relating to the operations and results of operations of the Company following the CVS/Revco Merger and the Arbor acquisition, including: risks relating to the Company's ability to combine the businesses of three major corporations and maintain current operating performance levels during the integration period and the challenges inherent in diverting the Company's management focus and resources from other strategic opportunities and from operational matters for an extended period of time; the Company's ability to continue to secure suitable new store locations on favorable lease terms as it seeks to open new stores and relocate a portion of its existing store base to free standing locations; the Company's ability to continue to purchase inventory on favorable terms; the Company's ability to attract, hire and retain suitable pharmacists and management personnel; relationships with suppliers; and the impact of inflation.

9

Management's Responsibility for Financial Reporting

The integrity and objectivity of the financial statements and related financial information in this report are the responsibility of the management of the Company. The financial statements have been prepared in conformity with generally accepted accounting principles and include, when necessary, the best estimates and judgments of management.

The Company maintains a system of internal controls designed to provide reasonable assurance, at appropriate cost, that assets are safeguarded, transactions are executed in accordance with management's authorization, and the accounting records provide a reliable basis for the preparation of the financial statements. The system of internal accounting controls is continually reviewed by management and improved and modified as necessary in response to changing business conditions and recommendations of the Company's internal auditors and independent auditors.

KPMG Peat Marwick LLP, independent auditors, are engaged to render an opinion regarding the fair presentation of the consolidated financial statements of the Company. Their accompanying report is based upon an audit conducted in accordance with generally accepted accounting standards and included a review of the system of internal controls to the extent they considered necessary to support their opinion.

The Audit Committee of the Board of Directors, consisting solely of outside directors, meets periodically with management, internal auditors and the independent auditors to review matters relating to the Company's financial reporting, the adequacy of internal accounting controls and the scope and results of audit work. The internal auditors and independent auditors have free access to the Audit Committee.

/s/ Stanley P. Goldstein

Stanley P. Goldstein
Chairman of the Board and Chief Executive Officer


/s/ Thomas M. Ryan

Thomas M. Ryan
Vice Chairman and Chief Operating Officer


/s/ Charles C. Conaway

Charles C. Conaway
Executive Vice President and Chief Financial Officer

February 9, 1998

Independent
Auditors' Report

KPMG Peat Marwick LLP

Board of Directors and Shareholders of CVS Corporation:

We have audited the accompanying consolidated balance sheets of CVS Corporation and subsidiaries as of December 31, 1997 and 1996, and the related consolidated statements of operations, shareholders' equity, and cash flows for each of the years in the three year period ended December 31, 1997. These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of CVS Corporation and subsidiaries at December 31, 1997 and 1996, and the results of their operations and their cash flows for each of the years in the three year period ended December 31, 1997, in conformity with generally accepted accounting principles.

/s/ KPMG PEAT MARWICK LLP

KPMG PEAT MARWICK LLP
Providence, Rhode Island

February 9, 1998

10

CONSOLIDATED STATEMENTS OF OPERATIONS

                                                                                       YEARS ENDED DECEMBER 31,
                                                                                    -------------------------------
IN MILLIONS, EXCEPT PER SHARE AMOUNTS                                                 1997       1996       1995
----------------------------------------------------------------------------------  ---------  ---------  ---------
Net sales.........................................................................  $12,738.2  $10,944.8  $ 9,763.4
Cost of goods sold, buying and warehousing costs..................................    9,298.5    7,892.7    7,016.5
                                                                                    ---------  ---------  ---------
  Gross margin....................................................................    3,439.7    3,052.1    2,746.9
Selling, general and administrative expenses......................................    2,575.4    2,309.7    2,180.3
Depreciation and amortization.....................................................      221.8      188.8      170.4
Merger, restructuring and other non-recurring charges.............................      442.7       12.8      165.5
                                                                                    ---------  ---------  ---------
  Total operating expenses........................................................    3,239.9    2,511.3    2,516.2
                                                                                    ---------  ---------  ---------
Operating profit..................................................................      199.8      540.8      230.7
Gain on sale of securities........................................................         --      121.4         --
Dividend income...................................................................         --        5.6         --
Interest expense, net.............................................................      (44.8)     (75.7)    (114.5)
                                                                                    ---------  ---------  ---------
  Other (expense) income, net.....................................................      (44.8)      51.3     (114.5)
                                                                                    ---------  ---------  ---------
Earnings from continuing operations before income taxes and extraordinary item....      155.0      592.1      116.2
Income tax provision..............................................................     (117.7)    (251.3)     (58.4)
                                                                                    ---------  ---------  ---------
Earnings from continuing operations before extraordinary item.....................       37.3      340.8       57.8
Discontinued operations:
  Loss from operations, net of tax benefit of $31.0 and $171.4 in 1996 and 1995,
    respectively..................................................................         --      (54.8)    (607.4)
  Loss on disposal, net of tax (provision) benefit of $(12.4), $56.2 and $9.9 in
    1997, 1996 and 1995, respectively and minority interest of $22.2 and $38.4 in
    1996 and 1995, respectively...................................................       17.5     (109.4)     (23.2)
                                                                                    ---------  ---------  ---------
  Earnings (loss) from discontinued operations....................................       17.5     (164.2)    (630.6)
                                                                                    ---------  ---------  ---------
Earnings (loss) before extraordinary item.........................................       54.8      176.6     (572.8)
  Extraordinary item, loss related to early retirement of debt, net of income tax
    benefit of $11.4..............................................................      (17.1)        --         --
Net earnings (loss)...............................................................       37.7      176.6     (572.8)
                                                                                    ---------  ---------  ---------
Preference dividends, net of tax benefit..........................................      (13.7)     (14.5)     (17.0)
                                                                                    ---------  ---------  ---------
Net earnings (loss) available to common shareholders..............................  $    24.0  $   162.1  $  (589.8)
                                                                                    ---------  ---------  ---------
                                                                                    ---------  ---------  ---------
Basic Earnings (Loss) per Common Share:
  Earnings from continuing operations before extraordinary item...................  $    0.14  $    1.97  $    0.25
  Earnings (loss) from discontinued operations....................................       0.10      (0.99)     (3.85)
  Extraordinary item, net of tax benefit..........................................      (0.10)        --         --
                                                                                    ---------  ---------  ---------
  Net earnings (loss).............................................................  $    0.14  $    0.98  $   (3.60)
                                                                                    ---------  ---------  ---------
  Weighted average common shares outstanding......................................      169.8      165.3      163.7
                                                                                    ---------  ---------  ---------
                                                                                    ---------  ---------  ---------
Diluted Earnings (loss) per Common Share:
  Earnings from continuing operations before extraordinary item...................  $    0.14  $    1.92  $    0.25
  Earnings (loss) from discontinued operations....................................       0.10      (0.94)     (3.84)
  Extraordinary item, net of tax benefit..........................................      (0.10)        --         --
                                                                                    ---------  ---------  ---------
  Net earnings (loss).............................................................  $    0.14  $    0.98  $   (3.59)
                                                                                    ---------  ---------  ---------
  Weighted average common shares outstanding......................................      173.0      173.2      164.3
                                                                                    ---------  ---------  ---------
                                                                                    ---------  ---------  ---------
Dividends per Common Share........................................................  $    0.44  $    0.44  $    1.52
                                                                                    ---------  ---------  ---------

SEE ACCOMPANYING NOTES TO CONSOLIDATED FINANCIAL STATEMENTS.

2

CONSOLIDATED BALANCE SHEETS

                                                                                                    DECEMBER 31,
                                                                                                --------------------
IN MILLIONS                                                                                       1997       1996
----------------------------------------------------------------------------------------------  ---------  ---------
ASSETS:
  Cash and cash equivalents...................................................................  $   168.5  $   471.8
  Investments.................................................................................         --      181.4
  Accounts receivable, net....................................................................      452.4      350.7
  Inventories.................................................................................    2,709.5    2,328.2
  Other current assets........................................................................      354.6      196.8
                                                                                                ---------  ---------
    TOTAL CURRENT ASSETS......................................................................    3,685.0    3,528.9
  Property and equipment, net.................................................................      958.2      965.5
  Goodwill, net...............................................................................      711.3      721.7
  Deferred charges and other assets...........................................................      174.5      282.8
  Reorganization value in excess of amounts allocated to identifiable assets, net.............      107.9      194.8
                                                                                                ---------  ---------
  TOTAL ASSETS................................................................................  $ 5,636.9  $ 5,693.7
                                                                                                ---------  ---------
                                                                                                ---------  ---------
LIABILITIES:
  Accounts payable............................................................................  $ 1,181.9  $ 1,046.3
  Accrued expenses............................................................................    1,165.7    1,007.1
  Short-term borrowings.......................................................................      466.4        --
  Other current liabilities...................................................................       41.0       69.4
                                                                                                ---------  ---------
    TOTAL CURRENT LIABILITIES.................................................................    2,855.0    2,122.8
  Long-term debt..............................................................................      272.6    1,184.3
  Other long-term liabilities.................................................................      147.9      190.2
SHAREHOLDERS' EQUITY:
  Preference stock............................................................................      284.6      298.6
  Common stock................................................................................        1.8        1.7
  Treasury stock, at cost.....................................................................     (262.9)    (273.1)
  Guaranteed ESOP obligation..................................................................     (292.1)    (292.1)
  Capital surplus.............................................................................    1,079.0      875.9
  Retained earnings...........................................................................    1,551.0    1,587.8
  Other.......................................................................................         --       (2.4)
                                                                                                ---------  ---------
    TOTAL SHAREHOLDERS' EQUITY................................................................    2,361.4    2,196.4
                                                                                                ---------  ---------
  TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY..................................................  $ 5,636.9  $ 5,693.7
                                                                                                ---------  ---------
                                                                                                ---------  ---------

See accompanying notes to consolidated financial statements.

3

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

                                                                     YEARS ENDED DECEMBER 31,
                                                                     ------------------------
                                                                    SHARES                   DOLLARS
                                                              -------------------  ----------------------------
                                                               1997   1996   1995     1997      1996      1995
                                                              -----  -----  -----  --------  --------  --------
                                                                                 IN MILLIONS
PREFERENCE STOCK:
  Beginning of year.........................................    5.6    6.3    6.4  $  298.6  $  334.9  $  340.9
  Conversion to common stock................................   (0.3)  (0.7)  (0.1)    (14.0)    (36.3)     (6.0)
                                                              -----  -----  -----  --------  --------  --------
  End of year...............................................    5.3    5.6    6.3     284.6     298.6     334.9
                                                              -----  -----  -----  --------  --------  --------
                                                              -----  -----  -----  --------  --------  --------
COMMON STOCK:
  Beginning of year.........................................  172.2  170.8  170.3       1.7     170.8     170.3
  Stock options exercised and awards under stock plans......    5.4    1.7    0.4       0.1       1.7       0.4
  Effect of change in par value.............................     --     --     --        --    (170.5)       --
  Other.....................................................    0.4   (0.3)   0.1        --      (0.3)      0.1
                                                              -----  -----  -----  --------  --------  --------
  End of year...............................................  178.0  172.2  170.8       1.8       1.7     170.8
                                                              -----  -----  -----  --------  --------  --------
                                                              -----  -----  -----  --------  --------  --------
TREASURY STOCK:
  Beginning of year.........................................   (5.8)  (6.5)  (5.8)   (273.1)   (304.6)   (283.8)
  Repurchase of common stock................................     --     --   (0.8)       --        --     (26.3)
  Conversion of preference stock............................    0.3    0.7    0.1      12.2      31.6       5.5
  Other.....................................................   (0.1)    --     --      (2.0)     (0.1)       --
                                                              -----  -----  -----  --------  --------  --------
  End of year...............................................   (5.6)  (5.8)  (6.5)   (262.9)   (273.1)   (304.6)
                                                              -----  -----  -----  --------  --------  --------
                                                              -----  -----  -----  --------  --------  --------
GUARANTEED ESOP OBLIGATION:
  Beginning of year.........................................                         (292.1)   (309.7)   (328.1)
  Reduction of guaranteed ESOP obligation...................                             --      17.6      18.4
                                                              -----  -----  -----  --------  --------  --------
  End of year...............................................                         (292.1)   (292.1)   (309.7)
                                                              -----  -----  -----  --------  --------  --------
                                                              -----  -----  -----  --------  --------  --------
CAPITAL SURPLUS:
  Beginning of year.........................................                          875.9     668.2     656.5
  Conversion of preference stock............................                            1.8       4.7       0.5
  Stock options exercised and awards under stock plans......                          186.2      41.9       8.3
  Effect of change in par value.............................                             --     170.5        --
  Other.....................................................                           15.1      (9.4)      2.9
                                                              -----  -----  -----  --------  --------  --------
  End of year...............................................                        1,079.0     875.9     668.2
                                                              -----  -----  -----  --------  --------  --------
                                                              -----  -----  -----  --------  --------  --------
RETAINED EARNINGS:
  Beginning of year.........................................                        1,587.8   1,833.0   2,582.7
  Net earnings (loss).......................................                           37.7     176.6    (572.8)
  Dividends:
    Preference stock, net of tax benefit....................                          (13.7)    (14.4)    (16.9)
    Redeemable preferred stock..............................                             --      (0.1)     (0.1)
    Common stock............................................                          (60.8)    (46.5)   (159.9)
    Footstar Distribution...................................                             --    (360.8)       --
                                                              -----  -----  -----  --------  --------  --------
  End of year...............................................                        1,551.0   1,587.8   1,833.0
                                                              -----  -----  -----  --------  --------  --------
                                                              -----  -----  -----  --------  --------  --------
OTHER:
  Beginning of year.........................................                           (2.4)      0.2    (111.4)
  Cumulative translation adjustment.........................                             --      (0.2)      1.6
  Unrealized holding gain (loss) on investments, net........                            2.4      (2.4)       --
                                                              -----  -----  -----  --------  --------  --------
  End of year...............................................                             --      (2.4)      0.2
                                                              -----  -----  -----  --------  --------  --------
TOTAL SHAREHOLDERS' EQUITY..................................                       $2,361.4  $2,196.4  $2,392.8
                                                              -----  -----  -----  --------  --------  --------
                                                              -----  -----  -----  --------  --------  --------

See accompanying notes to consolidated financial statements.

4

CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                                             YEARS ENDED DECEMBER 31,
                                                                                          -------------------------------
                                                                                            1997       1996       1995
                                                                                          ---------  ---------  ---------
                                                                                                    IN MILLIONS
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net earnings (loss)...................................................................  $    37.7  $   176.6  $  (572.8)
  Adjustments required to reconcile net earnings (loss) to net cash (used in) provided
    by operating activities:
    Merger, restructuring and other non-recurring charges...............................      486.7      235.0      982.4
    Depreciation and amortization.......................................................      226.2      246.2      327.7
    Gain on sale of securities..........................................................      (30.0)    (121.4)        --
    Minority interest in net earnings...................................................         --       22.2       38.4
    Income (loss) from unconsolidated subsidiary........................................        0.3       (4.5)        --
    Deferred income taxes and other non-cash items......................................     (195.1)     115.1      (89.7)
    Net operating loss carryforwards utilized...........................................       69.4       15.3       18.8
    Extraordinary item, loss on early retirement of debt, net of tax....................       17.1         --         --
  Change in assets and liabilities, excluding acquisitions and dispositions:
    (Increase) decrease in accounts receivable, net.....................................      (80.6)       4.6      (59.0)
    (Increase) in inventories...........................................................     (531.0)    (233.6)    (349.7)
    (Increase) in other current assets, deferred charges and other assets...............      (66.7)     (93.5)     (32.9)
    Increase in accounts payable........................................................       21.3      337.9      205.5
    (Decrease) increase in accrued expenses.............................................     (224.4)    (219.9)      54.6
    (Decrease) in Federal incomes taxes payable and other liabilities...................       (6.1)     (16.9)     (63.3)
                                                                                          ---------  ---------  ---------
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES.....................................     (275.2)     463.1      460.0
                                                                                          ---------  ---------  ---------
                                                                                          ---------  ---------  ---------
CASH FLOWS FROM INVESTING ACTIVITIES:
  Additions to property and equipment...................................................     (312.1)    (297.5)    (528.9)
  Proceeds from sale of businesses and other property and equipment.....................      192.7      240.4      423.6
  Proceeds from initial and secondary public offerings of Linens 'n Things, Inc.........      147.4      189.4         --
  Proceeds from sale of investments.....................................................      162.3      296.4         --
  Acquisitions, net of cash.............................................................         --     (373.9)      (4.8)
                                                                                          ---------  ---------  ---------
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES.....................................      190.3       54.8     (110.1)
                                                                                          ---------  ---------  ---------
                                                                                          ---------  ---------  ---------
CASH FLOWS FROM FINANCING ACTIVITIES:
  Dividends paid or payable.............................................................      (74.6)    (132.3)    (240.0)
  Additions to (reductions in) short-term borrowings....................................      466.4      (52.0)    (148.0)
  Increase (decrease) in book overdrafts................................................      144.3     (158.2)      74.8
  Repurchase of common stock............................................................         --      (11.2)     (39.1)
  (Reductions in) additions to long-term debt...........................................     (911.7)     131.4       21.6
  Proceeds from exercise of stock options and other issuances of stock..................      159.5       45.6       14.0
  Other.................................................................................       (2.3)     (14.6)      (8.9)
                                                                                          ---------  ---------  ---------
NET CASH USED IN FINANCING ACTIVITIES...................................................     (218.4)    (191.3)    (325.6)
                                                                                          ---------  ---------  ---------
                                                                                          ---------  ---------  ---------
Net (decrease) increase in cash and cash equivalents....................................     (303.3)     326.6       24.3
Cash and cash equivalents at beginning of year..........................................      471.8      145.2      120.9
                                                                                          ---------  ---------  ---------
CASH AND CASH EQUIVALENTS AT END OF YEAR................................................  $   168.5  $   471.8  $   145.2
                                                                                          ---------  ---------  ---------
                                                                                          ---------  ---------  ---------

See accompanying notes to consolidated financial statements.

5

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1 CVS/REVCO MERGER

On May 29, 1997, CVS Corporation ("CVS") completed a merger with Revco D.S., Inc. ("Revco"), hereafter collectively referred to as the Company, by exchanging 60.3 million shares of CVS common stock for all of the outstanding common stock of Revco (the "Merger"). Each outstanding share of Revco common stock was exchanged for 0.8842 of a share of CVS common stock. In addition, outstanding Revco employee stock options were converted at the same exchange ratio into options to purchase approximately 3.3 million shares of CVS common stock.

The Merger, which constituted a tax-free reorganization, has been accounted for as a pooling of interests under Accounting Principles Board ("APB") Opinion No. 16, "Accounting for Business Combinations." Accordingly, all prior period financial statements presented have been restated to include the combined results of operations, financial position and cash flows of Revco as if it had always been part of CVS.

Pursuant to a consent decree with the Federal Trade Commission entered into in connection with the Merger, the Company divested 120 Revco stores, primarily in Richmond and the Tidewater area of Virginia.

Prior to the Merger, Revco's fiscal year ended on the Saturday closest to May 31. In recording the business combination, Revco's consolidated financial statements for the fiscal years ended June 1, 1996 and June 3, 1995 have been restated to reflect a December 31 year-end, to conform with CVS' fiscal year- end.

Revco's cost of sales and inventories have been restated from the last-in, first-out method to the first-in, first-out method in order to conform to CVS' accounting method for inventories. The impact of the restatement was to increase earnings from continuing operations by $13.5 million in 1996 and $11.9 million in 1995.

There were no material transactions between CVS and Revco prior to the Merger. Certain reclassifications have been made to Revco's historical consolidated financial statements to conform to CVS' presentation.

In accordance with Emerging Issues Task Force ("EITF") Issue No. 94-3, "Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (Including Certain Costs Incurred in a Restructuring)," the Company recorded a charge to operating expenses of $411.7 million during the second quarter of 1997 for direct and other merger-related costs pertaining to the merger transaction and certain restructuring activities (the "CVS/Revco Restructuring Charge").

Following is a summary of the significant components of the CVS/Revco Restructuring Charge:

                                                                      CVS/REVCO
                                                                    RESTRUCTURING      UTILIZED IN    BALANCE AT
IN MILLIONS                                                            CHARGE             1997         12/31/97
---------------------------------------------------------------  -------------------  -------------  -------------
Merger transaction costs.......................................       $    35.0         $    32.1      $     2.9
Restructuring costs:
  Employee severance...........................................            89.8              37.4           52.4
  Exit costs...................................................           286.9             126.1          160.8
                                                                 -------------------  -------------  -------------
                                                                      $   411.7         $   195.6      $   216.1
                                                                 -------------------  -------------  -------------
                                                                 -------------------  -------------  -------------

Merger transaction costs primarily include fees for investment bankers, attorneys, accountants, financial printing and other related charges. Restructuring activities primarily relate to the consolidation of administrative functions. These actions resulted in the reduction of approximately 1,000 employees, primarily in Revco's Twinsburg, Ohio Headquarters, and will include the consolidation and closure of certain facilities. Exit costs primarily relate to activities such as the cancellation of lease agreements, closing of certain facilities and the write-down of unutilized fixed assets.

Asset write-offs included in the CVS/Revco Restructuring Charge totaled $53.7 million. The balance of the charge, $358.0 million, will require cash outlays of which $164.8 million had been incurred as of December 31, 1997. The remaining balance, $193.2 million, which primarily includes non-cancelable operating lease commitments and severance, is expected to be incurred in 1998 and beyond.

The Company also recorded a $75 million charge to cost of goods sold during the second quarter of 1997 to reflect markdowns on non-compatible Revco merchandise.

15

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Following is a summary of the results of operations for the separate companies prior to the Merger and the combined amounts presented in the consolidated financial statements:

                                                                          THREE MONTHS          YEARS ENDED
                                                                              ENDED            DECEMBER 31,
                                                                             MARCH 29,      --------------------
IN MILLIONS                                                                    1997           1996        1995
----------------------------------------------------------------------  -----------------  ----------  ---------
NET SALES:
  CVS.................................................................     $   1,515.0     $  5,528.1  $ 4,865.0
  Revco...............................................................         1,645.8        5,416.7    4,898.4
                                                                              --------     ----------  ---------
                                                                           $   3,160.8     $ 10,944.8  $ 9,763.4
                                                                              --------     ----------  ---------
                                                                              --------     ----------  ---------
Earnings (loss) from continuing operations:

  CVS.................................................................     $      58.4     $    239.6     $(26.5)
  Revco...............................................................            24.2          101.2       84.3
                                                                              --------     ----------  ---------
                                                                           $      82.6     $    340.8  $    57.8
                                                                              --------     ----------  ---------
                                                                              --------     ----------  ---------

2 SIGNIFICANT ACCOUNTING POLICIES

DESCRIPTION OF BUSINESS--At December 31, 1997, the Company operated 3,888 retail drugstores in 24 Northeast, Mid-Atlantic, Southeast and Midwest states and the District of Columbia. CVS offers customers convenience, selection, and superior customer service as well as comprehensive prescription and pharmacy services.

BASIS OF PRESENTATION--The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated.

As a result of the CVS Strategic Restructuring Program, the results of operations of the former (i) footwear segment (which included the Meldisco, Footaction and Thom McAn businesses), (ii) apparel segment (which included the Marshalls, Wilsons, and Bob's Stores businesses) and (iii) toys and home furnishings segment (which included the Kay-Bee Toys, This End Up and Linens 'n Things businesses) have been classified as discontinued operations in the accompanying consolidated statements of operations for all periods presented. See Note 3 for further information about the CVS Strategic Restructuring Program.

USE OF ESTIMATES--The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.

CASH AND CASH EQUIVALENTS--Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased.

INVESTMENTS--Investments, which consist of available-for-sale securities, are recorded at fair value. Unrealized holding gains and losses, net of related tax effects, are reported as a separate component of shareholders' equity until realized.

FINANCIAL INSTRUMENTS--The Company's financial instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and commercial paper. Due to the short-term nature of these instruments, the Company's carrying value approximates fair value. The Company also utilizes letters of credit to guarantee foreign purchases. At December 31, 1997 and 1996, approximately $58.2 million and $34.0 million, respectively, was outstanding under letters of credit.

ACCOUNTS RECEIVABLE--Accounts receivable are stated net of an allowance for uncollectible accounts of $38.0 million and $36.0 million at December 31, 1997 and 1996, respectively. The balance primarily includes trade receivables due from managed care organizations, pharmacy benefit management companies, insurance companies, governmental agencies and vendors.

INVENTORIES--Inventories are stated at the lower of cost or market using the first-in, first-out method.

PROPERTY AND EQUIPMENT--Depreciation of property and equipment is computed on a straight-line basis, generally over the estimated useful lives of the asset or, when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 10 to 40 years for buildings and improvements, 3 to 10 years for fixtures and equipment, and 3 to 10 years for leasehold improvements.

IMPAIRMENT OF LONG-LIVED ASSETS--An impairment loss is recognized whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company primarily groups and evaluates assets at an individual store level, which is the lowest level at which independent cash flows can be identified. When evaluating assets for potential impairment, the Company considers historical performance and, in addition, estimates future results. If the carrying amount of the related asset exceeds the expected future cash flows, the Company considers the asset to be impaired and records an impairment loss.

DEFERRED CHARGES AND OTHER ASSETS--Deferred charges, consisting primarily of beneficial leasehold costs, are amortized on a straight-line basis, generally over the remaining life of the leasehold acquired or 15 years, whichever is shorter. At December 31, 1996, other assets primarily included notes receivable that were received as a portion of the proceeds from the sale of certain businesses and deferred financing fees.

16

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

GOODWILL--Goodwill is the excess of the cost of net assets acquired in purchase business combinations over their fair value. It is amortized on a straight-line basis generally over periods of 40 years. Accumulated amortization was $65.6 million and $46.3 million at December 31, 1997 and 1996, respectively. The Company evaluates goodwill for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. In completing its evaluation, the Company compares estimated future cash flows to the carrying amount of the goodwill. If the carrying amount of the goodwill exceeds the expected future cash flows, the Company considers the goodwill to be impaired and records an impairment loss.

REORGANIZATION VALUE IN EXCESS OF AMOUNTS ALLOCABLE TO IDENTIFIABLE ASSETS--In June 1992, Revco and certain of its subsidiaries which filed petitions for relief, emerged from Chapter 11 of the United States Bankruptcy Code ("Chapter 11") pursuant to a confirmed plan of reorganization. At that time, the Company implemented the recommended accounting principles for entities emerging from Chapter 11 ("Fresh Start Reporting") set forth in the American Institute of Certified Public Accountants ("AICPA") Statement of Position 90-7, "Financial Reporting by Entities in Reorganization Under the Bankruptcy Code." Revco's reorganization value in excess of amounts allocable to identifiable assets ("Reorganization Goodwill") is being amortized on a straight-line basis over 20 years. This amortization is a non-deductible expense for tax purposes.

Revco has net operating loss carryforwards ("NOLs") available to offset future federal and state taxable income. Substantially all of the NOLs are attributable to the time period prior to Revco's emergence from Chapter 11. Under Fresh Start Reporting, any benefits realized from the utilization of these NOLs should reduce Reorganization Goodwill.

Following is a reconciliation of the original Reorganization Goodwill recorded by Revco upon emergence from Chapter 11 to the net amount reflected in the consolidated balance sheets at December 31:

IN MILLIONS                                                                                        1997       1996
-----------------------------------------------------------------------------------------------  ---------  ---------
Original balance recorded......................................................................  $   352.1  $   352.1
Accumulated amortization.......................................................................      (98.1)     (80.6)
Cumulative NOLs utilized.......................................................................     (146.1)     (76.7)
                                                                                                 ---------  ---------
                                                                                                 $   107.9  $   194.8
                                                                                                 ---------  ---------
                                                                                                 ---------  ---------

MAINTENANCE AND REPAIRS--Maintenance and repair costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated.

STORE OPENING AND CLOSING COSTS--New store opening costs are charged directly to expense when incurred. In the event a store closes before its lease expires, the remaining lease obligation is fully accrued for in the year of closing.

INCOME TAXES--Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The tax benefit for dividends on unallocated shares of Series One ESOP Convertible Preference Stock (the "ESOP Preference Stock") is recorded as a credit to retained earnings.

ADVERTISING COSTS--External costs incurred to produce media advertising are expensed when the advertising takes place.

POSTRETIREMENT BENEFITS--The annual cost of postretirement benefits is funded in the period incurred and the cost is recognized over an employee's term of service with the Company. The Company also provides health and life insurance benefits to certain retired employees who met eligibility requirements and were grandfathered under former benefit plans which have since been amended or terminated. The cost of these benefits has been fully accrued by the Company.

EARNINGS PER COMMON SHARE--Basic earnings per common share is computed by dividing (i) net earnings, after deducting the ESOP Preference Stock dividends, net of tax benefits, by (ii) the weighted average number of common shares outstanding during the year (the "Basic Shares").

Diluted earnings per common share assumes that the ESOP Preference Stock is converted into common stock. Diluted earnings per common share is computed by dividing (i) net earnings, after accounting for the difference between the current dividends on the ESOP Preference Stock and the common stock and after making adjustments for certain non-discretionary expenses that are based on net earnings such as incentive bonuses and profit sharing by (ii) Basic Shares plus the additional shares that would be issued assuming that dilutive stock options are exercised and the ESOP Preference Stock is converted into common stock. In 1995 and 1997, the assumed conversion of the ESOP Preference Stock would have increased diluted earnings per common share and, therefore, was not considered.

ACCOUNTING CHANGES--The Company was required to retroactively adopt Statement of Financial Accounting Standards ("SFAS") No. 128, "Earnings Per Share" during the fourth quarter of 1997. This statement requires companies with complex capital structures to present basic and diluted earnings per common share in lieu of previously reported primary and

17

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

fully diluted earnings per common share. The statement also requires additional informational disclosures and makes certain modifications to the previous calculation method.

Effective January 1, 1996, the Company adopted SFAS No. 123, "Accounting for Stock-Based Compensation." While SFAS No. 123 established financial accounting and reporting standards for stock-based employee compensation plans using a fair value method of accounting, it allows companies to continue to measure compensation using the intrinsic value method of accounting as prescribed in APB Opinion No. 25, "Accounting for Stock Issued to Employees." The Company will continue to use its present APB Opinion No. 25 accounting treatment for stock-based compensation. See Note 11 for further information about SFAS No. 123.

Effective October 1, 1995, the Company early adopted SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of" and recorded a pre-tax asset impairment charge of $110.4 million ($5.0 million of which pertained to continuing operations) in connection with the write-down of certain fixed and intangible assets. The above charge resulted when the Company began identifying and measuring impairment at a lower level under SFAS No. 121 than under its previous accounting policy. Under the Company's previous accounting policy, long lived assets were evaluated in total for impairment at the operating business level if the operating business was either incurring operating losses or was expecting to incur operating losses in the future. Since the expected future cash flows measured at the operating business level were in excess of the carrying value of the related assets, no previous impairment losses were recorded.

During the fourth quarter of 1995, the Company changed its policy from capitalizing internally developed software costs to expensing the costs as incurred and recorded a charge of $74.5 million ($37.8 million of which pertained to continuing operations). The effect of the change in accounting principle has been treated as a change in accounting principle that is inseparable from the effect of the change in accounting estimate. As a result, the entire amount has been treated as a change in accounting estimate. The effect of this charge was to reduce net earnings by $45.8 million or $0.28 per diluted common share in 1995.

RECLASSIFICATIONS--Certain reclassifications have been made to the consolidated financial statements of prior years to conform to the 1997 presentation.

3 CVS STRATEGIC RESTRUCTURING PROGRAM

THE 1995 PLAN

On October 24, 1995, (the "1995 Measurement Date"), the Board of Directors approved a comprehensive restructuring plan that was the product of a strategic review initiated in 1994. The restructuring plan included, among other things: (i) the continued operation of CVS (which included CVS, and initially Linens 'n Things and Bob's Stores), (ii) the disposal of Marshalls, Kay-Bee Toys, Wilsons and This End Up, (iii) the spin-off of Footstar, Inc. ("Footstar"), which included Meldisco, Footaction and Thom McAn, and (iv) the elimination of certain corporate overhead costs.

In connection with the approval of the 1995 Plan, the Company recorded a pre-tax charge of $872.0 million in the fourth quarter of 1995 (the "1995 Restructuring Charge") and discontinued the footwear segment in accordance with APB Opinion No. 30, "Reporting the Results of Operations--Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions." As a result of the 1996 Plan discussed below, the apparel segment and toys and home furnishings segment were also discontinued. Accordingly, the portion of the 1995 Restructuring Charge that pertains to these segments, $711.4 million, is reflected as a component of discontinued operations, and the remainder, $160.6 million, is included in continuing operations. The amount recorded in continuing operations primarily includes costs associated with: (i) exiting certain geographic markets, (ii) closing duplicate warehouse facilities and (iii) closing the Company's corporate headquarters in Rye, New York. These costs primarily included asset write-offs, closed store and warehouse lease liabilities and employee severance.

Management determined the amount of: (i) asset write-offs by comparing the carrying value of the assets to be disposed of to the anticipated proceeds, (ii) closed store and warehouse lease liabilities by calculating the present value of the future minimum lease payments and (iii) employee severance based on an employee's compensation level and years of service with the Company. The Company applied the guidance of EITF Issue No. 94-3 to determine the appropriate accounting treatment for these charges.

Asset write-offs included in the 1995 Restructuring Charge totaled $659.7 million. The balance of the charge, $212.3 million, will require cash outlays of which $190.3 million had been incurred as of December 31, 1997. The remaining cash outlays, which primarily include non-cancelable operating lease commitments, are expected to be incurred in 1998 and beyond.

18

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

THE 1996 PLAN

On May 29, 1996, (the "1996 Measurement Date"), the Board of Directors approved further refinements to the restructuring plan. The refinements included (i) a formal plan to separate Linens 'n Things and Bob's Stores from the Company and (ii) a formal plan to convert 80 to 100 of Thom McAn's stores to the Footaction store format and to sell or close the remaining Thom McAn stores, and thereby exit the Thom McAn business by mid-1997.

In connection with the approval of the 1996 Plan, the Company recorded, as a component of discontinued operations, a pre-tax charge of $235.0 million during the second quarter of 1996 (the "1996 Restructuring Charge") substantially all of which related to asset write-offs that will not require cash outlays. As a result of adopting the plan to separate Linens 'n Things and Bob's Stores from the Company, the apparel and toys and home furnishings segments were discontinued in accordance with APB Opinion No. 30.

The asset write-offs of $659.7 million and $235.0 million included in the 1995 Restructuring Charge and 1996 Restructuring Charge, respectively, primarily relate to the write-down of the businesses to be disposed of to estimated fair value. The significant judgment included in the above write-offs relates to the estimation of fair value for each business. These estimates were prepared by independent third parties.

The CVS Strategic Restructuring Program was completed in 1997 without significant changes to the Board approved plan. In connection with completing this program, the Company recorded, as a component of discontinued operations, a pre-tax charge of approximately $35 million during the second quarter of 1997 (the "1997 Restructuring Charge") to finalize certain liabilities accrued for in the 1996 Restructuring Charge.

THE DISPOSALS

On November 17, 1995, the Company completed the sale of Marshalls to The TJX Companies, Inc. for total proceeds of approximately $600 million.

On May 4, 1996, the Company completed the sale of Kay-Bee Toys to Consolidated Stores Corporation for total proceeds of approximately $285.7 million.

On May 25, 1996, the Company completed the sale of Wilsons to an investor group led by Wilsons' management for total proceeds of approximately $69.7 million.

On May 31, 1996, the Company completed the sale of This End Up to an investor group for approximately $18.2 million.

On October 12, 1996, the Company completed the spin-off of Footstar by distributing 100% of the shares of Footstar common stock held by the Company to its shareholders of record as of the close of business on October 2, 1996 (the "Footstar Distribution"). See Note 15 for further information about the Footstar Distribution.

On December 2, 1996, the Company completed the initial public offering of 67.5% of Linens 'n Things, Inc. for net proceeds of approximately $189.4 million.

On June 4, 1997, the Company sold its remaining 32.5% ownership interest in Linens 'n Things, Inc. for total proceeds of approximately $147 million.

On November 25, 1997, the Company completed the sale of Bob's Stores to an investor group for total proceeds of approximately $92 million.

The gains and losses that resulted from the above disposals are reflected in the "Discontinued Operations" section of the consolidated statements of operations. The Company has no continuing involvement with the divested operations.

Following is a summary of the significant components of the charges related to the CVS Strategic Restructuring Program:

                                                                                         UTILIZED
                                                                                         THROUGH
                                                                   RESTRUCTURING         12/31/97      BALANCE AT
IN MILLIONS                                                          CHARGE(1)          (2)(3)(4)      12/31/97(5)
---------------------------------------------------------------  ------------------  ----------------  -----------
Loss on sale of businesses.....................................      $    721.8         $    702.2      $    19.6
Lease obligations and asset write-offs relating to store,
  office and warehouse closings................................           187.4              117.3           70.1
Contract termination costs and asset write-offs relating to
  outsourcing certain technology functions.....................            64.3               64.3             --
Severance and employee benefits................................            58.6               45.5           13.1
Costs relating to the consolidation of the footwear businesses
  and exit from Thom McAn......................................           104.0              104.0             --
Other..........................................................             5.9                5.9             --
                                                                       --------           --------     -----------
                                                                     $  1,142.0         $  1,039.2      $   102.8
                                                                       --------           --------     -----------
                                                                       --------           --------     -----------


(1) Includes the 1997 Restructuring Charge, the 1996 Restructuring Charge and the 1995 Restructuring Charge.

(2) Includes utilization of $190.1 million in 1997, $353.7 million in 1996 and $495.4 million in 1995.

(3) $104.6 million, $79.6 million and $6.1 million of the amounts utilized in 1997, 1996 and 1995, respectively, required cash outlays.

(4) $80.0 million and $2.4 million of the amount utilized in 1996 represents reserve balances that were retained by Footstar and Linens 'n Things, Inc., respectively.

(5) The Company believes that the reserve balance at December 31, 1997 is adequate to cover the remaining liabilities associated with the CVS Strategic Restructuring Program.

19

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

4 DISCONTINUED OPERATIONS

Following is a summary of discontinued operations by reporting segment for the years ended December 31:

IN MILLIONS                                                                        1997       1996       1995
-------------------------------------------------------------------------------  ---------  ---------  ---------
Net sales:
  Footwear.....................................................................  $      --  $ 1,391.1  $ 1,827.3
  Apparel......................................................................      348.3      526.4    3,055.7
  Toys and Home Furnishings....................................................         --      900.3    1,768.4
                                                                                 ---------  ---------  ---------
                                                                                 $   348.3  $ 2,817.8  $ 6,651.4
                                                                                 ---------  ---------  ---------
Operating (loss) profit:(1)
  Footwear.....................................................................  $      --  $   (12.4) $    47.5
  Apparel......................................................................         --     (171.3)    (704.0)
  Toys and Home Furnishings....................................................         --      (49.7)    (115.9)
                                                                                 ---------  ---------  ---------
                                                                                 $      --    $(233.4)    (772.4)
                                                                                 ---------  ---------  ---------
                                                                                 ---------  ---------  ---------


(1) Includes the effect of the charges related to the CVS Strategic Restructuring Program.

As of December 31, 1997, there were no assets or liabilities of the discontinued operations reflected in the accompanying consolidated balance sheet. The December 31, 1996 consolidated balance sheet included total assets of $141.0 million and total liabilities of $61.0 million, for the apparel segment.

5 ACQUISITION OF BIG B, INC.

On October 27, 1996, the Company and Big B, Inc. ("Big B"), a retail drugstore chain formerly headquartered in Bessemer, Alabama operating approximately 400 drugstores in five southern states, signed a definitive merger agreement whereby the Company would acquire all of the outstanding shares of Big B common stock at a price of $17.25 per share in cash. On November 15, 1996, the Company announced that it completed its cash tender offer for Big B's common stock (the "Offer"), resulting in the Company owning approximately 85% of Big B. On December 23, 1996, the Company completed a second step acquisition in which all remaining Big B shareholders received the same cash price paid in the Offer. The aggregate transaction value, including the assumption of approximately $49.3 million of existing Big B debt, was $423.2 million.

The acquisition of Big B was accounted for as a purchase business combination under APB Opinion No. 16 using an effective date of November 16, 1996. The purchase price was allocated to assets acquired and liabilities assumed based on estimated fair values at the date of acquisition. This resulted in an excess of purchase price over net assets acquired of approximately $249 million, which is being amortized on a straight-line basis over 40 years. Big B's results of operations have been consolidated with the Company's results of operations beginning November 16, 1996.

During the first quarter of 1997, the Company recorded a charge to operating expenses of $31.0 million for certain non-capitalizable costs associated with the restructuring of Big B. The significant components of the charge included: (i) $5.3 million for store, distribution and system conversion costs, (ii) $18.7 million for store closing costs and (iii) $7.0 million for duplicate headquarters and administration costs. In accordance with the guidance provided in EITF Issue No. 94-3, this charge includes accrued liabilities related to certain exit plans for identified stores and duplicate corporate facilities, such as the cancellation of lease agreements and the write-down of unutilized fixed assets. These exit plans do not benefit the future activities of the retained stores or corporate facilities.

Asset write-offs included in the above charge totaled $5.1 million. The balance of the charge, $25.9 million, will require cash outlays, of which $8.9 million had been incurred as of December 31, 1997. The remaining cash outlays, which primarily include non-cancelable operating lease commitments, are expected to be incurred in 1998 and beyond.

6 INVESTMENTS

Investments consisted of the following at December 31:

IN MILLIONS                                                                                        1997       1996
-----------------------------------------------------------------------------------------------  ---------  ---------
Note receivable................................................................................  $      --  $   100.0
Investment in Linens 'n Things, Inc............................................................         --       83.2
Other..........................................................................................         --        2.0
                                                                                                 ---------  ---------
                                                                                                        --      185.2
Unrealized holding loss........................................................................         --       (3.8)
                                                                                                 ---------  ---------
                                                                                                 $      --  $   181.4
                                                                                                 ---------  ---------
                                                                                                 ---------  ---------

The note receivable, which was received as a portion of the proceeds from the sale of Kay-Bee Toys, was sold during the second quarter of 1997 to an unrelated third party for its approximate carrying value.

On June 4, 1997, the Company sold its remaining 32.5% ownership interest in Linens 'n Things, Inc. for total proceeds of approximately $147 million, which resulted in a pre-tax gain of approximately $65 million. This gain is reflected in discontinued operations.

20

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

7 BORROWINGS AND CREDIT AGREEMENTS

Following is a summary of the Company's borrowings at December 31:

IN MILLIONS                                        1997             1996
----------------------------------------------  -----------      ---------
CVS debt:
  Commercial paper............................     $450.0        $      --
  Lines of credit.............................       16.4               --
  Guaranteed ESOP obligation(1)...............      292.1            309.4
  Other notes and mortgages payable...........         --             12.2
Revco debt:
  Bank facility...............................         --            585.4
  9.125% Senior Notes.........................       19.2            140.0
  10.125% Senior Notes........................         --            144.9
  Other.......................................        2.1             10.3
                                                -----------      ---------
                                                    779.8          1,202.2
Less current portion..........................     (507.2)           (17.9)
                                                -----------      ---------
                                                   $272.6        $ 1,184.3
                                                -----------      ---------
                                                -----------      ---------


(1) See Note 13 for further information about the Company's ESOP Plan.

The Company issues commercial paper to finance, in part, its seasonal inventory requirements and capital expenditures. The commercial paper program is supported by a $670 million, five year unsecured revolving credit facility which expires on May 30, 2002 (the "Credit Facility"). The Credit Facility requires the Company to pay a quarterly facility fee of 0.07%, regardless of usage. The weighted average interest rate on the commercial paper issued as of December 31, 1997 was 5.9%.

The Company can also obtain up to $220 million of short-term financing through various uncommitted lines of credit. At December 31, 1997, borrowings under these lines totaled $16.4 million with a weighted average interest rate of 5.5%.

The Company was not obligated under any formal or informal compensating balance agreements with respect to the short-term borrowings.

REVCO DEBT RETIREMENT

On May 30, 1997, the Company repaid all $600 million of bank debt outstanding under the Revco bank facility which was subsequently terminated (the "Bank Facility Repayment"). On June 30, 1997, the Company redeemed all $144.9 million aggregate principal amount of its 10.125% Senior Notes (the "Debt Redemption") at 105% of the principal amount plus accrued interest. In addition, on June 25, 1997, the Company commenced an offer (the "Debt Tender Offer") to purchase for cash all $140.0 million aggregate principal amount of its 9.125% Senior Notes. The Debt Tender Offer expired on July 2, 1997 and $120.8 million aggregate principal amount was repurchased at an average price of 104.61% of the principal amount plus accrued interest.

At December 31, 1997, the bid price for the remaining 9.125% Senior Notes was $103.25. Accordingly, the fair value of the notes was $19.8 million, compared to their carrying value of $19.2 million.

The Bank Facility Repayment, the Debt Redemption and the Debt Tender Offer (collectively, the "Revco Debt Retirement") were financed with cash on hand and borrowings under the Company's commercial paper program.

As a result of the Revco Debt Retirement, the Company recorded an after-tax charge of $17.1 million during the second quarter of 1997. This charge, which included early retirement premiums and the write-off of unamortized finance costs, has been classified as an extraordinary item in the accompanying consolidated statements of operations.

On January 15, 1998, the Company redeemed the remaining $19.2 million aggregate principal amount of its 9.125% Senior Notes at 103% of principal plus accrued interest.

The Company remains party to an interest rate cap agreement entered into to hedge its interest rate exposure on a portion of the Revco bank facility. The interest rate cap established a maximum interest rate payable when the variable rate exceeds certain rates. At December 31, 1997, the total notional principal amount of this interest rate cap agreement was $29.3 million, having capped LIBOR rates of 7.00%, terminating through July 31, 2000.

21

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

AGGREGATE FUTURE MATURITIES

At December 31, 1997, the aggregate long-term debt maturing during the next five years was as follows: $21.4 million in 1998, $13.8 million in 1999, $16.5 million in 2000, $20.8 million in 2001, $200.1 million in 2002 and thereafter.

Following is a summary of net interest expense for the years ended December 31:

IN MILLIONS                                                                                1997       1996       1995
---------------------------------------------------------------------------------------  ---------  ---------  ---------
Interest expense(1)....................................................................  $    57.9  $    83.2  $   114.9
Less interest income and capitalized interest..........................................      (13.1)      (7.5)      (0.4)
                                                                                         ---------  ---------  ---------
Net interest expense...................................................................  $    44.8  $    75.7  $   114.5
                                                                                         ---------  ---------  ---------
Interest paid..........................................................................  $    56.9  $    78.3  $   112.2
                                                                                         ---------  ---------  ---------
                                                                                         ---------  ---------  ---------


(1) In accordance with the provisions of AICPA Statement of Position 76-3, "Accounting Practices for Certain Employee Stock Ownership Plans" and allowable under the transition provisions of AICPA Statement of Position 93-6, "Employers' Accounting for Employee Stock Ownership Plans," interest expense excludes interest related to the guaranteed ESOP note, but includes interest recognized in connection with the Company's contribution to the ESOP Plan.

8 CONTINGENCIES

In connection with certain dispositions completed between 1991 and 1997, the Company continues to guarantee lease obligations for approximately 2,000 former stores. The Company is indemnified for these obligations by the respective purchasers. Assuming that each respective purchaser became insolvent, an event which the Company believes to be highly unlikely, management estimates that it could settle these obligations for approximately $1.2 billion at December 31, 1997. In the opinion of management, the ultimate disposition of these guarantees will not have a material adverse effect on the Company's consolidated financial condition, results of operations or future cash flows.

The Company is also a defendant in various lawsuits arising in the ordinary course of business. In the opinion of management and the Company's outside counsel, the ultimate disposition of these lawsuits, exclusive of potential insurance recoveries, will not have a material adverse effect on the Company's consolidated financial condition, results of operations or future cash flows.

9 LEASES

The Company and its subsidiaries lease retail stores, warehouse facilities and office facilities over periods generally ranging from 5 to 20 years and generally has options to renew such terms over periods ranging from 5 to 15 years.

Following is a summary of the Company's net rent expense for operating leases relating to continuing operations for the years ended December 31:

IN MILLIONS                                                                              1997       1996       1995
-------------------------------------------------------------------------------------  ---------  ---------  ---------
Minimum rent.........................................................................  $   385.5  $   316.4  $   299.4
Contingent rent......................................................................       58.0       71.7       61.3
                                                                                       ---------  ---------  ---------
                                                                                           443.5      388.1      360.7
Less sublease income.................................................................       (6.3)     (10.1)      (7.7)
                                                                                       ---------  ---------  ---------
                                                                                       $   437.2  $   378.0  $   353.0
                                                                                       ---------  ---------  ---------
                                                                                       ---------  ---------  ---------

Following is a summary of the future minimum lease payments under capital leases, rent payments required under operating leases, and future minimum sublease income, excluding lease obligations for closed stores, at December 31, 1997:

                                                                                             CAPITAL      OPERATING
IN MILLIONS                                                                                  LEASES         LEASES
----------------------------------------------------------------------------------------  -------------  -----------
1998....................................................................................    $     0.6     $    352.1
1999....................................................................................          0.6          323.9
2000....................................................................................          0.6          295.3
2001....................................................................................          0.6          268.6
2002....................................................................................          0.4          230.1
Thereafter..............................................................................          1.4        1,479.4
                                                                                          -------------  -----------
                                                                                            $     4.2     $  2,949.4
Less amount representing interest.......................................................         (2.4)            --
                                                                                          -------------  -----------
Present value of minimum lease payments.................................................    $     1.8             --
                                                                                          -------------  -----------
Total future minimum sublease income....................................................    $     0.1     $     29.4
                                                                                          -------------  -----------
                                                                                          -------------  -----------

10 CAPITAL STOCK

The Certificate of Incorporation provides for the authorization of 350,120,619 shares of capital stock of which 300,000,000 shares are common stock, $0.01 par value per share, 120,619 shares are cumulative preferred stock, $0.01 par value per share and 50,000,000 shares are preference stock, $1.00 par value per share.

22

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

11 STOCK INCENTIVE PLANS

At December 31, 1996, the Company had stock incentive plans that included the pre-merger plans of Revco. Effective with the Merger, and in accordance with the terms of the Revco stock incentive plans, each outstanding Revco stock option was exchanged for 0.8842 options to purchase CVS common stock.

Following is a summary of the Company's stock-based incentive plans as of December 31, 1997:

1997 INCENTIVE COMPENSATION PLAN

The 1997 Incentive Compensation Plan, (the "1997 ICP") superseded the 1990 Omnibus Stock Incentive Plan, the 1987 Stock Option Plan and the 1973 Stock Option Plan (collectively, the "Preexisting Plans"). Upon approval of the 1997 ICP, authority to make future grants under the Preexisting Plans was terminated, although previously granted awards remain outstanding in accordance with their terms and the terms of the Preexisting Plans. As of December 31, 1997, the 1997 ICP provided for the granting of up to 9,914,761 shares of common stock to key employees in the form of fixed stock options, stock appreciation rights ("SARs"), restricted stock and performance-based awards. All grants under the 1997 ICP are awarded at fair market value on the date of grant. The right to exercise these awards generally commences between one and five years from the date of the grant and expires not more than ten years after the date of the grant, provided that the option holder continues to be employed by the Company. As of December 31, 1997, there were 9,863,709 shares available for grant under the 1997 ICP.

The 1997 ICP permits the granting of performance-based share awards which represent the right to receive common stock grants upon the achievement of certain business performance goals. Compensation expense related to grants under these provisions is based on the current market price of the Company's common stock and the extent to which the performance criteria is being met. There were no performance-based units awarded or shares granted during 1997.

Following is a summary of performance-based share awards for the years ended December 31:

DOLLARS IN MILLIONS                                                                                1997       1996         1995
-----------------------------------------------------------------------------------------------  ---------  ---------   ---------
Units awarded..................................................................................         --         --      32,297
Fair market value of units awarded.............................................................         --         --   $     1.2
Shares granted related to units previously awarded.............................................         --     35,380      60,807
Fair market value of shares granted............................................................         --    $   1.3   $     2.2
                                                                                                 ---------  ---------   ---------
                                                                                                 ---------  ---------   ---------

The weighted-average grant date fair value of performance-based shares granted in 1996 and 1995 was $37.01 and $35.79, respectively.

The 1997 ICP also permits the granting of up to 1.8 million restricted stock awards. Restricted stock awards are subject to the achievement of certain business performance goals and/or future service requirements as determined by the Compensation Committee. During the restricted period, the stock awards can not be sold, transferred or encumbered, although they retain all of the rights of a shareholder.

Following is a summary of restricted stock awards for the years ended December 31:

DOLLARS IN MILLIONS                                                                   1997       1996       1995
----------------------------------------------------------------------------------  ---------  ---------  ---------
Shares granted....................................................................     22,305    316,550    112,773
Fair market value of shares granted...............................................  $     1.0  $     8.3  $     4.1
Shares canceled...................................................................         --     63,543     11,452
                                                                                    ---------  ---------  ---------
                                                                                    ---------  ---------  ---------

The weighted-average grant date fair value of restricted stock granted in 1997, 1996 and 1995 was $46.04, $26.28 and $32.54, respectively.

THE 1996 DIRECTORS STOCK PLAN

The 1996 Directors Stock Plan (the "1996 DSP") provides for the granting of up to 173,230 shares of common stock to the Company's non-employee directors (the "Eligible Directors"). Eligible Directors (i) are entitled to receive an annual grant of 350 shares of common stock, (ii) are paid one-half of their annual retainer fee in shares of common stock and (iii) may elect to receive common stock as compensation for certain other services rendered. In addition, Eligible Directors may elect to defer compensation payable in common stock until their service as a director concludes. In this case, Eligible Directors are entitled to receive dividend equivalent credits on their deferred shares. The 1996 DSP replaced the Company's 1989 Directors Stock Option Plan.

In connection with the termination of certain retirement benefits, the 1996 DSP provided each Eligible Director the option to receive the actuarial present value of these benefits in the form of a common stock grant in lieu of receiving the previously accrued benefit in pension payments upon retirement. All Eligible Directors elected to receive the common stock grant and to defer the grant until their service as a director concludes. The impact of this grant was not material to the Company's results of operations. At December 31, 1997, there were 140,253 shares available for grant under the 1996 DSP.

23

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Following is a summary of the fixed stock option activity in the 1997 ICP, the 1996 DSP and the Preexisting Plans:

                                    1997                             1996                               1995
                       ------------------------------  ---------------------------------  ---------------------------------
                                        WEIGHTED-                         WEIGHTED-                          WEIGHTED-
                                         AVERAGE                           AVERAGE                            AVERAGE
                         SHARES      EXERCISE PRICE       SHARES       EXERCISE PRICE        SHARES       EXERCISE PRICE
                       -----------  -----------------  ------------  -------------------  ------------  -------------------
Outstanding at
  beginning of
  year...............    9,512,126     $     29.10       10,669,028       $   29.84          7,238,636       $   28.23
Granted..............    1,308,482           46.73        2,773,180           29.33          3,735,552           31.40
Exercised............   (5,317,081)          26.39       (1,514,061)          24.15           (188,876)          14.92
Canceled.............     (108,445)          39.97       (2,416,021)          36.32           (116,284)          21.04
                       -----------  -----------------  ------------  -------------------  ------------  -------------------
Outstanding at end of
  year...............    5,395,082     $     36.56        9,512,126       $   29.10         10,669,028       $   29.84
                       -----------  -----------------  ------------  -------------------  ------------  -------------------
Options exercisable
  at year-end........    3,256,056                        4,759,432                          5,344,464
                       -----------  -----------------  ------------  -------------------  ------------  -------------------
                       -----------  -----------------  ------------  -------------------  ------------  -------------------

Following is a summary of fixed stock options outstanding as of December 31, 1997:

                                     OPTIONS OUTSTANDING                                              OPTIONS EXERCISABLE
---------------------------------------------------------------------------------------------  -----------------------------------
                      WEIGHTED-AVERAGE
                         REMAINING
    RANGE OF               NUMBER                  YEARS OF              WEIGHTED-AVERAGE          NUMBER       WEIGHTED-AVERAGE
 EXERCISE PRICES        OUTSTANDING            CONTRACTUAL LIFE           EXERCISE PRICE        EXERCISABLE      EXERCISE PRICE
-----------------  ----------------------  -------------------------  -----------------------  --------------  -------------------
 $9.89 to $25.00            154,756                     5.70                 $   18.52              154,756         $   18.52
  25.01 to 35.00          3,222,403                     6.23                     32.38            2,321,407             32.16
  35.01 to 45.00            695,591                     3.75                     40.67              695,591             40.67
  45.01 to 55.00          1,245,792                     8.66                     45.99               84,302             45.49
      Over 55.01             76,540                     9.70                     58.22                   --                --
                   ----------------------  -------------------------  -----------------------  --------------  -------------------
                          5,395,082                     6.54                 $   36.56            3,256,056         $   33.68
                   ----------------------  -------------------------  -----------------------  --------------  -------------------
                   ----------------------  -------------------------  -----------------------  --------------  -------------------

The number of shares and the weighted-average exercise prices included in the above tables have been restated to reflect the effect of the Footstar Distribution.

Compensation cost recognized in net earnings under the Company's stock-based compensation plans amounted to $3.5 million in 1997, $3.9 million in 1996 and $3.3 million in 1995. Had compensation cost been recognized based on the fair value of options granted consistent with SFAS No. 123, the Company's net earnings and net earnings per common share for the years ended December 31, would approximate the pro forma amounts shown below:

IN MILLIONS, EXCEPT PER SHARE AMOUNTS                                                     1997       1996       1995
--------------------------------------------------------------------------------------  ---------  ---------  ---------
Net earnings (loss):
  As reported.........................................................................  $    37.7  $   176.6    $(572.8)
  Pro forma...........................................................................       26.6      169.5     (577.9)
                                                                                        ---------  ---------  ---------
Basic net earnings (loss) per common share:
  As reported.........................................................................  $    0.14  $    0.98    $ (3.60)
  Pro forma...........................................................................       0.08       0.94      (3.63)
                                                                                        ---------  ---------  ---------
Diluted net earnings (loss) per common share:
  As reported.........................................................................  $    0.14  $    0.98    $ (3.59)
  Pro forma...........................................................................       0.07       0.94      (3.62)
                                                                                        ---------  ---------  ---------
                                                                                        ---------  ---------  ---------

The weighted-average grant date fair value of options granted during the years ended December 31, was $14.57 in 1997, $10.94 in 1996 and $8.14 in 1995 per option, respectively.

Following are the weighted-average assumptions used in the Black-Scholes Option Pricing Model to estimate, at the date of grant, the weighted average fair value of options granted during the years ended December 31:

                                                                                           1997       1996(1)      1995(1)
                                                                                         ---------  -----------  -----------
Dividend yield.........................................................................       0.70%       1.07%        1.07%
Expected volatility....................................................................      22.77%      20.51%       20.51%
Risk-free interest rate................................................................       5.50%       7.00%        7.00%
Expected life..........................................................................        5.5         5.0          4.1
                                                                                        ---------  ---------  ---------
                                                                                        ---------  ---------  ---------


(1) In 1996 and 1995, Revco options were valued using a dividend yield of 0.0%, an expected volatility of 36.0% and an expected life of 7.0 years.

The effects of applying SFAS No. 123 in this pro forma disclosure are not indicative of future amounts. SFAS No. 123 does not apply to awards prior to 1995.

24

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

12 RETIREMENT PLANS

The Company sponsors various retirement programs, including defined benefit plans and defined contribution plans that cover most full-time employees.

DEFINED BENEFIT PLANS

The Company has a non-contributory defined benefit pension plan (the "Revco Retirement Income Plan"). The plan covers certain full-time employees of Revco who are 201/2 years of age with six months of service and who are not covered by collective bargaining agreements. The Company also has non-qualified supplemental executive retirement plans ("SERPs") in place for certain key employees for which it has purchased cost recovery variable life insurance on the lives of such employees. Amounts payable under the SERPs are in addition to the benefits payable under other retirement plans.

Benefits paid to retirees are based upon age at retirement, years of credited service and average compensation during the final five years of employment. It is the policy of the Company to fund its plans based on actuarial calculations and the applicable regulations.

The following table sets forth the funded status of the defined benefit plans administered by the Company and the amounts recognized in the accompanying consolidated balance sheets as of December 31:

IN MILLIONS                                                                                        1997       1996
-----------------------------------------------------------------------------------------------  ---------  ---------
Accumulated benefit obligation:
  Vested benefits..............................................................................  $   216.1  $   194.4
  Nonvested benefits...........................................................................        7.1        8.3
                                                                                                 ---------  ---------
Accumulated benefit obligation.................................................................      223.2      202.7
Impact of future salary increases..............................................................        1.4       26.7
                                                                                                 ---------  ---------
Projected benefit obligation...................................................................      224.6      229.4
Plan assets at fair value......................................................................      201.5      172.8
                                                                                                 ---------  ---------
Projected benefit obligation in excess of plan assets..........................................       23.1       56.6
Unrecognized prior service cost................................................................       (1.6)      (5.4)
Unrecognized net gain (loss)...................................................................       15.2       (5.0)
                                                                                                 ---------  ---------
Accrued pension cost...........................................................................  $    36.7  $    46.2
                                                                                                 ---------  ---------
                                                                                                 ---------  ---------

Following is a summary of the components of net periodic pension cost for the defined benefit plans:

IN MILLIONS                                                                                   1997       1996       1995
------------------------------------------------------------------------------------------  ---------  ---------  ---------
Service cost..............................................................................  $     6.9  $     9.2  $     9.1
Interest cost on projected benefit obligation.............................................       17.4       16.8       14.8
Return on plan assets.....................................................................      (14.9)     (18.2)     (18.6)
Net amortization and deferral.............................................................        0.4        6.5        6.6
                                                                                            ---------  ---------  ---------
Net periodic pension cost.................................................................  $     9.8  $    14.3  $    11.9
                                                                                            ---------  ---------  ---------
                                                                                            ---------  ---------  ---------

In connection with the Merger, the Company suspended the Revco Retirement Income Plan, resulting in a curtailment gain of approximately $6.0 million.

Following is a summary of the assumptions used to measure the actuarial present value of the projected benefit obligation:

                                                                                                        1997       1996
                                                                                                      ---------  ---------
Discount rate.......................................................................................       7.50%      7.75%
Rate of compensation increase.......................................................................       4.50%      4.50%
Expected rate of return on plan assets..............................................................       9.00%      9.00%
                                                                                                      ---------  ---------
                                                                                                      ---------  ---------

Plan assets consist primarily of mutual funds, common stock and insurance contracts.

In addition to the above defined benefit plans, and pursuant to various labor agreements, the Company is required to make contributions to certain union-administered pension plans which totaled $1.6 million, $1.2 million and $1.2 million in 1997, 1996 and 1995, respectively. The Company may be liable for its share of the plans' unfunded liabilities if the plans are terminated.

DEFINED CONTRIBUTION PLANS

The Company sponsors certain defined contribution plans covering substantially all employees who meet the plan's eligibility requirements. The Profit Sharing Plan, contains a profit sharing component that makes tax deferred contributions to each employee based on the Company achieving certain performance goals. The 401(k) Savings Plan allows employees to make voluntary contributions up to the maximum limits allowed by Section 401(k) of the Internal Revenue Code. The Company matches a portion of the employee's contribution under a predetermined formula based on the employee's contribution level and years of service. The Company's contributions to these plans totaled $16.2 million, $25.5 million and $24.4 million in 1997, 1996 and 1995, respectively.

The company also sponsors an Employee Stock Ownership Plan. See Note 13 for further information.

25

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

13 EMPLOYEE STOCK OWNERSHIP PLAN

The Company sponsors a defined contribution Employee Stock Ownership Plan (the "ESOP") for its full-time employees.

In 1989, the ESOP Trust borrowed $357.5 million through a 20-year loan that is guaranteed by the Company. The proceeds from the loan were used to purchase 6.7 million shares of Series One ESOP Convertible Preference Stock (the "ESOP Preference Stock") from the Company. Each share of ESOP Preference Stock is convertible into 1.157 shares of common stock. The original liquidation value ($53.45) is guaranteed by the Company.

The total number of new shares to be allocated each year is calculated by multiplying (i) the ratio of each year's debt service payment to total current and future debt service payments by (ii) the number of unallocated shares of ESOP Preference Stock in the plan. At December 31, 1997, 5.3 million shares of ESOP Preference Stock were outstanding, of which 1.3 million shares were allocated to participants and the remaining 4.0 million shares were held in the ESOP Trust for future allocations. The fair value of the allocated shares was approximately $83 million at December 31, 1997. The Company is required to repurchase at the original liquidation value, for cash or common stock at the Company's option, the ESOP Preference Stock allocated to participants upon distribution to the participant. Dividends are cumulative at the stated rate or the common rate if higher.

Following is a summary of the ESOP for the years ended December 31:

IN MILLIONS                                                                                  1997       1996       1995
-----------------------------------------------------------------------------------------  ---------  ---------  ---------
Dividends paid...........................................................................  $    20.8  $    21.8  $    24.3
Cash contributions.......................................................................       22.9       19.3       14.2
Tax benefit of annual dividend...........................................................        8.5        8.8        9.8
Interest costs incurred by ESOP Trust....................................................       26.4       27.5       28.4
Compensation expense recognized(1).......................................................        3.5        3.4        6.2
Interest expense recognized(1)...........................................................       10.3       12.0        6.4
                                                                                           ---------  ---------  ---------
                                                                                           ---------  ---------  ---------


(1) Amounts include discontinued operations.

The Company's contribution to the ESOP, plus the dividends paid on the ESOP Preference Stock held by the ESOP Trust, are used to repay the loan principal and interest. The Company has reflected the guaranteed ESOP obligation as long-term debt on the consolidated balance sheets. The ESOP obligation is collateralized by the unallocated shares of ESOP Preference Stock. A corresponding amount of "Guaranteed ESOP obligation" is recorded as a reduction of shareholder's equity. The ESOP Preference Stock is not considered when computing basic earnings per common share, but is considered when computing diluted earnings per common share.

14 POSTRETIREMENT BENEFITS OTHER THAN PENSIONS

The Company provides postretirement health benefits to retirees who meet certain eligibility requirements. Following is a summary of the net postretirement benefit cost as of December 31:

IN MILLIONS                                                                                    1997       1996       1995
-------------------------------------------------------------------------------------------  ---------  ---------  ---------
Service cost...............................................................................  $      --  $     0.4  $     0.4
Interest cost on projected benefit obligation..............................................        1.0        2.5        2.9
Net amortization and deferral..............................................................       (0.3)      (1.1)     (11.4)
                                                                                             ---------  ---------  ---------
Net postretirement benefit cost............................................................  $     0.7  $     1.8  $    (8.1)
                                                                                             ---------  ---------  ---------
                                                                                             ---------  ---------  ---------

Following is a summary of the accrued postretirement benefit cost at December 31:

IN MILLIONS                                                                                          1997       1996
-------------------------------------------------------------------------------------------------  ---------  ---------
Retirees.........................................................................................  $    14.4  $    15.5
Fully eligible active plan participants..........................................................         --        0.1
Other active plan participants...................................................................        0.1        0.1
                                                                                                   ---------  ---------
Total accumulated postretirement benefit obligation..............................................       14.5       15.7
Unrecognized prior service cost..................................................................        1.1        1.2
Unrecognized net gain............................................................................        1.0        1.0
                                                                                                   ---------  ---------
Accrued postretirement benefit cost..............................................................  $    16.6  $    17.9
                                                                                                   ---------  ---------
                                                                                                   ---------  ---------

In 1994, the Company amended various Revco health benefit plans to terminate benefits for all non-retirees. The amendment resulted in a negative plan change of $10.1 million which was recorded in 1995.

26

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Following are the primary assumptions used to determine the costs and accumulated postretirement benefit obligation (the "APBO") for the years ended December 31:

                                                                                               1997       1996       1995
                                                                                             ---------  ---------  ---------
Discount rates.............................................................................       7.25%      7.50%      6.90%
Health care cost trend rates:
  Initial..................................................................................       7.00%      9.25%     10.00%
  Ultimate.................................................................................       5.00%      5.00%      5.00%
Year in which ultimate trend rate is achieved..............................................       2003       2005       2005

A one percent increase in the health care cost trend rate would increase the APBO by $0.8 million at December 31, 1997 and the annual expense by $0.06 million in 1997.

15 INCOME TAXES

Deferred income taxes reflect the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

The Company's income tax (provision) benefit for continuing operations for the years ended December 31 consisted of the following:

IN MILLIONS                                                                             FEDERAL       STATE        TOTAL
------------------------------------------------------------------------------------  -----------  -----------  -----------
1997:
  Current.........................................................................    $(162.4)     $ (66.4)      $(228.8)
  Deferred........................................................................       83.0         28.1         111.1
                                                                                      --------     --------      --------
                                                                                      $ (79.4)     $ (38.3)      $(117.7)
1996:
  Current.........................................................................    $(179.3)     $ (52.3)      $(231.6)
  Deferred........................................................................      (16.9)        (2.8)        (19.7)
                                                                                      --------     --------      --------
                                                                                      $(196.2)     $ (55.1)      $(251.3)
1995:
  Current.........................................................................    $(130.7)     $ (14.2)      $(144.9)
  Deferred........................................................................       84.6          1.9          86.5
                                                                                      --------     --------      --------
                                                                                      $ (46.1)     $ (12.3)      $ (58.4)

Following is a reconciliation of the statutory income tax rate to the Company's effective tax rate for the years ended December 31:

                                                                                                1997       1996       1995
                                                                                              ---------  ---------  ---------
Statutory income tax rate...................................................................     35.0%      35.0%      35.0%
State income taxes, net of Federal tax benefit..............................................      6.9        5.7        6.6
Goodwill and other..........................................................................      1.6        1.7        8.7
                                                                                              ---------  ---------  ---------
Effective tax rate before merger related costs..............................................     43.5       42.4       50.3
                                                                                                 32.4       --         --
Merger related costs(1).....................................................................  ---------  ---------  ---------
Effective tax rate..........................................................................     75.9%      42.4%      50.3%


(1) Includes state tax effect.

Income taxes paid (refunded) were $243.8 million, $(49.2) million, and $116.4 million during the years ended December 31, 1997, 1996 and 1995, respectively.

Following is a summary of the significant components of the Company's deferred tax assets and liabilities as of December 31:

IN MILLIONS                                                                                        1997       1996
-----------------------------------------------------------------------------------------------  ---------  ---------
Deferred tax assets:
Employee benefits..............................................................................  $   118.3  $    81.6
Other assets...................................................................................      252.5      201.8
                                                                                                 ---------  ---------
Total deferred tax assets......................................................................  $   370.8  $   283.4
                                                                                                 ---------  ---------
Deferred tax liabilities:
  Property and equipment.......................................................................  $   (20.3) $   (48.9)
  Inventories..................................................................................      (20.5)     (79.2)
  Other liabilities............................................................................      (10.6)     (23.1)
                                                                                                 ---------- ----------
Total deferred tax liability...................................................................      (51.4)    (151.2)
                                                                                                 ---------- ----------
Net deferred tax assets........................................................................  $   319.4  $   132.2

Based on historical pre-tax earnings, the Company believes it is more likely than not that the deferred tax assets will be realized.

27

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

As of December 31, 1997, the Company had federal net operating loss carryforwards ("NOLs") of approximately $33.9 million which are attributable to Revco for periods prior to its emergence from Chapter 11. As previously discussed in Note 2, under Fresh Start Reporting, the benefits realized from these NOLs should reduce Reorganization Goodwill. Accordingly, the tax benefit of such NOLs utilized during the three years ended December 31, 1997 (approximately $69.4 million, $15.3 million and $18.8 million for 1997, 1996 and 1995, respectively), have not been included in the computation of the Company's income tax provision, but instead have been reflected as reductions of Reorganization Goodwill.

On October 12, 1996, the Company completed the Footstar Distribution which is believed to be tax-free to the Company and its shareholders based on a legal opinion provided by outside counsel. However, since opinions of counsel are not binding on the Internal Revenue Service or the courts, it could ultimately be determined that the Footstar Distribution does not qualify as a tax-free distribution. If such occurred, the Company would be required to recognize a capital gain for tax purposes equal to the difference between the fair market value of the shares of Footstar stock distributed and the Company's basis in such shares. The Company, however, believes the likelihood of the Footstar Distribution not qualifying as a tax-free distribution to be remote.

16 SUBSEQUENT EVENT (UNAUDITED)

On February 8, 1998, the Company signed a definitive merger agreement to acquire Arbor Drugs, Inc. ("Arbor") in a stock-for-stock merger valued at approximately $1.48 billion.

Under the terms of the merger agreement, which was unanimously approved by the Boards of Directors of both companies, the Company would acquire Arbor in an exchange of stock that is expected to qualify as a pooling of interests transaction, tax free to Arbor shareholders. The exchange ratio will be calculated by dividing an Arbor common stock price of $23 by an average closing price of the Company's common stock to be determined over a specified period prior to the Arbor shareholder meeting. For each share of Arbor common stock they own, Arbor shareholders will receive not less than 0.3182 shares of the Company's common stock and not more than 0.3660 shares of the Company's common stock.

The transaction is subject to approval by the shareholders of Arbor, expiration of the applicable Hart-Scott-Rodino waiting period and other customary closing conditions. Subject to satisfying applicable closing conditions, it is expected that the transaction will be completed by March 31, 1998.

17 SUPPLEMENTAL INFORMATION

Following are the components of amounts included in the consolidated balance sheets as of December 31:

IN MILLIONS                                                                                    1997       1996
-------------------------------------------------------------------------------------------  ---------  ---------
OTHER CURRENT ASSETS:
  Deferred income taxes....................................................................  $   302.2  $   154.7
  Other....................................................................................       52.4       42.1
                                                                                             ---------  ---------
                                                                                             $   354.6  $   196.8
                                                                                             ---------  ---------
PROPERTY AND EQUIPMENT:
  Land.....................................................................................  $    50.8  $    72.2
  Buildings and improvements...............................................................      206.2      226.9
  Fixtures and equipment...................................................................      860.5      787.5
  Leasehold improvements...................................................................      395.1      381.7
  Capital leases...........................................................................        3.3        3.3
                                                                                             ---------  ---------
                                                                                               1,515.9    1,471.6
  Accumulated depreciation and amortization..................................................   (557.7)    (506.1)
                                                                                             ---------  ---------
                                                                                             $   958.2  $   965.5
                                                                                             ---------  ---------
                                                                                             ---------  ---------
ACCRUED EXPENSES:
  CVS/Revco Restructuring reserves.........................................................  $   216.1  $   --
  CVS Strategic Restructuring Program reserves.............................................      102.8      245.9
  Taxes other than Federal income taxes....................................................      124.7      109.9
  Salaries and wages.......................................................................       96.1      131.8
  Rent.....................................................................................       76.3      124.9
  Other....................................................................................      549.7      394.6
                                                                                             ---------  ---------
                                                                                             $ 1,165.7  $ 1,007.1
                                                                                             ---------  ---------
                                                                                             ---------  ---------

Following is a summary of the Company's non-cash financing activities for the years ended December 31:

IN MILLIONS                                                                              1997       1996       1995
-------------------------------------------------------------------------------------  ---------  ---------  ---------
Fair value of assets acquired........................................................  $  --      $   423.2  $     4.8
Cash paid ...........................................................................     --          373.9        4.8
                                                                                       ---------  ---------  ---------
Liabilities assumed  ................................................................  $  --           49.3  $    --
                                                                                       ---------  ---------  ---------
Stock or notes received for divisions sold...........................................  $    52.0  $   172.4  $   175.0


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

18 RECONCILIATION OF EARNINGS PER COMMON SHARE

Following is a reconciliation of basic and diluted earnings per common share from continuing operations before extraordinary item for the years ended December 31:

-------------------------------------------------------------------------  -----------  -----------  -----------------
                                                                                                        PER COMMON
IN MILLIONS, EXCEPT PER SHARE AMOUNTS                                       EARNINGS      SHARES           SHARE
-------------------------------------------------------------------------  -----------  -----------  -----------------
1997:
Basic EPS:
  Earnings from continuing operations before extraordinary item.........        $37.3         --                --
  Preference dividends, net of tax benefit..............................        (13.7)        --                --
------------------------------------------------------------------------  -----------  -----------  -----------------
  Earnings from continuing operations available to common shareholders..    $    23.6        169.8       $    0.14
  Effect of dilutive securities:(1)
    Dilutive stock options..............................................           --          3.2              --
                                                                           -----------       -----           -----
DILUTED EPS:
  Earnings from continuing operations available to common shareholders.....   $    23.6        173.0       $    0.14
--------------------------------------------------------------------------  -----------  -----------  -----------------

1996:
Basic EPS:
  Earnings from continuing operations before extraordinary item............  $    340.8           --              --
  Preference dividends, net of tax benefit.................................       (14.5)         --               --
---------------------------------------------------------------------------  -----------  -----------  -----------------
  Earnings from continuing operations available to common shareholders.....   $   326.3        165.3       $    1.97
  Effect of dilutive securities:(1)
    Preference dividends, net of tax benefit...............................        14.5          5.9              --
    Dilutive earnings adjustments..........................................        (7.5)         --               --
    Dilutive stock options ................................................         --           2.0              --
---------------------------------------------------------------------------  -----------  -----------  -----------------
DILUTED EPS:
  Earnings from continuing operations available to common shareholders.....   $   333.3        173.2       $    1.92
---------------------------------------------------------------------------  -----------  -----------  -----------------
1995:
Basic EPS:
  Earnings from continuing operations before extraordinary item............   $    57.8          --               --
  Preference dividends, net of tax benefit.................................       (17.0)         --               --
---------------------------------------------------------------------------  -----------  -----------  -----------------
  Earnings from continuing operations available to common shareholders.....   $    40.8        163.7       $    0.25
  Effect of dilutive securities:(1)
    Dilutive stock options.................................................         --           0.6            --
---------------------------------------------------------------------------  -----------  -----------  -----------------
DILUTED EPS:
  Earnings from continuing operations available to common shareholders.....   $    40.8        164.3       $    0.25
---------------------------------------------------------------------------  -----------  -----------  -----------------


(1) See Note 2 for further information about earnings per common share.

29

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

19 QUARTERLY FINANCIAL INFORMATION

UNAUDITED; IN MILLIONS, EXCEPT PER SHARE AMOUNTS      1ST QUARTER    2ND QUARTER      3RD QUARTER      4TH QUARTER
------------------------------------------------     -------------  ---------------  ---------------  ---------------
Net sales:
1997..........................................    $  3,160.8      $   3,160.6      $   3,080.3      $   3,336.5
1996..........................................       2,558.2          2,674.7          2,638.1          3,073.8

Gross margin:
1997..........................................    $    900.1      $     806.4      $     839.5      $     893.7
1996..........................................         736.0            755.0            727.0            834.1
Earnings (loss) from continuing operations
  before extraordinary item:
1997..........................................    $     82.6          $(230.8)     $      74.7      $     110.8
1996..........................................          72.3            114.2             60.8             93.5
Net earnings (loss):
1997..........................................    $     82.7          $(230.5)     $      74.7      $     110.8
1996..........................................          46.0            (39.3)            79.6             90.3
Earnings (loss) per common share from
  continuing operations before extraordinary
  item:
1997:
  Basic.........................................  $     0.48           $(1.39)     $      0.41      $      0.62
  Diluted.......................................        0.47            (1.39)            0.41             0.61
1996:
  Basic.........................................        0.42             0.67             0.35             0.54
  Diluted.......................................        0.40             0.66             0.34             0.53
Net earnings (loss) per common share:
1997:
  Basic.........................................  $     0.48           $(1.39)     $      0.41      $      0.62
  Diluted.......................................        0.47            (1.39)            0.41             0.61
1996:
  Basic.........................................        0.26            (0.26)            0.46             0.52
  Diluted.......................................        0.25            (0.26)            0.45             0.51

20 MARKET INFORMATION

The Company's common stock is listed on the New York Stock Exchange. Its trading symbol is CVS. Information with respect to quarterly trading ranges (based on low/high sales prices), dividends per share and the number of record shareholders is as follows:

UNAUDITED                             1ST QUARTER        2ND QUARTER      3RD QUARTER      4TH QUARTER      YEAR
-----------------------------------  --------------    ---------------  ---------------  ---------------  ---------
Market price per share:(1)
1997...............................   $       39-$48    $44 1/4-$53 3/4    $  50 7/8-$60    $  54 5/8-$70   $   39-$70
1996...............................    27 1/4-36 3/8      35 1/4-44 1/2        36 5/8-46    36 3/8-44 3/4    27 1/4-46
Dividends paid per share:
1997...............................   $       0.11      $        0.11    $        0.11    $        0.11   $     0.44
1996...............................           0.11               0.11             0.11             0.11         0.44
Number of common shareholders:
1997...............................                                                                           10,200
1996(2)............................                                                                            5,700


(1) On October 12, 1996, the Company completed the Footstar Distribution. The stock prices shown in the above table are actual trading prices and do not reflect any adjustment for the when-issued price of Footstar prior to its October 16, 1996 commencement of trading on the New York Stock Exchange.

(2) The number of common shareholders has not been adjusted for the effect of the CVS/Revco Merger.


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

FIVE-YEAR FINANCIAL SUMMARY

--------------------------------------------------------------------------------------------------------------
IN MILLIONS, EXCEPT PER SHARE AMOUNTS                     1997        1996       1995       1994       1993
-----------------------------------------------------  ----------  ----------  ---------  ---------  ---------
RESULTS OF OPERATIONS:(3)
Net sales............................................  $ 12,738.2  $ 10,944.8  $ 9,763.4  $ 8,762.0  $ 6,452.2
Operating profit.....................................       199.8       540.8      230.7      376.3      284.9
Comparable operating profit(1).......................       717.5       553.6      445.7      376.3      284.9
Earnings from continuing operations before
  extraordinary item.................................        37.3       340.8       57.8      161.3      134.9
Comparable earnings from continuing operations before
  extraordinary item(2)..............................       380.1       275.2      184.7      161.3      134.9
Net earnings (loss)..................................        37.7       176.6     (572.8)     375.7      374.8
Net earnings (loss) available to common
  shareholders.......................................        24.0       162.1     (589.8)     358.7      358.0
Dividends declared...................................        82.2        68.6      184.3      185.4      184.9
--------------------------------------------------------------------------------------------------------------
PER COMMON SHARE:
Earnings from continuing operations before
  extraordinary item:
Basic................................................  $     0.14  $     1.97  $    0.25  $    0.89  $    0.79
Diluted..............................................        0.14        1.92       0.25       0.88       0.78
Comparable earnings from continuing operations before
  extraordinary item:(2)
Basic................................................        2.16        1.58       1.02       0.89       0.79
Diluted..............................................        2.12        1.55       1.02       0.88       0.78
Net earnings (loss):
Basic................................................        0.14        0.98      (3.60)      2.21       2.39
Diluted..............................................        0.14        0.98      (3.59)      2.20       2.38
Dividends............................................        0.44        0.44       1.52       1.52       1.52
--------------------------------------------------------------------------------------------------------------
FINANCIAL POSITION:
Total assets.........................................  $  5,636.9  $  5,693.7  $ 6,335.6  $ 6,885.3  $ 5,318.8
Current liabilities..................................     2,855.0     2,122.8    2,561.1    2,332.2    1,633.3
Total long-term obligations and redeemable preferred
  stock..............................................       274.1     1,254.6    1,092.6      991.4      565.9
--------------------------------------------------------------------------------------------------------------
PERCENTAGE OF NET SALES:
Operating profit.....................................         1.6%        4.9%       2.4%       4.3%       4.4%
Comparable operating profit(1).......................         5.6         5.1        4.6        4.3        4.4
Earnings from continuing operations before
  extraordinary item.................................         0.3         3.1        0.6        1.8        2.1
Comparable earnings from continuing operations before
  extraordinary item(2)..............................         3.0         2.5        1.9        1.8        2.1
Net earnings (loss)..................................         0.3         1.6       (5.9)       4.3        5.8
--------------------------------------------------------------------------------------------------------------


(1) Comparable operating profit excludes the pre-tax effect of the following non-recurring charges: (i) in 1997, $411.7 million ($273.7 million after-tax) related to the CVS/Revco Merger, $75.0 million ($49.9 million after-tax) related to the markdown of non-compatible Revco merchandise and $31.0 million ($19.1 million after-tax) related to the restructuring of Big B, Inc., (ii) in 1996, $12.8 million ($6.5 million after-tax) related to the failed merger of Rite Aid Corporation and Revco and (iii) in 1995, $165.5 million ($97.7 million after-tax) related to the CVS Strategic Restructuring Program and the early adoption of SFAS No. 121 and $49.5 million ($29.1 million after-tax) related to the Company changing its policy from capitalizing internally developed software cost to expensing the costs as incurred, outsourcing certain technology functions and retaining certain employees until their respective job functions were transitioned.

(2) Comparable earnings from continuing operations before extraordinary item and comparable earnings per common share from continuing operations before extraordinary item excludes the after-tax effect of the charges discussed in Note (1) above and the $121.4 million ($72.1 million after-tax) gain on sale of securities in 1996.

(3) Prior to the CVS/Revco Merger, Revco's fiscal year ended on the Saturday closest to May 31. In recording the business combination, Revco's consolidated financial statements have been restated to a December 31 year-end, to conform with CVS' fiscal year-end. As permitted by the rules and regulations of the Securities and Exchange Commission, Revco's fiscal years ended June 3, 1995 and May 28, 1994 have been combined with CVS' fiscal years ended December 31, 1994 and 1993.

31

EXHIBIT 21

SUBSIDIARIES OF THE REGISTRANT

As of December 31, 1997, CVS Corporation had the following significant subsidiaries:

CVS Center, Inc. (a New Hampshire corporation) CVS Pharmacy, Inc. (a Rhode Island corporation) Nashua Hollis CVS, Inc. (a New Hampshire corporation)(1) CVS Vanguard, Inc. (a Minnesota corporation) CVS New York, Inc. (a New York corporation, formerly Melville Corporation) CVS Revco D.S., Inc. (a Delaware corporation, formerly Revco D.S., Inc.) Revco Discount Drug Centers, Inc. (a Michigan corporation)(2) Hook-SupeRx, Inc. (a Delaware corporation)(3) Big B, Inc. (a Delaware corporation)(4)
PharmaCare Management Services, Inc. (a Delaware corporation)(5)
(1) Nashua Hollis CVS, Inc. is the immediate parent corporation of approximately 1,400 corporations that operate drugstores, all of which drugstores are in the United States. CVS of DC and VA, Inc. (formerly Peoples Drug Stores, Inc.), a direct subsidiary of Nashua Hollis CVS, Inc., is, in turn, the immediate parent of approximately 6 corporations that operate drugstores, all of which drugstores are in the United States.

(2) Revco Discount Drug Centers, Inc. (a Michigan corporation) is the immediate parent corporation of two corporations that operate drugstores, all of which drugstores are in the United States. Revco Discount Drug Centers, Inc. (an Ohio corporation), a direct subsidiary of Revco Discount Drug Centers, Inc. (a Michigan corporation) is, in turn, the immediate parent corporation of one corporation that operates drugstores, all of which drugstores are in the United States.

(3) Hook-SupeRx, Inc. is the immediate parent corporation of one corporation that operates drugstores, all of which drugstores are in the United States.

(4) Big B, Inc. is the immediate parent corporation of one corporation that operates drugstores, all of which drugstores are in the United States.

(5) PharmaCare Management Services, Inc., the Company's prescription benefits management subsidiary, is 95.8% owned by indirect subsidiaries of CVS Corporation. PharmaCare Management Services, Inc. is, in turn, the immediate parent corporation of PharmaCare Direct, Inc., a mail order pharmacy corporation.


EXHIBIT 23

CONSENT OF INDEPENDENT AUDITORS

The Board of Directors and Shareholders
of CVS Corporation:

We consent to incorporation by reference in the Registration Statements Numbers 33-40251, 33-17181, 2-97913, 2-77397, 2-53766, 333-34927, and 333-28043 on Form S-8 of CVS Corporation of our report dated February 9, 1998, relating to the consolidated balance sheets of CVS Corporation and subsidiaries as of December 31, 1997 and 1996, and the related consolidated statement of operations, shareholders' equity and cash flows for each of the years in the three-year period ended December 31, 1997, which report is incorporated by reference in the December 31, 1997 annual report on Form 10-K of CVS Corporation and to our report dated February 9, 1998 on the related financial statement schedule, which report appears in the December 31, 1997 annual report on Form 10-K of CVS Corporation.

/s/ KPMG PEAT MARWICK LLP
----------------------------
    KPMG PEAT MARWICK LLP

Providence, Rhode Island
March 27, 1998


ARTICLE 5
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED BALANCE SHEETS AND THE CONSOLIDATED STATEMENTS OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
MULTIPLIER: 1,000


PERIOD TYPE YEAR
FISCAL YEAR END DEC 31 1997
PERIOD START JAN 01 1997
PERIOD END DEC 31 1997
CASH 168,500
SECURITIES 0
RECEIVABLES 490,400
ALLOWANCES 38,000
INVENTORY 2,709,500
CURRENT ASSETS 3,685,000
PP&E 1,515,900
DEPRECIATION 557,700
TOTAL ASSETS 5,636,900
CURRENT LIABILITIES 2,855,000
BONDS 779,800
PREFERRED MANDATORY 0
PREFERRED 284,600
COMMON 1,800
OTHER SE 2,075,000
TOTAL LIABILITY AND EQUITY 5,636,900
SALES 12,738,200
TOTAL REVENUES 12,738,200
CGS 9,298,500
TOTAL COSTS 9,298,500
OTHER EXPENSES 3,239,900
LOSS PROVISION 7,300
INTEREST EXPENSE 44,800
INCOME PRETAX 155,000
INCOME TAX 117,700
INCOME CONTINUING 37,300
DISCONTINUED 17,500
EXTRAORDINARY (17,100)
CHANGES 0
NET INCOME 37,700
EPS PRIMARY 0.14
EPS DILUTED 0.14

ARTICLE 5
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED BALANCE SHEETS AND THE CONSOLIDATED STATEMENTS OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
RESTATED:
CIK: 0000064803
NAME: CVS CORPORATION
MULTIPLIER: 1,000


PERIOD TYPE YEAR
FISCAL YEAR END DEC 31 1996
PERIOD START JAN 01 1996
PERIOD END DEC 31 1996
CASH 471,800
SECURITIES 181,400
RECEIVABLES 386,700
ALLOWANCES 36,000
INVENTORY 2,328,100
CURRENT ASSETS 3,528,900
PP&E 1,471,600
DEPRECIATION 506,100
TOTAL ASSETS 5,693,700
CURRENT LIABILITIES 2,122,800
BONDS 1,184,300
PREFERRED MANDATORY 0
PREFERRED 298,600
COMMON 1,700
OTHER SE 1,896,100
TOTAL LIABILITY AND EQUITY 5,693,700
SALES 10,944,800
TOTAL REVENUES 10,944,800
CGS 7,892,700
TOTAL COSTS 7,892,700
OTHER EXPENSES 2,511,300
LOSS PROVISION 11,200
INTEREST EXPENSE 75,700
INCOME PRETAX 592,100
INCOME TAX 251,300
INCOME CONTINUING 340,800
DISCONTINUED (164,200)
EXTRAORDINARY 0
CHANGES 0
NET INCOME 176,600
EPS PRIMARY 0.98
EPS DILUTED 0.98

ARTICLE 5
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED BALANCE SHEETS AND THE CONSOLIDATED STATEMENTS OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
RESTATED:
CIK: 0000064803
NAME: CVS CORPORATION
MULTIPLIER: 1,000


PERIOD TYPE YEAR
FISCAL YEAR END DEC 31 1995
PERIOD START JAN 01 1995
PERIOD END DEC 31 1995
CASH 145,200
SECURITIES 176,900
RECEIVABLES 505,200
ALLOWANCES 58,600
INVENTORY 2,802,900
CURRENT ASSETS 3,878,800
PP&E 2,225,200
DEPRECIATION 737,200
TOTAL ASSETS 6,335,600
CURRENT LIABILITIES 2,561,100
BONDS 1,027,600
PREFERRED MANDATORY 1,300
PREFERRED 334,900
COMMON 170,800
OTHER SE 1,885,800
TOTAL LIABILITY AND EQUITY 6,335,600
SALES 9,763,400
TOTAL REVENUES 9,763,400
CGS 7,016,500
TOTAL COSTS 7,016,500
OTHER EXPENSES 2,516,200
LOSS PROVISION 43,600
INTEREST EXPENSE 114,500
INCOME PRETAX 116,200
INCOME TAX 58,400
INCOME CONTINUING 57,800
DISCONTINUED (630,600)
EXTRAORDINARY 0
CHANGES 0
NET INCOME (572,800)
EPS PRIMARY (3.60)
EPS DILUTED (3.59)